white f 66 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  1000  ml ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; buspirone  15  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; docusate sodium  100  mg ; senna  17.2  mg ; aspirin  325  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; cetirizine  10  mg ; 
streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation hemorrhage complicating a procedure depressive disorder, not elsewhere classified subarachnoid hemorrhage urinary tract infection, site not specified other constipation 
black african american f 51 $nan$nan$chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  223  k ul; hematology blood platelet count  229  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  176  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  3.2  g dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; hydralazine  50  mg ; isosorbide mononitrate  120  mg ; lisinopril  10  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; furosemide  10  mg ; ipratropium-albuterol neb  1  neb ; bag  1  bag ; magnesium sulfate  2  gm ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  111  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; hydralazine  50  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; furosemide  10  mg ; ipratropium-albuterol neb  1  neb ; bag  1  bag ; magnesium sulfate  2  gm ; lisinopril  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; hydralazine  25  mg ; hydralazine  10  mg ; albuterol 0.083% neb soln  1  neb ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  104  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; lisinopril  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; hydralazine  10  mg ; albuterol 0.083% neb soln  1  neb ; hydralazine  75  mg ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  109  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydralazine  100  mg ; lisinopril  40  mg ; enoxaparin sodium  80  mg ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  255  k ul$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydralazine  100  mg ; lisinopril  40  mg ; enoxaparin sodium  80  mg ; carvedilol  37.5  mg ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  106  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydralazine  100  mg ; enoxaparin sodium  80  mg ; carvedilol  50  mg ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
black african american f 51 $nan$nan$chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  81  mg ; atorvastatin  80  mg ; divalproex (extended release)  500  mg ; doxazosin  1  mg ; milk of magnesia  30  ml ; pantoprazole  40  mg ; risperidone  2  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydralazine  100  mg ; enoxaparin sodium  80  mg ; carvedilol  50  mg ; 
body mass index (bmi) 29.0-29.9, adult personal history of nicotine dependence unspecified asthma, uncomplicated long term (current) use of antithrombotics/antiplatelets anemia due to antineoplastic chemotherapy personal history of pulmonary embolism personal history of other diseases of the digestive system presence of functional implant, unspecified unspecified urinary incontinence personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits malignant neoplasm of stomach, unspecified personal history of other venous thrombosis and embolism mild intellectual disabilities schizoaffective disorder, unspecified hypertensive heart disease with heart failure secondary and unspecified malignant neoplasm of lymph nodes of multiple regions hyperlipidemia, unspecified type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral family history of ischemic heart disease and other diseases of the circulatory system bipolar disorder, unspecified cardiomyopathy, unspecified pericardial effusion (noninflammatory) unspecified systolic (congestive) heart failure personal history of diseases of the skin and subcutaneous tissue obesity, unspecified old myocardial infarction personal history of other diseases of the circulatory system malignant neoplasm of pyloric antrum encounter for antineoplastic chemotherapy other cardiomyopathies hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits secondary and unspecified malignant neoplasm of axilla and upper limb lymph nodes mild intellectual disabilities long term (current) use of antithrombotics/antiplatelets secondary and unspecified malignant neoplasm of intrathoracic lymph nodes personal history of nicotine dependence bipolar disorder, unspecified old myocardial infarction obesity, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral personal history of other venous thrombosis and embolism body mass index (bmi) 28.0-28.9, adult unspecified asthma, uncomplicated secondary malignant neoplasm of unspecified lung essential (primary) hypertension personal history of pulmonary embolism
white f 91 $nan$nan$lisinopril  5  mg ; levothyroxine sodium  100  mcg ; 
 
white f 91 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  59  mg dl$lisinopril  5  mg ; levothyroxine sodium  100  mcg ; 1 2 ns  1000  ml ; heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ciprofloxacin hcl  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white f 91 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  140  mg dl$lisinopril  5  mg ; levothyroxine sodium  100  mcg ; heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ciprofloxacin hcl  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; levothyroxine sodium  75  mcg ; prednisolone acetate 1% ophth. susp.  1  drop ; 
 
white f 91 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  123  mg dl$heparin  5000  unit ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; senna  1  tab ; insulin  0  unit ; levothyroxine sodium  75  mcg ; prednisolone acetate 1% ophth. susp.  1  drop ; oxybutynin  5  mg ; 
 
white f 79 $nan$hematology blood hematocrit  38.9  %; hematology blood hematocrit  38.1  %; hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  241  k ul; hematology blood platelet count  231  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  11.0  mg dl; chemistry blood calcium, total  10.4  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  106  mg dl; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  121  mg dl; blood gas blood glucose  164  mg dl; blood gas blood hematocrit, calculated  39  %; blood gas blood hematocrit, calculated  39  %; blood gas blood hemoglobin  13.1  g dl; blood gas blood hemoglobin  12.9  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  137  meq l$sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; heparin sodium  25,000  unit ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; d5ns  1000  ml ; carvedilol  12.5  mg ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  139  mg dl$sw  50  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; lr  1000  ml ; morphine sulfate  50  mg ; hydrocodone-acetaminophen  1-2  tab ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; magnesium sulfate  2  gm ; pneumococcal vac polyvalent  0.5  ml ; ondansetron  4  mg ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  155  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sw  50  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; morphine sulfate  50  mg ; hydrocodone-acetaminophen  1-2  tab ; heparin  5000  unit ; magnesium sulfate  2  gm ; pneumococcal vac polyvalent  0.5  ml ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; morphine sulfate  50  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; neutra-phos  2  pkt ; triamterene-hydrochlorothiazide  1  cap ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; morphine sulfate  50  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; albuterol 0.083% neb soln  1  neb ; neutra-phos  2  pkt ; triamterene-hydrochlorothiazide  1  cap ; lactulose  30  ml ; ciprofloxacin hcl  500  mg ; bisacodyl  10  mg ; diphenhydramine  25  mg ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; albuterol 0.083% neb soln  1  neb ; triamterene-hydrochlorothiazide  1  cap ; bisacodyl  10  mg ; diphenhydramine  25  mg ; warfarin  1  dose ; warfarin  5  mg ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; albuterol 0.083% neb soln  1  neb ; triamterene-hydrochlorothiazide  1  cap ; bisacodyl  10  mg ; warfarin  5  mg ; neutra-phos  1  pkt ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; albuterol 0.083% neb soln  1  neb ; triamterene-hydrochlorothiazide  1  cap ; bisacodyl  10  mg ; neutra-phos  1  pkt ; enoxaparin sodium  90  mg ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$hematology urine wbc  21-50  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; albuterol 0.083% neb soln  1  neb ; triamterene-hydrochlorothiazide  1  cap ; bisacodyl  10  mg ; enoxaparin sodium  90  mg ; guaifenesin-dextromethorphan  5  ml ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white f 79 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; lotemax  1  drop ; simvastatin  20  mg ; carvedilol  12.5  mg ; hydrocodone-acetaminophen  1-2  tab ; pneumococcal vac polyvalent  0.5  ml ; albuterol 0.083% neb soln  1  neb ; triamterene-hydrochlorothiazide  1  cap ; bisacodyl  10  mg ; enoxaparin sodium  90  mg ; guaifenesin-dextromethorphan  5  ml ; 
atherosclerosis of aorta malignant neoplasm of upper lobe, bronchus or lung other pulmonary embolism and infarction acute venous embolism and thrombosis of deep vessels of proximal lower extremity unspecified essential hypertension 
white m 71 $nan$hematology blood hematocrit  39.5  %; hematology blood hematocrit  39.2  %; hematology blood hematocrit  39.1  %; hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  292  k ul; hematology blood platelet count  277  k ul; hematology blood platelet count  231  k ul; hematology blood platelet count  183  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  2.7  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  77  mg dl; chemistry blood glucose  254  mg dl; chemistry blood glucose  324  mg dl; chemistry blood glucose  410  mg dl; chemistry blood glucose  367  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  6.4  mmol l; blood gas blood lactate  5.3  mmol l; blood gas blood lactate  4.7  mmol l; blood gas blood lactate  7.4  mmol l; blood gas blood lactate  4.2  mmol l; blood gas blood glucose  211  mg dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.6  meq l; hematology urine glucose  1000  mg dl$ns  100  ml ; influenza vaccine quadrivalent  0.5  ml ; lidocaine jelly 2% (glydo)  1  appl ; heparin  5000  unit ; rocuronium  100  mg ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; midazolam  100  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; epinephrine  2  mg ; cisatracurium besylate  100  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; metronidazole  500  mg ; ceftriaxone  1  gm ; albumin 5% (12.5g   250ml)  12.5  g ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  10  unit ; vial  1  vial ; pantoprazole  40  mg ; bag  1  bag ; magnesium sulfate  4  gm ; albumin 5% (12.5g   250ml)  25  g ; rocuronium  60  mg ; fentanyl citrate  25-50  mcg ; albuterol inhaler  6-8  puff ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tears gel 1%  2  drop ; epinephrine  8  mg ; norepinephrine  16  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; potassium chloride  40  meq ; cisatracurium besylate  200  mg ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; potassium chl 40 meq   1000 ml d5ns  1000  ml ; ceftriaxone  2  gm ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; buspirone  10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  34.2  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  134  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  206  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood glucose  196  mg dl; blood gas blood glucose  203  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; midazolam  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; albuterol inhaler  6-8  puff ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tears gel 1%  2  drop ; epinephrine  8  mg ; norepinephrine  16  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; cisatracurium besylate  200  mg ; sterile water  100  ml ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ceftriaxone  2  gm ; buspirone  10  mg ; metoprolol tartrate  5  mg ; sodium chloride 0.9%  flush  3-10  ml ; amiodarone  150  mg ; 0.9% nacl (excel viaflo bag)  250  ml ; amiodarone  450  mg ; acetaminophen iv  1000  mg ; insulin  0  unit ; 
 
white m 71 $nan$hematology blood hematocrit  34.6  %; hematology blood hematocrit  33.2  %; hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  125  k ul; hematology blood platelet count  160  k ul; hematology blood platelet count  147  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  221  mg dl; chemistry blood glucose  181  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  206  mg dl; blood gas blood glucose  202  mg dl; blood gas blood glucose  198  mg dl; blood gas blood glucose  195  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; albuterol inhaler  6-8  puff ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; artificial tears gel 1%  2  drop ; norepinephrine  16  mg ; cisatracurium besylate  200  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ceftriaxone  2  gm ; buspirone  10  mg ; metoprolol tartrate  5  mg ; amiodarone  150  mg ; 0.9% nacl (excel viaflo bag)  250  ml ; amiodarone  450  mg ; acetaminophen iv  1000  mg ; insulin  0  unit ; digoxin  0.25  mg ; propofol  1000  mg ; soln  100  ml ; 
 
white m 71 $nan$hematology blood hematocrit  29.9  %; hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  143  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  188  mg dl; chemistry blood glucose  184  mg dl; chemistry blood glucose  162  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood glucose  180  mg dl; blood gas blood glucose  169  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; albuterol inhaler  6-8  puff ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ceftriaxone  2  gm ; insulin  0  unit ; propofol  1000  mg ; soln  100  ml ; sodium phosphate  30  mmol ; aspirin  300  mg ; dexmedetomidine  0.4  mg ; quetiapine fumarate  25  mg ; senna  8.6  mg ; furosemide  20  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexmedetomidine  1  mg ; docusate sodium (liquid)  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  195  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  200  mg dl$influenza vaccine quadrivalent  0.5  ml ; 0.9% sodium chloride  100  ml ; vasopressin  40  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ceftriaxone  2  gm ; propofol  1000  mg ; soln  100  ml ; aspirin  300  mg ; quetiapine fumarate  25  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; dexmedetomidine  1  mg ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25-100  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; propofol  200  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
 
white m 71 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  214  k ul; hematology blood platelet count  239  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  228  mg dl; chemistry blood glucose  204  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.04  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  213  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; soln  100  ml ; aspirin  300  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25-100  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; propofol  200  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; bisacodyl  10  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; furosemide  40  mg ; 5% dextrose  40  ml ; quetiapine fumarate  50  mg ; albumin 25% (12.5g   50ml)  25  g ; lansoprazole oral disintegrating tab  30  mg ; 
 
white m 71 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  295  mg dl; chemistry blood glucose  300  mg dl; chemistry blood glucose  244  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood glucose  244  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; fentanyl citrate  25-100  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; propofol  200  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; vancomycin  1250  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; metoprolol tartrate  12.5  mg ; phosphorus  250  mg ; fluconazole  400  mg ; incruse ellipta  1  inh ; methylprednisolone sodium succ  40  mg ; 0.9% sodium chloride  50  ml ; ipratropium-albuterol neb  1  neb ; 
 
white m 71 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  262  k ul; hematology blood platelet count  291  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  189  mg dl; chemistry blood glucose  385  mg dl; blood gas blood free calcium  0.97  mmol l; blood gas blood glucose  362  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; vancomycin  1250  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; metoprolol tartrate  12.5  mg ; fluconazole  400  mg ; 0.9% sodium chloride  50  ml ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; prednisone  40  mg ; furosemide  80  mg ; metoprolol tartrate  25  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; ramelteon  8  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  285  k ul; hematology blood platelet count  444  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  244  mg dl; chemistry blood glucose  132  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  120  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  50  ml ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  25  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; ramelteon  8  mg ; phosphorus  500  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; lidocaine 2%  20  ml ; midazolam  1  mg ; propofol  30  mg ; ketamine  30  mg ; fentanyl citrate  50  mcg ; 
 
white m 71 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  292  mg dl; blood gas blood glucose  97  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  50  ml ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  25  mg ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; ramelteon  8  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; lidocaine 2%  20  ml ; midazolam  1  mg ; propofol  30  mg ; ketamine  30  mg ; fentanyl citrate  50  mcg ; metoprolol tartrate  37.5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  447  k ul; hematology blood platelet count  478  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  7  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  82  mg dl; blood gas blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  50  ml ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; ramelteon  8  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; 0.45% sodium chloride  1000  ml ; dextrose 5%  1000  ml ; 
 
white m 71 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  458  k ul; hematology blood platelet count  497  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  162  mg dl; chemistry urine sodium, urine  21  meq l; chemistry urine urea nitrogen, urine  1424  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  215  mg dl; chemistry blood glucose  185  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; ramelteon  8  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; d5lr  1000  ml ; quetiapine fumarate  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  490  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  241  mg dl; chemistry blood glucose  166  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetaminophen (liquid)  650  mg ; metoprolol tartrate  5-10  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; d5lr  1000  ml ; quetiapine fumarate  100  mg ; 
 
white m 71 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  520  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  144  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; quetiapine fumarate  50  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; quetiapine fumarate  100  mg ; sodium chloride 3% inhalation soln  15  ml ; 
 
white m 71 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  521  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  140  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; norepinephrine  16  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; oxycodone (immediate release)  5-10  mg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; phenylephrine  50  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; sodium chloride 3% inhalation soln  15  ml ; 
 
white m 71 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  515  k ul; hematology blood platelet count  423  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  126  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; neutra-phos  2  pkt ; guaifenesin  5-10  ml ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  115  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; quetiapine fumarate  12.5  mg ; insulin  15  unit ; 
 
white m 71 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  20  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  184  mg dl; chemistry blood glucose  147  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.8  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; quetiapine fumarate  12.5  mg ; insulin  15  unit ; trazodone  50  mg ; acetazolamide  250  mg ; insulin  25  unit ; 
 
white m 71 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  185  mg dl; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.6  mmol l$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; metoprolol tartrate  5-10  mg ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; quetiapine fumarate  12.5  mg ; trazodone  50  mg ; acetazolamide  250  mg ; insulin  25  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
 
white m 71 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  372  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  142  mg dl$iso-osmotic dextrose  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; metoprolol tartrate  37.5  mg ; insulin  25  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone liquid  5  mg ; metoprolol tartrate  50  mg ; phenazopyridine  200  mg ; 
 
white m 71 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  177  mg dl$iso-osmotic dextrose  50  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; insulin  25  unit ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone liquid  5  mg ; metoprolol tartrate  50  mg ; phenazopyridine  200  mg ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; 
 
white m 71 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  17  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  122  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; calcium gluconate  4  g ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; neutra-phos  2  pkt ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone liquid  5  mg ; metoprolol tartrate  50  mg ; phenazopyridine  200  mg ; ciprofloxacin hcl  500  mg ; insulin  8  unit ; insulin  6  unit ; meropenem  500  mg ; 
 
white m 71 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  136  mg dl; hematology blood bands  1  %$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; lansoprazole oral disintegrating tab  30  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; meropenem  500  mg ; olanzapine (disintegrating tablet)  5  mg ; trazodone  25  mg ; 
 
white m 71 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  147  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; meropenem  500  mg ; lidocaine 5% patch  2  ptch ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  157  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; maalox diphenhydramine lidocaine  15  ml ; levofloxacin  750  mg ; dextrose 5%  150  ml ; 
 
white m 71 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  167  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; maalox diphenhydramine lidocaine  15  ml ; dextrose 5%  150  ml ; chloraseptic throat spray  1  spry ; 
 
white m 71 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  122  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium (liquid)  100  mg ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; ipratropium-albuterol neb  1  neb ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; dextrose 5%  150  ml ; chloraseptic throat spray  1  spry ; acetaminophen  650  mg ; docusate sodium  100  mg ; furosemide  120  mg ; ranitidine  150  mg ; 
 
white m 71 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  131  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1800-3600  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; acetaminophen  650  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  131  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; acetaminophen  650  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 71 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  140  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 71 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  132  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; 
 
white m 71 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bisacodyl  10  mg ; aspirin  81  mg ; incruse ellipta  62.5  mcg ; polyethylene glycol  17  g ; acetylcysteine 20%  3-5  ml ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  50  mg ; insulin  6  unit ; lidocaine 5% patch  2  ptch ; docusate sodium  100  mg ; ranitidine  150  mg ; apixaban  10  mg ; acetaminophen  1000  mg ; lidocaine 5% patch  1  ptch ; 
 
white f 50 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; 
esophageal reflux other complications due to other vascular device, implant, and graft occlusion and stenosis of vertebral artery without mention of cerebral infarction obesity, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure stricture of artery aortocoronary bypass status atherosclerosis of other specified arteries other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication intermediate coronary syndrome coronary atherosclerosis of native coronary artery disturbance of skin sensation percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension coronary atherosclerosis of native coronary artery stricture of artery coronary atherosclerosis of autologous vein bypass graft other and unspecified hyperlipidemia acute myocardial infarction of unspecified site, subsequent episode of care intermediate coronary syndrome pneumococcal pneumonia [streptococcus pneumoniae pneumonia] congestive heart failure, unspecified cardiogenic shock anemia, unspecified automatic implantable cardiac defibrillator in situ acute respiratory failure acute myocardial infarction of other anterior wall, initial episode of care chronic airway obstruction, not elsewhere classified other complications due to other cardiac device, implant, and graft
white f 50 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  368  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  88  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; nicotine patch  14  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; carvedilol  3.125  mg ; senna  1  tab ; nicotine lozenge  2  mg ; furosemide  20  mg ; magnesium sulfate  2  gm ; atropine sulfate  0.5  mg ; 
esophageal reflux other complications due to other vascular device, implant, and graft occlusion and stenosis of vertebral artery without mention of cerebral infarction obesity, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure stricture of artery aortocoronary bypass status atherosclerosis of other specified arteries other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication intermediate coronary syndrome coronary atherosclerosis of native coronary artery disturbance of skin sensation percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension coronary atherosclerosis of native coronary artery stricture of artery coronary atherosclerosis of autologous vein bypass graft other and unspecified hyperlipidemia acute myocardial infarction of unspecified site, subsequent episode of care intermediate coronary syndrome pneumococcal pneumonia [streptococcus pneumoniae pneumonia] congestive heart failure, unspecified cardiogenic shock anemia, unspecified automatic implantable cardiac defibrillator in situ acute respiratory failure acute myocardial infarction of other anterior wall, initial episode of care chronic airway obstruction, not elsewhere classified other complications due to other cardiac device, implant, and graft
white f 50 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; carvedilol  3.125  mg ; senna  1  tab ; nicotine lozenge  2  mg ; furosemide  20  mg ; magnesium sulfate  2  gm ; atropine sulfate  0.5  mg ; 
esophageal reflux other complications due to other vascular device, implant, and graft occlusion and stenosis of vertebral artery without mention of cerebral infarction obesity, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure stricture of artery aortocoronary bypass status atherosclerosis of other specified arteries other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication intermediate coronary syndrome coronary atherosclerosis of native coronary artery disturbance of skin sensation percutaneous transluminal coronary angioplasty status chronic airway obstruction, not elsewhere classified tobacco use disorder unspecified essential hypertension coronary atherosclerosis of native coronary artery stricture of artery coronary atherosclerosis of autologous vein bypass graft other and unspecified hyperlipidemia acute myocardial infarction of unspecified site, subsequent episode of care intermediate coronary syndrome pneumococcal pneumonia [streptococcus pneumoniae pneumonia] congestive heart failure, unspecified cardiogenic shock anemia, unspecified automatic implantable cardiac defibrillator in situ acute respiratory failure acute myocardial infarction of other anterior wall, initial episode of care chronic airway obstruction, not elsewhere classified other complications due to other cardiac device, implant, and graft
white m 19 $temp  100.0  heartrate  90.0  resprate  16.0  o2sat  97.0  sbp  108.0  dbp  59.0  rhythm    pain    ; temp  98.6  heartrate  92.0  resprate  16.0  o2sat  98.0  sbp  106.0  dbp  68.0  rhythm    pain    ; temp  98.2  heartrate  81.0  resprate  16.0  o2sat  98.0  sbp  106.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  805  iu l; chemistry blood albumin  3.5  g dl; hematology blood bands  0  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; acetaminophen iv  1000  mg ; 
 
white m 19 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  1.0  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  854  iu l; hematology blood bands  1  %; chemistry blood bilirubin, direct  2.4  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; acetaminophen iv  1000  mg ; soln  100  ml ; cepastat (phenol) lozenge  1  loz ; ibuprofen  600  mg ; 
 
white m 19 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  832  iu l; hematology blood bands  0  %; chemistry blood bilirubin, direct  2.3  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; cepastat (phenol) lozenge  1  loz ; ibuprofen  600  mg ; oxymetazoline  1  spry ; guaifenesin-codeine phosphate  5  ml ; 
 
white m 19 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  804  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; cepastat (phenol) lozenge  1  loz ; ibuprofen  600  mg ; oxymetazoline  1  spry ; guaifenesin-codeine phosphate  5  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; chloraseptic throat spray  1  spry ; oseltamivir  75  mg ; 
 
white m 19 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; cepastat (phenol) lozenge  1  loz ; ibuprofen  600  mg ; oxymetazoline  1  spry ; chloraseptic throat spray  1  spry ; oseltamivir  75  mg ; acetaminophen  325  mg ; 
 
white m 19 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4-8  mg ; dextromethorphan poly complex  30  mg ; lorazepam  1  mg ; cepastat (phenol) lozenge  1  loz ; ibuprofen  600  mg ; chloraseptic throat spray  1  spry ; oseltamivir  75  mg ; acetaminophen  325  mg ; 
 
white f 48 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  147  mg dl; chemistry blood lactate dehydrogenase (ld)  105  iu l$hydromorphone (dilaudid)  0.25-0.5  mg ; influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; lactated ringers  1000  ml ; acetaminophen  325-650  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; cyclobenzaprine  5  mg ; duloxetine  30  mg ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  2  mg ; levothyroxine sodium  50  mcg ; loratadine  10  mg ; methadone  5  mg ; pantoprazole  40  mg ; pregabalin  25  mg ; hydromorphone (dilaudid)  0.25  mg ; heparin flush (10 units ml)  2  ml ; 
personal history of antineoplastic chemotherapy thrombocytopenia, unspecified other and unspecified hyperlipidemia tobacco use disorder hypoxemia large cell lymphoma, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism displacement of thoracic intervertebral disc without myelopathy common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other iatrogenic hypotension other opiates and related narcotics causing adverse effects in therapeutic use asthma, unspecified type, unspecified other chronic pain unspecified acquired hypothyroidism anxiety state, unspecified colostomy status acquired absence of intestine (large) (small) other malignant lymphomas, lymph nodes of multiple sites depressive disorder, not elsewhere classified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus backache, unspecified intestinal infection due to other organism, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pancytopenia hyposmolality and/or hyponatremia cyst of pharynx or nasopharynx other and unspecified diseases of the oral soft tissues asthma, unspecified type, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism personal history of antineoplastic chemotherapy rotator cuff (capsule) sprain systemic sclerosis tobacco use disorder common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other diseases of pharynx, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency personal history of tobacco use other chronic pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction
white f 48 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  148  mg dl; chemistry blood lactate dehydrogenase (ld)  126  iu l$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; lactated ringers  1000  ml ; acetaminophen  325-650  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; clonazepam  1  mg ; cyclobenzaprine  5  mg ; duloxetine  30  mg ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  2  mg ; levothyroxine sodium  50  mcg ; loratadine  10  mg ; methadone  5  mg ; pantoprazole  40  mg ; pregabalin  25  mg ; hydromorphone (dilaudid)  0.25  mg ; heparin flush (10 units ml)  2  ml ; moviprep  1  l ; magnesium citrate  300  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ondansetron  8  mg ; sterile water  100  ml ; potassium chloride  40  meq ; dicyclomine  20  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  1  mg ; bottle  500  ml ; gammagard s d  50  g ; bottle  1000  ml ; loperamide  2  mg ; 
personal history of antineoplastic chemotherapy thrombocytopenia, unspecified other and unspecified hyperlipidemia tobacco use disorder hypoxemia large cell lymphoma, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism displacement of thoracic intervertebral disc without myelopathy common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other iatrogenic hypotension other opiates and related narcotics causing adverse effects in therapeutic use asthma, unspecified type, unspecified other chronic pain unspecified acquired hypothyroidism anxiety state, unspecified colostomy status acquired absence of intestine (large) (small) other malignant lymphomas, lymph nodes of multiple sites depressive disorder, not elsewhere classified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus backache, unspecified intestinal infection due to other organism, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pancytopenia hyposmolality and/or hyponatremia cyst of pharynx or nasopharynx other and unspecified diseases of the oral soft tissues asthma, unspecified type, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism personal history of antineoplastic chemotherapy rotator cuff (capsule) sprain systemic sclerosis tobacco use disorder common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other diseases of pharynx, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency personal history of tobacco use other chronic pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction
white f 48 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  288  mg dl; chemistry blood lactate dehydrogenase (ld)  116  iu l; chemistry blood albumin  3.9  g dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; cyclobenzaprine  5  mg ; duloxetine  30  mg ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  2  mg ; levothyroxine sodium  50  mcg ; loratadine  10  mg ; methadone  5  mg ; pantoprazole  40  mg ; pregabalin  25  mg ; hydromorphone (dilaudid)  0.25  mg ; heparin flush (10 units ml)  2  ml ; magnesium citrate  300  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ondansetron  8  mg ; sterile water  100  ml ; potassium chloride  40  meq ; dicyclomine  20  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  1  mg ; bottle  1000  ml ; loperamide  2  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 
personal history of antineoplastic chemotherapy thrombocytopenia, unspecified other and unspecified hyperlipidemia tobacco use disorder hypoxemia large cell lymphoma, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism displacement of thoracic intervertebral disc without myelopathy common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other iatrogenic hypotension other opiates and related narcotics causing adverse effects in therapeutic use asthma, unspecified type, unspecified other chronic pain unspecified acquired hypothyroidism anxiety state, unspecified colostomy status acquired absence of intestine (large) (small) other malignant lymphomas, lymph nodes of multiple sites depressive disorder, not elsewhere classified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus backache, unspecified intestinal infection due to other organism, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pancytopenia hyposmolality and/or hyponatremia cyst of pharynx or nasopharynx other and unspecified diseases of the oral soft tissues asthma, unspecified type, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism personal history of antineoplastic chemotherapy rotator cuff (capsule) sprain systemic sclerosis tobacco use disorder common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other diseases of pharynx, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency personal history of tobacco use other chronic pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction
white f 48 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; cyclobenzaprine  5  mg ; duloxetine  30  mg ; fluticasone propionate 110mcg  2  puff ; hydromorphone (dilaudid)  2  mg ; levothyroxine sodium  50  mcg ; loratadine  10  mg ; methadone  5  mg ; pantoprazole  40  mg ; pregabalin  25  mg ; hydromorphone (dilaudid)  0.25  mg ; heparin flush (10 units ml)  2  ml ; magnesium citrate  300  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ondansetron  8  mg ; dicyclomine  20  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  1  mg ; loperamide  2  mg ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; 
personal history of antineoplastic chemotherapy thrombocytopenia, unspecified other and unspecified hyperlipidemia tobacco use disorder hypoxemia large cell lymphoma, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism displacement of thoracic intervertebral disc without myelopathy common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other iatrogenic hypotension other opiates and related narcotics causing adverse effects in therapeutic use asthma, unspecified type, unspecified other chronic pain unspecified acquired hypothyroidism anxiety state, unspecified colostomy status acquired absence of intestine (large) (small) other malignant lymphomas, lymph nodes of multiple sites depressive disorder, not elsewhere classified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus backache, unspecified intestinal infection due to other organism, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency unspecified car occupant injured in collision with heavy transport vehicle or bus in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other pancytopenia hyposmolality and/or hyponatremia cyst of pharynx or nasopharynx other and unspecified diseases of the oral soft tissues asthma, unspecified type, unspecified other malignant lymphomas, unspecified site, extranodal and solid organ sites unspecified acquired hypothyroidism personal history of antineoplastic chemotherapy rotator cuff (capsule) sprain systemic sclerosis tobacco use disorder common variable immunodeficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other diseases of pharynx, not elsewhere classified chronic obstructive asthma, unspecified common variable immunodeficiency personal history of tobacco use other chronic pain other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled peptic ulcer of unspecified site, unspecified as acute or chronic, without mention of hemorrhage or perforation, without mention of obstruction
white f 71 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  108  mg dl$acetaminophen  500-1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; lisinopril  2.5  mg ; atorvastatin  80  mg ; carvedilol  3.125  mg ; ranitidine  150  mg ; potassium chloride  40  meq ; pregabalin  75  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; torsemide  20  mg ; potassium chloride  60  meq ; potassium chloride  80  meq ; 
 
white f 71 $nan$nan$acetaminophen  500-1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; carvedilol  3.125  mg ; ranitidine  150  mg ; potassium chloride  40  meq ; pregabalin  75  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; torsemide  20  mg ; potassium chloride  60  meq ; potassium chloride  80  meq ; 
 
white f 40 $nan$nan$risperidone  1  mg ; 
unspecified psychosis 
white f 40 $nan$nan$risperidone  1  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; quetiapine fumarate  25  mg ; diazepam  2  mg ; quetiapine extended-release  200  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; quetiapine extended-release  200  mg ; lorazepam  1  mg ; haloperidol  2.5  mg ; haloperidol  5  mg ; quetiapine extended-release  400  mg ; benztropine mesylate  2  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; lorazepam  1  mg ; haloperidol  2.5  mg ; quetiapine extended-release  400  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; diazepam  2  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  600  mg ; quetiapine extended-release  800  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  800  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  800  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  800  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  800  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  2  mg ; quetiapine extended-release  800  mg ; benztropine mesylate  1  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; quetiapine extended-release  800  mg ; benztropine mesylate  1  mg ; senna  1  tab ; bisacodyl  5  mg ; haloperidol decanoate  100  mg ; docusate sodium  100  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; quetiapine extended-release  800  mg ; benztropine mesylate  1  mg ; senna  1  tab ; bisacodyl  5  mg ; haloperidol decanoate  100  mg ; docusate sodium  100  mg ; 
unspecified psychosis 
white f 40 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; quetiapine fumarate  25  mg ; benztropine mesylate  1  mg ; senna  1  tab ; bisacodyl  5  mg ; docusate sodium  100  mg ; 
unspecified psychosis 
white f 85 $nan$nan$vitamin d  800  unit ; levothyroxine sodium  25  mcg ; aspirin  325  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; timolol maleate 0.5%  1  drop ; 
 
white f 85 $nan$nan$vitamin d  800  unit ; levothyroxine sodium  25  mcg ; aspirin  325  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; timolol maleate 0.5%  1  drop ; senna  2  tab ; donepezil  5  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   2.5  mg ; heparin  5000  unit ; acetaminophen  500-1000  mg ; 
 
white f 52 $nan$nan$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white f 52 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  366  k ul; hematology blood platelet count  323  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  119  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  576  iu l$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  3-10  ml ; nicotine patch  14  mg ; fosaprepitant  150  mg ; ondansetron  8  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  24.5  ml ; doxorubicin  49  mg ; mesna  4900  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4900  mg ; sodium chloride 0.9%  1000  ml ; heparin flush (100 units ml)  5  ml ; lisinopril  30  mg ; heparin  5000  unit ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white f 52 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  105  mg dl$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; nicotine patch  14  mg ; fosaprepitant  150  mg ; ondansetron  8  mg ; 0.9% sodium chloride  150  ml ; dexamethasone sod phosphate  12  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  24.5  ml ; doxorubicin  49  mg ; mesna  4900  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4900  mg ; heparin flush (100 units ml)  5  ml ; lisinopril  30  mg ; heparin  5000  unit ; 0.9% sodium chloride  50  ml ; 5% dextrose  50  ml ; ondansetron  16  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white f 52 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  75  mg dl$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; nicotine patch  14  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  24.5  ml ; doxorubicin  49  mg ; mesna  4900  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4900  mg ; heparin flush (100 units ml)  5  ml ; lisinopril  30  mg ; heparin  5000  unit ; 5% dextrose  50  ml ; ondansetron  16  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white f 52 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  71  mg dl$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; nicotine patch  14  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; syringe (chemo)  24.5  ml ; doxorubicin  49  mg ; mesna  4900  mg ; 0.9% sodium chloride  1000  ml ; ifosfamide  4900  mg ; heparin flush (100 units ml)  5  ml ; lisinopril  30  mg ; heparin  5000  unit ; 5% dextrose  50  ml ; ondansetron  16  mg ; calcium carbonate  500  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mesna  1550  mg ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white f 52 $nan$nan$0.45% sodium chloride  1000  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; nicotine patch  14  mg ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; heparin flush (100 units ml)  5  ml ; lisinopril  30  mg ; heparin  5000  unit ; calcium carbonate  500  mg ; famotidine  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; mesna  1550  mg ; 
hypoxemia secondary malignant neoplasm of bladder malignant neoplasm of right fallopian tube abnormal uterine and vaginal bleeding, unspecified leiomyoma of uterus, unspecified secondary malignant neoplasm of large intestine and rectum other ascites secondary malignant neoplasm of small intestine neoplasm related pain (acute) (chronic) nicotine dependence, cigarettes, uncomplicated secondary malignant neoplasm of retroperitoneum and peritoneum acute posthemorrhagic anemia secondary malignant neoplasm of genital organs hemoperitoneum
white m 78 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  131  mg dl; chemistry blood lactate dehydrogenase (ld)  140  iu l; chemistry blood albumin  4.0  g dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  40  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  20  mg ; 
 
white m 78 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  40  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  20  mg ; 
 
white m 78 $nan$hematology blood hematocrit  42.2  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  107  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; acetaminophen  650  mg ; atorvastatin  40  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lisinopril  20  mg ; 
 
black african american m 22 $temp  98.2  heartrate  120.0  resprate  21.0  o2sat  99.0  sbp  137.0  dbp  82.0  rhythm    pain  5  ; temp  98.2  heartrate  117.0  resprate  20.0  o2sat  100.0  sbp  142.0  dbp  83.0  rhythm    pain  6  $hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  238  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  516  iu l$acyclovir  400  mg ; albuterol inhaler  1-2  puff ; alprazolam  0.5  mg ; gabapentin  100  mg ; ondansetron odt  4  mg ; oxycodone (immediate release)  10-20  mg ; oxycodone sr (oxycontin)  40  mg ; pantoprazole  40  mg ; prednisone  10  mg ; prednisone  2.5  mg ; senna  8.6  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sulfameth trimethoprim ss  1  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; oxycodone (immediate release)  5  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; multivitamins  1  tab ; vitamin d  2000  unit ; lorazepam  0.5  mg ; lamotrigine  100  mg ; ranitidine  150  mg ; 
pain in left wrist graft-versus-host disease, unspecified gastro-esophageal reflux disease without esophagitis unspecified asthma, uncomplicated osteomyelitis of vertebra, lumbar region chronic myeloid leukemia, bcr/abl-positive, not having achieved remission unspecified place or not applicable complications of stem cell transplant nicotine dependence, unspecified, uncomplicated major depressive disorder, single episode, unspecified neoplasm related pain (acute) (chronic) parainfluenza virus pneumonia adverse effect of antifungal antibiotics, systemically used, initial encounter anxiety disorder, unspecified unspecified injury of left wrist, hand and finger(s), subsequent encounter effusion, left wrist nonfamilial hypogammaglobulinemia exposure to other specified factors, subsequent encounter major depressive disorder, single episode, unspecified acute pulmonary manifestations due to radiation complications of stem cell transplant gastro-esophageal reflux disease without esophagitis chronic myeloid leukemia, bcr/abl-positive, in remission pericardial effusion (noninflammatory) anxiety disorder, unspecified acute graft-versus-host disease angioneurotic edema, initial encounter adverse effect of antifungal antibiotics, systemically used, initial encounter bronchopneumonia, unspecified organism adverse effect of glucocorticoids and synthetic analogues, initial encounter neutropenia, unspecified other pancytopenia pain in left foot drug-induced tremor fever presenting with conditions classified elsewhere oral mucositis (ulcerative) due to antineoplastic therapy bacteremia adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter gastro-esophageal reflux disease without esophagitis generalized skin eruption due to drugs and medicaments taken internally unspecified place in hospital as the place of occurrence of the external cause adjustment disorder with mixed anxiety and depressed mood adverse effect of antineoplastic and immunosuppressive drugs, initial encounter pain in right foot nausea localized skin eruption due to drugs and medicaments taken internally acute lymphoblastic leukemia, in remission diarrhea, unspecified
white m 36 $temp    heartrate  77.0  resprate  16.0  o2sat  97.0  sbp  114.0  dbp  77.0  rhythm    pain    ; temp  97.3  heartrate  96.0  resprate  16.0  o2sat  95.0  sbp  107.0  dbp  72.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl$influenza virus vaccine  0.5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; lithium carbonate  600  mg ; acetaminophen  325-650  mg ; ibuprofen  400-600  mg ; ibuprofen  600  mg ; lithium carbonate  900  mg ; 
 
white m 71 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; enoxaparin sodium  40  mg ; 
 
white m 71 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  299  k ul$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lorazepam  0.5  mg ; 
 
white m 71 $nan$hematology blood hematocrit  28.9  %$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; lorazepam  0.5  mg ; bisacodyl  10  mg ; 
 
white m 71 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  381  k ul$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; senna  1  tab ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; bisacodyl  10  mg ; calcium carbonate  500  mg ; chlorpromazine  25  mg ; tamsulosin  0.4  mg ; ranitidine  75  mg ; 
 
white f 91 $nan$nan$aspirin  325  mg ; 
 
white f 91 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  739  k ul; hematology blood platelet count  678  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  119  mg dl; blood gas blood lactate  1.0  mmol l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; heparin  5000  unit ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; propofol  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  500  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midazolam  0.5-2  mg ; albuterol inhaler  4  puff ; 
 
white f 91 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  638  k ul; hematology blood platelet count  558  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  162  mg dl; blood gas blood lactate  0.9  mmol l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; famotidine  20  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  500  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midazolam  0.5-2  mg ; albuterol inhaler  4  puff ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; cosyntropin  250  mcg ; 
 
white f 91 $nan$hematology blood hematocrit  25.6  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  518  k ul; hematology blood platelet count  496  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  221  mg dl; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.14  mmol l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midazolam  0.5-2  mg ; albuterol inhaler  4  puff ; cosyntropin  250  mcg ; 5% dextrose  150  ml ; vancomycin  500  mg ; quetiapine fumarate  25  mg ; furosemide  40  mg ; labetalol  5  mg ; senna  1  tab ; polyethylene glycol  17  g ; furosemide  20  mg ; 
 
white f 91 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  551  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  184  mg dl; blood gas blood free calcium  1.13  mmol l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; midazolam  0.5-2  mg ; albuterol inhaler  4  puff ; furosemide  40  mg ; labetalol  5  mg ; senna  1  tab ; polyethylene glycol  17  g ; furosemide  20  mg ; docusate  100  mg ; potassium chloride (powder)  20  meq ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; morphine sulfate  1  mg ; sodium phosphate  15  mmol ; ipratropium bromide mdi  4  puff ; 
 
white f 91 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  448  k ul; hematology blood platelet count  517  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  154  mg dl; chemistry blood glucose  126  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  0.8  mmol l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  4  puff ; senna  1  tab ; polyethylene glycol  17  g ; docusate  100  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; sodium phosphate  15  mmol ; ipratropium bromide mdi  4  puff ; furosemide  10  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; potassium chloride (powder)  40  meq ; prednisone  60  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; 
 
white f 91 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  205  mg dl; chemistry blood albumin  2.7  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood potassium, whole blood  3.9  meq l$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  4  puff ; senna  1  tab ; polyethylene glycol  17  g ; docusate  100  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; ipratropium bromide mdi  4  puff ; furosemide  10  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; potassium chloride (powder)  40  meq ; prednisone  60  mg ; 5% dextrose  100  ml ; furosemide  100  mg ; 
 
white f 91 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  106  mg dl$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  4  puff ; senna  1  tab ; polyethylene glycol  17  g ; docusate  100  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; ipratropium bromide mdi  4  puff ; prednisone  60  mg ; 
 
white f 91 $nan$hematology blood hematocrit  24.4  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  426  k ul; hematology blood platelet count  450  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  124  mg dl$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  4  puff ; senna  1  tab ; polyethylene glycol  17  g ; docusate  100  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; ipratropium bromide mdi  4  puff ; prednisone  60  mg ; neutra-phos  1  pkt ; vancomycin  750  mg ; morphine sulfate  100  mg ; lorazepam  2  mg ; 
 
white f 91 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  479  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  92  mg dl$iso-osmotic sodium chloride  50  ml ; aspirin  325  mg ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; soln  50  ml ; fentanyl citrate  2.5  mg ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; albuterol inhaler  4  puff ; senna  1  tab ; polyethylene glycol  17  g ; docusate  100  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; ipratropium bromide mdi  4  puff ; prednisone  60  mg ; neutra-phos  1  pkt ; vancomycin  750  mg ; morphine sulfate  100  mg ; lorazepam  2  mg ; metoprolol tartrate  12.5  mg ; scopolamine patch  1  ptch ; metoprolol tartrate  5  mg ; ipratropium bromide neb  1  neb ; 
 
white f 91 $nan$nan$iso-osmotic sodium chloride  50  ml ; sodium chloride 0.9%  flush  10  ml ; pneumococcal vac polyvalent  0.5  ml ; famotidine  20  mg ; albuterol inhaler  4  puff ; polyethylene glycol  17  g ; vancomycin  750  mg ; morphine sulfate  100  mg ; scopolamine patch  1  ptch ; ipratropium bromide neb  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
 
white m 63 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  212  k ul; hematology blood platelet count  213  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  86  mg dl; chemistry blood albumin  2.4  g dl; blood gas blood lactate  0.9  mmol l$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; morphine sulfate  2-4  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  1000  ml ; neutra-phos  2  pkt ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; methylprednisolone sodium succ  125  mg ; morphine sulfate  1-2  mg ; 
 
white m 63 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  1000  ml ; neutra-phos  2  pkt ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; methylprednisolone sodium succ  125  mg ; morphine sulfate  1-2  mg ; morphine sulfate  4  mg ; lorazepam  1  mg ; olanzapine (disintegrating tablet)  5  mg ; 
 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  650  mg ; heparin  5000  unit ; lidocaine 5% patch  1  ptch ; methylprednisolone sodium succ  125  mg ; olanzapine (disintegrating tablet)  5  mg ; morphine sulfate  2  mg ; furosemide  20  mg ; morphine sulfate (oral soln.)  5-10  mg ; methylprednisolone sodium succ  50  mg ; 
 
white m 63 $nan$nan$ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; olanzapine (disintegrating tablet)  5  mg ; methylprednisolone sodium succ  50  mg ; bisacodyl  10  mg ; 
 
white m 63 $nan$nan$ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; olanzapine (disintegrating tablet)  5  mg ; methylprednisolone sodium succ  50  mg ; bisacodyl  10  mg ; morphine sulfate  100  mg ; haloperidol  2  mg ; 
 
white m 63 $nan$nan$ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; methylprednisolone sodium succ  50  mg ; bisacodyl  10  mg ; morphine sulfate  100  mg ; haloperidol  2  mg ; 
 
white m 63 $nan$nan$ipratropium bromide neb  1  neb ; ondansetron  4-8  mg ; lidocaine 5% patch  1  ptch ; methylprednisolone sodium succ  50  mg ; bisacodyl  10  mg ; morphine sulfate  100  mg ; haloperidol  2  mg ; 
 
black african american m 92 $temp  99.6  heartrate  67.0  resprate  24.0  o2sat  99.0  sbp  106.0  dbp  93.0  rhythm    pain  0  $nan$warfarin  2.5  mg ; 
gout, unspecified chronic airway obstruction, not elsewhere classified unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia congestive heart failure, unspecified long-term (current) use of anticoagulants acute on chronic diastolic heart failure
black african american m 92 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  129  mg dl$warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; aspirin  325  mg ; carvedilol  3.125  mg ; fluticasone propionate 110mcg  2  puff ; pravastatin  40  mg ; valsartan  160  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; allopurinol  100  mg ; diltiazem extended-release  180  mg ; doxycycline hyclate  100  mg ; warfarin  5  mg ; furosemide  80  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
gout, unspecified chronic airway obstruction, not elsewhere classified unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia congestive heart failure, unspecified long-term (current) use of anticoagulants acute on chronic diastolic heart failure
black african american m 92 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  178  mg dl$warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; carvedilol  3.125  mg ; fluticasone propionate 110mcg  2  puff ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; allopurinol  100  mg ; diltiazem extended-release  180  mg ; warfarin  5  mg ; furosemide  80  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; aspirin  81  mg ; bumetanide  3  mg ; 
gout, unspecified chronic airway obstruction, not elsewhere classified unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia congestive heart failure, unspecified long-term (current) use of anticoagulants acute on chronic diastolic heart failure
black african american m 92 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  136  mg dl$warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; carvedilol  3.125  mg ; fluticasone propionate 110mcg  2  puff ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; allopurinol  100  mg ; warfarin  5  mg ; potassium chloride  40  meq ; aspirin  81  mg ; bumetanide  3  mg ; diltiazem extended-release  120  mg ; valsartan  80  mg ; 
gout, unspecified chronic airway obstruction, not elsewhere classified unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia congestive heart failure, unspecified long-term (current) use of anticoagulants acute on chronic diastolic heart failure
black african american m 92 $nan$nan$warfarin  2.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; carvedilol  3.125  mg ; fluticasone propionate 110mcg  2  puff ; pravastatin  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; allopurinol  100  mg ; warfarin  5  mg ; aspirin  81  mg ; bumetanide  3  mg ; diltiazem extended-release  120  mg ; valsartan  80  mg ; 
gout, unspecified chronic airway obstruction, not elsewhere classified unspecified essential hypertension atrial fibrillation other and unspecified hyperlipidemia congestive heart failure, unspecified long-term (current) use of anticoagulants acute on chronic diastolic heart failure
unknown m 39 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  31.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  137  k ul; hematology blood platelet count  101  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  8.9  mg dl; chemistry blood creatinine  9.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  148  mg dl; chemistry blood albumin  4.6  g dl$iso-osmotic dextrose  50  ml ; heparin  5000  unit ; mycophenolate mofetil  1000  mg ; cefazolin  2  g ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; 5 syringes (ns)  250  ml ; anti-thymocyte globulin (rabbit)  100  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; famotidine  20  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; metoprolol tartrate  5  mg ; nystatin oral suspension  5  ml ; docusate sodium  100  mg ; 
 
unknown m 39 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  125  mg dl$iso-osmotic dextrose  50  ml ; heparin  5000  unit ; mycophenolate mofetil  1000  mg ; cefazolin  2  g ; 0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; 5 syringes (ns)  250  ml ; anti-thymocyte globulin (rabbit)  100  mg ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; sulfameth trimethoprim ss  1  tab ; valganciclovir  450  mg ; famotidine  20  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; nystatin oral suspension  5  ml ; docusate sodium  100  mg ; methylprednisolone sodium succ  100  mg ; lamivudine  100  mg ; transplant self medication program  1  bag ; metoprolol tartrate  25  mg ; tacrolimus  2  mg ; metoprolol tartrate  75  mg ; 
 
unknown m 39 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  95  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  23  mg dl; hematology urine wbc  56  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  20  mg ; docusate sodium  100  mg ; methylprednisolone sodium succ  100  mg ; lamivudine  100  mg ; transplant self medication program  1  bag ; metoprolol tartrate  25  mg ; metoprolol tartrate  75  mg ; methylprednisolone sodium succ  50  mg ; lamivudine  25  mg ; sodium chloride 0.9%  1000  ml ; ciprofloxacin hcl  250  mg ; tacrolimus  4  mg ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; amlodipine  5  mg ; senna  8.6  mg ; 
 
unknown m 39 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  129  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; transplant self medication program  1  bag ; metoprolol tartrate  75  mg ; methylprednisolone sodium succ  50  mg ; lamivudine  25  mg ; tacrolimus  4  mg ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; amlodipine  5  mg ; senna  8.6  mg ; sarna lotion  1  appl ; amlodipine  10  mg ; phosphorus  500  mg ; bisacodyl  10  mg ; tacrolimus  1  mg ; tacrolimus  5  mg ; atorvastatin  10  mg ; 
 
unknown m 39 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  21  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  103  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; transplant self medication program  1  bag ; metoprolol tartrate  75  mg ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; sarna lotion  1  appl ; amlodipine  10  mg ; phosphorus  500  mg ; tacrolimus  1  mg ; tacrolimus  5  mg ; atorvastatin  10  mg ; prednisone  20  mg ; prednisone  5  mg ; lamivudine  50  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; phenazopyridine  100  mg ; tacrolimus  3  mg ; milk of magnesia  30  ml ; carvedilol  25  mg ; 
 
unknown m 39 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  97  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; transplant self medication program  1  bag ; levofloxacin  750  mg ; hydromorphone (dilaudid)  2-4  mg ; senna  8.6  mg ; sarna lotion  1  appl ; amlodipine  10  mg ; atorvastatin  10  mg ; prednisone  20  mg ; prednisone  5  mg ; lamivudine  50  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; phenazopyridine  100  mg ; tacrolimus  3  mg ; milk of magnesia  30  ml ; carvedilol  25  mg ; sodium chloride 0.9%  flush  3  ml ; lidocaine 1%  1  ml ; carvedilol  37.5  mg ; 
 
white m 24 $temp    heartrate  69.0  resprate  16.0  o2sat  100.0  sbp  139.0  dbp  47.0  rhythm    pain  2  ; temp    heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  117.0  dbp  67.0  rhythm    pain  1  ; temp    heartrate  70.0  resprate  18.0  o2sat  100.0  sbp  133.0  dbp  67.0  rhythm    pain  1  ; temp  98.0  heartrate  66.0  resprate  20.0  o2sat  98.0  sbp  129.0  dbp  52.0  rhythm    pain  sleeping  ; temp  97.4  heartrate  64.0  resprate  20.0  o2sat  97.0  sbp  124.0  dbp  54.0  rhythm    pain  sleeping  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  97.4  heartrate  57.0  resprate  16.0  o2sat  99.0  sbp  124.0  dbp  61.0  rhythm    pain  sleeping  ; temp  97.5  heartrate  68.0  resprate  18.0  o2sat  99.0  sbp  112.0  dbp  50.0  rhythm    pain  1  ; temp  97.3  heartrate  75.0  resprate  18.0  o2sat  95.0  sbp  117.0  dbp  59.0  rhythm    pain  1  $hematology blood hematocrit  45.3  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0  # hpf; chemistry blood glucose  89  mg dl$nan
intracerebral hemorrhage person boarding or alighting a pedal cycle injured in collision with fixed or stationary object tobacco use disorder family history of ischemic heart disease family history of other cardiovascular diseases 
white m 24 $temp    heartrate  75.0  resprate  18.0  o2sat  100.0  sbp  119.0  dbp  58.0  rhythm    pain  6  ; temp  97.5  heartrate  81.0  resprate  17.0  o2sat  100.0  sbp  106.0  dbp  58.0  rhythm    pain  4  $hematology blood hematocrit  42.4  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; clonazepam  1  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; senna  8.6  mg ; hydralazine  10  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   10  mg ; 
intracerebral hemorrhage person boarding or alighting a pedal cycle injured in collision with fixed or stationary object tobacco use disorder family history of ischemic heart disease family history of other cardiovascular diseases 
white m 24 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; clonazepam  1  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; senna  8.6  mg ; hydralazine  10  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   10  mg ; nicotine patch  21  mg ; 
intracerebral hemorrhage person boarding or alighting a pedal cycle injured in collision with fixed or stationary object tobacco use disorder family history of ischemic heart disease family history of other cardiovascular diseases 
black african american m 76 $temp  98.1  heartrate  125.0  resprate  28.0  o2sat  97.0  sbp  107.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  115.0  resprate  22.0  o2sat  98.0  sbp  122.0  dbp  80.0  rhythm    pain  0  ; temp  99.8  heartrate  109.0  resprate  21.0  o2sat  100.0  sbp  130.0  dbp  82.0  rhythm    pain  0  ; temp  97.5  heartrate  83.0  resprate  18.0  o2sat  100.0  sbp  132.0  dbp  77.0  rhythm    pain  0  ; temp  97.5  heartrate  78.0  resprate  16.0  o2sat  100.0  sbp  140.0  dbp  72.0  rhythm    pain  0  ; temp  97.4  heartrate  87.0  resprate  20.0  o2sat  100.0  sbp  140.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.9  g dl; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  106  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  268  mg dl; hematology blood bands  2  %; blood gas blood lactate  3.6  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood potassium, whole blood  4.8  meq l$nan
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
black african american m 76 $temp  97.5  heartrate  84.0  resprate  20.0  o2sat  99.0  sbp  133.0  dbp  77.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; mirtazapine  15  mg ; 
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
black african american m 76 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  407  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  6.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; mirtazapine  15  mg ; 
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
black african american m 76 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  471  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  146  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; mirtazapine  15  mg ; acetaminophen  325-650  mg ; 
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
black african american m 76 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  450  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; mirtazapine  15  mg ; acetaminophen  325-650  mg ; adenosine  6  mg ; sulfameth trimethoprim ds  1  tab ; 
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
black african american m 76 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  421  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; amlodipine  10  mg ; aspirin  81  mg ; atorvastatin  40  mg ; mirtazapine  15  mg ; acetaminophen  325-650  mg ; adenosine  6  mg ; sulfameth trimethoprim ds  1  tab ; neutra-phos  2  pkt ; 
other mechanical complication of other urinary catheter, initial encounter essential (primary) hypertension urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure resistance to other single specified antibiotic personal history of nicotine dependence tubulo-interstitial nephritis, not specified as acute or chronic unspecified place or not applicable infection and inflammatory reaction due to indwelling urinary catheter, initial encounter other retention of urine facial weakness following cerebral infarction hyperlipidemia, unspecified acute kidney failure, unspecified dehydration benign prostatic hyperplasia without lower urinary tract symptoms enterocolitis due to clostridium difficile other retention of urine acute kidney failure, unspecified medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure sepsis, unspecified organism essential (primary) hypertension hyperlipidemia, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system, initial encounter hyperkalemia unspecified place or not applicable nicotine dependence, unspecified, uncomplicated pulmonary collapse urinary tract infection, site not specified esophageal reflux unspecified protein-calorie malnutrition nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] other and unspecified hyperlipidemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) unspecified essential hypertension bacteremia other cystostomy other and unspecified escherichia coli [e. coli] diarrhea retention of urine, unspecified other and unspecified hyperlipidemia infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) other and unspecified escherichia coli [e. coli] personal history of tobacco use personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified essential hypertension
white m 84 $nan$nan$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
white m 84 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  83  mg dl; chemistry blood albumin  4.2  g dl; hematology blood bands  0  %; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; trazodone  50  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
white m 84 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  98  mg dl$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; lorazepam  1  mg ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; trazodone  50  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; diazepam  2  mg ; diazepam  1  mg ; morphine sulfate  4  mg ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
white m 84 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  101  mg dl$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; trazodone  50  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; diazepam  1  mg ; morphine sulfate  4  mg ; potassium chloride  20  meq ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
white m 84 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  79  mg dl$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; trazodone  50  mg ; levofloxacin  250  mg ; metronidazole (flagyl)  500  mg ; diazepam  1  mg ; potassium chloride  20  meq ; potassium chloride  60  meq ; vancomycin oral liquid  125  mg ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
white m 84 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  103  mg dl$folic acid  1  mg ; levothyroxine sodium  88  mcg ; nadolol  20  mg ; paroxetine  10  mg ; aspirin  325  mg ; thiamine  100  mg ; furosemide  20  mg ; lactulose  30  ml ; tamsulosin  0.4  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; pantoprazole  40  mg ; trazodone  50  mg ; levofloxacin  250  mg ; diazepam  1  mg ; potassium chloride  60  meq ; vancomycin oral liquid  125  mg ; 
unspecified acquired hypothyroidism personal history of venous thrombosis and embolism spontaneous bacterial peritonitis other ascites hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) malignant neoplasm of liver, primary diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled alcoholic cirrhosis of liver unspecified essential hypertension calculus of gallbladder without mention of cholecystitis, without mention of obstruction malignant neoplasm of liver, primary cirrhosis of liver without mention of alcohol unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled portal hypertension other chronic nonalcoholic liver disease intestinal infection due to clostridium difficile diseases of tricuspid valve hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) spontaneous bacterial peritonitis dehydration urinary frequency other ascites personal history of venous thrombosis and embolism spontaneous bacterial peritonitis hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) intestinal infection due to clostridium difficile alcoholic cirrhosis of liver diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled malignant neoplasm of liver, primary calculus of gallbladder without mention of cholecystitis, without mention of obstruction percutaneous transluminal coronary angioplasty status unspecified essential hypertension coronary atherosclerosis of native coronary artery unspecified acquired hypothyroidism 
black african american m 49 $temp  98.0  heartrate  71.0  resprate  15.0  o2sat  98.0  sbp  145.0  dbp  95.0  rhythm    pain  sleeping  $hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  110  mg dl$d5 1 2ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; ondansetron  8  mg ; 0.9% sodium chloride  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  1-2  mg ; readi-cat 2 (barium sulfate 2% suspension)  450  ml ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  153  mg dl; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  134  meq l$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  1  mg ; hydromorphone (dilaudid)  1-2  mg ; readi-cat 2 (barium sulfate 2% suspension)  450  ml ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; bag  100  ml ; magnesium sulfate  4  gm ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  89  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  1-2  mg ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; bag  100  ml ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10-20  ml ; lidocaine jelly 2% (urojet)  1  appl ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; lidocaine jelly 2% (urojet)  1  appl ; warfarin  5  mg ; magnesium sulfate  2  gm ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  70  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; magnesium sulfate  2  gm ; nicotine patch  7  mg ; bag  50  ml ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  113  k ul; hematology blood inr(pt)  1.1  $influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; creon 12  3  cap ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; nicotine patch  7  mg ; bag  50  ml ; creon 12  1  cap ; acetaminophen  1000  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood inr(pt)  1.6  $influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; heparin  4750  unit ; heparin  1200-2500  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; labetalol  200  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; nicotine patch  7  mg ; creon 12  1  cap ; acetaminophen  1000  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; enoxaparin sodium  60  mg ; oxycodone (immediate release)   5-10  mg ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
black african american m 49 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  192  mg dl$influenza virus vaccine  0.5  ml ; bisacodyl  10  mg ; calcium carbonate  500  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; senna  1  tab ; zolpidem tartrate  5  mg ; ondansetron  8  mg ; labetalol  200  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; nicotine patch  7  mg ; creon 12  1  cap ; 5% dextrose  50  ml ; clindamycin  600  mg ; enoxaparin sodium  60  mg ; oxycodone (immediate release)   5-10  mg ; 
chronic pancreatitis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure mechanical complication of other vascular device, implant, and graft chronic pancreatitis infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities acute pancreatitis unspecified essential hypertension tobacco use disorder acute pancreatitis pernicious anemia cyst and pseudocyst of pancreas other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure chronic pancreatitis constipation, unspecified thrombocytopenia, unspecified unspecified essential hypertension infection and inflammatory reaction due to other vascular device, implant, and graft phlebitis and thrombophlebitis of superficial veins of upper extremities disorders of magnesium metabolism tobacco use disorder pernicious anemia unspecified essential hypertension acute pancreatitis chronic pancreatitis acute kidney failure, unspecified acidosis alcohol abuse, in remission thrombocytopenia, unspecified pernicious anemia other and unspecified alcohol dependence, unspecified depressive disorder, not elsewhere classified thrombocytopenia, unspecified unspecified essential hypertension tobacco use disorder abdominal pain, right upper quadrant other chest pain contact dermatitis and other eczema, unspecified cause loss of weight nonspecific abnormal results of function study of kidney alcohol abuse, unspecified pernicious anemia unspecified essential hypertension fever, unspecified chronic pancreatitis other specified diseases of pancreas thrombocytopenia, unspecified thrombocytopenia, unspecified
white m 63 $nan$nan$aspirin  325  mg ; metoprolol xl (toprol xl)  200  mg ; lisinopril  40  mg ; simvastatin  40  mg ; allopurinol  100  mg ; citalopram hydrobromide  40  mg ; niacin sr  500  mg ; isosorbide mononitrate (extended release)  120  mg ; 
 
white m 63 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  105  mg dl$aspirin  325  mg ; metoprolol xl (toprol xl)  200  mg ; lisinopril  40  mg ; simvastatin  40  mg ; allopurinol  100  mg ; citalopram hydrobromide  40  mg ; niacin sr  500  mg ; isosorbide mononitrate (extended release)  120  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; acetaminophen  500-1000  mg ; senna  1  tab ; docusate sodium  100  mg ; clonazepam  1  mg ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; ranolazine  500  mg ; multivitamins  1  cap ; 
 
white m 63 $nan$nan$aspirin  325  mg ; metoprolol xl (toprol xl)  200  mg ; lisinopril  40  mg ; simvastatin  40  mg ; allopurinol  100  mg ; citalopram hydrobromide  40  mg ; niacin sr  500  mg ; isosorbide mononitrate (extended release)  120  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol  1-2  puff ; acetaminophen  500-1000  mg ; senna  1  tab ; docusate sodium  100  mg ; clonazepam  1  mg ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; ranolazine  500  mg ; multivitamins  1  cap ; 
 
black african american m 59 $temp  98.9  heartrate  103.0  resprate  16.0  o2sat  100.0  sbp  105.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  39.2  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  111  mg dl$5% dextrose  100  ml ; naloxone  2  mg ; d5 1 2ns  1000  ml ; brimonidine tartrate 0.15% ophth.  1  drop ; dorzolamide 2% timolol 0.5% ophth.  1  drop ; acetaminophen  325-650  mg ; citalopram  40  mg ; nicotine patch  14  mg ; buspirone  10  mg ; heparin  5000  unit ; 
 
white f 38 $nan$hematology urine wbc  6  # hpf$nan
 
white f 38 $temp  98.5  heartrate  85.0  resprate  16.0  o2sat    sbp  123.0  dbp  68.0  rhythm    pain  4  $hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  190  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  3.6  mg dl; chemistry blood glucose  165  mg dl; chemistry blood albumin  4.1  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; hydromorphone (dilaudid)  0.5  mg ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 38 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  121  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; acetaminophen iv  1000  mg ; 
 
white f 38 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  120  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; 
 
white f 38 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  4.1  g dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; ondansetron  4-8  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   5-10  mg ; omeprazole  20  mg ; 
 
white m 86 $nan$nan$amlodipine  10  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; metoprolol succinate xl  12.5  mg ; aspirin ec  325  mg ; 
coronary atherosclerosis of autologous vein bypass graft personal history of malignant neoplasm of prostate old myocardial infarction atrial fibrillation unspecified essential hypertension chronic total occlusion of coronary artery other and unspecified hyperlipidemia unspecified essential hypertension aortic valve disorders other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of prostate other complications due to other cardiac device, implant, and graft aortocoronary bypass status unspecified essential hypertension 
white m 86 $nan$hematology blood hematocrit  28.3  %; hematology blood platelet count  132  k ul; hematology blood platelet count  142  k ul; chemistry blood chloride  105  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl$amlodipine  10  mg ; clopidogrel  75  mg ; lisinopril  10  mg ; metoprolol succinate xl  12.5  mg ; aspirin ec  325  mg ; influenza virus vaccine  0.5  ml ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; d5 1 2ns  1000  ml ; atropine sulfate  0.5  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; niacin sr  500  mg ; 
coronary atherosclerosis of autologous vein bypass graft personal history of malignant neoplasm of prostate old myocardial infarction atrial fibrillation unspecified essential hypertension chronic total occlusion of coronary artery other and unspecified hyperlipidemia unspecified essential hypertension aortic valve disorders other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of prostate other complications due to other cardiac device, implant, and graft aortocoronary bypass status unspecified essential hypertension 
white m 86 $nan$nan$clopidogrel  75  mg ; lisinopril  10  mg ; metoprolol succinate xl  12.5  mg ; aspirin ec  325  mg ; nitroglycerin sl  0.3  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; atropine sulfate  0.5  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; niacin sr  500  mg ; 
coronary atherosclerosis of autologous vein bypass graft personal history of malignant neoplasm of prostate old myocardial infarction atrial fibrillation unspecified essential hypertension chronic total occlusion of coronary artery other and unspecified hyperlipidemia unspecified essential hypertension aortic valve disorders other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery personal history of malignant neoplasm of prostate other complications due to other cardiac device, implant, and graft aortocoronary bypass status unspecified essential hypertension 
asian f 56 $nan$hematology blood hematocrit  43.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; amoxicillin-clavulanic acid  875  mg ; chlorthalidone  25  mg ; guaifenesin-codeine phosphate  5-10  ml ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; 
pneumonia due to pseudomonas hypopotassemia unspecified essential hypertension asthma, unspecified type, unspecified acquired absence of both cervix and uterus personal history of tuberculosis unspecified acquired hypothyroidism bronchiectasis without acute exacerbation bronchiectasis without acute exacerbation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other chronic pulmonary heart diseases unspecified essential hypertension pneumonia, organism unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism 
asian f 56 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; amoxicillin-clavulanic acid  875  mg ; chlorthalidone  25  mg ; guaifenesin-codeine phosphate  5-10  ml ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; senna  8.6  mg ; 
pneumonia due to pseudomonas hypopotassemia unspecified essential hypertension asthma, unspecified type, unspecified acquired absence of both cervix and uterus personal history of tuberculosis unspecified acquired hypothyroidism bronchiectasis without acute exacerbation bronchiectasis without acute exacerbation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other chronic pulmonary heart diseases unspecified essential hypertension pneumonia, organism unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism 
asian f 56 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; amoxicillin-clavulanic acid  875  mg ; chlorthalidone  25  mg ; guaifenesin-codeine phosphate  5-10  ml ; levothyroxine sodium  100  mcg ; ipratropium-albuterol neb  1  neb ; senna  8.6  mg ; 
pneumonia due to pseudomonas hypopotassemia unspecified essential hypertension asthma, unspecified type, unspecified acquired absence of both cervix and uterus personal history of tuberculosis unspecified acquired hypothyroidism bronchiectasis without acute exacerbation bronchiectasis without acute exacerbation person boarding or alighting a pedal cycle injured in collision with pedestrian or animal other chronic pulmonary heart diseases unspecified essential hypertension pneumonia, organism unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism 
white f 92 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry urine creatinine, urine  36  mg dl; chemistry urine sodium, urine  36  meq l; chemistry urine urea nitrogen, urine  316  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  117  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$d5w  250  ml ; nitroglycerin  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; metoprolol tartrate  25  mg ; gabapentin  300  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; aspirin  325  mg ; simvastatin  10  mg ; isosorbide mononitrate (extended release)  30  mg ; tiotropium bromide  1  cap ; ferrous sulfate  325  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh disorder of bone and cartilage, unspecified coronary atherosclerosis of native coronary artery sciatica osteoporosis, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified unspecified hearing loss constipation, unspecified 
white f 92 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  33.3  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  432  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  3.4  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; metoprolol tartrate  25  mg ; gabapentin  300  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; aspirin  325  mg ; simvastatin  10  mg ; isosorbide mononitrate (extended release)  30  mg ; ferrous sulfate  325  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; metoprolol tartrate  50  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh disorder of bone and cartilage, unspecified coronary atherosclerosis of native coronary artery sciatica osteoporosis, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified unspecified hearing loss constipation, unspecified 
white f 92 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  443  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; gabapentin  300  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; aspirin  325  mg ; simvastatin  10  mg ; isosorbide mononitrate (extended release)  30  mg ; ferrous sulfate  325  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; metoprolol tartrate  50  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh disorder of bone and cartilage, unspecified coronary atherosclerosis of native coronary artery sciatica osteoporosis, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified unspecified hearing loss constipation, unspecified 
white f 92 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  489  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; gabapentin  300  mg ; heparin  5000  unit ; fluticasone-salmeterol (100 50)  1  inh ; aspirin  325  mg ; simvastatin  10  mg ; isosorbide mononitrate (extended release)  30  mg ; ferrous sulfate  325  mg ; docusate sodium  100  mg ; mirtazapine  15  mg ; metoprolol tartrate  50  mg ; lisinopril  5  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh disorder of bone and cartilage, unspecified coronary atherosclerosis of native coronary artery sciatica osteoporosis, unspecified unspecified essential hypertension depressive disorder, not elsewhere classified unspecified hearing loss constipation, unspecified 
other m 50 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  398  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  162  iu l$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; adefovir  10  mg ; 
cirrhosis of liver without mention of alcohol chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta malignant neoplasm of liver, primary 
other m 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone-acetaminophen  1-2  tab ; adefovir  10  mg ; 
cirrhosis of liver without mention of alcohol chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta malignant neoplasm of liver, primary 
white f 35 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  156  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; acetaminophen iv  1000  mg ; lorazepam  0.5  mg ; atenolol  12.5  mg ; ketorolac  15-30  mg ; 
 
white f 35 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; lorazepam  0.5  mg ; atenolol  12.5  mg ; ketorolac  15-30  mg ; simethicone  40-80  mg ; ondansetron  4-8  mg ; calcium carbonate  500  mg ; 
 
white f 35 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ibuprofen  600  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; atenolol  12.5  mg ; simethicone  40-80  mg ; ondansetron  4-8  mg ; calcium carbonate  500  mg ; 
 
black african american m 73 $temp  98.6  heartrate  66.0  resprate  14.0  o2sat  98.0  sbp  182.0  dbp  90.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0  ; temp  97.9  heartrate  64.0  resprate  18.0  o2sat  97.0  sbp  152.0  dbp  64.0  rhythm    pain  0  ; temp  98.0  heartrate  64.0  resprate  18.0  o2sat  96.0  sbp  154.0  dbp  69.0  rhythm    pain  0  ; temp    heartrate  65.0  resprate  20.0  o2sat  98.0  sbp  148.0  dbp  57.0  rhythm    pain  0  ; temp  97.8  heartrate  65.0  resprate  18.0  o2sat  96.0  sbp  142.0  dbp  63.0  rhythm    pain    ; temp    heartrate  73.0  resprate  18.0  o2sat  99.0  sbp  148.0  dbp  73.0  rhythm    pain  0  $hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  157  mg dl; chemistry blood albumin  4.3  g dl; blood gas blood lactate  1.3  mmol l$insulin  10  unit ; insulin  6  unit ; 
 
black african american m 73 $temp  98.2  heartrate  77.0  resprate  18.0  o2sat  100.0  sbp  165.0  dbp  74.0  rhythm    pain    $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  220  mg dl; chemistry blood % hemoglobin a1c  9.3  %$insulin  10  unit ; insulin  6  unit ; insulin  2  unit ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; insulin  0  unit ; metoprolol succinate xl  100  mg ; magnesium oxide  400  mg ; 
 
black african american m 73 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  164  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; aspirin  81  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; magnesium oxide  400  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; 
 
black african american m 73 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  217  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; 
 
black african american m 73 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; 
 
black african american m 73 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; 
 
black african american m 73 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  208  mg dl$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; sodium chloride 0.9%  flush  3-10  ml ; insulin  14  unit ; insulin  16  unit ; 
 
black african american m 73 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; sodium chloride 0.9%  flush  3-10  ml ; insulin  16  unit ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
black african american m 73 $nan$nan$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; atorvastatin  80  mg ; clopidogrel  75  mg ; amlodipine  5  mg ; losartan potassium  50  mg ; metoprolol succinate xl  100  mg ; ramelteon  8  mg ; cyanocobalamin  1000  mcg ; insulin  12  unit ; sodium chloride 0.9%  flush  3-10  ml ; insulin  16  unit ; latanoprost 0.005% ophth. soln.  1  drop ; 
 
other m 24 $temp  97.2  heartrate  74.0  resprate  18.0  o2sat  100.0  sbp  137.0  dbp  90.0  rhythm    pain  7  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  10  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  3  ; temp  98.1  heartrate  61.0  resprate  16.0  o2sat  99.0  sbp  133.0  dbp  71.0  rhythm    pain    ; temp  98.1  heartrate  65.0  resprate  16.0  o2sat  98.0  sbp  129.0  dbp  68.0  rhythm    pain  0  $nan$heparin  5000  unit ; 
 
other m 24 $temp  98.1  heartrate  75.0  resprate  17.0  o2sat  100.0  sbp  144.0  dbp  91.0  rhythm    pain  0  $nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.125  mg ; ibuprofen  800  mg ; 
 
other m 24 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; ibuprofen  800  mg ; 
 
other m 24 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.125  mg ; ibuprofen  800  mg ; 
 
white m 44 $nan$hematology blood hematocrit  40.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  104  mg dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  100  mg ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
 
white m 44 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  101  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  100  mg ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  2  bag ; magnesium sulfate  4  gm ; chloraseptic throat spray  1  spry ; 5% dextrose  100  ml ; 
 
white m 44 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  102  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bag  2  bag ; magnesium sulfate  4  gm ; chloraseptic throat spray  1  spry ; 5% dextrose  100  ml ; cepastat (phenol) lozenge  1  loz ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5  mg ; 
 
white m 44 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; chloraseptic throat spray  1  spry ; cepastat (phenol) lozenge  1  loz ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; morphine sulfate  1-5  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; calcium carbonate  500  mg ; omeprazole  20  mg ; 
 
white m 44 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; chloraseptic throat spray  1  spry ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; acetaminophen  1000  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; calcium carbonate  500  mg ; 
 
white m 71 $nan$nan$fluticasone propionate nasal  1  spry ; furosemide  40  mg ; losartan potassium  12.5  mg ; pravastatin  20  mg ; 
history of fall obesity, unspecified chronic combined systolic and diastolic heart failure atrial fibrillation congestive heart failure, unspecified other and unspecified hyperlipidemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh cardiac pacemaker in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified mild cognitive impairment, so stated other constipation retention of urine, unspecified chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status old myocardial infarction disorder of bone and cartilage, unspecified other specified forms of chronic ischemic heart disease atrial flutter atrial fibrillation other and unspecified hyperlipidemia chronic systolic heart failure long-term (current) use of anticoagulants antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter automatic implantable cardiac defibrillator in situ obesity, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status myoglobinuria congestive heart failure, unspecified abnormal involuntary movements lumbago chronic kidney disease, unspecified unspecified episodic mood disorder toxic myopathy acute on chronic combined systolic and diastolic heart failure chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery atrial flutter acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled ventricular fibrillation esophageal reflux
white m 71 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  2.8  ; hematology blood inr(pt)  1.7  ; chemistry urine chloride, urine  11  meq l; chemistry urine creatinine, urine  68  mg dl; chemistry urine potassium, urine  13  meq l; chemistry urine sodium, urine  24  meq l; chemistry urine urea nitrogen, urine  486  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl; chemistry urine calcium, urine  0.3  mg dl$fluticasone propionate nasal  1  spry ; furosemide  40  mg ; losartan potassium  12.5  mg ; pravastatin  20  mg ; influenza virus vaccine  0.5  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; oxycodone (immediate release)   5  mg ; phytonadione  5  mg ; 0.9% sodium chloride  1000  ml ; carbidopa-levodopa (25-100)  1  tab ; cyanocobalamin  25  mcg ; docusate sodium  100  mg ; carvedilol  25  mg ; trihexyphenidyl hcl  2  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; enoxaparin sodium  40  mg ; cyanocobalamin  1000  mcg ; 0.9% sodium chloride  500  ml ; 
history of fall obesity, unspecified chronic combined systolic and diastolic heart failure atrial fibrillation congestive heart failure, unspecified other and unspecified hyperlipidemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh cardiac pacemaker in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified mild cognitive impairment, so stated other constipation retention of urine, unspecified chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status old myocardial infarction disorder of bone and cartilage, unspecified other specified forms of chronic ischemic heart disease atrial flutter atrial fibrillation other and unspecified hyperlipidemia chronic systolic heart failure long-term (current) use of anticoagulants antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter automatic implantable cardiac defibrillator in situ obesity, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status myoglobinuria congestive heart failure, unspecified abnormal involuntary movements lumbago chronic kidney disease, unspecified unspecified episodic mood disorder toxic myopathy acute on chronic combined systolic and diastolic heart failure chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery atrial flutter acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled ventricular fibrillation esophageal reflux
white m 71 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood glucose  73  mg dl$fluticasone propionate nasal  1  spry ; furosemide  40  mg ; losartan potassium  12.5  mg ; pravastatin  20  mg ; influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; oxycodone (immediate release)   5  mg ; phytonadione  5  mg ; carbidopa-levodopa (25-100)  1  tab ; cyanocobalamin  25  mcg ; docusate sodium  100  mg ; carvedilol  25  mg ; trihexyphenidyl hcl  2  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; cyanocobalamin  1000  mcg ; 0.9% sodium chloride  500  ml ; carvedilol  12.5  mg ; ciprofloxacin hcl  250  mg ; 
history of fall obesity, unspecified chronic combined systolic and diastolic heart failure atrial fibrillation congestive heart failure, unspecified other and unspecified hyperlipidemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh cardiac pacemaker in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified mild cognitive impairment, so stated other constipation retention of urine, unspecified chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status old myocardial infarction disorder of bone and cartilage, unspecified other specified forms of chronic ischemic heart disease atrial flutter atrial fibrillation other and unspecified hyperlipidemia chronic systolic heart failure long-term (current) use of anticoagulants antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter automatic implantable cardiac defibrillator in situ obesity, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status myoglobinuria congestive heart failure, unspecified abnormal involuntary movements lumbago chronic kidney disease, unspecified unspecified episodic mood disorder toxic myopathy acute on chronic combined systolic and diastolic heart failure chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery atrial flutter acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled ventricular fibrillation esophageal reflux
white m 71 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  78  mg dl$fluticasone propionate nasal  1  spry ; furosemide  40  mg ; losartan potassium  12.5  mg ; pravastatin  20  mg ; influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; oxycodone (immediate release)   5  mg ; carbidopa-levodopa (25-100)  1  tab ; docusate sodium  100  mg ; trihexyphenidyl hcl  2  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; cyanocobalamin  1000  mcg ; carvedilol  12.5  mg ; ciprofloxacin hcl  250  mg ; 
history of fall obesity, unspecified chronic combined systolic and diastolic heart failure atrial fibrillation congestive heart failure, unspecified other and unspecified hyperlipidemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh cardiac pacemaker in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified mild cognitive impairment, so stated other constipation retention of urine, unspecified chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status old myocardial infarction disorder of bone and cartilage, unspecified other specified forms of chronic ischemic heart disease atrial flutter atrial fibrillation other and unspecified hyperlipidemia chronic systolic heart failure long-term (current) use of anticoagulants antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter automatic implantable cardiac defibrillator in situ obesity, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status myoglobinuria congestive heart failure, unspecified abnormal involuntary movements lumbago chronic kidney disease, unspecified unspecified episodic mood disorder toxic myopathy acute on chronic combined systolic and diastolic heart failure chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery atrial flutter acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled ventricular fibrillation esophageal reflux
white m 71 $nan$nan$fluticasone propionate nasal  1  spry ; furosemide  40  mg ; losartan potassium  12.5  mg ; pravastatin  20  mg ; influenza virus vaccine  0.5  ml ; morphine sulfate  2-4  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; senna  1  tab ; oxycodone (immediate release)   5  mg ; carbidopa-levodopa (25-100)  1  tab ; docusate sodium  100  mg ; trihexyphenidyl hcl  2  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; cyanocobalamin  1000  mcg ; carvedilol  12.5  mg ; warfarin  5  mg ; ciprofloxacin hcl  500  mg ; 
history of fall obesity, unspecified chronic combined systolic and diastolic heart failure atrial fibrillation congestive heart failure, unspecified other and unspecified hyperlipidemia osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh cardiac pacemaker in situ hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified anemia, unspecified mild cognitive impairment, so stated other constipation retention of urine, unspecified chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled aortocoronary bypass status old myocardial infarction disorder of bone and cartilage, unspecified other specified forms of chronic ischemic heart disease atrial flutter atrial fibrillation other and unspecified hyperlipidemia chronic systolic heart failure long-term (current) use of anticoagulants antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use old myocardial infarction diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter automatic implantable cardiac defibrillator in situ obesity, unspecified personal history of tobacco use hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status myoglobinuria congestive heart failure, unspecified abnormal involuntary movements lumbago chronic kidney disease, unspecified unspecified episodic mood disorder toxic myopathy acute on chronic combined systolic and diastolic heart failure chronic airway obstruction, not elsewhere classified coronary atherosclerosis of native coronary artery atrial flutter acute kidney failure, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled ventricular fibrillation esophageal reflux
white m 64 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  162  mg dl$simvastatin  20  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; hydrocodone-acetaminophen  1-2  tab ; ketorolac  15  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; zolpidem tartrate  5  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; 
 
white m 64 $nan$nan$simvastatin  20  mg ; lisinopril  5  mg ; sodium chloride 0.9%  flush  3  ml ; hydrocodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  100  mg ; zolpidem tartrate  5  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; tamsulosin  0.4  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 81 $temp  98.2  heartrate  95.0  resprate  16.0  o2sat    sbp  115.0  dbp  63.0  rhythm    pain  4 10  ; temp  98.3  heartrate  80.0  resprate  16.0  o2sat  96.0  sbp  116.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  205  mg dl$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; lidocaine viscous 2%  20  ml ; ibuprofen  600  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; 0.9% sodium chloride  1000  ml ; ketorolac  15  mg ; simethicone  40-80  mg ; 0.9% sodium chloride  500  ml ; 
long-term (current) use of antibiotics mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism mononeuritis of lower limb, unspecified arthropathy, unspecified, site unspecified fever, unspecified other musculoskeletal symptoms referable to limbs anxiety state, unspecified loss of weight diverticulitis of colon (without mention of hemorrhage) osteoporosis, unspecified mitral valve disorders unspecified acquired hypothyroidism pain in joint, pelvic region and thigh unspecified acquired hypothyroidism mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism osteoporosis, unspecified mitral valve disorders diverticulitis of colon (without mention of hemorrhage) anxiety state, unspecified unspecified acquired hypothyroidism constipation, unspecified nonspecific (abnormal) findings on radiological and other examination of biliary tract anxiety state, unspecified mitral valve disorders loss of weight anemia, unspecified herpes zoster with other nervous system complications osteoporosis, unspecified hypotension, unspecified diverticulitis of colon (without mention of hemorrhage) abdominal aneurysm without mention of rupture leukocytopenia, unspecified anxiety state, unspecified hypopotassemia urticaria, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism anemia, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism other constipation irritable bowel syndrome other malaise and fatigue microscopic hematuria
white f 81 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ibuprofen  600  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; ketorolac  15  mg ; simethicone  40-80  mg ; 0.9% sodium chloride  500  ml ; diazepam  5  mg ; maalox diphenhydramine lidocaine  15  ml ; omeprazole  20  mg ; 
long-term (current) use of antibiotics mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism mononeuritis of lower limb, unspecified arthropathy, unspecified, site unspecified fever, unspecified other musculoskeletal symptoms referable to limbs anxiety state, unspecified loss of weight diverticulitis of colon (without mention of hemorrhage) osteoporosis, unspecified mitral valve disorders unspecified acquired hypothyroidism pain in joint, pelvic region and thigh unspecified acquired hypothyroidism mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism osteoporosis, unspecified mitral valve disorders diverticulitis of colon (without mention of hemorrhage) anxiety state, unspecified unspecified acquired hypothyroidism constipation, unspecified nonspecific (abnormal) findings on radiological and other examination of biliary tract anxiety state, unspecified mitral valve disorders loss of weight anemia, unspecified herpes zoster with other nervous system complications osteoporosis, unspecified hypotension, unspecified diverticulitis of colon (without mention of hemorrhage) abdominal aneurysm without mention of rupture leukocytopenia, unspecified anxiety state, unspecified hypopotassemia urticaria, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism anemia, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism other constipation irritable bowel syndrome other malaise and fatigue microscopic hematuria
white f 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ibuprofen  600  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; simethicone  40-80  mg ; diazepam  5  mg ; maalox diphenhydramine lidocaine  15  ml ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride (powder)  60  meq ; sodium chloride nasal  1-2  spry ; 
long-term (current) use of antibiotics mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism mononeuritis of lower limb, unspecified arthropathy, unspecified, site unspecified fever, unspecified other musculoskeletal symptoms referable to limbs anxiety state, unspecified loss of weight diverticulitis of colon (without mention of hemorrhage) osteoporosis, unspecified mitral valve disorders unspecified acquired hypothyroidism pain in joint, pelvic region and thigh unspecified acquired hypothyroidism mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism osteoporosis, unspecified mitral valve disorders diverticulitis of colon (without mention of hemorrhage) anxiety state, unspecified unspecified acquired hypothyroidism constipation, unspecified nonspecific (abnormal) findings on radiological and other examination of biliary tract anxiety state, unspecified mitral valve disorders loss of weight anemia, unspecified herpes zoster with other nervous system complications osteoporosis, unspecified hypotension, unspecified diverticulitis of colon (without mention of hemorrhage) abdominal aneurysm without mention of rupture leukocytopenia, unspecified anxiety state, unspecified hypopotassemia urticaria, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism anemia, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism other constipation irritable bowel syndrome other malaise and fatigue microscopic hematuria
white f 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ibuprofen  600  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; simethicone  40-80  mg ; diazepam  5  mg ; maalox diphenhydramine lidocaine  15  ml ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride (powder)  60  meq ; sodium chloride nasal  1-2  spry ; fluconazole  100  mg ; 
long-term (current) use of antibiotics mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism mononeuritis of lower limb, unspecified arthropathy, unspecified, site unspecified fever, unspecified other musculoskeletal symptoms referable to limbs anxiety state, unspecified loss of weight diverticulitis of colon (without mention of hemorrhage) osteoporosis, unspecified mitral valve disorders unspecified acquired hypothyroidism pain in joint, pelvic region and thigh unspecified acquired hypothyroidism mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism osteoporosis, unspecified mitral valve disorders diverticulitis of colon (without mention of hemorrhage) anxiety state, unspecified unspecified acquired hypothyroidism constipation, unspecified nonspecific (abnormal) findings on radiological and other examination of biliary tract anxiety state, unspecified mitral valve disorders loss of weight anemia, unspecified herpes zoster with other nervous system complications osteoporosis, unspecified hypotension, unspecified diverticulitis of colon (without mention of hemorrhage) abdominal aneurysm without mention of rupture leukocytopenia, unspecified anxiety state, unspecified hypopotassemia urticaria, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism anemia, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism other constipation irritable bowel syndrome other malaise and fatigue microscopic hematuria
white f 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lidocaine viscous 2%  20  ml ; ibuprofen  600  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; levothyroxine sodium  88  mcg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; simethicone  40-80  mg ; diazepam  5  mg ; maalox diphenhydramine lidocaine  15  ml ; omeprazole  20  mg ; albuterol 0.083% neb soln  1  neb ; sodium chloride nasal  1-2  spry ; fluconazole  100  mg ; nysta  500,000  unit ; 
long-term (current) use of antibiotics mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism mononeuritis of lower limb, unspecified arthropathy, unspecified, site unspecified fever, unspecified other musculoskeletal symptoms referable to limbs anxiety state, unspecified loss of weight diverticulitis of colon (without mention of hemorrhage) osteoporosis, unspecified mitral valve disorders unspecified acquired hypothyroidism pain in joint, pelvic region and thigh unspecified acquired hypothyroidism mitral valve disorders diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism osteoporosis, unspecified mitral valve disorders diverticulitis of colon (without mention of hemorrhage) anxiety state, unspecified unspecified acquired hypothyroidism constipation, unspecified nonspecific (abnormal) findings on radiological and other examination of biliary tract anxiety state, unspecified mitral valve disorders loss of weight anemia, unspecified herpes zoster with other nervous system complications osteoporosis, unspecified hypotension, unspecified diverticulitis of colon (without mention of hemorrhage) abdominal aneurysm without mention of rupture leukocytopenia, unspecified anxiety state, unspecified hypopotassemia urticaria, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism anemia, unspecified diverticulitis of colon (without mention of hemorrhage) unspecified acquired hypothyroidism other constipation irritable bowel syndrome other malaise and fatigue microscopic hematuria
white f 78 $nan$nan$vitamin d  400  unit ; multivitamins  1  tab ; aspirin  325  mg ; 
chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal disaccharidase deficiencies and disaccharide malabsorption esophageal reflux chronic airway obstruction, not elsewhere classified bipolar disorder, unspecified sinoatrial node dysfunction 
white f 78 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$vitamin d  400  unit ; multivitamins  1  tab ; aspirin  325  mg ; oxycodone-acetaminophen  1  tab ; cephalexin  500  mg ; calcium carbonate  500  mg ; amlodipine  2.5  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lithium carbonate  300  mg ; ns  500  ml ; acetaminophen  325-650  mg ; lorazepam  0.5  mg ; pantoprazole  40  mg ; albuterol mdi  1  puff ; 
chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal disaccharidase deficiencies and disaccharide malabsorption esophageal reflux chronic airway obstruction, not elsewhere classified bipolar disorder, unspecified sinoatrial node dysfunction 
white f 78 $nan$nan$vitamin d  400  unit ; multivitamins  1  tab ; aspirin  325  mg ; cephalexin  500  mg ; calcium carbonate  500  mg ; amlodipine  2.5  mg ; docusate sodium  100  mg ; heparin  5000  unit ; lithium carbonate  300  mg ; ns  500  ml ; lorazepam  0.5  mg ; pantoprazole  40  mg ; albuterol mdi  1  puff ; 
chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified intestinal disaccharidase deficiencies and disaccharide malabsorption esophageal reflux chronic airway obstruction, not elsewhere classified bipolar disorder, unspecified sinoatrial node dysfunction 
white m 39 $temp  99.0  heartrate  123.0  resprate  17.0  o2sat  98.0  sbp  146.0  dbp  100.0  rhythm    pain  10  ; temp    heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  148.0  dbp  88.0  rhythm    pain  9  ; temp    heartrate  82.0  resprate  18.0  o2sat  98.0  sbp  125.0  dbp  68.0  rhythm    pain  8  ; temp    heartrate  60.0  resprate  9.0  o2sat  97.0  sbp  115.0  dbp  61.0  rhythm    pain  10  ; temp  97.8  heartrate  59.0  resprate  10.0  o2sat  96.0  sbp  111.0  dbp  55.0  rhythm    pain  8  ; temp  97.7  heartrate  66.0  resprate  16.0  o2sat  98.0  sbp  113.0  dbp  68.0  rhythm    pain    $hematology blood hematocrit  44.3  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  143  k ul; chemistry blood creatinine  1.0  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  0  # hpf$nan
fall from, out of or through roof, initial encounter arthrodesis status cervicalgia dorsalgia, unspecified nondisplaced fracture of base of fifth metacarpal bone, right hand, initial encounter for closed fracture unspecified place or not applicable
white m 73 $nan$nan$isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; aspirin ec  325  mg ; atorvastatin  80  mg ; ezetimibe  10  mg ; tricor  145  mg ; polyethylene glycol  17  g ; 
 
white m 73 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l; chemistry blood albumin  4.3  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; chemistry blood % hemoglobin a1c  6.7  %$isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; aspirin ec  325  mg ; atorvastatin  80  mg ; ezetimibe  10  mg ; tricor  145  mg ; polyethylene glycol  17  g ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.4  mg ; pramipexole  1  mg ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1  tab ; metoclopramide  5  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; tamsulosin  0.4  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  181  k ul; hematology blood inr(pt)  1.5  ; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood chloride, whole blood  100  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  121  mg dl; blood gas blood glucose  179  mg dl; blood gas blood glucose  167  mg dl; blood gas blood glucose  150  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  13.2  g dl; blood gas blood hemoglobin  10.2  g dl; blood gas blood hemoglobin  10.1  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  134  meq l$isosorbide mononitrate (extended release)  30  mg ; lisinopril  5  mg ; omeprazole  20  mg ; aspirin ec  325  mg ; atorvastatin  80  mg ; ezetimibe  10  mg ; tricor  145  mg ; polyethylene glycol  17  g ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.4  mg ; pramipexole  1  mg ; tramadol (ultram)  50  mg ; oxycodone-acetaminophen  1  tab ; metoclopramide  5  mg ; metoprolol tartrate  25  mg ; furosemide  20  mg ; tamsulosin  0.4  mg ; lorazepam  0.5-1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; aspirin  81  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  27.2  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  95  mg dl; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood glucose  121  mg dl; blood gas blood glucose  131  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.7  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  136  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sw  50  ml ; pneumococcal vac polyvalent  0.5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; pantoprazole  40  mg ; ketorolac  15  mg ; dexmedetomidine  0.4  mg ; meperidine  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; albuterol inhaler  8  puff ; albuterol-ipratropium  8  puff ; furosemide  40  mg ; atorvastatin  40  mg ; mirapex  1  mg ; aspirin  300  mg ; 
 
white m 73 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  91  mg dl; chemistry blood glucose  164  mg dl; chemistry blood lactate dehydrogenase (ld)  264  iu l; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.03  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  104  mg dl; blood gas blood glucose  135  mg dl; blood gas blood glucose  153  mg dl; blood gas blood glucose  131  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  3.7  meq l$sw  50  ml ; pneumococcal vac polyvalent  0.5  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin ec  81  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; vial  1  vial ; pantoprazole sodium  40  mg ; pantoprazole  40  mg ; ketorolac  15  mg ; dexmedetomidine  0.4  mg ; meperidine  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; albuterol inhaler  8  puff ; albuterol-ipratropium  8  puff ; furosemide  40  mg ; atorvastatin  40  mg ; mirapex  1  mg ; aspirin  300  mg ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; thiamine  100  mg ; amiodarone  150  mg ; d5w (excel bag)  250  ml ; amiodarone  600  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  101  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sw  50  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5.0  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; pantoprazole  40  mg ; docusate sodium  100  mg ; albuterol inhaler  8  puff ; albuterol-ipratropium  8  puff ; atorvastatin  40  mg ; mirapex  1  mg ; aspirin  300  mg ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; thiamine  100  mg ; amiodarone  150  mg ; d5w (excel bag)  250  ml ; amiodarone  600  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; diltiazem  10  mg ; diltiazem  15  mg ; metoprolol tartrate  5  mg ; lorazepam  0.25  mg ; folic acid  1  mg ; metoprolol tartrate  10  mg ; furosemide  100  mg ; furosemide  80  mg ; 
 
white m 73 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  137  mg dl$sw  50  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; docusate sodium  100  mg ; atorvastatin  40  mg ; mirapex  1  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; diltiazem  10  mg ; diltiazem  15  mg ; metoprolol tartrate  5  mg ; lorazepam  0.25  mg ; metoprolol tartrate  10  mg ; furosemide  100  mg ; furosemide  80  mg ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; 
 
white m 73 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  87  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood potassium, whole blood  3.4  meq l$sw  50  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; potassium chloride  20  meq ; calcium gluconate  2  g ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; oxycodone-acetaminophen  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; docusate sodium  100  mg ; atorvastatin  40  mg ; mirapex  1  mg ; heparin  5000  unit ; albuterol 0.083% neb soln  1  neb ; morphine sulfate  2-4  mg ; ranitidine  150  mg ; cepacol (menthol)  1  loz ; milk of magnesia  30  ml ; warfarin  1  dose ; furosemide  60  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; warfarin  4  mg ; amiodarone  400  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic sodium chloride  400  ml ; fluconazole  800  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; 
 
white m 73 $nan$hematology blood hematocrit  20.6  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  252  k ul; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.4  $pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; furosemide  60  mg ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; warfarin  4  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic sodium chloride  400  ml ; fluconazole  800  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; warfarin  5  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; furosemide  10  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood glucose  101  mg dl$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; warfarin  5  mg ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; furosemide  10  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  5.8  ; hematology blood inr(pt)  5.3  ; hematology blood inr(pt)  6.1  ; chemistry blood glucose  75  mg dl$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; bisacodyl  10  mg ; lorazepam  0.5  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; warfarin  0  mg ; glipizide xl  2.5  mg ; insulin  15  unit ; 
 
white m 73 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  365  k ul; hematology blood platelet count  376  k ul; hematology blood platelet count  410  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  3.4  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  6.7  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  271  iu l$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; bisacodyl  10  mg ; lorazepam  0.5  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; warfarin  0  mg ; nystatin oral suspension  5  ml ; phytonadione  10  mg ; 
 
white m 73 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  471  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  261  iu l; chemistry blood albumin  3.4  g dl; hematology blood bands  3  %$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; bisacodyl  10  mg ; lorazepam  0.5  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; iso-osmotic sodium chloride  200  ml ; fluconazole  400  mg ; nystatin oral suspension  5  ml ; phytonadione  10  mg ; warfarin  1  mg ; warfarin  2  mg ; diphenhydramine  25  mg ; 
 
white m 73 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; warfarin  1  dose ; bisacodyl  10  mg ; lorazepam  0.5  mg ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; diphenhydramine  25  mg ; 
 
white m 73 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  511  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  4.2  ; chemistry blood glucose  86  mg dl$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; bisacodyl  10  mg ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; fexofenadine  60  mg ; albumin 5% (12.5g   250ml)  12.5  g ; 
 
white m 73 $nan$hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.8  $pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; bisacodyl  10  mg ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; fexofenadine  60  mg ; albumin 5% (12.5g   250ml)  12.5  g ; diphenhydramine  12.5  mg ; 
 
white m 73 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; ranitidine  150  mg ; bisacodyl  10  mg ; metoprolol tartrate  12.5  mg ; ondansetron  4  mg ; qualaquin  324  mg ; heparin flush (10 units ml)  2  ml ; fexofenadine  60  mg ; diphenhydramine  12.5  mg ; 
 
white m 43 $nan$hematology blood hematocrit  19.5  %; hematology blood hematocrit  23.6  %; hematology blood hematocrit  27.4  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  24.4  %; hematology blood hematocrit  34.1  %; hematology blood hemoglobin  6.4  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  500  k ul; hematology blood platelet count  421  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  96  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  0.99  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  110  mg dl; blood gas blood glucose  112  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  9.8  g dl; blood gas blood hemoglobin  11.5  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  134  meq l$fentanyl citrate  25-100  mcg ; ondansetron  4  mg ; lr  1000  ml ; insulin  0  unit ; hydromorphone (dilaudid)  0.5-1  mg ; fentanyl citrate  50  mcg ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; d5 1 2ns  1000  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; 
 
white m 43 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  134  mg dl$insulin  0  unit ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  12.5  mg ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; 
 
white m 43 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  565  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  108  mg dl$insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; trazodone  25  mg ; haemophilus b conj. vaccine  0.5  ml ; meningococcal conj vaccine (menactra)  0.5  ml ; 
 
white m 43 $nan$nan$insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; trazodone  25  mg ; haemophilus b conj. vaccine  0.5  ml ; meningococcal conj vaccine (menactra)  0.5  ml ; 
 
white m 43 $nan$nan$insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; 
 
white m 43 $nan$nan$insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; 
 
white m 43 $nan$nan$insulin  0  unit ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; 
 
white m 43 $nan$nan$insulin  0  unit ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; trazodone  25  mg ; hydromorphone (dilaudid)  2-4  mg ; docusate sodium  100  mg ; 
 
other f 31 $nan$nan$oxazepam  15-30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nifedipine  10  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; fluticasone propionate 110mcg  2  puff ; cetir  10  mg ; rhinocort aqua  32  mcg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; 
 
other f 31 $nan$hematology blood hematocrit  37.9  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  219  k ul; hematology blood inr(pt)  0.9  $oxazepam  15-30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nifedipine  10  mg ; lactated ringers  1000  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; fluticasone propionate 110mcg  2  puff ; cetir  10  mg ; rhinocort aqua  32  mcg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  gm ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; amoxicillin  500  mg ; fluconazole  150  mg ; 
 
other f 31 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  255  k ul$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; amoxicillin  500  mg ; fluconazole  150  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; diphenhydramine  25  mg ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; 
 
other f 31 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; fluticasone propionate 110mcg  2  puff ; rhinocort aqua  32  mcg ; bisacodyl  10  mg ; cetiri  5  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; dibucaine  1  appl ; 
 
white f 66 $nan$nan$indapamide  1.25  mg ; 
 
white f 66 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  155  mg dl$indapamide  1.25  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; lamotrigine  100  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  1000  ml ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; senna  17.2  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; hydralazine  10  mg ; labetalol  5  mg ; ondansetron  4  mg ; morphine sulfate  1-2  mg ; hydralazine  10-20  mg ; ondansetron  4-8  mg ; metoclopramide  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; metoprolol tartrate  5-10  mg ; acetaminophen iv  1000  mg ; potassium chloride  20  meq ; atenolol  100  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; 
 
white f 66 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  233  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  123  mg dl$indapamide  1.25  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; lamotrigine  100  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  1000  ml ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; senna  17.2  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; morphine sulfate  1-2  mg ; ondansetron  4-8  mg ; metoclopramide  10-20  mg ; metoprolol tartrate  5-10  mg ; acetaminophen iv  1000  mg ; potassium chloride  20  meq ; atenolol  100  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  500  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoclopramide  10  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; atorvastatin  40  mg ; calcium carbonate  500  mg ; 
 
white f 66 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  106  mg dl$indapamide  1.25  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; lamotrigine  100  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; senna  17.2  mg ; morphine sulfate  1-2  mg ; ondansetron  4-8  mg ; potassium chloride  20  meq ; atenolol  100  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoclopramide  10  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; atorvastatin  40  mg ; calcium carbonate  500  mg ; potassium chloride (powder)  20  meq ; 
 
white f 66 $nan$nan$indapamide  1.25  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; lamotrigine  100  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; senna  17.2  mg ; morphine sulfate  1-2  mg ; ondansetron  4-8  mg ; potassium chloride  20  meq ; atenolol  100  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; metoclopramide  10  mg ; atorvastatin  40  mg ; calcium carbonate  500  mg ; potassium chloride (powder)  20  meq ; 
 
white m 36 $nan$hematology blood hematocrit  37.4  %; hematology blood hematocrit  38.6  %; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  168  mg dl; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  166  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hemoglobin  12.7  g dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood calculated bicarbonate, whole blood  28  meq l$bag  100  ml ; magnesium sulfate  4  gm ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; naloxone  0.4  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; propofol  1000  mg ; propofol  200  mg ; heparin  5000  unit ; cepacol (menthol)  1  loz ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 36 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  84  mg dl$bag  100  ml ; magnesium sulfate  4  gm ; ondansetron  4  mg ; naloxone  0.4  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; heparin  5000  unit ; cepacol (menthol)  1  loz ; acetaminophen iv  1000  mg ; acetaminophen  1000  mg ; bupropion (sustained release)  450  mg ; propranolol la  80  mg ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 36 $nan$nan$ondansetron  4  mg ; naloxone  0.4  mg ; diphenhydramine  25  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; metoprolol tartrate  5  mg ; heparin  5000  unit ; cepacol (menthol)  1  loz ; acetaminophen  1000  mg ; bupropion (sustained release)  450  mg ; propranolol la  80  mg ; trazodone  100  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.25  mg ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cepacol (menthol)  1  loz ; acetaminophen  1000  mg ; bupropion (sustained release)  450  mg ; propranolol la  80  mg ; trazodone  100  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; senna  1  tab ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cepacol (menthol)  1  loz ; acetaminophen  1000  mg ; bupropion (sustained release)  450  mg ; propranolol la  80  mg ; trazodone  100  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; senna  1  tab ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 36 $nan$nan$sodium chloride 0.9%  flush  3  ml ; cepacol (menthol)  1  loz ; acetaminophen  1000  mg ; bupropion (sustained release)  450  mg ; propranolol la  80  mg ; trazodone  100  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; senna  1  tab ; 
esophageal reflux marfan syndrome chest pain, unspecified peritoneal adhesions (postoperative) (postinfection) diaphragmatic hernia without mention of obstruction or gangrene surgical or other procedure not carried out because of contraindication depressive disorder, not elsewhere classified diaphragmatic hernia without mention of obstruction or gangrene marfan syndrome esophageal reflux pain in joint, shoulder region passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
black african american m 19 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
 
black african american m 19 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  5.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l$sodium chloride 0.9%  flush  3-10  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; acetaminophen  650  mg ; ibuprofen  600  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; oxycodone (immediate release)  5  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
 
black african american m 19 $nan$hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  6.3  mg dl; chemistry blood lactate dehydrogenase (ld)  249  iu l; chemistry blood albumin  4.2  g dl$sodium chloride 0.9%  flush  3-10  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ibuprofen  600  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; 
 
black african american m 19 $nan$hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  5.6  mg dl; chemistry blood lactate dehydrogenase (ld)  256  iu l$sodium chloride 0.9%  flush  3-10  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ibuprofen  600  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
 
black african american m 19 $nan$hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  4.5  mg dl; chemistry blood lactate dehydrogenase (ld)  253  iu l$sodium chloride 0.9%  flush  3-10  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ibuprofen  600  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
 
black african american m 19 $nan$hematology blood hematocrit  44.4  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  429  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.1  mg dl; chemistry blood bilirubin, total  3.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  242  iu l$sodium chloride 0.9%  flush  3-10  ml ; ondansetron odt  4  mg ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; ibuprofen  600  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
 
white f 27 $nan$hematology blood hematocrit  19.3  %; hematology blood hematocrit  17.9  %; hematology blood hematocrit  20.6  %; hematology blood hematocrit  21.8  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.3  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  17  k ul; hematology blood platelet count  16  k ul; hematology blood platelet count  37  k ul; hematology blood platelet count  47  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  106  mg dl; hematology blood bands  0  %; hematology blood bands  0  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; acetaminophen  500  mg ; sodium chloride 0.9%  1000  ml ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; atovaquone suspension  1500  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; diphenhydramine  25  mg ; hydrocortisone na succ.  50  mg ; ipratropium bromide neb  1  neb ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$hematology blood hematocrit  19.6  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  48  k ul; hematology blood platelet count  67  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  97  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  0  %; hematology blood bands  3  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; acetaminophen  500  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; diphenhydramine  25  mg ; hydrocortisone na succ.  50  mg ; ipratropium bromide neb  1  neb ; fluconazole  200  mg ; furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  480  mcg ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  93  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  134  iu l; chemistry blood albumin  3.9  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  200  mg ; furosemide  20  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  480  mcg ; docusate sodium  100  mg ; senna  8.6  mg ; caphosol  30  ml ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  169  iu l; chemistry blood albumin  4.0  g dl; hematology blood bands  4  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  200  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  480  mcg ; docusate sodium  100  mg ; senna  8.6  mg ; caphosol  30  ml ; lidocaine 2%  10  ml ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  71  mg dl; chemistry blood lactate dehydrogenase (ld)  249  iu l; hematology blood bands  0  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  200  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; filgrastim  480  mcg ; docusate sodium  100  mg ; senna  8.6  mg ; caphosol  30  ml ; lidocaine 2%  10  ml ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  455  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  71  mg dl; chemistry blood lactate dehydrogenase (ld)  297  iu l; chemistry blood albumin  4.3  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; zolpidem tartrate  5  mg ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  200  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; caphosol  30  ml ; trazodone  25  mg ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
white f 27 $nan$nan$sodium chloride 0.9%  flush  10  ml ; oxycodone (immediate release)   10  mg ; mupirocin ointment 2%  1  appl ; lorazepam  0.5  mg ; dextroamphetamine  20  mg ; acyclovir  400  mg ; albuterol inhaler  2  puff ; vitamin d  1000  unit ; venlafaxine xr  150  mg ; omeprazole  20  mg ; folic acid  1  mg ; multivitamins  1  tab ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; sterile water  200  ml ; potassium chloride  80  meq ; fluconazole  200  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; caphosol  30  ml ; trazodone  25  mg ; allopurinol  300  mg ; 
tobacco use disorder encounter for antineoplastic chemotherapy other fluid overload personal history of venous thrombosis and embolism other specified diseases of hair and hair follicles obesity, unspecified body mass index 40.0-44.9, adult anxiety state, unspecified tachycardia, unspecified attention deficit disorder with hyperactivity depressive disorder, not elsewhere classified headache asthma, unspecified type, unspecified acute lymphoid leukemia, in relapse cellulitis and abscess of face tobacco use disorder unspecified essential hypertension nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute lymphoid leukemia, in relapse dysthymic disorder obesity, unspecified body mass index 40.0-44.9, adult car passenger injured in collision with van in traffic accident personal history of venous thrombosis and embolism aseptic necrosis of bone, other anemia in neoplastic disease thrombocytopenia, unspecified dental caries, unspecified other specified diseases of hair and hair follicles neutropenia, unspecified headache abdominal pain, unspecified site hip joint replacement solitary cyst of breast asthma, unspecified type, unspecified long-term (current) use of antibiotics car passenger injured in collision with van in traffic accident adrenal cortical steroids causing adverse effects in therapeutic use hip joint replacement obesity, unspecified anxiety state, unspecified depressive disorder, not elsewhere classified other specified cardiac dysrhythmias personal history of venous thrombosis and embolism aseptic necrosis of head and neck of femur obstructive sleep apnea (adult)(pediatric) body mass index 39.0-39.9, adult personal history of antineoplastic chemotherapy
black african american m 61 $temp    heartrate  129.0  resprate    o2sat  95.0  sbp  139.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  40.3  %; hematology blood hematocrit  38.1  %; hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  320  k ul; hematology blood platelet count  269  k ul; hematology blood platelet count  269  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  210  mg dl; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  2.1  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; docusate sodium  100  mg ; gabapentin  300  mg ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  1000  ml ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
black african american m 61 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  151  mg dl; blood gas blood lactate  2.3  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; docusate sodium  100  mg ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium (liquid)  100  mg ; d5 1 2ns  1000  ml ; 0.45% sodium chloride  1000  ml ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
black african american m 61 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  123  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; docusate sodium (liquid)  100  mg ; 0.45% sodium chloride  1000  ml ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
black african american m 61 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  114  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; docusate sodium (liquid)  100  mg ; 0.45% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; acetaminophen (liquid)  650  mg ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
black african american m 61 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  149  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; docusate sodium (liquid)  100  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; acetaminophen (liquid)  650  mg ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
black african american m 61 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; artificial tears  1-2  drop ; guaifenesin-dextromethorphan  10  ml ; senna  17.2  mg ; loratadine  10  mg ; guaifenesin er  600  mg ; multivitamins  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; docusate sodium (liquid)  100  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; acetaminophen (liquid)  650  mg ; 
osteoporosis, unspecified dementia, unspecified, without behavioral disturbance acute and chronic cholecystitis laparoscopic surgical procedure converted to open procedure malignant neoplasm of prostate neurogenic bladder nos obstructive sleep apnea (adult)(pediatric) esophageal reflux multiple sclerosis dementia, unspecified, without behavioral disturbance personal history of pneumonia (recurrent) personal history, urinary (tract) infection wheelchair dependence person on outside of bus injured in collision with pedestrian or animal in traffic accident aphasia anemia of other chronic disease leukocytosis, unspecified quadriplegia, unspecified multiple sclerosis esophageal reflux neurogenic bladder nos severe sepsis obstructive sleep apnea (adult)(pediatric) polyneuropathy in diabetes unspecified septicemia malignant neoplasm of prostate diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled calculus of gallbladder with acute cholecystitis, with obstruction osteoporosis, unspecified unspecified car occupant injured in collision with other nonmotor vehicle in nontraffic accident examination of participant in clinical trial obesity, unspecified do not resuscitate status mononeuritis of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified malignant neoplasm of prostate multiple sclerosis pneumonitis due to inhalation of food or vomitus neurogenic bladder nos long-term (current) use of insulin obstructive sleep apnea (adult)(pediatric) hyperosmolality and/or hypernatremia unspecified septicemia esophageal reflux osteoporosis, unspecified anemia, unspecified dementia, unspecified, without behavioral disturbance
white f 59 $nan$nan$insulin  50  unit ; isosorbide mononitrate (extended release)  30  mg ; metoprolol succinate xl  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; 
other chronic pulmonary heart diseases diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled chronic combined systolic and diastolic heart failure long-term (current) use of insulin peripheral vascular disease, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy other and unspecified hyperlipidemia polyneuropathy in diabetes congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) other primary cardiomyopathies acute osteomyelitis, ankle and foot polyneuropathy in diabetes arthropathy associated with neurological disorders long-term (current) use of insulin chronic kidney disease, unspecified diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot unspecified acquired hypothyroidism other bone involvement in diseases classified elsewhere hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction
white f 59 $nan$hematology blood hematocrit  31.2  %; hematology blood platelet count  248  k ul; hematology blood platelet count  247  k ul; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  28  mg dl$insulin  50  unit ; isosorbide mononitrate (extended release)  30  mg ; metoprolol succinate xl  100  mg ; aspirin  325  mg ; clopidogrel  75  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydralazine  37.5  mg ; 1 2 ns  1000  ml ; atropine sulfate  0.5  mg ; insulin  0  unit ; acetylcysteine 20%  600  mg ; acetylcysteine  600  mg ; atorvastatin  40  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; 
other chronic pulmonary heart diseases diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled chronic combined systolic and diastolic heart failure long-term (current) use of insulin peripheral vascular disease, unspecified unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified coronary atherosclerosis of native coronary artery diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy other and unspecified hyperlipidemia polyneuropathy in diabetes congestive heart failure, unspecified chronic kidney disease, stage iii (moderate) other primary cardiomyopathies acute osteomyelitis, ankle and foot polyneuropathy in diabetes arthropathy associated with neurological disorders long-term (current) use of insulin chronic kidney disease, unspecified diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy atherosclerosis of native arteries of the extremities with ulceration diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled urinary tract infection, site not specified diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled ulcer of other part of foot unspecified acquired hypothyroidism other bone involvement in diseases classified elsewhere hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified occlusion and stenosis of multiple and bilateral precerebral arteries without mention of cerebral infarction
hispanic latino f 58 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; heparin  5000  unit ; lopinavir-ritonavir  1  tab ; aspirin  325  mg ; emtricitabine-tenofovir (truvada)  1  tab ; 
 
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  120  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; diltiazem  30  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  135  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; diltiazem  30  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; magnesium sulfate  4  gm ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  143  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; diltiazem  30  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; magnesium sulfate  4  gm ; morphine sulfate  2  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; potassium chloride  40  meq ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  146  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; diltiazem  30  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; morphine sulfate  2  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; potassium chloride  40  meq ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; 0.9% sodium chloride  500  ml ; lidocaine 1%  1  ml ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; lidocaine 1%  1  ml ; diazepam  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  3  ml ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  42.5  %; hematology blood hematocrit  26.0  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  13.9  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  77  k ul; hematology blood platelet count  55  k ul; hematology blood platelet count  55  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  2.5  g dl; chemistry blood bilirubin, direct  0.3  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; heparin flush (10 units ml)  3  ml ; triamcinolone acetonide 0.1% cream  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  50  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  355  iu l; chemistry blood lactate dehydrogenase (ld)  342  iu l$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  335  iu l$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; syringe  2  ml ; alteplase (catheter clearance)  1  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  76  k ul; hematology blood inr(pt)  1.2  ; chemistry blood lactate dehydrogenase (ld)  280  iu l; hematology blood bands  1  %$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; syringe  2  ml ; alteplase (catheter clearance)  1  mg ; calcium carbonate  500  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  91  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  258  iu l$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; pantoprazole  40  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  116  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  120  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; enoxaparin sodium  40  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; lidocaine jelly 2% (urojet)  1  appl ; metoprolol tartrate  5  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  125  k ul; hematology blood platelet count  123  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  108  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  159  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  110  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  107  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; sw  50  ml ; magnesium sulfate  2  gm ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  105  mg dl$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; sw  50  ml ; magnesium sulfate  2  gm ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  188  k ul$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.1  g dl$sw  100  ml ; fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  118  mg dl$sw  100  ml ; fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  235  k ul$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diltiazem  60  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; ferrous sulfate  325  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; ferrous sulfate  325  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 43 $nan$nan$fluoxetine  40  mg ; nicotine patch  21  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  4  mg ; quetiapine fumarate  25  mg ; senna  1  tab ; gabapentin  300  mg ; acetaminophen  1000  mg ; fentanyl patch  50  mcg hr ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; daptomycin  700  mg ; diazepam  5  mg ; triamcinolone acetonide 0.1% cream  1  appl ; calcium carbonate  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; omeprazole  40  mg ; ferrous sulfate  325  mg ; 
sinoatrial node dysfunction paroxysmal supraventricular tachycardia acute kidney failure with lesion of tubular necrosis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation acute kidney failure, unspecified infection and inflammatory reaction due to internal joint prosthesis personal history of noncompliance with medical treatment, presenting hazards to health thrombocytopenia, unspecified unspecified osteomyelitis, pelvic region and thigh methicillin resistant staphylococcus aureus septicemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation tobacco use disorder antisocial personality disorder cocaine dependence, continuous opioid type dependence, episodic sepsis car passenger injured in collision with van in traffic accident hip joint replacement pyogenic arthritis, pelvic region and thigh accidents occurring in other specified places depressive disorder, not elsewhere classified tobacco use disorder osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh alcohol abuse, continuous drug-induced mood disorder cannabis abuse, continuous opioid type dependence, continuous cocaine dependence, continuous unspecified disturbance of conduct other chronic pain suicide and self-inflicted poisoning by other specified drugs and medicinal substances depressive disorder, not elsewhere classified suicide and self-inflicted injury by cutting and piercing instrument hypovolemia injury to radial blood vessels home accidents other and unspecified alcohol dependence, unspecified cocaine dependence, continuous poisoning by other specified central nervous system stimulants poisoning by aromatic analgesics, not elsewhere classified suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics acute kidney failure, unspecified injury to other specified nerve(s) acute posthemorrhagic anemia
white m 27 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; adderall xr  10  mg ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 27 $nan$chemistry blood bilirubin, total  0.9  mg dl; chemistry blood albumin  5.1  g dl$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; carbamazepine  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 27 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; carbamazepine  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 27 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 27 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 27 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; hydroxyzine  25  mg ; thiamine  100  mg ; folic acid  1  mg ; multivitamins  1  tab ; 
suicidal ideation depressive disorder, not elsewhere classified
white m 68 $temp    heartrate  101.0  resprate  22.0  o2sat  93.0  sbp  105.0  dbp  75.0  rhythm    pain    ; temp  99.4  heartrate  100.0  resprate  20.0  o2sat  93.0  sbp  115.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  102  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; acetaminophen  1000  mg ; acetaminophen iv  1000  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  92  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; acetaminophen iv  1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; tamsulosin  0.4  mg ; omeprazole  20  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  117  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; acetaminophen iv  1000  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; tamsulosin  0.4  mg ; omeprazole  20  mg ; acetaminophen-caff-butalbital  1-2  tab ; ondansetron  4  mg ; lisinopril  40  mg ; morphine sulfate  1-3  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  104  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; morphine sulfate  1-3  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; lisinopril  20  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; morphine sulfate  1-3  mg ; lisinopril  20  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; lactated ringers  1000  ml ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  2  g ; lisinopril  20  mg ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; metoprolol succinate xl  50  mg ; amino acids 4.25%-dextrose 5%  1000  ml ; sw  400  ml ; potassium chloride  40  meq ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  416  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  225  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  50  mg ; amino acids 4.25%-dextrose 5%  1000  ml ; sw  400  ml ; potassium chloride  40  meq ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; d5ns  1000  ml ; potassium chl 40 meq   1000 ml d5ns  1000  ml ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  421  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  104  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; potassium chl 40 meq   1000 ml d5ns  1000  ml ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; aspirin  81  mg ; atorvastatin  80  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white m 68 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; metoprolol succinate xl  50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; aspirin  81  mg ; atorvastatin  80  mg ; 
esophageal reflux unspecified essential hypertension percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery backache, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia old myocardial infarction personal history of tobacco use rash and other nonspecific skin eruption sciatica chest pain, unspecified anemia, unspecified percutaneous transluminal coronary angioplasty status other postprocedural status intervertebral disc disorder with myelopathy, lumbar region personal history of tobacco use unspecified essential hypertension depressive disorder, not elsewhere classified old myocardial infarction other and unspecified hyperlipidemia esophageal reflux depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery depressive disorder, not elsewhere classified unspecified essential hypertension esophageal reflux subendocardial infarction, initial episode of care sciatica coronary atherosclerosis of native coronary artery esophageal reflux other and unspecified noninfectious gastroenteritis and colitis depressive disorder, not elsewhere classified other vitamin b12 deficiency anemia unspecified hereditary and idiopathic peripheral neuropathy unspecified essential hypertension diaphragmatic hernia without mention of obstruction or gangrene depressive disorder, not elsewhere classified esophageal reflux unspecified essential hypertension
white f 56 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  7  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  4  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  7  $nan$clonazepam  0.5  mg ; senna  1  tab ; multivitamins  1  cap ; amlodipine  10  mg ; fluticasone propionate nasal  1  spry ; aspirin  81  mg ; omeprazole  20  mg ; amlodipine  5  mg ; simvastatin  20  mg ; docusate sodium  100  mg ; sildenafil  20  mg ; 
unspecified disease of pericardium occlusion and stenosis of carotid artery without mention of cerebral infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malignant neoplasm of upper lobe, bronchus or lung cardiac tamponade other postprocedural status acute kidney failure, unspecified unspecified essential hypertension other and unspecified hyperlipidemia raynaud's syndrome other and unspecified coagulation defects hepatomegaly personal history of malignant neoplasm of breast systemic sclerosis hypovolemia hyposmolality and/or hyponatremia anemia, unspecified person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health other and unspecified noninfectious gastroenteritis and colitis raynaud's syndrome other finger(s) amputation status tobacco use disorder unspecified disease of pericardium systemic sclerosis chronic ulcer of other specified sites personal history of malignant neoplasm of breast malignant neoplasm of other parts of bronchus or lung unspecified essential hypertension other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute bronchiolitis due to other infectious organisms malignant neoplasm of middle lobe, bronchus or lung other finger(s) amputation status unspecified essential hypertension occlusion and stenosis of carotid artery without mention of cerebral infarction other and unspecified hyperlipidemia raynaud's syndrome malignant neoplasm of upper lobe, bronchus or lung person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident occlusion and stenosis of carotid artery without mention of cerebral infarction systemic sclerosis hyposmolality and/or hyponatremia antineoplastic chemotherapy induced anemia other secondary thrombocytopenia raynaud's syndrome cough esophageal reflux
white f 56 $temp  98.0  heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  126.0  dbp  76.0  rhythm    pain  4  $hematology blood hematocrit  42.1  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  4  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  118  mg dl$clonazepam  0.5  mg ; senna  1  tab ; multivitamins  1  cap ; amlodipine  10  mg ; fluticasone propionate nasal  1  spry ; aspirin  81  mg ; omeprazole  20  mg ; amlodipine  5  mg ; simvastatin  20  mg ; docusate sodium  100  mg ; sildenafil  20  mg ; clonazepam  1  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.4-0.8  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  1-3  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
unspecified disease of pericardium occlusion and stenosis of carotid artery without mention of cerebral infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malignant neoplasm of upper lobe, bronchus or lung cardiac tamponade other postprocedural status acute kidney failure, unspecified unspecified essential hypertension other and unspecified hyperlipidemia raynaud's syndrome other and unspecified coagulation defects hepatomegaly personal history of malignant neoplasm of breast systemic sclerosis hypovolemia hyposmolality and/or hyponatremia anemia, unspecified person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health other and unspecified noninfectious gastroenteritis and colitis raynaud's syndrome other finger(s) amputation status tobacco use disorder unspecified disease of pericardium systemic sclerosis chronic ulcer of other specified sites personal history of malignant neoplasm of breast malignant neoplasm of other parts of bronchus or lung unspecified essential hypertension other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute bronchiolitis due to other infectious organisms malignant neoplasm of middle lobe, bronchus or lung other finger(s) amputation status unspecified essential hypertension occlusion and stenosis of carotid artery without mention of cerebral infarction other and unspecified hyperlipidemia raynaud's syndrome malignant neoplasm of upper lobe, bronchus or lung person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident occlusion and stenosis of carotid artery without mention of cerebral infarction systemic sclerosis hyposmolality and/or hyponatremia antineoplastic chemotherapy induced anemia other secondary thrombocytopenia raynaud's syndrome cough esophageal reflux
white f 56 $nan$hematology blood hematocrit  43.8  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  120  mg dl$clonazepam  0.5  mg ; senna  1  tab ; multivitamins  1  cap ; fluticasone propionate nasal  1  spry ; aspirin  81  mg ; omeprazole  20  mg ; amlodipine  5  mg ; simvastatin  20  mg ; docusate sodium  100  mg ; sildenafil  20  mg ; clonazepam  1  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.4-0.8  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  1-3  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
unspecified disease of pericardium occlusion and stenosis of carotid artery without mention of cerebral infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malignant neoplasm of upper lobe, bronchus or lung cardiac tamponade other postprocedural status acute kidney failure, unspecified unspecified essential hypertension other and unspecified hyperlipidemia raynaud's syndrome other and unspecified coagulation defects hepatomegaly personal history of malignant neoplasm of breast systemic sclerosis hypovolemia hyposmolality and/or hyponatremia anemia, unspecified person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health other and unspecified noninfectious gastroenteritis and colitis raynaud's syndrome other finger(s) amputation status tobacco use disorder unspecified disease of pericardium systemic sclerosis chronic ulcer of other specified sites personal history of malignant neoplasm of breast malignant neoplasm of other parts of bronchus or lung unspecified essential hypertension other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute bronchiolitis due to other infectious organisms malignant neoplasm of middle lobe, bronchus or lung other finger(s) amputation status unspecified essential hypertension occlusion and stenosis of carotid artery without mention of cerebral infarction other and unspecified hyperlipidemia raynaud's syndrome malignant neoplasm of upper lobe, bronchus or lung person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident occlusion and stenosis of carotid artery without mention of cerebral infarction systemic sclerosis hyposmolality and/or hyponatremia antineoplastic chemotherapy induced anemia other secondary thrombocytopenia raynaud's syndrome cough esophageal reflux
white f 56 $nan$nan$clonazepam  0.5  mg ; senna  1  tab ; multivitamins  1  cap ; fluticasone propionate nasal  1  spry ; aspirin  81  mg ; omeprazole  20  mg ; amlodipine  5  mg ; simvastatin  20  mg ; docusate sodium  100  mg ; sildenafil  20  mg ; clonazepam  1  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.4-0.8  mg ; enoxaparin sodium  40  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  1-3  mg ; acetaminophen  650  mg ; 
unspecified disease of pericardium occlusion and stenosis of carotid artery without mention of cerebral infarction person boarding or alighting a pedal cycle injured in collision with pedestrian or animal malignant neoplasm of upper lobe, bronchus or lung cardiac tamponade other postprocedural status acute kidney failure, unspecified unspecified essential hypertension other and unspecified hyperlipidemia raynaud's syndrome other and unspecified coagulation defects hepatomegaly personal history of malignant neoplasm of breast systemic sclerosis hypovolemia hyposmolality and/or hyponatremia anemia, unspecified person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle personal history of irradiation, presenting hazards to health other and unspecified noninfectious gastroenteritis and colitis raynaud's syndrome other finger(s) amputation status tobacco use disorder unspecified disease of pericardium systemic sclerosis chronic ulcer of other specified sites personal history of malignant neoplasm of breast malignant neoplasm of other parts of bronchus or lung unspecified essential hypertension other and unspecified hyperlipidemia person boarding or alighting a pedal cycle injured in collision with pedestrian or animal acute bronchiolitis due to other infectious organisms malignant neoplasm of middle lobe, bronchus or lung other finger(s) amputation status unspecified essential hypertension occlusion and stenosis of carotid artery without mention of cerebral infarction other and unspecified hyperlipidemia raynaud's syndrome malignant neoplasm of upper lobe, bronchus or lung person boarding or alighting a pedal cycle injured in collision with other nonmotor vehicle in nontraffic accident occlusion and stenosis of carotid artery without mention of cerebral infarction systemic sclerosis hyposmolality and/or hyponatremia antineoplastic chemotherapy induced anemia other secondary thrombocytopenia raynaud's syndrome cough esophageal reflux
white m 57 $nan$nan$enoxaparin sodium  40  mg ; multivitamins  1  cap ; ferrous sulfate  325  mg ; aspirin  81  mg ; diazepam  5  mg ; lorazepam  1  mg ; 
 
white m 57 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  118  mg dl$enoxaparin sodium  40  mg ; multivitamins  1  cap ; ferrous sulfate  325  mg ; aspirin  81  mg ; diazepam  5  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; influenza virus vaccine  0.5  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  20  mg ; hydromorphone (dilaudid)  2-4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ketorolac  15  mg ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 
 
white m 57 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  138  k ul$enoxaparin sodium  40  mg ; multivitamins  1  cap ; ferrous sulfate  325  mg ; aspirin  81  mg ; diazepam  5  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  2-4  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; 
 
white m 57 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  138  k ul$enoxaparin sodium  40  mg ; multivitamins  1  cap ; ferrous sulfate  325  mg ; aspirin  81  mg ; diazepam  5  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; 
 
white m 57 $nan$nan$enoxaparin sodium  40  mg ; multivitamins  1  cap ; ferrous sulfate  325  mg ; aspirin  81  mg ; diazepam  5  mg ; lorazepam  1  mg ; docusate sodium  100  mg ; senna  1  tab ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; diphenhydramine  12.5-50  mg ; 
 
white m 21 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; trazodone  25  mg ; 
depressive disorder, not elsewhere classified poisoning by propionic acid derivatives unspecified gastritis and gastroduodenitis, without mention of hemorrhage suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics
white m 21 $nan$nan$trazodone  25  mg ; 
depressive disorder, not elsewhere classified poisoning by propionic acid derivatives unspecified gastritis and gastroduodenitis, without mention of hemorrhage suicide and self-inflicted poisoning by analgesics, antipyretics, and antirheumatics
white m 81 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  77  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  2.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  2.8  g dl; hematology blood bands  4  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  12  unit ; carvedilol  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoclopramide  5  mg ; nitroglycerin sl  0.3  mg ; ondansetron  4-8  mg ; pantoprazole  40  mg ; oxycodone (immediate release)  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; oxycodone sr (oxycontin)  80  mg ; potassium chloride (powder)  60  meq ; cefepime  2  g ; metronidazole  500  mg ; 
cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth backache, unspecified other and unspecified coagulation defects personal history of malignant neoplasm of bronchus and lung thrombocytopenia, unspecified congestive heart failure, unspecified cardiac pacemaker in situ calculus of bile duct without mention of cholecystitis, with obstruction severe sepsis swelling of limb acute kidney failure, unspecified hypopotassemia other chronic pain unspecified essential hypertension septicemia due to escherichia coli [e. coli] 
white m 81 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  93  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; insulin  12  unit ; carvedilol  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoclopramide  5  mg ; nitroglycerin sl  0.3  mg ; ondansetron  4-8  mg ; pantoprazole  40  mg ; oxycodone (immediate release)  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; heparin  5000  unit ; oxycodone sr (oxycontin)  80  mg ; potassium chloride (powder)  60  meq ; cefepime  2  g ; metronidazole  500  mg ; lisinopril  20  mg ; 
cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth backache, unspecified other and unspecified coagulation defects personal history of malignant neoplasm of bronchus and lung thrombocytopenia, unspecified congestive heart failure, unspecified cardiac pacemaker in situ calculus of bile duct without mention of cholecystitis, with obstruction severe sepsis swelling of limb acute kidney failure, unspecified hypopotassemia other chronic pain unspecified essential hypertension septicemia due to escherichia coli [e. coli] 
white m 81 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; insulin  12  unit ; carvedilol  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoclopramide  5  mg ; nitroglycerin sl  0.3  mg ; ondansetron  4-8  mg ; pantoprazole  40  mg ; oxycodone (immediate release)  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; heparin  5000  unit ; oxycodone sr (oxycontin)  80  mg ; cefepime  2  g ; metronidazole  500  mg ; lisinopril  20  mg ; lisinopril  40  mg ; acyclovir  200  mg ; hydralazine  25  mg ; 
cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth backache, unspecified other and unspecified coagulation defects personal history of malignant neoplasm of bronchus and lung thrombocytopenia, unspecified congestive heart failure, unspecified cardiac pacemaker in situ calculus of bile duct without mention of cholecystitis, with obstruction severe sepsis swelling of limb acute kidney failure, unspecified hypopotassemia other chronic pain unspecified essential hypertension septicemia due to escherichia coli [e. coli] 
white m 81 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; carvedilol  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoclopramide  5  mg ; nitroglycerin sl  0.3  mg ; ondansetron  4-8  mg ; pantoprazole  40  mg ; oxycodone (immediate release)  10  mg ; acetaminophen  325  mg ; heparin  5000  unit ; oxycodone sr (oxycontin)  80  mg ; cefepime  2  g ; lisinopril  40  mg ; acyclovir  200  mg ; furosemide  20  mg ; 
cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth backache, unspecified other and unspecified coagulation defects personal history of malignant neoplasm of bronchus and lung thrombocytopenia, unspecified congestive heart failure, unspecified cardiac pacemaker in situ calculus of bile duct without mention of cholecystitis, with obstruction severe sepsis swelling of limb acute kidney failure, unspecified hypopotassemia other chronic pain unspecified essential hypertension septicemia due to escherichia coli [e. coli] 
white m 81 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; carvedilol  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoclopramide  5  mg ; nitroglycerin sl  0.3  mg ; ondansetron  4-8  mg ; pantoprazole  40  mg ; oxycodone (immediate release)  10  mg ; acetaminophen  325  mg ; heparin  5000  unit ; oxycodone sr (oxycontin)  80  mg ; cefepime  2  g ; lisinopril  40  mg ; acyclovir  200  mg ; furosemide  20  mg ; potassium chloride  40  meq ; 
cholangitis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled candidiasis of mouth backache, unspecified other and unspecified coagulation defects personal history of malignant neoplasm of bronchus and lung thrombocytopenia, unspecified congestive heart failure, unspecified cardiac pacemaker in situ calculus of bile duct without mention of cholecystitis, with obstruction severe sepsis swelling of limb acute kidney failure, unspecified hypopotassemia other chronic pain unspecified essential hypertension septicemia due to escherichia coli [e. coli] 
white f 45 $temp  98.2  heartrate  93.0  resprate  16.0  o2sat  96.0  sbp  122.0  dbp  77.0  rhythm    pain  7  ; temp    heartrate  88.0  resprate  15.0  o2sat  96.0  sbp  148.0  dbp  103.0  rhythm    pain  7  ; temp    heartrate  87.0  resprate  15.0  o2sat  97.0  sbp  120.0  dbp  78.0  rhythm    pain  7  ; temp    heartrate  88.0  resprate  16.0  o2sat  96.0  sbp  177.0  dbp  112.0  rhythm    pain  9  ; temp    heartrate  91.0  resprate  12.0  o2sat  96.0  sbp  140.0  dbp  87.0  rhythm    pain  7  ; temp  97.9  heartrate  94.0  resprate  21.0  o2sat  95.0  sbp  145.0  dbp  91.0  rhythm    pain  8  ; temp  98.3  heartrate  97.0  resprate  19.0  o2sat  95.0  sbp  151.0  dbp  97.0  rhythm    pain  9  $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  3.3  g dl$nan
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
white f 45 $temp  98.5  heartrate  93.0  resprate  18.0  o2sat  97.0  sbp  144.0  dbp  87.0  rhythm    pain  3  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; oxycodone (immediate release)   5-10  mg ; fentanyl patch  25  mcg h ; pantoprazole  40  mg ; thiamine  100  mg ; ketorolac  15  mg ; tizanidine  2  mg ; alendronate sodium  5  mg ; omeprazole  40  mg ; potassium chloride  40  meq ; zolpidem tartrate  10  mg ; tramadol (ultram)  50  mg ; magnesium oxide  400  mg ; gabapentin  600  mg ; heparin  5000  unit ; 
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
white f 45 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  87  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; oxycodone (immediate release)   5-10  mg ; fentanyl patch  25  mcg h ; pantoprazole  40  mg ; thiamine  100  mg ; tizanidine  2  mg ; alendronate sodium  5  mg ; omeprazole  40  mg ; potassium chloride  40  meq ; zolpidem tartrate  10  mg ; tramadol (ultram)  50  mg ; magnesium oxide  400  mg ; gabapentin  600  mg ; heparin  5000  unit ; multivitamins  1  tab ; folic acid  1  mg ; furosemide  20  mg ; nadolol  20  mg ; sertraline  25  mg ; spironolactone  50  mg ; cyanocobalamin  1000  mcg ; calcitriol  0.25  mcg ; tizanidine  1  mg ; 
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
white f 45 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  152  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; diazepam  10  mg ; oxycodone (immediate release)   5-10  mg ; fentanyl patch  25  mcg h ; pantoprazole  40  mg ; thiamine  100  mg ; alendronate sodium  5  mg ; omeprazole  40  mg ; potassium chloride  40  meq ; zolpidem tartrate  10  mg ; tramadol (ultram)  50  mg ; magnesium oxide  400  mg ; gabapentin  600  mg ; heparin  5000  unit ; multivitamins  1  tab ; folic acid  1  mg ; furosemide  20  mg ; nadolol  20  mg ; sertraline  25  mg ; spironolactone  50  mg ; cyanocobalamin  1000  mcg ; calcitriol  0.25  mcg ; tizanidine  1  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 0.9%  1000  ml ; trazodone  50  mg ; 
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
white f 45 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fentanyl patch  25  mcg h ; pantoprazole  40  mg ; thiamine  100  mg ; alendronate sodium  5  mg ; omeprazole  40  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; gabapentin  600  mg ; heparin  5000  unit ; multivitamins  1  tab ; folic acid  1  mg ; furosemide  20  mg ; sertraline  25  mg ; spironolactone  50  mg ; cyanocobalamin  1000  mcg ; calcitriol  0.25  mcg ; trazodone  50  mg ; 
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
white f 45 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fentanyl patch  25  mcg h ; pantoprazole  40  mg ; alendronate sodium  5  mg ; omeprazole  40  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; gabapentin  600  mg ; heparin  5000  unit ; multivitamins  1  tab ; folic acid  1  mg ; furosemide  20  mg ; sertraline  25  mg ; spironolactone  50  mg ; cyanocobalamin  1000  mcg ; calcitriol  0.25  mcg ; 
acute alcoholic intoxication in alcoholism, continuous alcoholic cirrhosis of liver lack of housing driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident
hispanic latino m 77 $nan$nan$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  39.3  %; hematology blood hematocrit  40.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  370  k ul; hematology blood platelet count  337  k ul; chemistry blood anion gap  29  meq l; chemistry blood anion gap  26  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  133  meq l; chemistry blood chloride  135  meq l; chemistry blood chloride  122  meq l; chemistry blood creatinine  10.4  mg dl; chemistry blood creatinine  9.6  mg dl; chemistry blood creatinine  9.9  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  161  meq l; chemistry blood sodium  170  meq l; chemistry blood sodium  176  meq l; chemistry blood urea nitrogen  224  mg dl; chemistry blood urea nitrogen  228  mg dl; chemistry blood urea nitrogen  235  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  15  meq l; chemistry urine creatinine, urine  279  mg dl; chemistry urine potassium, urine  63  meq l; chemistry urine sodium, urine  38  meq l; chemistry blood calcium, total  10.1  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  372  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  212  iu l; chemistry blood albumin  3.5  g dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; lidocaine jelly 2% (urojet)  1  appl ; sodium polystyrene sulfonate  30  gm ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  500  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 5% dextrose  1000  ml ; insulin  4  unit ; fentanyl citrate  12.5-25  mcg ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-1  mg ; haloperidol  0.5-2  mg ; fentanyl citrate  25  mcg ; chloraseptic throat spray  1  spry ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  30.4  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  215  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  131  meq l; chemistry blood chloride  132  meq l; chemistry blood chloride  133  meq l; chemistry blood chloride  132  meq l; chemistry blood chloride  130  meq l; chemistry blood creatinine  9.6  mg dl; chemistry blood creatinine  8.6  mg dl; chemistry blood creatinine  8.1  mg dl; chemistry blood creatinine  8.8  mg dl; chemistry blood creatinine  9.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  166  meq l; chemistry blood sodium  168  meq l; chemistry blood sodium  165  meq l; chemistry blood sodium  164  meq l; chemistry blood sodium  164  meq l; chemistry blood urea nitrogen  225  mg dl; chemistry blood urea nitrogen  199  mg dl; chemistry blood urea nitrogen  195  mg dl; chemistry blood urea nitrogen  216  mg dl; chemistry blood urea nitrogen  210  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  195  mg dl; chemistry blood glucose  177  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; lidocaine jelly 2% (urojet)  1  appl ; sodium polystyrene sulfonate  30  gm ; 0.9% sodium chloride  500  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; insulin  4  unit ; fentanyl citrate  12.5-25  mcg ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; fentanyl citrate  25  mcg ; chloraseptic throat spray  1  spry ; d5 1 2ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  129  meq l; chemistry blood chloride  128  meq l; chemistry blood chloride  122  meq l; chemistry blood chloride  127  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood creatinine  7.4  mg dl; chemistry blood creatinine  7.3  mg dl; chemistry blood creatinine  6.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  162  meq l; chemistry blood sodium  162  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  158  meq l; chemistry blood urea nitrogen  186  mg dl; chemistry blood urea nitrogen  177  mg dl; chemistry blood urea nitrogen  164  mg dl; chemistry blood urea nitrogen  160  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  124  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  1000  mg ; haloperidol  2  mg ; haloperidol  0.5-4  mg ; fentanyl citrate  25-50  mcg ; meropenem  500  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  123  meq l; chemistry blood creatinine  6.6  mg dl; chemistry blood creatinine  6.1  mg dl; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  152  meq l; chemistry blood urea nitrogen  154  mg dl; chemistry blood urea nitrogen  134  mg dl; chemistry blood urea nitrogen  144  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  122  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; haloperidol  0.5-4  mg ; fentanyl citrate  25-50  mcg ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; potassium chl 40 meq   1000 ml d5w  1000  ml ; potassium chl 20 meq   1000 ml d5w  1000  ml ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chl 40 meq   1000 ml ns  1000  ml ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  5.0  mg dl; chemistry blood creatinine  4.5  mg dl; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  122  mg dl; chemistry blood urea nitrogen  108  mg dl; chemistry blood urea nitrogen  102  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  151  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bag  50  ml ; magnesium sulfate  2  gm ; sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  79  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  94  mg dl; chemistry blood glucose  131  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  108  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  113  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; magnesium sulfate  4  gm ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  112  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; magnesium sulfate  4  gm ; olanzapine (disintegrating tablet)  5  mg ; acetaminophen  1000  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  105  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; olanzapine (disintegrating tablet)  5  mg ; acetaminophen  1000  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  89  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  1000  mg ; potassium chloride  60  meq ; bag  100  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  88  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  1000  mg ; bag  100  ml ; 5% dextrose  500  ml ; potassium chloride  40  meq ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  89  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  1000  mg ; 
 
hispanic latino m 77 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  324  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  91  mg dl$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  1000  mg ; 
 
hispanic latino m 77 $nan$nan$folic acid  1  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; baclofen  10  mg ; simvastatin  10  mg ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; dipyridamole-aspirin  1  cap ; heparin flush (10 units ml)  2  ml ; haloperidol  0.5-2  mg ; chloraseptic throat spray  1  spry ; meropenem  500  mg ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; acetaminophen  1000  mg ; 
 
white m 41 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  38.4  %; hematology blood hematocrit  38.9  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  261  k ul; hematology blood platelet count  310  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  6.6  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  96  mg dl; chemistry urine sodium, urine  77  meq l; chemistry blood calcium, total  6.9  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  4.3  mg dl; chemistry blood bilirubin, total  4.0  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  326  mg dl; chemistry blood glucose  276  mg dl; chemistry blood lactate dehydrogenase (ld)  248  iu l; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood albumin  3.5  g dl; chemistry blood albumin  3.2  g dl; hematology blood bands  13  %; hematology blood bands  4  %; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.9  mmol l; chemistry blood bilirubin, direct  4.1  mg dl; blood gas blood glucose  258  mg dl; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  6.0  meq l; blood gas blood potassium, whole blood  6.1  meq l; blood gas blood sodium, whole blood  134  meq l; hematology urine glucose  300  mg dl$0.9% sodium chloride  1  bag ; iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  10  ml ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  30  gm ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; 0.9% sodium chloride  1500  ml ; 0.9% sodium chloride  500  ml ; albuterol inhaler  2  puff ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; insulin  6  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vancomycin  1000  mg ; heparin  5000  unit ; 5% dextrose  50  ml ; phytonadione  10  mg ; cisatracurium besylate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; acetaminophen  325-650  mg ; albuterol inhaler  4  puff ; 0.9% sodium chloride  1000  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; 
 
white m 41 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  59  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  169  mg dl; chemistry blood lactate dehydrogenase (ld)  114  iu l; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l$0.9% sodium chloride  1  bag ; iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  10  ml ; calcium gluconate  2  g ; insulin  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  30  gm ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; 0.9% sodium chloride  1500  ml ; 0.9% sodium chloride  500  ml ; albuterol inhaler  2  puff ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vancomycin  1000  mg ; heparin  5000  unit ; 5% dextrose  50  ml ; phytonadione  10  mg ; cisatracurium besylate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; acetaminophen  325-650  mg ; albuterol inhaler  4  puff ; 0.9% sodium chloride  1000  ml ; 5% dextrose  100  ml ; vasopressin  40  unit ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; neutra-phos  2  pkt ; potassium phosphate  15  mmol ; 
 
white m 41 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  81  mg dl; chemistry blood lactate dehydrogenase (ld)  138  iu l; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.8  mmol l$0.9% sodium chloride  1  bag ; iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; vancomycin  1000  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; 5% dextrose  100  ml ; vasopressin  40  unit ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; potassium phosphate  15  mmol ; 
 
white m 41 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  127  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  0.8  mmol l; blood gas blood lactate  0.6  mmol l$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; midazolam  1-5  mg ; 
 
white m 41 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  119  mg dl; blood gas blood lactate  1.0  mmol l$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; midazolam  1-5  mg ; senna  1  tab ; docusate sodium  100  mg ; furosemide  10  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; docusate sodium (liquid)  100  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; 
 
white m 41 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  161  mg dl; chemistry blood lactate dehydrogenase (ld)  161  iu l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.8  mmol l$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; azithromycin   500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; vial  1  vial ; pantoprazole  40  mg ; norepinephrine  8  mg ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; senna  1  tab ; furosemide  10  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; docusate sodium (liquid)  100  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; famotidine  20  mg ; guaifenesin-dextromethorphan  5  ml ; lorazepam  1  mg ; 
 
white m 41 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  153  mg dl; blood gas blood free calcium  1.11  mmol l$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; fentanyl citrate  25-100  mcg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; senna  1  tab ; docusate sodium (liquid)  100  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; famotidine  20  mg ; guaifenesin-dextromethorphan  5  ml ; lorazepam  1  mg ; diazepam  2  mg ; diazepam  5  mg ; 
 
white m 41 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  418  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  110  mg dl$0.9% sodium chloride  1  bag ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 0.9% sodium chloride  2  bag ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; albuterol inhaler  4  puff ; potassium chloride  20  meq ; potassium chloride  40  meq ; sw  150  ml ; potassium chloride  60  meq ; senna  1  tab ; docusate sodium (liquid)  100  mg ; guaifenesin-dextromethorphan  5  ml ; diazepam  2  mg ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; vancomycin  1250  mg ; 
 
white m 41 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  534  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  115  mg dl$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; albuterol inhaler  4  puff ; senna  1  tab ; guaifenesin-dextromethorphan  5  ml ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; vancomycin  1250  mg ; heparin flush (10 units ml)  2  ml ; trazodone  25  mg ; 
 
white m 41 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  469  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  121  mg dl$iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; heparin  5000  unit ; albuterol inhaler  4  puff ; senna  1  tab ; guaifenesin-dextromethorphan  5  ml ; diazepam  5  mg ; sodium chloride 0.9%  flush  3  ml ; vancomycin  1250  mg ; heparin flush (10 units ml)  2  ml ; trazodone  25  mg ; 
 
white m 64 $nan$nan$bacitracin ointment  1  appl ; aspirin  81  mg ; lisinopril  10  mg ; 
neoplasm of uncertain behavior of pharynx neoplasm of uncertain behavior of other specified sites epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension rheumatoid arthritis, unspecified 
white m 64 $nan$nan$bacitracin ointment  1  appl ; aspirin  81  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; dexamethasone  10  mg ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  750  mg ; enoxaparin sodium  40  mg ; keppra xr  1500  mg ; levothyroxine sodium  160  mcg ; 
neoplasm of uncertain behavior of pharynx neoplasm of uncertain behavior of other specified sites epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension rheumatoid arthritis, unspecified 
white m 64 $nan$nan$bacitracin ointment  1  appl ; aspirin  81  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; enoxaparin sodium  40  mg ; keppra xr  1500  mg ; levothyroxine sodium  200  mcg ; 
neoplasm of uncertain behavior of pharynx neoplasm of uncertain behavior of other specified sites epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension rheumatoid arthritis, unspecified 
white m 64 $nan$nan$bacitracin ointment  1  appl ; aspirin  81  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; calcium carbonate  1250  mg ; enoxaparin sodium  40  mg ; keppra xr  1500  mg ; levothyroxine sodium  200  mcg ; 
neoplasm of uncertain behavior of pharynx neoplasm of uncertain behavior of other specified sites epilepsy, unspecified, not intractable, without status epilepticus essential (primary) hypertension rheumatoid arthritis, unspecified 
black african american f 67 $nan$hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin  325  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; famotidine  20  mg ; heparin  5000  unit ; aspirin (buffered)  325  mg ; 
 
black african american f 67 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  87  mg dl; chemistry blood % hemoglobin a1c  6.2  %$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; famotidine  20  mg ; heparin  5000  unit ; aspirin (buffered)  325  mg ; 
 
black african american f 67 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; heparin  5000  unit ; aspirin (buffered)  325  mg ; 
 
white m 69 $temp    heartrate  66.0  resprate  18.0  o2sat  99.0  sbp  124.0  dbp  47.0  rhythm    pain  0  ; temp  98.4  heartrate  61.0  resprate  15.0  o2sat  98.0  sbp  121.0  dbp  46.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  13.0  o2sat  99.0  sbp  109.0  dbp  56.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  13.0  o2sat  97.0  sbp  147.0  dbp  52.0  rhythm    pain  0  ; temp  97.6  heartrate  77.0  resprate  20.0  o2sat  96.0  sbp  12.0  dbp  45.0  rhythm    pain  0  ; temp  97.6  heartrate  77.0  resprate  20.0  o2sat  96.0  sbp  120.0  dbp  45.0  rhythm    pain  0  $hematology blood hematocrit  43.1  %; hematology blood hematocrit  42.0  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  199  k ul; hematology blood platelet count  198  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  264  mg dl; chemistry blood glucose  308  mg dl; chemistry blood glucose  238  mg dl; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; insulin  0  unit ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; lactated ringers  1000  ml ; insulin  48  unit ; insulin  8  unit ; docusate sodium  100  mg ; insulin  10  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  10  unit ; 0.9% sodium chloride  100  ml ; lacosamide  400  mg ; lacosamide  200  mg ; insulin  44  unit ; albuterol inhaler  2  puff ; insulin  7  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; insulin  44  unit ; albuterol inhaler  2  puff ; insulin  7  unit ; clobazam  5  mg ; tamsulosin  0.4  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$hematology blood hematocrit  43.7  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  208  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; clobazam  5  mg ; tamsulosin  0.4  mg ; allopurinol  100  mg ; insulin  9  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  274  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; insulin  9  unit ; ondansetron  4  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  250  ml ; acyclovir  750  mg ; insulin  12  unit ; insulin  46  unit ; polyethylene glycol  17  g ; insulin  11  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; ondansetron  4  mg ; sodium chloride 0.9%  1000  ml ; insulin  46  unit ; polyethylene glycol  17  g ; insulin  42  unit ; insulin  13  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  13  unit ; metformin  1000  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; fleet enema (saline)  1  enema ; metformin xr (glucophage xr)  1000  mg ; insulin  40  unit ; insulin  33  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; quetiapine fumarate  25  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; quetiapine fumarate  50  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; quetiapine fumarate  50  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; haloperidol  2  mg ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 69 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; levetiracetam  1500  mg ; amlodipine  10  mg ; aspirin  325  mg ; fluticasone propionate 110mcg  2  puff ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lacosamide  200  mg ; albuterol inhaler  2  puff ; tamsulosin  0.4  mg ; allopurinol  100  mg ; polyethylene glycol  17  g ; insulin  33  unit ; 
other and unspecified hyperlipidemia anemia, unspecified background diabetic retinopathy unspecified essential hypertension other forms of epilepsy and recurrent seizures, without mention of intractable epilepsy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled
white m 71 $nan$hematology blood hematocrit  24.3  %; hematology blood hematocrit  23.6  %; hematology blood hematocrit  24.4  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  205  k ul; hematology blood platelet count  208  k ul; hematology blood platelet count  246  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.9  ; hematology blood inr(pt)  2.8  ; hematology blood inr(pt)  2.4  ; chemistry urine chloride, urine  82  meq l; chemistry urine creatinine, urine  127  mg dl; chemistry urine potassium, urine  50  meq l; chemistry urine sodium, urine  80  meq l; chemistry urine urea nitrogen, urine  950  mg dl; hematology urine wbc  54  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  113  mg dl$0.9% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; omeprazole  20  mg ; amiodarone  100  mg ; simvastatin  10  mg ; 0.9% sodium chloride  500  ml ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  50  mg ; tamsulosin  0.4  mg ; 
 
white m 71 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  23.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  165  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; omeprazole  20  mg ; amiodarone  100  mg ; simvastatin  10  mg ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  50  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; potassium chloride  20  meq ; neutra-phos  1  pkt ; 
 
white m 71 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; omeprazole  20  mg ; amiodarone  100  mg ; simvastatin  10  mg ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  50  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; potassium chloride  20  meq ; neutra-phos  1  pkt ; potassium chloride  40  meq ; 
 
white m 71 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; omeprazole  20  mg ; amiodarone  100  mg ; simvastatin  10  mg ; oxycodone (immediate release)   5  mg ; metoprolol tartrate  50  mg ; tamsulosin  0.4  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; potassium chloride  40  meq ; cefpodoxime proxetil  200  mg ; neutra-phos  2  pkt ; 
 
white f 93 $nan$nan$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  64  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  127  mg dl; blood gas blood lactate  2.3  mmol l$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; famotidine  20  mg ; heparin  800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; metoprolol tartrate  12.5  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; d5w  250  ml ; nitroglycerin  100  mg ; furosemide  10  mg ; 0.9% sodium chloride  250  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  95  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; famotidine  20  mg ; heparin  800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; d5w  250  ml ; nitroglycerin  100  mg ; furosemide  10  mg ; 0.9% sodium chloride  1000  ml ; metoprolol tartrate  25  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; potassium chloride (powder)  20  meq ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  104  mg dl$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; famotidine  20  mg ; heparin  800  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; d5w  250  ml ; nitroglycerin  100  mg ; metoprolol tartrate  25  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; potassium chloride (powder)  20  meq ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$nan$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; famotidine  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$nan$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; senna  1  tab ; famotidine  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$nan$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 93 $nan$nan$atorvastatin  80  mg ; aspirin  325  mg ; clopidogrel  75  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; bisacodyl  10  mg ; famotidine  20  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; 
senile dementia, uncomplicated diarrhea unspecified essential hypertension esophageal reflux foreign body in esophagus diverticulum of esophagus, acquired hyperosmolality and/or hypernatremia pneumonitis due to inhalation of food or vomitus foreign body accidentally entering other orifice chronic kidney disease, stage iii (moderate) pulmonary insufficiency following trauma and surgery pathologic fracture of vertebrae anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified
white f 74 $temp  97.1  heartrate  83.0  resprate  16.0  o2sat  100.0  sbp  163.0  dbp  77.0  rhythm    pain  6  ; temp    heartrate  94.0  resprate  28.0  o2sat  99.0  sbp  180.0  dbp  73.0  rhythm    pain    ; temp    heartrate  90.0  resprate  22.0  o2sat  96.0  sbp  155.0  dbp  103.0  rhythm    pain  8  ; temp  97.9  heartrate  88.0  resprate  21.0  o2sat  99.0  sbp  156.0  dbp  72.0  rhythm    pain    ; temp    heartrate  87.0  resprate  20.0  o2sat  98.0  sbp  155.0  dbp  87.0  rhythm    pain    $nan$ranitidine  150  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; 
age-related osteoporosis without current pathological fracture essential (primary) hypertension unspecified osteoarthritis, unspecified site unspecified asthma, uncomplicated irritable bowel syndrome without diarrhea fracture of one rib, right side, initial encounter for closed fracture gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture other place in unspecified non-institutional (private) residence as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter history of falling syncope and collapse disorientation, unspecified essential (primary) hypertension unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified dorsalgia, unspecified other place in single-family (private) house as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter other specified deforming dorsopathies, thoracolumbar region unspecified fracture of third thoracic vertebra, initial encounter for closed fracture pain in right shoulder pain in left shoulder migraine, unspecified, not intractable, without status migrainosus 
white f 74 $temp  98.1  heartrate  85.0  resprate  20.0  o2sat  98.0  sbp  141.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  98  mg dl; chemistry blood lactate dehydrogenase (ld)  205  iu l; chemistry blood albumin  4.3  g dl; chemistry blood % hemoglobin a1c  5.2  %$ranitidine  150  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; duloxetine dr  90  mg ; mirtazapine  15  mg ; 
age-related osteoporosis without current pathological fracture essential (primary) hypertension unspecified osteoarthritis, unspecified site unspecified asthma, uncomplicated irritable bowel syndrome without diarrhea fracture of one rib, right side, initial encounter for closed fracture gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture other place in unspecified non-institutional (private) residence as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter history of falling syncope and collapse disorientation, unspecified essential (primary) hypertension unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified dorsalgia, unspecified other place in single-family (private) house as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter other specified deforming dorsopathies, thoracolumbar region unspecified fracture of third thoracic vertebra, initial encounter for closed fracture pain in right shoulder pain in left shoulder migraine, unspecified, not intractable, without status migrainosus 
white f 74 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  120  mg dl$ranitidine  150  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; duloxetine dr  90  mg ; mirtazapine  15  mg ; lamotrigine  25  mg ; verapamil  40  mg ; verapamil sr  120  mg ; 
age-related osteoporosis without current pathological fracture essential (primary) hypertension unspecified osteoarthritis, unspecified site unspecified asthma, uncomplicated irritable bowel syndrome without diarrhea fracture of one rib, right side, initial encounter for closed fracture gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture other place in unspecified non-institutional (private) residence as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter history of falling syncope and collapse disorientation, unspecified essential (primary) hypertension unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified dorsalgia, unspecified other place in single-family (private) house as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter other specified deforming dorsopathies, thoracolumbar region unspecified fracture of third thoracic vertebra, initial encounter for closed fracture pain in right shoulder pain in left shoulder migraine, unspecified, not intractable, without status migrainosus 
white f 74 $nan$hematology blood hematocrit  44.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  121  mg dl$ranitidine  150  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; duloxetine dr  90  mg ; mirtazapine  15  mg ; verapamil  40  mg ; verapamil sr  120  mg ; 
age-related osteoporosis without current pathological fracture essential (primary) hypertension unspecified osteoarthritis, unspecified site unspecified asthma, uncomplicated irritable bowel syndrome without diarrhea fracture of one rib, right side, initial encounter for closed fracture gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture other place in unspecified non-institutional (private) residence as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter history of falling syncope and collapse disorientation, unspecified essential (primary) hypertension unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified dorsalgia, unspecified other place in single-family (private) house as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter other specified deforming dorsopathies, thoracolumbar region unspecified fracture of third thoracic vertebra, initial encounter for closed fracture pain in right shoulder pain in left shoulder migraine, unspecified, not intractable, without status migrainosus 
white f 74 $nan$nan$ranitidine  150  mg ; vitamin d  2000  unit ; multivitamins  1  tab ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; duloxetine dr  90  mg ; mirtazapine  15  mg ; verapamil sr  120  mg ; 
age-related osteoporosis without current pathological fracture essential (primary) hypertension unspecified osteoarthritis, unspecified site unspecified asthma, uncomplicated irritable bowel syndrome without diarrhea fracture of one rib, right side, initial encounter for closed fracture gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified wedge compression fracture of third thoracic vertebra, initial encounter for closed fracture other place in unspecified non-institutional (private) residence as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter history of falling syncope and collapse disorientation, unspecified essential (primary) hypertension unspecified asthma, uncomplicated major depressive disorder, single episode, unspecified hyperlipidemia, unspecified dorsalgia, unspecified other place in single-family (private) house as the place of occurrence of the external cause fall (on) (from) unspecified stairs and steps, initial encounter traumatic subdural hemorrhage with loss of consciousness of 30 minutes or less, initial encounter other specified deforming dorsopathies, thoracolumbar region unspecified fracture of third thoracic vertebra, initial encounter for closed fracture pain in right shoulder pain in left shoulder migraine, unspecified, not intractable, without status migrainosus 
white f 92 $nan$nan$polyethylene glycol  17  g ; multivitamins  1  tab ; 
 
white f 92 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  396  k ul; hematology blood platelet count  446  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  832  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  93  mg dl; hematology urine glucose  100  mg dl; hematology urine bilirubin  lg  mg dl$polyethylene glycol  17  g ; multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white f 92 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  431  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  100  mg dl$polyethylene glycol  17  g ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; neutra-phos  1  pkt ; 
 
white f 92 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  100  mg dl$polyethylene glycol  17  g ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; neutra-phos  1  pkt ; acetaminophen  325-650  mg ; magnesium citrate  150  ml ; 
 
white f 92 $nan$nan$polyethylene glycol  17  g ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; magnesium citrate  150  ml ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride  500  ml ; 
 
white f 92 $nan$nan$polyethylene glycol  17  g ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  1  tab ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; 
 
white f 79 $nan$nan$prednisone  40  mg ; metoprolol succinate xl  25  mg ; clopidogrel  75  mg ; aspirin  81  mg ; 
 
white f 79 $nan$hematology blood hematocrit  29.2  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  263  k ul; hematology blood platelet count  252  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.4  g dl$prednisone  40  mg ; metoprolol succinate xl  25  mg ; clopidogrel  75  mg ; aspirin  81  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; morphine sulfate  1-4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; multivitamins  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; acetaminophen  650  mg ; 
 
white f 79 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  82  mg dl$prednisone  40  mg ; metoprolol succinate xl  25  mg ; clopidogrel  75  mg ; aspirin  81  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  1-4  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; multivitamins  10  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; pantoprazole  40  mg ; 
 
white f 79 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  75  mg dl$prednisone  40  mg ; metoprolol succinate xl  25  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; pantoprazole  40  mg ; potassium chloride  60  meq ; magnesium citrate  300  ml ; 
 
white f 79 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  79  mg dl; chemistry blood albumin  3.5  g dl$prednisone  40  mg ; metoprolol succinate xl  25  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; potassium chloride  60  meq ; magnesium citrate  300  ml ; magnesium oxide  800  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  50  mg ; 0.9% sodium chloride  500  ml ; golytely  4  l ; 
 
white f 79 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  111  mg dl$prednisone  40  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; magnesium oxide  800  mg ; metoprolol tartrate  25  mg ; metoprolol succinate xl  50  mg ; 0.9% sodium chloride  500  ml ; golytely  4  l ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white f 79 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  92  mg dl$prednisone  40  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; sw  50  ml ; magnesium sulfate  2  gm ; fat emulsion 20%  250  ml ; 
 
white f 79 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  96  mg dl$prednisone  40  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; fat emulsion 20%  250  ml ; 
 
white f 79 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl$prednisone  40  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; metoprolol succinate xl  50  mg ; 
 
white f 79 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  82  mg dl$prednisone  40  mg ; heparin  5000  unit ; mesalamine  2000  mg ; atorvastatin  20  mg ; morphine sulfate  1-4  mg ; zolpidem tartrate  10  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; 
 
white f 76 $nan$nan$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; polyethylene glycol  17  g ; 
staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus esophageal reflux edema cellulitis and abscess of leg, except foot paralysis agitans anemia, unspecified delirium due to conditions classified elsewhere paralysis agitans other and unspecified special symptoms or syndromes, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other malaise and fatigue paralysis agitans esophageal reflux flatulence, eructation, and gas pain esophageal reflux iron deficiency anemia, unspecified dysphagia, unspecified paralysis agitans stricture and stenosis of esophagus anemia, unspecified contusion of buttock poisoning by anti-parkinsonism drugs other specified metabolic disorders esophageal reflux accidental poisoning by anticonvulsant and anti-parkinsonism drugs personal history of tobacco use drug-induced delirium restless legs syndrome (rls) unspecified fall paralysis agitans paralysis agitans restless legs syndrome (rls) unspecified essential hypertension esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident loss of weight abdominal pain, other specified site other chronic pain family history of malignant neoplasm of gastrointestinal tract personal history of colonic polyps anemia, unspecified solitary cyst of breast other acute pain unspecified essential hypertension paralysis agitans family history of malignant neoplasm of gastrointestinal tract personal history of tobacco use drug-induced psychotic disorder with hallucinations
white f 76 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  160  mg dl; chemistry blood albumin  3.9  g dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; polyethylene glycol  17  g ; 1 2 ns  1000  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; senna  1  tab ; docusate sodium  100  mg ; carbidopa-levodopa (25-100)  2  tab ; carbidopa-levodopa cr (25-100)  1  tab ; 
staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus esophageal reflux edema cellulitis and abscess of leg, except foot paralysis agitans anemia, unspecified delirium due to conditions classified elsewhere paralysis agitans other and unspecified special symptoms or syndromes, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other malaise and fatigue paralysis agitans esophageal reflux flatulence, eructation, and gas pain esophageal reflux iron deficiency anemia, unspecified dysphagia, unspecified paralysis agitans stricture and stenosis of esophagus anemia, unspecified contusion of buttock poisoning by anti-parkinsonism drugs other specified metabolic disorders esophageal reflux accidental poisoning by anticonvulsant and anti-parkinsonism drugs personal history of tobacco use drug-induced delirium restless legs syndrome (rls) unspecified fall paralysis agitans paralysis agitans restless legs syndrome (rls) unspecified essential hypertension esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident loss of weight abdominal pain, other specified site other chronic pain family history of malignant neoplasm of gastrointestinal tract personal history of colonic polyps anemia, unspecified solitary cyst of breast other acute pain unspecified essential hypertension paralysis agitans family history of malignant neoplasm of gastrointestinal tract personal history of tobacco use drug-induced psychotic disorder with hallucinations
white f 76 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  96  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; polyethylene glycol  17  g ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; senna  1  tab ; docusate sodium  100  mg ; carbidopa-levodopa (25-100)  2  tab ; carbidopa-levodopa cr (25-100)  1  tab ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  2.5  mg ; 
staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus esophageal reflux edema cellulitis and abscess of leg, except foot paralysis agitans anemia, unspecified delirium due to conditions classified elsewhere paralysis agitans other and unspecified special symptoms or syndromes, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other malaise and fatigue paralysis agitans esophageal reflux flatulence, eructation, and gas pain esophageal reflux iron deficiency anemia, unspecified dysphagia, unspecified paralysis agitans stricture and stenosis of esophagus anemia, unspecified contusion of buttock poisoning by anti-parkinsonism drugs other specified metabolic disorders esophageal reflux accidental poisoning by anticonvulsant and anti-parkinsonism drugs personal history of tobacco use drug-induced delirium restless legs syndrome (rls) unspecified fall paralysis agitans paralysis agitans restless legs syndrome (rls) unspecified essential hypertension esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident loss of weight abdominal pain, other specified site other chronic pain family history of malignant neoplasm of gastrointestinal tract personal history of colonic polyps anemia, unspecified solitary cyst of breast other acute pain unspecified essential hypertension paralysis agitans family history of malignant neoplasm of gastrointestinal tract personal history of tobacco use drug-induced psychotic disorder with hallucinations
white f 76 $nan$nan$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; polyethylene glycol  17  g ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; famotidine  20  mg ; senna  1  tab ; docusate sodium  100  mg ; carbidopa-levodopa (25-100)  2  tab ; carbidopa-levodopa cr (25-100)  1  tab ; olanzapine (disintegrating tablet)  2.5  mg ; olanzapine  2.5  mg ; quetiapine fumarate  25  mg ; 
staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus esophageal reflux edema cellulitis and abscess of leg, except foot paralysis agitans anemia, unspecified delirium due to conditions classified elsewhere paralysis agitans other and unspecified special symptoms or syndromes, not elsewhere classified personal history of noncompliance with medical treatment, presenting hazards to health other malaise and fatigue paralysis agitans esophageal reflux flatulence, eructation, and gas pain esophageal reflux iron deficiency anemia, unspecified dysphagia, unspecified paralysis agitans stricture and stenosis of esophagus anemia, unspecified contusion of buttock poisoning by anti-parkinsonism drugs other specified metabolic disorders esophageal reflux accidental poisoning by anticonvulsant and anti-parkinsonism drugs personal history of tobacco use drug-induced delirium restless legs syndrome (rls) unspecified fall paralysis agitans paralysis agitans restless legs syndrome (rls) unspecified essential hypertension esophageal reflux pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident loss of weight abdominal pain, other specified site other chronic pain family history of malignant neoplasm of gastrointestinal tract personal history of colonic polyps anemia, unspecified solitary cyst of breast other acute pain unspecified essential hypertension paralysis agitans family history of malignant neoplasm of gastrointestinal tract personal history of tobacco use drug-induced psychotic disorder with hallucinations
hispanic latino f 41 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; ranitidine  150  mg ; pyridoxine  25  mg ; diphenhydramine  25  mg ; progesterone micronized 200mg cap  1  cap ; nifedipine (immediate release)  10  mg ; progesterone micronized  200  mg ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; 
cervical shortening, second trimester 23 weeks gestation of pregnancy
hispanic latino f 41 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; pyridoxine  25  mg ; diphenhydramine  25  mg ; nifedipine (immediate release)  10  mg ; progesterone micronized  200  mg ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; diphenhydramine  50  mg ; 
cervical shortening, second trimester 23 weeks gestation of pregnancy
hispanic latino f 41 $nan$nan$docusate sodium  100  mg ; acetaminophen  650  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; prenatal vitamins  1  tab ; pyridoxine  25  mg ; nifedipine (immediate release)  10  mg ; progesterone micronized  200  mg ; syringe  2  ml ; betamethasone na. phos acet  12  mg ; diphenhydramine  50  mg ; 
cervical shortening, second trimester 23 weeks gestation of pregnancy
white m 68 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  106  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  20  mg ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; heparin  5000  unit ; metoprolol tartrate  5  mg ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; warfarin  7.5  mg ; 
personal history of tobacco use personal history of other diseases of circulatory system obstructive sleep apnea (adult)(pediatric) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other complications due to other vascular device, implant, and graft idiopathic sleep related non-obstructive alveolar hypoventilation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 68 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  140  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  20  mg ; bag  100  ml ; magnesium sulfate  4  gm ; insulin  0  unit ; heparin  5000  unit ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; warfarin  5  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.5  mg ; oxazepam  15  mg ; 
personal history of tobacco use personal history of other diseases of circulatory system obstructive sleep apnea (adult)(pediatric) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other complications due to other vascular device, implant, and graft idiopathic sleep related non-obstructive alveolar hypoventilation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 68 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; hydromorphone (dilaudid)  20  mg ; heparin  5000  unit ; acetaminophen  650  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.5  mg ; oxazepam  15  mg ; lisinopril  20  mg ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; 
personal history of tobacco use personal history of other diseases of circulatory system obstructive sleep apnea (adult)(pediatric) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other complications due to other vascular device, implant, and graft idiopathic sleep related non-obstructive alveolar hypoventilation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 68 $nan$hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  $sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; acetaminophen  650  mg ; aspirin  81  mg ; oxazepam  15  mg ; lisinopril  20  mg ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; 
personal history of tobacco use personal history of other diseases of circulatory system obstructive sleep apnea (adult)(pediatric) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other complications due to other vascular device, implant, and graft idiopathic sleep related non-obstructive alveolar hypoventilation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 68 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; heparin  5000  unit ; acetaminophen  650  mg ; aspirin  81  mg ; oxazepam  15  mg ; lisinopril  20  mg ; hydromorphone (dilaudid)  2-4  mg ; simvastatin  40  mg ; metformin (glucophage)  1000  mg ; glyburide  20  mg ; 
personal history of tobacco use personal history of other diseases of circulatory system obstructive sleep apnea (adult)(pediatric) surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation obesity, unspecified other complications due to other vascular device, implant, and graft idiopathic sleep related non-obstructive alveolar hypoventilation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white f 90 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  174  mg dl$valsartan  80  mg ; nifedipine  30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; heparin  5000  unit ; clonidine  0.3  mg ; metoprolol tartrate  100  mg ; isosorbide mononitrate (extended release)  60  mg ; nifedipine cr  30  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; senna  1  tab ; docusate sodium  100  mg ; 
automatic implantable cardiac defibrillator in situ esophageal reflux depressive disorder, not elsewhere classified aortocoronary bypass status diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by hormones and synthetic substitutes old myocardial infarction other chest pain poisoning by insulins and antidiabetic agents chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of renal artery automatic implantable cardiac defibrillator in situ chronic kidney disease, unspecified urinary tract infection, site not specified aortocoronary bypass status long-term (current) use of insulin coronary atherosclerosis of native coronary artery intermediate coronary syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of bladder automatic implantable cardiac defibrillator in situ esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux old myocardial infarction aortocoronary bypass status atherosclerosis of renal artery other specified diseases of pancreas congestive heart failure, unspecified automatic implantable cardiac defibrillator in situ chronic diastolic heart failure personal history of malignant neoplasm of kidney other symptoms involving head and neck chronic kidney disease, unspecified 
white f 90 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  245  mg dl$valsartan  80  mg ; nifedipine  30  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; insulin  0  unit ; heparin  5000  unit ; clonidine  0.3  mg ; metoprolol tartrate  100  mg ; isosorbide mononitrate (extended release)  60  mg ; nifedipine cr  30  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; senna  1  tab ; docusate sodium  100  mg ; nitrofurantoin (macrodantin)  50  mg ; insulin  10  unit ; acetaminophen w codeine  1-2  tab ; 
automatic implantable cardiac defibrillator in situ esophageal reflux depressive disorder, not elsewhere classified aortocoronary bypass status diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by hormones and synthetic substitutes old myocardial infarction other chest pain poisoning by insulins and antidiabetic agents chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of renal artery automatic implantable cardiac defibrillator in situ chronic kidney disease, unspecified urinary tract infection, site not specified aortocoronary bypass status long-term (current) use of insulin coronary atherosclerosis of native coronary artery intermediate coronary syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of bladder automatic implantable cardiac defibrillator in situ esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux old myocardial infarction aortocoronary bypass status atherosclerosis of renal artery other specified diseases of pancreas congestive heart failure, unspecified automatic implantable cardiac defibrillator in situ chronic diastolic heart failure personal history of malignant neoplasm of kidney other symptoms involving head and neck chronic kidney disease, unspecified 
white f 90 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  159  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; clonidine  0.3  mg ; metoprolol tartrate  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; senna  1  tab ; docusate sodium  100  mg ; nitrofurantoin (macrodantin)  50  mg ; acetaminophen w codeine  1-2  tab ; insulin  20  unit ; 
automatic implantable cardiac defibrillator in situ esophageal reflux depressive disorder, not elsewhere classified aortocoronary bypass status diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by hormones and synthetic substitutes old myocardial infarction other chest pain poisoning by insulins and antidiabetic agents chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of renal artery automatic implantable cardiac defibrillator in situ chronic kidney disease, unspecified urinary tract infection, site not specified aortocoronary bypass status long-term (current) use of insulin coronary atherosclerosis of native coronary artery intermediate coronary syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of bladder automatic implantable cardiac defibrillator in situ esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux old myocardial infarction aortocoronary bypass status atherosclerosis of renal artery other specified diseases of pancreas congestive heart failure, unspecified automatic implantable cardiac defibrillator in situ chronic diastolic heart failure personal history of malignant neoplasm of kidney other symptoms involving head and neck chronic kidney disease, unspecified 
white f 90 $nan$nan$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; heparin  5000  unit ; clonidine  0.3  mg ; metoprolol tartrate  100  mg ; isosorbide mononitrate (extended release)  60  mg ; clopidogrel  75  mg ; simvastatin  40  mg ; aspirin  325  mg ; nitroglycerin sl  0.3  mg ; senna  1  tab ; docusate sodium  100  mg ; nitrofurantoin (macrodantin)  50  mg ; 
automatic implantable cardiac defibrillator in situ esophageal reflux depressive disorder, not elsewhere classified aortocoronary bypass status diabetes with other specified manifestations, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified accidental poisoning by hormones and synthetic substitutes old myocardial infarction other chest pain poisoning by insulins and antidiabetic agents chronic kidney disease, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux chronic kidney disease, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of malignant neoplasm of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft atherosclerosis of renal artery automatic implantable cardiac defibrillator in situ chronic kidney disease, unspecified urinary tract infection, site not specified aortocoronary bypass status long-term (current) use of insulin coronary atherosclerosis of native coronary artery intermediate coronary syndrome diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified personal history of malignant neoplasm of bladder automatic implantable cardiac defibrillator in situ esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified esophageal reflux old myocardial infarction aortocoronary bypass status atherosclerosis of renal artery other specified diseases of pancreas congestive heart failure, unspecified automatic implantable cardiac defibrillator in situ chronic diastolic heart failure personal history of malignant neoplasm of kidney other symptoms involving head and neck chronic kidney disease, unspecified 
white f 80 $temp  98.8  heartrate  76.0  resprate  20.0  o2sat  99.0  sbp  157.0  dbp  70.0  rhythm    pain  7  ; temp  98.7  heartrate  75.0  resprate  17.0  o2sat  100.0  sbp  128.0  dbp  51.0  rhythm    pain  7  ; temp  101.0  heartrate  74.0  resprate  20.0  o2sat  100.0  sbp  159.0  dbp  49.0  rhythm    pain  5  ; temp  100.9  heartrate  73.0  resprate  20.0  o2sat  100.0  sbp  170.0  dbp  49.0  rhythm    pain  5  $hematology blood hematocrit  42.9  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  239  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  2.0  mmol l$nan
 
white f 80 $nan$hematology blood hematocrit  39.7  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  3.1  mg dl; chemistry blood glucose  271  mg dl; blood gas blood lactate  1.8  mmol l; chemistry blood bilirubin, direct  2.2  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; senna  8.6  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; alprazolam  0.25  mg ; amlodipine  10  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 5% dextrose  50  ml ; clindamycin  600  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; gabapentin  300  mg ; hydralazine  50  mg ; lidocaine 5% patch  1  ptch ; fentanyl patch  75  mcg h ; furosemide  20  mg ; loratadine  10  mg ; metoprolol succinate xl  50  mg ; prednisone  10  mg ; tiotropium bromide  1  cap ; oxycodone (immediate release)  10  mg ; insulin  0  unit ; breo ellipta 200-25 mcg dose  1  inh ; heparin  5000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  30  unit ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  2.5  mg ; insulin  16  unit ; 
 
white f 80 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  147  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; amlodipine  10  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 5% dextrose  50  ml ; clindamycin  600  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; hydralazine  50  mg ; lidocaine 5% patch  1  ptch ; furosemide  20  mg ; loratadine  10  mg ; metoprolol succinate xl  50  mg ; prednisone  10  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; breo ellipta 200-25 mcg dose  1  inh ; heparin  5000  unit ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  30  unit ; hydromorphone (dilaudid)  0.125  mg ; oxycodone (immediate release)  2.5  mg ; insulin  16  unit ; oxycodone (immediate release)  2.5-5  mg ; fentanyl patch  50  mcg h ; potassium chloride  20  meq ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; acetaminophen  650  mg ; ondansetron  4  mg ; 
 
white f 80 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  117  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 5% dextrose  50  ml ; clindamycin  600  mg ; hydralazine  50  mg ; lidocaine 5% patch  1  ptch ; furosemide  20  mg ; loratadine  10  mg ; metoprolol succinate xl  50  mg ; prednisone  10  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; breo ellipta 200-25 mcg dose  1  inh ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  30  unit ; insulin  16  unit ; oxycodone (immediate release)  2.5-5  mg ; potassium chloride  20  meq ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; acetaminophen  650  mg ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; albuterol 0.083% neb soln  1  neb ; 
 
white f 80 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  136  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  50  mg ; lidocaine 5% patch  1  ptch ; loratadine  10  mg ; metoprolol succinate xl  50  mg ; prednisone  10  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; breo ellipta 200-25 mcg dose  1  inh ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  30  unit ; insulin  16  unit ; oxycodone (immediate release)  2.5-5  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; ondansetron  4  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; potassium chloride  40  meq ; neutra-phos  2  pkt ; albuterol 0.083% neb soln  1  neb ; furosemide  40  mg ; neutra-phos  1  pkt ; cepacol (sore throat lozenge)  1  loz ; amoxicillin-clavulanic acid  875  mg ; sarna lotion  1  appl ; trazodone  25  mg ; acetaminophen  1000  mg ; 
 
white f 80 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  107  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; clopidogrel  75  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  50  mg ; lidocaine 5% patch  1  ptch ; loratadine  10  mg ; metoprolol succinate xl  50  mg ; prednisone  10  mg ; tiotropium bromide  1  cap ; insulin  0  unit ; breo ellipta 200-25 mcg dose  1  inh ; heparin  5000  unit ; docusate sodium  100  mg ; insulin  30  unit ; insulin  16  unit ; oxycodone (immediate release)  2.5-5  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; neutra-phos  1  pkt ; cepacol (sore throat lozenge)  1  loz ; amoxicillin-clavulanic acid  875  mg ; sarna lotion  1  appl ; trazodone  25  mg ; acetaminophen  1000  mg ; loperamide  2  mg ; hydralazine  75  mg ; 
 
white f 86 $temp  98.1  heartrate  88.0  resprate  18.0  o2sat  96.0  sbp  137.0  dbp  67.0  rhythm    pain  0  $chemistry urine creatinine, urine  25  mg dl; chemistry urine protein creatinine ratio  0.3  mg mg; chemistry urine albumin, urine  1.5  mg dl; chemistry urine albumin creatinine, urine  60.0  mg g$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; furosemide  20  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; potassium chloride  40  meq ; carvedilol  25  mg ; 
 
white f 86 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  120  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; furosemide  20  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; potassium chloride  40  meq ; carvedilol  25  mg ; loperamide  2  mg ; heparin  5000  unit ; furosemide  40  mg ; lisinopril  20  mg ; 
 
white f 86 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; carvedilol  25  mg ; loperamide  2  mg ; heparin  5000  unit ; furosemide  40  mg ; lisinopril  20  mg ; 
 
white f 86 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  67  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; carvedilol  25  mg ; loperamide  2  mg ; heparin  5000  unit ; lisinopril  20  mg ; ciprofloxacin hcl  500  mg ; lactated ringers  1000  ml ; 
 
white f 86 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  213  k ul$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; carvedilol  25  mg ; loperamide  2  mg ; lisinopril  20  mg ; ciprofloxacin hcl  500  mg ; lactated ringers  1000  ml ; 
 
white f 86 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  218  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood bilirubin, total  1.2  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; amlodipine  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; pravastatin  20  mg ; carvedilol  25  mg ; loperamide  2  mg ; lisinopril  20  mg ; ciprofloxacin hcl  500  mg ; 
 
white m 71 $nan$nan$aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; thiamine  100  mg ; cyanocobalamin  100  mcg ; finasteride  5  mg ; 
orchitis and epididymitis, unspecified alcohol abuse, unspecified unspecified septicemia delirium due to conditions classified elsewhere benign essential hypertension personal history of malignant neoplasm of prostate other and unspecified hyperlipidemia septic shock severe sepsis acute kidney failure, unspecified other encephalopathy other specified retention of urine subendocardial infarction, initial episode of care acidosis acute glomerulonephritis with other specified pathological lesion in kidney hematuria, unspecified
white m 71 $nan$hematology blood hematocrit  24.1  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  26.2  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  112  k ul; hematology blood platelet count  110  k ul; hematology blood platelet count  82  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  9  # hpf; chemistry blood glucose  102  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  111  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  152  mg dl; blood gas blood glucose  103  mg dl; blood gas blood glucose  90  mg dl; blood gas blood glucose  117  mg dl; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  20  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hemoglobin  7.0  g dl; blood gas blood hemoglobin  6.8  g dl; blood gas blood hemoglobin  8.1  g dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l$aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; thiamine  100  mg ; cyanocobalamin  100  mcg ; finasteride  5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  500  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; donepezil  10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; clopidogrel  75  mg ; lorazepam  0.5-1  mg ; metoprolol tartrate  5  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
orchitis and epididymitis, unspecified alcohol abuse, unspecified unspecified septicemia delirium due to conditions classified elsewhere benign essential hypertension personal history of malignant neoplasm of prostate other and unspecified hyperlipidemia septic shock severe sepsis acute kidney failure, unspecified other encephalopathy other specified retention of urine subendocardial infarction, initial episode of care acidosis acute glomerulonephritis with other specified pathological lesion in kidney hematuria, unspecified
white m 71 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  123  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood potassium, whole blood  3.7  meq l$aspirin ec  81  mg ; milk of magnesia  30  ml ; thiamine  100  mg ; cyanocobalamin  100  mcg ; finasteride  5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; donepezil  10  mg ; d5w  250  ml ; nitroglycerin  100  mg ; clopidogrel  75  mg ; lorazepam  0.5-1  mg ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; haloperidol  0.5  mg ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
orchitis and epididymitis, unspecified alcohol abuse, unspecified unspecified septicemia delirium due to conditions classified elsewhere benign essential hypertension personal history of malignant neoplasm of prostate other and unspecified hyperlipidemia septic shock severe sepsis acute kidney failure, unspecified other encephalopathy other specified retention of urine subendocardial infarction, initial episode of care acidosis acute glomerulonephritis with other specified pathological lesion in kidney hematuria, unspecified
white m 71 $nan$hematology blood hematocrit  23.5  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  120  mg dl$aspirin ec  81  mg ; milk of magnesia  30  ml ; thiamine  100  mg ; cyanocobalamin  100  mcg ; finasteride  5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; donepezil  10  mg ; furosemide  20  mg ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol (ultram)  50  mg ; 
orchitis and epididymitis, unspecified alcohol abuse, unspecified unspecified septicemia delirium due to conditions classified elsewhere benign essential hypertension personal history of malignant neoplasm of prostate other and unspecified hyperlipidemia septic shock severe sepsis acute kidney failure, unspecified other encephalopathy other specified retention of urine subendocardial infarction, initial episode of care acidosis acute glomerulonephritis with other specified pathological lesion in kidney hematuria, unspecified
white m 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  92  mg dl$aspirin ec  81  mg ; milk of magnesia  30  ml ; thiamine  100  mg ; cyanocobalamin  100  mcg ; finasteride  5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; atorvastatin  40  mg ; tamsulosin  0.4  mg ; donepezil  10  mg ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; tramadol (ultram)  50  mg ; metoprolol tartrate  6.25  mg ; 
orchitis and epididymitis, unspecified alcohol abuse, unspecified unspecified septicemia delirium due to conditions classified elsewhere benign essential hypertension personal history of malignant neoplasm of prostate other and unspecified hyperlipidemia septic shock severe sepsis acute kidney failure, unspecified other encephalopathy other specified retention of urine subendocardial infarction, initial episode of care acidosis acute glomerulonephritis with other specified pathological lesion in kidney hematuria, unspecified
white f 50 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  339  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood lactate  1.8  mmol l; blood gas blood potassium, whole blood  4.7  meq l$nan
background diabetic retinopathy driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident anemia in chronic kidney disease kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anomalies of cerebrovascular system hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease gastroparesis nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled personal history of tobacco use diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unemployment diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders polyneuropathy in diabetes renal dialysis status long-term (current) use of insulin car passenger injured in collision with railway train or railway vehicle in nontraffic accident hypotension of hemodialysis chronic kidney disease, stage v other persistent mental disorders due to conditions classified elsewhere background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified transient cerebral ischemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes end stage renal disease encounter for extracorporeal dialysis end stage renal disease driver of pick-up truck or van injured in collision with other nonmotor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders gastroparesis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes
white f 50 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  6.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  260  mg dl$sodium chloride 0.9%  flush  3  ml ; amlodipine  5  mg ; metoclopramide  5  mg ; insulin  0  unit ; metoprolol succinate xl  25  mg ; pravastatin  40  mg ; aspirin  81  mg ; pantoprazole  40  mg ; amitriptyline  25  mg ; insulin  30  unit ; 
background diabetic retinopathy driver of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident anemia in chronic kidney disease kidney dialysis as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anomalies of cerebrovascular system hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease gastroparesis nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled personal history of tobacco use diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled unemployment diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders polyneuropathy in diabetes renal dialysis status long-term (current) use of insulin car passenger injured in collision with railway train or railway vehicle in nontraffic accident hypotension of hemodialysis chronic kidney disease, stage v other persistent mental disorders due to conditions classified elsewhere background diabetic retinopathy diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled unspecified transient cerebral ischemia long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes end stage renal disease encounter for extracorporeal dialysis end stage renal disease driver of pick-up truck or van injured in collision with other nonmotor vehicle in nontraffic accident diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders gastroparesis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes
white m 73 $nan$hematology blood hematocrit  38.9  %; hematology blood platelet count  223  k ul; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  14  mg dl$0.45% sodium chloride  1000  ml ; atropine sulfate  0.5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; simethicone  40-80  mg ; triazolam  0.25  mg ; bupropion (sustained release)  100  mg ; aspirin ec  325  mg ; clopidogrel  75  mg ; amlodipine  10  mg ; atenolol  50  mg ; atorvastatin  40  mg ; 
 
unknown m 82 $nan$nan$aspirin  81  mg ; pravastatin  40  mg ; allopurinol  300  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; nicotine patch  21  mg ; 
 
unknown m 82 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  192  mg dl$aspirin  81  mg ; pravastatin  40  mg ; allopurinol  300  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; nicotine patch  21  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; albuterol inhaler  1-2  puff ; senna  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
unknown m 82 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl$aspirin  81  mg ; pravastatin  40  mg ; allopurinol  300  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; nicotine patch  21  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; senna  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
unknown m 82 $nan$nan$aspirin  81  mg ; pravastatin  40  mg ; allopurinol  300  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; nicotine patch  21  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; senna  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
unknown m 82 $nan$nan$aspirin  81  mg ; pravastatin  40  mg ; allopurinol  300  mg ; ferrous sulfate  325  mg ; folic acid  1  mg ; multivitamins  1  tab ; vitamin d  1000  unit ; nicotine patch  21  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  1-2  puff ; senna  1  tab ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; heparin  5000  unit ; metoprolol tartrate  25  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; lorazepam  0.5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  650  mg ; 
 
white m 46 $temp  97.9  heartrate  62.0  resprate  16.0  o2sat  100.0  sbp  131.0  dbp  75.0  rhythm    pain  10 10  $hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  437  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  146  mg dl$senna  8.6  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  1-2  mg ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; d5ns  1000  ml ; citalopram  20  mg ; ezetimibe  10  mg ; losartan potassium  25  mg ; rosuvastatin calcium  40  mg ; tiotropium bromide  1  cap ; omeprazole  20  mg ; pregabalin  225  mg ; insulin  0  unit ; insulin  60  unit ; atenolol  50  mg ; nicotine patch  21  mg ; hydromorphone (dilaudid)  2-3  mg ; oxycodone sr (oxycontin)  40  mg ; oxycodone (immediate release)   20  mg ; 
loss of weight chronic airway obstruction, not elsewhere classified tobacco use disorder diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled body mass index 28.0-28.9, adult long-term (current) use of insulin unspecified essential hypertension incisional ventral hernia with obstruction esophageal reflux other and unspecified hyperlipidemia chronic pancreatitis other specified vaccinations against streptococcus pneumoniae [pneumococcus] cyst and pseudocyst of pancreas esophageal reflux portal hypertension unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic airway obstruction, not elsewhere classified obstructive sleep apnea (adult)(pediatric) loss of weight other diseases of spleen chronic pancreatitis other specified diseases of pancreas other and unspecified hyperlipidemia body mass index 29.0-29.9, adult obesity, unspecified polyneuropathy in diabetes calculus of gallbladder with other cholecystitis, without mention of obstruction
white m 46 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  395  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood glucose  163  mg dl$senna  8.6  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; d5ns  1000  ml ; citalopram  20  mg ; ezetimibe  10  mg ; losartan potassium  25  mg ; rosuvastatin calcium  40  mg ; tiotropium bromide  1  cap ; omeprazole  20  mg ; pregabalin  225  mg ; atenolol  50  mg ; nicotine patch  21  mg ; oxycodone sr (oxycontin)  40  mg ; oxycodone (immediate release)   20  mg ; docusate sodium  100  mg ; diazepam  5  mg ; oxycodone (immediate release)   20-25  mg ; creon 12  2  cap ; 
loss of weight chronic airway obstruction, not elsewhere classified tobacco use disorder diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled body mass index 28.0-28.9, adult long-term (current) use of insulin unspecified essential hypertension incisional ventral hernia with obstruction esophageal reflux other and unspecified hyperlipidemia chronic pancreatitis other specified vaccinations against streptococcus pneumoniae [pneumococcus] cyst and pseudocyst of pancreas esophageal reflux portal hypertension unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic airway obstruction, not elsewhere classified obstructive sleep apnea (adult)(pediatric) loss of weight other diseases of spleen chronic pancreatitis other specified diseases of pancreas other and unspecified hyperlipidemia body mass index 29.0-29.9, adult obesity, unspecified polyneuropathy in diabetes calculus of gallbladder with other cholecystitis, without mention of obstruction
white m 46 $nan$nan$senna  8.6  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; multivitamins  1  tab ; citalopram  20  mg ; ezetimibe  10  mg ; losartan potassium  25  mg ; rosuvastatin calcium  40  mg ; tiotropium bromide  1  cap ; omeprazole  20  mg ; pregabalin  225  mg ; atenolol  50  mg ; nicotine patch  21  mg ; oxycodone sr (oxycontin)  40  mg ; docusate sodium  100  mg ; diazepam  5  mg ; oxycodone (immediate release)   20-25  mg ; creon 12  2  cap ; 
loss of weight chronic airway obstruction, not elsewhere classified tobacco use disorder diabetes with other specified manifestations, type i [juvenile type], not stated as uncontrolled body mass index 28.0-28.9, adult long-term (current) use of insulin unspecified essential hypertension incisional ventral hernia with obstruction esophageal reflux other and unspecified hyperlipidemia chronic pancreatitis other specified vaccinations against streptococcus pneumoniae [pneumococcus] cyst and pseudocyst of pancreas esophageal reflux portal hypertension unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic airway obstruction, not elsewhere classified obstructive sleep apnea (adult)(pediatric) loss of weight other diseases of spleen chronic pancreatitis other specified diseases of pancreas other and unspecified hyperlipidemia body mass index 29.0-29.9, adult obesity, unspecified polyneuropathy in diabetes calculus of gallbladder with other cholecystitis, without mention of obstruction
white f 90 $temp  97.7  heartrate  101.0  resprate  20.0  o2sat  98.0  sbp  108.0  dbp  51.0  rhythm    pain  0  $hematology blood hematocrit  39.4  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; furosemide  40  mg ; heparin  1200-2500  unit ; 0.9% sodium chloride  250  ml ; heparin sodium  25,000  unit ; clobetasol propionate 0.05% cream  1  appl ; calcium carbonate  1000  mg ; levothyroxine sodium  100  mcg ; valsartan  40  mg ; vitamin d  2000  unit ; metoprolol tartrate  25  mg ; famotidine  20  mg ; potassium chloride  20  meq ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydrocerin  1  appl ; apixaban  5  mg ; apixaban  2.5  mg ; 
chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified unspecified vitamin d deficiency personal history of pneumonia (recurrent) other and unspecified hyperlipidemia venous (peripheral) insufficiency, unspecified aseptic necrosis of head and neck of femur macular degeneration (senile), unspecified personal history of traumatic fracture personal history of tobacco use unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh atrial fibrillation chronic kidney disease, stage iii (moderate) disorder of bone and cartilage, unspecified diseases of tricuspid valve bronchiectasis without acute exacerbation pathologic fracture of neck of femur monoclonal paraproteinemia chronic diastolic heart failure congestive heart failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation mitral valve disorders unspecified acquired hypothyroidism 
white f 90 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% cream  1  appl ; calcium carbonate  1000  mg ; levothyroxine sodium  100  mcg ; valsartan  40  mg ; vitamin d  2000  unit ; famotidine  20  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydrocerin  1  appl ; apixaban  2.5  mg ; loratadine  10  mg ; torsemide  20  mg ; torsemide  10  mg ; potassium chloride  40  meq ; metoprolol succinate xl  50  mg ; 
chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified unspecified vitamin d deficiency personal history of pneumonia (recurrent) other and unspecified hyperlipidemia venous (peripheral) insufficiency, unspecified aseptic necrosis of head and neck of femur macular degeneration (senile), unspecified personal history of traumatic fracture personal history of tobacco use unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh atrial fibrillation chronic kidney disease, stage iii (moderate) disorder of bone and cartilage, unspecified diseases of tricuspid valve bronchiectasis without acute exacerbation pathologic fracture of neck of femur monoclonal paraproteinemia chronic diastolic heart failure congestive heart failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation mitral valve disorders unspecified acquired hypothyroidism 
white f 90 $nan$nan$sodium chloride 0.9%  flush  3  ml ; clobetasol propionate 0.05% cream  1  appl ; calcium carbonate  1000  mg ; levothyroxine sodium  100  mcg ; valsartan  40  mg ; vitamin d  2000  unit ; famotidine  20  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; hydrocerin  1  appl ; apixaban  2.5  mg ; loratadine  10  mg ; torsemide  10  mg ; potassium chloride  40  meq ; metoprolol succinate xl  50  mg ; metoprolol succinate xl  75  mg ; 
chronic diastolic heart failure hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified unspecified vitamin d deficiency personal history of pneumonia (recurrent) other and unspecified hyperlipidemia venous (peripheral) insufficiency, unspecified aseptic necrosis of head and neck of femur macular degeneration (senile), unspecified personal history of traumatic fracture personal history of tobacco use unspecified acquired hypothyroidism osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh atrial fibrillation chronic kidney disease, stage iii (moderate) disorder of bone and cartilage, unspecified diseases of tricuspid valve bronchiectasis without acute exacerbation pathologic fracture of neck of femur monoclonal paraproteinemia chronic diastolic heart failure congestive heart failure, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation mitral valve disorders unspecified acquired hypothyroidism 
white m 67 $nan$nan$ezetimibe  10  mg ; montelukast sodium  10  mg ; pravastatin  20  mg ; 
 
white m 67 $nan$nan$ezetimibe  10  mg ; montelukast sodium  10  mg ; pravastatin  20  mg ; heparin  5000  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; senna  1  tab ; 
 
white m 73 $temp    heartrate  88.0  resprate  22.0  o2sat  96.0  sbp  119.0  dbp  60.0  rhythm    pain  0  ; temp    heartrate  82.0  resprate  20.0  o2sat  98.0  sbp  126.0  dbp  60.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  20.0  o2sat  97.0  sbp  146.0  dbp  65.0  rhythm    pain    ; temp    heartrate  86.0  resprate  24.0  o2sat  95.0  sbp  117.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  93.0  resprate  20.0  o2sat  98.0  sbp  143.0  dbp  75.0  rhythm    pain  0  $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.9  mmol l$bag  1  bag ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  40  mg ; losartan potassium  100  mg ; metoprolol succinate xl  50  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; isosorbide mononitrate (extended release)  30  mg ; potassium chloride  60  meq ; magnesium sulfate  2  gm ; furosemide  80  mg ; hydralazine  10  mg ; sodium chloride 0.9%  1000  ml ; 5% dextrose  250  ml ; dobutamine  250  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
 
white m 73 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  106  mg dl; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  1.2  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; isosorbide mononitrate (extended release)  30  mg ; hydralazine  10  mg ; lidocaine jelly 2% (urojet)  1  appl ; furosemide  120  mg ; potassium chloride  40  meq ; 5% dextrose  50  ml ; furosemide  250  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
white m 73 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  122  mg dl; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.1  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; isosorbide mononitrate (extended release)  30  mg ; hydralazine  10  mg ; potassium chloride  40  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
white m 73 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  134  mg dl; chemistry blood glucose  109  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; isosorbide mononitrate (extended release)  30  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride  20  meq ; hydralazine  20  mg ; 
 
white m 73 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  113  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; isosorbide mononitrate (extended release)  30  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; potassium chloride  20  meq ; hydralazine  20  mg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; 
 
white m 73 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydralazine  20  mg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; isosorbide mononitrate (extended release)  60  mg ; spironolactone  12.5  mg ; hydralazine  25  mg ; 
 
white m 73 $nan$hematology blood hematocrit  37.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; miconazole powder 2%  1  appl ; isosorbide mononitrate (extended release)  60  mg ; spironolactone  12.5  mg ; hydralazine  25  mg ; 
 
white m 73 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; miconazole powder 2%  1  appl ; spironolactone  12.5  mg ; hydralazine  25  mg ; 
 
white m 73 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; miconazole powder 2%  1  appl ; spironolactone  12.5  mg ; hydralazine  25  mg ; torsemide  40  mg ; carvedilol  3.125  mg ; 
 
white m 73 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; losartan potassium  100  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; aspirin  81  mg ; miconazole powder 2%  1  appl ; spironolactone  12.5  mg ; hydralazine  25  mg ; torsemide  40  mg ; carvedilol  3.125  mg ; 
 
white f 75 $temp    heartrate  94.0  resprate  14.0  o2sat  100.0  sbp  134.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  15.2  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  26.9  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  413  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.6  g dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; cyanocobalamin  1000  mcg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; sucralfate  1  gm ; albuterol inhaler  1  puff ; 
ulcer of esophagus without bleeding unspecified essential hypertension secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acquired hypertrophic pyloric stenosis urinary tract infection, site not specified anemia in neoplastic disease esophageal reflux malignant neoplasm of pylorus loss of weight esophagitis, unspecified chronic cholecystitis 
white f 75 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  26.0  %$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; cyanocobalamin  1000  mcg ; sodium chloride 0.9%  flush  3  ml ; sucralfate  1  gm ; albuterol inhaler  1  puff ; ondansetron odt  4  mg ; 
ulcer of esophagus without bleeding unspecified essential hypertension secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes acquired hypertrophic pyloric stenosis urinary tract infection, site not specified anemia in neoplastic disease esophageal reflux malignant neoplasm of pylorus loss of weight esophagitis, unspecified chronic cholecystitis 
white m 61 $nan$hematology blood hematocrit  35.0  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  244  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  142  iu l; chemistry blood lactate dehydrogenase (ld)  181  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; alprazolam  0.5  mg ; fluconazole  200  mg ; metoprolol tartrate  12.5  mg ; mirtazapine  15  mg ; sulindac  150  mg ; prochlorperazine  10  mg ; sodium chloride 0.9%  1000  ml ; levofloxacin  750  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; gastroview (diatrizoate meglumine & sodium)  30  ml ; acetaminophen  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere intestinal bypass and anastomosis status acute kidney failure, unspecified personal history of other malignant neoplasm of skin bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere acquired absence of other specified parts of digestive tract anemia, unspecified fistula of intestine anxiety disorder, unspecified family history of colonic polyps acquired absence of stomach [part of] unspecified osteoarthritis, unspecified site personal history of colonic polyps peritoneal abscess hydronephrosis with renal and ureteral calculous obstruction enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue insomnia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for examination for normal comparison and control in clinical research program klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere insomnia, unspecified peritoneal abscess personal history of other malignant neoplasm of skin unspecified place or not applicable fistula of intestine enterococcus as the cause of diseases classified elsewhere acute kidney failure, unspecified insomnia, unspecified essential (primary) hypertension intra-abdominal and pelvic swelling, mass and lump, unspecified site neoplasm of uncertain behavior of connective and other soft tissue peritoneal abscess anxiety disorder, unspecified personal history of other malignant neoplasm of skin personal history of other specified conditions delirium due to conditions classified elsewhere anxiety state, unspecified scar conditions and fibrosis of skin bilious emesis examination of participant in clinical trial peritoneal adhesions (postoperative) (postinfection) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acquired partial absence of pancreas pulmonary collapse
white m 61 $nan$hematology blood hematocrit  28.5  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  148  k ul; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  141  iu l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  3.6  mmol l$0.9% sodium chloride  500  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; alprazolam  0.5  mg ; fluconazole  200  mg ; mirtazapine  15  mg ; sulindac  150  mg ; prochlorperazine  10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium phosphate  30  mmol ; lactated ringers  1000  ml ; 0.9% sodium chloride  250  ml ; gentamicin sulfate  490  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; acetaminophen  650  mg ; 
klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere intestinal bypass and anastomosis status acute kidney failure, unspecified personal history of other malignant neoplasm of skin bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere acquired absence of other specified parts of digestive tract anemia, unspecified fistula of intestine anxiety disorder, unspecified family history of colonic polyps acquired absence of stomach [part of] unspecified osteoarthritis, unspecified site personal history of colonic polyps peritoneal abscess hydronephrosis with renal and ureteral calculous obstruction enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue insomnia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for examination for normal comparison and control in clinical research program klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere insomnia, unspecified peritoneal abscess personal history of other malignant neoplasm of skin unspecified place or not applicable fistula of intestine enterococcus as the cause of diseases classified elsewhere acute kidney failure, unspecified insomnia, unspecified essential (primary) hypertension intra-abdominal and pelvic swelling, mass and lump, unspecified site neoplasm of uncertain behavior of connective and other soft tissue peritoneal abscess anxiety disorder, unspecified personal history of other malignant neoplasm of skin personal history of other specified conditions delirium due to conditions classified elsewhere anxiety state, unspecified scar conditions and fibrosis of skin bilious emesis examination of participant in clinical trial peritoneal adhesions (postoperative) (postinfection) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acquired partial absence of pancreas pulmonary collapse
white m 61 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; alprazolam  0.5  mg ; fluconazole  200  mg ; mirtazapine  15  mg ; prochlorperazine  10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  250  ml ; gentamicin sulfate  490  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; acetaminophen  650  mg ; 
klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere intestinal bypass and anastomosis status acute kidney failure, unspecified personal history of other malignant neoplasm of skin bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere acquired absence of other specified parts of digestive tract anemia, unspecified fistula of intestine anxiety disorder, unspecified family history of colonic polyps acquired absence of stomach [part of] unspecified osteoarthritis, unspecified site personal history of colonic polyps peritoneal abscess hydronephrosis with renal and ureteral calculous obstruction enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue insomnia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for examination for normal comparison and control in clinical research program klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere insomnia, unspecified peritoneal abscess personal history of other malignant neoplasm of skin unspecified place or not applicable fistula of intestine enterococcus as the cause of diseases classified elsewhere acute kidney failure, unspecified insomnia, unspecified essential (primary) hypertension intra-abdominal and pelvic swelling, mass and lump, unspecified site neoplasm of uncertain behavior of connective and other soft tissue peritoneal abscess anxiety disorder, unspecified personal history of other malignant neoplasm of skin personal history of other specified conditions delirium due to conditions classified elsewhere anxiety state, unspecified scar conditions and fibrosis of skin bilious emesis examination of participant in clinical trial peritoneal adhesions (postoperative) (postinfection) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acquired partial absence of pancreas pulmonary collapse
white m 61 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; alprazolam  0.5  mg ; fluconazole  200  mg ; mirtazapine  15  mg ; prochlorperazine  10  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; acetaminophen  650  mg ; 
klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere intestinal bypass and anastomosis status acute kidney failure, unspecified personal history of other malignant neoplasm of skin bacteroides fragilis [b. fragilis] as the cause of diseases classified elsewhere acquired absence of other specified parts of digestive tract anemia, unspecified fistula of intestine anxiety disorder, unspecified family history of colonic polyps acquired absence of stomach [part of] unspecified osteoarthritis, unspecified site personal history of colonic polyps peritoneal abscess hydronephrosis with renal and ureteral calculous obstruction enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue insomnia, unspecified other mechanical complication of other specified internal prosthetic devices, implants and grafts, initial encounter enterococcus as the cause of diseases classified elsewhere neoplasm of uncertain behavior of connective and other soft tissue other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure encounter for examination for normal comparison and control in clinical research program klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere insomnia, unspecified peritoneal abscess personal history of other malignant neoplasm of skin unspecified place or not applicable fistula of intestine enterococcus as the cause of diseases classified elsewhere acute kidney failure, unspecified insomnia, unspecified essential (primary) hypertension intra-abdominal and pelvic swelling, mass and lump, unspecified site neoplasm of uncertain behavior of connective and other soft tissue peritoneal abscess anxiety disorder, unspecified personal history of other malignant neoplasm of skin personal history of other specified conditions delirium due to conditions classified elsewhere anxiety state, unspecified scar conditions and fibrosis of skin bilious emesis examination of participant in clinical trial peritoneal adhesions (postoperative) (postinfection) other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms acquired partial absence of pancreas pulmonary collapse
unknown f 72 $nan$nan$multivitamins  1  tab ; 
 
unknown f 72 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  18  meq l; chemistry urine creatinine, urine  63  mg dl; chemistry urine potassium, urine  27  meq l; chemistry urine sodium, urine  14  meq l; chemistry blood calcium, total  16.9  mg dl; chemistry blood calcium, total  13.8  mg dl; chemistry blood calcium, total  14.8  mg dl; chemistry blood calcium, total  14.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  371  iu l; chemistry blood lactate dehydrogenase (ld)  393  iu l; chemistry blood lactate dehydrogenase (ld)  424  iu l; chemistry blood lactate dehydrogenase (ld)  447  iu l; chemistry blood albumin  3.5  g dl; blood gas blood free calcium  2.18  mmol l$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride  1000  ml ; sertraline  50  mg ; acetaminophen  325-650  mg ; calcitonin salmon  300  unit ; 0.9% sodium chloride  250  ml ; pamidronate  60  mg ; allopurinol  300  mg ; 0.9% sodium chloride  50  ml ; rasburicase  6  mg ; trazodone  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; 
 
unknown f 72 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  12.4  mg dl; chemistry blood calcium, total  12.2  mg dl; chemistry blood calcium, total  12.3  mg dl; chemistry blood calcium, total  13.2  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  125  mg dl; chemistry blood lactate dehydrogenase (ld)  456  iu l; chemistry blood lactate dehydrogenase (ld)  462  iu l; chemistry blood lactate dehydrogenase (ld)  447  iu l; chemistry blood lactate dehydrogenase (ld)  432  iu l; chemistry blood albumin  3.4  g dl; blood gas blood free calcium  1.65  mmol l$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; calcitonin salmon  300  unit ; 0.9% sodium chloride  250  ml ; pamidronate  60  mg ; allopurinol  300  mg ; 0.9% sodium chloride  50  ml ; rasburicase  6  mg ; trazodone  25  mg ; bag  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20  meq ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; ondansetron  8  mg ; dexamethasone  12  mg ; lorazepam  0.5-1  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; rituximab  630  mg ; etoposide  125  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  278  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  11.9  mg dl; chemistry blood calcium, total  11.7  mg dl; chemistry blood calcium, total  11.4  mg dl; chemistry blood calcium, total  10.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  457  iu l; chemistry blood lactate dehydrogenase (ld)  448  iu l; chemistry blood lactate dehydrogenase (ld)  412  iu l; chemistry blood lactate dehydrogenase (ld)  415  iu l$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; potassium chloride  40  meq ; neutra-phos  2  pkt ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride  500  ml ; rituximab  630  mg ; etoposide  125  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 5% dextrose  250  ml ; carboplatin  280  mg ; mesna  6300  mg ; ifosfamide  6300  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  420  iu l; chemistry blood lactate dehydrogenase (ld)  384  iu l; chemistry blood albumin  3.4  g dl$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; etoposide  125  mg ; 5% dextrose  250  ml ; carboplatin  280  mg ; mesna  6300  mg ; ifosfamide  6300  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  119  mg dl; chemistry blood lactate dehydrogenase (ld)  360  iu l; chemistry blood lactate dehydrogenase (ld)  318  iu l; chemistry blood albumin  3.4  g dl; chemistry blood albumin  3.2  g dl$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; etoposide  125  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  75  mg dl; chemistry blood lactate dehydrogenase (ld)  321  iu l; chemistry blood albumin  3.1  g dl$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; polyethylene glycol  17  g ; 
 
unknown f 72 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  211  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  46  mg dl; chemistry urine chloride, urine  45  meq l; chemistry urine creatinine, urine  29  mg dl; chemistry urine potassium, urine  49  meq l; chemistry urine sodium, urine  60  meq l; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  82  mg dl; chemistry blood glucose  118  mg dl; chemistry blood lactate dehydrogenase (ld)  346  iu l$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; polyethylene glycol  17  g ; 
 
unknown f 72 $nan$hematology blood hematocrit  24.3  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  107  mg dl$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; polyethylene glycol  17  g ; 0.45% sodium chloride  1000  ml ; 
 
unknown f 72 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  83  k ul; hematology blood platelet count  79  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  40  mg dl; hematology urine wbc  16  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  92  mg dl; hematology urine glucose  300  mg dl$multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; polyethylene glycol  17  g ; sodium bicarbonate  650  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  45  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  13  meq l; chemistry blood chloride  114  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry urine chloride, urine  44  meq l; chemistry urine potassium, urine  37  meq l; chemistry urine sodium, urine  52  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  96  mg dl; hematology blood bands  0  %; chemistry urine bicarbonate, urine  6.2  meq l; chemistry urine calcium, urine  1.8  mg dl$lactated ringers  1000  ml ; sterile water  100  ml ; multivitamins  1  tab ; heparin  5000  unit ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; polyethylene glycol  17  g ; sodium bicarbonate  650  mg ; sodium bicarbonate  1300  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  27  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology urine wbc  2  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  119  mg dl; hematology blood bands  0  %; hematology urine glucose  300  mg dl; hematology urine glucose  1000  mg dl$sterile water  100  ml ; multivitamins  1  tab ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; polyethylene glycol  17  g ; sodium bicarbonate  1300  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 
 
unknown f 72 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  22.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  9  k ul; hematology blood platelet count  74  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  120  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  167  mg dl; chemistry blood lactate dehydrogenase (ld)  291  iu l; chemistry blood albumin  3.1  g dl; hematology blood bands  0  %; blood gas blood lactate  0.6  mmol l$multivitamins  1  tab ; sertraline  50  mg ; acetaminophen  325-650  mg ; allopurinol  300  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; senna  1  tab ; omeprazole  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; polyethylene glycol  17  g ; sodium bicarbonate  1300  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate  1  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; lorazepam  1  mg ; furosemide  20  mg ; vial  1  vial ; pantoprazole  40  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  21.4  %; hematology blood hematocrit  20.9  %; hematology blood hematocrit  19.9  %; hematology blood hemoglobin  7.2  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  46  k ul; hematology blood platelet count  32  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  120  meq l; chemistry blood chloride  121  meq l; chemistry blood chloride  122  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, indirect  0.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  123  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  263  iu l; chemistry blood lactate dehydrogenase (ld)  242  iu l; hematology blood bands  0  %; blood gas blood lactate  0.8  mmol l; chemistry blood bilirubin, direct  0.3  mg dl$sertraline  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; fluticasone-salmeterol diskus (250 50)   1  inh ; furosemide  20  mg ; vial  1  vial ; pantoprazole  40  mg ; allopurinol  100  mg ; furosemide  40  mg ; sterile water  50  ml ; sterile water  150  ml ; potassium chloride  60  meq ; diltiazem  15  mg ; diltiazem  30  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; diltiazem  20  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; furosemide  80  mg ; bag  100  ml ; magnesium sulfate  4  gm ; metolazone  5  mg ; quetiapine fumarate  25  mg ; 5% dextrose  500  ml ; sodium bicarbonate  50  meq ; hydromorphone (dilaudid)  0.25  mg ; 
 
unknown f 72 $nan$hematology blood hematocrit  22.9  %; hematology blood hematocrit  22.2  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  18  k ul; hematology blood platelet count  13  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  117  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  139  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  142  mg dl; blood gas blood lactate  0.5  mmol l$sertraline  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vial  1  vial ; pantoprazole  40  mg ; allopurinol  100  mg ; sterile water  50  ml ; sterile water  150  ml ; potassium chloride  60  meq ; diltiazem  15  mg ; diltiazem  20  mg ; amiodarone  150  mg ; furosemide  80  mg ; bag  100  ml ; magnesium sulfate  4  gm ; metolazone  5  mg ; quetiapine fumarate  25  mg ; sodium bicarbonate  50  meq ; hydromorphone (dilaudid)  0.25  mg ; morphine sulfate  0.5  mg ; sodium glycerophosphate  20  mmol ; 
 
unknown f 72 $nan$hematology blood hematocrit  21.9  %; hematology blood hematocrit  21.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  11  k ul; hematology blood platelet count  6  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  119  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  3.8  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  109  mg dl; hematology blood bands  0  %; hematology blood bands  2  %; blood gas blood lactate  0.6  mmol l$sertraline  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vial  1  vial ; pantoprazole  40  mg ; allopurinol  100  mg ; sterile water  50  ml ; sterile water  150  ml ; potassium chloride  60  meq ; morphine sulfate  0.5  mg ; sodium glycerophosphate  20  mmol ; hydromorphone (dilaudid)  0.125  mg ; 5% dextrose  50  ml ; furosemide  120  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; chlorothiazide sodium  500  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; morphine sulfate  4-10  mg ; lorazepam  0.5-2  mg ; olanzapine (disintegrating tablet)  5  mg ; ondansetron  4-8  mg ; 
 
unknown f 72 $nan$nan$sertraline  50  mg ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; ondansetron  8  mg ; prochlorperazine  10  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate  4-10  mg ; olanzapine (disintegrating tablet)  5  mg ; ondansetron  4-8  mg ; scopolamine patch  1  ptch ; glycopyrrolate  0.2  mg ; hyoscyamine  0.125  mg ; 
 
other f 45 $nan$blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  108  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hemoglobin  13.6  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood calculated bicarbonate, whole blood  28  meq l$bisacodyl  10  mg ; omeprazole  20  mg ; simvastatin  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen  325-650  mg ; albuterol inhaler  1  puff ; alprazolam  2  mg ; baclofen  10  mg ; cyclobenzaprine  10  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; oxycodone sr (oxycontin)  40  mg ; oxycodone (immediate release)   30  mg ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; clonidine  0.1  mg ; senna  1  tab ; 
scoliosis [and kyphoscoliosis], idiopathic urinary tract infection, site not specified esophageal reflux drug-induced delirium asthma, unspecified type, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other mechanical complication of other internal orthopedic device, implant, and graft metabolic encephalopathy dysthymic disorder other drugs and medicinal substances causing adverse effects in therapeutic use unspecified pleural effusion tobacco use disorder surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diaphragmatic hernia without mention of obstruction or gangrene person boarding or alighting a car injured in collision with railway train or railway vehicle chronic hepatitis c without mention of hepatic coma other chronic pain scoliosis [and kyphoscoliosis], idiopathic lumbago tobacco use disorder asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status gout, unspecified opioid type dependence, continuous arthropathy, unspecified, site unspecified esophageal reflux degeneration of lumbar or lumbosacral intervertebral disc
other f 45 $nan$nan$bisacodyl  10  mg ; omeprazole  20  mg ; simvastatin  5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; albuterol inhaler  1  puff ; alprazolam  2  mg ; baclofen  10  mg ; cyclobenzaprine  10  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; 0.9% sodium chloride  500  ml ; docusate sodium  100  mg ; clonidine  0.1  mg ; senna  1  tab ; oxycodone (immediate release)   15-30  mg ; diphenhydramine  50  mg ; 
scoliosis [and kyphoscoliosis], idiopathic urinary tract infection, site not specified esophageal reflux drug-induced delirium asthma, unspecified type, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other mechanical complication of other internal orthopedic device, implant, and graft metabolic encephalopathy dysthymic disorder other drugs and medicinal substances causing adverse effects in therapeutic use unspecified pleural effusion tobacco use disorder surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diaphragmatic hernia without mention of obstruction or gangrene person boarding or alighting a car injured in collision with railway train or railway vehicle chronic hepatitis c without mention of hepatic coma other chronic pain scoliosis [and kyphoscoliosis], idiopathic lumbago tobacco use disorder asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status gout, unspecified opioid type dependence, continuous arthropathy, unspecified, site unspecified esophageal reflux degeneration of lumbar or lumbosacral intervertebral disc
other f 45 $nan$nan$bisacodyl  10  mg ; omeprazole  20  mg ; simvastatin  5  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; albuterol inhaler  1  puff ; alprazolam  2  mg ; baclofen  10  mg ; cyclobenzaprine  10  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; docusate sodium  100  mg ; clonidine  0.1  mg ; senna  1  tab ; oxycodone (immediate release)   15-30  mg ; diphenhydramine  50  mg ; oxycodone (immediate release)   15  mg ; 
scoliosis [and kyphoscoliosis], idiopathic urinary tract infection, site not specified esophageal reflux drug-induced delirium asthma, unspecified type, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation other mechanical complication of other internal orthopedic device, implant, and graft metabolic encephalopathy dysthymic disorder other drugs and medicinal substances causing adverse effects in therapeutic use unspecified pleural effusion tobacco use disorder surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diaphragmatic hernia without mention of obstruction or gangrene person boarding or alighting a car injured in collision with railway train or railway vehicle chronic hepatitis c without mention of hepatic coma other chronic pain scoliosis [and kyphoscoliosis], idiopathic lumbago tobacco use disorder asthma, unspecified type, unspecified other mechanical complication of other internal orthopedic device, implant, and graft arthrodesis status gout, unspecified opioid type dependence, continuous arthropathy, unspecified, site unspecified esophageal reflux degeneration of lumbar or lumbosacral intervertebral disc
white m 84 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  26.8  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  197  k ul; hematology blood platelet count  184  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; vial  1  vial ; pantoprazole  40  mg ; clopidogrel  75  mg ; heparin  1300  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; nitroglycerin sl  0.3  mg ; morphine sulfate  1-2  mg ; labetalol  200  mg ; aspirin  325  mg ; morphine sulfate  2-4  mg ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
white m 84 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  32.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  198  k ul; hematology blood platelet count  235  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  122  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; vial  1  vial ; pantoprazole  40  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; atorvastatin  40  mg ; ramelteon  8  mg ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
white m 84 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  189  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood glucose  108  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; vial  1  vial ; pantoprazole  40  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; atorvastatin  40  mg ; ramelteon  8  mg ; trazodone  25  mg ; moviprep  2  l ; bag  1  bag ; magnesium sulfate  2  gm ; metoprolol tartrate  12.5  mg ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
white m 84 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  106  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; atorvastatin  40  mg ; ramelteon  8  mg ; trazodone  25  mg ; moviprep  2  l ; bag  1  bag ; magnesium sulfate  2  gm ; metoprolol tartrate  12.5  mg ; furosemide  40  mg ; losartan potassium  100  mg ; rivaroxaban  20  mg ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
white m 84 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  104  mg dl$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; atorvastatin  40  mg ; ramelteon  8  mg ; trazodone  25  mg ; moviprep  2  l ; metoprolol tartrate  12.5  mg ; furosemide  40  mg ; losartan potassium  100  mg ; metoprolol succinate xl  37.5  mg ; sodium chloride 0.9%  1000  ml ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
white m 84 $nan$nan$albuterol 0.083% neb soln  1  neb ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; clopidogrel  75  mg ; nitroglycerin sl  0.3  mg ; morphine sulfate  2-4  mg ; atorvastatin  40  mg ; ramelteon  8  mg ; trazodone  25  mg ; moviprep  2  l ; metoprolol succinate xl  37.5  mg ; furosemide  20  mg ; 
chronic obstructive pulmonary disease, unspecified unspecified atrial fibrillation personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis mixed hyperlipidemia long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants pulmonary hypertension, unspecified essential (primary) hypertension atherosclerotic heart disease of native coronary artery without angina pectoris encounter for examination for normal comparison and control in clinical research program combined rheumatic disorders of mitral, aortic and tricuspid valves long term (current) use of anticoagulants body mass index (bmi) 29.0-29.9, adult hyperlipidemia, unspecified dependence on supplemental oxygen obesity, unspecified chronic obstructive pulmonary disease, unspecified benign prostatic hyperplasia without lower urinary tract symptoms atherosclerotic heart disease of native coronary artery without angina pectoris nonrheumatic aortic (valve) stenosis hypertensive heart disease with heart failure personal history of nicotine dependence acute systolic (congestive) heart failure chronic atrial fibrillation personal history of nicotine dependence unspecified atrial fibrillation acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia atherosclerotic heart disease of native coronary artery without angina pectoris influenza due to unidentified influenza virus with other respiratory manifestations chronic obstructive pulmonary disease with (acute) exacerbation hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis acute bronchitis, unspecified chronic obstructive pulmonary disease with (acute) exacerbation unspecified atrial fibrillation essential (primary) hypertension hyperlipidemia, unspecified acute respiratory failure with hypoxia chronic obstructive pulmonary disease with (acute) lower respiratory infection gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence influenza due to unidentified influenza virus with other respiratory manifestations sepsis, unspecified organism obstructive chronic bronchitis with (acute) exacerbation other and unspecified hyperlipidemia unspecified essential hypertension
black african american m 32 $nan$hematology blood hematocrit  43.0  %; hematology blood hematocrit  42.6  %; hematology blood hemoglobin  14.8  g dl; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  253  k ul; hematology blood platelet count  275  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  126  mg dl$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology urine wbc  1  # hpf$iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; 0.9% sodium chloride  500  ml ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  236  k ul$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ondansetron  4  mg ; 0.9% sodium chloride  500  ml ; bisacodyl  10  mg ; lr  1000  ml ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$nan$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; lr  1000  ml ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ceftriaxone  2  gm ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood inr(pt)  1.1  $docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  500-1000  mg ; vancomycin  1500  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  36.4  %; hematology blood hematocrit  36.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  246  k ul; hematology blood platelet count  298  k ul; chemistry blood creatinine  0.8  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood albumin  3.4  g dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  500-1000  mg ; vancomycin  1500  mg ; vancomycin  2000  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$nan$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; vancomycin  1500  mg ; vancomycin  2000  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  38.1  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.5  g dl; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  386  k ul; hematology blood platelet count  409  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  103  mg dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; vancomycin  1500  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; vancomycin  1750  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  455  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  120  mg dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  131  mg dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  408  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  387  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology urine wbc  3  # hpf$docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$hematology blood hematocrit  36.8  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  415  k ul; hematology blood platelet count  375  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  109  mg dl$5% dextrose  500  ml ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  150  ml ; vancomycin  250  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
black african american m 32 $nan$nan$5% dextrose  500  ml ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; acetaminophen  500-1000  mg ; oxycodone (immediate release)   15  mg ; oxycodone (immediate release)   5  mg ; heparin flush (10 units ml)  2  ml ; 5% dextrose  150  ml ; vancomycin  250  mg ; 
other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of one rib nontoxic uninodular goiter open wound of forehead, without mention of complication closed fracture of multiple cervical vertebrae 
white m 70 $nan$hematology blood hematocrit  44.7  %; hematology blood hematocrit  42.0  %; hematology blood hematocrit  40.4  %; hematology blood hemoglobin  14.7  g dl; hematology blood hemoglobin  14.4  g dl; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  298  k ul; hematology blood platelet count  251  k ul; hematology blood platelet count  205  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  321  mg dl; chemistry blood glucose  84  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  1156  iu l; chemistry blood lactate dehydrogenase (ld)  1876  iu l; chemistry blood lactate dehydrogenase (ld)  2091  iu l; chemistry blood albumin  3.8  g dl; chemistry blood albumin  3.8  g dl; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  .96  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  242  mg dl; blood gas blood glucose  175  mg dl; blood gas blood potassium, whole blood  3.2  meq l; hematology urine glucose  300  mg dl; chemistry blood % hemoglobin a1c  7.4  %$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; aspirin ec  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; pantoprazole  40  mg ; heparin sodium  25,000  unit ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; furosemide  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; metoprolol tartrate  2.5  mg ; furosemide  40  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 
 
white m 70 $nan$hematology blood hematocrit  36.7  %; hematology blood hematocrit  36.6  %; hematology blood hematocrit  35.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  149  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  255  mg dl; chemistry blood glucose  274  mg dl; chemistry blood lactate dehydrogenase (ld)  1873  iu l; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood glucose  247  mg dl; blood gas blood glucose  140  mg dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  2.5  meq l$cefepime  1  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; aspirin ec  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; furosemide  20  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; metoprolol tartrate  2.5  mg ; furosemide  40  mg ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; cefepime  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  10  unit ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 
 
white m 70 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  136  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  281  mg dl; chemistry blood glucose  214  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood glucose  262  mg dl; blood gas blood potassium, whole blood  3.6  meq l$cefepime  1  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; aspirin ec  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; furosemide  40  mg ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  10  unit ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; furosemide  60  mg ; metoprolol tartrate  5  mg ; oxycodone (immediate release)  5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  28.3  %; hematology blood hematocrit  32.5  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  86  k ul; hematology blood platelet count  81  k ul; hematology blood platelet count  79  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  181  mg dl; hematology blood bands  2  %; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.01  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  5.1  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  223  mg dl; blood gas blood glucose  224  mg dl; blood gas blood glucose  213  mg dl; blood gas blood glucose  206  mg dl; blood gas blood glucose  182  mg dl; blood gas blood glucose  276  mg dl; blood gas blood glucose  200  mg dl; blood gas blood glucose  181  mg dl; blood gas blood glucose  148  mg dl; blood gas blood glucose  82  mg dl; blood gas blood glucose  180  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  9.4  g dl; blood gas blood hemoglobin  9.6  g dl; blood gas blood hemoglobin  8.8  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  132  meq l$cefepime  1  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; albuterol 0.083% neb soln  1  neb ; aspirin ec  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ondansetron  4  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; metoprolol tartrate  5  mg ; oxycodone (immediate release)  5  mg ; insulin  4  unit ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; acetaminophen  650  mg ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; norepinephrine  8  mg ; epinephrine  2  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; atorvastatin  40  mg ; mupirocin ointment 2%  1  appl ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; albumin 5% (25g   500ml)  25  g ; acetaminophen iv  1000  mg ; 
 
white m 70 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  23.4  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  83  k ul; hematology blood platelet count  93  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  125  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood glucose  110  mg dl; blood gas blood glucose  116  mg dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  3.8  meq l$iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; phenylephrine  60  mg ; syringe (iso-osmotic dextrose)  50  ml ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; acetaminophen  650  mg ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; norepinephrine  8  mg ; epinephrine  2  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atorvastatin  40  mg ; mupirocin ointment 2%  1  appl ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; albumin 5% (25g   500ml)  25  g ; acetaminophen iv  1000  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin  81  mg ; milk of magnesia  30  ml ; d5w  100  ml ; milrinone  20  mg ; 
 
white m 70 $nan$hematology blood hematocrit  25.7  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  130  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood glucose  95  mg dl; blood gas blood glucose  84  mg dl; blood gas blood glucose  139  mg dl; blood gas blood glucose  181  mg dl; blood gas blood glucose  132  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.8  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.4  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; norepinephrine  8  mg ; epinephrine  2  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atorvastatin  40  mg ; mupirocin ointment 2%  1  appl ; aspirin  81  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; fentanyl citrate  100  mcg ; propofol  20  mg ; albumin 25% (12.5g   50ml)  12.5  g ; 5% dextrose  50  ml ; furosemide  250  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; albumin 5% (12.5g   250ml)  12.5  g ; midazolam  0.5-1  mg ; 
 
white m 70 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  25.6  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  159  mg dl; chemistry blood lactate dehydrogenase (ld)  848  iu l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood glucose  131  mg dl; blood gas blood glucose  170  mg dl; blood gas blood glucose  159  mg dl; blood gas blood glucose  99  mg dl; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  3.7  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; norepinephrine  8  mg ; epinephrine  2  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atorvastatin  40  mg ; mupirocin ointment 2%  1  appl ; aspirin  81  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; fentanyl citrate  100  mcg ; propofol  20  mg ; albumin 25% (12.5g   50ml)  12.5  g ; 5% dextrose  50  ml ; furosemide  250  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; albumin 5% (12.5g   250ml)  12.5  g ; midazolam  0.5-1  mg ; fentanyl citrate  2.5  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; epinephrine  8  mg ; nystatin oral suspension  5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dexmedetomidine  0.4  mg ; 
 
white m 70 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  140  k ul; hematology blood platelet count  132  k ul; hematology blood platelet count  147  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  144  mg dl; chemistry blood lactate dehydrogenase (ld)  814  iu l; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood glucose  87  mg dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.7  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atorvastatin  40  mg ; mupirocin ointment 2%  1  appl ; aspirin  81  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; midazolam  0.5-1  mg ; fentanyl citrate  2.5  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; epinephrine  8  mg ; nystatin oral suspension  5  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; dexmedetomidine  0.4  mg ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; 
 
white m 70 $nan$hematology blood hematocrit  28.7  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  69  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  213  mg dl; chemistry blood lactate dehydrogenase (ld)  856  iu l; chemistry blood albumin  2.6  g dl; chemistry blood albumin  2.6  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  93  mg dl; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood potassium, whole blood  3.3  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; bag  1  ml ; norepinephrine  8  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; atorvastatin  40  mg ; aspirin  81  mg ; midazolam  0.5-1  mg ; fentanyl citrate  2.5  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; epinephrine  8  mg ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; acetaminophen  325-650  mg ; ipratropium-albuterol neb  1  neb ; warfarin  1  mg ; insulin  20  unit ; 
 
white m 70 $nan$hematology blood hematocrit  28.0  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  154  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  126  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.14  mmol l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; norepinephrine  8  mg ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; acetaminophen  325-650  mg ; ipratropium-albuterol neb  1  neb ; warfarin  1  mg ; insulin  20  unit ; sodium chloride 0.9%  1000  ml ; warfarin  2.5  mg ; warfarin  1  dose ; hydralazine  5  mg ; isordil  5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  156  meq l; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  296  mg dl; chemistry blood glucose  278  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood free calcium  1.08  mmol l$5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  1000  ml ; warfarin  2.5  mg ; warfarin  1  dose ; hydralazine  5  mg ; isordil  5  mg ; amiodarone  400  mg ; carvedilol  3.125  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.7  %; hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  216  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  2.3  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  196  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood glucose  255  mg dl; blood gas blood glucose  190  mg dl$5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; ipratropium-albuterol neb  1  neb ; sodium chloride 0.9%  1000  ml ; warfarin  1  dose ; hydralazine  5  mg ; isordil  5  mg ; amiodarone  400  mg ; carvedilol  3.125  mg ; 
 
white m 70 $nan$hematology blood hematocrit  30.2  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  4.3  ; hematology urine wbc  5  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  321  mg dl; chemistry blood glucose  165  mg dl; blood gas blood free calcium  1.01  mmol l; blood gas blood potassium, whole blood  3.8  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; sodium chloride 0.9%  1000  ml ; warfarin  1  dose ; isordil  5  mg ; amiodarone  400  mg ; carvedilol  3.125  mg ; warfarin  2  mg ; 
 
white m 70 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  493  iu l; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.09  mmol l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  150  ml ; sodium chloride 0.9%  1000  ml ; warfarin  1  dose ; amiodarone  400  mg ; warfarin  2  mg ; captopril  3.125  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  110  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood potassium, whole blood  3.7  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; 0.9% sodium chloride  150  ml ; sodium chloride 0.9%  1000  ml ; warfarin  1  dose ; amiodarone  400  mg ; captopril  3.125  mg ; warfarin  0  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  83  mg dl; chemistry blood lactate dehydrogenase (ld)  357  iu l; chemistry blood albumin  2.5  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood potassium, whole blood  3.9  meq l$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; sodium chloride 0.9%  1000  ml ; warfarin  1  dose ; amiodarone  400  mg ; captopril  3.125  mg ; warfarin  0  mg ; warfarin  0.5  mg ; captopril  6.25  mg ; 
 
white m 70 $nan$nan$sodium chloride 0.9%  flush  10  ml ; bag  1  ml ; atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; amiodarone  400  mg ; warfarin  0.5  mg ; captopril  6.25  mg ; heparin flush (10 units ml)  1  ml ; 
 
white m 70 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  326  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood glucose  196  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; captopril  6.25  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole (granules for dr suspension)  40  mg ; guaifenesin  10  ml ; 
 
white m 70 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  238  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; captopril  6.25  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole (granules for dr suspension)  40  mg ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
white m 70 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  201  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; captopril  6.25  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole (granules for dr suspension)  40  mg ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; diphenhydramine  25  mg ; 
 
white m 70 $nan$hematology blood hematocrit  29.8  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  270  k ul; hematology blood platelet count  229  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood glucose  180  mg dl; chemistry blood glucose  194  mg dl; chemistry blood glucose  185  mg dl; blood gas blood free calcium  1.02  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood glucose  105  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; captopril  6.25  mg ; heparin flush (10 units ml)  1  ml ; pantoprazole (granules for dr suspension)  40  mg ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; diphenhydramine  25  mg ; acetaminophen  1000  mg ; furosemide  80  mg ; 
 
white m 70 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  48  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  161  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; heparin flush (10 units ml)  1  ml ; pantoprazole (granules for dr suspension)  40  mg ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; acetaminophen  1000  mg ; furosemide  80  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin  5000  unit ; insulin  30  unit ; 
 
white m 70 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  64  mg dl$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; heparin flush (10 units ml)  1  ml ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin  5000  unit ; insulin  30  unit ; chlorothiazide sodium  500  mg ; insulin  16  unit ; insulin  40  unit ; lorazepam  0.5  mg ; 
 
white m 70 $nan$hematology urine wbc  4  # hpf$atorvastatin  40  mg ; artificial tears preserv. free  1-2  drop ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; heparin flush (10 units ml)  1  ml ; guaifenesin  10  ml ; heparin flush (10 units ml)  2  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin  5000  unit ; chlorothiazide sodium  500  mg ; insulin  16  unit ; insulin  40  unit ; lorazepam  0.5  mg ; warfarin  3  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; furosemide  100  mg ; insulin  46  unit ; 
 
white m 70 $nan$hematology blood hematocrit  28.0  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  60  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin  5000  unit ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; furosemide  100  mg ; insulin  46  unit ; 
 
white m 70 $nan$nan$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin  5000  unit ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  60  mg ; 
 
white m 70 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood glucose  78  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  60  mg ; metronidazole  500  mg ; 
 
white m 70 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood glucose  93  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; warfarin  1  dose ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  60  mg ; metronidazole  500  mg ; 
 
white m 70 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  56  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  60  mg ; metronidazole  500  mg ; lidocaine 1% epinephrine 1:100000  5  ml ; 
 
white m 70 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  63  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  60  mg ; metronidazole  500  mg ; 
 
white m 70 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  84  mg dl$atorvastatin  40  mg ; polyethylene glycol  17  g ; nystatin oral suspension  5  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; lorazepam  0.5  mg ; amiodarone  200  mg ; guaifenesin er  1200  mg ; sodium chloride nasal  1-2  spry ; dronabinol  2.5  mg ; torsemide  20  mg ; 
 
white f 59 $nan$hematology blood hematocrit  36.4  %; hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; ketorolac  30  mg ; morphine sulfate  50  mg ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; lr  500  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
 
white f 59 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  189  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3  ml ; ketorolac  30  mg ; morphine sulfate  50  mg ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; lr  500  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; ondansetron  4  mg ; sumatriptan succinate  6  mg ; 
 
white f 59 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; sumatriptan succinate  6  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; 
 
white f 59 $nan$nan$promethazine  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; diphenhydramine  50  mg ; 
 
white f 59 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  122  mg dl$promethazine  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; diphenhydramine  50  mg ; scopolamine patch  1  ptch ; sw  50  ml ; magnesium sulfate  2  gm ; 
 
white f 59 $nan$nan$sodium chloride 0.9%  flush  3  ml ; metoclopramide  10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; neutra-phos  1  pkt ; 
 
white f 68 $temp  98.2  heartrate  77.0  resprate  19.0  o2sat  96.0  sbp  132.0  dbp  52.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  91.0  resprate  18.0  o2sat  100.0  sbp  169.0  dbp  64.0  rhythm    pain  0  ; temp    heartrate  83.0  resprate  18.0  o2sat  99.0  sbp  154.0  dbp  55.0  rhythm    pain  0  ; temp  98.8  heartrate  88.0  resprate  18.0  o2sat    sbp  138.0  dbp  79.0  rhythm    pain    ; temp    heartrate  87.0  resprate  15.0  o2sat  98.0  sbp    dbp    rhythm    pain  0  ; temp  98.6  heartrate  80.0  resprate  16.0  o2sat  99.0  sbp  136.0  dbp  78.0  rhythm    pain  0  $nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; gabapentin  100  mg ; lorazepam  1  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; insulin  0  unit ; 
need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified peripheral vascular disease, unspecified other and unspecified hyperlipidemia personal history of colonic polyps unspecified essential hypertension iron deficiency anemia, unspecified
white f 68 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  145  mg dl; blood gas blood lactate  1.5  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; gabapentin  100  mg ; lorazepam  1  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; lisinopril  20  mg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; bag  2  bag ; magnesium sulfate  4  gm ; atorvastatin  80  mg ; 
need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified peripheral vascular disease, unspecified other and unspecified hyperlipidemia personal history of colonic polyps unspecified essential hypertension iron deficiency anemia, unspecified
white f 68 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  158  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; gabapentin  100  mg ; lorazepam  1  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; lisinopril  20  mg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; bag  2  bag ; magnesium sulfate  4  gm ; atorvastatin  80  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified peripheral vascular disease, unspecified other and unspecified hyperlipidemia personal history of colonic polyps unspecified essential hypertension iron deficiency anemia, unspecified
white f 68 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  142  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; lorazepam  1  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; lisinopril  20  mg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; 
need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified peripheral vascular disease, unspecified other and unspecified hyperlipidemia personal history of colonic polyps unspecified essential hypertension iron deficiency anemia, unspecified
white f 68 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  330  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  81  mg ; lorazepam  1  mg ; nitroglycerin sl  0.4  mg ; omeprazole  20  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5  mg ; senna  8.6  mg ; insulin  0  unit ; metoprolol tartrate  12.5  mg ; lisinopril  20  mg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; 
need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery chronic airway obstruction, not elsewhere classified peripheral vascular disease, unspecified other and unspecified hyperlipidemia personal history of colonic polyps unspecified essential hypertension iron deficiency anemia, unspecified
white f 47 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  86  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; 
 
white m 50 $temp  99.1  heartrate  85.0  resprate  18.0  o2sat  99.0  sbp  117.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  40.7  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  94  mg dl; blood gas blood lactate  0.8  mmol l$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; ondansetron  4  mg ; fluticasone propionate 110mcg  2  puff ; lorazepam  0.25  mg ; chloraseptic throat spray  1  spry ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; 
 
white m 50 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; ondansetron  4  mg ; fluticasone propionate 110mcg  2  puff ; lorazepam  0.25  mg ; chloraseptic throat spray  1  spry ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; sw  400  ml ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white f 75 $nan$hematology blood hematocrit  29.3  %; hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  144  k ul; hematology blood platelet count  133  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  94  mg dl$mirtazapine  15  mg ; bag  1  bag ; magnesium sulfate  4  gm ; levothyroxine sodium  50  mcg ; diltiazem extended-release  300  mg ; sertraline  50  mg ; enoxaparin sodium  40  mg ; 
 
white f 75 $nan$hematology blood hematocrit  21.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  75  mg dl$mirtazapine  15  mg ; bag  1  bag ; magnesium sulfate  4  gm ; levothyroxine sodium  50  mcg ; diltiazem extended-release  300  mg ; sertraline  50  mg ; enoxaparin sodium  40  mg ; rosuvastatin calcium  10  mg ; potassium chloride  20  meq ; acetaminophen iv  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; oxycodone (immediate release)  2.5  mg ; morphine sulfate  0.5-1  mg ; d5 1 2ns  1000  ml ; 
 
white f 75 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  133  k ul; hematology blood platelet count  143  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  91  mg dl$ceftriaxone  1  gm ; mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; potassium chloride  20  meq ; acetaminophen iv  1000  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; morphine sulfate  0.5-1  mg ; d5 1 2ns  1000  ml ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; captopril  12.5  mg ; diltiazem  45  mg ; vial  1  vial ; azithromycin  500  mg ; diltiazem  60  mg ; 
 
white f 75 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  130  mg dl$ceftriaxone  1  gm ; mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; captopril  12.5  mg ; vial  1  vial ; azithromycin  500  mg ; diltiazem  60  mg ; captopril  6.25  mg ; azithromycin  250  mg ; captopril  25  mg ; 
 
white f 75 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  186  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  109  mg dl$ceftriaxone  1  gm ; mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; vial  1  vial ; azithromycin  250  mg ; captopril  25  mg ; lidocaine jelly 2% (glydo)  1  appl ; potassium chloride (powder)  60  meq ; 
 
white f 75 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.18  mmol l$ceftriaxone  1  gm ; mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; vial  1  vial ; azithromycin  250  mg ; captopril  25  mg ; lidocaine jelly 2% (glydo)  1  appl ; potassium chloride (powder)  60  meq ; captopril  50  mg ; 
 
white f 75 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  310  k ul$ceftriaxone  1  gm ; mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; vial  1  vial ; azithromycin  250  mg ; potassium chloride (powder)  60  meq ; captopril  50  mg ; lisinopril  30  mg ; lisinopril  40  mg ; cefpodoxime proxetil  400  mg ; 
 
white f 75 $nan$nan$mirtazapine  15  mg ; sertraline  50  mg ; rosuvastatin calcium  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; ondansetron  4  mg ; clonazepam  0.5  mg ; apixaban  5  mg ; oxycodone liquid  5  mg ; azithromycin  250  mg ; lisinopril  40  mg ; 
 
white f 55 $nan$nan$levothyroxine sodium  50  mcg ; 
 
white f 55 $temp  100.8  heartrate  95.0  resprate  18.0  o2sat  95.0  sbp  100.0  dbp  66.0  rhythm    pain    $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  189  k ul; chemistry blood bilirubin, total  1.5  mg dl$levothyroxine sodium  50  mcg ; influenza virus vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; vial  1  vial ; pantoprazole  40  mg ; levothyroxine sodium  100  mcg ; simvastatin  30  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin ec  81  mg ; 
 
white f 55 $nan$nan$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; levothyroxine sodium  100  mcg ; simvastatin  30  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin ec  81  mg ; omeprazole  40  mg ; 
 
white f 92 $nan$nan$sertraline  25  mg ; ferrous sulfate  325  mg ; potassium chloride  10  meq ; multivitamins  1  tab ; furosemide  80  mg ; digoxin  0.0625  mg ; lisinopril  10  mg ; 
unspecified essential hypertension hydronephrosis long-term (current) use of anticoagulants chronic diastolic heart failure congestive heart failure, unspecified acute kidney failure, unspecified urinary tract infection, site not specified calculus of kidney other persistent mental disorders due to conditions classified elsewhere atrial fibrillation other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl$sertraline  25  mg ; ferrous sulfate  325  mg ; potassium chloride  10  meq ; multivitamins  1  tab ; furosemide  80  mg ; digoxin  0.0625  mg ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; hydralazine  10  mg ; insulin  0  unit ; trazodone  12.5  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; simvastatin  40  mg ; donepezil  5  mg ; furosemide  40  mg ; 
unspecified essential hypertension hydronephrosis long-term (current) use of anticoagulants chronic diastolic heart failure congestive heart failure, unspecified acute kidney failure, unspecified urinary tract infection, site not specified calculus of kidney other persistent mental disorders due to conditions classified elsewhere atrial fibrillation other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  141  k ul; hematology urine wbc  0-2  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sertraline  25  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; furosemide  80  mg ; digoxin  0.0625  mg ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; hydralazine  10  mg ; insulin  0  unit ; trazodone  12.5  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; simvastatin  40  mg ; donepezil  5  mg ; furosemide  40  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; 5% dextrose  250  ml ; azithromycin   500  mg ; 
unspecified essential hypertension hydronephrosis long-term (current) use of anticoagulants chronic diastolic heart failure congestive heart failure, unspecified acute kidney failure, unspecified urinary tract infection, site not specified calculus of kidney other persistent mental disorders due to conditions classified elsewhere atrial fibrillation other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  85  mg dl$sertraline  25  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; furosemide  80  mg ; digoxin  0.0625  mg ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; hydralazine  10  mg ; insulin  0  unit ; trazodone  12.5  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; simvastatin  40  mg ; donepezil  5  mg ; furosemide  40  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; 5% dextrose  250  ml ; azithromycin   500  mg ; 
unspecified essential hypertension hydronephrosis long-term (current) use of anticoagulants chronic diastolic heart failure congestive heart failure, unspecified acute kidney failure, unspecified urinary tract infection, site not specified calculus of kidney other persistent mental disorders due to conditions classified elsewhere atrial fibrillation other and unspecified hyperlipidemia 
white f 92 $nan$nan$sertraline  25  mg ; ferrous sulfate  325  mg ; multivitamins  1  tab ; furosemide  80  mg ; digoxin  0.0625  mg ; lisinopril  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; hydralazine  10  mg ; insulin  0  unit ; trazodone  12.5  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; simvastatin  40  mg ; donepezil  5  mg ; furosemide  40  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; 5% dextrose  250  ml ; azithromycin   500  mg ; 
unspecified essential hypertension hydronephrosis long-term (current) use of anticoagulants chronic diastolic heart failure congestive heart failure, unspecified acute kidney failure, unspecified urinary tract infection, site not specified calculus of kidney other persistent mental disorders due to conditions classified elsewhere atrial fibrillation other and unspecified hyperlipidemia 
white m 62 $nan$nan$aspirin  325  mg ; glipizide xl  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; atorvastatin  80  mg ; levothyroxine sodium  150  mcg ; ranitidine  150  mg ; ibuprofen  200  mg ; 
 
white m 62 $nan$hematology blood hematocrit  39.3  %; hematology blood platelet count  319  k ul; hematology blood platelet count  296  k ul; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl$aspirin  325  mg ; glipizide xl  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; atorvastatin  80  mg ; levothyroxine sodium  150  mcg ; ranitidine  150  mg ; ibuprofen  200  mg ; influenza virus vaccine  0.5  ml ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.45% sodium chloride  1000  ml ; insulin  0  unit ; artificial tears  1-2  drop ; gemfibrozil  600  mg ; 
 
white m 62 $nan$nan$aspirin  325  mg ; glipizide xl  5  mg ; lisinopril  5  mg ; multivitamins  1  tab ; clopidogrel  75  mg ; atorvastatin  80  mg ; levothyroxine sodium  150  mcg ; ranitidine  150  mg ; ibuprofen  200  mg ; acetaminophen  650  mg ; nitroglycerin sl  0.3  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5-10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; artificial tears  1-2  drop ; gemfibrozil  600  mg ; 
 
white f 67 $temp  98.0  heartrate  94.0  resprate  22.0  o2sat    sbp  176.0  dbp  76.0  rhythm    pain  10 10  $hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  156  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; verapamil sr  180  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2  mg ; heparin  5000  unit ; clonidine  0.1  mg ; furosemide  120  mg ; pregabalin  50  mg ; ranitidine  150  mg ; senna  1  tab ; docusate sodium  100  mg ; aspirin  81  mg ; colchicine  0.6  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  150  mcg ; valsartan  320  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; lactulose  30  ml ; bisacodyl  10  mg ; insulin  46  unit ; 
acute kidney failure with lesion of tubular necrosis edema unspecified acquired hypothyroidism personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of steroids long-term (current) use of insulin chronic kidney disease, stage iv (severe) arthropathy, unspecified, site unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psoriatic arthropathy gout, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled disruption of external operation (surgical) wound other postoperative infection obstructive sleep apnea (adult)(pediatric) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy person injured while boarding or alighting from special construction vehicle hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obesity, unspecified chronic kidney disease, unspecified anemia in chronic kidney disease body mass index 40 and over, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified spinal stenosis, unspecified region unspecified accident pure hypercholesterolemia sprain of ribs chronic kidney disease, unspecified cellulitis and abscess of leg, except foot other postoperative infection anemia, unspecified knee joint replacement urinary tract infection, site not specified unspecified acquired hypothyroidism intestinal infection due to clostridium difficile surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site drug-induced delirium other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate)
white f 67 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  82  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  58  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; verapamil sr  180  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; clonidine  0.1  mg ; furosemide  120  mg ; pregabalin  50  mg ; ranitidine  150  mg ; senna  1  tab ; docusate sodium  100  mg ; aspirin  81  mg ; colchicine  0.6  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  150  mcg ; valsartan  320  mg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; lactulose  30  ml ; bisacodyl  10  mg ; insulin  46  unit ; calcitriol  0.25  mcg ; lidocaine 5% patch  1  ptch ; abatacept  125  mg ; miconazole powder 2%  1  appl ; 0.9% sodium chloride  500  ml ; 
acute kidney failure with lesion of tubular necrosis edema unspecified acquired hypothyroidism personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of steroids long-term (current) use of insulin chronic kidney disease, stage iv (severe) arthropathy, unspecified, site unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psoriatic arthropathy gout, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled disruption of external operation (surgical) wound other postoperative infection obstructive sleep apnea (adult)(pediatric) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy person injured while boarding or alighting from special construction vehicle hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obesity, unspecified chronic kidney disease, unspecified anemia in chronic kidney disease body mass index 40 and over, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified spinal stenosis, unspecified region unspecified accident pure hypercholesterolemia sprain of ribs chronic kidney disease, unspecified cellulitis and abscess of leg, except foot other postoperative infection anemia, unspecified knee joint replacement urinary tract infection, site not specified unspecified acquired hypothyroidism intestinal infection due to clostridium difficile surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site drug-induced delirium other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate)
white f 67 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  85  mg dl; chemistry blood glucose  63  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; verapamil sr  180  mg ; acetaminophen  1000  mg ; heparin  5000  unit ; clonidine  0.1  mg ; furosemide  120  mg ; pregabalin  50  mg ; ranitidine  150  mg ; aspirin  81  mg ; colchicine  0.6  mg ; isosorbide mononitrate (extended release)  60  mg ; levothyroxine sodium  150  mcg ; vitamin d  1000  unit ; polyethylene glycol  17  g ; bisacodyl  10  mg ; insulin  46  unit ; calcitriol  0.25  mcg ; lidocaine 5% patch  1  ptch ; abatacept  125  mg ; miconazole powder 2%  1  appl ; welchol  3.75  gm ; 
acute kidney failure with lesion of tubular necrosis edema unspecified acquired hypothyroidism personal history of noncompliance with medical treatment, presenting hazards to health long-term (current) use of steroids long-term (current) use of insulin chronic kidney disease, stage iv (severe) arthropathy, unspecified, site unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psoriatic arthropathy gout, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled disruption of external operation (surgical) wound other postoperative infection obstructive sleep apnea (adult)(pediatric) surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy person injured while boarding or alighting from special construction vehicle hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified obesity, unspecified chronic kidney disease, unspecified anemia in chronic kidney disease body mass index 40 and over, adult hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified spinal stenosis, unspecified region unspecified accident pure hypercholesterolemia sprain of ribs chronic kidney disease, unspecified cellulitis and abscess of leg, except foot other postoperative infection anemia, unspecified knee joint replacement urinary tract infection, site not specified unspecified acquired hypothyroidism intestinal infection due to clostridium difficile surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation obstructive sleep apnea (adult)(pediatric) diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled friedländer's bacillus infection in conditions classified elsewhere and of unspecified site drug-induced delirium other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate)
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  325  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  650  mg ; scopolamine patch  1  ptch ; enoxaparin sodium  40  mg ; 
 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; acetaminophen  650  mg ; scopolamine patch  1  ptch ; enoxaparin sodium  40  mg ; 
 
white m 24 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; enoxaparin sodium  40  mg ; docusate sodium  100  mg ; 
 
white f 62 $nan$nan$heparin  5000  unit ; 
 
white f 62 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  135  mg dl$heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; bupropion  100  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  20  mg ; 
 
white f 62 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  109  mg dl$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; bupropion  100  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  20  mg ; fluoxetine  20  mg ; omeprazole  20  mg ; atenolol  25  mg ; hydrochlorothiazide  25  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; hydrocodone-acetaminophen (5mg-500mg)  1-2  tab ; 
 
white f 82 $nan$nan$clopidogrel  75  mg ; aspirin ec  325  mg ; lisinopril  10  mg ; isosorbide mononitrate (extended release)  30  mg ; atorvastatin  80  mg ; 
 
white f 82 $nan$hematology blood hematocrit  33.7  %; hematology blood platelet count  254  k ul; hematology blood platelet count  275  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.2  meq l; chemistry blood urea nitrogen  21  mg dl$clopidogrel  75  mg ; aspirin ec  325  mg ; lisinopril  10  mg ; isosorbide mononitrate (extended release)  30  mg ; atorvastatin  80  mg ; 1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; gabapentin  400  mg ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; hydrochlorothiazide  25  mg ; 
 
white f 82 $nan$nan$aspirin ec  325  mg ; atorvastatin  80  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; gabapentin  400  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  325-650  mg ; hydrochlorothiazide  25  mg ; 
 
white m 75 $nan$hematology blood hematocrit  45.3  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl; chemistry blood albumin  4.1  g dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  112  mg dl; blood gas blood glucose  108  mg dl; blood gas blood hematocrit, calculated  41  %; blood gas blood hematocrit, calculated  40  %; blood gas blood hemoglobin  13.7  g dl; blood gas blood hemoglobin  13.2  g dl; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  141  meq l$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; amlodipine  5  mg ; atorvastatin  40  mg ; fish oil (omega 3)  1000  mg ; fluoxetine  20  mg ; furosemide  80  mg ; ipratropium bromide neb  1  neb ; isosorbide mononitrate (extended release)  60  mg ; pantoprazole  40  mg ; clopidogrel  300  mg ; mupirocin nasal ointment 2%  1  appl ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  8.6  mg ; clopidogrel  75  mg ; aspirin  325  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; sodium chloride 0.9%  flush  10  ml ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  38.2  %; hematology blood hematocrit  34.5  %; hematology blood hematocrit  35.6  %; hematology blood hematocrit  36.8  %; hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  144  k ul; hematology blood platelet count  122  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.3  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l; chemistry blood albumin  2.8  g dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  95  mg dl; blood gas blood hematocrit, calculated  37  %; blood gas blood hemoglobin  12.3  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  138  meq l$sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; atorvastatin  40  mg ; fish oil (omega 3)  1000  mg ; fluoxetine  20  mg ; furosemide  80  mg ; ipratropium bromide neb  1  neb ; isosorbide mononitrate (extended release)  60  mg ; pantoprazole  40  mg ; clopidogrel  300  mg ; mupirocin nasal ointment 2%  1  appl ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; senna  8.6  mg ; clopidogrel  75  mg ; aspirin  325  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; sodium chloride 0.9%  flush  10  ml ; clindamycin  150  mg ; vial  1  vial ; propofol  1000  mg ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; furosemide  40  mg ; aspirin ec  81  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; clindamycin  300  mg ; nitroglycerin  100  mg ; aspirin  81  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  136  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; furosemide  40  mg ; aspirin ec  81  mg ; clindamycin  300  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; potassium chloride  20  meq ; chloraseptic throat spray  1  spry ; furosemide  60  mg ; losartan potassium  100  mg ; amlodipine  10  mg ; isosorbide mononitrate (extended release)  30  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  28.8  %; hematology blood hematocrit  32.1  %; hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  171  mg dl$heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; carvedilol  6.25  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  130  mg dl$heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; hydralazine  20  mg ; carvedilol  12.5  mg ; carvedilol  25  mg ; furosemide  100  mg ; colchicine  0.6  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  91  mg dl$heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; hydralazine  20  mg ; carvedilol  25  mg ; furosemide  100  mg ; colchicine  0.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$nan$heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; colchicine  0.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; carvedilol  50  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood glucose  113  mg dl$heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; colchicine  0.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; carvedilol  50  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white m 75 $nan$nan$heparin  5000  unit ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; chloraseptic throat spray  1  spry ; losartan potassium  100  mg ; amlodipine  10  mg ; colchicine  0.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; carvedilol  50  mg ; 
coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status other and unspecified hyperlipidemia chronic kidney disease, stage iii (moderate) hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified aortic valve disorders obstructive sleep apnea (adult)(pediatric) esophageal reflux other chronic pulmonary heart diseases person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident chronic airway obstruction, not elsewhere classified other dependence on machines, supplemental oxygen
white f 70 $temp  97.5  heartrate  60.0  resprate  16.0  o2sat  97.0  sbp  98.0  dbp  55.0  rhythm    pain  0  ; temp    heartrate  119.0  resprate  18.0  o2sat  100.0  sbp  95.0  dbp  54.0  rhythm    pain    ; temp    heartrate  107.0  resprate  20.0  o2sat  95.0  sbp  106.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  122.0  resprate  18.0  o2sat  100.0  sbp  111.0  dbp  80.0  rhythm    pain    ; temp    heartrate  108.0  resprate  18.0  o2sat  98.0  sbp  96.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  119.0  resprate  19.0  o2sat  96.0  sbp  106.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  113.0  resprate  21.0  o2sat  99.0  sbp  104.0  dbp  83.0  rhythm    pain  4  ; temp    heartrate  109.0  resprate  19.0  o2sat  95.0  sbp  122.0  dbp  92.0  rhythm    pain  0  ; temp    heartrate  108.0  resprate  19.0  o2sat  96.0  sbp  116.0  dbp  85.0  rhythm    pain  0  ; temp  98.0  heartrate  108.0  resprate  17.0  o2sat  95.0  sbp  129.0  dbp  97.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  110.0  resprate  18.0  o2sat  92.0  sbp  113.0  dbp  50.0  rhythm    pain    ; temp  98.0  heartrate  108.0  resprate  18.0  o2sat  94.0  sbp  114.0  dbp  91.0  rhythm    pain  0  ; temp  98.0  heartrate  116.0  resprate  18.0  o2sat  94.0  sbp  82.0  dbp  59.0  rhythm    pain  0  ; temp    heartrate  108.0  resprate  22.0  o2sat  94.0  sbp  82.0  dbp  59.0  rhythm    pain    ; temp  98.0  heartrate  113.0  resprate  21.0  o2sat  90.0  sbp  79.0  dbp  66.0  rhythm    pain    ; temp    heartrate  106.0  resprate  21.0  o2sat  92.0  sbp  81.0  dbp  53.0  rhythm    pain    ; temp    heartrate  106.0  resprate  17.0  o2sat  94.0  sbp  88.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology urine wbc  158  # hpf; chemistry blood glucose  77  mg dl; chemistry blood glucose  86  mg dl; hematology blood bands  0  %; blood gas blood lactate  1.3  mmol l; hematology urine glucose  150  mg dl$nan
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $temp    heartrate  109.0  resprate  26.0  o2sat  92.0  sbp  75.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  30.3  %; hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  263  k ul; hematology blood platelet count  257  k ul; chemistry blood anion gap  25  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood creatinine  5.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  77  mg dl; chemistry blood urea nitrogen  74  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  58  mg dl; chemistry blood lactate dehydrogenase (ld)  367  iu l; chemistry blood lactate dehydrogenase (ld)  507  iu l; hematology blood bands  0  %; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  2.9  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood potassium, whole blood  4.1  meq l$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; warfarin  2.5  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; heparin  2500  unit ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  6.25  mg ; allopurinol  100  mg ; amiodarone  200  mg ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  213  mg dl; chemistry blood lactate dehydrogenase (ld)  391  iu l; blood gas blood lactate  2.5  mmol l$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; warfarin  2.5  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; amiodarone  200  mg ; warfarin  1  dose ; warfarin  1  mg ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; amiodarone  200  mg ; warfarin  1  dose ; warfarin  1  mg ; lorazepam  0.5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; metoprolol succinate xl  25  mg ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  34.3  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  304  k ul; hematology blood platelet count  321  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  31  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  5.5  mg dl; chemistry blood creatinine  5.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  312  mg dl; chemistry blood glucose  156  mg dl; blood gas blood lactate  2.1  mmol l; chemistry blood % hemoglobin a1c  7.2  %$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; amiodarone  200  mg ; lorazepam  0.5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; metoprolol succinate xl  25  mg ; warfarin  2  mg ; oxycodone (immediate release)  2.5  mg ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; syringe (intraperitoneal)  1  ml ; heparin  1000  units ; syringe (intraperitoneal)  9  ml ; heparin  9000  units ; syringe (intraperitoneal)  3  ml ; heparin  3000  units ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  289  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  205  mg dl; chemistry blood lactate dehydrogenase (ld)  360  iu l; chemistry blood albumin  2.4  g dl; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  235  mg dl; blood gas blood glucose  190  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.2  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.4  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  132  meq l$sodium chloride 0.9%  flush  3  ml ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; amiodarone  200  mg ; metoprolol succinate xl  25  mg ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4  mg ; syringe (intraperitoneal)  1  ml ; heparin  1000  units ; syringe (intraperitoneal)  3  ml ; heparin  3000  units ; tramadol  50  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$hematology blood hematocrit  31.6  %; hematology blood hematocrit  30.3  %; hematology blood hematocrit  28.4  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  322  k ul; hematology blood platelet count  333  k ul; hematology blood platelet count  275  k ul; hematology blood platelet count  277  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  33  meq l; chemistry blood anion gap  33  meq l; chemistry blood anion gap  33  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood creatinine  4.9  mg dl; chemistry blood creatinine  4.4  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  221  mg dl; chemistry blood glucose  336  mg dl; chemistry blood glucose  194  mg dl; chemistry blood glucose  309  mg dl; chemistry blood glucose  241  mg dl; chemistry blood lactate dehydrogenase (ld)  418  iu l; chemistry blood lactate dehydrogenase (ld)  415  iu l; chemistry blood albumin  2.5  g dl; hematology blood bands  2  %; hematology blood bands  2  %; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.00  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  0.96  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood free calcium  0.94  mmol l; blood gas blood lactate  3.9  mmol l; blood gas blood lactate  8.0  mmol l; blood gas blood lactate  4.5  mmol l; blood gas blood lactate  9.8  mmol l; blood gas blood lactate  4.4  mmol l; blood gas blood lactate  9.2  mmol l; blood gas blood lactate  8.1  mmol l; blood gas blood lactate  5.4  mmol l; blood gas blood lactate  8.4  mmol l; blood gas blood lactate  9.2  mmol l; blood gas blood lactate  7.5  mmol l; blood gas blood lactate  6.5  mmol l; blood gas blood lactate  8.4  mmol l; blood gas blood chloride, whole blood  95  meq l; blood gas blood glucose  188  mg dl; blood gas blood glucose  236  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  8.6  g dl; blood gas blood hemoglobin  8.7  g dl; blood gas blood hemoglobin  8.9  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood sodium, whole blood  131  meq l$prismasate (b32 k2)  5000  ml ; bag  5000  ml ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; polyethylene glycol  17  g ; senna  8.6  mg ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; benzonatate  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; insulin  0  unit ; insulin  10  unit ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; amiodarone  200  mg ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; sodium bicarbonate  50  meq ; dobutamine  250  mg ; prismasate (b22 k4)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  5  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; cefepime  2  g ; phytonadione  2.5  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; norepinephrine  16  mg ; meropenem  1000  mg ; methylprednisolone sodium succ  125  mg ; phenylephrine  60  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; d5w  100  ml ; milrinone  20  mg ; phenylephrine  240  mg ; acetaminophen iv  1000  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white f 70 $nan$nan$prismasate (b32 k2)  5000  ml ; bag  5000  ml ; bisacodyl  10  mg ; cinacalcet  30  mg ; midodrine  10  mg ; nephrocaps  1  cap ; sevelamer carbonate  1600  mg ; levothyroxine sodium  150  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol inhaler  1-2  puff ; gabapentin  100  mg ; acetaminophen  500-1000  mg ; allopurinol  100  mg ; sodium chloride 0.9%  flush  10  ml ; dobutamine  250  mg ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium chloride 0.9%  flush  100-200  ml ; sodium citrate 4%  5  ml ; 0.9% sodium chloride  500  ml ; calcium gluconate  20  g ; sw  100  ml ; potassium chloride  10  meq ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; neomycin-polymyxin-bacitracin  1  appl ; heparin (crrt machine priming)  5000  unit ; 0.9% sodium chloride  50  ml ; thiamine  200  mg ; norepinephrine  16  mg ; meropenem  1000  mg ; phenylephrine  240  mg ; acetaminophen iv  1000  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; hydromorphone (dilaudid)  0.25  mg ; micafungin  100  mg ; 
type 2 diabetes mellitus with hypoglycemia without coma unspecified fall, initial encounter persistent atrial fibrillation cellulitis of right lower limb type 2 diabetes mellitus with hyperglycemia hypothyroidism, unspecified morbid (severe) obesity due to excess calories unspecified place or not applicable type 2 diabetes mellitus with diabetic chronic kidney disease other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure end stage renal disease personal history of other malignant neoplasm of skin non-pressure chronic ulcer of left calf with unspecified severity type 2 diabetes mellitus with other skin ulcer hypokalemia rheumatoid arthritis, unspecified anemia in chronic kidney disease presence of right artificial knee joint long term (current) use of anticoagulants hypo-osmolality and hyponatremia personal history of malignant neoplasm of breast dependence on renal dialysis type 2 diabetes mellitus with diabetic polyneuropathy body mass index (bmi) 40.0-44.9, adult pain in right shoulder type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene ventricular tachycardia nontoxic single thyroid nodule heart failure, unspecified other chest pain pressure ulcer of right heel, unstageable rheumatic tricuspid insufficiency hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease pneumonia, unspecified organism long term (current) use of insulin hemorrhage due to internal orthopedic prosthetic devices, implants and grafts, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits bed confinement status sepsis, unspecified organism atrial fibrillation long-term (current) use of insulin other candidiasis of other specified sites pulmonary collapse gout, unspecified staphylococcus infection in conditions classified elsewhere and of unspecified site, staphylococcus, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled end stage renal disease morbid obesity
white m 48 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  754  k ul; hematology blood platelet count  602  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  79  mg dl; chemistry blood glucose  115  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  3.8  g dl$lorazepam  1  mg ; d5w  50  ml ; aldesleukin  39.5  mu ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  491  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  112  mg dl; chemistry blood lactate dehydrogenase (ld)  173  iu l; chemistry blood albumin  3.0  g dl; hematology blood bands  0  %$lorazepam  1  mg ; d5w  50  ml ; aldesleukin  39.5  mu ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; ondansetron  8  mg ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; hematology blood bands  0  %$d5w  50  ml ; aldesleukin  39.5  mu ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; ondansetron  8  mg ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  2.6  g dl; hematology blood bands  8  %$d5w  50  ml ; aldesleukin  39.5  mu ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  204  iu l; hematology blood bands  1  %$d5w  50  ml ; aldesleukin  39.5  mu ; heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$nan$heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; diphenoxylate-atropine  1-2  tab ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; neutra-phos  1  pkt ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 48 $nan$nan$heparin flush (10 units ml)  1  ml ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; diphenoxylate-atropine  1-2  tab ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  50  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; gelclair  15  ml ; gabapentin  200  mg ; ranitidine  150  mg ; cephalexin  500  mg ; neutra-phos  1  pkt ; 
diarrhea malignant neoplasm of kidney, except pelvis acute kidney failure, unspecified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use disorders of phosphorus metabolism secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes encounter for antineoplastic chemotherapy anemia, unspecified disorders of magnesium metabolism rash and other nonspecific skin eruption restless legs syndrome (rls) toxic encephalopathy hypotension, unspecified 
white m 43 $temp    heartrate  86.0  resprate  16.0  o2sat  95.0  sbp  150.0  dbp  80.0  rhythm  normal sinus rhythm  pain  0  ; temp    heartrate  78.0  resprate  16.0  o2sat  96.0  sbp    dbp    rhythm  normal sinus rhythm  pain  0  ; temp    heartrate  68.0  resprate  16.0  o2sat  95.0  sbp  122.0  dbp  77.0  rhythm  normal sinus rhythm  pain  0  ; temp    heartrate  65.0  resprate  16.0  o2sat  95.0  sbp  131.0  dbp  70.0  rhythm    pain    ; temp  97.9  heartrate  72.0  resprate  16.0  o2sat  94.0  sbp  127.0  dbp  73.0  rhythm  normal sinus rhythm  pain  0  $nan$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  10  mg ; 
obesity, unspecified tobacco use disorder other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled facial weakness cerebral artery occlusion, unspecified with cerebral infarction unspecified essential hypertension 
white m 43 $temp  98.0  heartrate  74.0  resprate  16.0  o2sat  95.0  sbp  121.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  45.4  %; hematology blood hemoglobin  15.5  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  4.4  g dl; chemistry blood % hemoglobin a1c  9.0  %$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; bupropion  75  mg ; metformin (glucophage)  500  mg ; glimepiride  2  mg ; 
obesity, unspecified tobacco use disorder other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled facial weakness cerebral artery occlusion, unspecified with cerebral infarction unspecified essential hypertension 
white m 43 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; bupropion  75  mg ; glimepiride  2  mg ; 
obesity, unspecified tobacco use disorder other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled facial weakness cerebral artery occlusion, unspecified with cerebral infarction unspecified essential hypertension 
white m 80 $temp  98.2  heartrate  68.0  resprate  15.0  o2sat  97.0  sbp  140.0  dbp  79.0  rhythm    pain  0 10  ; temp    heartrate  66.0  resprate  17.0  o2sat  95.0  sbp  138.0  dbp  63.0  rhythm    pain  10 10  ; temp  98.4  heartrate  69.0  resprate  14.0  o2sat  95.0  sbp  134.0  dbp  69.0  rhythm    pain  0 10  $hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; labetalol  400  mg ; tramadol (ultram)  25  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; trazodone  25  mg ; 
personal history of nicotine dependence personal history of other malignant neoplasm of large intestine essential (primary) hypertension facial weakness headache fecal impaction acquired absence of other specified parts of digestive tract dysarthria and anarthria neurologic neglect syndrome occlusion and stenosis of bilateral carotid arteries hemiplegia, unspecified affecting left nondominant side nontraumatic intracerebral hemorrhage in hemisphere, subcortical nontraumatic intracerebral hemorrhage, intraventricular personal history of malignant neoplasm of large intestine constipation, unspecified unspecified essential hypertension lumbosacral spondylosis without myelopathy other acute postoperative pain degeneration of lumbar or lumbosacral intervertebral disc personal history of tobacco use unspecified essential hypertension other and unspecified hyperlipidemia acquired absence of intestine (large) (small) person on outside of bus injured in collision with pedestrian or animal in traffic accident abdominal aneurysm without mention of rupture personal history of malignant neoplasm of large intestine examination of participant in clinical trial 
white m 80 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry urine chloride, urine  46  meq l; chemistry urine creatinine, urine  100  mg dl; chemistry urine potassium, urine  32  meq l; chemistry urine sodium, urine  43  meq l; chemistry urine urea nitrogen, urine  950  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; labetalol  400  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; trazodone  25  mg ; acetaminophen  650  mg ; 
personal history of nicotine dependence personal history of other malignant neoplasm of large intestine essential (primary) hypertension facial weakness headache fecal impaction acquired absence of other specified parts of digestive tract dysarthria and anarthria neurologic neglect syndrome occlusion and stenosis of bilateral carotid arteries hemiplegia, unspecified affecting left nondominant side nontraumatic intracerebral hemorrhage in hemisphere, subcortical nontraumatic intracerebral hemorrhage, intraventricular personal history of malignant neoplasm of large intestine constipation, unspecified unspecified essential hypertension lumbosacral spondylosis without myelopathy other acute postoperative pain degeneration of lumbar or lumbosacral intervertebral disc personal history of tobacco use unspecified essential hypertension other and unspecified hyperlipidemia acquired absence of intestine (large) (small) person on outside of bus injured in collision with pedestrian or animal in traffic accident abdominal aneurysm without mention of rupture personal history of malignant neoplasm of large intestine examination of participant in clinical trial 
white m 80 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  108  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; labetalol  400  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; 
personal history of nicotine dependence personal history of other malignant neoplasm of large intestine essential (primary) hypertension facial weakness headache fecal impaction acquired absence of other specified parts of digestive tract dysarthria and anarthria neurologic neglect syndrome occlusion and stenosis of bilateral carotid arteries hemiplegia, unspecified affecting left nondominant side nontraumatic intracerebral hemorrhage in hemisphere, subcortical nontraumatic intracerebral hemorrhage, intraventricular personal history of malignant neoplasm of large intestine constipation, unspecified unspecified essential hypertension lumbosacral spondylosis without myelopathy other acute postoperative pain degeneration of lumbar or lumbosacral intervertebral disc personal history of tobacco use unspecified essential hypertension other and unspecified hyperlipidemia acquired absence of intestine (large) (small) person on outside of bus injured in collision with pedestrian or animal in traffic accident abdominal aneurysm without mention of rupture personal history of malignant neoplasm of large intestine examination of participant in clinical trial 
white m 80 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen-caff-butalbital  1-2  tab ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; labetalol  400  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; 
personal history of nicotine dependence personal history of other malignant neoplasm of large intestine essential (primary) hypertension facial weakness headache fecal impaction acquired absence of other specified parts of digestive tract dysarthria and anarthria neurologic neglect syndrome occlusion and stenosis of bilateral carotid arteries hemiplegia, unspecified affecting left nondominant side nontraumatic intracerebral hemorrhage in hemisphere, subcortical nontraumatic intracerebral hemorrhage, intraventricular personal history of malignant neoplasm of large intestine constipation, unspecified unspecified essential hypertension lumbosacral spondylosis without myelopathy other acute postoperative pain degeneration of lumbar or lumbosacral intervertebral disc personal history of tobacco use unspecified essential hypertension other and unspecified hyperlipidemia acquired absence of intestine (large) (small) person on outside of bus injured in collision with pedestrian or animal in traffic accident abdominal aneurysm without mention of rupture personal history of malignant neoplasm of large intestine examination of participant in clinical trial 
white m 75 $temp  97.9  heartrate  80.0  resprate  14.0  o2sat  97.0  sbp  102.0  dbp  59.0  rhythm    pain  4  $hematology blood hematocrit  36.8  %; hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  266  k ul; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  84  meq l; chemistry blood chloride  86  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  57  mg dl; chemistry urine creatinine, urine  38  mg dl; chemistry urine potassium, urine  18  meq l; chemistry urine sodium, urine  110  meq l; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  107  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  268  iu l; chemistry urine protein creatinine ratio  0.1  mg mg$tramadol  50  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; 
 
white m 75 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  86  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l$tramadol  50  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; trazodone  25  mg ; 
 
asian m 86 $temp  98.2  heartrate  80.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  85.0  rhythm    pain  4  $hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  82  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; hydrochlorothiazide  12.5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; hydrocortisone cream 1%  1  appl ; 
 
asian m 86 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; triamcinolone acetonide 0.1% ointment  1  appl ; hydrochlorothiazide  12.5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; heparin  5000  unit ; hydrocortisone cream 1%  1  appl ; multivitamins w minerals  1  tab ; amlodipine  5  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; betamethasone dipro 0.05% oint  1  appl ; 
 
white f 90 $nan$nan$aspirin  325  mg ; atenolol  25  mg ; simvastatin  20  mg ; 
closed fracture of middle or proximal phalanx or phalanges of hand hypertonicity of bladder unspecified essential hypertension closed fracture of metatarsal bone(s) home accidents osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified metabolic syndrome fall resulting in striking against other object
white f 90 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  3  # hpf; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l; chemistry blood albumin  3.8  g dl$aspirin  325  mg ; atenolol  25  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydralazine  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ns (mini bag plus)  100  ml ; ampicillin sodium  2  g ; sw  100  ml ; magnesium sulfate  4  gm ; heparin flush (10 units ml)  2  ml ; 
closed fracture of middle or proximal phalanx or phalanges of hand hypertonicity of bladder unspecified essential hypertension closed fracture of metatarsal bone(s) home accidents osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified metabolic syndrome fall resulting in striking against other object
white f 90 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  149  mg dl$aspirin  325  mg ; atenolol  25  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydralazine  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; heparin  5000  unit ; sw  100  ml ; magnesium sulfate  4  gm ; heparin flush (10 units ml)  2  ml ; 
closed fracture of middle or proximal phalanx or phalanges of hand hypertonicity of bladder unspecified essential hypertension closed fracture of metatarsal bone(s) home accidents osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified metabolic syndrome fall resulting in striking against other object
white f 90 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  168  mg dl$aspirin  325  mg ; atenolol  25  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydralazine  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; 
closed fracture of middle or proximal phalanx or phalanges of hand hypertonicity of bladder unspecified essential hypertension closed fracture of metatarsal bone(s) home accidents osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified metabolic syndrome fall resulting in striking against other object
white f 90 $nan$nan$aspirin  325  mg ; atenolol  25  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydralazine  10  mg ; acetaminophen  325  mg ; insulin  0  unit ; heparin  5000  unit ; heparin flush (10 units ml)  2  ml ; metformin (glucophage)  1000  mg ; 
closed fracture of middle or proximal phalanx or phalanges of hand hypertonicity of bladder unspecified essential hypertension closed fracture of metatarsal bone(s) home accidents osteoporosis, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled constipation, unspecified metabolic syndrome fall resulting in striking against other object
white f 40 $temp  98.9  heartrate  110.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  85.0  rhythm    pain  1  ; temp  99.4  heartrate  85.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  74.0  rhythm    pain  1  ; temp  100.0  heartrate  88.0  resprate  15.0  o2sat  99.0  sbp  122.0  dbp  76.0  rhythm    pain  1  $hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  107  mg dl; chemistry blood albumin  3.7  g dl; hematology blood bands  2  %; blood gas blood lactate  2.4  mmol l$nan
estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of intrathoracic lymph nodes fever presenting with conditions classified elsewhere pneumonia, unspecified organism candidal stomatitis major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast neutropenia, unspecified secondary malignant neoplasm of unspecified lung estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb driver of special all-terrain or other off-road motor vehicle injured in traffic accident other iatrogenic hypotension malignant neoplasm of upper-outer quadrant of female breast nausea alone unspecified pruritic disorder
white f 40 $temp  98.6  heartrate  89.0  resprate  16.0  o2sat  98.0  sbp  102.0  dbp  75.0  rhythm    pain  1  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; citalopram  20  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; 
estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of intrathoracic lymph nodes fever presenting with conditions classified elsewhere pneumonia, unspecified organism candidal stomatitis major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast neutropenia, unspecified secondary malignant neoplasm of unspecified lung estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb driver of special all-terrain or other off-road motor vehicle injured in traffic accident other iatrogenic hypotension malignant neoplasm of upper-outer quadrant of female breast nausea alone unspecified pruritic disorder
white f 40 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  105  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; citalopram  20  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; ondansetron  8  mg ; prochlorperazine  10  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of intrathoracic lymph nodes fever presenting with conditions classified elsewhere pneumonia, unspecified organism candidal stomatitis major depressive disorder, single episode, unspecified malignant neoplasm of unspecified site of left female breast neutropenia, unspecified secondary malignant neoplasm of unspecified lung estrogen receptor positive status [er+] secondary and unspecified malignant neoplasm of lymph nodes of axilla and upper limb driver of special all-terrain or other off-road motor vehicle injured in traffic accident other iatrogenic hypotension malignant neoplasm of upper-outer quadrant of female breast nausea alone unspecified pruritic disorder
white m 74 $nan$hematology blood hematocrit  29.7  %; hematology blood hematocrit  31.0  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  156  k ul; hematology blood platelet count  167  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  128  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  2.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  34  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  230  iu l; chemistry blood albumin  3.9  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; carvedilol  3.125  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; furosemide  160  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; amiodarone  200  mg ; lisinopril  10  mg ; metoprolol succinate xl  25  mg ; potassium chloride  40  meq ; heparin  5000  unit ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  141  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  264  iu l$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; amiodarone  200  mg ; heparin  5000  unit ; warfarin  1.25  mg ; potassium chloride  20  meq ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  96  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  10.0  g dl; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  9.0  g dl; blood gas blood hemoglobin  10.7  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  11.1  g dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; heparin  5000  unit ; warfarin  1.25  mg ; d5w  100  ml ; milrinone  20  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  94  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.8  g dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; heparin  5000  unit ; warfarin  1.25  mg ; d5w  100  ml ; milrinone  20  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; warfarin  3.75  mg ; sodium chloride 0.9%  flush  10-20  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  2.1  ; chemistry urine creatinine, urine  73  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  91  mg dl; chemistry urine protein creatinine ratio  0.2  mg mg; chemistry urine 24 hr creatinine  1095  mg 24hr$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; heparin  5000  unit ; warfarin  1.25  mg ; d5w  100  ml ; milrinone  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; warfarin  3.75  mg ; sodium chloride 0.9%  flush  10-20  ml ; bag  1  bag ; magnesium sulfate  2  gm ; furosemide  80  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; furosemide  80  mg ; sodium chloride 0.9%  1000  ml ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  52  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  307  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  98  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; pantoprazole  40  mg ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; amiodarone  200  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  2.4  ; hematology urine wbc  2  # hpf; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  95  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; simvastatin  20  mg ; sucralfate  1  gm ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; levofloxacin  750  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  96  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; simvastatin  20  mg ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  98  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  88  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.8  ; chemistry urine creatinine, urine  79  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  117  mg dl; chemistry blood lactate dehydrogenase (ld)  322  iu l; chemistry blood lactate dehydrogenase (ld)  274  iu l; chemistry blood albumin  2.9  g dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  84  mg dl; blood gas blood lactate  1.0  mmol l$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; dextrose 5%  150  ml ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  119  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; dextrose 5%  150  ml ; torsemide  40  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  93  mg dl; blood gas blood lactate  0.9  mmol l$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  300  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  93  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  321  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  86  mg dl$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  356  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; torsemide  20  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  237  iu l$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; torsemide  20  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
white m 74 $nan$nan$aspirin  81  mg ; fluticasone propionate nasal  1  spry ; multivitamins  1  tab ; sucralfate  1  gm ; acetaminophen  650  mg ; docusate sodium  100  mg ; warfarin  2.5  mg ; warfarin  1.25  mg ; sodium chloride 0.9%  flush  10-20  ml ; calcium carbonate  500  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; sodium chloride nasal  1-2  spry ; torsemide  20  mg ; 
long term (current) use of anticoagulants presence of aortocoronary bypass graft ischemic cardiomyopathy alcohol dependence, in remission unspecified atrial fibrillation old myocardial infarction acute on chronic systolic (congestive) heart failure chronic kidney disease, unspecified other secondary pulmonary hypertension hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris personal history of nicotine dependence presence of coronary angioplasty implant and graft hyperlipidemia, unspecified gastro-esophageal reflux disease without esophagitis anemia, unspecified nonrheumatic mitral (valve) insufficiency encounter for adjustment and management of automatic implantable cardiac defibrillator old myocardial infarction encounter for adjustment and management of automatic implantable cardiac defibrillator atherosclerotic heart disease of native coronary artery without angina pectoris paroxysmal atrial fibrillation essential (primary) hypertension ischemic cardiomyopathy long term (current) use of anticoagulants nonrheumatic mitral (valve) insufficiency presence of aortocoronary bypass graft immune thrombocytopenic purpura presence of coronary angioplasty implant and graft chronic systolic (congestive) heart failure atrioventricular block, first degree long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified presence of cardiac pacemaker hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease gastro-esophageal reflux disease without esophagitis old myocardial infarction immune thrombocytopenic purpura family history of ischemic heart disease and other diseases of the circulatory system atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of aortocoronary bypass graft acute kidney failure, unspecified ischemic cardiomyopathy nonrheumatic mitral (valve) insufficiency chronic kidney disease, unspecified other secondary pulmonary hypertension
unknown m 65 $nan$hematology blood hematocrit  34.1  %; hematology blood hematocrit  32.0  %; hematology blood hematocrit  32.7  %; hematology blood hematocrit  30.4  %; hematology blood hematocrit  32.0  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  226  k ul; hematology blood platelet count  207  k ul; hematology blood platelet count  198  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  213  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  195  mg dl; chemistry blood lactate dehydrogenase (ld)  652  iu l; chemistry blood lactate dehydrogenase (ld)  1594  iu l$0.9% sodium chloride  2  bag ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; lactated ringers  1000  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; simvastatin  20  mg ; nifedipine cr  30  mg ; metoprolol tartrate  5  mg ; furosemide  20  mg ; labetalol  10  mg ; albuterol 0.083% neb soln  1  neb ; 
 
unknown m 65 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  28.8  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  25.3  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  188  k ul; hematology blood platelet count  179  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  48  mg dl; chemistry urine chloride, urine  30  meq l; chemistry urine creatinine, urine  184  mg dl; chemistry urine sodium, urine  16  meq l; chemistry urine urea nitrogen, urine  1190  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  173  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  171  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.5  mmol l$0.9% sodium chloride  2  bag ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; simvastatin  20  mg ; nifedipine cr  30  mg ; furosemide  20  mg ; labetalol  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; albumin 5%  25  g ; 
 
unknown m 65 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  25.0  %; hematology blood hematocrit  22.7  %; hematology blood hematocrit  22.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  152  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  47  mg dl; hematology urine wbc  22  # hpf; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  150  mg dl; blood gas blood lactate  1.2  mmol l$0.9% sodium chloride  2  bag ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; simvastatin  20  mg ; nifedipine cr  30  mg ; labetalol  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; haloperidol  5  mg ; lorazepam  2  mg ; hydralazine  10  mg ; propofol  1000  mg ; succinylcholine  60  mg ; propofol  50  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
unknown m 65 $nan$hematology blood hematocrit  21.2  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  155  k ul; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood urea nitrogen  49  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  137  mg dl$0.9% sodium chloride  2  bag ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; simvastatin  20  mg ; nifedipine cr  30  mg ; labetalol  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  2  mg ; hydralazine  10  mg ; propofol  1000  mg ; succinylcholine  60  mg ; propofol  50  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; senna  5  ml ; senna  1  tab ; lidocaine jelly 2% (urojet)  1  appl ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; 
 
unknown m 65 $nan$hematology blood hematocrit  23.9  %; hematology blood hematocrit  24.0  %; hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  183  k ul; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  141  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  0.7  mmol l$0.9% sodium chloride  2  bag ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; calcium gluconate  4  g ; simvastatin  20  mg ; nifedipine cr  30  mg ; labetalol  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; lorazepam  2  mg ; propofol  1000  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; senna  5  ml ; senna  1  tab ; lidocaine jelly 2% (urojet)  1  appl ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; 5% dextrose  200  ml ; labetalol  600  mg ; sw  400  ml ; sw  600  ml ; sw  200  ml ; labetalol  20  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; potassium chloride (powder)  20  meq ; valsartan  40  mg ; 0.9% sodium chloride  100  ml ; albuterol inhaler  6  puff ; albumin 5%   25  g ; 
 
unknown m 65 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  191  k ul; hematology blood platelet count  208  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  164  mg dl; chemistry blood glucose  141  mg dl; blood gas blood lactate  0.7  mmol l; blood gas blood glucose  140  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; hydromorphone (dilaudid)  0.5-1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; simvastatin  20  mg ; lorazepam  2  mg ; propofol  1000  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; sw  400  ml ; sw  600  ml ; sw  200  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; potassium chloride (powder)  20  meq ; valsartan  40  mg ; 0.9% sodium chloride  100  ml ; albuterol inhaler  6  puff ; labetalol  100  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; labetalol  200  mg ; calcium acetate  1334  mg ; d5 1 2ns  1000  ml ; 
 
unknown m 65 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  244  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  83  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  128  mg dl; blood gas blood free calcium  1.12  mmol l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; sw  400  ml ; sw  600  ml ; bisacodyl  10  mg ; valsartan  40  mg ; 0.9% sodium chloride  100  ml ; albuterol inhaler  6  puff ; soln  50  ml ; fentanyl citrate  2.5  mg ; labetalol  200  mg ; calcium acetate  1334  mg ; d5 1 2ns  1000  ml ; midazolam  1  mg ; midazolam  2  mg ; propofol  200  mg ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  83  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  137  mg dl; blood gas blood free calcium  1.14  mmol l; blood gas blood glucose  119  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; sw  400  ml ; sw  600  ml ; bisacodyl  10  mg ; valsartan  40  mg ; 0.9% sodium chloride  100  ml ; albuterol inhaler  6  puff ; soln  50  ml ; fentanyl citrate  2.5  mg ; d5 1 2ns  1000  ml ; propofol  200  mg ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  105  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; bag  50  ml ; magnesium sulfate  2  gm ; bag  100  ml ; magnesium sulfate  4  gm ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; sw  400  ml ; sw  600  ml ; bisacodyl  10  mg ; valsartan  40  mg ; 0.9% sodium chloride  100  ml ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; 
 
unknown m 65 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  399  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  107  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  415  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  113  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; oxycodone (immediate release)   10-15  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  467  k ul$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; oxycodone (immediate release)   10-15  mg ; aspirin  81  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  468  k ul$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; oxycodone (immediate release)   10-15  mg ; aspirin  81  mg ; ciprofloxacin hcl  500  mg ; 
 
unknown m 65 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  558  k ul$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; simvastatin  20  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  5  ml ; senna  1  tab ; docusate sodium (liquid)  100  mg ; clotrimazole cream  1  appl ; bisacodyl  10  mg ; valsartan  40  mg ; albuterol inhaler  6  puff ; sodium chloride 0.9%  flush  3  ml ; lanthanum  500  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; oxycodone (immediate release)   10-15  mg ; aspirin  81  mg ; ciprofloxacin hcl  500  mg ; docusate sodium  100  mg ; 
 
white m 42 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; ns  1000  ml ; folic acid  1  mg ; diazepam  5  mg ; nitroglycerin sl  0.3  mg ; ibuprofen  800  mg ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; metoprolol tartrate  12.5  mg ; morphine sulfate  2  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5  mg ; aspirin  325  mg ; nicotine patch  21  mg ; 
 
white m 42 $nan$nan$diazepam  5  mg ; nitroglycerin sl  0.3  mg ; ibuprofen  800  mg ; pantoprazole  40  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; metoprolol tartrate  12.5  mg ; morphine sulfate  2  mg ; acetaminophen  325-650  mg ; aspirin  325  mg ; nicotine patch  21  mg ; multivitamins  1  cap ; 
 
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; clozapine  300  mg ; fluticasone  1  spry ; clozapine  50  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; clozapine  50  mg ; milk of magnesia  30  ml ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; clozapine  50  mg ; milk of magnesia  30  ml ; clozapine  400  mg ; hydroxyzine  25  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; clozapine  50  mg ; milk of magnesia  30  ml ; clozapine  400  mg ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; multivitamins  1  tab ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; clozapine  50  mg ; milk of magnesia  30  ml ; clozapine  400  mg ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  450  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$hematology blood hematocrit  43.6  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  163  k ul$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  450  mg ; omeprazole  20  mg ; clozapine  500  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; omeprazole  20  mg ; clozapine  500  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  500  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  500  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  500  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$influenza virus vaccine  0.5  ml ; divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; clozapine  500  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$hematology blood hematocrit  47.5  %; hematology blood hemoglobin  15.7  g dl; hematology blood platelet count  215  k ul$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; hydroxyzine  25  mg ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; haloperidol  10  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; clozapine  100  mg ; haloperidol  5  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; clozapine  100  mg ; nicotine polacrilex  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; clozapine  100  mg ; nicotine polacrilex  2  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$hematology blood hematocrit  45.3  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  194  k ul$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; clozapine  100  mg ; nicotine polacrilex  2  mg ; aripiprazole  10  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; nicotine polacrilex  2  mg ; aripiprazole  10  mg ; benztropine mesylate  1  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; nicotine polacrilex  2  mg ; aripiprazole  10  mg ; benztropine mesylate  1  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; nicotine polacrilex  2  mg ; aripiprazole  10  mg ; benztropine mesylate  1  mg ; aripiprazole  15  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$divalproex (delayed release)  750  mg ; docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; glycopyrrolate  2  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; aripiprazole  15  mg ; artificial tears  1-2  drop ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; hydroxyzine  50  mg ; aripiprazole  5  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; hydroxyzine  50  mg ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; hydroxyzine  50  mg ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; hydroxyzine  100  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; lorazepam  0.5  mg ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; hydroxyzine  100  mg ; lorazepam  1  mg ; benztropine mesylate  0.5  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; lorazepam  1  mg ; benztropine mesylate  0.5  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; lorazepam  1  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
hispanic latino m 44 $nan$nan$docusate sodium  100  mg ; meclizine  12.5  mg ; polyethylene glycol  17  g ; tolterodine  2  mg ; acetaminophen  650  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; fluticasone  1  spry ; milk of magnesia  30  ml ; prochlorperazine  10  mg ; omeprazole  40  mg ; nicotine polacrilex  2  mg ; benztropine mesylate  1  mg ; artificial tears  1-2  drop ; aripiprazole  5  mg ; divalproex (delayed release)  1500  mg ; aripiprazole  20  mg ; lorazepam  1  mg ; 
depressive disorder, not elsewhere classified suicidal ideation unspecified essential hypertension abrasion or friction burn of face, neck, and scalp except eye, without mention of infection esophageal reflux accidents occurring in unspecified place accident caused by unspecified firearm missile unspecified schizophrenia, unspecified bipolar i disorder, most recent episode (or current) manic, unspecified other and unspecified special symptoms or syndromes, not elsewhere classified disturbance of skin sensation tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health alcohol abuse, unspecified schizoaffective disorder, chronic with acute exacerbation other, mixed, or unspecified drug abuse, unspecified insomnia, unspecified unspecified essential hypertension esophageal reflux schizoaffective disorder, unspecified unspecified psychosis schizoaffective disorder, unspecified bipolar disorder, unspecified unspecified psychosis
white m 56 $temp    heartrate  115.0  resprate  22.0  o2sat  100.0  sbp  104.0  dbp  43.0  rhythm    pain  0  $hematology blood hematocrit  27.1  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  139  k ul; chemistry blood anion gap  44  meq l; chemistry blood anion gap  31  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  9  meq l; chemistry blood chloride  83  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood creatinine  3.6  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  202  mg dl; chemistry blood glucose  251  mg dl; chemistry blood glucose  196  mg dl; chemistry blood glucose  146  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  0.97  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood glucose  141  mg dl; chemistry blood % hemoglobin a1c  7.1  %$0.9% sodium chloride  1  bag ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; 5% dextrose  50  ml ; thiamine  100  mg ; 5% dextrose  100  ml ; folic acid  1  mg ; aspirin  81  mg ; omeprazole  40  mg ; ondansetron  2-4  mg ; phenobarbital  790  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; insulin  5  unit ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole  40  mg ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; phosphorus  500  mg ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 56 $nan$hematology blood hematocrit  26.0  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  130  k ul; hematology blood platelet count  120  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  244  mg dl; chemistry blood albumin  3.2  g dl; blood gas blood free calcium  1.02  mmol l; blood gas blood lactate  1.0  mmol l; hematology urine glucose  1000  mg dl$0.9% sodium chloride  1  bag ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; 5% dextrose  50  ml ; thiamine  100  mg ; 5% dextrose  100  ml ; folic acid  1  mg ; aspirin  81  mg ; ondansetron  2-4  mg ; phenobarbital  790  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; insulin  5  unit ; acetaminophen  650  mg ; vial  1  vial ; pantoprazole  40  mg ; phosphorus  500  mg ; neutra-phos  3  pkt ; insulin  0  unit ; insulin  60  unit ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  15  unit ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 56 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  181  mg dl; blood gas blood lactate  1.2  mmol l$0.9% sodium chloride  1  bag ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; ondansetron  2-4  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  15  unit ; phosphorus  250  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; insulin  20  unit ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 56 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  191  mg dl$0.9% sodium chloride  1  bag ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; ondansetron  2-4  mg ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phenobarbital alcohol withdrawal dose taper (days 2-7)  44  mg ; acetaminophen  650  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; phosphorus  250  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; insulin  20  unit ; artificial tears  1-2  drop ; trazodone  25  mg ; insulin  22  unit ; insulin  25  unit ; insulin  2  unit ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 56 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  154  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; ondansetron  2-4  mg ; acetaminophen  650  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; artificial tears  1-2  drop ; trazodone  25  mg ; insulin  22  unit ; insulin  25  unit ; insulin  2  unit ; trazodone  25-50  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  12  mg ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 56 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; maalox diphenhydramine lidocaine  15-30  ml ; sodium chloride 0.9%  flush  3  ml ; aspirin  81  mg ; ondansetron  2-4  mg ; acetaminophen  650  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  22  mg ; artificial tears  1-2  drop ; insulin  25  unit ; trazodone  25-50  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  12  mg ; phenobarbital alcohol withdrawal dose taper (days 2-7)  6  mg ; 
long term (current) use of insulin drug-induced hypoglycemia without coma essential (primary) hypertension hyperlipidemia, unspecified hypokalemia diarrhea, unspecified dehydration hypovolemia gastro-esophageal reflux disease without esophagitis patient room in hospital as the place of occurrence of the external cause anxiety disorder, unspecified type 1 diabetes mellitus with ketoacidosis without coma acute kidney failure, unspecified anemia, unspecified elevated white blood cell count, unspecified other secondary thrombocytopenia adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, initial encounter alcohol abuse, uncomplicated abnormal results of liver function studies major depressive disorder, single episode, unspecified other and unspecified hyperlipidemia leukocytosis, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled dehydration alcohol abuse, unspecified acute kidney failure, unspecified esophageal reflux unspecified essential hypertension long-term (current) use of insulin anxiety state, unspecified personal history of noncompliance with medical treatment, presenting hazards to health hypopotassemia cirrhosis of liver without mention of alcohol diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled insomnia, unspecified shortness of breath nausea alone shortness of breath diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chest pain, unspecified chest pain, unspecified 
white m 57 $temp    heartrate  94.0  resprate  17.0  o2sat  98.0  sbp  167.0  dbp  105.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  18.0  o2sat  100.0  sbp  148.0  dbp  84.0  rhythm    pain    ; temp    heartrate  82.0  resprate  15.0  o2sat  97.0  sbp  152.0  dbp  91.0  rhythm  sinus rhythm  pain  0  $nan$valsartan  160  mg ; atorvastatin  10  mg ; multivitamins  1  tab ; 
 
white m 57 $temp  98.3  heartrate  77.0  resprate  18.0  o2sat  98.0  sbp  144.0  dbp  85.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  36.2  %; hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  108  mg dl$valsartan  160  mg ; atorvastatin  10  mg ; multivitamins  1  tab ; 0.45% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; aspirin  325  mg ; losartan potassium  100  mg ; 
 
white m 57 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  261  k ul$atorvastatin  10  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; aspirin  325  mg ; losartan potassium  100  mg ; 
 
white m 57 $nan$nan$atorvastatin  10  mg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; aspirin  325  mg ; losartan potassium  100  mg ; 
 
white f 66 $nan$nan$simvastatin  20  mg ; lisinopril  10  mg ; clopidogrel  75  mg ; aspirin  81  mg ; 
 
white f 66 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  35.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  106  mg dl$simvastatin  20  mg ; lisinopril  10  mg ; clopidogrel  75  mg ; aspirin  81  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 1 2 ns  1000  ml ; hydralazine  20  mg ; metoprolol tartrate  5  mg ; ns  250  ml ; pneumococcal vac polyvalent  0.5  ml ; 
 
white f 66 $nan$nan$simvastatin  20  mg ; lisinopril  10  mg ; clopidogrel  75  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1-2  mg ; 
 
white m 62 $temp  97.8  heartrate  86.0  resprate  18.0  o2sat  100.0  sbp  153.0  dbp  89.0  rhythm    pain  0  ; temp    heartrate  87.0  resprate  16.0  o2sat  99.0  sbp  159.0  dbp  87.0  rhythm    pain  0  ; temp    heartrate  86.0  resprate  16.0  o2sat  95.0  sbp  120.0  dbp  73.0  rhythm    pain  0  ; temp    heartrate  93.0  resprate    o2sat    sbp  126.0  dbp  75.0  rhythm    pain    ; temp    heartrate  110.0  resprate    o2sat    sbp  121.0  dbp  74.0  rhythm    pain    ; temp  98.9  heartrate  82.0  resprate  16.0  o2sat  100.0  sbp  125.0  dbp  62.0  rhythm    pain    ; temp    heartrate  85.0  resprate  25.0  o2sat  98.0  sbp  131.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  89.0  resprate  19.0  o2sat  98.0  sbp  122.0  dbp  58.0  rhythm    pain  0  ; temp    heartrate  86.0  resprate  20.0  o2sat  98.0  sbp  123.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  91.0  resprate  19.0  o2sat  100.0  sbp  124.0  dbp  85.0  rhythm    pain  0  $hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  314  mg dl; chemistry blood albumin  3.1  g dl; blood gas blood lactate  1.0  mmol l$nan
presence of coronary angioplasty implant and graft type 2 diabetes mellitus with diabetic chronic kidney disease gastroparesis other fall from one level to another in water transport injuring occupant of other watercraft -- crew liver transplant status paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy acute kidney failure, unspecified noninfective gastroenteritis and colitis, unspecified type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia chronic kidney disease, stage 3 (moderate) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of insulin hypovolemia nonexudative age-related macular degeneration, bilateral, stage unspecified long term (current) use of anticoagulants hyperlipidemia, unspecified other specified diseases of the digestive system unspecified diastolic (congestive) heart failure dehydration long term (current) use of antithrombotics/antiplatelets fall on stairs or ladders in water transport injuring unspecified person bacterial intestinal infection, unspecified hyperkalemia hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of insulin type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene other disorders of phosphorus metabolism chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease paroxysmal atrial fibrillation hyperlipidemia, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 24.0-24.9, adult liver transplant status nicotine dependence, cigarettes, uncomplicated chronic kidney disease, unspecified acute kidney failure, unspecified presence of coronary angioplasty implant and graft unspecified protein-calorie malnutrition long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 62 $temp  98.8  heartrate  95.0  resprate  19.0  o2sat  98.0  sbp  123.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  286  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  3.3  g dl; hematology urine glucose  1000  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; cilostazol  100  mg ; isosorbide mononitrate (extended release)  120  mg ; pantoprazole  40  mg ; rifaximin  550  mg ; rivaroxaban  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; metoprolol tartrate  12.5  mg ; insulin  0  unit ; aspirin  81  mg ; lisinopril  20  mg ; bag  2  bag ; magnesium sulfate  4  gm ; bag  1  bag ; magnesium sulfate  2  gm ; loperamide  2  mg ; fenofibrate  145  mg ; meclizine  12.5  mg ; docusate sodium  100  mg ; 
presence of coronary angioplasty implant and graft type 2 diabetes mellitus with diabetic chronic kidney disease gastroparesis other fall from one level to another in water transport injuring occupant of other watercraft -- crew liver transplant status paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy acute kidney failure, unspecified noninfective gastroenteritis and colitis, unspecified type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia chronic kidney disease, stage 3 (moderate) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of insulin hypovolemia nonexudative age-related macular degeneration, bilateral, stage unspecified long term (current) use of anticoagulants hyperlipidemia, unspecified other specified diseases of the digestive system unspecified diastolic (congestive) heart failure dehydration long term (current) use of antithrombotics/antiplatelets fall on stairs or ladders in water transport injuring unspecified person bacterial intestinal infection, unspecified hyperkalemia hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of insulin type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene other disorders of phosphorus metabolism chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease paroxysmal atrial fibrillation hyperlipidemia, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 24.0-24.9, adult liver transplant status nicotine dependence, cigarettes, uncomplicated chronic kidney disease, unspecified acute kidney failure, unspecified presence of coronary angioplasty implant and graft unspecified protein-calorie malnutrition long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 62 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  286  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; cilostazol  100  mg ; isosorbide mononitrate (extended release)  120  mg ; pantoprazole  40  mg ; rivaroxaban  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; lisinopril  20  mg ; bag  2  bag ; magnesium sulfate  4  gm ; bag  1  bag ; magnesium sulfate  2  gm ; loperamide  2  mg ; fenofibrate  145  mg ; meclizine  12.5  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; senna  8.6  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; insulin  24  unit ; multivitamins w minerals  1  tab ; meclizine  25  mg ; 
presence of coronary angioplasty implant and graft type 2 diabetes mellitus with diabetic chronic kidney disease gastroparesis other fall from one level to another in water transport injuring occupant of other watercraft -- crew liver transplant status paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy acute kidney failure, unspecified noninfective gastroenteritis and colitis, unspecified type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia chronic kidney disease, stage 3 (moderate) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of insulin hypovolemia nonexudative age-related macular degeneration, bilateral, stage unspecified long term (current) use of anticoagulants hyperlipidemia, unspecified other specified diseases of the digestive system unspecified diastolic (congestive) heart failure dehydration long term (current) use of antithrombotics/antiplatelets fall on stairs or ladders in water transport injuring unspecified person bacterial intestinal infection, unspecified hyperkalemia hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of insulin type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene other disorders of phosphorus metabolism chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease paroxysmal atrial fibrillation hyperlipidemia, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 24.0-24.9, adult liver transplant status nicotine dependence, cigarettes, uncomplicated chronic kidney disease, unspecified acute kidney failure, unspecified presence of coronary angioplasty implant and graft unspecified protein-calorie malnutrition long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 62 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  41  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  220  mg dl; chemistry blood albumin  3.0  g dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; cilostazol  100  mg ; isosorbide mononitrate (extended release)  120  mg ; pantoprazole  40  mg ; rivaroxaban  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; lisinopril  20  mg ; loperamide  2  mg ; fenofibrate  145  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; insulin  24  unit ; multivitamins w minerals  1  tab ; meclizine  25  mg ; 
presence of coronary angioplasty implant and graft type 2 diabetes mellitus with diabetic chronic kidney disease gastroparesis other fall from one level to another in water transport injuring occupant of other watercraft -- crew liver transplant status paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy acute kidney failure, unspecified noninfective gastroenteritis and colitis, unspecified type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia chronic kidney disease, stage 3 (moderate) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of insulin hypovolemia nonexudative age-related macular degeneration, bilateral, stage unspecified long term (current) use of anticoagulants hyperlipidemia, unspecified other specified diseases of the digestive system unspecified diastolic (congestive) heart failure dehydration long term (current) use of antithrombotics/antiplatelets fall on stairs or ladders in water transport injuring unspecified person bacterial intestinal infection, unspecified hyperkalemia hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of insulin type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene other disorders of phosphorus metabolism chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease paroxysmal atrial fibrillation hyperlipidemia, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 24.0-24.9, adult liver transplant status nicotine dependence, cigarettes, uncomplicated chronic kidney disease, unspecified acute kidney failure, unspecified presence of coronary angioplasty implant and graft unspecified protein-calorie malnutrition long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; atorvastatin  80  mg ; cilostazol  100  mg ; isosorbide mononitrate (extended release)  120  mg ; pantoprazole  40  mg ; rivaroxaban  15  mg ; tacrolimus  0.5  mg ; tacrolimus  2  mg ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; lisinopril  20  mg ; loperamide  2  mg ; fenofibrate  145  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; calcium carbonate  500  mg ; insulin  24  unit ; multivitamins w minerals  1  tab ; meclizine  25  mg ; 
presence of coronary angioplasty implant and graft type 2 diabetes mellitus with diabetic chronic kidney disease gastroparesis other fall from one level to another in water transport injuring occupant of other watercraft -- crew liver transplant status paroxysmal atrial fibrillation type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy acute kidney failure, unspecified noninfective gastroenteritis and colitis, unspecified type 2 diabetes mellitus with hyperglycemia atherosclerotic heart disease of native coronary artery without angina pectoris nicotine dependence, cigarettes, uncomplicated hypomagnesemia chronic kidney disease, stage 3 (moderate) hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease long term (current) use of insulin hypovolemia nonexudative age-related macular degeneration, bilateral, stage unspecified long term (current) use of anticoagulants hyperlipidemia, unspecified other specified diseases of the digestive system unspecified diastolic (congestive) heart failure dehydration long term (current) use of antithrombotics/antiplatelets fall on stairs or ladders in water transport injuring unspecified person bacterial intestinal infection, unspecified hyperkalemia hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of insulin type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene other disorders of phosphorus metabolism chronic diastolic (congestive) heart failure type 2 diabetes mellitus with diabetic chronic kidney disease paroxysmal atrial fibrillation hyperlipidemia, unspecified hypomagnesemia other fall from one level to another in water transport injuring occupant of other watercraft -- crew body mass index (bmi) 24.0-24.9, adult liver transplant status nicotine dependence, cigarettes, uncomplicated chronic kidney disease, unspecified acute kidney failure, unspecified presence of coronary angioplasty implant and graft unspecified protein-calorie malnutrition long term (current) use of insulin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
white m 89 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  10  mg ; folic acid  1  mg ; aspirin  81  mg ; 
 
white m 89 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine chloride, urine  14  meq l; chemistry urine creatinine, urine  131  mg dl; chemistry urine potassium, urine  49  meq l; chemistry urine sodium, urine  33  meq l; chemistry urine urea nitrogen, urine  808  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  98  mg dl$vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  10  mg ; folic acid  1  mg ; aspirin  81  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; 0.45% sodium chloride  1000  ml ; senna  2  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; atenolol  12.5  mg ; methimazole  5  mg ; erythromycin 0.5% ophth oint  0.5  in ; 
 
white m 89 $nan$nan$vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  10  mg ; folic acid  1  mg ; aspirin  81  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.45% sodium chloride  1000  ml ; senna  2  tab ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; tramadol (ultram)  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; atenolol  12.5  mg ; methimazole  5  mg ; erythromycin 0.5% ophth oint  0.5  in ; 
 
white m 36 $temp  98.0  heartrate  85.0  resprate  16.0  o2sat  97.0  sbp  103.0  dbp  62.0  rhythm    pain  sleeping  $hematology blood hematocrit  42.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; senna  8.6  mg ; ibuprofen  400-600  mg ; 
 
white m 36 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; senna  8.6  mg ; ibuprofen  400-600  mg ; ramelteon  8  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 36 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; senna  8.6  mg ; ibuprofen  400-600  mg ; ramelteon  8  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; ceftriaxone  2  gm ; 
 
white m 36 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ibuprofen  400-600  mg ; ramelteon  8  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; ceftriaxone  2  gm ; 
 
white m 36 $nan$hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ibuprofen  400-600  mg ; ramelteon  8  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; ceftriaxone  2  gm ; 
 
white m 36 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ibuprofen  400-600  mg ; ramelteon  8  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; ketorolac  30  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
 
white m 36 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  274  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ramelteon  8  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; ketorolac  30  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 36 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ramelteon  8  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; ketorolac  30  mg ; bag  1  bag ; magnesium sulfate  2  gm ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ibuprofen  600  mg ; 
 
white m 36 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry urine creatinine, urine  79  mg dl; chemistry urine sodium, urine  67  meq l; chemistry urine urea nitrogen, urine  346  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; acetaminophen  500  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ramelteon  8  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; ibuprofen  600  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
 
white m 36 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  127  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ramelteon  8  mg ; vial  1  vial ; ceftriaxone  2  gm ; lidocaine 5% patch  1  ptch ; cyclobenzaprine  10  mg ; ibuprofen  600  mg ; sodium chloride 0.9%  flush  10-20  ml ; magnesium sulfate  4  gm ; baclofen  10  mg ; senna  17.2  mg ; 
 
white m 36 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; gabapentin  600  mg ; escitalopram oxalate  20  mg ; polyethylene glycol  17  g ; methadone  50  mg ; amphetamine-dextroamphetamine xr  20  mg ; amphetamine-dextroamphetamine xr  10  mg ; ramelteon  8  mg ; ibuprofen  600  mg ; sodium chloride 0.9%  flush  10-20  ml ; senna  17.2  mg ; gabapentin  300  mg ; baclofen  5  mg ; diazepam  5  mg ; 
 
white m 33 $temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  2  ; temp  98.3  heartrate  61.0  resprate  14.0  o2sat  97.0  sbp  116.0  dbp  76.0  rhythm    pain    ; temp  97.8  heartrate  57.0  resprate  16.0  o2sat  99.0  sbp  106.0  dbp  68.0  rhythm    pain  0  ; temp  98.1  heartrate  61.0  resprate  16.0  o2sat  100.0  sbp  113.0  dbp  75.0  rhythm    pain    ; temp  98.1  heartrate  61.0  resprate  16.0  o2sat  100.0  sbp  113.0  dbp  75.0  rhythm    pain    $nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 33 $nan$hematology blood hematocrit  41.7  %; hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.0  g dl; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  234  k ul; hematology blood platelet count  276  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  93  mg dl$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; morphine sulfate  2-4  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; 
 
white m 33 $nan$hematology blood hematocrit  43.4  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  112  mg dl$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; 5% dextrose  500  ml ; vancomycin  1500  mg ; diphenhydramine  12.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; 
 
white m 33 $nan$hematology blood hematocrit  43.0  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  104  mg dl$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; diphenhydramine  12.5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
 
white m 33 $nan$nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
 
white m 33 $nan$nan$enoxaparin sodium  40  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; acetaminophen-caff-butalbital  1-2  tab ; oxycodone (immediate release)   5-10  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
 
white f 50 $temp  97.9  heartrate  111.0  resprate  16.0  o2sat  95.0  sbp  107.0  dbp  68.0  rhythm    pain    ; temp  98.7  heartrate  114.0  resprate  16.0  o2sat  94.0  sbp  107.0  dbp  61.0  rhythm    pain  sleeping  ; temp  98.6  heartrate  110.0  resprate  16.0  o2sat  92.0  sbp  95.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  26.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, indirect  0.8  mg dl; chemistry blood bilirubin, total  4.2  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  56  mg dl; chemistry blood albumin  2.4  g dl; blood gas blood lactate  5.9  mmol l; chemistry blood bilirubin, direct  3.4  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; phosphorus  500  mg ; furosemide  20  mg ; oxycodone (immediate release)  5-10  mg ; oxycodone sr (oxycontin)  20  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; metronidazole  500  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; 
 
white f 50 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  24.3  %; hematology blood hematocrit  26.5  %; hematology blood hemoglobin  7.0  g dl; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  153  k ul; hematology blood platelet count  148  k ul; hematology blood platelet count  130  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  4.6  mg dl; chemistry blood glucose  71  mg dl; chemistry blood lactate dehydrogenase (ld)  2224  iu l; chemistry blood albumin  2.3  g dl; blood gas blood lactate  8.7  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; phosphorus  500  mg ; furosemide  20  mg ; oxycodone (immediate release)  5-10  mg ; oxycodone sr (oxycontin)  20  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; metronidazole  500  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; heparin  5000  unit ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  40  meq ; 
 
white f 50 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  27.1  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  119  k ul; hematology blood platelet count  124  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  5.1  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  77  mg dl; chemistry blood lactate dehydrogenase (ld)  1977  iu l; chemistry blood albumin  2.4  g dl; blood gas blood lactate  4.3  mmol l$sw  400  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)  5-10  mg ; oxycodone sr (oxycontin)  20  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; metronidazole  500  mg ; iso-osmotic dextrose  100  ml ; cefepime  2  g ; heparin  5000  unit ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  500  ml ; sodium phosphate  30  mmol ; oxycodone sr (oxycontin)  10  mg ; neutra-phos  2  pkt ; lactulose  30  ml ; 
 
white f 50 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  5.0  mg dl; chemistry blood glucose  51  mg dl; chemistry blood lactate dehydrogenase (ld)  1633  iu l; chemistry blood albumin  2.2  g dl$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lactulose  30  ml ; oxycodone sr (oxycontin)  30  mg ; haloperidol  0.5-1  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lactulose  30  ml ; oxycodone sr (oxycontin)  30  mg ; haloperidol  0.5-1  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lactulose  30  ml ; oxycodone sr (oxycontin)  30  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; oxycodone (immediate release)  5-10  mg ; sarna lotion  1  appl ; heparin flush (100 units ml)  5  ml ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; lactulose  30  ml ; oxycodone sr (oxycontin)  30  mg ; 
 
black african american f 92 $nan$nan$aspirin  325  mg ; multivitamins  1  tab ; amlodipine  10  mg ; losartan potassium  100  mg ; 
below knee amputation status coronary atherosclerosis of native coronary artery poisoning by insulins and antidiabetic agents accidental poisoning by hormones and synthetic substitutes diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled diabetes with other specified manifestations, type ii or unspecified type, uncontrolled acute on chronic diastolic heart failure dietary surveillance and counseling congestive heart failure, unspecified anorexia unspecified essential hypertension loss of weight other specified cardiac dysrhythmias long-term (current) use of insulin unspecified occupant of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident below knee amputation status old myocardial infarction coronary atherosclerosis of native coronary artery hypertrophic obstructive cardiomyopathy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin polyneuropathy in diabetes pneumonia, organism unspecified lesion of radial nerve peripheral vascular disease, unspecified cerebral artery occlusion, unspecified with cerebral infarction stricture and stenosis of esophagus long-term (current) use of insulin below knee amputation status unspecified essential hypertension old myocardial infarction home accidents osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery congestive heart failure, unspecified cervical spondylosis without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled stricture and stenosis of esophagus hypertrophic obstructive cardiomyopathy acute kidney failure, unspecified accidental fall from wheelchair hyperpotassemia open wound of scalp, without mention of complication 
black african american f 92 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology urine wbc  >50  # hpf; chemistry blood glucose  168  mg dl; chemistry blood glucose  123  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$aspirin  325  mg ; multivitamins  1  tab ; amlodipine  10  mg ; losartan potassium  100  mg ; clotrimazole cream  1  appl ; ranitidine  150  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; loperamide  2-4  mg ; gabapentin  100  mg ; guaifenesin  5-10  ml ; insulin  0  unit ; levofloxacin  750  mg ; ciprofloxacin hcl  500  mg ; 
below knee amputation status coronary atherosclerosis of native coronary artery poisoning by insulins and antidiabetic agents accidental poisoning by hormones and synthetic substitutes diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled diabetes with other specified manifestations, type ii or unspecified type, uncontrolled acute on chronic diastolic heart failure dietary surveillance and counseling congestive heart failure, unspecified anorexia unspecified essential hypertension loss of weight other specified cardiac dysrhythmias long-term (current) use of insulin unspecified occupant of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident below knee amputation status old myocardial infarction coronary atherosclerosis of native coronary artery hypertrophic obstructive cardiomyopathy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin polyneuropathy in diabetes pneumonia, organism unspecified lesion of radial nerve peripheral vascular disease, unspecified cerebral artery occlusion, unspecified with cerebral infarction stricture and stenosis of esophagus long-term (current) use of insulin below knee amputation status unspecified essential hypertension old myocardial infarction home accidents osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery congestive heart failure, unspecified cervical spondylosis without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled stricture and stenosis of esophagus hypertrophic obstructive cardiomyopathy acute kidney failure, unspecified accidental fall from wheelchair hyperpotassemia open wound of scalp, without mention of complication 
black african american f 92 $nan$nan$aspirin  325  mg ; multivitamins  1  tab ; amlodipine  10  mg ; clotrimazole cream  1  appl ; ranitidine  150  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; loperamide  2-4  mg ; guaifenesin  5-10  ml ; insulin  0  unit ; ciprofloxacin hcl  500  mg ; 
below knee amputation status coronary atherosclerosis of native coronary artery poisoning by insulins and antidiabetic agents accidental poisoning by hormones and synthetic substitutes diabetes with peripheral circulatory disorders, type ii or unspecified type, uncontrolled diabetes with other specified manifestations, type ii or unspecified type, uncontrolled acute on chronic diastolic heart failure dietary surveillance and counseling congestive heart failure, unspecified anorexia unspecified essential hypertension loss of weight other specified cardiac dysrhythmias long-term (current) use of insulin unspecified occupant of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident below knee amputation status old myocardial infarction coronary atherosclerosis of native coronary artery hypertrophic obstructive cardiomyopathy diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled long-term (current) use of insulin polyneuropathy in diabetes pneumonia, organism unspecified lesion of radial nerve peripheral vascular disease, unspecified cerebral artery occlusion, unspecified with cerebral infarction stricture and stenosis of esophagus long-term (current) use of insulin below knee amputation status unspecified essential hypertension old myocardial infarction home accidents osteoarthrosis, unspecified whether generalized or localized, site unspecified coronary atherosclerosis of native coronary artery congestive heart failure, unspecified cervical spondylosis without myelopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled stricture and stenosis of esophagus hypertrophic obstructive cardiomyopathy acute kidney failure, unspecified accidental fall from wheelchair hyperpotassemia open wound of scalp, without mention of complication 
white m 72 $temp    heartrate  74.0  resprate  14.0  o2sat  100.0  sbp  156.0  dbp  90.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3-10  ml ; d5 1 2ns  1000  ml ; heparin  5000  unit ; racepinephrine  0.5  ml ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; acetaminophen iv  1000  mg ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; dexamethasone  10  mg ; losartan potassium  50  mg ; ezetimibe  10  mg ; hydralazine  10  mg ; ipratropium-albuterol neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; insulin  0  unit ; 
 
white m 72 $nan$hematology blood hematocrit  42.1  %; hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; racepinephrine  0.5  ml ; acetaminophen iv  1000  mg ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; dexamethasone  10  mg ; losartan potassium  50  mg ; ezetimibe  10  mg ; hydralazine  10  mg ; ipratropium-albuterol neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; insulin  0  unit ; morphine sulfate  4  mg ; ampicillin-sulbactam  3  g ; 
 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; racepinephrine  0.5  ml ; bag  1  bag ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; dexamethasone  10  mg ; losartan potassium  50  mg ; ezetimibe  10  mg ; hydralazine  10  mg ; ipratropium-albuterol neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; insulin  0  unit ; morphine sulfate  4  mg ; ampicillin-sulbactam  3  g ; 
 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; dexamethasone  10  mg ; losartan potassium  50  mg ; ezetimibe  10  mg ; hydralazine  10  mg ; ipratropium-albuterol neb  1  neb ; 
 
hispanic latino m 47 $temp  98.0  heartrate  92.0  resprate  16.0  o2sat  97.0  sbp  134.0  dbp  75.0  rhythm    pain  6  $nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; penicillin g potassium  3  million units ; 
 
hispanic latino m 47 $temp  98.4  heartrate  98.0  resprate  16.0  o2sat  95.0  sbp  140.0  dbp  68.0  rhythm    pain  6  $hematology blood hematocrit  26.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  110  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; penicillin g potassium  3  million units ; haloperidol  5  mg ; 0.9% sodium chloride  1000  ml ; influenza virus vaccine  0.5  ml ; insulin  20  unit ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  50  ml ; gentamicin  80  mg ; quetiapine fumarate  25  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  145  mg dl; chemistry blood % hemoglobin a1c  8.9  %$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; 0.9% sodium chloride  50  ml ; gentamicin  80  mg ; quetiapine fumarate  25  mg ; insulin  44  unit ; mupirocin nasal ointment 2%  1  appl ; acetaminophen  650  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  150  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; insulin  44  unit ; mupirocin nasal ointment 2%  1  appl ; acetaminophen  650  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; ampicillin  500  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  202  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; insulin  44  unit ; mupirocin nasal ointment 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; mupirocin nasal ointment 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol tartrate  12.5  mg ; insulin  55  unit ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  170  mg dl; chemistry blood albumin  3.6  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; mupirocin nasal ointment 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol tartrate  12.5  mg ; insulin  55  unit ; 
 
hispanic latino m 47 $nan$chemistry blood chloride  103  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; mupirocin nasal ointment 2%  1  appl ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol tartrate  12.5  mg ; insulin  55  unit ; 
 
hispanic latino m 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol tartrate  12.5  mg ; insulin  55  unit ; 
 
hispanic latino m 47 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  254  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; insulin  55  unit ; metoprolol tartrate  25  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  28.4  %; hematology blood hematocrit  25.7  %; hematology blood hematocrit  24.5  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  279  k ul; hematology blood platelet count  243  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; chemistry blood glucose  367  mg dl; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood free calcium  1.38  mmol l; blood gas blood free calcium  1.38  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  187  mg dl; blood gas blood glucose  214  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  126  mg dl; blood gas blood glucose  108  mg dl; blood gas blood glucose  145  mg dl; blood gas blood glucose  159  mg dl; blood gas blood glucose  132  mg dl; blood gas blood glucose  183  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  24  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hemoglobin  9.5  g dl; blood gas blood hemoglobin  7.9  g dl; blood gas blood hemoglobin  7.8  g dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  5.7  meq l; blood gas blood potassium, whole blood  5.7  meq l; blood gas blood potassium, whole blood  4.9  meq l; blood gas blood potassium, whole blood  6.1  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  131  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l$heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lisinopril  10  mg ; mirtazapine  15  mg ; quetiapine fumarate  100  mg ; simvastatin  20  mg ; quetiapine fumarate  25  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; metoprolol tartrate  25  mg ; insulin  12  unit ; milk of magnesia  30  ml ; propofol  1000  mg ; propofol  500  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; lactated ringers  1000  ml ; cefazolin  2  g ; hydralazine  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  0.5  mg ; dexmedetomidine  0.2  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  21.8  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  27.5  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  191  k ul; hematology blood platelet count  172  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  3.2  mg dl; chemistry blood creatinine  3.5  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.9  meq l; chemistry blood potassium  7.1  meq l; chemistry blood potassium  7.4  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  76  meq l; chemistry urine potassium, urine  56  meq l; chemistry urine sodium, urine  75  meq l; chemistry urine urea nitrogen, urine  136  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  140  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood glucose  97  mg dl; blood gas blood glucose  103  mg dl; blood gas blood glucose  109  mg dl; blood gas blood glucose  151  mg dl; blood gas blood glucose  129  mg dl; blood gas blood glucose  134  mg dl; blood gas blood glucose  132  mg dl; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  8.7  g dl; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  5.2  meq l; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  7.2  meq l; blood gas blood potassium, whole blood  6.9  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood potassium, whole blood  6.0  meq l$milk of magnesia  30  ml ; propofol  1000  mg ; propofol  500  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; hydralazine  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; ketorolac  15  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; norepinephrine  8  mg ; albumin 5% (12.5g   250ml)  12.5  g ; insulin  10  unit ; furosemide  40  mg ; furosemide  100  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; metoclopramide  5  mg ; sodium bicarbonate  50  meq ; furosemide  80  mg ; chlorothiazide sodium  500  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  10  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  25.1  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  165  k ul; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  7.0  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  206  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  196  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  0.86  mmol l; blood gas blood free calcium  0.91  mmol l; blood gas blood free calcium  0.98  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  143  mg dl; blood gas blood glucose  170  mg dl; blood gas blood glucose  197  mg dl; blood gas blood glucose  190  mg dl; blood gas blood glucose  93  mg dl; blood gas blood potassium, whole blood  3.0  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  3.7  meq l$milk of magnesia  30  ml ; propofol  1000  mg ; propofol  500  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; hydralazine  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydromorphone (dilaudid)  0.5  mg ; 0.9% sodium chloride  150  ml ; dexmedetomidine  0.6  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; norepinephrine  8  mg ; albumin 5% (12.5g   250ml)  12.5  g ; furosemide  40  mg ; furosemide  100  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; metoclopramide  5  mg ; sodium bicarbonate  50  meq ; furosemide  80  mg ; chlorothiazide sodium  500  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  10  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; penicillin g potassium  2  million units ; metoprolol tartrate  5  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  260  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood creatinine  3.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  208  mg dl$milk of magnesia  30  ml ; propofol  1000  mg ; propofol  500  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; hydralazine  10-20  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; hydromorphone (dilaudid)  0.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; norepinephrine  8  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; metoclopramide  5  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  10  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; penicillin g potassium  2  million units ; metoprolol tartrate  5  mg ; metoprolol tartrate  37.5  mg ; hydromorphone (dilaudid)  2-4  mg ; polyethylene glycol  17  g ; senna  2  tab ; hydralazine  50  mg ; acetaminophen  1000  mg ; metoprolol tartrate  50  mg ; hydralazine  20  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  23.1  %; hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  3.1  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  243  iu l; chemistry blood albumin  3.3  g dl; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.8  mmol l$d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; hydralazine  10-20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; metoclopramide  5  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; bag  1  bag ; citrate dextrose 3% (acd-a) crrt  1000  ml ; sodium citrate 4%  10  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; heparin (crrt machine priming)  5000  unit ; neomycin-polymyxin-bacitracin  1  appl ; penicillin g potassium  2  million units ; hydromorphone (dilaudid)  2-4  mg ; polyethylene glycol  17  g ; senna  2  tab ; hydralazine  50  mg ; acetaminophen  1000  mg ; metoprolol tartrate  50  mg ; hydralazine  20  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  1-2  mg ; methylnaltrexone  12  mg ; lorazepam  1  mg ; amiodarone  150  mg ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; bisacodyl  10  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  119  mg dl$d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; hydralazine  10-20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; metoclopramide  5  mg ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; neomycin-polymyxin-bacitracin  1  appl ; penicillin g potassium  2  million units ; ondansetron  4  mg ; bisacodyl  10  mg ; aspirin  300  mg ; sterile water  100  ml ; potassium chloride  40  meq ; metoprolol tartrate  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  219  mg dl$sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; hydralazine  10-20  mg ; sodium chloride 0.9%  flush  10  ml ; bag  5000  ml ; prismasate (b32 k2)  5000  ml ; 5% dextrose  500  ml ; calcium gluconate  20  gm ; sw  100  ml ; potassium chloride  10  meq ; neomycin-polymyxin-bacitracin  1  appl ; penicillin g potassium  2  million units ; ondansetron  4  mg ; bisacodyl  10  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; senna  1  tab ; tramadol (ultram)  50  mg ; insulin  25  unit ; chlorpromazine  25  mg ; sodium chloride 0.9%  flush  10-20  ml ; heparin flush (1000 units ml)  4000-11000  unit ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  361  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood glucose  242  mg dl$insulin  25  unit ; sodium chloride 0.9%  flush  10-20  ml ; heparin flush (1000 units ml)  4000-11000  unit ; insulin  30  unit ; lactulose  30  ml ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  384  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood glucose  246  mg dl$sodium chloride 0.9%  flush  10-20  ml ; heparin flush (1000 units ml)  4000-11000  unit ; insulin  30  unit ; lactulose  30  ml ; amlodipine  10  mg ; insulin  18  unit ; 
 
hispanic latino m 47 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  360  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  10-20  ml ; heparin flush (1000 units ml)  4000-11000  unit ; amlodipine  10  mg ; insulin  18  unit ; hydralazine  25  mg ; 
 
hispanic latino m 47 $nan$nan$sodium chloride 0.9%  flush  10-20  ml ; heparin flush (1000 units ml)  4000-11000  unit ; amlodipine  10  mg ; hydralazine  25  mg ; 
 
white m 69 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  141  mg dl$creon 12  1  cap ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; morphine sulfate  100  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sodium chloride 0.9%  1000  ml ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; propranolol  60  mg ; 
personal history of irradiation essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated personal history of antineoplastic chemotherapy chronic obstructive pulmonary disease, unspecified polyneuropathy, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes malignant neoplasm of head of pancreas foot drop, right foot personal history of malignant melanoma of skin chronic cholecystitis syncope and collapse malignant neoplasm of head of pancreas personal history of malignant melanoma of skin alcohol abuse, uncomplicated nontoxic single thyroid nodule chronic obstructive pulmonary disease, unspecified nicotine dependence, cigarettes, uncomplicated essential (primary) hypertension 
white m 69 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  219  mg dl$creon 12  1  cap ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; morphine sulfate  100  mg ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; enoxaparin sodium  40  mg ; oxybutynin  5  mg ; senna  17.2  mg ; 
personal history of irradiation essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated personal history of antineoplastic chemotherapy chronic obstructive pulmonary disease, unspecified polyneuropathy, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes malignant neoplasm of head of pancreas foot drop, right foot personal history of malignant melanoma of skin chronic cholecystitis syncope and collapse malignant neoplasm of head of pancreas personal history of malignant melanoma of skin alcohol abuse, uncomplicated nontoxic single thyroid nodule chronic obstructive pulmonary disease, unspecified nicotine dependence, cigarettes, uncomplicated essential (primary) hypertension 
white m 69 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  120  mg dl$creon 12  1  cap ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; diphenhydramine  25-50  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; oxycodone (immediate release)  5  mg ; enoxaparin sodium  40  mg ; oxybutynin  5  mg ; senna  17.2  mg ; nicotine patch  14  mg day ; 
personal history of irradiation essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated personal history of antineoplastic chemotherapy chronic obstructive pulmonary disease, unspecified polyneuropathy, unspecified secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes malignant neoplasm of head of pancreas foot drop, right foot personal history of malignant melanoma of skin chronic cholecystitis syncope and collapse malignant neoplasm of head of pancreas personal history of malignant melanoma of skin alcohol abuse, uncomplicated nontoxic single thyroid nodule chronic obstructive pulmonary disease, unspecified nicotine dependence, cigarettes, uncomplicated essential (primary) hypertension 
white f 69 $nan$nan$escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; 
 
white f 69 $nan$nan$escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; verapamil sr  180  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; clonidine  0.1  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; bupropion (sustained release)  200  mg ; 
 
white f 69 $nan$nan$escitalopram oxalate  20  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  125  mcg ; omeprazole  20  mg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; verapamil sr  180  mg ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; clonidine  0.1  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; bupropion (sustained release)  200  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
unknown m 76 $nan$nan$docusate sodium  100  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; losartan potassium  12.5  mg ; metoprolol succinate xl  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; diazepam  5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
 
unknown m 76 $nan$nan$docusate sodium  100  mg ; aspirin  81  mg ; latanoprost 0.005% ophth. soln.  1  drop ; losartan potassium  12.5  mg ; metoprolol succinate xl  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lidocaine jelly 2% (urojet)  1  appl ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; diazepam  5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; 
 
white m 64 $nan$hematology blood hematocrit  37.8  %; hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  187  k ul; hematology blood platelet count  183  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  116  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  138  iu l; chemistry blood albumin  3.4  g dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen w codeine  1-2  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; potassium chloride  40  meq ; potassium chl 40 meq   1000 ml ns  1000  ml ; heparin  5000  unit ; simvastatin  40  mg ; aspirin  325  mg ; neutra-phos  2  pkt ; 
transient retinal arterial occlusion occlusion and stenosis of carotid artery without mention of cerebral infarction asthma, unspecified type, unspecified pure hypercholesterolemia
white m 64 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  242  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  278  iu l$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen w codeine  1-2  tab ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; potassium chloride  40  meq ; heparin  5000  unit ; simvastatin  40  mg ; aspirin  325  mg ; neutra-phos  2  pkt ; ciprofloxacin hcl  500  mg ; 
transient retinal arterial occlusion occlusion and stenosis of carotid artery without mention of cerebral infarction asthma, unspecified type, unspecified pure hypercholesterolemia
white m 64 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen w codeine  1-2  tab ; heparin  5000  unit ; simvastatin  40  mg ; aspirin  325  mg ; ciprofloxacin hcl  500  mg ; 
transient retinal arterial occlusion occlusion and stenosis of carotid artery without mention of cerebral infarction asthma, unspecified type, unspecified pure hypercholesterolemia
white m 68 $temp  98.0  heartrate  90.0  resprate  18.0  o2sat  99.0  sbp    dbp    rhythm    pain  0  $hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  6  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  89  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry blood albumin  4.0  g dl$influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; vitamin d  2000  unit ; ferrous sulfate  325  mg ; amiodarone  300  mg ; levothyroxine sodium  112  mcg ; metoprolol succinate xl  12.5  mg ; mexiletine  150  mg ; pantoprazole  40  mg ; pravastatin  20  mg ; sildenafil  20  mg ; spironolactone  25  mg ; tamsulosin  0.4  mg ; warfarin  3  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; warfarin  1  mg ; warfarin  2  mg ; 
dilated cardiomyopathy thrombocytopenia, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission deficiency of other specified b group vitamins other secondary thrombocytopenia cellulitis of left upper limb benign prostatic hyperplasia without lower urinary tract symptoms presence of xenogenic heart valve personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis ventricular tachycardia presence of heart assist device anemia, unspecified encounter for adjustment and management of automatic implantable cardiac defibrillator hypothyroidism, unspecified pleural effusion in other conditions classified elsewhere history of falling other specified abnormal findings of blood chemistry alcohol abuse, in remission hyperlipidemia, unspecified family history of ischemic heart disease and other diseases of the circulatory system acute on chronic systolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) other secondary pulmonary hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified persistent atrial fibrillation unspecified atrial flutter gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure presence of prosthetic heart valve dysarthria following cerebral infarction dehydration presence of heart assist device presence of automatic (implantable) cardiac defibrillator benign prostatic hyperplasia without lower urinary tract symptoms facial weakness following cerebral infarction adverse effect of loop [high-ceiling] diuretics, initial encounter chronic lymphocytic leukemia of b-cell type not having achieved remission long term (current) use of anticoagulants deficiency of other specified b group vitamins hypothyroidism, unspecified other specified hypothyroidism dilated cardiomyopathy unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause obstructive sleep apnea (adult) (pediatric) end stage heart failure anemia, unspecified
white m 68 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; vitamin d  2000  unit ; ferrous sulfate  325  mg ; amiodarone  300  mg ; levothyroxine sodium  112  mcg ; metoprolol succinate xl  12.5  mg ; mexiletine  150  mg ; pantoprazole  40  mg ; pravastatin  20  mg ; sildenafil  20  mg ; spironolactone  25  mg ; tamsulosin  0.4  mg ; warfarin  3  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; trazodone  25  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; warfarin  1  mg ; warfarin  2  mg ; 
dilated cardiomyopathy thrombocytopenia, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission deficiency of other specified b group vitamins other secondary thrombocytopenia cellulitis of left upper limb benign prostatic hyperplasia without lower urinary tract symptoms presence of xenogenic heart valve personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis ventricular tachycardia presence of heart assist device anemia, unspecified encounter for adjustment and management of automatic implantable cardiac defibrillator hypothyroidism, unspecified pleural effusion in other conditions classified elsewhere history of falling other specified abnormal findings of blood chemistry alcohol abuse, in remission hyperlipidemia, unspecified family history of ischemic heart disease and other diseases of the circulatory system acute on chronic systolic (congestive) heart failure obstructive sleep apnea (adult) (pediatric) other secondary pulmonary hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits chronic kidney disease, unspecified persistent atrial fibrillation unspecified atrial flutter gastro-esophageal reflux disease without esophagitis chronic systolic (congestive) heart failure presence of prosthetic heart valve dysarthria following cerebral infarction dehydration presence of heart assist device presence of automatic (implantable) cardiac defibrillator benign prostatic hyperplasia without lower urinary tract symptoms facial weakness following cerebral infarction adverse effect of loop [high-ceiling] diuretics, initial encounter chronic lymphocytic leukemia of b-cell type not having achieved remission long term (current) use of anticoagulants deficiency of other specified b group vitamins hypothyroidism, unspecified other specified hypothyroidism dilated cardiomyopathy unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause obstructive sleep apnea (adult) (pediatric) end stage heart failure anemia, unspecified
white f 62 $temp  98.6  heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  115.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  296  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  128  mg dl; chemistry blood glucose  108  mg dl; blood gas blood sodium, whole blood  126  meq l; blood gas blood sodium, whole blood  126  meq l; blood gas blood sodium, whole blood  127  meq l; blood gas blood sodium, whole blood  122  meq l; blood gas blood sodium, whole blood  123  meq l; blood gas blood sodium, whole blood  120  meq l; blood gas blood sodium, whole blood  123  meq l; blood gas blood sodium, whole blood  119  meq l; blood gas blood sodium, whole blood  118  meq l; blood gas blood sodium, whole blood  118  meq l; blood gas blood sodium, whole blood  118  meq l$heparin  5000  unit ; dextrose 5%  1000  ml ; lidocaine 5% patch  1  ptch ; 0.9% sodium chloride  50  ml ; desmopressin acetate  2  mcg ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; oxcarbazepine  600  mg ; 
 
white f 62 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  120  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry urine sodium, urine  25  meq l; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  101  mg dl; blood gas blood sodium, whole blood  120  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  120  meq l; blood gas blood sodium, whole blood  119  meq l; blood gas blood sodium, whole blood  122  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  122  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  119  meq l; blood gas blood sodium, whole blood  120  meq l; blood gas blood sodium, whole blood  122  meq l; blood gas blood sodium, whole blood  122  meq l$heparin  5000  unit ; dextrose 5%  1000  ml ; lidocaine 5% patch  1  ptch ; 0.9% sodium chloride  50  ml ; desmopressin acetate  2  mcg ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; oxcarbazepine  600  mg ; sodium chloride  1  gm ; 
 
white f 62 $nan$chemistry blood sodium  128  meq l; chemistry urine chloride, urine  23  meq l; chemistry urine creatinine, urine  60  mg dl; chemistry urine sodium, urine  35  meq l; blood gas blood sodium, whole blood  126  meq l; blood gas blood sodium, whole blood  127  meq l; blood gas blood sodium, whole blood  127  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  122  meq l; blood gas blood sodium, whole blood  123  meq l; blood gas blood sodium, whole blood  121  meq l; blood gas blood sodium, whole blood  122  meq l$heparin  5000  unit ; lidocaine 5% patch  1  ptch ; acetaminophen  1000  mg ; albuterol inhaler  2  puff ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; oxcarbazepine  600  mg ; sodium chloride  1  gm ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  1000  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white f 62 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry urine sodium, urine  50  meq l; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  138  meq l$heparin  5000  unit ; lidocaine 5% patch  1  ptch ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; sodium chloride  1  gm ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3-10  ml ; 
 
white f 62 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry urine sodium, urine  71  meq l; chemistry blood calcium, total  9.8  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  150  mg dl; blood gas blood sodium, whole blood  137  meq l$heparin  5000  unit ; lidocaine 5% patch  1  ptch ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3-10  ml ; ibuprofen  800  mg ; 
 
white f 62 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  131  mg dl$heparin  5000  unit ; lidocaine 5% patch  1  ptch ; acetaminophen  1000  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3-10  ml ; ibuprofen  800  mg ; tramadol  25  mg ; tramadol  50  mg ; 
 
white f 62 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  105  mg dl$heparin  5000  unit ; lidocaine 5% patch  1  ptch ; aluminum-magnesium hydrox.-simethicone  30  ml ; bisacodyl  5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone propionate nasal  1  spry ; folic acid  1  mg ; lorazepam  1  mg ; montelukast  10  mg ; multivitamins  1  tab ; thiamine  50  mg ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  flush  3-10  ml ; tramadol  25  mg ; tramadol  50  mg ; 
 
white m 60 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; diazepam  5  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)   30  mg ; famotidine  20  mg ; baclofen  10  mg ; lamotrigine  200  mg ; levetiracetam  500  mg ; docusate sodium  100  mg ; sertraline  100  mg ; lisinopril  10  mg ; simvastatin  40  mg ; senna  2  tab ; 0.9% sodium chloride  500  ml ; hydralazine  10-20  mg ; lamotrigine  100  mg ; 
accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unarmed fight or brawl personal history of noncompliance with medical treatment, presenting hazards to health subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other late effects of cerebrovascular disease unspecified leukemia, without mention of having achieved remission cocaine dependence, episodic subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness heart valve replaced by other means long-term (current) use of anticoagulants other musculoskeletal symptoms referable to limbs 
white m 60 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; morphine sr (ms contin)  30  mg ; oxycodone (immediate release)   30  mg ; famotidine  20  mg ; baclofen  10  mg ; lamotrigine  200  mg ; levetiracetam  500  mg ; docusate sodium  100  mg ; sertraline  100  mg ; lisinopril  10  mg ; simvastatin  40  mg ; senna  2  tab ; hydralazine  10-20  mg ; lamotrigine  100  mg ; acetaminophen-caff-butalbital  1-2  tab ; milk of magnesia  30  ml ; 
accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unarmed fight or brawl personal history of noncompliance with medical treatment, presenting hazards to health subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other late effects of cerebrovascular disease unspecified leukemia, without mention of having achieved remission cocaine dependence, episodic subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness heart valve replaced by other means long-term (current) use of anticoagulants other musculoskeletal symptoms referable to limbs 
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; morphine sr (ms contin)  30  mg ; famotidine  20  mg ; baclofen  10  mg ; lamotrigine  200  mg ; levetiracetam  500  mg ; docusate sodium  100  mg ; sertraline  100  mg ; lisinopril  10  mg ; simvastatin  40  mg ; senna  2  tab ; hydralazine  10-20  mg ; lamotrigine  100  mg ; acetaminophen-caff-butalbital  1-2  tab ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unarmed fight or brawl personal history of noncompliance with medical treatment, presenting hazards to health subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other late effects of cerebrovascular disease unspecified leukemia, without mention of having achieved remission cocaine dependence, episodic subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness heart valve replaced by other means long-term (current) use of anticoagulants other musculoskeletal symptoms referable to limbs 
white m 60 $nan$hematology blood inr(pt)  1.4  $sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; morphine sr (ms contin)  30  mg ; famotidine  20  mg ; baclofen  10  mg ; lamotrigine  200  mg ; levetiracetam  500  mg ; docusate sodium  100  mg ; sertraline  100  mg ; lisinopril  10  mg ; simvastatin  40  mg ; lamotrigine  100  mg ; acetaminophen-caff-butalbital  1-2  tab ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; diazepam  10  mg ; levetiracetam  750  mg ; chloraseptic throat spray  2  spry ; 
accidents occurring in other specified places epilepsy, unspecified, without mention of intractable epilepsy unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident unarmed fight or brawl personal history of noncompliance with medical treatment, presenting hazards to health subdural hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness other late effects of cerebrovascular disease unspecified leukemia, without mention of having achieved remission cocaine dependence, episodic subarachnoid hemorrhage following injury without mention of open intracranial wound, with no loss of consciousness heart valve replaced by other means long-term (current) use of anticoagulants other musculoskeletal symptoms referable to limbs 
white f 75 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  205  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  135  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; heparin  1700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; enoxaparin sodium  90  mg ; senna  1  tab ; valsartan  80  mg ; atenolol  25  mg ; vitamin d  800  unit ; warfarin  5  mg ; 
 
white m 67 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; morphine sulfate  1-2  mg ; heparin  5000  unit ; ondansetron  4  mg ; atorvastatin  10  mg ; oxycodone (immediate release)  5  mg ; allopurinol  200  mg ; tamsulosin  0.4  mg ; metoprolol succinate xl  25  mg ; aspirin  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  40  meq ; warfarin  5  mg ; 
benign prostatic hyperplasia without lower urinary tract symptoms cerebral aneurysm, nonruptured rheumatic heart disease, unspecified gout, unspecified long term (current) use of anticoagulants presence of left artificial knee joint long term (current) use of antithrombotics/antiplatelets presence of prosthetic heart valve gout, unspecified hyperlipidemia, unspecified insomnia, unspecified unspecified atrial fibrillation heart failure, unspecified disease of stomach and duodenum, unspecified gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms duodenitis without bleeding personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits long term (current) use of anticoagulants presence of prosthetic heart valve pleural effusion, not elsewhere classified other specified sepsis calculus of bile duct with acute cholangitis with obstruction fluid overload, unspecified nausea cerebral aneurysm, nonruptured aneurysm of heart other specified diseases of biliary tract benign prostatic hyperplasia without lower urinary tract symptoms presence of left artificial knee joint patient room in hospital as the place of occurrence of the external cause other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gout, unspecified asymptomatic microscopic hematuria presence of prosthetic heart valve long term (current) use of antithrombotics/antiplatelets abnormal coagulation profile long term (current) use of anticoagulants unspecified protein-calorie malnutrition calculus of gallbladder and bile duct without cholecystitis with obstruction body mass index (bmi) 25.0-25.9, adult postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure other nonautoimmune hemolytic anemias acute posthemorrhagic anemia hyperlipidemia, unspecified hemiplegia, unspecified affecting left nondominant side presence of prosthetic heart valve cerebral infarction, unspecified
white m 76 $nan$nan$atenolol  25  mg ; lisinopril  5  mg ; fluticasone propionate nasal  2  spry ; 
 
white m 76 $nan$nan$atenolol  25  mg ; lisinopril  5  mg ; fluticasone propionate nasal  2  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ciprofloxacin hcl  250  mg ; hyoscyamine  0.125  mg ; 1 2 ns  1000  ml ; phenazopyridine hcl  100  mg ; doxazosin  4  mg ; atorvastatin  20  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 76 $nan$nan$atenolol  25  mg ; lisinopril  5  mg ; fluticasone propionate nasal  2  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ciprofloxacin hcl  250  mg ; hyoscyamine  0.125  mg ; phenazopyridine hcl  100  mg ; doxazosin  4  mg ; atorvastatin  20  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 56 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  150  mg dl$nan
personal history of colonic polyps degeneration of lumbar or lumbosacral intervertebral disc unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled epilepsy, unspecified, without mention of intractable epilepsy person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident difficulty in walking presence of cerebrospinal fluid drainage device other specified hemiplegia and hemiparesis affecting unspecified side urinary tract infection, site not specified unspecified visual loss malignant neoplasm of rectosigmoid junction hemiplegia, unspecified, affecting unspecified side person on outside of car injured in collision with railway train or railway vehicle in nontraffic accident unspecified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled presence of cerebrospinal fluid drainage device unspecified essential hypertension unspecified nonpsychotic mental disorder epilepsy, unspecified, without mention of intractable epilepsy osteoarthrosis, unspecified whether generalized or localized, site unspecified obesity, unspecified personal history of colonic polyps 
white f 71 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)   5  mg ; 
 
white f 71 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  112  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.5  mg ; oxycodone (immediate release)   5  mg ; verapamil sr  240  mg ; docusate sodium  100  mg ; dicyclomine  10  mg ; hydrochlorothiazide  25  mg ; simvastatin  80  mg ; lisinopril  10  mg ; ranitidine  150  mg ; 
 
asian f 47 $nan$nan$ferrous sulfate  325  mg ; 
sinoatrial node dysfunction pneumonia, organism unspecified benign neoplasm of pancreas, except islets of langerhans atrial fibrillation rheumatic heart disease, unspecified acute gastritis, with hemorrhage atrial flutter hypotension, unspecified urinary tract infection, site not specified other respiratory complications anemia, unspecified other specified cardiac dysrhythmias unspecified essential hypertension rheumatic heart disease, unspecified syncope and collapse atrial flutter heart valve replaced by other means anemia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident 
asian f 47 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  23.2  %; hematology blood hematocrit  20.6  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  151  k ul; hematology blood platelet count  136  k ul; hematology blood platelet count  123  k ul; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.4  $ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; medroxyprogesterone acetate  10  mg ; 
sinoatrial node dysfunction pneumonia, organism unspecified benign neoplasm of pancreas, except islets of langerhans atrial fibrillation rheumatic heart disease, unspecified acute gastritis, with hemorrhage atrial flutter hypotension, unspecified urinary tract infection, site not specified other respiratory complications anemia, unspecified other specified cardiac dysrhythmias unspecified essential hypertension rheumatic heart disease, unspecified syncope and collapse atrial flutter heart valve replaced by other means anemia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident 
asian f 47 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  23.7  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  111  k ul; hematology blood platelet count  115  k ul; hematology blood platelet count  121  k ul; hematology blood inr(pt)  1.3  $ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; medroxyprogesterone acetate  10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; medroxyprogesterone acetate  150  mg ; 
sinoatrial node dysfunction pneumonia, organism unspecified benign neoplasm of pancreas, except islets of langerhans atrial fibrillation rheumatic heart disease, unspecified acute gastritis, with hemorrhage atrial flutter hypotension, unspecified urinary tract infection, site not specified other respiratory complications anemia, unspecified other specified cardiac dysrhythmias unspecified essential hypertension rheumatic heart disease, unspecified syncope and collapse atrial flutter heart valve replaced by other means anemia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident 
asian f 47 $nan$nan$lr  1000  ml ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; medroxyprogesterone acetate  150  mg ; dabigatran etexilate  150  mg ; 
sinoatrial node dysfunction pneumonia, organism unspecified benign neoplasm of pancreas, except islets of langerhans atrial fibrillation rheumatic heart disease, unspecified acute gastritis, with hemorrhage atrial flutter hypotension, unspecified urinary tract infection, site not specified other respiratory complications anemia, unspecified other specified cardiac dysrhythmias unspecified essential hypertension rheumatic heart disease, unspecified syncope and collapse atrial flutter heart valve replaced by other means anemia, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident 
white m 46 $nan$nan$famotidine  20  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; methylphenidate (ritalin)  15  mg ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; diazepam  2-5  mg ; 
displacement of lumbar intervertebral disc without myelopathy other acute pain displacement of lumbar intervertebral disc without myelopathy dysthymic disorder disturbance of skin sensation 
white m 46 $nan$nan$famotidine  20  mg ; methylphenidate (ritalin)  15  mg ; lidocaine jelly 2% (urojet)  1  appl ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.12  mg ; diazepam  2-5  mg ; gabapentin  300  mg ; hydromorphone (dilaudid)  2-4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; 
displacement of lumbar intervertebral disc without myelopathy other acute pain displacement of lumbar intervertebral disc without myelopathy dysthymic disorder disturbance of skin sensation 
black african american f 23 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  438  k ul$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
threatened premature labor, antepartum condition or complication long-term (current) use of insulin abnormal glucose tolerance of mother, antepartum condition or complication cervical shortening, antepartum condition or complication
black african american f 23 $nan$hematology blood hematocrit  26.4  %$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
threatened premature labor, antepartum condition or complication long-term (current) use of insulin abnormal glucose tolerance of mother, antepartum condition or complication cervical shortening, antepartum condition or complication
black african american f 23 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
threatened premature labor, antepartum condition or complication long-term (current) use of insulin abnormal glucose tolerance of mother, antepartum condition or complication cervical shortening, antepartum condition or complication
black african american f 23 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
threatened premature labor, antepartum condition or complication long-term (current) use of insulin abnormal glucose tolerance of mother, antepartum condition or complication cervical shortening, antepartum condition or complication
black african american f 49 $temp    heartrate  114.0  resprate  35.0  o2sat  99.0  sbp  170.0  dbp  107.0  rhythm  sinus tachycardia  pain  unable  ; temp    heartrate  108.0  resprate  15.0  o2sat  99.0  sbp  170.0  dbp  89.0  rhythm  sinus tachycardia  pain  0  $nan$montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $temp  98.6  heartrate  116.0  resprate  22.0  o2sat  100.0  sbp  157.0  dbp  90.0  rhythm    pain    ; temp  98.6  heartrate  122.0  resprate  26.0  o2sat  99.0  sbp  146.0  dbp  83.0  rhythm  sinus tachycardia  pain    $hematology blood hematocrit  37.2  %; hematology blood hematocrit  35.5  %; hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  11.6  g dl; chemistry blood anion gap  25  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  203  mg dl; chemistry blood glucose  135  mg dl; chemistry blood glucose  118  mg dl; hematology blood bands  8  %; hematology blood bands  3  %; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  5.5  mmol l; blood gas blood lactate  6.6  mmol l; chemistry blood % hemoglobin a1c  6.1  %$0.9% sodium chloride  1000  ml ; montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  125  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; gastroview (diatrizoate meglumine & sodium)  30  ml ; morphine sulfate  1-2  mg ; prednisone  60  mg ; potassium chloride  40  meq ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; ciprofloxacin hcl  500  mg ; lisinopril  20  mg ; guaifenesin-codeine phosphate  5-10  ml ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.4  g dl; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  41  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  121  mg dl; blood gas blood lactate  1.5  mmol l$0.9% sodium chloride  1000  ml ; montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; gastroview (diatrizoate meglumine & sodium)  30  ml ; morphine sulfate  1-2  mg ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; ciprofloxacin hcl  500  mg ; lisinopril  20  mg ; guaifenesin-codeine phosphate  5-10  ml ; metoprolol tartrate  100  mg ; lisinopril  40  mg ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.0  g dl; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  84  mg dl$montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sulfate  1-2  mg ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; ciprofloxacin hcl  500  mg ; guaifenesin-codeine phosphate  5-10  ml ; metoprolol tartrate  100  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride nasal  1-2  spry ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.2  g dl; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  83  mg dl$montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sulfate  1-2  mg ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; metoprolol tartrate  100  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride nasal  1-2  spry ; polyethylene glycol  17  g ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology urine wbc  12  # hpf; chemistry blood glucose  85  mg dl$montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sulfate  1-2  mg ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; metoprolol tartrate  100  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride nasal  1-2  spry ; polyethylene glycol  17  g ; milk of magnesia  30  ml ; tramadol (ultram)  50  mg ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
black african american f 49 $nan$nan$montelukast sodium  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; lorazepam  0.5-1  mg ; albuterol 0.083% neb soln  1  neb ; heparin  5000  unit ; fluticasone-salmeterol diskus (500 50)   1  inh ; docusate sodium  100  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol inhaler  2-4  puff ; ipratropium bromide mdi  2  puff ; amlodipine  5  mg ; prednisone  40  mg ; guaifenesin-codeine phosphate  5-10  ml ; metoprolol tartrate  100  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride nasal  1-2  spry ; milk of magnesia  30  ml ; tramadol (ultram)  50  mg ; 
acute posthemorrhagic anemia pneumonitis due to inhalation of food or vomitus obstructive sleep apnea (adult)(pediatric) dysthymic disorder anxiety state, unspecified esophageal reflux unspecified gastritis and gastroduodenitis, with hemorrhage asthma, unspecified type, unspecified esophagitis, unspecified chronic rhinitis asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified essential hypertension other chest pain other acute pericarditis depressive disorder, not elsewhere classified paroxysmal ventricular tachycardia other constipation asthma, unspecified type, unspecified unspecified essential hypertension paroxysmal ventricular tachycardia antiasthmatics causing adverse effects in therapeutic use transient alteration of awareness unspecified essential hypertension surface and infiltration anesthetics causing adverse effects in therapeutic use lack of coordination asthma, unspecified type, unspecified 
white f 67 $temp  98.6  heartrate  75.0  resprate  14.0  o2sat  94.0  sbp  132.0  dbp  57.0  rhythm    pain  6  $hematology blood hematocrit  36.7  %; hematology blood hematocrit  33.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  333  k ul; hematology blood platelet count  278  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.8  g dl; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  2.0  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5  mg ; amlodipine  5  mg ; estradiol  10  mg ; ipratropium bromide mdi  1  puff ; lisinopril  10  mg ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; ipratropium-albuterol inhalation spray  1  inh ; diltiazem extended-release  360  mg ; aspirin  81  mg ; potassium chloride  20  meq ; albuterol inhaler  1-2  puff ; sodium chloride 0.9%  1000  ml ; hydromorphone (dilaudid)  0.5-1.0  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; levofloxacin  750  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; meropenem  500  mg ; hydromorphone (dilaudid)  1  mg ; levothyroxine sodium  88  mcg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  120  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide mdi  1  puff ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  0.5-1.0  mg ; levothyroxine sodium  88  mcg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; ketorolac  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; fleet enema  1  enema ; polyethylene glycol  17  g ; morphine sulfate ir  15  mg ; morphine sulfate  2-4  mg ; dextrose 5%  150  ml ; ipratropium-albuterol neb  1  neb ; guaifenesin er  600  mg ; methylnaltrexone  12  mg ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  139  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide mdi  1  puff ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; levothyroxine sodium  88  mcg ; polyethylene glycol  17  g ; morphine sulfate ir  15  mg ; morphine sulfate  2-4  mg ; dextrose 5%  150  ml ; ipratropium-albuterol neb  1  neb ; guaifenesin er  600  mg ; methylnaltrexone  12  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; lactulose  30  ml ; mineral oil  15-30  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  231  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; levothyroxine sodium  88  mcg ; polyethylene glycol  17  g ; morphine sulfate ir  15  mg ; morphine sulfate  2-4  mg ; dextrose 5%  150  ml ; guaifenesin er  600  mg ; methylnaltrexone  12  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; mineral oil  15-30  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  224  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; levothyroxine sodium  88  mcg ; morphine sulfate ir  15  mg ; morphine sulfate  2-4  mg ; guaifenesin er  600  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; lactulose  45  ml ; magnesium citrate  300  ml ; acetaminophen  325-650  mg ; golytely  4  l ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  147  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; levothyroxine sodium  88  mcg ; guaifenesin er  600  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; lactulose  45  ml ; magnesium citrate  300  ml ; acetaminophen  325-650  mg ; golytely  4  l ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 67 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; montelukast  10  mg ; omeprazole  20  mg ; ondansetron  8  mg ; rosuvastatin calcium  20  mg ; aspirin  81  mg ; albuterol inhaler  1-2  puff ; levothyroxine sodium  88  mcg ; guaifenesin er  600  mg ; trazodone  25  mg ; lorazepam  0.5  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; lactulose  45  ml ; magnesium citrate  300  ml ; acetaminophen  325-650  mg ; golytely  4  l ; senna  17.2  mg ; 
unspecified acquired hypothyroidism unspecified glaucoma asthma, unspecified type, unspecified long-term (current) use of aspirin iron deficiency anemia, unspecified esophageal reflux other constipation obstructive sleep apnea (adult)(pediatric) personal history of pneumonia (recurrent) acquired absence of kidney personal history, urinary (tract) infection other abnormal glucose hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified person boarding or alighting a car injured in collision with railway train or railway vehicle hemicrania continua chronic kidney disease, unspecified personal history of venous thrombosis and embolism arthrodesis status other and unspecified hyperlipidemia other specified visual disturbances cough personal history of venous thrombosis and embolism unspecified acquired hypothyroidism other and unspecified hyperlipidemia unspecified glaucoma nausea with vomiting asthma, unspecified type, unspecified paroxysmal ventricular tachycardia chronic kidney disease, unspecified headache acquired absence of kidney hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified cervicalgia disturbance of skin sensation abdominal pain, right lower quadrant nausea with vomiting unspecified car occupant injured in collision with railway train or railway vehicle in nontraffic accident hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified glaucoma iron deficiency anemia secondary to blood loss (chronic) palpitations long-term (current) use of other medications intestinal bypass or anastomosis status constipation, unspecified unspecified acquired hypothyroidism ulceration of intestine personal history of venous thrombosis and embolism chronic kidney disease, unspecified
white f 91 $temp  98.6  heartrate  76.0  resprate  18.0  o2sat  98.0  sbp  136.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  124  mg dl$docusate sodium (liquid)  100  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; heparin  1200-2400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; potassium chloride (powder)  40  meq ; enoxaparin sodium  80  mg ; warfarin  3  mg ; 
 
white f 91 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  146  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; potassium chloride (powder)  40  meq ; enoxaparin sodium  80  mg ; warfarin  3  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; lisinopril  30  mg ; fluticasone propionate nasal  2  spry ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  1000  ml ; warfarin  4  mg ; 
 
white f 91 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  195  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  171  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; enoxaparin sodium  80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; lisinopril  30  mg ; fluticasone propionate nasal  2  spry ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  1000  ml ; warfarin  4  mg ; labetalol  100  mg ; sodium chloride nasal  1-2  spry ; lisinopril  40  mg ; 
 
white f 91 $nan$hematology blood inr(pt)  2.7  $influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; lisinopril  30  mg ; fluticasone propionate nasal  2  spry ; labetalol  100  mg ; sodium chloride nasal  1-2  spry ; lisinopril  40  mg ; labetalol  200  mg ; enoxaparin sodium  40  mg ; felodipine  10  mg ; artificial tears  1-2  drop ; 
 
white f 91 $nan$hematology urine wbc  178  # hpf$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; fluticasone propionate nasal  2  spry ; sodium chloride nasal  1-2  spry ; lisinopril  40  mg ; labetalol  200  mg ; enoxaparin sodium  40  mg ; felodipine  10  mg ; artificial tears  1-2  drop ; senna  1  tab ; 
 
white f 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; fluticasone propionate nasal  2  spry ; sodium chloride nasal  1-2  spry ; lisinopril  40  mg ; labetalol  200  mg ; enoxaparin sodium  40  mg ; felodipine  10  mg ; artificial tears  1-2  drop ; senna  1  tab ; sulfameth trimethoprim ds  1  tab ; 
 
black african american m 56 $temp  98.3  heartrate  76.0  resprate  16.0  o2sat  95.0  sbp  143.0  dbp  84.0  rhythm    pain  0  $hematology blood hematocrit  45.9  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  90  mg dl; chemistry blood % hemoglobin a1c  5.9  %$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; aspirin  81  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  11  mg dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
black african american m 56 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; lisinopril  20  mg ; baclofen  10  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; heparin  5000  unit ; levetiracetam  1000  mg ; clopidogrel  75  mg ; pravastatin  40  mg ; 
ostium secundum type atrial septal defect tobacco use disorder occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension homonymous bilateral field defects other late effects of cerebrovascular disease other and unspecified hyperlipidemia hemiplegia, unspecified, affecting nondominant side other musculoskeletal symptoms referable to limbs cerebral embolism with cerebral infarction other generalized ischemic cerebrovascular disease unspecified essential hypertension late effects of cerebrovascular disease, hemiplegia affecting nondominant side tobacco use disorder dehydration occlusion and stenosis of carotid artery with cerebral infarction bell's palsy ostium secundum type atrial septal defect flaccid hemiplegia and hemiparesis affecting nondominant side unspecified essential hypertension occlusion and stenosis of carotid artery with cerebral infarction tobacco use disorder long-term (current) use of anticoagulants other and unspecified hyperlipidemia chest pain, unspecified 
white m 37 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  3.7  g dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; oxycodone (immediate release)   5  mg ; 
paralytic ileus obstruction of bile duct lack of housing removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of internal operation (surgical) wound driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident tobacco use disorder constipation, unspecified
white m 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; oxycodone (immediate release)   5  mg ; 
paralytic ileus obstruction of bile duct lack of housing removal of other organ (partial) (total) causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation disruption of internal operation (surgical) wound driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident tobacco use disorder constipation, unspecified
black african american f 63 $nan$nan$atorvastatin  10  mg ; omeprazole  20  mg ; venlafaxine xr  300  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.5  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  200  mg dl; chemistry blood lactate dehydrogenase (ld)  193  iu l; chemistry blood albumin  3.4  g dl; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  172  mg dl; blood gas blood hematocrit, calculated  28  %; blood gas blood hemoglobin  9.2  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood sodium, whole blood  132  meq l; hematology urine glucose  250  mg dl; blood gas blood calculated bicarbonate, whole blood  22  meq l; hematology urine bilirubin  neg  mg dl$atorvastatin  10  mg ; omeprazole  20  mg ; venlafaxine xr  300  mg ; 0.45% sodium chloride  1000  ml ; benzonatate  100  mg ; fluticasone propionate 110mcg  4  puff ; bupropion (sustained release)  200  mg ; heparin  5000  unit ; oseltamivir  75  mg ; influenza virus vaccine  0.5  ml ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; trazodone  25  mg ; acetaminophen  500-1000  mg ; sterile water  50  ml ; potassium chloride  20-40  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 5% dextrose  250  ml ; norepinephrine  8  mg ; lr  1000  ml ; albuterol inhaler  2  puff ; ipratropium bromide mdi  2  puff ; 
 
black african american f 63 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  112  mg dl$atorvastatin  10  mg ; omeprazole  20  mg ; venlafaxine xr  300  mg ; benzonatate  100  mg ; fluticasone propionate 110mcg  4  puff ; bupropion (sustained release)  200  mg ; heparin  5000  unit ; oseltamivir  75  mg ; influenza virus vaccine  0.5  ml ; senna  1  tab ; salmeterol xinafoate diskus (50 mcg)  1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; trazodone  25  mg ; acetaminophen  500-1000  mg ; sterile water  50  ml ; potassium chloride  20-40  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 5% dextrose  250  ml ; norepinephrine  8  mg ; lr  1000  ml ; albuterol inhaler  2  puff ; ipratropium bromide mdi  2  puff ; neutra-phos  1  pkt ; guaifenesin  5-10  ml ; 
 
black african american f 63 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  123  mg dl$atorvastatin  10  mg ; omeprazole  20  mg ; venlafaxine xr  300  mg ; benzonatate  100  mg ; fluticasone propionate 110mcg  4  puff ; bupropion (sustained release)  200  mg ; heparin  5000  unit ; influenza virus vaccine  0.5  ml ; senna  1  tab ; salmeterol xinafoate diskus (50 mcg)  1  inh ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; doxycycline hyclate  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; trazodone  25  mg ; acetaminophen  500-1000  mg ; sterile water  50  ml ; potassium chloride  20-40  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 5% dextrose  250  ml ; norepinephrine  8  mg ; albuterol inhaler  2  puff ; ipratropium bromide mdi  2  puff ; neutra-phos  1  pkt ; guaifenesin  5-10  ml ; sodium chloride 0.9%  flush  3  ml ; 
 
black african american f 63 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  167  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.1  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  199  mg dl; chemistry blood glucose  184  mg dl; chemistry blood lactate dehydrogenase (ld)  222  iu l; chemistry blood lactate dehydrogenase (ld)  218  iu l; chemistry blood albumin  3.1  g dl; chemistry blood albumin  3.0  g dl; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  0.9  mmol l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; albuterol inhaler  1-2  puff ; hydrocortisone na succ.  100  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; propofol  1000  mg ; 5% dextrose  100  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; qvar  1  puff ; magnesium sulfate  2-4  gm ; 5% dextrose  500  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  261  iu l; chemistry blood albumin  2.6  g dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; propofol  1000  mg ; 5% dextrose  100  ml ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; qvar  1  puff ; magnesium sulfate  2-4  gm ; 5% dextrose  500  ml ; potassium chloride  40-60  meq ; potassium chloride  60  meq ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; potassium chloride  20  meq ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  60  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  230  mg dl$propofol  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; qvar  1  puff ; magnesium sulfate  2-4  gm ; 5% dextrose  500  ml ; potassium chloride  40-60  meq ; potassium chloride  20  meq ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  60  mg ; potassium chloride (powder)  40  meq ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; quetiapine fumarate  50  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  264  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  197  mg dl$propofol  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; qvar  1  puff ; magnesium sulfate  2-4  gm ; 5% dextrose  500  ml ; potassium chloride  40-60  meq ; potassium chloride  20  meq ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  60  mg ; potassium chloride (powder)  40  meq ; heparin flush (10 units ml)  2  ml ; olanzapine (disintegrating tablet)  5  mg ; olanzapine (disintegrating tablet)  2.5  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  315  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  172  mg dl$propofol  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; qvar  1  puff ; magnesium sulfate  2-4  gm ; 5% dextrose  500  ml ; potassium chloride  40-60  meq ; potassium chloride  20  meq ; dextrose 5%  150  ml ; levofloxacin  750  mg ; methylprednisolone sodium succ  60  mg ; heparin flush (10 units ml)  2  ml ; acetaminophen w codeine  1  tab ; insulin  5  unit ; prednisone  60  mg ; prednisone  40  mg ; prednisone  50  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; calcium carbonate  1000  mg ; acetaminophen w codeine  1-2  tab ; 
 
black african american f 63 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  330  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  122  mg dl$dextrose 5%  150  ml ; levofloxacin  750  mg ; insulin  5  unit ; prednisone  60  mg ; prednisone  40  mg ; prednisone  50  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; calcium carbonate  1000  mg ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; metformin xr (glucophage xr)  2000  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american f 63 $nan$nan$dextrose 5%  150  ml ; levofloxacin  750  mg ; insulin  5  unit ; prednisone  40  mg ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; calcium carbonate  1000  mg ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; metformin (glucophage)  1000  mg ; 
 
black african american f 63 $nan$nan$dextrose 5%  150  ml ; levofloxacin  750  mg ; insulin  5  unit ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; calcium carbonate  1000  mg ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; metformin (glucophage)  1000  mg ; 
 
black african american f 63 $nan$nan$insulin  5  unit ; fluticasone propionate nasal  1  spry ; lisinopril  20  mg ; hydrochlorothiazide  25  mg ; calcium carbonate  1000  mg ; acetaminophen w codeine  1-2  tab ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; pneumococcal vac polyvalent  0.5  ml ; metformin (glucophage)  1000  mg ; 
 
white m 78 $temp  97.8  heartrate  78.0  resprate  18.0  o2sat  97.0  sbp  115.0  dbp  51.0  rhythm    pain  8  $hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  194  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  2.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry urine chloride, urine  45  meq l; chemistry urine creatinine, urine  48  mg dl; chemistry urine potassium, urine  32  meq l; chemistry urine sodium, urine  37  meq l; chemistry urine urea nitrogen, urine  412  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  150  mg dl; blood gas blood lactate  2.2  mmol l$5% dextrose  500  ml ; vancomycin  1500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  40  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; potassium chloride (powder)  40  meq ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  134  mg dl; hematology blood bands  0  %$5% dextrose  500  ml ; vancomycin  1500  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  40  meq ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; ciprofloxacin hcl  500  mg ; acetaminophen  325-650  mg ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; 0.9% sodium chloride  500  ml ; oxycodone (immediate release)   5  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  99  mg dl; hematology blood bands  4  %$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; 0.9% sodium chloride  500  ml ; oxycodone (immediate release)   5  mg ; levofloxacin  750  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  109  mg dl; hematology blood bands  3  %$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; levofloxacin  750  mg ; acetaminophen  1000  mg ; lorazepam  0.5  mg ; duloxetine  30  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; levofloxacin  750  mg ; acetaminophen  1000  mg ; duloxetine  30  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  2-4  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  119  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  107  mg dl; chemistry blood lactate dehydrogenase (ld)  165  iu l$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; levofloxacin  750  mg ; acetaminophen  1000  mg ; duloxetine  30  mg ; ibuprofen  400  mg ; hydromorphone (dilaudid)  2-4  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 78 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  100  mg ; fluticasone propionate nasal  1  spry ; omeprazole  20  mg ; levofloxacin  750  mg ; acetaminophen  1000  mg ; duloxetine  30  mg ; ibuprofen  400  mg ; 
unspecified essential hypertension long-term (current) use of anticoagulants long-term (current) use of other medications arthropathy, unspecified, multiple sites unspecified disease of pancreas diarrhea personal history of tobacco use other and unspecified hyperlipidemia cervical spondylosis without myelopathy primary hypercoagulable state gout, unspecified abnormal coagulation profile personal history of tobacco use personal history of venous thrombosis and embolism malignant neoplasm of head of pancreas primary hypercoagulable state exostosis of unspecified site other disorders of calcium metabolism unspecified essential hypertension other and unspecified hyperlipidemia swelling of limb long-term (current) use of anticoagulants do not resuscitate status obstruction of bile duct unspecified deficiency anemia osteoarthrosis, unspecified whether generalized or localized, site unspecified chondrocalcinosis, unspecified, multiple sites primary hypercoagulable state unspecified deficiency anemia other specified inflammatory polyarthropathies abnormal coagulation profile nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] disorder of bone and cartilage, unspecified other and unspecified hyperlipidemia unspecified essential hypertension microscopic hematuria esophageal reflux swelling of limb diarrhea 
white m 70 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  2.1  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  4.4  g dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; labetalol  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; acetaminophen  325-650  mg ; labetalol  100  mg ; 
 
white m 70 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  89  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  111  mg dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; labetalol  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; acetaminophen  325-650  mg ; labetalol  100  mg ; phosphorus  250  mg ; amlodipine  5  mg ; heparin  5000  unit ; 
 
white m 70 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  108  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  145  mg dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; labetalol  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; acetaminophen  325-650  mg ; labetalol  100  mg ; amlodipine  5  mg ; heparin  5000  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; hydralazine  15  mg ; neutra-phos  1  pkt ; 
 
white m 70 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  107  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  148  mg dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; neutra-phos  1  pkt ; 
 
white m 70 $nan$nan$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; 
 
white m 70 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  139  mg dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; amitriptyline  10  mg ; nortriptyline  10  mg ; 
 
white m 70 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  110  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  136  mg dl$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; nortriptyline  10  mg ; 
 
white m 70 $nan$nan$glucagon  1  mg ; glucose gel  15  g ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; metoprolol succinate xl  50  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; nortriptyline  10  mg ; polyethylene glycol  17  g ; 
 
white f 86 $nan$nan$cyanocobalamin  2000  mcg ; vitamin d  800  unit ; 
dementia in conditions classified elsewhere without behavioral disturbance polymyalgia rheumatica chronic obstructive asthma with (acute) exacerbation alzheimer's disease
white f 86 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  72  mg dl; blood gas blood lactate  1.4  mmol l$cyanocobalamin  2000  mcg ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; donepezil  5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; senna  2  tab ; potassium chloride  40  meq ; 
dementia in conditions classified elsewhere without behavioral disturbance polymyalgia rheumatica chronic obstructive asthma with (acute) exacerbation alzheimer's disease
white f 86 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  309  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  71  mg dl$cyanocobalamin  2000  mcg ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; donepezil  5  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; senna  2  tab ; potassium chloride  40  meq ; heparin flush (10 units ml)  2  ml ; 
dementia in conditions classified elsewhere without behavioral disturbance polymyalgia rheumatica chronic obstructive asthma with (acute) exacerbation alzheimer's disease
white f 86 $nan$hematology blood hematocrit  38.5  %; hematology blood hematocrit  41.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood glucose  82  mg dl$cyanocobalamin  2000  mcg ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; donepezil  5  mg ; senna  2  tab ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
dementia in conditions classified elsewhere without behavioral disturbance polymyalgia rheumatica chronic obstructive asthma with (acute) exacerbation alzheimer's disease
white f 86 $nan$nan$cyanocobalamin  2000  mcg ; vitamin d  800  unit ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  100  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; heparin  5000  unit ; donepezil  5  mg ; senna  2  tab ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
dementia in conditions classified elsewhere without behavioral disturbance polymyalgia rheumatica chronic obstructive asthma with (acute) exacerbation alzheimer's disease
white f 50 $nan$nan$darunavir  800  mg ; abacavir sulfate  600  mg ; lamivudine  300  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; multivitamins  1  tab ; 
altered mental status asymptomatic human immunodeficiency virus [hiv] infection status personal history of venous thrombosis and embolism long-term (current) use of anticoagulants person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident benzodiazepine-based tranquilizers causing adverse effects in therapeutic use other and unspecified postsurgical nonabsorption car passenger injured in collision with heavy transport vehicle or bus in traffic accident unspecified intestinal obstruction other chronic pain other opiates and related narcotics causing adverse effects in therapeutic use disorders of phosphorus metabolism personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus fever, unspecified mononeuritis of lower limb, unspecified other artificial opening of urinary tract status other and unspecified coagulation defects ileostomy status other and unspecified anticonvulsants causing adverse effects in therapeutic use methadone causing averse effects in therapeutic use abnormal coagulation profile urinary tract infection, site not specified asymptomatic human immunodeficiency virus [hiv] infection status anemia, unspecified other specified intestinal obstruction disorders of phosphorus metabolism personal history of irradiation, presenting hazards to health ileostomy status other chronic pain hypopotassemia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus long-term (current) use of anticoagulants unspecified hereditary and idiopathic peripheral neuropathy other and unspecified postsurgical nonabsorption person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of venous thrombosis and embolism late effect of radiation other specified diseases of pancreas friedländer's bacillus infection in conditions classified elsewhere and of unspecified site pneumonia, organism unspecified gastroenteritis and colitis due to radiation car passenger injured in collision with heavy transport vehicle or bus in traffic accident abdominal pain, generalized disorders of magnesium metabolism mononeuritis of lower limb, unspecified personal history of antineoplastic chemotherapy
white f 50 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  273  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  377  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  98  mg dl$darunavir  800  mg ; abacavir sulfate  600  mg ; lamivudine  300  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; pregabalin  50  mg ; ritonavir  100  mg ; methadone  10  mg ; pantoprazole  40  mg ; d5ns  1000  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; bag  50  ml ; magnesium sulfate  2  gm ; phosphorus  500  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; heparin  5000  unit ; 
altered mental status asymptomatic human immunodeficiency virus [hiv] infection status personal history of venous thrombosis and embolism long-term (current) use of anticoagulants person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident benzodiazepine-based tranquilizers causing adverse effects in therapeutic use other and unspecified postsurgical nonabsorption car passenger injured in collision with heavy transport vehicle or bus in traffic accident unspecified intestinal obstruction other chronic pain other opiates and related narcotics causing adverse effects in therapeutic use disorders of phosphorus metabolism personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus fever, unspecified mononeuritis of lower limb, unspecified other artificial opening of urinary tract status other and unspecified coagulation defects ileostomy status other and unspecified anticonvulsants causing adverse effects in therapeutic use methadone causing averse effects in therapeutic use abnormal coagulation profile urinary tract infection, site not specified asymptomatic human immunodeficiency virus [hiv] infection status anemia, unspecified other specified intestinal obstruction disorders of phosphorus metabolism personal history of irradiation, presenting hazards to health ileostomy status other chronic pain hypopotassemia person on outside of car injured in collision with heavy transport vehicle or bus in nontraffic accident personal history of malignant neoplasm of rectum, rectosigmoid junction, and anus long-term (current) use of anticoagulants unspecified hereditary and idiopathic peripheral neuropathy other and unspecified postsurgical nonabsorption person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure personal history of venous thrombosis and embolism late effect of radiation other specified diseases of pancreas friedländer's bacillus infection in conditions classified elsewhere and of unspecified site pneumonia, organism unspecified gastroenteritis and colitis due to radiation car passenger injured in collision with heavy transport vehicle or bus in traffic accident abdominal pain, generalized disorders of magnesium metabolism mononeuritis of lower limb, unspecified personal history of antineoplastic chemotherapy
black african american m 25 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; docusate sodium  100  mg ; heparin  5000  unit ; ranitidine  150  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; trazodone  25  mg ; 0.9% sodium chloride  100  ml ; methylprednisolone na suc  1000  mg ; insulin  0  unit ; oxycodone (immediate release)   5  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; diazepam  2-5  mg ; diazepam  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; dexamethasone  4  mg ; hydromorphone  20  mg ; 
other external cause status fall from other slipping, tripping, or stumbling c1-c4 level with central cord syndrome activities involving soccer injury to cervical nerve root accidents occurring in place for recreation and sport
black african american m 25 $nan$nan$potassium chl 20 meq   1000 ml ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; diazepam  2-5  mg ; diazepam  5  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; dexamethasone  4  mg ; hydromorphone  20  mg ; milk of magnesia  30  ml ; acetaminophen (liquid)  650  mg ; docusate sodium (liquid)  100  mg ; 
other external cause status fall from other slipping, tripping, or stumbling c1-c4 level with central cord syndrome activities involving soccer injury to cervical nerve root accidents occurring in place for recreation and sport
black african american m 25 $nan$nan$potassium chl 20 meq   1000 ml ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; diazepam  5  mg ; dexamethasone  4  mg ; hydromorphone  20  mg ; milk of magnesia  30  ml ; acetaminophen (liquid)  650  mg ; docusate sodium (liquid)  100  mg ; hydromorphone (dilaudid)  2-4  mg ; cyclobenzaprine  10  mg ; dexamethasone  2  mg ; 
other external cause status fall from other slipping, tripping, or stumbling c1-c4 level with central cord syndrome activities involving soccer injury to cervical nerve root accidents occurring in place for recreation and sport
black african american m 25 $nan$nan$potassium chl 20 meq   1000 ml ns  1000  ml ; bisacodyl  10  mg ; ondansetron  4  mg ; milk of magnesia  30  ml ; acetaminophen (liquid)  650  mg ; docusate sodium (liquid)  100  mg ; cyclobenzaprine  10  mg ; dexamethasone  2  mg ; 
other external cause status fall from other slipping, tripping, or stumbling c1-c4 level with central cord syndrome activities involving soccer injury to cervical nerve root accidents occurring in place for recreation and sport
other f 46 $nan$nan$sulfameth trimethoprim ss  1  tab ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
other f 46 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  376  k ul; hematology blood platelet count  386  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  203  mg dl; chemistry blood lactate dehydrogenase (ld)  432  iu l; chemistry blood albumin  4.0  g dl; hematology blood bands  4  %; hematology blood bands  4  %$sulfameth trimethoprim ss  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; doxorubicin  29  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  145  mg ; prednisone  100  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25-50  mg ; warfarin  2.5  mg ; warfarin  5  mg ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
other f 46 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  171  mg dl; hematology blood bands  3  %$sulfameth trimethoprim ss  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; doxorubicin  29  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  145  mg ; prednisone  100  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25-50  mg ; warfarin  2.5  mg ; warfarin  5  mg ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
other f 46 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  387  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  139  mg dl; chemistry blood lactate dehydrogenase (ld)  391  iu l$sulfameth trimethoprim ss  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; doxorubicin  29  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  145  mg ; prednisone  100  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25-50  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
other f 46 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  158  mg dl$sulfameth trimethoprim ss  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; doxorubicin  29  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  145  mg ; prednisone  100  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25-50  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
other f 46 $nan$hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sulfameth trimethoprim ss  1  tab ; senna  1  tab ; docusate sodium  100  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; doxorubicin  29  mg ; vincristine (oncovin)  0.7  mg ; 0.9% sodium chloride  1000  ml ; etoposide  145  mg ; prednisone  100  mg ; ondansetron  8  mg ; lorazepam  0.5-2  mg ; prochlorperazine  10  mg ; 5% dextrose  50  ml ; ondansetron  16  mg ; acyclovir  400  mg ; albuterol inhaler  1-2  puff ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25-50  mg ; potassium chloride replacement (oncology)  40  meq ; potassium chloride replacement (oncology)  60  meq ; potassium chloride replacement (oncology)  80  meq ; 0.9% sodium chloride  250  ml ; cyclophosphamide  2200  mg ; 
personal history of venous thrombosis and embolism asthma, unspecified type, unspecified encounter for antineoplastic chemotherapy long-term (current) use of anticoagulants other malignant lymphomas, unspecified site, extranodal and solid organ sites home accidents unspecified drug or medicinal substance causing adverse effects in therapeutic use other complications due to other vascular device, implant, and graft other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other malignant lymphomas, unspecified site, extranodal and solid organ sites nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] anemia, unspecified personal history of tobacco use acute venous embolism and thrombosis of internal jugular veins acute venous embolism and thrombosis of superficial veins of upper extremity encounter for antineoplastic chemotherapy asthma, unspecified type, unspecified other complications due to other vascular device, implant, and graft nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute venous embolism and thrombosis of internal jugular veins other malignant lymphomas, unspecified site, extranodal and solid organ sites asthma, unspecified type, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] asthma, unspecified type, unspecified personal history of tobacco use family history of other specified malignant neoplasm personal history of tuberculosis acute venous embolism and thrombosis of subclavian veins encounter for antineoplastic chemotherapy other malignant lymphomas, unspecified site, extranodal and solid organ sites acute venous embolism and thrombosis of superficial veins of upper extremity other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other complications due to other vascular device, implant, and graft family history of malignant neoplasm of prostate anemia of other chronic disease personal history of tuberculosis other malignant lymphomas, lymph nodes of multiple sites personal history of tobacco use encounter for antineoplastic chemotherapy
hispanic latino f 28 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dermoplast spray  1  spry ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
hispanic latino f 28 $nan$hematology blood hematocrit  35.3  %$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dermoplast spray  1  spry ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
hispanic latino f 28 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dermoplast spray  1  spry ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
black african american f 85 $temp  96.6  heartrate  74.0  resprate  16.0  o2sat  100.0  sbp  102.0  dbp  56.0  rhythm    pain  u a  ; temp    heartrate  71.0  resprate  18.0  o2sat  100.0  sbp  110.0  dbp  53.0  rhythm    pain  0  ; temp  98.6  heartrate  68.0  resprate  16.0  o2sat  96.0  sbp  122.0  dbp  53.0  rhythm    pain  0  ; temp    heartrate  61.0  resprate  17.0  o2sat  96.0  sbp  167.0  dbp  51.0  rhythm    pain    ; temp    heartrate  60.0  resprate  14.0  o2sat  98.0  sbp  138.0  dbp  48.0  rhythm    pain  sleeping  ; temp    heartrate  60.0  resprate  14.0  o2sat  97.0  sbp  170.0  dbp  52.0  rhythm    pain  sleeping  ; temp    heartrate  60.0  resprate  16.0  o2sat  100.0  sbp  158.0  dbp  55.0  rhythm    pain  sleeping  ; temp  98.8  heartrate  61.0  resprate  17.0  o2sat  96.0  sbp  152.0  dbp  51.0  rhythm    pain  sleeping  $hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood creatinine  4.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  66  mg dl; chemistry urine creatinine, urine  160  mg dl; chemistry urine sodium, urine  24  meq l; hematology urine wbc  3  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  190  mg dl; chemistry blood glucose  215  mg dl; chemistry blood albumin  4.0  g dl; blood gas blood lactate  3.2  mmol l; blood gas blood lactate  6.1  mmol l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  6.0  meq l$nan
acute kidney failure, unspecified chronic kidney disease, unspecified presence of cardiac pacemaker hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease anemia in chronic kidney disease hypotension, unspecified dehydration chronic diastolic (congestive) heart failure thrombocytopenia, unspecified personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant neoplasm of pancreas viral intestinal infection, unspecified unspecified atrial flutter rheumatic disorders of both mitral and tricuspid valves encounter for immunization hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of nicotine dependence rheumatic disorders of both mitral and tricuspid valves pure hypercholesterolemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of aspirin acute kidney failure, unspecified age-related osteoporosis without current pathological fracture unspecified atrial flutter unspecified atrial fibrillation do not resuscitate chronic kidney disease, stage 4 (severe) presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure toxic encephalopathy hyperkalemia personal history of malignant neoplasm of pancreas do not resuscitate type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, stage 3 (moderate) chronic atrial fibrillation acidosis anemia in chronic kidney disease patient room in hospital as the place of occurrence of the external cause adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis, unspecified organism hypotension due to drugs type 2 diabetes mellitus with diabetic cataract
black african american f 85 $temp  98.7  heartrate  60.0  resprate  16.0  o2sat  96.0  sbp  142.0  dbp  51.0  rhythm    pain  sleeping  $chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  4.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry urine creatinine, urine  52  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  191  mg dl; chemistry urine protein creatinine ratio  0.5  mg mg$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; diltiazem  90  mg ; aspirin  81  mg ; folic acid  1  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified presence of cardiac pacemaker hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease anemia in chronic kidney disease hypotension, unspecified dehydration chronic diastolic (congestive) heart failure thrombocytopenia, unspecified personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant neoplasm of pancreas viral intestinal infection, unspecified unspecified atrial flutter rheumatic disorders of both mitral and tricuspid valves encounter for immunization hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of nicotine dependence rheumatic disorders of both mitral and tricuspid valves pure hypercholesterolemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of aspirin acute kidney failure, unspecified age-related osteoporosis without current pathological fracture unspecified atrial flutter unspecified atrial fibrillation do not resuscitate chronic kidney disease, stage 4 (severe) presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure toxic encephalopathy hyperkalemia personal history of malignant neoplasm of pancreas do not resuscitate type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, stage 3 (moderate) chronic atrial fibrillation acidosis anemia in chronic kidney disease patient room in hospital as the place of occurrence of the external cause adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis, unspecified organism hypotension due to drugs type 2 diabetes mellitus with diabetic cataract
black african american f 85 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  176  k ul; hematology blood platelet count  143  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  4.3  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood urea nitrogen  61  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  148  mg dl; chemistry blood glucose  181  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; diltiazem  90  mg ; aspirin  81  mg ; folic acid  1  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified presence of cardiac pacemaker hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease anemia in chronic kidney disease hypotension, unspecified dehydration chronic diastolic (congestive) heart failure thrombocytopenia, unspecified personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant neoplasm of pancreas viral intestinal infection, unspecified unspecified atrial flutter rheumatic disorders of both mitral and tricuspid valves encounter for immunization hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of nicotine dependence rheumatic disorders of both mitral and tricuspid valves pure hypercholesterolemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of aspirin acute kidney failure, unspecified age-related osteoporosis without current pathological fracture unspecified atrial flutter unspecified atrial fibrillation do not resuscitate chronic kidney disease, stage 4 (severe) presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure toxic encephalopathy hyperkalemia personal history of malignant neoplasm of pancreas do not resuscitate type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, stage 3 (moderate) chronic atrial fibrillation acidosis anemia in chronic kidney disease patient room in hospital as the place of occurrence of the external cause adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis, unspecified organism hypotension due to drugs type 2 diabetes mellitus with diabetic cataract
black african american f 85 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  53  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  104  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; diltiazem  90  mg ; aspirin  81  mg ; folic acid  1  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified presence of cardiac pacemaker hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease anemia in chronic kidney disease hypotension, unspecified dehydration chronic diastolic (congestive) heart failure thrombocytopenia, unspecified personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant neoplasm of pancreas viral intestinal infection, unspecified unspecified atrial flutter rheumatic disorders of both mitral and tricuspid valves encounter for immunization hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of nicotine dependence rheumatic disorders of both mitral and tricuspid valves pure hypercholesterolemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of aspirin acute kidney failure, unspecified age-related osteoporosis without current pathological fracture unspecified atrial flutter unspecified atrial fibrillation do not resuscitate chronic kidney disease, stage 4 (severe) presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure toxic encephalopathy hyperkalemia personal history of malignant neoplasm of pancreas do not resuscitate type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, stage 3 (moderate) chronic atrial fibrillation acidosis anemia in chronic kidney disease patient room in hospital as the place of occurrence of the external cause adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis, unspecified organism hypotension due to drugs type 2 diabetes mellitus with diabetic cataract
black african american f 85 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; metoprolol tartrate  50  mg ; diltiazem  90  mg ; aspirin  81  mg ; folic acid  1  mg ; 
acute kidney failure, unspecified chronic kidney disease, unspecified presence of cardiac pacemaker hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease age-related osteoporosis without current pathological fracture type 2 diabetes mellitus with diabetic chronic kidney disease anemia in chronic kidney disease hypotension, unspecified dehydration chronic diastolic (congestive) heart failure thrombocytopenia, unspecified personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant neoplasm of pancreas viral intestinal infection, unspecified unspecified atrial flutter rheumatic disorders of both mitral and tricuspid valves encounter for immunization hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of nicotine dependence rheumatic disorders of both mitral and tricuspid valves pure hypercholesterolemia, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of aspirin acute kidney failure, unspecified age-related osteoporosis without current pathological fracture unspecified atrial flutter unspecified atrial fibrillation do not resuscitate chronic kidney disease, stage 4 (severe) presence of cardiac pacemaker acute on chronic diastolic (congestive) heart failure toxic encephalopathy hyperkalemia personal history of malignant neoplasm of pancreas do not resuscitate type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, stage 3 (moderate) chronic atrial fibrillation acidosis anemia in chronic kidney disease patient room in hospital as the place of occurrence of the external cause adverse effect of beta-adrenoreceptor antagonists, initial encounter long term (current) use of aspirin hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease sepsis, unspecified organism hypotension due to drugs type 2 diabetes mellitus with diabetic cataract
white m 71 $temp  98.0  heartrate  102.0  resprate  20.0  o2sat  97.0  sbp  96.0  dbp  63.0  rhythm    pain    $hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  165  iu l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  600  mg ; heparin  5000  unit ; folic acid  1  mg ; gabapentin  100  mg ; levothyroxine sodium  50  mcg ; simvastatin  20  mg ; vitamin d  1000  unit ; sodium chloride 0.9%  1000  ml ; colchicine  0.6  mg ; calcium carbonate  1500  mg ; metoprolol tartrate  25  mg ; 
alcohol abuse, continuous conductive hearing loss, middle ear intracerebral hemorrhage unspecified essential hypertension
white m 73 $nan$nan$aspirin  81  mg ; lisinopril  5  mg ; simvastatin  80  mg ; 
 
white m 73 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  185  mg dl; chemistry blood lactate dehydrogenase (ld)  213  iu l; chemistry blood albumin  4.1  g dl; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  97  meq l; blood gas blood glucose  180  mg dl; blood gas blood hematocrit, calculated  46  %; blood gas blood hemoglobin  15.2  g dl; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood sodium, whole blood  133  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; chemistry blood % hemoglobin a1c  9.0  %$aspirin  81  mg ; lisinopril  5  mg ; simvastatin  80  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; metoprolol tartrate  50  mg ; milk of magnesia  30  ml ; insulin  30  unit ; acetaminophen  650  mg ; aspirin ec  81  mg ; 
 
white m 73 $nan$hematology blood hematocrit  31.1  %; hematology blood hematocrit  33.0  %; hematology blood hematocrit  36.3  %; hematology blood hematocrit  35.4  %; hematology blood hematocrit  36.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  201  k ul; hematology blood platelet count  186  k ul; hematology blood platelet count  234  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; blood gas blood free calcium  1.33  mmol l; blood gas blood free calcium  1.23  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.27  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  1.9  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  160  mg dl; blood gas blood glucose  164  mg dl; blood gas blood glucose  125  mg dl; blood gas blood glucose  95  mg dl; blood gas blood glucose  92  mg dl; blood gas blood glucose  93  mg dl; blood gas blood glucose  78  mg dl; blood gas blood glucose  90  mg dl; blood gas blood glucose  108  mg dl; blood gas blood glucose  115  mg dl; blood gas blood glucose  87  mg dl; blood gas blood glucose  122  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.4  g dl; blood gas blood hemoglobin  11.6  g dl; blood gas blood hemoglobin  11.4  g dl; blood gas blood potassium, whole blood  5.9  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  3.9  meq l; blood gas blood potassium, whole blood  3.2  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood sodium, whole blood  133  meq l; blood gas blood sodium, whole blood  134  meq l$aspirin  81  mg ; lisinopril  5  mg ; simvastatin  80  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; metoprolol tartrate  50  mg ; milk of magnesia  30  ml ; insulin  30  unit ; acetaminophen  650  mg ; aspirin ec  81  mg ; sodium chloride 0.9%  flush  10  ml ; lr  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; morphine sulfate  0.5-4  mg ; metoclopramide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone-acetaminophen  1-2  tab ; sucralfate  1  gm ; dextrose 50%  12.5  gm ; ns  100  ml ; insulin human regular  100  unit ; albuterol-ipratropium  2  puff ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; docusate sodium (liquid)  100  mg ; qvar  1  puff ; ns  50  ml ; dexmedetomidine  0.2  mg ; 
 
white m 73 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood lactate dehydrogenase (ld)  493  iu l; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood glucose  109  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  141  mg dl; blood gas blood glucose  75  mg dl; blood gas blood glucose  157  mg dl; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.8  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.8  meq l$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; aspirin ec  81  mg ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; morphine sulfate  0.5-4  mg ; metoclopramide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone-acetaminophen  1-2  tab ; dextrose 50%  12.5  gm ; ns  100  ml ; insulin human regular  100  unit ; albuterol-ipratropium  2  puff ; ranitidine  150  mg ; docusate sodium  100  mg ; qvar  1  puff ; bag  50  ml ; albumin, human  25  g ; albumin 5% (25g   500ml)  25  g ; amiodarone  150  mg ; d5w (excel bag)  250  ml ; amiodarone  600  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  25  mg ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; simvastatin  20  mg ; furosemide  10  mg ; 
 
white m 73 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  160  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; aspirin ec  81  mg ; sodium chloride 0.9%  flush  10  ml ; d5w  250  ml ; nitroglycerin  100  mg ; phenylephrine  60  mg ; sw  50  ml ; potassium chloride  20  meq ; calcium gluconate  2  gm ; magnesium sulfate  2  gm ; morphine sulfate  0.5-4  mg ; metoclopramide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; oxycodone-acetaminophen  1-2  tab ; dextrose 50%  12.5  gm ; ns  100  ml ; insulin human regular  100  unit ; albuterol-ipratropium  2  puff ; ranitidine  150  mg ; docusate sodium  100  mg ; qvar  1  puff ; albumin 5% (25g   500ml)  25  g ; amiodarone  150  mg ; metoprolol tartrate  5  mg ; lorazepam  0.5  mg ; diphenhydramine  25  mg ; simvastatin  20  mg ; furosemide  10  mg ; metoclopramide  10  mg ; furosemide  20  mg ; amiodarone  400  mg ; insulin  20  unit ; 
 
white m 73 $nan$nan$influenza virus vaccine  0.5  ml ; simvastatin  20  mg ; furosemide  40  mg ; fluticasone propionate 110mcg  2  puff ; insulin  35  unit ; ibuprofen  800  mg ; 
 
white m 73 $nan$nan$influenza virus vaccine  0.5  ml ; simvastatin  20  mg ; furosemide  40  mg ; fluticasone propionate 110mcg  2  puff ; insulin  35  unit ; ibuprofen  800  mg ; 
 
white f 77 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  82  mg dl$furosemide  80  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; metolazone  2.5  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; torsemide  80  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  301  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  127  mg dl$furosemide  80  mg ; vial  1  vial ; pantoprazole  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; torsemide  80  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; omeprazole  40  mg ; warfarin  5  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  243  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; torsemide  80  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; omeprazole  40  mg ; warfarin  5  mg ; furosemide  40  mg ; colchicine  1.2  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  266  iu l$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; torsemide  80  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; omeprazole  40  mg ; warfarin  5  mg ; furosemide  40  mg ; colchicine  1.2  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  145  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; warfarin  7.5  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  261  k ul; hematology blood inr(pt)  2.0  $dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; heparin  4400  unit ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.8  $dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; moviprep  1  l ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; moviprep  1  l ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood inr(pt)  1.5  $dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; ferrous sulfate  325  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  204  k ul; hematology blood inr(pt)  1.5  $dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; ferrous sulfate  325  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  25.5  %; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  184  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; ferrous sulfate  325  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.2  ; chemistry blood glucose  165  mg dl; chemistry blood glucose  161  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; insulin  0  unit ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; ferrous sulfate  325  mg ; furosemide  20  mg ; glyburide  2.5  mg ; potassium chloride  40  meq ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  197  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; torsemide  100  mg ; ferrous sulfate  325  mg ; furosemide  20  mg ; glyburide  2.5  mg ; potassium chloride  40  meq ; calcium carbonate  1000  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white f 77 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; gabapentin  300  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; spironolactone  25  mg ; metoprolol tartrate  25  mg ; atorvastatin  10  mg ; digoxin  0.125  mg ; omeprazole  40  mg ; cepacol (menthol)  1  loz ; acetaminophen  325-650  mg ; ferrous sulfate  325  mg ; glyburide  2.5  mg ; calcium carbonate  1000  mg ; metformin (glucophage)  850  mg ; torsemide  20  mg ; 
unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident acute kidney failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ rheumatic heart disease, unspecified pain in joint, hand polyneuropathy in diabetes pure hypercholesterolemia angiodysplasia of intestine with hemorrhage congestive heart failure, unspecified acute on chronic systolic heart failure heart valve replaced by other means diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) chronic systolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident angiodysplasia of intestine with hemorrhage cardiac pacemaker in situ atrial fibrillation acute posthemorrhagic anemia other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means congestive heart failure, unspecified cardiac pacemaker in situ congestive heart failure, unspecified heart valve replaced by other means anticoagulants causing adverse effects in therapeutic use chronic systolic heart failure atrial fibrillation unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident long-term (current) use of anticoagulants acute posthemorrhagic anemia angiodysplasia of intestine with hemorrhage abnormal coagulation profile diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled iron deficiency anemia secondary to blood loss (chronic) heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident pure hypercholesterolemia unspecified essential hypertension other b-complex deficiencies blood in stool depressive disorder, not elsewhere classified atrial fibrillation congestive heart failure, unspecified chronic systolic heart failure
white m 75 $nan$nan$aspirin  81  mg ; 
 
white m 75 $temp  99.1  heartrate  99.0  resprate  16.0  o2sat  99.0  sbp  124.0  dbp  56.0  rhythm    pain  0  $hematology blood hematocrit  34.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  117  mg dl; blood gas blood lactate  1.8  mmol l; hematology urine glucose  100  mg dl$aspirin  81  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; trazodone  25  mg ; simvastatin  40  mg ; lisinopril  5  mg ; 0.9% sodium chloride  1000  ml ; 
 
white m 75 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  111  iu l$aspirin  81  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; lisinopril  5  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 75 $nan$hematology blood hematocrit  32.6  %; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l$d5 1 2ns  1000  ml ; aspirin  81  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; lisinopril  5  mg ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; clopidogrel  75  mg ; 
 
white m 75 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  146  mg dl$aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; metoprolol tartrate  25  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; clopidogrel  75  mg ; lactated ringers  1000  ml ; 0.45% sodium chloride  1000  ml ; 
 
white m 75 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  298  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  186  mg dl$aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; clopidogrel  75  mg ; 0.45% sodium chloride  1000  ml ; amoxicillin-clavulanic acid  875  mg ; 
 
white m 75 $nan$nan$aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; amoxicillin-clavulanic acid  875  mg ; loperamide  2  mg ; 
 
white m 75 $nan$nan$aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; trazodone  25  mg ; simvastatin  40  mg ; clopidogrel  75  mg ; amoxicillin-clavulanic acid  875  mg ; loperamide  2  mg ; 
 
white m 49 $temp  98.1  heartrate  72.0  resprate  16.0  o2sat  96.0  sbp  170.0  dbp  100.0  rhythm    pain  3  $hematology blood hematocrit  45.7  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood bilirubin, total  16.5  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; 
 
white m 49 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, indirect  5.1  mg dl; chemistry blood bilirubin, total  19.5  mg dl; chemistry blood glucose  86  mg dl; chemistry blood bilirubin, direct  14.4  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; 
 
white m 49 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  18.0  mg dl; chemistry blood glucose  113  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; potassium chloride  40  meq ; neutra-phos  1  pkt ; d5 1 2ns  1000  ml ; heparin  5000  unit ; 
 
white m 49 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  18.2  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; lactated ringers  1000  ml ; phytonadione  5  mg ; lorazepam  0.5  mg ; 
 
white m 49 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  21.4  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; lactated ringers  1000  ml ; phytonadione  5  mg ; lorazepam  0.5  mg ; 
 
white m 49 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  19.8  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; lactated ringers  1000  ml ; 
 
white m 49 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.6  mg dl; chemistry blood bilirubin, total  18.3  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; lactated ringers  1000  ml ; calcium carbonate  500  mg ; 
 
white m 49 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood bilirubin, total  17.7  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; lactated ringers  1000  ml ; calcium carbonate  500  mg ; 
 
white m 49 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  10.7  mg dl; chemistry blood bilirubin, total  19.8  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   5-10  mg ; phenazopyridine  200  mg ; 
 
white m 49 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry urine chloride, urine  23  meq l; chemistry urine creatinine, urine  172  mg dl; chemistry urine potassium, urine  47  meq l; chemistry urine sodium, urine  37  meq l; chemistry urine urea nitrogen, urine  781  mg dl; chemistry blood calcium, total  10.8  mg dl; chemistry blood bilirubin, total  20.8  mg dl; chemistry blood glucose  130  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; phenazopyridine  200  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; 
 
white m 49 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  10.9  mg dl; chemistry blood bilirubin, total  21.2  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; 
 
white m 49 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  268  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  11.0  mg dl; chemistry blood bilirubin, indirect  4.7  mg dl; chemistry blood bilirubin, total  20.9  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood bilirubin, direct  16.2  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; 
 
white m 49 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  18.6  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; senna  8.6  mg ; 
 
white m 49 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; docusate sodium  100  mg ; hydroxyzine  25  mg ; sarna lotion  1  appl ; heparin  5000  unit ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; tamsulosin  0.4  mg ; acetaminophen  325-650  mg ; senna  8.6  mg ; 
 
black african american m 74 $temp  98.5  heartrate  89.0  resprate  22.0  o2sat  96.0  sbp  103.0  dbp  82.0  rhythm    pain  0  $hematology blood hematocrit  47.2  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  241  mg dl; chemistry blood lactate dehydrogenase (ld)  258  iu l; chemistry blood albumin  4.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; trazodone  25  mg ; allopurinol  300  mg ; atorvastatin  10  mg ; diltiazem extended-release  240  mg ; loratadine  10  mg ; metoprolol succinate xl  100  mg ; tiotropium bromide  1  cap ; triamcinolone acetonide 0.1% ointment  1  appl ; torsemide  60  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; magnesium oxide  800  mg ; fluticasone propionate nasal  1  spry ; torsemide  80  mg ; furosemide  100  mg ; 
cholangitis infection following a procedure, initial encounter long term (current) use of anticoagulants gout, unspecified obstruction of bile duct chronic obstructive pulmonary disease, unspecified other nonspecific abnormal finding of lung field unspecified atrial fibrillation chronic diastolic (congestive) heart failure other secondary pulmonary hypertension pure hypercholesterolemia dependence on supplemental oxygen acute and chronic respiratory failure with hypoxia unspecified cirrhosis of liver esophageal obstruction sepsis due to methicillin resistant staphylococcus aureus other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence acute and chronic respiratory failure with hypercapnia essential (primary) hypertension chronic obstructive pulmonary disease, unspecified hypoxemia alcohol abuse, uncomplicated unspecified atrial fibrillation chronic diastolic (congestive) heart failure dependence on supplemental oxygen other secondary pulmonary hypertension gout, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence pure hypercholesterolemia pneumonia, organism unspecified physical restraints status foreign body in larynx unspecified essential hypertension other chronic pulmonary heart diseases other fluid overload accidents occurring in residential institution gout, unspecified esophageal reflux personal history of tobacco use pulmonary collapse acute respiratory failure ventilator associated pneumonia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute kidney failure, unspecified
black african american m 74 $nan$hematology blood hematocrit  44.1  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  114  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; trazodone  25  mg ; allopurinol  300  mg ; atorvastatin  10  mg ; diltiazem extended-release  240  mg ; loratadine  10  mg ; metoprolol succinate xl  100  mg ; tiotropium bromide  1  cap ; triamcinolone acetonide 0.1% ointment  1  appl ; fluticasone-salmeterol diskus (250 50)   1  inh ; magnesium oxide  800  mg ; fluticasone propionate nasal  1  spry ; furosemide  100  mg ; warfarin  2.5  mg ; furosemide  120  mg ; metoprolol succinate xl  25  mg ; 
cholangitis infection following a procedure, initial encounter long term (current) use of anticoagulants gout, unspecified obstruction of bile duct chronic obstructive pulmonary disease, unspecified other nonspecific abnormal finding of lung field unspecified atrial fibrillation chronic diastolic (congestive) heart failure other secondary pulmonary hypertension pure hypercholesterolemia dependence on supplemental oxygen acute and chronic respiratory failure with hypoxia unspecified cirrhosis of liver esophageal obstruction sepsis due to methicillin resistant staphylococcus aureus other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence acute and chronic respiratory failure with hypercapnia essential (primary) hypertension chronic obstructive pulmonary disease, unspecified hypoxemia alcohol abuse, uncomplicated unspecified atrial fibrillation chronic diastolic (congestive) heart failure dependence on supplemental oxygen other secondary pulmonary hypertension gout, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence pure hypercholesterolemia pneumonia, organism unspecified physical restraints status foreign body in larynx unspecified essential hypertension other chronic pulmonary heart diseases other fluid overload accidents occurring in residential institution gout, unspecified esophageal reflux personal history of tobacco use pulmonary collapse acute respiratory failure ventilator associated pneumonia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute kidney failure, unspecified
black african american m 74 $nan$hematology blood hematocrit  44.5  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  133  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; trazodone  25  mg ; allopurinol  300  mg ; atorvastatin  10  mg ; diltiazem extended-release  240  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; triamcinolone acetonide 0.1% ointment  1  appl ; fluticasone-salmeterol diskus (250 50)   1  inh ; fluticasone propionate nasal  1  spry ; warfarin  2.5  mg ; furosemide  120  mg ; metoprolol succinate xl  25  mg ; metoprolol succinate xl  150  mg ; prednisone  40  mg ; 
cholangitis infection following a procedure, initial encounter long term (current) use of anticoagulants gout, unspecified obstruction of bile duct chronic obstructive pulmonary disease, unspecified other nonspecific abnormal finding of lung field unspecified atrial fibrillation chronic diastolic (congestive) heart failure other secondary pulmonary hypertension pure hypercholesterolemia dependence on supplemental oxygen acute and chronic respiratory failure with hypoxia unspecified cirrhosis of liver esophageal obstruction sepsis due to methicillin resistant staphylococcus aureus other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence acute and chronic respiratory failure with hypercapnia essential (primary) hypertension chronic obstructive pulmonary disease, unspecified hypoxemia alcohol abuse, uncomplicated unspecified atrial fibrillation chronic diastolic (congestive) heart failure dependence on supplemental oxygen other secondary pulmonary hypertension gout, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence pure hypercholesterolemia pneumonia, organism unspecified physical restraints status foreign body in larynx unspecified essential hypertension other chronic pulmonary heart diseases other fluid overload accidents occurring in residential institution gout, unspecified esophageal reflux personal history of tobacco use pulmonary collapse acute respiratory failure ventilator associated pneumonia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute kidney failure, unspecified
black african american m 74 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; ipratropium-albuterol neb  1  neb ; multivitamins  1  tab ; omeprazole  20  mg ; polyethylene glycol  17  g ; sodium chloride nasal  1-2  spry ; trazodone  25  mg ; allopurinol  300  mg ; atorvastatin  10  mg ; diltiazem extended-release  240  mg ; loratadine  10  mg ; tiotropium bromide  1  cap ; triamcinolone acetonide 0.1% ointment  1  appl ; fluticasone-salmeterol diskus (250 50)   1  inh ; fluticasone propionate nasal  1  spry ; warfarin  2.5  mg ; metoprolol succinate xl  150  mg ; prednisone  40  mg ; 
cholangitis infection following a procedure, initial encounter long term (current) use of anticoagulants gout, unspecified obstruction of bile duct chronic obstructive pulmonary disease, unspecified other nonspecific abnormal finding of lung field unspecified atrial fibrillation chronic diastolic (congestive) heart failure other secondary pulmonary hypertension pure hypercholesterolemia dependence on supplemental oxygen acute and chronic respiratory failure with hypoxia unspecified cirrhosis of liver esophageal obstruction sepsis due to methicillin resistant staphylococcus aureus other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place in hospital as the place of occurrence of the external cause personal history of nicotine dependence acute and chronic respiratory failure with hypercapnia essential (primary) hypertension chronic obstructive pulmonary disease, unspecified hypoxemia alcohol abuse, uncomplicated unspecified atrial fibrillation chronic diastolic (congestive) heart failure dependence on supplemental oxygen other secondary pulmonary hypertension gout, unspecified gastro-esophageal reflux disease without esophagitis long term (current) use of anticoagulants personal history of nicotine dependence pure hypercholesterolemia pneumonia, organism unspecified physical restraints status foreign body in larynx unspecified essential hypertension other chronic pulmonary heart diseases other fluid overload accidents occurring in residential institution gout, unspecified esophageal reflux personal history of tobacco use pulmonary collapse acute respiratory failure ventilator associated pneumonia nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] acute kidney failure, unspecified
white f 95 $temp  98.1  heartrate  87.0  resprate  18.0  o2sat  99.0  sbp  109.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; metoprolol tartrate  12.5  mg ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; citalopram  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; lorazepam  0.5  mg ; rosuvastatin calcium  5  mg ; atenolol  25  mg ; senna  17.2  mg ; verapamil  80  mg ; 
essential (primary) hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits low back pain hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris malignant neoplasm of bladder, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence other chest pain do not resuscitate other and unspecified hyperlipidemia old myocardial infarction esophageal reflux unspecified vitamin d deficiency other specified cardiac dysrhythmias do not resuscitate status long-term (current) use of aspirin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety state, unspecified hydronephrosis cystitis, unspecified tobacco use disorder unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] stricture or kinking of ureter depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery 
white f 95 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  80  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; citalopram  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; senna  17.2  mg ; rosuvastatin calcium  10  mg ; 
essential (primary) hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits low back pain hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris malignant neoplasm of bladder, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence other chest pain do not resuscitate other and unspecified hyperlipidemia old myocardial infarction esophageal reflux unspecified vitamin d deficiency other specified cardiac dysrhythmias do not resuscitate status long-term (current) use of aspirin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety state, unspecified hydronephrosis cystitis, unspecified tobacco use disorder unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] stricture or kinking of ureter depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery 
white f 95 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; vitamin d  2000  unit ; lidocaine 5% patch  1  ptch ; heparin  5000  unit ; citalopram  10  mg ; aspirin  81  mg ; fluticasone propionate nasal  2  spry ; senna  17.2  mg ; rosuvastatin calcium  10  mg ; 
essential (primary) hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits low back pain hyperlipidemia, unspecified atherosclerotic heart disease of native coronary artery without angina pectoris malignant neoplasm of bladder, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence other chest pain do not resuscitate other and unspecified hyperlipidemia old myocardial infarction esophageal reflux unspecified vitamin d deficiency other specified cardiac dysrhythmias do not resuscitate status long-term (current) use of aspirin personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits anxiety state, unspecified hydronephrosis cystitis, unspecified tobacco use disorder unspecified essential hypertension streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] stricture or kinking of ureter depressive disorder, not elsewhere classified coronary atherosclerosis of native coronary artery 
white f 91 $nan$nan$omeprazole  40  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; 
 
white f 91 $nan$hematology blood hematocrit  42.6  %; hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.7  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  493  k ul; hematology blood platelet count  457  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  375  iu l; chemistry blood albumin  3.6  g dl$omeprazole  40  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; senna  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; lactulose  30  ml ; diltiazem  90  mg ; trazodone  25  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; vitamin d  400  unit ; atropine sulfate  0.5  mg ; morphine sulfate  2-4  mg ; heparin flush (100 units ml)  2  ml ; alendronate sodium  70  mg ; 
 
white f 91 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  371  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  119  mg dl$omeprazole  40  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; senna  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; lactulose  30  ml ; diltiazem  90  mg ; trazodone  25  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; vitamin d  400  unit ; atropine sulfate  0.5  mg ; morphine sulfate  2-4  mg ; heparin flush (100 units ml)  2  ml ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; morphine sulfate  2  mg ; heparin flush (10 units ml)  1  ml ; indomethacin  75  mg ; 
 
white f 91 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  111  mg dl$omeprazole  40  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; senna  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; diltiazem  90  mg ; trazodone  25  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; vitamin d  400  unit ; atropine sulfate  0.5  mg ; heparin flush (100 units ml)  2  ml ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  1  ml ; indomethacin  75  mg ; furosemide  60  mg ; 
 
white f 91 $nan$nan$omeprazole  40  mg ; polyethylene glycol  17  g ; digoxin  0.125  mg ; senna  2  tab ; docusate sodium  100  mg ; heparin  5000  unit ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; diltiazem  90  mg ; trazodone  25  mg ; ondansetron  4  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; vitamin d  400  unit ; atropine sulfate  0.5  mg ; heparin flush (100 units ml)  2  ml ; alendronate sodium  70  mg ; calcium carbonate  500  mg ; heparin flush (10 units ml)  1  ml ; indomethacin  75  mg ; furosemide  60  mg ; metoprolol tartrate  12.5  mg ; 
 
white f 36 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  117  mg dl$lr  1000  ml ; morphine sulfate  50  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  1  tab ; lorazepam  0.5  mg ; meperidine  12.5  mg ; promethazine hcl  6.25-12.5  mg ; prochlorperazine  2.5-5  mg ; haloperidol  0.25-0.5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.6  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; senna  2  tab ; hydromorphone (dilaudid)  12.5  mg ; acetaminophen w codeine  1-2  tab ; 
 
white f 36 $nan$nan$lr  1000  ml ; docusate sodium  100  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; senna  2  tab ; acetaminophen w codeine  1-2  tab ; hydromorphone (dilaudid)  0.5  mg ; 
 
white f 36 $nan$nan$lr  1000  ml ; docusate sodium  100  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; enoxaparin sodium  40  mg ; senna  2  tab ; acetaminophen w codeine  1-2  tab ; hydromorphone (dilaudid)  0.5  mg ; cephalexin  500  mg ; 
 
white f 36 $nan$nan$lr  1000  ml ; docusate sodium  100  mg ; lorazepam  0.5  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; senna  2  tab ; cephalexin  500  mg ; 
 
white f 36 $nan$nan$lr  1000  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; enoxaparin sodium  40  mg ; senna  2  tab ; 
 
white m 60 $temp  98.5  heartrate  72.0  resprate  18.0  o2sat  98.0  sbp  133.0  dbp  84.0  rhythm    pain  asleep  $hematology blood hematocrit  37.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  100  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  136  mg dl$prochlorperazine  10  mg ; sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5  mg ; insulin  0  unit ; enoxaparin sodium  100  mg ; sodium chloride 0.9%  1000  ml ; lactulose  30  ml ; insulin  5  unit ; lorazepam  0.5  mg ; magnesium oxide  400  mg ; 
type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy other problems related to lifestyle nonalcoholic steatohepatitis (nash) orthostatic hypotension familial dysautonomia [riley-day] type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified hypertensive encephalopathy hypertensive emergency multiple myeloma not having achieved remission other cirrhosis of liver major depressive disorder, single episode, unspecified long term (current) use of insulin acidosis personal history of other malignant neoplasm of kidney displaced trimalleolar fracture of left lower leg, subsequent encounter for closed fracture with routine healing long term (current) use of anticoagulants alcohol abuse, uncomplicated type 2 diabetes mellitus with diabetic chronic kidney disease personal history of malignant neoplasm of liver acute embolism and thrombosis of other specified veins hypomagnesemia portal vein thrombosis long term (current) use of anticoagulants drug-induced polyneuropathy personal history of other malignant neoplasm of kidney patient room in hospital as the place of occurrence of the external cause fall from chair, initial encounter obesity, unspecified other fracture of left lower leg, initial encounter for closed fracture displaced comminuted fracture of shaft of left fibula, initial encounter for closed fracture chronic kidney disease, stage 3 (moderate) headache body mass index (bmi) 36.0-36.9, adult anemia, unspecified volume depletion, unspecified delirium due to known physiological condition adverse effect of antineoplastic and immunosuppressive drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nonalcoholic steatohepatitis (nash) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other cirrhosis of liver hypotension due to drugs type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of malignant neoplasm of other organs and systems other fall from one level to another in water transport injuring occupant of other watercraft -- crew obstructive sleep apnea (adult) (pediatric)
white m 60 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  97  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  140  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acyclovir  400  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; oxycodone (immediate release)  5  mg ; insulin  5  unit ; lorazepam  0.5  mg ; magnesium oxide  400  mg ; 
type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy other problems related to lifestyle nonalcoholic steatohepatitis (nash) orthostatic hypotension familial dysautonomia [riley-day] type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified hypertensive encephalopathy hypertensive emergency multiple myeloma not having achieved remission other cirrhosis of liver major depressive disorder, single episode, unspecified long term (current) use of insulin acidosis personal history of other malignant neoplasm of kidney displaced trimalleolar fracture of left lower leg, subsequent encounter for closed fracture with routine healing long term (current) use of anticoagulants alcohol abuse, uncomplicated type 2 diabetes mellitus with diabetic chronic kidney disease personal history of malignant neoplasm of liver acute embolism and thrombosis of other specified veins hypomagnesemia portal vein thrombosis long term (current) use of anticoagulants drug-induced polyneuropathy personal history of other malignant neoplasm of kidney patient room in hospital as the place of occurrence of the external cause fall from chair, initial encounter obesity, unspecified other fracture of left lower leg, initial encounter for closed fracture displaced comminuted fracture of shaft of left fibula, initial encounter for closed fracture chronic kidney disease, stage 3 (moderate) headache body mass index (bmi) 36.0-36.9, adult anemia, unspecified volume depletion, unspecified delirium due to known physiological condition adverse effect of antineoplastic and immunosuppressive drugs, initial encounter unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause nonalcoholic steatohepatitis (nash) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease other cirrhosis of liver hypotension due to drugs type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy personal history of malignant neoplasm of other organs and systems other fall from one level to another in water transport injuring occupant of other watercraft -- crew obstructive sleep apnea (adult) (pediatric)
white m 65 $temp    heartrate  111.0  resprate  15.0  o2sat  100.0  sbp  127.0  dbp  73.0  rhythm    pain  asleep  ; temp    heartrate  103.0  resprate  16.0  o2sat  97.0  sbp  119.0  dbp  45.0  rhythm    pain    ; temp  98.5  heartrate  96.0  resprate  16.0  o2sat  96.0  sbp  137.0  dbp  67.0  rhythm    pain    $hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  170  mg dl; chemistry blood albumin  3.8  g dl; chemistry blood % hemoglobin a1c  6.2  %$clozapine  300  mg ; divalproex (delayed release)  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; lisinopril  5  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 
 
white m 65 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  1  # hpf; chemistry blood glucose  157  mg dl; blood gas blood lactate  2.5  mmol l$clozapine  300  mg ; divalproex (delayed release)  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; lisinopril  5  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; magnesium sulfate  4  gm ; lactated ringers  1000  ml ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; 
 
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; magnesium sulfate  4  gm ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; 
 
white m 65 $nan$hematology blood hematocrit  30.6  %; hematology blood hematocrit  29.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  160  k ul; hematology blood platelet count  176  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry urine chloride, urine  116  meq l; chemistry urine creatinine, urine  61  mg dl; chemistry urine potassium, urine  41  meq l; chemistry urine sodium, urine  124  meq l; chemistry urine urea nitrogen, urine  694  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  173  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  50  ml ; thiamine  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sodium chloride  1  gm ; 
 
white m 65 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood glucose  181  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; guaifenesin  5-10  ml ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sodium chloride  1  gm ; bisacodyl  10  mg ; 
 
white m 65 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sodium chloride  1  gm ; bisacodyl  10  mg ; 
 
white m 65 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  225  mg dl$bag  2  bag ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sodium chloride  1  gm ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; 
 
white m 65 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  223  mg dl$bag  2  bag ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; cepacol (sore throat lozenge)  1  loz ; albuterol inhaler  2  puff ; aspirin  81  mg ; atorvastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; folic acid  1  mg ; sertraline  75  mg ; omeprazole  20  mg ; montelukast  10  mg ; tamsulosin  0.4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; guaifenesin  5-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; sodium chloride  1  gm ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; clozapine  200  mg ; clozapine  50  mg ; 
 
white f 92 $nan$hematology urine wbc  >50  # hpf; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$nan
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  220  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; heparin  5000  unit ; aspirin  300  mg ; simvastatin  10  mg ; vitamin d  800  unit ; cyanocobalamin  100  mcg ; aspirin  81  mg ; donepezil  10  mg ; 
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry urine chloride, urine  38  meq l; chemistry urine creatinine, urine  55  mg dl; chemistry urine potassium, urine  48  meq l; chemistry urine sodium, urine  37  meq l; chemistry urine urea nitrogen, urine  565  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  172  mg dl; chemistry blood albumin  2.5  g dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; heparin  5000  unit ; simvastatin  10  mg ; vitamin d  800  unit ; cyanocobalamin  100  mcg ; aspirin  81  mg ; donepezil  10  mg ; 
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  286  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  40  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  157  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; heparin  5000  unit ; simvastatin  10  mg ; vitamin d  800  unit ; cyanocobalamin  100  mcg ; aspirin  81  mg ; donepezil  10  mg ; 0.9% sodium chloride  1000  ml ; 
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  312  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; heparin  5000  unit ; simvastatin  10  mg ; vitamin d  800  unit ; cyanocobalamin  100  mcg ; aspirin  81  mg ; donepezil  10  mg ; 
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 92 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; heparin  5000  unit ; simvastatin  10  mg ; vitamin d  800  unit ; cyanocobalamin  100  mcg ; aspirin  81  mg ; donepezil  10  mg ; ciprofloxacin hcl  500  mg ; 
adult failure to thrive urinary tract infection, site not specified irritable bowel syndrome other b-complex deficiencies vascular dementia, uncomplicated spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia 
white f 65 $nan$nan$levothyroxine sodium  75  mcg ; hydrochlorothiazide  25  mg ; duloxetine  20  mg ; levothyroxine sodium  100  mcg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; buspirone  10  mg ; duloxetine  30  mg ; gabapentin  300  mg ; 
 
white f 65 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  109  mg dl$levothyroxine sodium  75  mcg ; hydrochlorothiazide  25  mg ; duloxetine  20  mg ; levothyroxine sodium  100  mcg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; buspirone  10  mg ; duloxetine  30  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  325-650  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; morphine sulfate  50  mg ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; buspirone  15  mg ; zolpidem tartrate  5  mg ; proair hfa  1  puff ; mirtazapine  15  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
 
white f 65 $nan$chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry urine creatinine, urine  14  mg dl; chemistry urine sodium, urine  49  meq l; hematology urine wbc  2  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  105  mg dl$levothyroxine sodium  100  mcg ; hydrochlorothiazide  12.5  mg ; docusate sodium  100  mg ; duloxetine  30  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; acetaminophen  325-650  mg ; morphine sulfate  50  mg ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; lorazepam  0.5  mg ; buspirone  15  mg ; zolpidem tartrate  5  mg ; proair hfa  1  puff ; mirtazapine  15  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; metoprolol tartrate  25  mg ; multivitamins w minerals  1  tab ; hydromorphone (dilaudid)  2-4  mg ; sw  50  ml ; magnesium sulfate  2  gm ; d5 1 2ns  1000  ml ; metoprolol tartrate  5  mg ; 
 
white f 65 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  91  mg dl$levothyroxine sodium  100  mcg ; docusate sodium  100  mg ; duloxetine  30  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; buspirone  15  mg ; zolpidem tartrate  5  mg ; proair hfa  1  puff ; mirtazapine  15  mg ; metoprolol tartrate  25  mg ; multivitamins w minerals  1  tab ; sw  50  ml ; magnesium sulfate  2  gm ; d5 1 2ns  1000  ml ; metoprolol tartrate  5  mg ; 0.9% sodium chloride  1000  ml ; hydromorphone (dilaudid)  4  mg ; aspirin  325  mg ; 
 
white f 65 $nan$nan$levothyroxine sodium  100  mcg ; docusate sodium  100  mg ; duloxetine  30  mg ; gabapentin  300  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; buspirone  15  mg ; proair hfa  1  puff ; mirtazapine  15  mg ; multivitamins w minerals  1  tab ; hydromorphone (dilaudid)  4  mg ; aspirin  325  mg ; 
 
white f 35 $nan$hematology blood hematocrit  32.0  %; hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  119  k ul; hematology blood platelet count  102  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.0  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  94  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; tacrolimus  5  mg ; citalopram  20  mg ; mycophenolate sodium dr  720  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; valganciclovir  900  mg ; prednisone  7.5  mg ; heparin  5000  unit ; bag  2  bag ; magnesium sulfate  4  gm ; tamsulosin  0.4  mg ; tacrolimus  2  mg ; methylprednisolone sodium succ  125  mg ; heparin  1000  unit ; hydrocortisone na succ  20  mg ; 0.9% sodium chloride  500  ml ; anti-thymocyte globulin (rabbit)  75  mg ; acetaminophen  650  mg ; diphenhydramine  25  mg ; fluconazole  400  mg ; transplant self medication program  1  bag ; mycophenolate sodium dr  360  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  218  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; potassium chloride  40  meq ; bag  1  bag ; magnesium sulfate  2  gm ; tacrolimus  5  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; methylprednisolone sodium succ  125  mg ; heparin  1000  unit ; hydrocortisone na succ  20  mg ; 0.9% sodium chloride  500  ml ; anti-thymocyte globulin (rabbit)  75  mg ; transplant self medication program  1  bag ; mycophenolate sodium dr  360  mg ; quetiapine fumarate  200  mg ; tacrolimus  0  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  172  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; tacrolimus  0  mg ; prednisone  20  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  130  mg dl; hematology urine glucose  150  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; prednisone  20  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; insulin  9  unit ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  166  mg dl; chemistry blood albumin  3.0  g dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; insulin  9  unit ; ciprofloxacin hcl  250  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  152  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; ciprofloxacin hcl  250  mg ; potassium chloride  20  meq ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  160  mg dl$glucagon  1  mg ; d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; ciprofloxacin hcl  250  mg ; potassium chloride  20  meq ; insulin  22  unit ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  99  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; tamsulosin  0.4  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; ciprofloxacin hcl  250  mg ; insulin  22  unit ; ciprofloxacin hcl  500  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  96  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; insulin  22  unit ; ciprofloxacin hcl  500  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  122  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; senna  8.6  mg ; docusate sodium  100  mg ; insulin  20  unit ; insulin  22  unit ; ciprofloxacin hcl  500  mg ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bisacodyl  10  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  116  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; bisacodyl  10  mg ; milk of magnesia  60  ml ; tacrolimus  3  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  106  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; ciprofloxacin hcl  500  mg ; milk of magnesia  60  ml ; tacrolimus  3  mg ; nicotine patch  14  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  142  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; clopidogrel  75  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  205  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; clopidogrel  75  mg ; tacrolimus  4  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  137  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; clopidogrel  75  mg ; tacrolimus  4  mg ; insulin  24  unit ; tacrolimus  1  mg ; heparin flush (1000 units ml)  1000-2200  unit ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  30.9  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  151  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  0.86  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  125  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; clopidogrel  75  mg ; insulin  24  unit ; tacrolimus  1  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; albumin 5% (25g   500ml)  150  g ; bottle  100  ml ; gammagard liquid  10  g ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  31.0  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  128  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; nicotine patch  14  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; albumin 5% (25g   500ml)  150  g ; bottle  100  ml ; gammagard liquid  10  g ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  224  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; oxycodone (immediate release)   5-10  mg ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; tramadol (ultram)  50  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  114  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$chemistry blood chloride  100  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood bilirubin, total  0.5  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$chemistry blood bilirubin, total  0.5  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  107  mg dl$glucagon  1  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$chemistry blood bilirubin, total  0.5  mg dl$glucagon  1  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  77  mg dl$glucagon  1  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; bottle  0.5  ml ; gammagard liquid  10  gm ; oseltamivir  75  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white f 35 $nan$nan$glucagon  1  mg ; dextrose 50%  12.5  gm ; glucose gel  15  g ; citalopram  20  mg ; transplant self medication program  1  bag ; quetiapine fumarate  200  mg ; docusate sodium  100  mg ; aspirin  81  mg ; clopidogrel  75  mg ; heparin flush (1000 units ml)  1000-2200  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; prednisone  15  mg ; oseltamivir  75  mg ; 
other and unspecified alcohol dependence, in remission depressive disorder, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of immunosuppressive therapy tobacco use disorder dental caries, unspecified liver replaced by transplant person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident long-term (current) use of insulin alcohol abuse, in remission long-term (current) use of insulin secondary diabetes mellitus with other specified manifestations, not stated as uncontrolled, or unspecified dehydration person on outside of car injured in collision with two- or three-wheeled motor vehicle in traffic accident depressive disorder, not elsewhere classified adrenal cortical steroids causing adverse effects in therapeutic use liver replaced by transplant personal history of tobacco use dental caries, unspecified dental caries, unspecified hepatic encephalopathy accidental poisoning by aromatic analgesics, not elsewhere classified malnutrition of moderate degree other and unspecified coagulation defects body mass index between 19-24, adult other pulmonary insufficiency, not elsewhere classified other specified forms of effusion, except tuberculous tobacco use disorder acute and subacute necrosis of liver hyposmolality and/or hyponatremia passenger of special construction vehicle injured in traffic accident mixed acid-base balance disorder acute kidney failure with lesion of tubular necrosis accidents occurring in residential institution poisoning by aromatic analgesics, not elsewhere classified surgical operation with transplant of whole organ causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation adrenal cortical steroids causing adverse effects in therapeutic use physical restraints status other fluid overload hemorrhage complicating a procedure secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified 
white m 79 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  96  mg dl; chemistry blood albumin  4.2  g dl; chemistry blood % hemoglobin a1c  5.4  %$levofloxacin  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; tramadol (ultram)  25  mg ; 
 
white m 79 $nan$blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  99  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hemoglobin  13.2  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood sodium, whole blood  137  meq l$levofloxacin  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; losartan potassium  100  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; amlodipine  10  mg ; clopidogrel  75  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.8  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  136  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  131  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  135  mg dl; blood gas blood glucose  124  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  12.5  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  135  meq l; blood gas blood sodium, whole blood  133  meq l$cepacol (menthol)  1  loz ; levofloxacin  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; losartan potassium  100  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; amlodipine  10  mg ; clopidogrel  75  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; clopidogrel  300  mg ; senna  1  tab ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  1000  ml ; losartan potassium  50  mg ; 
 
white m 79 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  108  mg dl$cepacol (menthol)  1  loz ; levofloxacin  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; clopidogrel  300  mg ; senna  1  tab ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; losartan potassium  50  mg ; potassium chloride  60  meq ; influenza virus vaccine  0.5  ml ; 
 
white m 79 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  99  mg dl$cepacol (menthol)  1  loz ; levofloxacin  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; tramadol (ultram)  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; sterile water  50  ml ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; losartan potassium  50  mg ; potassium chloride  60  meq ; influenza virus vaccine  0.5  ml ; 
 
white m 79 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  102  mg dl$cepacol (menthol)  1  loz ; levofloxacin  500  mg ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; losartan potassium  50  mg ; influenza virus vaccine  0.5  ml ; 
 
white m 79 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  103  mg dl$cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; losartan potassium  50  mg ; influenza virus vaccine  0.5  ml ; benzonatate  100  mg ; 
 
white m 79 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  103  mg dl$cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; losartan potassium  50  mg ; benzonatate  100  mg ; warfarin  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  144  mg dl$cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; losartan potassium  50  mg ; benzonatate  100  mg ; warfarin  10  mg ; 
 
white m 79 $nan$nan$cepacol (menthol)  1  loz ; sodium chloride 0.9%  flush  3  ml ; trazodone  25  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; ezetimibe  10  mg ; rosuvastatin calcium  40  mg ; tamsulosin  0.4  mg ; ropinirole  0.5  mg ; niacin sr  500  mg ; aspirin  81  mg ; vitamin d  800  unit ; multivitamins  1  tab ; clopidogrel  75  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; senna  1  tab ; heparin  5000  unit ; losartan potassium  50  mg ; benzonatate  100  mg ; 
 
black african american f 49 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  500-1000  mg ; oxycodone (immediate release)  5  mg ; ketorolac  15  mg ; diazepam  5  mg ; ondansetron  2-4  mg ; 
intervertebral disc disorders with radiculopathy, lumbosacral region 
black african american f 49 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  119  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  500-1000  mg ; oxycodone (immediate release)  5  mg ; ketorolac  15  mg ; diazepam  5  mg ; ondansetron  2-4  mg ; acetaminophen  500  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; 
intervertebral disc disorders with radiculopathy, lumbosacral region 
black african american f 49 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  345  k ul; hematology blood inr(pt)  1.1  $influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; ketorolac  15  mg ; diazepam  5  mg ; ondansetron  2-4  mg ; acetaminophen  500  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; oxycodone (immediate release)  5-10  mg ; morphine sulfate  1  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  2-4  mg ; 
intervertebral disc disorders with radiculopathy, lumbosacral region 
black african american f 49 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; diazepam  5  mg ; ondansetron  2-4  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  800  mg ; 
intervertebral disc disorders with radiculopathy, lumbosacral region 
black african american f 49 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; diazepam  5  mg ; ondansetron  2-4  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  800  mg ; 
intervertebral disc disorders with radiculopathy, lumbosacral region 
unknown m 79 $nan$hematology blood hematocrit  40.5  %; hematology blood hematocrit  43.3  %; hematology blood hematocrit  44.7  %; hematology blood hemoglobin  12.7  g dl; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  146  k ul; hematology blood platelet count  153  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.0  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  90  mg dl; chemistry blood lactate dehydrogenase (ld)  342  iu l; blood gas blood lactate  1.5  mmol l$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; alprazolam  0.25  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; ondansetron  4  mg ; morphine sulfate  100  mg ; metoclopramide  10  mg ; 
 
unknown m 79 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  71  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; alprazolam  0.25  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; ondansetron  4  mg ; morphine sulfate  100  mg ; metoclopramide  10  mg ; heparin  5000  unit ; 
 
unknown m 79 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; alprazolam  0.25  mg ; morphine sulfate  100  mg ; metoclopramide  10  mg ; heparin  5000  unit ; warfarin  5  mg ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; 
 
unknown m 79 $nan$nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; alprazolam  0.25  mg ; metoclopramide  10  mg ; heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
unknown m 79 $nan$nan$heparin  5000  unit ; oxycodone (immediate release)   2.5  mg ; acetaminophen  650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; docusate sodium  100  mg ; senna  8.6  mg ; 
 
white m 79 $nan$hematology blood hematocrit  40.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  178  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  153  mg dl$meclizine  12.5  mg ; glipizide  5  mg ; metformin (glucophage)  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; lisinopril  40  mg ; metoprolol tartrate  50  mg ; omeprazole  20  mg ; rosuvastatin calcium  10  mg ; insulin  0  unit ; sodium chloride 0.9%  1000  ml ; lactated ringers  1000  ml ; 
abdominal pain, unspecified site unspecified essential hypertension obstruction of bile duct chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 47 $temp  98.0  heartrate  62.0  resprate  14.0  o2sat  98.0  sbp  132.0  dbp  78.0  rhythm    pain  asleep  $hematology blood hematocrit  38.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  132  mg dl; chemistry blood glucose  173  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; dexamethasone  4  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  23  mg dl$sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; morphine sulfate  2-4  mg ; morphine sulfate ir  15  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; pantoprazole  40  mg ; morphine sulfate ir  15  mg ; acetaminophen-caff-butalbital  1-2  tab ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  38.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; temozolomide  40  mg ; temozolomide  140  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; morphine sulfate  2  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  141  mg dl$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; morphine sulfate  2  mg ; lorazepam  1  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry urine chloride, urine  44  meq l; chemistry urine potassium, urine  47  meq l; chemistry urine sodium, urine  42  meq l; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  136  mg dl; blood gas blood lactate  1.2  mmol l; blood gas blood sodium, whole blood  130  meq l$sodium chloride 0.9%  flush  3  ml ; levetiracetam  500  mg ; ranitidine  150  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; acetaminophen-caff-butalbital  1-2  tab ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; lorazepam  1  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; 0.9% sodium chloride  100  ml ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; ondansetron  4-8  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  143  mg dl$sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; ondansetron  4-8  mg ; levetiracetam  1000  mg ; bisacodyl  10  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  208  k ul; hematology blood platelet count  210  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  87  meq l; chemistry blood chloride  86  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  89  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  124  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; chemistry urine chloride, urine  170  meq l; chemistry urine chloride, urine  120  meq l; chemistry urine creatinine, urine  32  mg dl; chemistry urine creatinine, urine  63  mg dl; chemistry urine potassium, urine  35  meq l; chemistry urine potassium, urine  58  meq l; chemistry urine sodium, urine  170  meq l; chemistry urine sodium, urine  107  meq l; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  149  mg dl; chemistry blood glucose  171  mg dl$sodium chloride 0.9%  flush  3  ml ; ranitidine  150  mg ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; ondansetron  4-8  mg ; levetiracetam  1000  mg ; bisacodyl  10  mg ; valproate sodium  1500  mg ; bag  500  ml ; sodium chloride 3% (hypertonic)  500  ml ; potassium chloride  40  meq ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; 0.9% sodium chloride  500  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; valproate sodium  1500  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; 0.9% sodium chloride  500  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lorazepam  2  mg ; bag  1  bag ; magnesium sulfate  2  gm ; phosphorus  250  mg ; neutra-phos  2  pkt ; sodium chloride 0.9%  flush  10-20  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  133  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; bag  1  bag ; magnesium sulfate  2  gm ; neutra-phos  2  pkt ; sodium chloride 0.9%  flush  10-20  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  164  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; d5ns  1000  ml ; potassium chloride  60  meq ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; d5ns  1000  ml ; potassium chloride  60  meq ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  56  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  117  mg dl$acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; potassium chl 40 meq   1000 ml d5ns  1000  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  48  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  131  mg dl$acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; potassium chl 40 meq   1000 ml d5ns  1000  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  37  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  123  mg dl; hematology blood bands  3  %$acetaminophen  650  mg ; temozolomide  40  mg ; temozolomide  140  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; ondansetron  4-8  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  34  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  154  mg dl; hematology blood bands  1  %$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; senna  8.6  mg ; vial  1  vial ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$hematology blood hematocrit  29.1  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  25  k ul; chemistry blood chloride  96  meq l; chemistry blood chloride  101  meq l; chemistry blood potassium  3.3  meq l; chemistry blood potassium  2.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; hematology blood bands  1  %$acetaminophen  650  mg ; docusate sodium  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; 0.9% sodium chloride  50  ml ; valproate sodium  750  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; dexamethasone  6  mg ; 5% dextrose  500  ml ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.25  mg ; vial  1  vial ; prochlorperazine  10  mg ; bisacodyl  10  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; dexamethasone  6  mg ; hydromorphone (dilaudid)  1-2  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white f 47 $nan$nan$acetaminophen  650  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; artificial tears  1-2  drop ; dexamethasone  6  mg ; hydromorphone (dilaudid)  1-2  mg ; 
facial weakness flaccid hemiplegia and hemiparesis affecting dominant side unspecified essential hypertension intracerebral hemorrhage aphasia malignant melanoma of skin of trunk, except scrotum cerebral edema other convulsions vomiting alone 
white m 30 $nan$hematology blood hematocrit  46.2  %; hematology blood hemoglobin  16.1  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  113  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; ondansetron  4  mg ; hydralazine  10  mg ; senna  1  tab ; docusate sodium  100  mg ; 
 
white m 30 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; ondansetron  4  mg ; hydralazine  10  mg ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen-caff-butalbital  1-2  tab ; hydromorphone (dilaudid)  2-4  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; ciprofloxacin   4  drop ; 
 
white m 30 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; oxycodone-acetaminophen  1  tab ; bisacodyl  10  mg ; ondansetron  4  mg ; hydralazine  10  mg ; senna  1  tab ; docusate sodium  100  mg ; acetaminophen-caff-butalbital  1-2  tab ; hydromorphone (dilaudid)  2-4  mg ; potassium chl 20 meq   1000 ml ns  1000  ml ; ciprofloxacin   4  drop ; 
 
unknown m 57 $nan$nan$aspirin ec  81  mg ; simvastatin  40  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  50.4  %; hematology blood hematocrit  37.7  %; hematology blood hemoglobin  16.5  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  176  k ul; hematology blood platelet count  114  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.0  ; hematology blood inr(pt)  1.2  ; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood albumin  5.0  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood free calcium  1.11  mmol l; blood gas blood free calcium  1.09  mmol l; blood gas blood lactate  0.9  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  108  meq l; blood gas blood glucose  179  mg dl; blood gas blood glucose  195  mg dl; blood gas blood glucose  191  mg dl; blood gas blood glucose  174  mg dl; blood gas blood glucose  155  mg dl; blood gas blood hematocrit, calculated  43  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  14.3  g dl; blood gas blood hemoglobin  11.1  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  10.9  g dl; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  6.3  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood sodium, whole blood  134  meq l; chemistry blood % hemoglobin a1c  7.4  %$aspirin ec  81  mg ; simvastatin  40  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nitroglycerin sl  0.4  mg ; acetaminophen  325-650  mg ; insulin  0  unit ; hydralazine  10  mg ; docusate sodium  100  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  12.5  mg ; glipizide xl  20  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
unknown m 57 $nan$hematology blood hematocrit  38.8  %; hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  114  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood glucose  103  mg dl; blood gas blood glucose  116  mg dl; blood gas blood glucose  112  mg dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood sodium, whole blood  134  meq l$aspirin  81  mg ; milk of magnesia  30  ml ; sodium chloride 0.9%  flush  10  ml ; 5% dextrose  250  ml ; propofol  1000  mg ; propofol  200  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ketorolac  15  mg ; 0.9% sodium chloride  50  ml ; dexmedetomidine  0.2  mg ; albuterol inhaler  2  puff ; meperidine  12.5  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  153  mg dl$milk of magnesia  30  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ketorolac  15  mg ; albuterol inhaler  2  puff ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  20  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood glucose  141  mg dl$milk of magnesia  30  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; ketorolac  15  mg ; albuterol inhaler  2  puff ; ranitidine  150  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; furosemide  40  mg ; pioglitazone  15  mg ; glipizide  10  mg ; 
 
unknown m 57 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  197  k ul$milk of magnesia  30  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; albuterol inhaler  2  puff ; ranitidine  150  mg ; pioglitazone  15  mg ; glipizide  10  mg ; metformin (glucophage)  500  mg ; 
 
unknown m 57 $nan$nan$milk of magnesia  30  ml ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; albuterol inhaler  2  puff ; ranitidine  150  mg ; pioglitazone  15  mg ; glipizide  10  mg ; metformin (glucophage)  500  mg ; 
 
white m 55 $nan$nan$atenolol  25  mg ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  43.0  %; hematology blood hematocrit  43.6  %; hematology blood hemoglobin  15.3  g dl; hematology blood hemoglobin  15.8  g dl; hematology blood platelet count  180  k ul; hematology blood platelet count  174  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  2.5  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  1.9  ; chemistry blood glucose  106  mg dl; chemistry blood glucose  99  mg dl$d5w  250  ml ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; phytonadione  2.5  mg ; magnesium sulfate  2  gm ; acetaminophen  325-650  mg ; heparin  2500-5000  unit ; heparin sodium  25,000  unit ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  45.4  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  99  mg dl$d5w  250  ml ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; zolpidem tartrate  5  mg ; phytonadione  2.5  mg ; magnesium sulfate  2  gm ; acetaminophen  325-650  mg ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  43.3  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  98  mg dl$d5w  250  ml ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  92  mg dl$d5w  250  ml ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  40.9  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  103  mg dl$d5w  250  ml ; atenolol  25  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; sw  50  ml ; atenolol  50  mg ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 55 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  155  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; atenolol  50  mg ; 
atrial fibrillation meralgia paresthetica ventricular fibrillation aortocoronary bypass status unspecified essential hypertension cardiac arrest paroxysmal ventricular tachycardia cardiac complications, not elsewhere classified enlargement of lymph nodes 
white m 54 $nan$hematology blood hematocrit  31.0  %; chemistry blood chloride  104  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l$iso-osmotic sodium chloride  50  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; hydromorphone (dilaudid)  20  mg ; famotidine  20  mg ; lorazepam  0.5  mg ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; clonazepam  0.5  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; ibuprofen  600  mg ; 
nontoxic uninodular goiter other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) anxiety state, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution other b-complex deficiencies unspecified disorder of stomach and duodenum unspecified acquired hypothyroidism blood in stool allergic urticaria 
white m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; oxycodone-acetaminophen  1-2  tab ; clonazepam  0.5  mg ; fluticasone propionate nasal  1  spry ; fexofenadine  60  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; cyanocobalamin  1000  mcg ; multivitamins w minerals  1  tab ; ibuprofen  600  mg ; 
nontoxic uninodular goiter other and unspecified hyperlipidemia iron deficiency anemia secondary to blood loss (chronic) anxiety state, unspecified other drugs and medicinal substances causing adverse effects in therapeutic use accidents occurring in residential institution other b-complex deficiencies unspecified disorder of stomach and duodenum unspecified acquired hypothyroidism blood in stool allergic urticaria 
white m 68 $temp    heartrate  65.0  resprate  18.0  o2sat  98.0  sbp  110.0  dbp  64.0  rhythm    pain  8  ; temp    heartrate  74.0  resprate  18.0  o2sat  98.0  sbp  120.0  dbp  73.0  rhythm    pain  8  ; temp  98.6  heartrate  71.0  resprate  18.0  o2sat  98.0  sbp  98.0  dbp  43.0  rhythm    pain  5  ; temp    heartrate  66.0  resprate  18.0  o2sat  98.0  sbp  118.0  dbp  96.0  rhythm    pain    ; temp    heartrate  71.0  resprate  19.0  o2sat    sbp  120.0  dbp  65.0  rhythm    pain  6  $hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  153  mg dl; blood gas blood lactate  1.0  mmol l$nan
 
white m 68 $temp  98.4  heartrate  82.0  resprate  22.0  o2sat  94.0  sbp  163.0  dbp  64.0  rhythm    pain  5  $nan$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; hydralazine  50  mg ; amlodipine  10  mg ; hydromorphone (dilaudid)  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  40  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; tamsulosin  0.4  mg ; rifampin  300  mg ; ceftriaxone  2  gm ; lactated ringers  1000  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; 
 
white m 68 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  306  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  147  mg dl; chemistry blood albumin  2.5  g dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; hydralazine  50  mg ; amlodipine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; metoprolol tartrate  25  mg ; omeprazole  40  mg ; oxycodone sr (oxycontin)  10  mg ; oxycodone sr (oxycontin)  20  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; tamsulosin  0.4  mg ; rifampin  300  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin flush (10 units ml)  2  ml ; bag  2  bag ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  20  mg ; 
 
white m 68 $nan$hematology blood hematocrit  24.0  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  158  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; lactated ringers  1000  ml ; ondansetron  4-8  mg ; senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin flush (10 units ml)  2  ml ; bag  2  bag ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  20  mg ; oxycodone sr (oxycontin)  30  mg ; potassium chloride  20  meq ; 
 
white m 68 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  334  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  206  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; docusate sodium  100  mg ; heparin flush (10 units ml)  2  ml ; hydromorphone (dilaudid)  20  mg ; oxycodone sr (oxycontin)  30  mg ; potassium chloride  20  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bisacodyl  10  mg ; cefazolin  2  g ; 
 
white m 68 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  375  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  148  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; docusate sodium  100  mg ; heparin flush (10 units ml)  2  ml ; hydromorphone (dilaudid)  20  mg ; oxycodone sr (oxycontin)  30  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bisacodyl  10  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; 
 
white m 68 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  400  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  151  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  30  mg ; bisacodyl  10  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; 
 
white m 68 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  427  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  139  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  30  mg ; bisacodyl  10  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  40  meq ; hydralazine  25  mg ; 
 
white m 68 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  449  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  141  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  30  mg ; bisacodyl  10  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; potassium chloride  40  meq ; hydralazine  25  mg ; hydralazine  75  mg ; trazodone  25  mg ; 
 
white m 68 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  120  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; senna  8.6  mg ; docusate sodium  100  mg ; oxycodone sr (oxycontin)  30  mg ; bisacodyl  10  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; trazodone  25  mg ; lisinopril  2.5  mg ; oxycodone (immediate release)   5  mg ; oxycodone sr (oxycontin)  40  mg ; 
 
white m 68 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  426  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  114  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; omeprazole  40  mg ; pravastatin  80  mg ; insulin  0  unit ; insulin  25  unit ; rifampin  300  mg ; ondansetron  4-8  mg ; docusate sodium  100  mg ; cefazolin  2  g ; sodium chloride 0.9%  flush  10  ml ; trazodone  25  mg ; lisinopril  2.5  mg ; oxycodone (immediate release)   5  mg ; oxycodone sr (oxycontin)  40  mg ; polyethylene glycol  17  g ; lisinopril  7.5  mg ; 
 
black african american f 59 $nan$nan$folic acid  2  mg ; ferrous sulfate  325  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; ferrous gluconate  325  mg ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
black african american f 59 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  485  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  8.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  98  mg dl$folic acid  2  mg ; ferrous sulfate  325  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; ferrous gluconate  325  mg ; paricalcitol  5  mcg ; vial  1  vial ; epoetin alfa  2000  unit ; epoetin alfa  3000  unit ; heparin dwell (1000 units ml)  2000-8000  unit ; 0.9% sodium chloride  250  ml ; sevelamer carbonate  2400  mg ; sodium chloride 0.9%  flush  3  ml ; tuberculin protein  0.1  ml ; heparin  5000  unit ; labetalol  100  mg ; acetaminophen  650  mg ; sertraline  50  mg ; trazodone  25  mg ; furosemide  40  mg ; nephrocaps  1  cap ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
black african american f 59 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  22.3  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  452  k ul; hematology blood platelet count  418  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  7.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  142  mg dl$folic acid  2  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; ferrous gluconate  325  mg ; sevelamer carbonate  2400  mg ; sodium chloride 0.9%  flush  3  ml ; tuberculin protein  0.1  ml ; heparin  5000  unit ; labetalol  100  mg ; acetaminophen  650  mg ; sertraline  50  mg ; trazodone  25  mg ; furosemide  40  mg ; nephrocaps  1  cap ; heparin flush (1000 units ml)  4000-11000  unit ; diphenhydramine  25  mg ; epoetin alfa  5000  unit ; lorazepam  0.5  mg ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
black african american f 59 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  490  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  81  mg dl$folic acid  2  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; ferrous gluconate  325  mg ; sevelamer carbonate  2400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; labetalol  100  mg ; acetaminophen  650  mg ; sertraline  50  mg ; trazodone  25  mg ; nephrocaps  1  cap ; heparin flush (1000 units ml)  4000-11000  unit ; epoetin alfa  5000  unit ; lorazepam  0.5  mg ; clonazepam  0.5  mg ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
black african american f 59 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  440  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  75  mg dl$folic acid  2  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; sevelamer carbonate  2400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; labetalol  100  mg ; acetaminophen  650  mg ; sertraline  50  mg ; trazodone  25  mg ; nephrocaps  1  cap ; heparin flush (1000 units ml)  4000-11000  unit ; clonazepam  0.5  mg ; vial  1.6  vial ; paricalcitol  7.5  mcg ; epoetin alfa  10,000  unit ; senna  1  tab ; polyethylene glycol  17  g ; docusate sodium  100  mg ; neomycin-polymyxin-bacitracin  1  appl ; furosemide  60  mg ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
black african american f 59 $nan$nan$folic acid  2  mg ; aspirin ec  325  mg ; nifedipine cr  60  mg ; sevelamer carbonate  2400  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; labetalol  100  mg ; acetaminophen  650  mg ; sertraline  50  mg ; trazodone  25  mg ; nephrocaps  1  cap ; heparin flush (1000 units ml)  4000-11000  unit ; clonazepam  0.5  mg ; senna  1  tab ; polyethylene glycol  17  g ; docusate sodium  100  mg ; neomycin-polymyxin-bacitracin  1  appl ; furosemide  60  mg ; 
homonymous bilateral field defects pulmonary congestion and hypostasis disorders of phosphorus metabolism acidosis hyposmolality and/or hyponatremia hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease late effects of cerebrovascular disease, disturbances of vision dysthymic disorder chronic kidney disease, stage v unspecified deficiency anemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease hyperparathyroidism, unspecified personal history of tobacco use end stage renal disease homonymous bilateral field defects late effects of cerebrovascular disease, disturbances of vision anemia in chronic kidney disease anxiety state, unspecified disorders of phosphorus metabolism acidosis chronic kidney disease, unspecified other and unspecified hyperlipidemia personal history of tobacco use late effects of cerebrovascular disease, disturbances of vision acidosis iron deficiency anemia, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with complex partial seizures, without mention of intractable epilepsy visual field defect, unspecified chronic kidney disease, stage v anemia in chronic kidney disease visual field defect, unspecified anxiety state, unspecified late effects of cerebrovascular disease, disturbances of vision disorder of bone and cartilage, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia hyposmolality and/or hyponatremia acidosis leukocytosis, unspecified unspecified essential hypertension personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nausea alone anxiety state, unspecified other late effects of cerebrovascular disease personal history of tobacco use leukocytosis, unspecified localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, without mention of intractable epilepsy
white f 56 $nan$nan$bisacodyl  10  mg ; 
 
white f 56 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  118  mg dl$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; morphine sulfate  1-4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; diazepam  2-5  mg ; paroxetine  10  mg ; cyclobenzaprine  10  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  1-4  mg ; diazepam  2-5  mg ; paroxetine  10  mg ; cyclobenzaprine  10  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  0.5  mg ; cyclobenzaprine  5-10  mg ; morphine sulfate  1-3  mg ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; cyclobenzaprine  5-10  mg ; morphine sulfate  1-3  mg ; diazepam  10  mg ; diazepam  5  mg ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; cyclobenzaprine  5-10  mg ; morphine sulfate  1-3  mg ; diazepam  5  mg ; diazepam  5-10  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.25  mg ; lorazepam  0.5  mg ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; morphine sulfate  1-3  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.25  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  4-8  mg ; tizanidine  2  mg ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; morphine sulfate  1-3  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  4-8  mg ; tizanidine  2  mg ; morphine sr (ms contin)  30  mg ; 
 
white f 56 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  288  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  153  mg dl$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; morphine sulfate  1-3  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  4-8  mg ; tizanidine  2  mg ; morphine sr (ms contin)  30  mg ; tizanidine  4  mg ; fleet enema  1  enema ; 
 
white f 56 $nan$nan$bisacodyl  10  mg ; verapamil sr  240  mg ; omeprazole  20  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; paroxetine  10  mg ; acetaminophen  1000  mg ; morphine sulfate  1-3  mg ; lorazepam  0.5  mg ; hydromorphone (dilaudid)  4-8  mg ; morphine sr (ms contin)  30  mg ; 
 
white f 41 $nan$nan$acetaminophen  1000  mg ; 
 
white f 41 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl$acetaminophen  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; docusate sodium  100  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; tizanidine  2  mg ; hydromorphone (dilaudid)  0.25  mg ; oxycodone (immediate release)  30  mg ; senna  17.2  mg ; hydromorphone (dilaudid)  6  mg ; clonazepam  1  mg ; hydromorphone (dilaudid)  0.5-1  mg ; naloxone  0.04  mg ; heparin  5000  unit ; omeprazole  40  mg ; 
 
white f 41 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; bisacodyl  10  mg ; tizanidine  2  mg ; senna  17.2  mg ; hydromorphone (dilaudid)  6  mg ; clonazepam  1  mg ; naloxone  0.04  mg ; heparin  5000  unit ; omeprazole  40  mg ; 
 
white m 76 $nan$nan$fluoxetine  40  mg ; ferrous sulfate  325  mg ; simvastatin  10  mg ; ramipril  2.5  mg ; multivitamins  1  cap ; vitamin d  400  unit ; glipizide  2.5  mg ; 
 
white m 76 $nan$hematology blood hematocrit  41.5  %; hematology blood hematocrit  37.6  %; hematology blood hemoglobin  14.2  g dl; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  161  k ul; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  64  mg dl$fluoxetine  40  mg ; ferrous sulfate  325  mg ; simvastatin  10  mg ; ramipril  2.5  mg ; multivitamins  1  cap ; vitamin d  400  unit ; glipizide  2.5  mg ; ibuprofen  400  mg ; senna  1  tab ; insulin  0  unit ; furosemide  20  mg ; gabapentin  600  mg ; heparin  5000  unit ; docusate sodium  100  mg ; ns  1000  ml ; tamsulosin  0.4  mg ; amitriptyline hcl  50  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
white m 76 $nan$nan$fluoxetine  40  mg ; ferrous sulfate  325  mg ; simvastatin  10  mg ; ramipril  2.5  mg ; multivitamins  1  cap ; vitamin d  400  unit ; senna  1  tab ; insulin  0  unit ; gabapentin  600  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; amitriptyline hcl  50  mg ; pneumococcal vac polyvalent  0.5  ml ; 
 
black african american m 28 $temp  98.3  heartrate  59.0  resprate  16.0  o2sat  99.0  sbp  125.0  dbp  63.0  rhythm    pain    ; temp  98.7  heartrate  69.0  resprate  16.0  o2sat  98.0  sbp  130.0  dbp  81.0  rhythm    pain    ; temp  98.7  heartrate  59.0  resprate  18.0  o2sat  100.0  sbp  129.0  dbp  71.0  rhythm    pain    ; temp  98.0  heartrate  62.0  resprate  17.0  o2sat  95.0  sbp  128.0  dbp  78.0  rhythm    pain    ; temp  98.2  heartrate  61.0  resprate  16.0  o2sat  100.0  sbp  115.0  dbp  68.0  rhythm    pain    ; temp  97.4  heartrate  62.0  resprate  15.0  o2sat  100.0  sbp  110.0  dbp  58.0  rhythm    pain  asleep  $hematology urine wbc  5  # hpf$nan
 
black african american m 28 $temp  98.1  heartrate  61.0  resprate  14.0  o2sat  99.0  sbp  119.0  dbp  66.0  rhythm    pain    ; temp  98.3  heartrate  55.0  resprate  14.0  o2sat  99.0  sbp  119.0  dbp  68.0  rhythm    pain    ; temp  98.1  heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  112.0  dbp  67.0  rhythm    pain  0  $nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; heparin  5000  unit ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; heparin  5000  unit ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  100  mg ; quetiapine fumarate  50  mg ; heparin  5000  unit ; haloperidol  0.5  mg ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; haloperidol  0.5  mg ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  200  mg ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  200  mg ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; quetiapine fumarate  200  mg ; 
 
black african american m 28 $nan$hematology urine wbc  15  # hpf$influenza vaccine quadrivalent  0.5  ml ; quetiapine fumarate  200  mg ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; 
 
black african american m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; quetiapine fumarate  300  mg ; 
 
black african american m 28 $nan$nan$
 
black african american m 28 $nan$nan$
 
white m 47 $temp  97.0  heartrate  83.0  resprate  16.0  o2sat  95.0  sbp  100.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  220  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; rivaroxaban  20  mg ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  1000  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; allopurinol  150  mg ; amiodarone  200  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; atorvastatin  40  mg ; digoxin  0.125  mg ; docusate sodium  100  mg ; loratadine  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; polyethylene glycol  17  g ; ciprofloxacin 0.3% ophth soln  4  drop ; 
neuromuscular dysfunction of bladder, unspecified gout, unspecified personal history of other infectious and parasitic diseases body mass index (bmi) 40.0-44.9, adult long term (current) use of insulin acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation obesity, unspecified other specified cardiac arrhythmias gastroparesis diagnostic and monitoring cardiovascular devices associated with adverse incidents nonrheumatic pulmonary valve insufficiency acute kidney failure, unspecified personal history of (corrected) congenital malformations of heart and circulatory system thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy anemia in other chronic diseases classified elsewhere obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified schizoaffective disorder, unspecified other symptoms and signs involving cognitive functions and awareness hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma obesity, unspecified neuromuscular dysfunction of bladder, unspecified acute kidney failure, unspecified other specified anemias chronic obstructive pulmonary disease, unspecified hypo-osmolality and hyponatremia presence of automatic (implantable) cardiac defibrillator type 2 diabetes mellitus with hyperglycemia gastroparesis acute on chronic systolic (congestive) heart failure body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy obstructive sleep apnea (adult) (pediatric) post-traumatic stress disorder, unspecified gout, unspecified unspecified atrial fibrillation other specified mental disorders due to known physiological condition nonrheumatic pulmonary valve insufficiency patient's noncompliance with dietary regimen hypo-osmolality and hyponatremia nonrheumatic pulmonary valve insufficiency long term (current) use of anticoagulants unspecified atrial fibrillation
white m 47 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  228  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  212  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; allopurinol  150  mg ; amiodarone  200  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; atorvastatin  40  mg ; digoxin  0.125  mg ; docusate sodium  100  mg ; loratadine  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; polyethylene glycol  17  g ; ciprofloxacin 0.3% ophth soln  4  drop ; rivaroxaban  15  mg ; insulin  88  unit ; 
neuromuscular dysfunction of bladder, unspecified gout, unspecified personal history of other infectious and parasitic diseases body mass index (bmi) 40.0-44.9, adult long term (current) use of insulin acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation obesity, unspecified other specified cardiac arrhythmias gastroparesis diagnostic and monitoring cardiovascular devices associated with adverse incidents nonrheumatic pulmonary valve insufficiency acute kidney failure, unspecified personal history of (corrected) congenital malformations of heart and circulatory system thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy anemia in other chronic diseases classified elsewhere obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified schizoaffective disorder, unspecified other symptoms and signs involving cognitive functions and awareness hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma obesity, unspecified neuromuscular dysfunction of bladder, unspecified acute kidney failure, unspecified other specified anemias chronic obstructive pulmonary disease, unspecified hypo-osmolality and hyponatremia presence of automatic (implantable) cardiac defibrillator type 2 diabetes mellitus with hyperglycemia gastroparesis acute on chronic systolic (congestive) heart failure body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy obstructive sleep apnea (adult) (pediatric) post-traumatic stress disorder, unspecified gout, unspecified unspecified atrial fibrillation other specified mental disorders due to known physiological condition nonrheumatic pulmonary valve insufficiency patient's noncompliance with dietary regimen hypo-osmolality and hyponatremia nonrheumatic pulmonary valve insufficiency long term (current) use of anticoagulants unspecified atrial fibrillation
white m 47 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  166  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; allopurinol  150  mg ; amiodarone  200  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; atorvastatin  40  mg ; digoxin  0.125  mg ; docusate sodium  100  mg ; loratadine  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; polyethylene glycol  17  g ; ciprofloxacin 0.3% ophth soln  4  drop ; rivaroxaban  15  mg ; insulin  88  unit ; 
neuromuscular dysfunction of bladder, unspecified gout, unspecified personal history of other infectious and parasitic diseases body mass index (bmi) 40.0-44.9, adult long term (current) use of insulin acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation obesity, unspecified other specified cardiac arrhythmias gastroparesis diagnostic and monitoring cardiovascular devices associated with adverse incidents nonrheumatic pulmonary valve insufficiency acute kidney failure, unspecified personal history of (corrected) congenital malformations of heart and circulatory system thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy anemia in other chronic diseases classified elsewhere obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified schizoaffective disorder, unspecified other symptoms and signs involving cognitive functions and awareness hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma obesity, unspecified neuromuscular dysfunction of bladder, unspecified acute kidney failure, unspecified other specified anemias chronic obstructive pulmonary disease, unspecified hypo-osmolality and hyponatremia presence of automatic (implantable) cardiac defibrillator type 2 diabetes mellitus with hyperglycemia gastroparesis acute on chronic systolic (congestive) heart failure body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy obstructive sleep apnea (adult) (pediatric) post-traumatic stress disorder, unspecified gout, unspecified unspecified atrial fibrillation other specified mental disorders due to known physiological condition nonrheumatic pulmonary valve insufficiency patient's noncompliance with dietary regimen hypo-osmolality and hyponatremia nonrheumatic pulmonary valve insufficiency long term (current) use of anticoagulants unspecified atrial fibrillation
white m 47 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  193  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; allopurinol  150  mg ; amiodarone  200  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; atorvastatin  40  mg ; digoxin  0.125  mg ; docusate sodium  100  mg ; loratadine  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; polyethylene glycol  17  g ; ciprofloxacin 0.3% ophth soln  4  drop ; rivaroxaban  15  mg ; insulin  88  unit ; 
neuromuscular dysfunction of bladder, unspecified gout, unspecified personal history of other infectious and parasitic diseases body mass index (bmi) 40.0-44.9, adult long term (current) use of insulin acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation obesity, unspecified other specified cardiac arrhythmias gastroparesis diagnostic and monitoring cardiovascular devices associated with adverse incidents nonrheumatic pulmonary valve insufficiency acute kidney failure, unspecified personal history of (corrected) congenital malformations of heart and circulatory system thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy anemia in other chronic diseases classified elsewhere obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified schizoaffective disorder, unspecified other symptoms and signs involving cognitive functions and awareness hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma obesity, unspecified neuromuscular dysfunction of bladder, unspecified acute kidney failure, unspecified other specified anemias chronic obstructive pulmonary disease, unspecified hypo-osmolality and hyponatremia presence of automatic (implantable) cardiac defibrillator type 2 diabetes mellitus with hyperglycemia gastroparesis acute on chronic systolic (congestive) heart failure body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy obstructive sleep apnea (adult) (pediatric) post-traumatic stress disorder, unspecified gout, unspecified unspecified atrial fibrillation other specified mental disorders due to known physiological condition nonrheumatic pulmonary valve insufficiency patient's noncompliance with dietary regimen hypo-osmolality and hyponatremia nonrheumatic pulmonary valve insufficiency long term (current) use of anticoagulants unspecified atrial fibrillation
white m 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; allopurinol  150  mg ; amiodarone  200  mg ; ascorbic acid  500  mg ; aspirin  325  mg ; atorvastatin  40  mg ; digoxin  0.125  mg ; docusate sodium  100  mg ; loratadine  10  mg ; magnesium oxide  400  mg ; metoprolol succinate xl  25  mg ; polyethylene glycol  17  g ; ciprofloxacin 0.3% ophth soln  4  drop ; rivaroxaban  15  mg ; insulin  88  unit ; 
neuromuscular dysfunction of bladder, unspecified gout, unspecified personal history of other infectious and parasitic diseases body mass index (bmi) 40.0-44.9, adult long term (current) use of insulin acute on chronic diastolic (congestive) heart failure unspecified atrial fibrillation obesity, unspecified other specified cardiac arrhythmias gastroparesis diagnostic and monitoring cardiovascular devices associated with adverse incidents nonrheumatic pulmonary valve insufficiency acute kidney failure, unspecified personal history of (corrected) congenital malformations of heart and circulatory system thrombosis due to cardiac prosthetic devices, implants and grafts, initial encounter type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy anemia in other chronic diseases classified elsewhere obstructive sleep apnea (adult) (pediatric) chronic obstructive pulmonary disease, unspecified schizoaffective disorder, unspecified other symptoms and signs involving cognitive functions and awareness hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease chronic kidney disease, unspecified unspecified viral hepatitis c without hepatic coma obesity, unspecified neuromuscular dysfunction of bladder, unspecified acute kidney failure, unspecified other specified anemias chronic obstructive pulmonary disease, unspecified hypo-osmolality and hyponatremia presence of automatic (implantable) cardiac defibrillator type 2 diabetes mellitus with hyperglycemia gastroparesis acute on chronic systolic (congestive) heart failure body mass index (bmi) 45.0-49.9, adult long term (current) use of insulin type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy obstructive sleep apnea (adult) (pediatric) post-traumatic stress disorder, unspecified gout, unspecified unspecified atrial fibrillation other specified mental disorders due to known physiological condition nonrheumatic pulmonary valve insufficiency patient's noncompliance with dietary regimen hypo-osmolality and hyponatremia nonrheumatic pulmonary valve insufficiency long term (current) use of anticoagulants unspecified atrial fibrillation
black african american f 26 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  378  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  163  iu l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  3.4  mmol l; hematology urine glucose  1000  mg dl; hematology urine bilirubin  neg  mg dl$nan
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  7  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  233  mg dl; chemistry blood glucose  193  mg dl; chemistry blood glucose  122  mg dl; chemistry blood % hemoglobin a1c  10.9  %$sodium chloride 0.9%  flush  3  ml ; potassium chl 40 meq   1000 ml ns  1000  ml ; zolpidem tartrate  10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; pantoprazole  40  mg ; insulin  0  unit ; ondansetron  4  mg ; insulin  15  unit ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; insulin  31  unit ; aspirin  81  mg ; 0.9% sodium chloride  1000  ml ; insulin  26  unit ; insulin  2  unit ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; lorazepam  1  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; promethazine  6.25  mg ; oxycodone-acetaminophen  1-2  tab ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  33.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  69  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; insulin  0  unit ; ondansetron  4  mg ; insulin  15  unit ; insulin  31  unit ; aspirin  81  mg ; 0.9% sodium chloride  1000  ml ; insulin  26  unit ; insulin  2  unit ; lorazepam  0.5  mg ; zolpidem tartrate  5  mg ; lorazepam  1  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; dextrose 50%  12.5  gm ; promethazine  6.25  mg ; oxycodone-acetaminophen  1-2  tab ; dextrose 50%  25  gm ; citalopram hydrobromide  10  mg ; acetaminophen  500-1000  mg ; acetaminophen  650  mg ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; aspirin  81  mg ; zolpidem tartrate  5  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; promethazine  6.25  mg ; dextrose 50%  25  gm ; citalopram hydrobromide  10  mg ; acetaminophen  500-1000  mg ; acetaminophen  650  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; potassium phosphate  15  mmol ; hydromorphone (dilaudid)  0.5  mg ; metoclopramide  10  mg ; insulin  8  unit ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  197  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; aspirin  81  mg ; zolpidem tartrate  5  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; promethazine  6.25  mg ; dextrose 50%  25  gm ; citalopram hydrobromide  10  mg ; acetaminophen  500-1000  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; potassium phosphate  15  mmol ; hydromorphone (dilaudid)  0.5  mg ; metoclopramide  10  mg ; insulin  8  unit ; lidocaine 5% patch  1  ptch ; acetaminophen  325-650  mg ; insulin  16  unit ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  184  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aspirin  81  mg ; zolpidem tartrate  5  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; promethazine  6.25  mg ; citalopram hydrobromide  10  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; lidocaine 5% patch  1  ptch ; acetaminophen  325-650  mg ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
black african american f 26 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.4  g dl; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  288  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; aspirin  81  mg ; zolpidem tartrate  5  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; promethazine  6.25  mg ; citalopram hydrobromide  10  mg ; dextromethorphan-guaifenesin (sugar free)  5-10  ml ; lidocaine 5% patch  1  ptch ; acetaminophen  325-650  mg ; tramadol (ultram)  50  mg ; 
other chest pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled backache, unspecified other chronic pain nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hypovolemia dysthymic disorder diarrhea nausea with vomiting diabetes with renal manifestations, type i [juvenile type], uncontrolled long-term (current) use of insulin goiter, unspecified abdominal pain, periumbilic diarrhea long-term (current) use of insulin nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia goiter, unspecified diabetes with ketoacidosis, type i [juvenile type], uncontrolled other opiates and related narcotics causing adverse effects in therapeutic use diabetes with renal manifestations, type i [juvenile type], uncontrolled other specified pruritic conditions panic disorder without agoraphobia genital herpes, unspecified nausea with vomiting dysthymic disorder diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified noninfectious gastroenteritis and colitis dehydration nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere other and unspecified hyperlipidemia other and unspecified hyperlipidemia nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere hyposmolality and/or hyponatremia dysthymic disorder goiter, unspecified unspecified essential hypertension long-term (current) use of insulin panic disorder without agoraphobia genital herpes, unspecified intestinal infection due to other organism, not elsewhere classified diabetes with renal manifestations, type i [juvenile type], uncontrolled intestinal infection due to other organism, not elsewhere classified other chronic pain diabetes with ketoacidosis, type i [juvenile type], uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere lumbago unspecified essential hypertension
white f 62 $temp  97.8  heartrate  73.0  resprate  18.0  o2sat  100.0  sbp  130.0  dbp  57.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  20.0  o2sat  93.0  sbp  120.0  dbp  62.0  rhythm    pain  asleep   ; temp    heartrate  71.0  resprate    o2sat  99.0  sbp  132.0  dbp  72.0  rhythm    pain  asleep  ; temp    heartrate  81.0  resprate    o2sat    sbp  85.0  dbp  55.0  rhythm    pain    $hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  110  mg dl$nan
 
hispanic latino f 31 $nan$nan$ketorolac  15  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; scopolamine patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; 

hispanic latino f 31 $nan$nan$ketorolac  15  mg ; iso-osmotic dextrose  100  ml ; cefazolin  2  g ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; acetaminophen iv  1000  mg ; scopolamine patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; acetaminophen (liquid)  650  mg ; gabapentin  300  mg ; simethicone  40-80  mg ; 

hispanic latino f 31 $nan$nan$ketorolac  15  mg ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; ondansetron  4  mg ; prochlorperazine  10  mg ; scopolamine patch  1  ptch ; albuterol 0.083% neb soln  1  neb ; acetaminophen (liquid)  650  mg ; gabapentin  300  mg ; simethicone  40-80  mg ; 

white f 55 $nan$hematology blood hematocrit  32.5  %; hematology blood hematocrit  31.3  %; hematology blood hematocrit  28.3  %$lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; acetaminophen iv  1000  mg ; lorazepam  0.5-2  mg ; ondansetron  4-8  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; diphenhydramine  25  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; 
 
white f 55 $nan$hematology blood hematocrit  31.8  %; hematology blood hematocrit  28.3  %$lactated ringers  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen iv  1000  mg ; lorazepam  0.5-2  mg ; ondansetron  4-8  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; chloraseptic throat spray  1  spry ; 5% dextrose  100  ml ; naloxone  2  mg ; hydromorphone (dilaudid)  0.25  mg ; venlafaxine  75  mg ; bupropion  100  mg ; losartan potassium  50  mg ; acetaminophen (liquid)  650  mg ; oxycodone liquid  5-10  mg ; 
 
white f 55 $nan$nan$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ondansetron  4-8  mg ; chloraseptic throat spray  1  spry ; venlafaxine  75  mg ; bupropion  100  mg ; losartan potassium  50  mg ; lorazepam  1-2  mg ; hydromorphone (dilaudid)  2-6  mg ; docusate sodium (liquid)  100  mg ; trazodone  100  mg ; 
 
white f 55 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  242  k ul$iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; ondansetron  4-8  mg ; chloraseptic throat spray  1  spry ; venlafaxine  75  mg ; bupropion  100  mg ; losartan potassium  50  mg ; lorazepam  1-2  mg ; docusate sodium (liquid)  100  mg ; trazodone  100  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  7  mg ; acetaminophen (liquid)  1000  mg ; gabapentin  300  mg ; 
 
white f 37 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  224  k ul; chemistry blood creatinine  0.6  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  0.9  $nan
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
white f 37 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  273  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  0.9  ; chemistry urine creatinine, urine  95  mg dl; hematology urine wbc  63  # hpf; chemistry urine protein creatinine ratio  0.4  mg mg$nan
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; sw  500  ml ; magnesium sulfate (ob)  20  gm ; levothyroxine sodium  125  mcg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
white f 37 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; levothyroxine sodium  125  mcg ; nifedipine cr  30  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
white f 37 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  314  k ul; chemistry blood creatinine  0.5  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry urine creatinine, urine  29  mg dl; chemistry urine protein creatinine ratio  0.3  mg mg$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; levothyroxine sodium  125  mcg ; nifedipine cr  30  mg ; 
diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled threatened premature labor, antepartum condition or complication diabetes mellitus of mother, complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication transient hypertension of pregnancy, antepartum condition or complication other and unspecified hyperlipidemia hemorrhage complicating a procedure other chronic nonalcoholic liver disease other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation morbid obesity asthma, unspecified type, unspecified unspecified acquired hypothyroidism unspecified vitamin d deficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled body mass index 45.0-49.9, adult
other m 34 $temp  98.2  heartrate  112.0  resprate  22.0  o2sat  98.0  sbp  120.0  dbp  83.0  rhythm    pain  0  $hematology blood hematocrit  55.8  %; hematology blood hematocrit  54.7  %; hematology blood hemoglobin  18.9  g dl; hematology blood hemoglobin  18.5  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  154  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  56  mg dl; chemistry urine creatinine, urine  58  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  240  iu l; chemistry blood albumin  3.2  g dl; chemistry urine protein creatinine ratio  1.6  mg mg; chemistry urine protein creatinine ratio  1.6  mg mg; hematology blood hemoglobin c  0  %; hematology blood hemoglobin a2  2.7  %; hematology blood hemoglobin f  0  %$acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; acetaminophen iv  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; heparin  5000  unit ; carvedilol  6.25  mg ; furosemide  40  mg ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; lisinopril  2.5  mg ; acetaminophen  1000  mg ; 
 
other m 34 $nan$hematology blood hematocrit  55.2  %; hematology blood hemoglobin  18.6  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  89  mg dl; hematology blood bands  5  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; lisinopril  2.5  mg ; acetaminophen  1000  mg ; torsemide  20  mg ; magnesium oxide  400  mg ; 
 
other m 34 $nan$hematology blood hematocrit  58.4  %; hematology blood hemoglobin  19.4  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; torsemide  20  mg ; magnesium oxide  400  mg ; lisinopril  5  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
other m 34 $nan$hematology blood hematocrit  58.4  %; hematology blood hemoglobin  19.4  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood glucose  91  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; torsemide  20  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; lisinopril  10  mg ; aspirin  81  mg ; 
 
other m 34 $nan$hematology blood hematocrit  60.3  %; hematology blood hemoglobin  20.0  g dl; hematology blood platelet count  202  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood glucose  83  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ipratropium-albuterol neb  1  neb ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; torsemide  10  mg ; lisinopril  30  mg ; 
 
other m 34 $nan$hematology blood hematocrit  59.6  %; hematology blood hemoglobin  19.8  g dl; hematology blood platelet count  210  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood glucose  80  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; torsemide  10  mg ; metoprolol succinate xl  12.5  mg ; 
 
other m 34 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood glucose  87  mg dl; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  4.9  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; torsemide  10  mg ; metoprolol succinate xl  12.5  mg ; digoxin  0.125  mg ; 
 
other m 34 $nan$hematology blood hematocrit  60.0  %; hematology blood hemoglobin  20.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  109  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; digoxin  0.125  mg ; fluticasone propionate nasal  1  spry ; 
 
other m 34 $nan$hematology blood hematocrit  58.8  %; hematology blood hemoglobin  19.5  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; spironolactone  12.5  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; fluticasone propionate nasal  1  spry ; sodium polystyrene sulfonate  30  gm ; 
 
other m 34 $nan$hematology blood hematocrit  58.1  %; hematology blood hemoglobin  19.2  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  85  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; fluticasone propionate nasal  1  spry ; sodium polystyrene sulfonate  30  gm ; carbamide peroxide 6.5%  5-10  drop ; 
 
other m 34 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  6.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  47  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  88  mg dl; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  5.4  meq l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; fluticasone propionate nasal  1  spry ; carbamide peroxide 6.5%  5-10  drop ; 
 
other m 34 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; allopurinol  300  mg ; allopurinol  200  mg ; colchicine  0.6  mg ; acetaminophen  1000  mg ; lidocaine jelly 2% (glydo)  1  appl ; aspirin  81  mg ; metoprolol succinate xl  12.5  mg ; fluticasone propionate nasal  1  spry ; carbamide peroxide 6.5%  5-10  drop ; 
 
unknown m 24 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  5.8  mg dl; chemistry blood glucose  192  mg dl; blood gas blood free calcium  0.77  mmol l; blood gas blood lactate  6.5  mmol l$insulin  0  unit ; lr  1000  ml ; influenza virus vaccine  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; soln.  250  ml ; mannitol 20 %  50  g ; isotonic sodium chloride  50  ml ; gentamicin  80  mg ; sodium chloride  120  meq ; syringe  30  ml ; sodium chloride   120  meq ; sodium chloride 0.9%  flush  10  ml ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; sterile water  50-100  ml ; potassium chloride  20-40  meq ; sterile water  100-150  ml ; potassium chloride  40-60  meq ; sterile water  150  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; 5% dextrose  250  ml ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1000  ml ; norepinephrine  8  mg ; 
 
white f 40 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; d5lr  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; 
 
white f 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)  5  mg ; 
 
unknown m 91 $temp  99.8  heartrate  74.0  resprate  14.0  o2sat  99.0  sbp  113.0  dbp  55.0  rhythm    pain  u  $hematology blood hematocrit  28.6  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  565  k ul; hematology blood platelet count  531  k ul; chemistry blood anion gap  20  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  92  mg dl; hematology blood inr(pt)  4.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  269  mg dl; chemistry blood glucose  299  mg dl; chemistry blood lactate dehydrogenase (ld)  228  iu l; chemistry blood albumin  3.1  g dl; blood gas blood free calcium  1.28  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood lactate  3.0  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  2.4  mmol l; blood gas blood lactate  2.1  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; hydrocortisone cream 2.5%  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; tobramycin-dexamethasone ophth oint  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyanocobalamin  1000  mcg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  0  unit ; 5% dextrose  100  ml ; vasopressin  40  unit ; sodium chloride 0.9%  1000  ml ; insulin  10  unit ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  540  mg ; 
 
unknown m 91 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  472  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  77  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  157  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; lactated ringers  1000  ml ; hydrocortisone cream 2.5%  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; tobramycin-dexamethasone ophth oint  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; aspirin  81  mg ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyanocobalamin  1000  mcg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 5% dextrose  100  ml ; vasopressin  40  unit ; sodium chloride 0.9%  1000  ml ; insulin  10  unit ; 0.9% sodium chloride  100  ml ; tobramycin sulfate  540  mg ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
 
unknown m 91 $nan$hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  409  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  71  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  262  mg dl$sterile water  150  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydrocortisone cream 2.5%  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; tobramycin-dexamethasone ophth oint  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyanocobalamin  1000  mcg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; insulin  10  unit ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; furosemide  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; insulin  22  unit ; 
 
unknown m 91 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  393  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  236  mg dl; chemistry blood glucose  228  mg dl; chemistry blood lactate dehydrogenase (ld)  156  iu l$sterile water  150  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydrocortisone cream 2.5%  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; tobramycin-dexamethasone ophth oint  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyanocobalamin  1000  mcg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; furosemide  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; insulin  22  unit ; linezolid  600  mg ; 
 
unknown m 91 $nan$nan$sterile water  150  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; hydrocortisone cream 2.5%  1  appl ; latanoprost 0.005% ophth. soln.  1  drop ; tobramycin-dexamethasone ophth oint  1  appl ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; levothyroxine sodium  100  mcg ; levothyroxine sodium  75  mcg ; ranitidine  150  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; cyanocobalamin  1000  mcg ; albuterol 0.083% neb soln  1  neb ; miconazole powder 2%  1  appl ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; furosemide  40  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; insulin  22  unit ; linezolid  600  mg ; 
 
white m 57 $nan$hematology blood hematocrit  29.2  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  90  mg dl$vancomycin  1000  mg ; 1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; flucytosine  1500  mg ; flucytosine  1000  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; nystatin oral suspension  5  ml ; flucytosine  2000  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  1  gm ; diphenhydramine  50  mg ; hydrocortisone na succ.  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; d5w  125  ml ; ambisome  500  mg ; iso-osmotic dextrose  200  ml ; valacyclovir  1  g ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; 
 
white m 57 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  129  mg dl$vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; nystatin oral suspension  5  ml ; flucytosine  2000  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  1  gm ; diphenhydramine  50  mg ; hydrocortisone na succ.  100  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; d5w  125  ml ; ambisome  500  mg ; iso-osmotic dextrose  200  ml ; prochlorperazine  10  mg ; lorazepam  0.5-1  mg ; azithromycin  1200  mg ; ferrous sulfate  325  mg ; lidocaine 1%  1  ml ; morphine sulfate  2  mg ; 
 
white m 57 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  115  mg dl$vancomycin  1000  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; nystatin oral suspension  5  ml ; flucytosine  2000  mg ; ns (mini bag plus)  100  ml ; ampicillin sodium  1  gm ; iso-osmotic dextrose  50  ml ; ceftriaxone  2  gm ; d5w  125  ml ; ambisome  500  mg ; iso-osmotic dextrose  200  ml ; ferrous sulfate  325  mg ; lidocaine 1%  1  ml ; morphine sulfate  2  mg ; potassium chloride  40  meq ; oxycodone-acetaminophen  1-2  tab ; 
 
white m 57 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  122  mg dl; hematology blood wbc count  7.3  k ul$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; d5w  125  ml ; ambisome  500  mg ; potassium chloride  40  meq ; oxycodone-acetaminophen  1-2  tab ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   10  mg ; ns  500  ml ; d5w  250  ml ; ketoconazole 2%   1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   10  mg ; ns  500  ml ; d5w  250  ml ; ketoconazole 2%   1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 57 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 57 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  236  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; magnesium sulfate  2  gm ; 
 
white m 57 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; magnesium sulfate  2  gm ; 
 
white m 57 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
 
white m 57 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  313  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry urine creatinine, urine  32  mg dl; chemistry urine potassium, urine  20  meq l; chemistry urine sodium, urine  72  meq l; chemistry urine urea nitrogen, urine  203  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  175  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; sulfameth trimethoprim ds  1  tab ; pantoprazole  40  mg ; flucytosine  2000  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  25.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  112  mg dl$sw  50  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  117  mg dl$sw  50  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; 
 
white m 57 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; magnesium oxide  400  mg ; 
 
white m 57 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry urine creatinine, urine  53  mg dl; chemistry urine sodium, urine  84  meq l; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; magnesium oxide  400  mg ; 
 
white m 57 $nan$hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; 
 
white m 57 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; lorazepam  1  mg ; 
 
white m 57 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  160  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; d5w  250  ml ; ketoconazole 2%   1  appl ; diphenhydramine  25  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; lorazepam  1  mg ; fluconazole  400  mg ; 
 
white m 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; senna  1  tab ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; pantoprazole  40  mg ; oxycodone (immediate release)   10  mg ; sarna lotion  1  appl ; atovaquone suspension  1500  mg ; valacyclovir  500  mg ; fluconazole  400  mg ; 
 
white f 75 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  39  mg dl; hematology urine wbc  6-10  # hpf; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  272  iu l; chemistry blood albumin  3.8  g dl; blood gas blood lactate  1.2  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; hematology urine calcium oxalate crystals  rare  $nan
 
white f 75 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry urine creatinine, urine  104  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  105  mg dl; chemistry blood lactate dehydrogenase (ld)  241  iu l; chemistry urine protein creatinine ratio  0.6  ratio; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  1000  mg ; metoprolol tartrate  50  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  20  mg ; amlodipine  10  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; atenolol  50  mg ; furosemide  20  mg ; candesartan  32  mg ; tuberculin protein  0.1  ml ; calcium carbonate  1500  mg ; 
 
white f 75 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  1000  mg ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  20  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; atenolol  50  mg ; candesartan  32  mg ; tuberculin protein  0.1  ml ; calcium carbonate  1500  mg ; 
 
white f 75 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  20  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; atenolol  50  mg ; candesartan  32  mg ; calcium carbonate  1500  mg ; 
 
white f 75 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  184  k ul; hematology blood platelet count  204  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; aspirin  325  mg ; atorvastatin  20  mg ; ascorbic acid  1000  mg ; multivitamins  1  tab ; atenolol  50  mg ; candesartan  32  mg ; calcium carbonate  1500  mg ; 
 
white f 66 $nan$nan$baclofen  10  mg ; levothyroxine sodium  125  mcg ; duloxetine  20  mg ; omeprazole  40  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; 5% dextrose  100  ml ; cefazolin  2  g ; atorvastatin  40  mg ; estradiol  0.5  mg ; vitamin d  400  unit ; bisacodyl  10  mg ; calcium carbonate  500  mg ; multivitamins  1  tab ; hydromorphone (dilaudid)  0.2-0.6  mg ; oxycodone (immediate release)   5-10  mg ; artificial tears preserv. free  1-2  drop ; hydromorphone (dilaudid)  20  mg ; senna  8.6  mg ; rasagiline  1  mg ; 
 
white f 66 $nan$nan$baclofen  10  mg ; levothyroxine sodium  125  mcg ; duloxetine  20  mg ; omeprazole  40  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; acetaminophen  325-650  mg ; 5% dextrose  100  ml ; cefazolin  2  g ; atorvastatin  40  mg ; estradiol  0.5  mg ; vitamin d  400  unit ; bisacodyl  10  mg ; calcium carbonate  500  mg ; multivitamins  1  tab ; hydromorphone (dilaudid)  0.2-0.6  mg ; oxycodone (immediate release)   5-10  mg ; artificial tears preserv. free  1-2  drop ; hydromorphone (dilaudid)  20  mg ; senna  8.6  mg ; rasagiline  1  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; 
 
white f 66 $nan$nan$baclofen  10  mg ; levothyroxine sodium  125  mcg ; duloxetine  20  mg ; omeprazole  40  mg ; docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; atorvastatin  40  mg ; estradiol  0.5  mg ; vitamin d  400  unit ; bisacodyl  10  mg ; calcium carbonate  500  mg ; multivitamins  1  tab ; hydromorphone (dilaudid)  0.2-0.6  mg ; oxycodone (immediate release)   5-10  mg ; artificial tears preserv. free  1-2  drop ; rasagiline  1  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; methylnaltrexone  8  mg ; 
 
white f 66 $nan$nan$baclofen  10  mg ; levothyroxine sodium  125  mcg ; duloxetine  20  mg ; omeprazole  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; atorvastatin  40  mg ; estradiol  0.5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; rasagiline  1  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; methylnaltrexone  8  mg ; 
 
white f 66 $nan$nan$baclofen  10  mg ; levothyroxine sodium  125  mcg ; duloxetine  20  mg ; omeprazole  40  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; atorvastatin  40  mg ; estradiol  0.5  mg ; vitamin d  400  unit ; calcium carbonate  500  mg ; multivitamins  1  tab ; rasagiline  1  mg ; hydromorphone (dilaudid)  2  mg ; acetaminophen  650  mg ; polyethylene glycol  17  g ; methylnaltrexone  8  mg ; 
 
white f 32 $temp  98.4  heartrate  111.0  resprate  20.0  o2sat  100.0  sbp  136.0  dbp  101.0  rhythm    pain  2  ; temp  97.9  heartrate  68.0  resprate  16.0  o2sat  100.0  sbp  121.0  dbp  77.0  rhythm    pain  5  ; temp    heartrate  76.0  resprate  16.0  o2sat  100.0  sbp  123.0  dbp  85.0  rhythm    pain    $hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  84  mg dl$nan
 
white f 32 $temp  98.0  heartrate  72.0  resprate  16.0  o2sat  100.0  sbp  112.0  dbp  64.0  rhythm    pain  0  $nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
 
white m 62 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; fluoxetine  40  mg ; omeprazole  40  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; multivitamins  1  tab ; fluocinonide 0.05% cream  1  appl ; metronidazole topical 1 % gel  1  appl ; lorazepam  1  mg ; trazodone  100  mg ; 
suicidal ideation depressive disorder, not elsewhere classified other acute postoperative pain infection and inflammatory reaction due to other internal prosthetic device, implant, and graft infected postoperative seroma esophageal reflux gout, unspecified cellulitis and abscess of trunk other postoperative infection unspecified essential hypertension asthma, unspecified type, unspecified infected postoperative seroma esophageal reflux insomnia, unspecified restless legs syndrome (rls) asthma, unspecified type, unspecified gout, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b primary open angle glaucoma abdominal pain, right upper quadrant accidents occurring in unspecified place methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site glaucoma stage, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation peritoneal abscess unspecified essential hypertension nausea alone impotence of organic origin unspecified essential hypertension paralytic ileus obstructive sleep apnea (adult)(pediatric) body mass index 29.0-29.9, adult disorder of bone and cartilage, unspecified insomnia, unspecified lumbago esophageal reflux obesity, unspecified other acute postoperative pain person on outside of bus injured in collision with pedestrian or animal in traffic accident incisional ventral hernia with obstruction examination of participant in clinical trial other chronic pain gout, unspecified asthma, unspecified type, unspecified unspecified essential hypertension blood in stool other ventral hernia without mention of obstruction or gangrene other specified intestinal obstruction
white m 62 $nan$chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; omeprazole  40  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; multivitamins  1  tab ; fluocinonide 0.05% cream  1  appl ; metronidazole topical 1 % gel  1  appl ; lorazepam  1  mg ; trazodone  100  mg ; diazepam  10  mg ; oxycodone (immediate release)   10  mg ; montelukast sodium  10  mg ; acyclovir  800  mg ; allopurinol  300  mg ; cyclosporine  1  vial ; celecoxib  200  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; duloxetine  30  mg ; 
suicidal ideation depressive disorder, not elsewhere classified other acute postoperative pain infection and inflammatory reaction due to other internal prosthetic device, implant, and graft infected postoperative seroma esophageal reflux gout, unspecified cellulitis and abscess of trunk other postoperative infection unspecified essential hypertension asthma, unspecified type, unspecified infected postoperative seroma esophageal reflux insomnia, unspecified restless legs syndrome (rls) asthma, unspecified type, unspecified gout, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b primary open angle glaucoma abdominal pain, right upper quadrant accidents occurring in unspecified place methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site glaucoma stage, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation peritoneal abscess unspecified essential hypertension nausea alone impotence of organic origin unspecified essential hypertension paralytic ileus obstructive sleep apnea (adult)(pediatric) body mass index 29.0-29.9, adult disorder of bone and cartilage, unspecified insomnia, unspecified lumbago esophageal reflux obesity, unspecified other acute postoperative pain person on outside of bus injured in collision with pedestrian or animal in traffic accident incisional ventral hernia with obstruction examination of participant in clinical trial other chronic pain gout, unspecified asthma, unspecified type, unspecified unspecified essential hypertension blood in stool other ventral hernia without mention of obstruction or gangrene other specified intestinal obstruction
white m 62 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; omeprazole  40  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; multivitamins  1  tab ; fluocinonide 0.05% cream  1  appl ; metronidazole topical 1 % gel  1  appl ; lorazepam  1  mg ; trazodone  100  mg ; diazepam  10  mg ; oxycodone (immediate release)   10  mg ; montelukast sodium  10  mg ; acyclovir  800  mg ; allopurinol  300  mg ; cyclosporine  1  vial ; celecoxib  200  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; duloxetine  30  mg ; 
suicidal ideation depressive disorder, not elsewhere classified other acute postoperative pain infection and inflammatory reaction due to other internal prosthetic device, implant, and graft infected postoperative seroma esophageal reflux gout, unspecified cellulitis and abscess of trunk other postoperative infection unspecified essential hypertension asthma, unspecified type, unspecified infected postoperative seroma esophageal reflux insomnia, unspecified restless legs syndrome (rls) asthma, unspecified type, unspecified gout, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b primary open angle glaucoma abdominal pain, right upper quadrant accidents occurring in unspecified place methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site glaucoma stage, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation peritoneal abscess unspecified essential hypertension nausea alone impotence of organic origin unspecified essential hypertension paralytic ileus obstructive sleep apnea (adult)(pediatric) body mass index 29.0-29.9, adult disorder of bone and cartilage, unspecified insomnia, unspecified lumbago esophageal reflux obesity, unspecified other acute postoperative pain person on outside of bus injured in collision with pedestrian or animal in traffic accident incisional ventral hernia with obstruction examination of participant in clinical trial other chronic pain gout, unspecified asthma, unspecified type, unspecified unspecified essential hypertension blood in stool other ventral hernia without mention of obstruction or gangrene other specified intestinal obstruction
white m 62 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; omeprazole  40  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; multivitamins  1  tab ; fluocinonide 0.05% cream  1  appl ; metronidazole topical 1 % gel  1  appl ; lorazepam  1  mg ; trazodone  100  mg ; diazepam  10  mg ; oxycodone (immediate release)   10  mg ; montelukast sodium  10  mg ; acyclovir  800  mg ; allopurinol  300  mg ; cyclosporine  1  vial ; celecoxib  200  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; duloxetine  30  mg ; 
suicidal ideation depressive disorder, not elsewhere classified other acute postoperative pain infection and inflammatory reaction due to other internal prosthetic device, implant, and graft infected postoperative seroma esophageal reflux gout, unspecified cellulitis and abscess of trunk other postoperative infection unspecified essential hypertension asthma, unspecified type, unspecified infected postoperative seroma esophageal reflux insomnia, unspecified restless legs syndrome (rls) asthma, unspecified type, unspecified gout, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b primary open angle glaucoma abdominal pain, right upper quadrant accidents occurring in unspecified place methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site glaucoma stage, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation peritoneal abscess unspecified essential hypertension nausea alone impotence of organic origin unspecified essential hypertension paralytic ileus obstructive sleep apnea (adult)(pediatric) body mass index 29.0-29.9, adult disorder of bone and cartilage, unspecified insomnia, unspecified lumbago esophageal reflux obesity, unspecified other acute postoperative pain person on outside of bus injured in collision with pedestrian or animal in traffic accident incisional ventral hernia with obstruction examination of participant in clinical trial other chronic pain gout, unspecified asthma, unspecified type, unspecified unspecified essential hypertension blood in stool other ventral hernia without mention of obstruction or gangrene other specified intestinal obstruction
white m 62 $nan$nan$acetaminophen  650  mg ; milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; albuterol inhaler  2  puff ; brimonidine tartrate 0.15% ophth.  1  drop ; omeprazole  40  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; multivitamins  1  tab ; fluocinonide 0.05% cream  1  appl ; metronidazole topical 1 % gel  1  appl ; lorazepam  1  mg ; trazodone  100  mg ; diazepam  10  mg ; oxycodone (immediate release)   10  mg ; montelukast sodium  10  mg ; acyclovir  800  mg ; allopurinol  300  mg ; cyclosporine  1  vial ; celecoxib  200  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; duloxetine  30  mg ; duloxetine  40  mg ; 
suicidal ideation depressive disorder, not elsewhere classified other acute postoperative pain infection and inflammatory reaction due to other internal prosthetic device, implant, and graft infected postoperative seroma esophageal reflux gout, unspecified cellulitis and abscess of trunk other postoperative infection unspecified essential hypertension asthma, unspecified type, unspecified infected postoperative seroma esophageal reflux insomnia, unspecified restless legs syndrome (rls) asthma, unspecified type, unspecified gout, unspecified streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group b primary open angle glaucoma abdominal pain, right upper quadrant accidents occurring in unspecified place methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site glaucoma stage, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation peritoneal abscess unspecified essential hypertension nausea alone impotence of organic origin unspecified essential hypertension paralytic ileus obstructive sleep apnea (adult)(pediatric) body mass index 29.0-29.9, adult disorder of bone and cartilage, unspecified insomnia, unspecified lumbago esophageal reflux obesity, unspecified other acute postoperative pain person on outside of bus injured in collision with pedestrian or animal in traffic accident incisional ventral hernia with obstruction examination of participant in clinical trial other chronic pain gout, unspecified asthma, unspecified type, unspecified unspecified essential hypertension blood in stool other ventral hernia without mention of obstruction or gangrene other specified intestinal obstruction
white m 89 $temp    heartrate  81.0  resprate  16.0  o2sat  97.0  sbp  134.0  dbp  65.0  rhythm    pain  0  $hematology blood hematocrit  49.3  %; hematology blood hemoglobin  16.2  g dl; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  4.8  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  90  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.4  mg ; simvastatin  10  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; neutra-phos  2  pkt ; potassium chloride (powder)  20  meq ; 
other and unspecified hyperlipidemia thrombocytopenia, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified hydronephrosis unspecified essential hypertension atrial fibrillation 
white m 89 $nan$nan$sodium chloride 0.9%  flush  3  ml ; tamsulosin  0.4  mg ; simvastatin  10  mg ; metoprolol tartrate  50  mg ; amlodipine  10  mg ; senna  8.6  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; neutra-phos  2  pkt ; potassium chloride (powder)  20  meq ; omeprazole  20  mg ; 
other and unspecified hyperlipidemia thrombocytopenia, unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) gout, unspecified hydronephrosis unspecified essential hypertension atrial fibrillation 
white m 84 $temp  98.2  heartrate  97.0  resprate  16.0  o2sat  98.0  sbp  101.0  dbp  62.0  rhythm    pain  0  ; temp  98.0  heartrate  97.0  resprate  18.0  o2sat  98.0  sbp  111.0  dbp  71.0  rhythm    pain  0  $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  133  mg dl; blood gas blood lactate  2.1  mmol l$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; simvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bupropion  150  mg ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white m 84 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; simvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bupropion  150  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; miconazole 2% cream  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white m 84 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; simvastatin  20  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bupropion  150  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; miconazole 2% cream  1  appl ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; furosemide  20  mg ; atorvastatin  80  mg ; lisinopril  5  mg ; potassium chloride  40  meq ; clopidogrel  300  mg ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; metoprolol tartrate  25  mg ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white m 84 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bupropion  150  mg ; miconazole 2% cream  1  appl ; atorvastatin  80  mg ; lisinopril  5  mg ; potassium chloride  40  meq ; clopidogrel  300  mg ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; clopidogrel  75  mg ; neutra-phos  1  pkt ; bag  100  ml ; magnesium sulfate  4  gm ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white m 84 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  116  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; bupropion  150  mg ; miconazole 2% cream  1  appl ; atorvastatin  80  mg ; lisinopril  5  mg ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; neutra-phos  1  pkt ; bag  100  ml ; magnesium sulfate  4  gm ; cefpodoxime proxetil  200  mg ; potassium chloride  60  meq ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white m 84 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; aspirin  81  mg ; ezetimibe  10  mg ; bupropion  150  mg ; miconazole 2% cream  1  appl ; atorvastatin  80  mg ; lisinopril  5  mg ; clopidogrel  75  mg ; cefpodoxime proxetil  200  mg ; potassium chloride  60  meq ; metoprolol succinate xl  100  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
other and unspecified hyperlipidemia urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use memory loss unspecified hearing loss mechanical complication due to urethral (indwelling) catheter urinary tract infection, site not specified urinary obstruction, unspecified unspecified essential hypertension need for prophylactic vaccination and inoculation against influenza malignant neoplasm of prostate accidents occurring in unspecified place other and unspecified hyperlipidemia unspecified essential hypertension home accidents other mechanical complication of genitourinary device, implant, and graft malignant neoplasm of prostate other nonspecific findings on examination of urine diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure osteoporosis, unspecified long-term (current) use of other medications retention of urine, unspecified personal history, urinary (tract) infection myoglobinuria injury to bladder and urethra, without mention of open wound into cavity malignant neoplasm of prostate urinary catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure unspecified accident other and unspecified hyperlipidemia toxic encephalopathy osteoporosis, unspecified gross hematuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled acute kidney failure, unspecified history of fall other specified retention of urine mechanical complication due to urethral (indwelling) catheter unspecified essential hypertension infection and inflammatory reaction due to indwelling urinary catheter urinary tract infection, site not specified rhabdomyolysis hyposmolality and/or hyponatremia mechanical complication due to urethral (indwelling) catheter hydronephrosis urinary tract infection, site not specified osteoporosis, unspecified
white f 40 $nan$hematology blood hematocrit  26.3  %; hematology blood hematocrit  27.0  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  22.8  %; hematology blood hematocrit  28.7  %; hematology blood hematocrit  26.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  239  k ul; hematology blood platelet count  138  k ul; hematology blood platelet count  140  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  71  mg dl; chemistry blood glucose  64  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  128  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  10.0  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  129  meq l$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; propofol  1000  mg ; lr  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; oxytocin  20  unit ; 0.9% sodium chloride  250  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; hydralazine  10  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetaminophen  650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; furosemide  10  mg ; oxycodone-acetaminophen  1-2  tab ; misoprostol  200  mcg ; furosemide  20  mg ; 
 
white f 40 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  127  mg dl$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; hydralazine  10  mg ; acetaminophen  650  mg ; sw  100  ml ; magnesium sulfate  4  gm ; furosemide  10  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; misoprostol  100  mcg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  400  mg ; 
 
white f 40 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; misoprostol  100  mcg ; 5% dextrose  50  ml ; clindamycin  900  mg ; 5% dextrose  250  ml ; gentamicin sulfate  400  mg ; 
 
white f 40 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; misoprostol  100  mcg ; 
 
white f 40 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; misoprostol  100  mcg ; 
 
white m 83 $temp  98.0  heartrate  81.0  resprate  18.0  o2sat  98.0  sbp  99.0  dbp  48.0  rhythm    pain  0  ; temp  97.9  heartrate  84.0  resprate    o2sat  94.0  sbp  106.0  dbp  44.0  rhythm    pain  0  $hematology blood hematocrit  22.3  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  145  k ul; hematology blood platelet count  169  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; warfarin  1  dose ; warfarin  4  mg ; pantoprazole  40  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  157  k ul; hematology blood platelet count  162  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  43  mg dl; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.0  ; chemistry urine creatinine, urine  49  mg dl; chemistry urine sodium, urine  32  meq l; chemistry urine urea nitrogen, urine  580  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  120  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; warfarin  1  dose ; warfarin  4  mg ; pantoprazole  40  mg ; furosemide  40  mg ; vial  1  vial ; potassium chloride  40  meq ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; warfarin  1  dose ; vial  1  vial ; potassium chloride  40  meq ; heparin  6400  unit ; heparin  1600-3200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; furosemide  120  mg ; potassium chloride  20  meq ; moviprep  1  l ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  85  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; warfarin  1  dose ; vial  1  vial ; moviprep  1  l ; 0.9% sodium chloride  500  ml ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  81  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; vial  1  vial ; furosemide  160  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  136  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; vial  1  vial ; furosemide  160  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; vial  1  vial ; potassium chloride  60  meq ; warfarin  5  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  22.7  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; warfarin  5  mg ; torsemide  100  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; torsemide  100  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; torsemide  60  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  145  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; torsemide  60  mg ; enoxaparin sodium  80  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
white m 83 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  1000  mg ; senna  17.2  mg ; allopurinol  150  mg ; aspirin  81  mg ; atorvastatin  80  mg ; latanoprost 0.005% ophth. soln.  1  drop ; tamsulosin  0.8  mg ; enoxaparin sodium  80  mg ; torsemide  40  mg ; 
gout, unspecified other pancytopenia acute kidney failure, unspecified stenosis of coronary artery stent, initial encounter ischemic cardiomyopathy monoclonal gammopathy presence of coronary angioplasty implant and graft other cardiomyopathies adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter other malaise unspecified b-cell lymphoma, unspecified site hypo-osmolality and hyponatremia atherosclerotic heart disease of native coronary artery without angina pectoris left bundle-branch block, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hyperlipidemia, unspecified acute on chronic systolic (congestive) heart failure deficiency of other specified b group vitamins pleural effusion in other conditions classified elsewhere presence of other heart-valve replacement presence of other cardiac implants and grafts chronic kidney disease, unspecified long term (current) use of anticoagulants cachexia body mass index (bmi) 26.0-26.9, adult pulmonary hypertension, unspecified end stage heart failure benign prostatic hyperplasia without lower urinary tract symptoms presence of aortocoronary bypass graft unspecified severe protein-calorie malnutrition prosthetic and other implants, materials and accessory cardiovascular devices associated with adverse incidents chronic atrial fibrillation hypotension due to drugs supraventricular tachycardia ventricular tachycardia other specified polyneuropathies rheumatic disorders of both mitral and tricuspid valves long term (current) use of anticoagulants acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure chronic atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure monoclonal gammopathy bradycardia, unspecified presence of aortocoronary bypass graft unspecified b-cell lymphoma, unspecified site other pancytopenia postprocedural hematoma of skin and subcutaneous tissue following other procedure adverse effect of beta-adrenoreceptor antagonists, initial encounter
black african american m 75 $temp  97.5  heartrate  46.0  resprate  16.0  o2sat  100.0  sbp  134.0  dbp  47.0  rhythm    pain  0  ; temp  97.5  heartrate  46.0  resprate  18.0  o2sat  100.0  sbp  151.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  45.0  resprate  16.0  o2sat  100.0  sbp  151.0  dbp  55.0  rhythm    pain  0  $hematology blood hematocrit  22.6  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  132  k ul; hematology blood platelet count  135  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  6.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; glucose gel  15  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
black african american m 75 $nan$hematology blood hematocrit  21.6  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  7.0  mg dl; chemistry blood creatinine  7.9  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  7.0  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  61  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood glucose  76  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; sodium chloride 0.9%  1000  ml ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; glucose gel  15  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
black african american m 75 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  128  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
black african american m 75 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  6.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
black african american m 75 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  8.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  50  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  150  mg dl$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; losartan potassium  25  mg ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
black african american m 75 $nan$nan$sodium chloride 0.9%  flush  3  ml ; atorvastatin  20  mg ; clobetasol propionate 0.05% ointment  1  appl ; docusate sodium  100  mg ; gabapentin  300  mg ; isosorbide mononitrate (extended release)  30  mg ; nephrocaps  1  cap ; oxycodone (immediate release)  5  mg ; polyethylene glycol  17  g ; sevelamer carbonate  800  mg ; lidocaine 1%  1  ml ; esomeprazole sodium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; losartan potassium  25  mg ; 
anemia, unspecified unspecified atrial fibrillation unspecified hemorrhoids personal history of malignant neoplasm of prostate personal history of other diseases of the digestive system long term (current) use of anticoagulants dependence on renal dialysis end stage renal disease unspecified systolic (congestive) heart failure constipation, unspecified personal history of nicotine dependence hyperkalemia residual hemorrhoidal skin tags hemorrhage of anus and rectum atherosclerotic heart disease of native coronary artery without angina pectoris gout, unspecified hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease hemorrhage of anus and rectum long term (current) use of anticoagulants unspecified atrial fibrillation end stage renal disease dependence on renal dialysis gout, unspecified unspecified atrial fibrillation hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease atherosclerotic heart disease of native coronary artery without angina pectoris long term (current) use of anticoagulants dependence on renal dialysis old myocardial infarction residual hemorrhoidal skin tags end stage renal disease gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence hyperkalemia eosinophilia unspecified systolic (congestive) heart failure personal history of malignant neoplasm of prostate melena anemia in chronic kidney disease end stage renal disease unspecified contact dermatitis due to other chemical products anemia in chronic kidney disease personal history of nicotine dependence chronic combined systolic (congestive) and diastolic (congestive) heart failure personal history of malignant neoplasm of prostate gastro-esophageal reflux disease without esophagitis hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
white m 86 $nan$nan$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; 
 
white m 86 $nan$nan$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; tramadol (ultram)  25  mg ; doxazosin  4  mg ; oxycodone (immediate release)   2.5  mg ; diazepam  2  mg ; morphine sulfate  1-2  mg ; 
 
white m 86 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  146  mg dl$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; doxazosin  4  mg ; diazepam  2  mg ; bisacodyl  10  mg ; hydromorphone (dilaudid)  12.5  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; hydralazine  10  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; morphine sulfate  2-4  mg ; 
 
white m 86 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  134  mg dl$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; doxazosin  4  mg ; diazepam  2  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; 
 
white m 86 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  190  mg dl$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; doxazosin  4  mg ; diazepam  2  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; haloperidol  0.5  mg ; 
 
white m 86 $nan$hematology urine wbc  3  # hpf$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; doxazosin  4  mg ; diazepam  2  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; haloperidol  0.5  mg ; 
 
white m 86 $nan$nan$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; doxazosin  4  mg ; diazepam  2  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
 
white m 86 $nan$nan$multivitamins  1  tab ; vitamin d  800  unit ; simvastatin  80  mg ; valsartan  160  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; pneumococcal vac polyvalent  0.5  ml ; doxazosin  4  mg ; diazepam  2  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; morphine sulfate  2-4  mg ; lorazepam  0.25  mg ; milk of magnesia  30  ml ; magnesium citrate  300  ml ; 
 
hispanic latino m 40 $temp    heartrate  85.0  resprate  12.0  o2sat  95.0  sbp  138.0  dbp  61.0  rhythm    pain  0  ; temp    heartrate  60.0  resprate  12.0  o2sat    sbp  126.0  dbp  69.0  rhythm    pain  0  ; temp    heartrate  86.0  resprate  16.0  o2sat  96.0  sbp  125.0  dbp  80.0  rhythm    pain  0  ; temp    heartrate  71.0  resprate  16.0  o2sat  95.0  sbp  135.0  dbp  59.0  rhythm    pain  0  ; temp  97.7  heartrate  82.0  resprate  20.0  o2sat  97.0  sbp  131.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  177  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, indirect  2.1  mg dl; chemistry blood bilirubin, total  2.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  104  mg dl; chemistry blood lactate dehydrogenase (ld)  170  iu l; chemistry blood lactate dehydrogenase (ld)  182  iu l; chemistry blood bilirubin, direct  0.4  mg dl; chemistry blood bilirubin, direct  0.5  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; 0.9% sodium chloride  1000  ml ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; lorazepam  0.5-1  mg ; heparin  5000  unit ; diazepam  10  mg ; 
depressive disorder, not elsewhere classified other and unspecified alcohol dependence, unspecified chronic pancreatitis abdominal pain, unspecified site abdominal pain, unspecified site other and unspecified alcohol dependence, unspecified suicidal ideation chronic pancreatitis suicidal ideation alcohol abuse, unspecified alcohol abuse, unspecified vomiting alone abdominal pain, other specified site alcohol abuse, unspecified bipolar i disorder, most recent episode (or current) depressed, unspecified acute alcoholic intoxication in alcoholism, continuous suicidal ideation depressive disorder, not elsewhere classified suicidal ideation acute alcoholic intoxication in alcoholism, continuous anemia, unspecified acute alcoholic intoxication in alcoholism, continuous mood disorder in conditions classified elsewhere disorders of magnesium metabolism alcohol withdrawal chronic pancreatitis nausea with vomiting alcohol abuse, unspecified nausea with vomiting abdominal pain, other specified site alcohol abuse, continuous suicidal ideation unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous alcohol abuse, unspecified hallucinations anemia, unspecified alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, continuous nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] suicidal ideation acute alcoholic intoxication in alcoholism, continuous other abnormal blood chemistry alcohol withdrawal abdominal pain, other specified site alcohol abuse, unspecified alcohol abuse, unspecified suicidal ideation
hispanic latino m 40 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  192  iu l$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; multivitamin iv  10  ml ; thiamine  100  mg ; 5% dextrose  1000  ml ; folic acid  1  mg ; heparin  5000  unit ; diazepam  10  mg ; potassium chloride  40  meq ; lamotrigine  25  mg ; 
depressive disorder, not elsewhere classified other and unspecified alcohol dependence, unspecified chronic pancreatitis abdominal pain, unspecified site abdominal pain, unspecified site other and unspecified alcohol dependence, unspecified suicidal ideation chronic pancreatitis suicidal ideation alcohol abuse, unspecified alcohol abuse, unspecified vomiting alone abdominal pain, other specified site alcohol abuse, unspecified bipolar i disorder, most recent episode (or current) depressed, unspecified acute alcoholic intoxication in alcoholism, continuous suicidal ideation depressive disorder, not elsewhere classified suicidal ideation acute alcoholic intoxication in alcoholism, continuous anemia, unspecified acute alcoholic intoxication in alcoholism, continuous mood disorder in conditions classified elsewhere disorders of magnesium metabolism alcohol withdrawal chronic pancreatitis nausea with vomiting alcohol abuse, unspecified nausea with vomiting abdominal pain, other specified site alcohol abuse, continuous suicidal ideation unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous alcohol abuse, unspecified hallucinations anemia, unspecified alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, continuous nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] suicidal ideation acute alcoholic intoxication in alcoholism, continuous other abnormal blood chemistry alcohol withdrawal abdominal pain, other specified site alcohol abuse, unspecified alcohol abuse, unspecified suicidal ideation
hispanic latino m 40 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; heparin  5000  unit ; potassium chloride  40  meq ; lamotrigine  25  mg ; potassium chloride  60  meq ; multivitamins  1  tab ; omeprazole  20  mg ; calcium carbonate  500  mg ; 
depressive disorder, not elsewhere classified other and unspecified alcohol dependence, unspecified chronic pancreatitis abdominal pain, unspecified site abdominal pain, unspecified site other and unspecified alcohol dependence, unspecified suicidal ideation chronic pancreatitis suicidal ideation alcohol abuse, unspecified alcohol abuse, unspecified vomiting alone abdominal pain, other specified site alcohol abuse, unspecified bipolar i disorder, most recent episode (or current) depressed, unspecified acute alcoholic intoxication in alcoholism, continuous suicidal ideation depressive disorder, not elsewhere classified suicidal ideation acute alcoholic intoxication in alcoholism, continuous anemia, unspecified acute alcoholic intoxication in alcoholism, continuous mood disorder in conditions classified elsewhere disorders of magnesium metabolism alcohol withdrawal chronic pancreatitis nausea with vomiting alcohol abuse, unspecified nausea with vomiting abdominal pain, other specified site alcohol abuse, continuous suicidal ideation unspecified episodic mood disorder acute alcoholic intoxication in alcoholism, continuous alcohol abuse, unspecified hallucinations anemia, unspecified alcohol withdrawal delirium acute alcoholic intoxication in alcoholism, continuous nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] suicidal ideation acute alcoholic intoxication in alcoholism, continuous other abnormal blood chemistry alcohol withdrawal abdominal pain, other specified site alcohol abuse, unspecified alcohol abuse, unspecified suicidal ideation
white f 57 $nan$nan$lamotrigine  100  mg ; lamotrigine  50  mg ; fluoxetine  80  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl$lamotrigine  100  mg ; lamotrigine  50  mg ; fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; divalproex (delayed release)  500  mg ; heparin  5000  unit ; lamotrigine  200  mg ; acetaminophen  650  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$lamotrigine  100  mg ; lamotrigine  50  mg ; fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; divalproex (delayed release)  500  mg ; heparin  5000  unit ; lamotrigine  200  mg ; acetaminophen  650  mg ; divalproex (delayed release)  250  mg ; ibuprofen  400  mg ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$lamotrigine  100  mg ; lamotrigine  50  mg ; fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; lamotrigine  200  mg ; acetaminophen  650  mg ; divalproex (delayed release)  250  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 57 $nan$nan$fluoxetine  80  mg ; sodium chloride 0.9%  flush  3  ml ; hydroxyzine  50  mg ; lorazepam  2  mg ; heparin  5000  unit ; acetaminophen  650  mg ; ibuprofen  400  mg ; docusate sodium  100  mg ; senna  1  tab ; 
migraine, unspecified, without mention of intractable migraine without mention of status migrainosus epilepsy, unspecified, without mention of intractable epilepsy acute posthemorrhagic anemia hemoptysis other specified disorders of liver hyposmolality and/or hyponatremia pneumonia, organism unspecified depressive disorder, not elsewhere classified
white f 62 $temp  98.0  heartrate  84.0  resprate  18.0  o2sat  96.0  sbp  112.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  136  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; bisacodyl  10  mg ; allopurinol  300  mg ; amlodipine  5  mg ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; folic acid  1  mg ; levetiracetam  1500  mg ; lidocaine 5% patch  2-3  ptch ; lisinopril  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; trazodone  25  mg ; trazodone  50  mg ; docusate sodium  100  mg ; 
carrier or suspected carrier of methicillin resistant staphylococcus aureus pure hypercholesterolemia other and unspecified manifestations of thiamine deficiency chronic systolic heart failure obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified unspecified hereditary and idiopathic peripheral neuropathy obesity, unspecified depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, lower leg epilepsy, unspecified, without mention of intractable epilepsy gouty arthropathy, unspecified other and unspecified alcohol dependence, in remission unspecified essential hypertension other b-complex deficiencies oliguria and anuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux congestive heart failure, unspecified atrial fibrillation acidosis alcohol abuse, in remission nonspecific abnormal results of function study of liver acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified unspecified essential hypertension esophageal reflux congestive heart failure, unspecified other specified cardiac dysrhythmias chronic systolic heart failure closed fracture of greater tuberosity of humerus unspecified essential hypertension alcohol abuse, unspecified other convulsions pure hypercholesterolemia congestive heart failure, unspecified other specified metabolic disorders unspecified fall
white f 62 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  138  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; bisacodyl  10  mg ; allopurinol  300  mg ; amlodipine  5  mg ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; folic acid  1  mg ; levetiracetam  1500  mg ; lidocaine 5% patch  2-3  ptch ; lisinopril  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; trazodone  50  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; 
carrier or suspected carrier of methicillin resistant staphylococcus aureus pure hypercholesterolemia other and unspecified manifestations of thiamine deficiency chronic systolic heart failure obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified unspecified hereditary and idiopathic peripheral neuropathy obesity, unspecified depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, lower leg epilepsy, unspecified, without mention of intractable epilepsy gouty arthropathy, unspecified other and unspecified alcohol dependence, in remission unspecified essential hypertension other b-complex deficiencies oliguria and anuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux congestive heart failure, unspecified atrial fibrillation acidosis alcohol abuse, in remission nonspecific abnormal results of function study of liver acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified unspecified essential hypertension esophageal reflux congestive heart failure, unspecified other specified cardiac dysrhythmias chronic systolic heart failure closed fracture of greater tuberosity of humerus unspecified essential hypertension alcohol abuse, unspecified other convulsions pure hypercholesterolemia congestive heart failure, unspecified other specified metabolic disorders unspecified fall
white f 62 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  344  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  184  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; bisacodyl  10  mg ; allopurinol  300  mg ; amlodipine  5  mg ; aspirin  81  mg ; cyanocobalamin  1000  mcg ; folic acid  1  mg ; levetiracetam  1500  mg ; lidocaine 5% patch  2-3  ptch ; lisinopril  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 
carrier or suspected carrier of methicillin resistant staphylococcus aureus pure hypercholesterolemia other and unspecified manifestations of thiamine deficiency chronic systolic heart failure obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified unspecified hereditary and idiopathic peripheral neuropathy obesity, unspecified depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, lower leg epilepsy, unspecified, without mention of intractable epilepsy gouty arthropathy, unspecified other and unspecified alcohol dependence, in remission unspecified essential hypertension other b-complex deficiencies oliguria and anuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux congestive heart failure, unspecified atrial fibrillation acidosis alcohol abuse, in remission nonspecific abnormal results of function study of liver acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified unspecified essential hypertension esophageal reflux congestive heart failure, unspecified other specified cardiac dysrhythmias chronic systolic heart failure closed fracture of greater tuberosity of humerus unspecified essential hypertension alcohol abuse, unspecified other convulsions pure hypercholesterolemia congestive heart failure, unspecified other specified metabolic disorders unspecified fall
white f 62 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  365  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  128  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; bisacodyl  10  mg ; allopurinol  300  mg ; cyanocobalamin  1000  mcg ; folic acid  1  mg ; levetiracetam  1500  mg ; lidocaine 5% patch  2-3  ptch ; lisinopril  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 
carrier or suspected carrier of methicillin resistant staphylococcus aureus pure hypercholesterolemia other and unspecified manifestations of thiamine deficiency chronic systolic heart failure obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified unspecified hereditary and idiopathic peripheral neuropathy obesity, unspecified depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, lower leg epilepsy, unspecified, without mention of intractable epilepsy gouty arthropathy, unspecified other and unspecified alcohol dependence, in remission unspecified essential hypertension other b-complex deficiencies oliguria and anuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux congestive heart failure, unspecified atrial fibrillation acidosis alcohol abuse, in remission nonspecific abnormal results of function study of liver acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified unspecified essential hypertension esophageal reflux congestive heart failure, unspecified other specified cardiac dysrhythmias chronic systolic heart failure closed fracture of greater tuberosity of humerus unspecified essential hypertension alcohol abuse, unspecified other convulsions pure hypercholesterolemia congestive heart failure, unspecified other specified metabolic disorders unspecified fall
white f 62 $nan$nan$heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; senna  8.6  mg ; bisacodyl  10  mg ; allopurinol  300  mg ; cyanocobalamin  1000  mcg ; folic acid  1  mg ; levetiracetam  1500  mg ; lidocaine 5% patch  2-3  ptch ; lisinopril  20  mg ; magnesium oxide  400  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 
carrier or suspected carrier of methicillin resistant staphylococcus aureus pure hypercholesterolemia other and unspecified manifestations of thiamine deficiency chronic systolic heart failure obstructive sleep apnea (adult)(pediatric) chronic airway obstruction, not elsewhere classified unspecified hereditary and idiopathic peripheral neuropathy obesity, unspecified depressive disorder, not elsewhere classified osteoarthrosis, unspecified whether generalized or localized, lower leg epilepsy, unspecified, without mention of intractable epilepsy gouty arthropathy, unspecified other and unspecified alcohol dependence, in remission unspecified essential hypertension other b-complex deficiencies oliguria and anuria diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled esophageal reflux congestive heart failure, unspecified atrial fibrillation acidosis alcohol abuse, in remission nonspecific abnormal results of function study of liver acute kidney failure, unspecified intestinal infection due to other organism, not elsewhere classified unspecified essential hypertension esophageal reflux congestive heart failure, unspecified other specified cardiac dysrhythmias chronic systolic heart failure closed fracture of greater tuberosity of humerus unspecified essential hypertension alcohol abuse, unspecified other convulsions pure hypercholesterolemia congestive heart failure, unspecified other specified metabolic disorders unspecified fall
white m 86 $nan$nan$acetaminophen  650  mg ; apixaban  5  mg ; amoxicillin-clavulanic acid  875  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1  mg ; tramadol  25  mg ; terazosin  5  mg ; hydralazine  10  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; amlodipine  10  mg ; carvedilol  6.25  mg ; losartan potassium  100  mg ; hydralazine  25  mg ; aspirin  81  mg ; 
essential (primary) hypertension gout, unspecified nephropathy induced by other drugs, medicaments and biological substances encounter for examination for normal comparison and control in clinical research program unspecified place in hospital as the place of occurrence of the external cause personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of diagnostic agents, initial encounter long term (current) use of anticoagulants paroxysmal atrial fibrillation nonrheumatic aortic (valve) stenosis bilateral primary osteoarthritis of knee personal history of malignant melanoma of skin hyperlipidemia, unspecified acute kidney failure, unspecified occlusion and stenosis of bilateral carotid arteries hyperlipidemia, unspecified benign prostatic hyperplasia without lower urinary tract symptoms transient cerebral ischemic attack, unspecified unspecified atrial fibrillation essential (primary) hypertension other abnormal glucose long term (current) use of anticoagulants personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant melanoma of skin long term (current) use of anticoagulants occlusion and stenosis of unspecified carotid artery other nonrheumatic aortic valve disorders hyperlipidemia, unspecified acute kidney failure, unspecified personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension 
white m 86 $nan$nan$acetaminophen  650  mg ; apixaban  5  mg ; amoxicillin-clavulanic acid  875  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1  mg ; tramadol  25  mg ; terazosin  5  mg ; hydralazine  10  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; amlodipine  10  mg ; carvedilol  6.25  mg ; losartan potassium  100  mg ; hydralazine  25  mg ; aspirin  81  mg ; atorvastatin  10  mg ; 
essential (primary) hypertension gout, unspecified nephropathy induced by other drugs, medicaments and biological substances encounter for examination for normal comparison and control in clinical research program unspecified place in hospital as the place of occurrence of the external cause personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of diagnostic agents, initial encounter long term (current) use of anticoagulants paroxysmal atrial fibrillation nonrheumatic aortic (valve) stenosis bilateral primary osteoarthritis of knee personal history of malignant melanoma of skin hyperlipidemia, unspecified acute kidney failure, unspecified occlusion and stenosis of bilateral carotid arteries hyperlipidemia, unspecified benign prostatic hyperplasia without lower urinary tract symptoms transient cerebral ischemic attack, unspecified unspecified atrial fibrillation essential (primary) hypertension other abnormal glucose long term (current) use of anticoagulants personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant melanoma of skin long term (current) use of anticoagulants occlusion and stenosis of unspecified carotid artery other nonrheumatic aortic valve disorders hyperlipidemia, unspecified acute kidney failure, unspecified personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension 
white m 86 $nan$nan$acetaminophen  650  mg ; apixaban  5  mg ; amoxicillin-clavulanic acid  875  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  1  mg ; tramadol  25  mg ; terazosin  5  mg ; hydralazine  10  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; amlodipine  10  mg ; carvedilol  6.25  mg ; losartan potassium  100  mg ; hydralazine  25  mg ; aspirin  81  mg ; atorvastatin  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension gout, unspecified nephropathy induced by other drugs, medicaments and biological substances encounter for examination for normal comparison and control in clinical research program unspecified place in hospital as the place of occurrence of the external cause personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of diagnostic agents, initial encounter long term (current) use of anticoagulants paroxysmal atrial fibrillation nonrheumatic aortic (valve) stenosis bilateral primary osteoarthritis of knee personal history of malignant melanoma of skin hyperlipidemia, unspecified acute kidney failure, unspecified occlusion and stenosis of bilateral carotid arteries hyperlipidemia, unspecified benign prostatic hyperplasia without lower urinary tract symptoms transient cerebral ischemic attack, unspecified unspecified atrial fibrillation essential (primary) hypertension other abnormal glucose long term (current) use of anticoagulants personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant melanoma of skin long term (current) use of anticoagulants occlusion and stenosis of unspecified carotid artery other nonrheumatic aortic valve disorders hyperlipidemia, unspecified acute kidney failure, unspecified personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension 
white m 86 $nan$nan$acetaminophen  650  mg ; apixaban  5  mg ; amoxicillin-clavulanic acid  875  mg ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  1  mg ; tramadol  25  mg ; terazosin  5  mg ; hydralazine  10  mg ; oxycodone (immediate release)  5  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; amlodipine  10  mg ; carvedilol  6.25  mg ; losartan potassium  100  mg ; hydralazine  25  mg ; aspirin  81  mg ; atorvastatin  10  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension gout, unspecified nephropathy induced by other drugs, medicaments and biological substances encounter for examination for normal comparison and control in clinical research program unspecified place in hospital as the place of occurrence of the external cause personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits adverse effect of diagnostic agents, initial encounter long term (current) use of anticoagulants paroxysmal atrial fibrillation nonrheumatic aortic (valve) stenosis bilateral primary osteoarthritis of knee personal history of malignant melanoma of skin hyperlipidemia, unspecified acute kidney failure, unspecified occlusion and stenosis of bilateral carotid arteries hyperlipidemia, unspecified benign prostatic hyperplasia without lower urinary tract symptoms transient cerebral ischemic attack, unspecified unspecified atrial fibrillation essential (primary) hypertension other abnormal glucose long term (current) use of anticoagulants personal history of nicotine dependence paroxysmal atrial fibrillation personal history of malignant melanoma of skin long term (current) use of anticoagulants occlusion and stenosis of unspecified carotid artery other nonrheumatic aortic valve disorders hyperlipidemia, unspecified acute kidney failure, unspecified personal history of nicotine dependence benign prostatic hyperplasia without lower urinary tract symptoms essential (primary) hypertension 
white m 52 $nan$nan$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white m 52 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; levetiracetam  2000  mg ; felbamate  1500  mg ; lamotrigine  300  mg ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; bag  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white m 52 $nan$nan$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; levetiracetam  2000  mg ; felbamate  1500  mg ; lamotrigine  300  mg ; 0.9% sodium chloride  500  ml ; sw  200  ml ; potassium chloride  20  meq ; potassium chloride  40  meq ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; bag  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; bag  1  bag ; calcium gluconate  2  g ; calcium gluconate  2-4  g ; calcium gluconate  4  g ; heparin  5000  unit ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white m 52 $nan$nan$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; levetiracetam  2000  mg ; felbamate  1500  mg ; lamotrigine  300  mg ; heparin  5000  unit ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white m 52 $nan$nan$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; levetiracetam  2000  mg ; felbamate  1500  mg ; lamotrigine  300  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white m 52 $nan$nan$aspirin  81  mg ; lamotrigine  200  mg ; citalopram  40  mg ; metoprolol succinate xl  50  mg ; atorvastatin  40  mg ; ezetimibe  10  mg ; omeprazole  20  mg ; lorazepam  0.5-2  mg ; docusate sodium  100  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; lorazepam  1  mg ; levetiracetam  2000  mg ; felbamate  1500  mg ; lamotrigine  300  mg ; heparin  5000  unit ; acetaminophen  650  mg ; 
personal history of venous thrombosis and embolism esophageal reflux depressive disorder, not elsewhere classified personal history of urinary calculi pure hypercholesterolemia obstructive sleep apnea (adult)(pediatric) vasectomy status mechanical complication of nervous system device, implant, and graft grand mal status other and unspecified hyperlipidemia localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation epilepsia partialis continua, with intractable epilepsy personal history of tobacco use obstructive sleep apnea (adult)(pediatric) other postprocedural status localization-related (focal) (partial) epilepsy and epileptic syndromes with simple partial seizures, with intractable epilepsy esophageal reflux other and unspecified hyperlipidemia other pulmonary embolism and infarction
white f 28 $nan$hematology blood hematocrit  34.7  %$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; naloxone  40-80  mcg ; 
 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ketorolac  15-30  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; naloxone  40-80  mcg ; lorazepam  0.5  mg ; 
 
white f 28 $nan$hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  208  k ul; chemistry blood creatinine  0.7  mg dl; chemistry urine creatinine, urine  109  mg dl; hematology urine wbc  9  # hpf; chemistry urine protein creatinine ratio  0.2  mg mg$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; naloxone  40-80  mcg ; lorazepam  0.5  mg ; 
 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; naloxone  40-80  mcg ; diphenhydramine  25  mg ; nifedipine (extended release)  30  mg ; 
 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; 0.9% sodium chloride  250  ml ; naloxone  0.4  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  2-4  mg ; naloxone  40-80  mcg ; diphenhydramine  25  mg ; nifedipine (extended release)  30  mg ; 
 
black african american m 52 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  88  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; zolpidem tartrate  5  mg ; metoprolol succinate xl  75  mg ; pantoprazole  40  mg ; olanzapine  5  mg ; metoclopramide  10  mg ; apixaban  5  mg ; ursodiol  300  mg ; psyllium wafer  1  waf ; 
other cholangitis persistent postprocedural fistula, initial encounter klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere chronic or unspecified gastric ulcer with hemorrhage fistula of intestine hyperosmolality and hypernatremia pleural effusion, not elsewhere classified cutaneous abscess of abdominal wall multiple fractures of ribs, left side, initial encounter for closed fracture encephalopathy, unspecified ventilator associated pneumonia nondisplaced transverse fracture of shaft of left ulna, initial encounter for closed fracture acute respiratory failure with hypoxia anemia in other chronic diseases classified elsewhere unspecified fracture of sternum, initial encounter for closed fracture traumatic shock, initial encounter crushing injury of abdomen, lower back, and pelvis, initial encounter contusion of lung, unspecified, initial encounter laceration of liver, unspecified degree, initial encounter other pulmonary collapse traumatic subcutaneous emphysema, initial encounter fracture of manubrium, initial encounter for closed fracture acute posthemorrhagic anemia budd-chiari syndrome severe sepsis with septic shock unspecified mycosis gram-negative sepsis, unspecified laceration of stomach, initial encounter unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere peritonitis, unspecified unspecified atrial flutter delirium due to known physiological condition car driver injured in collision with heavy transport vehicle or bus in traffic accident, initial encounter injury of bile duct, initial encounter unspecified injury of heart, unspecified with or without hemopericardium, initial encounter acute kidney failure with tubular necrosis unspecified laceration of spleen, initial encounter crushed chest, initial encounter unspecified atrial fibrillation 
black african american m 52 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; zolpidem tartrate  5  mg ; metoprolol succinate xl  75  mg ; pantoprazole  40  mg ; olanzapine  5  mg ; apixaban  5  mg ; psyllium wafer  1  waf ; 
other cholangitis persistent postprocedural fistula, initial encounter klebsiella pneumoniae [k. pneumoniae] as the cause of diseases classified elsewhere chronic or unspecified gastric ulcer with hemorrhage fistula of intestine hyperosmolality and hypernatremia pleural effusion, not elsewhere classified cutaneous abscess of abdominal wall multiple fractures of ribs, left side, initial encounter for closed fracture encephalopathy, unspecified ventilator associated pneumonia nondisplaced transverse fracture of shaft of left ulna, initial encounter for closed fracture acute respiratory failure with hypoxia anemia in other chronic diseases classified elsewhere unspecified fracture of sternum, initial encounter for closed fracture traumatic shock, initial encounter crushing injury of abdomen, lower back, and pelvis, initial encounter contusion of lung, unspecified, initial encounter laceration of liver, unspecified degree, initial encounter other pulmonary collapse traumatic subcutaneous emphysema, initial encounter fracture of manubrium, initial encounter for closed fracture acute posthemorrhagic anemia budd-chiari syndrome severe sepsis with septic shock unspecified mycosis gram-negative sepsis, unspecified laceration of stomach, initial encounter unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere peritonitis, unspecified unspecified atrial flutter delirium due to known physiological condition car driver injured in collision with heavy transport vehicle or bus in traffic accident, initial encounter injury of bile duct, initial encounter unspecified injury of heart, unspecified with or without hemopericardium, initial encounter acute kidney failure with tubular necrosis unspecified laceration of spleen, initial encounter crushed chest, initial encounter unspecified atrial fibrillation 
white f 36 $nan$nan$blue cadd cassette  1  cadd ; ropivacaine 0.2%  250  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; zolpidem tartrate  5  mg ; 
personal history of antineoplastic chemotherapy personal history of malignant neoplasm of bone candidiasis of mouth other acute postoperative pain pain in joint, lower leg tobacco use disorder personal history of pneumonia (recurrent) tobacco use disorder fall from other slipping, tripping, or stumbling personal history of malignant neoplasm of bone personal history of antineoplastic chemotherapy contusion of knee sprains and strains of other specified sites of knee and leg nausea alone other acquired deformity of other parts of limb personal history of antineoplastic chemotherapy personal history of malignant neoplasm of bone surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation anxiety state, unspecified knee joint replacement other acute postoperative pain personal history of antineoplastic chemotherapy personal history of malignant neoplasm of other sites tobacco use disorder infection and inflammatory reaction due to internal joint prosthesis other accidents personal history of antineoplastic chemotherapy personal history of malignant neoplasm of other sites dislocation of prosthetic joint disruption of internal operation (surgical) wound malignant neoplasm of long bones of lower limb other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure knee joint replacement other mechanical complication of other internal orthopedic device, implant, and graft infection and inflammatory reaction due to internal joint prosthesis knee joint replacement other mechanical complication of other internal orthopedic device, implant, and graft infection and inflammatory reaction due to internal joint prosthesis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus disruption of internal operation (surgical) wound malignant neoplasm of long bones of lower limb disruption of external operation (surgical) wound tobacco use disorder anxiety state, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of bone home accidents
white f 36 $nan$nan$blue cadd cassette  1  cadd ; ropivacaine 0.2%  250  ml ; 5% dextrose  50  ml ; clindamycin  600  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ondansetron  4  mg ; diphenhydramine  25  mg ; zolpidem tartrate  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  4-8  mg ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; ketorolac  15  mg ; 
personal history of antineoplastic chemotherapy personal history of malignant neoplasm of bone candidiasis of mouth other acute postoperative pain pain in joint, lower leg tobacco use disorder personal history of pneumonia (recurrent) tobacco use disorder fall from other slipping, tripping, or stumbling personal history of malignant neoplasm of bone personal history of antineoplastic chemotherapy contusion of knee sprains and strains of other specified sites of knee and leg nausea alone other acquired deformity of other parts of limb personal history of antineoplastic chemotherapy personal history of malignant neoplasm of bone surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation anxiety state, unspecified knee joint replacement other acute postoperative pain personal history of antineoplastic chemotherapy personal history of malignant neoplasm of other sites tobacco use disorder infection and inflammatory reaction due to internal joint prosthesis other accidents personal history of antineoplastic chemotherapy personal history of malignant neoplasm of other sites dislocation of prosthetic joint disruption of internal operation (surgical) wound malignant neoplasm of long bones of lower limb other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure knee joint replacement other mechanical complication of other internal orthopedic device, implant, and graft infection and inflammatory reaction due to internal joint prosthesis knee joint replacement other mechanical complication of other internal orthopedic device, implant, and graft infection and inflammatory reaction due to internal joint prosthesis other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus disruption of internal operation (surgical) wound malignant neoplasm of long bones of lower limb disruption of external operation (surgical) wound tobacco use disorder anxiety state, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of malignant neoplasm of bone home accidents
white m 61 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  8.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  102  mg dl; chemistry urine creatinine, urine  29  mg dl; chemistry urine sodium, urine  55  meq l; hematology urine wbc  3  # hpf; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  82  mg dl; chemistry urine protein creatinine ratio  1.8  ratio; hematology urine glucose  150  mg dl; hematology blood wbc count  13.6  k ul$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; ciprofloxacin hcl  500  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  800  mg ; oxycodone-acetaminophen  1  tab ; 0.9% sodium chloride  1000  ml ; aluminum hydroxide suspension  15  ml ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; sodium bicarb  50  meq ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  10.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  2.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  107  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  216  iu l$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; oxycodone-acetaminophen  1  tab ; aluminum hydroxide suspension  15  ml ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; sodium bicarb  50  meq ; potassium chloride  60  meq ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; tuberculin protein  0.1  ml ; potassium chloride  40  meq ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  10.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  101  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  84  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; tuberculin protein  0.1  ml ; potassium chloride  40  meq ; trazodone  25  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; morphine sulfate  1-2  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; oxycodone (immediate release)   5  mg ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  2.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.1  g dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; trazodone  25  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; morphine sulfate  1-2  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; oxycodone (immediate release)   5  mg ; 0.9% sodium chloride  500  ml ; morphine sulfate ir  15  mg ; morphine sulfate ir  30  mg ; diazepam  5  mg ; heparin flush (5000 units ml)  4000-11000  unit ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry urine creatinine, urine  26  mg dl; chemistry urine potassium, urine  46  meq l; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  96  mg dl; chemistry urine protein creatinine ratio  4.2  ratio$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; nicotine patch  14  mg ; heparin flush (10 units ml)  2  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; morphine sulfate ir  15  mg ; morphine sulfate ir  30  mg ; diazepam  5  mg ; heparin flush (5000 units ml)  4000-11000  unit ; nicotine patch  21  mg ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  150  mg ; zolpidem tartrate  5  mg ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; azithromycin  250  mg ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; prochlorperazine  10  mg ; heparin flush (10 units ml)  2  ml ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; heparin flush (5000 units ml)  4000-11000  unit ; nicotine patch  21  mg ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  150  mg ; zolpidem tartrate  5  mg ; guaifenesin-dextromethorphan  5  ml ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  4.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; heparin flush (10 units ml)  2  ml ; heparin flush (5000 units ml)  4000-11000  unit ; nicotine patch  21  mg ; ranitidine  150  mg ; guaifenesin-dextromethorphan  5  ml ; pentamidine-inhalation  300  mg ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; tramadol (ultram)  50  mg ; ipratropium bromide neb  2  neb ; albuterol 0.083% neb soln  1  neb ; sevelamer hydrochloride  1600  mg ; heparin flush (10 units ml)  2  ml ; heparin flush (5000 units ml)  4000-11000  unit ; nicotine patch  21  mg ; ranitidine  150  mg ; guaifenesin-dextromethorphan  5  ml ; pentamidine-inhalation  300  mg ; hydromorphone (dilaudid)  0.5  mg ; albuterol inhaler  2  puff ; calcium acetate  1334  mg ; ipratropium bromide mdi  2  puff ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white m 61 $nan$nan$sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  50  mg ; sevelamer hydrochloride  1600  mg ; heparin flush (10 units ml)  2  ml ; heparin flush (5000 units ml)  4000-11000  unit ; nicotine patch  21  mg ; ranitidine  150  mg ; guaifenesin-dextromethorphan  5  ml ; hydromorphone (dilaudid)  0.5  mg ; albuterol inhaler  2  puff ; calcium acetate  1334  mg ; ipratropium bromide mdi  2  puff ; 
chronic airway obstruction, not elsewhere classified antiviral drugs causing adverse effects in therapeutic use human immunodeficiency virus [hiv] disease other chronic pain anemia in chronic kidney disease chronic hepatitis c without mention of hepatic coma acute kidney failure with lesion of tubular necrosis hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified chronic kidney disease, unspecified 
white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; lactated ringers  1000  ml ; atorvastatin  20  mg ; heparin  5000  unit ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; lactated ringers  1000  ml ; atorvastatin  20  mg ; heparin  5000  unit ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; bag  1  bag ; magnesium sulfate  2  gm ; digoxin  0.125  mg ; diphenhydramine  12.5  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; heparin  5000  unit ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; diphenhydramine  12.5  mg ; furosemide  20  mg ; neutra-phos  1  pkt ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; neutra-phos  1  pkt ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; neutra-phos  2  pkt ; acetaminophen iv  1000  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; neutra-phos  2  pkt ; acetaminophen iv  1000  mg ; warfarin  1  dose ; warfarin  2  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  650  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; warfarin  1  dose ; acetaminophen  1000  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; warfarin  1  dose ; acetaminophen  1000  mg ; ciprofloxacin hcl  500  mg ; ondansetron  8  mg ; warfarin  3  mg ; vial  1  vial ; meropenem  500  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; warfarin  1  dose ; acetaminophen  1000  mg ; ondansetron  8  mg ; warfarin  3  mg ; vial  1  vial ; meropenem  500  mg ; enoxaparin sodium  90  mg ; warfarin  1  mg ; 

white f 87 $nan$nan$oxycodone (immediate release)  5-10  mg ; hydromorphone (dilaudid)  0.5-1  mg ; metoprolol tartrate  5  mg ; aspirin ec  81  mg ; lisinopril  10  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; pantoprazole  40  mg ; digoxin  0.125  mg ; furosemide  20  mg ; warfarin  1  dose ; acetaminophen  1000  mg ; ondansetron  8  mg ; vial  1  vial ; meropenem  500  mg ; enoxaparin sodium  90  mg ; warfarin  1  mg ; 

white f 51 $temp  97.7  heartrate  109.0  resprate  19.0  o2sat  98.0  sbp  144.0  dbp  90.0  rhythm    pain  7  ; temp  98.4  heartrate  96.0  resprate  16.0  o2sat  98.0  sbp  126.0  dbp  87.0  rhythm    pain  8  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  0 sleeping  ; temp  98.3  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  133.0  dbp  92.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  9  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  sleeping  ; temp    heartrate  75.0  resprate  16.0  o2sat  99.0  sbp    dbp    rhythm    pain    ; temp  98.6  heartrate  73.0  resprate  16.0  o2sat  98.0  sbp  132.0  dbp  92.0  rhythm    pain  7  $hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  573  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  4.2  g dl; blood gas blood lactate  1.6  mmol l$nan
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 51 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  514  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; hydromorphone (dilaudid)  1  mg ; ondansetron  4  mg ; gabapentin  900  mg ; levothyroxine sodium  25  mcg ; miconazole nitrate vag cream 2%  1  appl ; pantoprazole  40  mg ; simethicone  40-80  mg ; rivaroxaban  15  mg ; lorazepam  0.5-1  mg ; levothyroxine sodium  12.5  mcg ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  1000  ml ; artificial tears  1-2  drop ; 
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 51 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  494  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; gabapentin  900  mg ; miconazole nitrate vag cream 2%  1  appl ; pantoprazole  40  mg ; simethicone  40-80  mg ; lorazepam  0.5-1  mg ; levothyroxine sodium  12.5  mcg ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; sodium chloride 0.9%  1000  ml ; artificial tears  1-2  drop ; vial  1  vial ; hydromorphone (dilaudid)  4  mg ; senna  17.2  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  200  mg ; 
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 51 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  438  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  1  mg ; gabapentin  900  mg ; miconazole nitrate vag cream 2%  1  appl ; simethicone  40-80  mg ; lorazepam  0.5-1  mg ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; artificial tears  1-2  drop ; hydromorphone (dilaudid)  4  mg ; senna  17.2  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  200  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 51 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  428  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; gabapentin  900  mg ; miconazole nitrate vag cream 2%  1  appl ; simethicone  40-80  mg ; lorazepam  0.5-1  mg ; heparin  1600-3100  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; artificial tears  1-2  drop ; senna  17.2  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  200  mg ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 51 $nan$nan$sodium chloride 0.9%  flush  3  ml ; gabapentin  900  mg ; miconazole nitrate vag cream 2%  1  appl ; simethicone  40-80  mg ; artificial tears  1-2  drop ; senna  17.2  mg ; acetaminophen  650  mg ; bisacodyl  10  mg ; docusate sodium  200  mg ; rivaroxaban  20  mg ; 
personal history of pulmonary embolism nonrheumatic aortic (valve) insufficiency bariatric surgery status acquired absence of spleen unspecified abdominal pain other hypoglycemia migraine, unspecified, not intractable, without status migrainosus do not resuscitate major depressive disorder, single episode, unspecified personal history of other venous thrombosis and embolism nausea acquired partial absence of pancreas hypothyroidism, unspecified functional dyspepsia personal history of nicotine dependence cocaine dependence, in remission pain in left hand personality disorder, unspecified alcohol dependence, in remission bacteremia factitious disorder imposed on self, unspecified unspecified protein-calorie malnutrition acute embolism and thrombosis of deep veins of right upper extremity fever, unspecified body mass index (bmi) 27.0-27.9, adult personal history of pulmonary embolism personal history of other venous thrombosis and embolism phlebitis and thrombophlebitis of other sites patient room in hospital as the place of occurrence of the external cause constipation, unspecified long term (current) use of anticoagulants thrombosis due to vascular prosthetic devices, implants and grafts, initial encounter personal history of nicotine dependence personality disorder, unspecified bacteremia do not resuscitate bariatric surgery status acute embolism and thrombosis of deep veins of right upper extremity hypothyroidism, unspecified migraine, unspecified, not intractable, without status migrainosus unspecified place or not applicable nonrheumatic aortic (valve) insufficiency other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure vascular complications following infusion, transfusion and therapeutic injection, initial encounter hypothyroidism, unspecified sepsis due to escherichia coli [e. coli] cellulitis of left upper limb personal history of other venous thrombosis and embolism
white f 43 $temp  99.3  heartrate  74.0  resprate  22.0  o2sat  100.0  sbp  94.0  dbp  37.0  rhythm    pain  9  ; temp    heartrate  77.0  resprate  24.0  o2sat  100.0  sbp  80.0  dbp  53.0  rhythm    pain  8  ; temp    heartrate  66.0  resprate  28.0  o2sat  100.0  sbp  96.0  dbp  72.0  rhythm    pain  6  ; temp  97.8  heartrate  65.0  resprate  16.0  o2sat  100.0  sbp  102.0  dbp  54.0  rhythm    pain  5  ; temp  98.0  heartrate  62.0  resprate  26.0  o2sat  100.0  sbp  101.0  dbp  56.0  rhythm    pain  5  ; temp    heartrate  64.0  resprate  24.0  o2sat  100.0  sbp  98.0  dbp  60.0  rhythm    pain  7  $hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  116  mg dl$nan
 
white f 43 $temp  98.0  heartrate  73.0  resprate  22.0  o2sat  98.0  sbp  100.0  dbp  60.0  rhythm    pain  4  $hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  256  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen iv  1000  mg ; morphine sulfate  2-8  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; morphine sulfate  2-4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; 
 
black african american f 27 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  219  k ul$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; 
 
black african american f 27 $nan$hematology blood hematocrit  35.8  %$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; 
 
black african american f 27 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; dermoplast spray  1  spry ; 
 
white m 58 $temp  97.6  heartrate  87.0  resprate  22.0  o2sat  94.0  sbp  131.0  dbp  66.0  rhythm    pain  0  ; temp  97.6  heartrate  87.0  resprate  22.0  o2sat  94.0  sbp  131.0  dbp  66.0  rhythm    pain  0  $hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  359  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l; chemistry blood lactate dehydrogenase (ld)  157  iu l; chemistry blood albumin  4.3  g dl; chemistry blood % hemoglobin a1c  5.9  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  20  mg ; amlodipine  5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication tobacco use disorder unspecified essential hypertension
white m 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; aspirin  81  mg ; lisinopril  40  mg ; simvastatin  20  mg ; amlodipine  5  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; diazepam  10  mg ; 
other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication tobacco use disorder unspecified essential hypertension
white m 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lisinopril  40  mg ; simvastatin  20  mg ; amlodipine  5  mg ; diazepam  10  mg ; heparin  5000  unit ; dexamethasone  4  mg ; thiamine  100  mg ; folic acid  1  mg ; 
other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication tobacco use disorder unspecified essential hypertension
white m 58 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lisinopril  40  mg ; simvastatin  20  mg ; amlodipine  5  mg ; diazepam  10  mg ; heparin  5000  unit ; dexamethasone  4  mg ; thiamine  100  mg ; folic acid  1  mg ; pantoprazole  40  mg ; 
other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication tobacco use disorder unspecified essential hypertension
hispanic latino f 51 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  189  mg dl$insulin  4  unit ; ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; fentanyl citrate  25-100  mcg ; bag  100  ml ; magnesium sulfate  4  gm ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; fentanyl citrate  1000  mcg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  117  mg dl$ondansetron  4  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; fentanyl pca  2.5  mg ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; fentanyl pca  2.5  mg ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; ketorolac  15  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; acetaminophen  1300  mg ; vial  1  vial ; pantoprazole  40  mg ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  115  mg dl; chemistry blood albumin  3.7  g dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; fentanyl pca  2.5  mg ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; ketorolac  15  mg ; acetaminophen  1300  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; fentanyl pca  2.5  mg ; 0.45% sodium chloride  1000  ml ; potassium chloride  20  meq ; ketorolac  15  mg ; acetaminophen  1300  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; 0.9% sodium chloride  250  ml ; quetiapine fumarate  25  mg ; tolterodine  2  mg ; acetaminophen  325-650  mg ; trazodone  25  mg ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  350  mg dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; hydrocortisone na succ.  25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; fentanyl pca  2.5  mg ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; tolterodine  2  mg ; acetaminophen  325-650  mg ; trazodone  25  mg ; lamotrigine  25  mg ; 0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; insulin  24  unit ; insulin  15  unit ; creon 12  1  cap ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  130  mg dl$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; diphenhydramine  12.5-25  mg ; insulin  0  unit ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; tolterodine  2  mg ; trazodone  25  mg ; lamotrigine  25  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; insulin  24  unit ; insulin  15  unit ; creon 12  1  cap ; metformin (glucophage)  500  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; ciprofloxacin hcl  500  mg ; insulin  20  unit ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino f 51 $nan$nan$ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; diphenhydramine  12.5-25  mg ; chloraseptic throat spray  1  spry ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  10  ml ; tolterodine  2  mg ; trazodone  25  mg ; lamotrigine  25  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  1000  mg ; creon 12  1  cap ; metformin (glucophage)  500  mg ; diphenhydramine  25  mg ; sarna lotion  1  appl ; ciprofloxacin hcl  500  mg ; insulin  20  unit ; insulin  10  unit ; 
other diseases of lung, not elsewhere classified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
hispanic latino m 22 $nan$hematology blood hematocrit  37.3  %; hematology blood hematocrit  37.0  %; hematology blood hemoglobin  13.3  g dl; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  245  k ul; hematology blood platelet count  217  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; albuterol inhaler  2  puff ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; milk of magnesia  30  ml ; 
 
hispanic latino m 22 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol inhaler  2  puff ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; milk of magnesia  30  ml ; 
 
white f 31 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; naloxone  0.4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; levothyroxine sodium  50  mcg ; iso-osmotic dextrose  50  ml ; clindamycin  900  mg ; enoxaparin sodium  40  mg ; 
acute appendicitis without mention of peritonitis 
white f 31 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; naloxone  0.4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; levothyroxine sodium  50  mcg ; enoxaparin sodium  40  mg ; 
acute appendicitis without mention of peritonitis 
white f 31 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  191  k ul$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; levothyroxine sodium  50  mcg ; enoxaparin sodium  40  mg ; 
acute appendicitis without mention of peritonitis 
white f 31 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; levothyroxine sodium  50  mcg ; enoxaparin sodium  40  mg ; 
acute appendicitis without mention of peritonitis 
white f 31 $nan$nan$naloxone  40-80  mcg ; naloxone  0.4  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)  5-10  mg ; 0.9% sodium chloride  1000  ml ; oxytocin  20  unit ; levothyroxine sodium  50  mcg ; enoxaparin sodium  40  mg ; 
acute appendicitis without mention of peritonitis 
white f 81 $nan$nan$levothyroxine sodium  50  mcg ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 81 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  29.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  413  k ul; hematology blood platelet count  341  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  110  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  174  mg dl; blood gas blood potassium, whole blood  3.7  meq l$levothyroxine sodium  50  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; famotidine  20  mg ; morphine sulfate  1-2  mg ; metoprolol tartrate  5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; calcium carbonate  1000  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; atenolol  25  mg ; levothyroxine sodium  100  mcg ; valsartan  320  mg ; atenolol  50  mg ; levothyroxine sodium  75  mcg ; valsartan  160  mg ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 81 $nan$hematology blood hematocrit  28.8  %; chemistry blood anion gap  14  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry urine chloride, urine  92  meq l; chemistry urine creatinine, urine  189  mg dl; chemistry urine potassium, urine  81  meq l; chemistry urine sodium, urine  66  meq l; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, indirect  0.4  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  89  mg dl; chemistry blood bilirubin, direct  0.8  mg dl$levothyroxine sodium  50  mcg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; famotidine  20  mg ; morphine sulfate  1-2  mg ; metoprolol tartrate  5  mg ; sw  100  ml ; magnesium sulfate  4  gm ; calcium carbonate  1000  mg ; potassium chloride  60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; potassium phosphate  15  mmol ; potassium phosphate  30  mmol ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; atenolol  25  mg ; levothyroxine sodium  100  mcg ; valsartan  320  mg ; atenolol  50  mg ; levothyroxine sodium  75  mcg ; valsartan  160  mg ; pantoprazole  40  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; lr  1000  ml ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 81 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  103  mg dl$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; atenolol  50  mg ; levothyroxine sodium  75  mcg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; neutra-phos  1  pkt ; lr  1000  ml ; sodium chloride  1  gm ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 81 $nan$chemistry blood chloride  93  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l$pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; atenolol  50  mg ; levothyroxine sodium  75  mcg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; sodium chloride  1  gm ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 81 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; heparin  5000  unit ; atenolol  50  mg ; levothyroxine sodium  75  mcg ; valsartan  160  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; sodium chloride  1  gm ; 
glucocorticoid deficiency acquired hypertrophic pyloric stenosis passenger of special construction vehicle injured in traffic accident calculus of bile duct without mention of cholecystitis, with obstruction loss of weight body mass index between 19-24, adult diabetes insipidus unspecified essential hypertension hyposmolality and/or hyponatremia jaundice, unspecified, not of newborn unspecified acquired hypothyroidism neoplasm of unspecified nature of endocrine glands and other parts of nervous system nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [ldh] malignant neoplasm of intrahepatic bile ducts
white f 83 $temp  97.2  heartrate  82.0  resprate  16.0  o2sat  96.0  sbp  108.0  dbp  56.0  rhythm    pain  4  ; temp    heartrate  78.0  resprate  18.0  o2sat  97.0  sbp  99.0  dbp  52.0  rhythm    pain    ; temp    heartrate  80.0  resprate  16.0  o2sat  97.0  sbp  96.0  dbp  54.0  rhythm    pain    $hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  104  mg dl$nan
atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified hyperlipidemia, unspecified chronic obstructive pulmonary disease with (acute) exacerbation other cardiomyopathies acute on chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction 
white f 83 $temp    heartrate  88.0  resprate  18.0  o2sat  97.0  sbp  98.0  dbp  66.0  rhythm    pain    $hematology blood hematocrit  27.6  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  26.1  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  228  k ul$oxycodone (immediate release)  5-10  mg ; acetaminophen  650  mg ; lactated ringers  1000  ml ; levothyroxine sodium  50  mcg ; prednisone  30  mg ; albuterol inhaler  1  puff ; doxycycline hyclate  100  mg ; 
atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified hyperlipidemia, unspecified chronic obstructive pulmonary disease with (acute) exacerbation other cardiomyopathies acute on chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction 
white f 83 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  239  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  141  mg dl$oxycodone (immediate release)  5-10  mg ; levothyroxine sodium  50  mcg ; prednisone  30  mg ; albuterol inhaler  1  puff ; doxycycline hyclate  100  mg ; metoprolol succinate xl  12.5  mg ; fluticasone propionate 110mcg  2  puff ; fluticasone-salmeterol diskus (500 50)   1  inh ; tiotropium bromide  1  cap ; omeprazole  40  mg ; clopidogrel  75  mg ; tamsulosin  0.4  mg ; fluticasone propionate nasal  1  spry ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; atorvastatin  40  mg ; heparin  5000  unit ; 
atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified hyperlipidemia, unspecified chronic obstructive pulmonary disease with (acute) exacerbation other cardiomyopathies acute on chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction 
white f 83 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  105  mg dl$fluticasone propionate nasal  1  spry ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; 
atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified hyperlipidemia, unspecified chronic obstructive pulmonary disease with (acute) exacerbation other cardiomyopathies acute on chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction 
white f 83 $nan$nan$fluticasone propionate nasal  1  spry ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  5000  unit ; prednisone  20  mg ; oxycodone (immediate release)  5  mg ; 
atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified hyperlipidemia, unspecified chronic obstructive pulmonary disease with (acute) exacerbation other cardiomyopathies acute on chronic systolic (congestive) heart failure non-st elevation (nstemi) myocardial infarction 
white f 46 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  650  mg ; prochlorperazine  5  mg ; acetaminophen w codeine  1  tab ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; 
 
white f 46 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; prochlorperazine  5  mg ; acetaminophen w codeine  1  tab ; tramadol (ultram)  50  mg ; ondansetron  4  mg ; 
 
white m 75 $nan$blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  114  meq l; blood gas blood glucose  115  mg dl; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  11.7  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood sodium, whole blood  137  meq l$aspirin ec  81  mg ; aspirin  81  mg ; simvastatin  20  mg ; 
 
white m 75 $nan$hematology blood hematocrit  28.1  %; hematology blood hematocrit  28.5  %; hematology blood hematocrit  22.5  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  157  k ul; hematology blood platelet count  108  k ul; hematology blood platelet count  97  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  115  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  92  mg dl; blood gas blood free calcium  1.24  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood free calcium  1.14  mmol l; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  0.95  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  115  meq l; blood gas blood chloride, whole blood  116  meq l; blood gas blood chloride, whole blood  112  meq l; blood gas blood glucose  121  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  143  mg dl; blood gas blood glucose  152  mg dl; blood gas blood glucose  166  mg dl; blood gas blood glucose  156  mg dl; blood gas blood glucose  119  mg dl; blood gas blood glucose  88  mg dl; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  23  %; blood gas blood hematocrit, calculated  22  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  7.8  g dl; blood gas blood hemoglobin  7.7  g dl; blood gas blood hemoglobin  7.3  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  6.2  meq l; blood gas blood potassium, whole blood  6.4  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  136  meq l$syringe  1  syr ; aspirin ec  81  mg ; aspirin  81  mg ; simvastatin  20  mg ; pneumococcal vac polyvalent  0.5  ml ; lactated ringers  1000  ml ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; propofol  1000  mg ; propofol  200  mg ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; fentanyl citrate  12.5-25  mcg ; acetaminophen iv  1000  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; albumin 5% (25g   500ml)  25  g ; 
 
white m 75 $nan$hematology blood hematocrit  30.5  %; hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  434  mg dl; blood gas blood free calcium  1.09  mmol l$aspirin ec  81  mg ; simvastatin  20  mg ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  250  ml ; sodium chloride 0.9%  flush  10  ml ; nitroglycerin  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; milk of magnesia  30  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; fentanyl citrate  12.5-25  mcg ; acetaminophen iv  1000  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; albumin 5% (25g   500ml)  25  g ; ketorolac  30  mg ; furosemide  20  mg ; metoprolol tartrate  25  mg ; metoprolol tartrate  12.5  mg ; glucagon  1  mg ; insulin  0  unit ; ketorolac  15  mg ; metoprolol tartrate  5  mg ; amiodarone  150  mg ; amiodarone  400  mg ; 
 
white m 75 $nan$hematology blood hematocrit  36.0  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  101  k ul; hematology blood platelet count  80  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood glucose  159  mg dl; chemistry blood glucose  129  mg dl$furosemide  20  mg ; glucagon  1  mg ; insulin  0  unit ; ketorolac  15  mg ; metoprolol tartrate  5  mg ; amiodarone  150  mg ; amiodarone  400  mg ; metoprolol tartrate  37.5  mg ; warfarin  2.5  mg ; 
 
white m 75 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  38  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood glucose  132  mg dl$furosemide  20  mg ; glucagon  1  mg ; insulin  0  unit ; ketorolac  15  mg ; amiodarone  400  mg ; metoprolol tartrate  37.5  mg ; warfarin  2.5  mg ; warfarin  1  dose ; pantoprazole  40  mg ; bisacodyl  10  mg ; metoprolol tartrate  50  mg ; 
 
white m 75 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  91  k ul; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  2.6  $furosemide  20  mg ; glucagon  1  mg ; insulin  0  unit ; ketorolac  15  mg ; amiodarone  400  mg ; warfarin  1  dose ; pantoprazole  40  mg ; bisacodyl  10  mg ; metoprolol tartrate  50  mg ; metoprolol tartrate  75  mg ; warfarin  1  mg ; 
 
white m 75 $nan$nan$furosemide  20  mg ; glucagon  1  mg ; insulin  0  unit ; amiodarone  400  mg ; warfarin  1  dose ; pantoprazole  40  mg ; bisacodyl  10  mg ; warfarin  1  mg ; 
 
white m 29 $temp  97.8  heartrate  94.0  resprate  16.0  o2sat  95.0  sbp  137.0  dbp  77.0  rhythm    pain  4  ; temp  98.3  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  131.0  dbp  78.0  rhythm    pain  3  ; temp  98.1  heartrate  53.0  resprate  16.0  o2sat  100.0  sbp  124.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  43.9  %; hematology blood hemoglobin  15.9  g dl; hematology blood platelet count  247  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  4.8  g dl$nan
 
white m 29 $temp  97.9  heartrate  53.0  resprate  16.0  o2sat  100.0  sbp  144.0  dbp  74.0  rhythm    pain    $hematology blood hematocrit  43.0  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, indirect  1.2  mg dl; chemistry blood bilirubin, total  1.6  mg dl; chemistry blood glucose  82  mg dl; chemistry blood bilirubin, direct  0.4  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; 
 
white m 29 $nan$hematology blood hematocrit  41.5  %; hematology blood hemoglobin  14.5  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  88  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; 
 
white m 29 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  74  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; 
 
white m 29 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; 
 
white m 29 $nan$hematology blood hematocrit  40.5  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.7  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  89  mg dl; hematology blood bands  1  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; 
 
white m 29 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; 
 
white m 29 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  223  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, indirect  1.1  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  117  mg dl; chemistry blood bilirubin, direct  0.4  mg dl$influenza vaccine quadrivalent  0.5  ml ; heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; haloperidol  5  mg ; lorazepam  2  mg ; diphenhydramine  25  mg ; 
 
white m 29 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  0.9  ; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  99  mg dl; chemistry blood albumin  4.8  g dl$heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5  mg ; haloperidol  5  mg ; lorazepam  2  mg ; diphenhydramine  25  mg ; lorazepam  0.5-2  mg ; haloperidol  10  mg ; diphenhydramine  50  mg ; haloperidol  5-10  mg ; 
 
white m 29 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  95  mg dl$heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  5  mg ; lorazepam  0.5-2  mg ; haloperidol  10  mg ; diphenhydramine  50  mg ; haloperidol  5-10  mg ; 
 
white m 29 $nan$nan$heparin  5000  unit ; ibuprofen  600  mg ; lorazepam  0.5-2  mg ; olanzapine  10  mg ; diazepam  15  mg ; 
 
white m 29 $nan$nan$heparin  5000  unit ; ibuprofen  600  mg ; lorazepam  0.5-2  mg ; olanzapine  10  mg ; diazepam  15  mg ; 
 
white m 29 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.9  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  74  mg dl; chemistry blood lactate dehydrogenase (ld)  181  iu l; chemistry blood albumin  4.6  g dl$heparin  5000  unit ; ibuprofen  600  mg ; olanzapine  10  mg ; diazepam  15  mg ; lorazepam  1  mg ; 
 
white m 29 $nan$nan$heparin  5000  unit ; ibuprofen  600  mg ; lorazepam  1  mg ; diazepam  10  mg ; 
 
white m 29 $nan$nan$heparin  5000  unit ; ibuprofen  600  mg ; diazepam  10  mg ; 
 
white m 87 $temp  97.4  heartrate  75.0  resprate  16.0  o2sat  98.0  sbp  124.0  dbp  78.0  rhythm    pain  4  $hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; gabapentin  100  mg ; alprazolam  1  mg ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; enoxaparin sodium  40  mg ; finasteride  5  mg ; lisinopril  20  mg ; omeprazole  20  mg ; triamterene-hctz (37.5 25)  1  cap ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
white m 87 $nan$hematology blood hematocrit  39.1  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  137  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; gabapentin  100  mg ; alprazolam  1  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; lisinopril  20  mg ; omeprazole  20  mg ; triamterene-hctz (37.5 25)  1  cap ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; morphine sulfate  1-2  mg ; pregabalin  75  mg ; hydralazine  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; 
 
white m 87 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  150  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  112  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; gabapentin  100  mg ; alprazolam  1  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; lisinopril  20  mg ; omeprazole  20  mg ; triamterene-hctz (37.5 25)  1  cap ; morphine sulfate  1-2  mg ; pregabalin  75  mg ; hydralazine  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; 
 
white m 87 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; gabapentin  100  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; lisinopril  20  mg ; omeprazole  20  mg ; triamterene-hctz (37.5 25)  1  cap ; morphine sulfate  1-2  mg ; pregabalin  75  mg ; hydralazine  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; 
 
white m 87 $nan$hematology urine wbc  29  # hpf$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)  5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; gabapentin  100  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; lisinopril  20  mg ; omeprazole  20  mg ; triamterene-hctz (37.5 25)  1  cap ; morphine sulfate  1-2  mg ; pregabalin  75  mg ; hydralazine  10  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; cetirizine  10  mg ; 
 
white m 87 $nan$hematology blood hematocrit  32.2  %; hematology blood hematocrit  37.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  185  k ul; hematology blood platelet count  206  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  2.6  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  91  mg dl$morphine sulfate  1-2  mg ; pregabalin  75  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; cetirizine  10  mg ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; guaifenesin er  600  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; acetaminophen iv  1000  mg ; 
 
white m 87 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  123  mg dl$morphine sulfate  1-2  mg ; pregabalin  75  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; cetirizine  10  mg ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; guaifenesin er  600  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; acetaminophen iv  1000  mg ; oxycodone (immediate release)  2.5-5  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 87 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  94  mg dl$pregabalin  75  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; cetirizine  10  mg ; ciprofloxacin hcl  500  mg ; guaifenesin er  600  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; oxycodone (immediate release)  2.5-5  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white m 87 $nan$nan$pregabalin  75  mg ; senna  8.6  mg ; docusate sodium  100  mg ; tamsulosin  0.4  mg ; heparin  5000  unit ; cetirizine  10  mg ; ciprofloxacin hcl  500  mg ; guaifenesin er  600  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; oxycodone (immediate release)  2.5-5  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; bag  1  bag ; magnesium sulfate  2  gm ; 
 
white f 52 $nan$nan$gabapentin  100  mg ; acetaminophen  1000  mg ; 
 
white f 52 $nan$nan$iso-osmotic dextrose  50  ml ; clindamycin  600  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; aspirin  121.5  mg ; docusate sodium  100  mg ; omeprazole  20  mg ; omeprazole  40  mg ; bupropion xl (once daily)  300  mg ; enoxaparin sodium  30  mg ; doxycycline hyclate  100  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; 
 
white f 52 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; ondansetron  4  mg ; aspirin  121.5  mg ; docusate sodium  100  mg ; omeprazole  40  mg ; bupropion xl (once daily)  300  mg ; enoxaparin sodium  30  mg ; doxycycline hyclate  100  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; 
 
white f 52 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; aspirin  121.5  mg ; docusate sodium  100  mg ; omeprazole  40  mg ; bupropion xl (once daily)  300  mg ; enoxaparin sodium  30  mg ; doxycycline hyclate  100  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  25  mg ; 
 
white f 52 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; aspirin  121.5  mg ; docusate sodium  100  mg ; omeprazole  40  mg ; bupropion xl (once daily)  300  mg ; enoxaparin sodium  30  mg ; doxycycline hyclate  100  mg ; acetaminophen  650  mg ; lorazepam  0.5  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5-10  mg ; diphenhydramine  25  mg ; 
 
white m 73 $nan$hematology blood hematocrit  39.1  %; hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  141  k ul; hematology blood platelet count  146  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  92  mg dl; chemistry blood glucose  156  mg dl$bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; insulin  0  unit ; lorazepam  0.25-0.5  mg ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$hematology urine wbc  0  # hpf$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; lorazepam  0.25-0.5  mg ; acetaminophen iv  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  124  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; oxycodone-acetaminophen  1-2  tab ; oxycodone (immediate release)   5-10  mg ; insulin  12  unit ; insulin  6  unit ; insulin  8  unit ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; insulin  8  unit ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; insulin  8  unit ; docusate sodium  100  mg ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
white m 73 $nan$nan$dextrose 50%  12.5  gm ; glucagon  1  mg ; vial  1  vial ; pantoprazole  40  mg ; chloraseptic throat spray  1  spry ; lorazepam  0.5-1  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; 
car passenger injured in collision with van in traffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled hip joint replacement acute kidney failure, unspecified other and unspecified hyperlipidemia anomalies of pancreas hypoxemia cyst and pseudocyst of pancreas acute pancreatitis chronic pancreatitis
asian f 72 $temp    heartrate    resprate    o2sat    sbp  123.0  dbp  56.0  rhythm    pain    ; temp  98.7  heartrate  83.0  resprate  16.0  o2sat  97.0  sbp  164.0  dbp  77.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp  143.0  dbp  65.0  rhythm    pain    ; temp  98.7  heartrate  81.0  resprate  14.0  o2sat  99.0  sbp  123.0  dbp  56.0  rhythm    pain  0  $hematology blood hematocrit  35.0  %; hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.5  g dl; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  61  k ul; hematology blood platelet count  59  k ul; hematology blood platelet count  63  k ul; hematology blood platelet count  35  k ul; hematology blood platelet count  65  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, indirect  1.4  mg dl; chemistry blood bilirubin, total  2.5  mg dl; chemistry blood glucose  271  mg dl; chemistry blood lactate dehydrogenase (ld)  335  iu l; chemistry blood bilirubin, direct  1.1  mg dl; chemistry blood % hemoglobin a1c  7.9  %$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; hydralazine  10  mg ; lactulose  30  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; insulin  0  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; rifaximin  550  mg ; insulin  4  unit ; hydralazine  10-20  mg ; spironolactone  25  mg ; captopril  6.25  mg ; 
other constipation osteoporosis, unspecified other and unspecified alcohol dependence, in remission esophageal reflux alcoholic cirrhosis of liver tobacco use disorder hepatopulmonary syndrome long-term (current) use of insulin coronary atherosclerosis of native coronary artery paralytic ileus hyperosmolality and/or hypernatremia hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of unspecified type of vessel, native or graft hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding urinary tract infection, site not specified cramp of limb other ascites other and unspecified alcohol dependence, in remission tobacco use disorder alcoholic cirrhosis of liver hemorrhage of gastrointestinal tract, unspecified duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other and unspecified alcohol dependence, unspecified esophageal varices in diseases classified elsewhere, with bleeding varices of other sites other ascites osteoporosis, unspecified other specified disorders of stomach and duodenum esophageal reflux alcoholic cirrhosis of liver defibrination syndrome 
asian f 72 $nan$hematology blood hematocrit  33.2  %; hematology blood hematocrit  33.3  %; hematology blood hematocrit  31.3  %; hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  60  k ul; hematology blood platelet count  62  k ul; hematology blood platelet count  59  k ul; hematology blood platelet count  71  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  228  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; lactulose  30  ml ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; rifaximin  550  mg ; hydralazine  10-20  mg ; spironolactone  25  mg ; captopril  6.25  mg ; sodium chloride 0.9%  flush  10  ml ; 
other constipation osteoporosis, unspecified other and unspecified alcohol dependence, in remission esophageal reflux alcoholic cirrhosis of liver tobacco use disorder hepatopulmonary syndrome long-term (current) use of insulin coronary atherosclerosis of native coronary artery paralytic ileus hyperosmolality and/or hypernatremia hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of unspecified type of vessel, native or graft hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding urinary tract infection, site not specified cramp of limb other ascites other and unspecified alcohol dependence, in remission tobacco use disorder alcoholic cirrhosis of liver hemorrhage of gastrointestinal tract, unspecified duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other and unspecified alcohol dependence, unspecified esophageal varices in diseases classified elsewhere, with bleeding varices of other sites other ascites osteoporosis, unspecified other specified disorders of stomach and duodenum esophageal reflux alcoholic cirrhosis of liver defibrination syndrome 
asian f 72 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  31.9  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  63  k ul; hematology blood platelet count  73  k ul; hematology blood platelet count  63  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  321  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; lactulose  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; rifaximin  550  mg ; hydralazine  10-20  mg ; spironolactone  25  mg ; captopril  6.25  mg ; sodium chloride 0.9%  flush  10  ml ; insulin  30  unit ; insulin  6  unit ; captopril  12.5  mg ; 
other constipation osteoporosis, unspecified other and unspecified alcohol dependence, in remission esophageal reflux alcoholic cirrhosis of liver tobacco use disorder hepatopulmonary syndrome long-term (current) use of insulin coronary atherosclerosis of native coronary artery paralytic ileus hyperosmolality and/or hypernatremia hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of unspecified type of vessel, native or graft hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding urinary tract infection, site not specified cramp of limb other ascites other and unspecified alcohol dependence, in remission tobacco use disorder alcoholic cirrhosis of liver hemorrhage of gastrointestinal tract, unspecified duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other and unspecified alcohol dependence, unspecified esophageal varices in diseases classified elsewhere, with bleeding varices of other sites other ascites osteoporosis, unspecified other specified disorders of stomach and duodenum esophageal reflux alcoholic cirrhosis of liver defibrination syndrome 
asian f 72 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  69  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  125  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; lactulose  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; rifaximin  550  mg ; hydralazine  10-20  mg ; spironolactone  25  mg ; sodium chloride 0.9%  flush  10  ml ; insulin  6  unit ; captopril  12.5  mg ; metoprolol tartrate  5  mg ; 
other constipation osteoporosis, unspecified other and unspecified alcohol dependence, in remission esophageal reflux alcoholic cirrhosis of liver tobacco use disorder hepatopulmonary syndrome long-term (current) use of insulin coronary atherosclerosis of native coronary artery paralytic ileus hyperosmolality and/or hypernatremia hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of unspecified type of vessel, native or graft hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding urinary tract infection, site not specified cramp of limb other ascites other and unspecified alcohol dependence, in remission tobacco use disorder alcoholic cirrhosis of liver hemorrhage of gastrointestinal tract, unspecified duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other and unspecified alcohol dependence, unspecified esophageal varices in diseases classified elsewhere, with bleeding varices of other sites other ascites osteoporosis, unspecified other specified disorders of stomach and duodenum esophageal reflux alcoholic cirrhosis of liver defibrination syndrome 
asian f 72 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; lactulose  30  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; pantoprazole  40  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; rifaximin  550  mg ; hydralazine  10-20  mg ; spironolactone  25  mg ; sodium chloride 0.9%  flush  10  ml ; insulin  6  unit ; metoprolol tartrate  5  mg ; 
other constipation osteoporosis, unspecified other and unspecified alcohol dependence, in remission esophageal reflux alcoholic cirrhosis of liver tobacco use disorder hepatopulmonary syndrome long-term (current) use of insulin coronary atherosclerosis of native coronary artery paralytic ileus hyperosmolality and/or hypernatremia hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of unspecified type of vessel, native or graft hepatic encephalopathy diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled osteoporosis, unspecified esophageal varices in diseases classified elsewhere, without mention of bleeding urinary tract infection, site not specified cramp of limb other ascites other and unspecified alcohol dependence, in remission tobacco use disorder alcoholic cirrhosis of liver hemorrhage of gastrointestinal tract, unspecified duodenal ulcer, unspecified as acute or chronic, without hemorrhage or perforation, without mention of obstruction other and unspecified alcohol dependence, unspecified esophageal varices in diseases classified elsewhere, with bleeding varices of other sites other ascites osteoporosis, unspecified other specified disorders of stomach and duodenum esophageal reflux alcoholic cirrhosis of liver defibrination syndrome 
white m 71 $nan$hematology blood hematocrit  26.7  %; hematology blood hematocrit  30.2  %; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  175  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  3.8  ; hematology blood inr(pt)  2.1  ; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  135  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  124  k ul; hematology blood platelet count  103  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.8  ; hematology urine wbc  16  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  128  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; warfarin  5  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; magnesium oxide  400  mg ; warfarin  2.5  mg ; neutra-phos  1  pkt ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  111  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; magnesium oxide  400  mg ; warfarin  2.5  mg ; neutra-phos  1  pkt ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; warfarin  7.5  mg ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  98  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; 0.9% sodium chloride  250  ml ; vancomycin  1250  mg ; warfarin  7.5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood glucose  93  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  99  mg dl$multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  142  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.8  $multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; warfarin  3  mg ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
white m 71 $nan$hematology blood inr(pt)  1.9  $multivitamins  1  tab ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5-10  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; atenolol  50  mg ; desmopressin acetate  0.2  mg ; fluticasone propionate nasal  1-2  spry ; tamsulosin  0.4  mg ; trazodone  50  mg ; vitamin d  1000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; hydrochlorothiazide  12.5  mg ; losartan potassium  25  mg ; finasteride  5  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; warfarin  10  mg ; 
presence of prosthetic heart valve pure hypercholesterolemia other reconstructive surgery as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperparathyroidism, unspecified disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter personal history of nicotine dependence infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants postprocedural hypotension rash and other nonspecific skin eruption arthropathic psoriasis, unspecified personal history of nicotine dependence encounter for immunization disruption of external operation (surgical) wound, not elsewhere classified, initial encounter fever, unspecified infection and inflammatory reaction due to internal right knee prosthesis, initial encounter long term (current) use of anticoagulants presence of prosthetic heart valve unspecified place or not applicable nonalcoholic steatohepatitis (nash) proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere other acute postprocedural pain surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] secondary hyperparathyroidism, non-renal knee joint replacement heart valve replaced by other means unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site unspecified essential hypertension other and unspecified hyperlipidemia psoriatic arthropathy acute posthemorrhagic anemia long-term (current) use of anticoagulants infection and inflammatory reaction due to internal joint prosthesis other and unspecified hyperlipidemia long-term (current) use of anticoagulants hyperparathyroidism, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident infection and inflammatory reaction due to internal joint prosthesis surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation personal history of tobacco use disruption of internal operation (surgical) wound streptococcus infection in conditions classified elsewhere and of unspecified site, streptococcus, group d [enterococcus] heart valve replaced by other means other chronic nonalcoholic liver disease unspecified essential hypertension
other m 33 $nan$nan$sodium chloride 0.9%  flush  3  ml ; methadone (oral solution)  2 mg 1 ml  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
white m 71 $nan$hematology blood hematocrit  31.9  %; hematology blood hematocrit  38.6  %; hematology blood hematocrit  37.8  %; hematology blood hematocrit  34.8  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  132  k ul; hematology blood platelet count  144  k ul; hematology blood platelet count  123  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  116  mg dl; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.36  mmol l; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  3.8  mmol l; blood gas blood chloride, whole blood  104  meq l; blood gas blood chloride, whole blood  106  meq l; blood gas blood glucose  111  mg dl; blood gas blood glucose  150  mg dl; blood gas blood glucose  213  mg dl; blood gas blood glucose  217  mg dl; blood gas blood glucose  156  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  128  mg dl; blood gas blood glucose  126  mg dl; blood gas blood hematocrit, calculated  44  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  14.6  g dl; blood gas blood hemoglobin  12.1  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  10.5  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood potassium, whole blood  5.8  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  5.5  meq l; blood gas blood potassium, whole blood  4.2  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  139  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; simvastatin  20  mg ; multivitamins  1  tab ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  500  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; propofol (pf)  10  mg ; tamsulosin  0.4  mg ; furosemide  20  mg ; 
 
white m 71 $nan$nan$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; milk of magnesia  30  ml ; simvastatin  20  mg ; multivitamins  1  tab ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 5%  1000  ml ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; propofol (pf)  10  mg ; tamsulosin  0.4  mg ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; cepastat (phenol) lozenge  1  loz ; metoprolol tartrate  5  mg ; bag  1  bag ; 
 
white m 71 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood glucose  122  mg dl$propofol (pf)  10  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; cepastat (phenol) lozenge  1  loz ; metoprolol tartrate  5  mg ; bag  1  bag ; metoprolol tartrate  25  mg ; warfarin  5  mg ; amiodarone  400  mg ; metoprolol tartrate  50  mg ; 
 
white m 71 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  209  mg dl; chemistry blood albumin  3.1  g dl$propofol (pf)  10  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; cepastat (phenol) lozenge  1  loz ; warfarin  5  mg ; amiodarone  400  mg ; ondansetron  4  mg ; albumin 5% (12.5g   250ml)  12.5  g ; warfarin  1  dose ; amiodarone  200  mg ; 
 
white m 71 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  45  mg dl; hematology blood inr(pt)  4.2  ; chemistry blood glucose  133  mg dl$propofol (pf)  10  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; cepastat (phenol) lozenge  1  loz ; ondansetron  4  mg ; warfarin  1  dose ; amiodarone  200  mg ; senna  8.6  mg ; 
 
white m 71 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; hematology blood inr(pt)  5.5  ; chemistry blood glucose  172  mg dl$propofol (pf)  10  mg ; insulin  20  unit ; bisacodyl  10  mg ; insulin  0  unit ; cepastat (phenol) lozenge  1  loz ; ondansetron  4  mg ; warfarin  1  dose ; senna  8.6  mg ; furosemide  40  mg ; 
 
white m 71 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood glucose  104  mg dl$propofol (pf)  10  mg ; bisacodyl  10  mg ; cepastat (phenol) lozenge  1  loz ; ondansetron  4  mg ; senna  8.6  mg ; furosemide  40  mg ; amlodipine  10  mg ; 
 
white f 77 $nan$nan$sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white f 77 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  129  mg dl; chemistry blood albumin  3.8  g dl$sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; vitamin d  1000  unit ; potassium chloride  40  meq ; atorvastatin  10  mg ; magnesium oxide  400  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white f 77 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  146  mg dl$sodium chloride 0.9%  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; vitamin d  1000  unit ; potassium chloride  40  meq ; atorvastatin  10  mg ; magnesium oxide  400  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white f 77 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  185  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; vitamin d  1000  unit ; atorvastatin  10  mg ; bottle  300  ml ; gammagard liquid  30  g ; diphenhydramine  25  mg ; acetaminophen iv  1000  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white f 77 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  147  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; vitamin d  1000  unit ; atorvastatin  10  mg ; diphenhydramine  25  mg ; acetaminophen iv  1000  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white f 77 $nan$chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  190  mg dl; chemistry blood albumin  4.0  g dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; famotidine  20  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  325-650  mg ; diazepam  2  mg ; insulin  0  unit ; senna  17.2  mg ; hydrochlorothiazide  25  mg ; levothyroxine sodium  100  mcg ; vitamin d  1000  unit ; atorvastatin  10  mg ; 
displacement of lumbar intervertebral disc without myelopathy myasthenia gravis without (acute) exacerbation lumbosacral spondylosis without myelopathy unspecified acquired hypothyroidism thoracic or lumbosacral neuritis or radiculitis, unspecified closed fracture of one or more phalanges of foot other specified metabolic disorders myasthenia gravis without (acute) exacerbation unspecified fall unspecified acquired hypothyroidism home accidents 
white m 33 $temp  98.2  heartrate  78.0  resprate  16.0  o2sat  99.0  sbp  122.0  dbp  65.0  rhythm    pain  9 10  $nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   15-20  mg ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; gabapentin  800  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5  mg ; clonazepam  2  mg ; oxycodone (immediate release)   20-25  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  316  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; gabapentin  800  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5  mg ; clonazepam  2  mg ; oxycodone (immediate release)   20-25  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; gabapentin  800  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; clonazepam  2  mg ; oxycodone (immediate release)   20-25  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; amitriptyline  25  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; clonazepam  2  mg ; oxycodone (immediate release)   20-25  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25-50  mg ; hydromorphone (dilaudid)  1-2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; amitriptyline  25  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; hydromorphone (dilaudid)  2  mg ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; diphenhydramine  12.5  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  132  mg dl$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; clonazepam  2  mg ; oxycodone (immediate release)   20-25  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25-50  mg ; amitriptyline  25  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  50  ml ; daptomycin  600  mg ; diphenhydramine  12.5  mg ; sarna lotion  1  appl ; oxycodone (immediate release)   15-30  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; clonazepam  2  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25-50  mg ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; oxycodone (immediate release)   15-30  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 33 $nan$nan$potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  650  mg ; pantoprazole  40  mg ; docusate sodium  100  mg ; bisacodyl  10  mg ; senna  8.6  mg ; zolpidem tartrate  2.5-5  mg ; milk of magnesia  30  ml ; clonazepam  2  mg ; enoxaparin sodium  40  mg ; diphenhydramine  25-50  mg ; amitriptyline  25  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; sarna lotion  1  appl ; oxycodone (immediate release)   15-30  mg ; 
infection and inflammatory reaction due to other internal orthopedic device, implant, and graft shortness of breath dermatitis due to drugs and medicines taken internally accidents occurring in residential institution unspecified osteomyelitis, pelvic region and thigh nausea with vomiting tobacco use disorder penicillins causing adverse effects in therapeutic use anxiety state, unspecified surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation persistent postoperative fistula other postoperative infection disruption of internal operation (surgical) wound other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure cellulitis and abscess of leg, except foot anxiety state, unspecified accidents occurring in unspecified place person feigning illness sprains and strains of unspecified site of knee and leg motor vehicle traffic accident involving collision with pedestrian injuring pedestrian pain in joint, pelvic region and thigh other, mixed, or unspecified drug abuse, unspecified car passenger injured in collision with van in traffic accident person on outside of heavy transport vehicle injured in collision with railway train or railway vehicle in nontraffic accident hip joint replacement surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation late effect of fracture of spine and trunk without mention of spinal cord lesion methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site late effects of motor vehicle accident other specified antibiotics causing adverse effects in therapeutic use postoperative heterotopic calcification disruption of external operation (surgical) wound infection and inflammatory reaction due to other internal orthopedic device, implant, and graft pyogenic arthritis, pelvic region and thigh cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally personal history of noncompliance with medical treatment, presenting hazards to health cellulitis and abscess of leg, except foot methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection pain in joint, pelvic region and thigh fever, unspecified other postoperative infection methicillin susceptible staphylococcus aureus in conditions classified elsewhere and of unspecified site cellulitis and abscess of leg, except foot foreign body accidentally left during a procedure other postoperative infection other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure
white m 70 $temp  98.0  heartrate  102.0  resprate  16.0  o2sat  95.0  sbp  131.0  dbp  74.0  rhythm    pain  5  $hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  122  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; guaifenesin-dextromethorphan  5-10  ml ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25  mg ; omeprazole  20  mg ; pravastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; doxycycline hyclate  20  mg ; albuterol 0.083% neb soln  1  neb ; levetiracetam  500  mg ; verapamil sr  240  mg ; fluticasone propionate nasal  2  spry ; allopurinol  300  mg ; milk of magnesia  30  ml ; valsartan  320  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; benzonatate  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; guaifenesin-codeine phosphate  5-10  ml ; 
personal history of other endocrine, metabolic, and immunity disorders long-term (current) use of anticoagulants subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic obstructive asthma, unspecified personal history of tobacco use long-term (current) use of aspirin other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of scapula, unspecified part closed fracture of malar and maxillary bones diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled street and highway accidents acute pericarditis, unspecified unspecified essential hypertension closed fracture of clavicle, unspecified part closed fracture of six ribs other and unspecified hyperlipidemia contusion of hip esophageal reflux traumatic pneumothorax without mention of open wound into thorax asthma, unspecified type, unspecified diaphragmatic hernia without mention of obstruction or gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use mixed hyperlipidemia unspecified essential hypertension acute and chronic cholecystitis esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use rosacea asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified body mass index 32.0-32.9, adult alcohol abuse, unspecified chronic cholecystitis long-term (current) use of aspirin esophageal reflux unspecified essential hypertension
white m 70 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  2-4  mg ; trazodone  25  mg ; omeprazole  20  mg ; pravastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; levetiracetam  500  mg ; verapamil sr  240  mg ; fluticasone propionate nasal  2  spry ; allopurinol  300  mg ; milk of magnesia  30  ml ; valsartan  320  mg ; benzonatate  100  mg ; guaifenesin-codeine phosphate  5-10  ml ; levofloxacin  750  mg ; metoprolol tartrate  25  mg ; 
personal history of other endocrine, metabolic, and immunity disorders long-term (current) use of anticoagulants subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic obstructive asthma, unspecified personal history of tobacco use long-term (current) use of aspirin other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of scapula, unspecified part closed fracture of malar and maxillary bones diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled street and highway accidents acute pericarditis, unspecified unspecified essential hypertension closed fracture of clavicle, unspecified part closed fracture of six ribs other and unspecified hyperlipidemia contusion of hip esophageal reflux traumatic pneumothorax without mention of open wound into thorax asthma, unspecified type, unspecified diaphragmatic hernia without mention of obstruction or gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use mixed hyperlipidemia unspecified essential hypertension acute and chronic cholecystitis esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use rosacea asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified body mass index 32.0-32.9, adult alcohol abuse, unspecified chronic cholecystitis long-term (current) use of aspirin esophageal reflux unspecified essential hypertension
white m 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  17.2  mg ; hydromorphone (dilaudid)  2-4  mg ; omeprazole  20  mg ; pravastatin  40  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; fluticasone propionate nasal  2  spry ; allopurinol  300  mg ; milk of magnesia  30  ml ; valsartan  320  mg ; benzonatate  100  mg ; guaifenesin-codeine phosphate  5-10  ml ; levofloxacin  750  mg ; metoprolol tartrate  25  mg ; apixaban  5  mg ; 
personal history of other endocrine, metabolic, and immunity disorders long-term (current) use of anticoagulants subdural hemorrhage following injury without mention of open intracranial wound, unspecified state of consciousness hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) chronic obstructive asthma, unspecified personal history of tobacco use long-term (current) use of aspirin other motor vehicle traffic accident involving collision with motor vehicle injuring motorcyclist closed fracture of scapula, unspecified part closed fracture of malar and maxillary bones diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled street and highway accidents acute pericarditis, unspecified unspecified essential hypertension closed fracture of clavicle, unspecified part closed fracture of six ribs other and unspecified hyperlipidemia contusion of hip esophageal reflux traumatic pneumothorax without mention of open wound into thorax asthma, unspecified type, unspecified diaphragmatic hernia without mention of obstruction or gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of tobacco use mixed hyperlipidemia unspecified essential hypertension acute and chronic cholecystitis esophageal reflux other and unspecified hyperlipidemia personal history of tobacco use rosacea asthma, unspecified type, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obesity, unspecified body mass index 32.0-32.9, adult alcohol abuse, unspecified chronic cholecystitis long-term (current) use of aspirin esophageal reflux unspecified essential hypertension
white f 32 $nan$nan$nicotine patch  14  mg ; 
 
white f 32 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  92  mg dl$nicotine patch  14  mg ; heparin  5000  unit ; clonazepam  1  mg ; acarbose  50  mg ; gabapentin  900  mg ; omeprazole  20  mg ; amitriptyline  150  mg ; quetiapine extended-release  300  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; diphenhydramine  50  mg ; amp  1  amp ; octreotide acetate  50  mcg ; sumatriptan succinate  100  mg ; ferric gluconate  125  mg ; cyanocobalamin  1000  mcg ; ondansetron  4  mg ; 0.9% sodium chloride  100  ml ; ondansetron odt  4  mg ; glucose tab  2-4  tab ; 
 
white f 32 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  310  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  87  mg dl$nicotine patch  14  mg ; heparin  5000  unit ; clonazepam  1  mg ; gabapentin  900  mg ; omeprazole  20  mg ; amitriptyline  150  mg ; quetiapine extended-release  300  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; sumatriptan succinate  100  mg ; ondansetron  4  mg ; ondansetron odt  4  mg ; glucose tab  2-4  tab ; 
 
white f 32 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  83  mg dl$nicotine patch  14  mg ; heparin  5000  unit ; clonazepam  1  mg ; gabapentin  900  mg ; omeprazole  20  mg ; amitriptyline  150  mg ; quetiapine extended-release  300  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; senna  1  tab ; docusate sodium  100  mg ; ondansetron  4  mg ; iron dextran complex  500  mg ; 
 
hispanic latino f 72 $temp    heartrate  62.0  resprate  16.0  o2sat  99.0  sbp  119.0  dbp  72.0  rhythm    pain  0  ; temp  97.7  heartrate  80.0  resprate  16.0  o2sat  99.0  sbp  101.0  dbp  63.0  rhythm    pain    $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  220  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  20  unit ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; omeprazole  20  mg ; valsartan  320  mg ; metoprolol succinate xl  50  mg ; docusate sodium  100  mg ; 
other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled nontoxic multinodular goiter pure hypercholesterolemia coronary atherosclerosis of native coronary artery esophageal reflux other left bundle branch block cardiac pacemaker in situ supraventricular premature beats do not resuscitate status acute on chronic systolic heart failure hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified secondary cardiomyopathy, unspecified personal history of tobacco use congestive heart failure, unspecified other chronic pulmonary heart diseases mitral valve disorders leukocytosis, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified fever, unspecified long-term (current) use of aspirin other complications due to other cardiac device, implant, and graft long-term (current) use of insulin other acute and subacute forms of ischemic heart disease, other unspecified essential hypertension unspecified essential hypertension family history of ischemic heart disease esophageal reflux pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled shortness of breath cardiac pacemaker in situ person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, lower leg atrioventricular block, complete acute kidney failure, unspecified depressive disorder, not elsewhere classified pure hypercholesterolemia long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified heart disease, unspecified esophageal reflux unspecified essential hypertension unspecified drug or medicinal substance causing adverse effects in therapeutic use
hispanic latino f 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; atorvastatin  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  20  unit ; acetaminophen  650  mg ; senna  8.6  mg ; aspirin  81  mg ; omeprazole  20  mg ; valsartan  320  mg ; metoprolol succinate xl  50  mg ; docusate sodium  100  mg ; 
other and unspecified hyperlipidemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled nontoxic multinodular goiter pure hypercholesterolemia coronary atherosclerosis of native coronary artery esophageal reflux other left bundle branch block cardiac pacemaker in situ supraventricular premature beats do not resuscitate status acute on chronic systolic heart failure hyposmolality and/or hyponatremia depressive disorder, not elsewhere classified secondary cardiomyopathy, unspecified personal history of tobacco use congestive heart failure, unspecified other chronic pulmonary heart diseases mitral valve disorders leukocytosis, unspecified other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure acute kidney failure, unspecified fever, unspecified long-term (current) use of aspirin other complications due to other cardiac device, implant, and graft long-term (current) use of insulin other acute and subacute forms of ischemic heart disease, other unspecified essential hypertension unspecified essential hypertension family history of ischemic heart disease esophageal reflux pure hypercholesterolemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled shortness of breath cardiac pacemaker in situ person boarding or alighting a pedal cycle injured in collision with fixed or stationary object other and unspecified hyperlipidemia osteoarthrosis, unspecified whether generalized or localized, lower leg atrioventricular block, complete acute kidney failure, unspecified depressive disorder, not elsewhere classified pure hypercholesterolemia long-term (current) use of insulin diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled leukocytosis, unspecified heart disease, unspecified esophageal reflux unspecified essential hypertension unspecified drug or medicinal substance causing adverse effects in therapeutic use
white m 77 $temp  98.0  heartrate  65.0  resprate  17.0  o2sat  97.0  sbp  170.0  dbp  84.0  rhythm    pain  0  $hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  343  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  82  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  82  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  122  meq l; chemistry blood sodium  120  meq l; chemistry blood sodium  118  meq l; chemistry blood sodium  119  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  88  mg dl; chemistry blood albumin  3.7  g dl; blood gas blood sodium, whole blood  119  meq l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; captopril  6.25  mg ; heparin  5000  unit ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  82  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood glucose  94  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; lisinopril  5  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood glucose  84  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; lisinopril  5  mg ; lisinopril  10  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  124  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  123  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; lisinopril  10  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  82  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.7  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry urine creatinine, urine  112  mg dl; chemistry urine sodium, urine  56  meq l; chemistry urine sodium, urine  76  meq l; chemistry blood glucose  102  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  89  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; multivitamins w minerals  1  tab ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; furosemide  10  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; furosemide  10  mg ; nephrocaps  1  cap ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  340  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry urine sodium, urine  109  meq l; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; nephrocaps  1  cap ; levothyroxine sodium  25  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  75  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; nephrocaps  1  cap ; levothyroxine sodium  25  mcg ; tramadol  25  mg ; acetaminophen  650  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  6.5  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  99  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  2.7  g dl; chemistry urine protein creatinine ratio  0.8  mg mg; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood chloride, whole blood  90  meq l; blood gas blood glucose  102  mg dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  136  meq l$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; folic acid  1  mg ; senna  17.2  mg ; thiamine  100  mg ; heparin  5000  unit ; megestrol acetate  400  mg ; sodium chloride  1  gm ; polyethylene glycol  17  g ; nephrocaps  1  cap ; levothyroxine sodium  25  mcg ; tramadol  25  mg ; acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  1  bag ; cefepime  1  g ; lidocaine jelly 2% (urojet)  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; senna  8.6  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; sodium chloride 0.9%  1000  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  104  k ul; hematology blood platelet count  106  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  86  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  116  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.7  g dl$lidocaine jelly 2% (urojet)  1  appl ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; senna  8.6  mg ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; phosphorus  500  mg ; sterile water  100  ml ; sterile water  150  ml ; sterile water  200  ml ; potassium chloride  20  meq ; potassium chloride (powder)  20  meq ; levothyroxine sodium  12.5  mcg ; vitamin d  1000  unit ; multivitamins  1  tab ; albuterol inhaler  1  puff ; ipratropium bromide mdi  2  puff ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  81  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  103  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; 0.9% sodium chloride  250  ml ; norepinephrine  8  mg ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; phosphorus  500  mg ; potassium chloride (powder)  20  meq ; vitamin d  1000  unit ; multivitamins  1  tab ; albuterol inhaler  1  puff ; ipratropium bromide mdi  2  puff ; albuterol inhaler  4-6  puff ; sterile water  50  ml ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  58  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood glucose  116  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  250  ml ; thiamine  500  mg ; vitamin d  1000  unit ; albuterol inhaler  4-6  puff ; sterile water  50  ml ; fentanyl citrate  25-50  mcg ; multivitamins  5  ml ; dexmedetomidine  0.4  mg ; acetaminophen (liquid)  650  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  61  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  82  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; propofol  1000  mg ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; albuterol inhaler  4-6  puff ; sterile water  50  ml ; fentanyl citrate  25-50  mcg ; multivitamins  5  ml ; dexmedetomidine  0.4  mg ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  110  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; fentanyl citrate  25-50  mcg ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; midazolam  1-2  mg ; propofol  10  mg ; fentanyl citrate  25-100  mcg ; albuterol inhaler  2  puff ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  126  mg dl; chemistry blood glucose  101  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; fentanyl citrate  25-100  mcg ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; quetiapine fumarate  50  mg ; ciprofloxacin hcl  750  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  86  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  31  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  113  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.2  mmol l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; quetiapine fumarate  50  mg ; ciprofloxacin hcl  750  mg ; fentanyl citrate  12.5-25  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  105  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; ciprofloxacin hcl  750  mg ; fentanyl citrate  12.5-25  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.7  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  81  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; ciprofloxacin hcl  750  mg ; fentanyl citrate  12.5-25  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  24.5  %; hematology blood hematocrit  21.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  133  k ul; hematology blood platelet count  134  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl; chemistry blood albumin  2.5  g dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; acetaminophen (liquid)  650  mg ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; fentanyl citrate  12.5-25  mcg ; phenylephrine  60  mg ; midazolam  2  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; rocuronium  60  mg ; hydromorphone (dilaudid)  0.125  mg ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  0.25  mg ; fentanyl citrate  50  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  22.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine creatinine, urine  43  mg dl; chemistry urine sodium, urine  105  meq l; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  94  mg dl; blood gas blood free calcium  1.15  mmol l; blood gas blood lactate  1.6  mmol l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; hydromorphone (dilaudid)  0.25  mg ; fentanyl citrate  50  mcg ; propofol  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; metoprolol tartrate  25  mg ; atorvastatin  80  mg ; nystatin cream  1  appl ; lidocaine 5% patch  1  ptch ; aspirin  325  mg ; levothyroxine sodium  50  mcg ; metoprolol tartrate  12.5  mg ; tramadol  50  mg ; warfarin  4  mg ; warfarin  1  dose ; warfarin  3  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  20.7  %; hematology blood hematocrit  26.4  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  110  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; propofol  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; nystatin cream  1  appl ; lidocaine 5% patch  1  ptch ; aspirin  325  mg ; levothyroxine sodium  50  mcg ; metoprolol tartrate  12.5  mg ; tramadol  50  mg ; warfarin  1  dose ; warfarin  3  mg ; cosyntropin  250  mcg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  84  mg dl; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  0.8  mmol l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; nystatin cream  1  appl ; lidocaine 5% patch  1  ptch ; aspirin  325  mg ; levothyroxine sodium  50  mcg ; metoprolol tartrate  12.5  mg ; tramadol  50  mg ; warfarin  1  dose ; warfarin  3  mg ; hydrocortisone  5  mg ; hydrocortisone  10  mg ; warfarin  5  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  348  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  102  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; nystatin cream  1  appl ; lidocaine 5% patch  1  ptch ; aspirin  325  mg ; levothyroxine sodium  50  mcg ; metoprolol tartrate  12.5  mg ; tramadol  50  mg ; warfarin  1  dose ; warfarin  5  mg ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  105  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  50  mcg ; tramadol  50  mg ; warfarin  1  dose ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; miconazole powder 2%  1  appl ; aspirin  81  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  527  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  4.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  145  mg dl; chemistry blood albumin  2.9  g dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; sterile water  50  ml ; multivitamins  5  ml ; argatroban  50  mg ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  50  mcg ; tramadol  50  mg ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; miconazole powder 2%  1  appl ; aspirin  81  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; loperamide  2  mg ; warfarin  2  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  607  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  4.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  112  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; multivitamins  5  ml ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  50  mcg ; tramadol  50  mg ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; miconazole powder 2%  1  appl ; aspirin  81  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; warfarin  2  mg ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  580  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  2.8  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  94  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; multivitamins  5  ml ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  50  mcg ; tramadol  50  mg ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; miconazole powder 2%  1  appl ; aspirin  81  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; neutra-phos  2  pkt ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white m 77 $nan$nan$chlorhexidine gluconate 0.12% oral rinse  15  ml ; senna  8.6  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; vitamin d  1000  unit ; multivitamins  5  ml ; albuterol inhaler  6-8  puff ; ipratropium bromide mdi  6-8  puff ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; atorvastatin  80  mg ; lidocaine 5% patch  1  ptch ; levothyroxine sodium  50  mcg ; tramadol  50  mg ; hydrocortisone  20  mg ; amlodipine  2.5  mg ; miconazole powder 2%  1  appl ; aspirin  81  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; neutra-phos  2  pkt ; 
vitamin d deficiency, unspecified acute kidney failure, unspecified other microscopic hematuria body mass index (bmi) 19.9 or less, adult major depressive disorder, single episode, unspecified other specified hypothyroidism abnormal levels of other serum enzymes essential (primary) hypertension unspecified severe protein-calorie malnutrition bradycardia, unspecified cyst of kidney, acquired dyspnea, unspecified shortness of breath other musculoskeletal symptoms referable to limbs unspecified acquired hypothyroidism unspecified essential hypertension palpitations syncope and collapse other specified cardiac dysrhythmias 
white f 87 $nan$hematology blood hematocrit  48.1  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood glucose  151  mg dl$nan
 
white f 87 $temp  98.6  heartrate  61.0  resprate  16.0  o2sat    sbp  127.0  dbp  64.0  rhythm    pain    $hematology blood hematocrit  45.1  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  30  mg dl; hematology urine wbc  12  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  128  mg dl; hematology urine glucose  300  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; acetaminophen  650  mg ; pravastatin  40  mg ; metoprolol tartrate  25  mg ; 
 
white f 87 $nan$hematology blood hematocrit  45.3  %; hematology blood hemoglobin  14.4  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  143  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; acetaminophen  650  mg ; pravastatin  40  mg ; metoprolol tartrate  25  mg ; 
 
white f 87 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  119  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; acetaminophen  650  mg ; pravastatin  40  mg ; metoprolol tartrate  25  mg ; 
 
black african american f 44 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  214  k ul; chemistry blood creatinine  0.6  mg dl$misoprostol  25  mcg ; 
 
black african american f 44 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  203  k ul; chemistry blood creatinine  1.1  mg dl; chemistry urine creatinine, urine  70  mg dl; chemistry urine protein creatinine ratio  0.5  mg mg$misoprostol  25  mcg ; omeprazole  20  mg ; 
 
black african american f 44 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  175  k ul; chemistry blood creatinine  0.9  mg dl; chemistry blood urea nitrogen  12  mg dl$misoprostol  25  mcg ; omeprazole  20  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; simethicone  80  mg ; fentanyl citrate  25-100  mcg ; heparin  5000  unit ; 
 
black african american f 44 $nan$nan$misoprostol  25  mcg ; omeprazole  20  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ketorolac  15  mg ; ketorolac  30  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; simethicone  80  mg ; fentanyl citrate  25-100  mcg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; ibuprofen  600  mg ; 
 
black african american f 44 $nan$nan$omeprazole  20  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; ibuprofen  600  mg ; 
 
black african american f 44 $nan$nan$omeprazole  20  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; ibuprofen  600  mg ; 
 
black african american f 44 $nan$nan$omeprazole  20  mg ; naloxone  40-80  mcg ; naloxone  0.4  mg ; metoclopramide  10  mg ; ondansetron  4  mg ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; heparin  5000  unit ; oxycodone (immediate release)   5-10  mg ; ibuprofen  600  mg ; 
 
other m 45 $temp  97.9  heartrate  77.0  resprate  14.0  o2sat  100.0  sbp  113.0  dbp  45.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  39.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  111  mg dl$influenza virus vaccine  0.5  ml ; albuterol inhaler  2  puff ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  650  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; docusate sodium  100  mg ; vial  1  vial ; pantoprazole  40  mg ; d5lr  1000  ml ; lamotrigine  100  mg ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; quetiapine fumarate  12.5  mg ; senna  1  tab ; 
 
white m 80 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  3.6  ; hematology blood inr(pt)  4.0  ; chemistry blood glucose  155  mg dl$lorazepam  0.5  mg ; vitamin d  50,000  unit ; aspirin  81  mg ; allopurinol  100  mg ; lisinopril  10  mg ; nifedipine cr  60  mg ; valsartan  120  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; tricor  48  mg ; heparin  5000  unit ; metoprolol tartrate  50  mg ; tamsulosin  0.4  mg ; metoprolol tartrate  25  mg ; 0.9% sodium chloride  500  ml ; ranitidine  150  mg ; simvastatin  80  mg ; trazodone  25  mg ; 
malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sinoatrial node dysfunction chronic kidney disease, stage iii (moderate) atrial fibrillation acute kidney failure, unspecified gout, unspecified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic lymphoid leukemia, without mention of having achieved remission 
white m 80 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  4.1  ; chemistry blood glucose  137  mg dl$lorazepam  0.5  mg ; vitamin d  50,000  unit ; aspirin  81  mg ; allopurinol  100  mg ; lisinopril  10  mg ; nifedipine cr  60  mg ; valsartan  120  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; tricor  48  mg ; tamsulosin  0.4  mg ; 0.9% sodium chloride  500  ml ; ranitidine  150  mg ; simvastatin  80  mg ; trazodone  25  mg ; insulin  0  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; 
malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sinoatrial node dysfunction chronic kidney disease, stage iii (moderate) atrial fibrillation acute kidney failure, unspecified gout, unspecified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic lymphoid leukemia, without mention of having achieved remission 
white m 80 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  3.7  $lorazepam  0.5  mg ; vitamin d  50,000  unit ; aspirin  81  mg ; allopurinol  100  mg ; lisinopril  10  mg ; nifedipine cr  60  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; tricor  48  mg ; tamsulosin  0.4  mg ; ranitidine  150  mg ; simvastatin  80  mg ; trazodone  25  mg ; insulin  0  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; omeprazole  20  mg ; metoprolol tartrate  75  mg ; 
malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sinoatrial node dysfunction chronic kidney disease, stage iii (moderate) atrial fibrillation acute kidney failure, unspecified gout, unspecified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic lymphoid leukemia, without mention of having achieved remission 
white m 80 $nan$nan$lorazepam  0.5  mg ; vitamin d  50,000  unit ; aspirin  81  mg ; allopurinol  100  mg ; lisinopril  10  mg ; nifedipine cr  60  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; tricor  48  mg ; tamsulosin  0.4  mg ; simvastatin  80  mg ; trazodone  25  mg ; insulin  0  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; omeprazole  20  mg ; metoprolol tartrate  75  mg ; lisinopril  2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; 
malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sinoatrial node dysfunction chronic kidney disease, stage iii (moderate) atrial fibrillation acute kidney failure, unspecified gout, unspecified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic lymphoid leukemia, without mention of having achieved remission 
white m 80 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood glucose  214  mg dl$lorazepam  0.5  mg ; vitamin d  50,000  unit ; aspirin  81  mg ; allopurinol  100  mg ; nifedipine cr  60  mg ; sodium chloride 0.9%  flush  3  ml ; calcium carbonate  500  mg ; tricor  48  mg ; tamsulosin  0.4  mg ; simvastatin  80  mg ; trazodone  25  mg ; insulin  0  unit ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; omeprazole  20  mg ; lisinopril  2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; 
malignant neoplasm of prostate hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified sinoatrial node dysfunction chronic kidney disease, stage iii (moderate) atrial fibrillation acute kidney failure, unspecified gout, unspecified long-term (current) use of anticoagulants coronary atherosclerosis of native coronary artery diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic lymphoid leukemia, without mention of having achieved remission 
white f 85 $nan$hematology blood hematocrit  30.8  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  116  mg dl$heparin  5000  unit ; guaifenesin-codeine phosphate  10  ml ; montelukast  10  mg ; ns  100  ml ; metronidazole  500  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; losartan potassium  25  mg ; pregabalin  25  mg ; pregabalin  75  mg ; pregabalin  50  mg ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  1000  mg ; vial  1  vial ; ceftriaxone  1  gm ; omeprazole  40  mg ; 
toxic encephalopathy acidosis hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified macular degeneration gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic diastolic (congestive) heart failure hypomagnesemia delirium due to known physiological condition unspecified asthma, uncomplicated other specified noninfective gastroenteritis and colitis diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding hypokalemia chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified other chest pain chronic diastolic (congestive) heart failure toxic encephalopathy acute posthemorrhagic anemia unspecified asthma, uncomplicated hypothyroidism, unspecified type 2 diabetes mellitus without complications unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other recreation area as the place of occurrence of the external cause major depressive disorder, single episode, unspecified personal history of nicotine dependence resistance to other specified beta lactam antibiotics hypertensive heart disease with heart failure gastro-esophageal reflux disease without esophagitis fracture of unspecified part of neck of right femur, initial encounter for closed fracture constipation, unspecified other fall on same level, initial encounter long term (current) use of oral hypoglycemic drugs personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified obstructive sleep apnea (adult) (pediatric) chronic diastolic (congestive) heart failure postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure type 2 diabetes mellitus without complications hyperlipidemia, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified asthma, uncomplicated acute posthemorrhagic anemia
white f 85 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  258  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl$heparin  5000  unit ; guaifenesin-codeine phosphate  10  ml ; montelukast  10  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; losartan potassium  25  mg ; pregabalin  25  mg ; pregabalin  75  mg ; pregabalin  50  mg ; acetaminophen  1000  mg ; vial  1  vial ; ceftriaxone  1  gm ; omeprazole  40  mg ; fleet enema (mineral oil)  1  enema ; loperamide  2  mg ; 
toxic encephalopathy acidosis hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified macular degeneration gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic diastolic (congestive) heart failure hypomagnesemia delirium due to known physiological condition unspecified asthma, uncomplicated other specified noninfective gastroenteritis and colitis diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding hypokalemia chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified other chest pain chronic diastolic (congestive) heart failure toxic encephalopathy acute posthemorrhagic anemia unspecified asthma, uncomplicated hypothyroidism, unspecified type 2 diabetes mellitus without complications unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other recreation area as the place of occurrence of the external cause major depressive disorder, single episode, unspecified personal history of nicotine dependence resistance to other specified beta lactam antibiotics hypertensive heart disease with heart failure gastro-esophageal reflux disease without esophagitis fracture of unspecified part of neck of right femur, initial encounter for closed fracture constipation, unspecified other fall on same level, initial encounter long term (current) use of oral hypoglycemic drugs personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified obstructive sleep apnea (adult) (pediatric) chronic diastolic (congestive) heart failure postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure type 2 diabetes mellitus without complications hyperlipidemia, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified asthma, uncomplicated acute posthemorrhagic anemia
white f 85 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  114  mg dl$heparin  5000  unit ; guaifenesin-codeine phosphate  10  ml ; montelukast  10  mg ; atorvastatin  10  mg ; levothyroxine sodium  50  mcg ; pregabalin  25  mg ; pregabalin  75  mg ; pregabalin  50  mg ; omeprazole  40  mg ; loperamide  2  mg ; losartan potassium  50  mg ; 
toxic encephalopathy acidosis hypertensive heart disease with heart failure major depressive disorder, single episode, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified macular degeneration gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus without complications other fall from one level to another in water transport injuring occupant of other watercraft -- crew chronic diastolic (congestive) heart failure hypomagnesemia delirium due to known physiological condition unspecified asthma, uncomplicated other specified noninfective gastroenteritis and colitis diverticulosis of intestine, part unspecified, without perforation or abscess without bleeding hypokalemia chronic lymphocytic leukemia of b-cell type not having achieved remission urinary tract infection, site not specified other chest pain chronic diastolic (congestive) heart failure toxic encephalopathy acute posthemorrhagic anemia unspecified asthma, uncomplicated hypothyroidism, unspecified type 2 diabetes mellitus without complications unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere other recreation area as the place of occurrence of the external cause major depressive disorder, single episode, unspecified personal history of nicotine dependence resistance to other specified beta lactam antibiotics hypertensive heart disease with heart failure gastro-esophageal reflux disease without esophagitis fracture of unspecified part of neck of right femur, initial encounter for closed fracture constipation, unspecified other fall on same level, initial encounter long term (current) use of oral hypoglycemic drugs personal history of nicotine dependence gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified obstructive sleep apnea (adult) (pediatric) chronic diastolic (congestive) heart failure postprocedural hemorrhage of a digestive system organ or structure following a digestive system procedure type 2 diabetes mellitus without complications hyperlipidemia, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified asthma, uncomplicated acute posthemorrhagic anemia
black african american f 54 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  134  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; vial  1  vial ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; d5 1 2ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  292  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; d5 1 2ns  1000  ml ; bag  1  bag ; magnesium sulfate  2  gm ; acetaminophen iv  1000  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  279  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; acetaminophen iv  1000  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  96  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; bupivacaine 0.1%  250  ml ; yellow cadd cassette  1  cadd ; hydromorphone  2500  mcg ; ondansetron  4  mg ; 5% dextrose  100  ml ; naloxone  2  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$hematology blood hematocrit  36.9  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  402  k ul; hematology blood platelet count  425  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  146  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; docusate sodium  100  mg ; senna  1  tab ; ciprofloxacin hcl  500  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-10  mg ; docusate sodium  100  mg ; senna  1  tab ; ciprofloxacin hcl  500  mg ; ketorolac  15  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  672  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  104  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; ciprofloxacin hcl  500  mg ; ketorolac  15  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  813  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  101  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; ciprofloxacin hcl  500  mg ; ketorolac  15  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american f 54 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; chloraseptic throat spray  1  spry ; heparin  5000  unit ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; ciprofloxacin hcl  500  mg ; ketorolac  15  mg ; 
iron deficiency anemia, unspecified adjustment disorder with depressed mood calculus of bile duct without mention of cholecystitis, with obstruction cholangitis bacteremia body mass index 33.0-33.9, adult obesity, unspecified unspecified hemorrhoids with other complication
black african american m 87 $temp  97.7  heartrate  98.0  resprate  18.0  o2sat  99.0  sbp  139.0  dbp  73.0  rhythm    pain  0  ; temp    heartrate  103.0  resprate  16.0  o2sat  97.0  sbp  162.0  dbp  78.0  rhythm    pain    $hematology blood hematocrit  34.1  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  116  mg dl; chemistry blood albumin  3.4  g dl$nan
hypoxemia dementia in other diseases classified elsewhere without behavioral disturbance acute on chronic systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease old myocardial infarction recurrent oral aphthae hyperosmolality and hypernatremia other specified disorders of muscle personal history of other venous thrombosis and embolism unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris zoster without complications spinal stenosis, site unspecified alzheimer's disease, unspecified retention of urine, unspecified chronic kidney disease, stage 3 (moderate) gout, unspecified gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation behcet's disease sleep terrors [night terrors] toxic encephalopathy myositis, unspecified personal history of nicotine dependence delirium due to known physiological condition iron deficiency anemia, unspecified presence of coronary angioplasty implant and graft other specified diseases of spinal cord acute kidney failure, unspecified polyneuropathy, unspecified obstructive sleep apnea (adult) (pediatric) influenza due to unidentified influenza virus with other respiratory manifestations toxic encephalopathy anemia, unspecified behcet's disease benign prostatic hyperplasia with lower urinary tract symptoms personal history of nicotine dependence frequency of micturition personal history of other venous thrombosis and embolism chronic kidney disease, stage 3 (moderate) old myocardial infarction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease polyneuropathy, unspecified encounter for immunization atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unilateral primary osteoarthritis, right hip hyperlipidemia, unspecified
black african american m 87 $temp    heartrate  80.0  resprate  15.0  o2sat  97.0  sbp  141.0  dbp  47.0  rhythm    pain    $chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  101  mg dl; blood gas blood potassium, whole blood  5.0  meq l; blood gas blood potassium, whole blood  4.3  meq l$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  2.5  mg ; acetaminophen  650  mg ; aspirin  81  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; 
hypoxemia dementia in other diseases classified elsewhere without behavioral disturbance acute on chronic systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease old myocardial infarction recurrent oral aphthae hyperosmolality and hypernatremia other specified disorders of muscle personal history of other venous thrombosis and embolism unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris zoster without complications spinal stenosis, site unspecified alzheimer's disease, unspecified retention of urine, unspecified chronic kidney disease, stage 3 (moderate) gout, unspecified gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation behcet's disease sleep terrors [night terrors] toxic encephalopathy myositis, unspecified personal history of nicotine dependence delirium due to known physiological condition iron deficiency anemia, unspecified presence of coronary angioplasty implant and graft other specified diseases of spinal cord acute kidney failure, unspecified polyneuropathy, unspecified obstructive sleep apnea (adult) (pediatric) influenza due to unidentified influenza virus with other respiratory manifestations toxic encephalopathy anemia, unspecified behcet's disease benign prostatic hyperplasia with lower urinary tract symptoms personal history of nicotine dependence frequency of micturition personal history of other venous thrombosis and embolism chronic kidney disease, stage 3 (moderate) old myocardial infarction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease polyneuropathy, unspecified encounter for immunization atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unilateral primary osteoarthritis, right hip hyperlipidemia, unspecified
black african american m 87 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  87  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; amlodipine  2.5  mg ; acetaminophen  650  mg ; aspirin  81  mg ; multivitamins  1  tab ; tamsulosin  0.4  mg ; vitamin d  2000  unit ; senna  8.6  mg ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; 
hypoxemia dementia in other diseases classified elsewhere without behavioral disturbance acute on chronic systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease old myocardial infarction recurrent oral aphthae hyperosmolality and hypernatremia other specified disorders of muscle personal history of other venous thrombosis and embolism unspecified osteoarthritis, unspecified site atherosclerotic heart disease of native coronary artery without angina pectoris zoster without complications spinal stenosis, site unspecified alzheimer's disease, unspecified retention of urine, unspecified chronic kidney disease, stage 3 (moderate) gout, unspecified gastro-esophageal reflux disease without esophagitis unspecified atrial fibrillation behcet's disease sleep terrors [night terrors] toxic encephalopathy myositis, unspecified personal history of nicotine dependence delirium due to known physiological condition iron deficiency anemia, unspecified presence of coronary angioplasty implant and graft other specified diseases of spinal cord acute kidney failure, unspecified polyneuropathy, unspecified obstructive sleep apnea (adult) (pediatric) influenza due to unidentified influenza virus with other respiratory manifestations toxic encephalopathy anemia, unspecified behcet's disease benign prostatic hyperplasia with lower urinary tract symptoms personal history of nicotine dependence frequency of micturition personal history of other venous thrombosis and embolism chronic kidney disease, stage 3 (moderate) old myocardial infarction hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease polyneuropathy, unspecified encounter for immunization atherosclerotic heart disease of native coronary artery without angina pectoris presence of coronary angioplasty implant and graft unilateral primary osteoarthritis, right hip hyperlipidemia, unspecified
other f 29 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; sucralfate  1  gm ; 
morbid (severe) obesity due to excess calories gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation bariatric surgery status other specified postprocedural states epigastric pain dehydration obesity, unspecified unspecified place or not applicable personal history of nicotine dependence vitamin d deficiency, unspecified body mass index (bmi) 27.0-27.9, adult other specified disorders of peritoneum other complications of other bariatric procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis bariatric surgery status chronic or unspecified gastrojejunal ulcer with perforation morbid (severe) obesity due to excess calories body mass index (bmi) 40.0-44.9, adult encounter for immunization personal history of nicotine dependence outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
other f 29 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; sucralfate  1  gm ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  2-4  mg ; omeprazole  40  mg ; tamsulosin  0.4  mg ; 
morbid (severe) obesity due to excess calories gastric ulcer, unspecified as acute or chronic, without hemorrhage or perforation bariatric surgery status other specified postprocedural states epigastric pain dehydration obesity, unspecified unspecified place or not applicable personal history of nicotine dependence vitamin d deficiency, unspecified body mass index (bmi) 27.0-27.9, adult other specified disorders of peritoneum other complications of other bariatric procedure surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure gastro-esophageal reflux disease without esophagitis bariatric surgery status chronic or unspecified gastrojejunal ulcer with perforation morbid (severe) obesity due to excess calories body mass index (bmi) 40.0-44.9, adult encounter for immunization personal history of nicotine dependence outcome of delivery, single liveborn previous cesarean delivery, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident
white m 31 $temp  98.4  heartrate  100.0  resprate  16.0  o2sat  100.0  sbp  134.0  dbp  797.0  rhythm    pain  0  $hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  389  iu l; chemistry blood % hemoglobin a1c  5.2  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; potassium chloride  40  meq ; 
 
white m 31 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  426  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; potassium chloride  40  meq ; 
 
white m 31 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  257  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; 
 
white m 31 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  326  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; 
 
white m 56 $nan$hematology blood hematocrit  43.5  %; hematology blood hemoglobin  15.6  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  91  mg dl$0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  20  mg ; lisinopril  5  mg ; neut  1  pkt ; warfarin  10  mg ; 
atrial fibrillation other and unspecified hyperlipidemia unspecified essential hypertension other psoriasis
other m 74 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  88  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  165  mg dl; chemistry blood % hemoglobin a1c  6.9  %$ondansetron  4  mg ; lidocaine jelly 2% (urojet)  1  appl ; promethazine  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1  ml ; heparin  5000  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; lactated ringers  1000  ml ; 
 
other m 74 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  116  mg dl$ondansetron  4  mg ; lidocaine jelly 2% (urojet)  1  appl ; promethazine  6.25  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; lactated ringers  1000  ml ; 
 
other m 74 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 
 
other m 51 $temp    heartrate  112.0  resprate  22.0  o2sat    sbp  133.0  dbp  79.0  rhythm    pain    ; temp    heartrate  106.0  resprate  22.0  o2sat  100.0  sbp  121.0  dbp  69.0  rhythm  sinus tachycardia  pain  0  ; temp    heartrate  98.0  resprate  18.0  o2sat  100.0  sbp  132.0  dbp  74.0  rhythm  sinus rhythm  pain  0  $nan$simvastatin  40  mg ; ferrous sulfate  325  mg ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
other m 51 $temp  97.6  heartrate  102.0  resprate  24.0  o2sat  100.0  sbp  116.0  dbp  59.0  rhythm  sinus tachycardia  pain  0  ; temp  98.2  heartrate  105.0  resprate  16.0  o2sat  98.0  sbp  102.0  dbp  64.0  rhythm  sinus tachycardia  pain  0  ; temp  98.1  heartrate  102.0  resprate  19.0  o2sat  100.0  sbp  113.0  dbp  61.0  rhythm  sinus tachycardia  pain  0  ; temp  98.2  heartrate  100.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  67.0  rhythm  sinus tachycardia  pain  0  $hematology blood hematocrit  20.5  %; hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  299  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  89  mg dl$simvastatin  40  mg ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; alendronate sodium  70  mg ; nortriptyline  25  mg ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
other m 51 $nan$hematology blood hematocrit  25.5  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  80  mg dl$simvastatin  40  mg ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; alendronate sodium  70  mg ; nortriptyline  25  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
other m 51 $nan$hematology blood hematocrit  31.2  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  92  mg dl$simvastatin  40  mg ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole  40  mg ; alendronate sodium  70  mg ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; moviprep  1  l ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
other m 51 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  110  mg dl$simvastatin  40  mg ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; alendronate sodium  70  mg ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
other m 51 $nan$nan$simvastatin  40  mg ; ferrous sulfate  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 
personal history of colonic polyps fever, unspecified personal history of peptic ulcer disease other specified cardiac dysrhythmias other and unspecified hyperlipidemia precipitous drop in hematocrit blood in stool 
black african american f 59 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  271  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood glucose  89  mg dl$nan
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  284  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  67  mg dl; blood gas blood lactate  1.2  mmol l$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ondansetron  4  mg ; tramadol (ultram)  50  mg ; lorazepam  1  mg ; insulin  14  unit ; metoclopramide  10  mg ; heparin  5000  unit ; morphine sulfate  2-4  mg ; furosemide  40  mg ; nifedipine cr  90  mg ; omeprazole  20  mg ; spironolactone  50  mg ; spironolactone  100  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  30  unit ; d5ns  1000  ml ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  5  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; ondansetron  4  mg ; tramadol (ultram)  50  mg ; lorazepam  1  mg ; insulin  14  unit ; metoclopramide  10  mg ; heparin  5000  unit ; furosemide  40  mg ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; hydromorphone (dilaudid)  0.5-1  mg ; insulin  30  unit ; d5ns  1000  ml ; hydromorphone (dilaudid)  0.25  mg ; diphenhydramine  25  mg ; golytely  4  l ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; insulin  14  unit ; metoclopramide  10  mg ; heparin  5000  unit ; furosemide  40  mg ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; insulin  30  unit ; diphenhydramine  25  mg ; golytely  4  l ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; magnesium sulfate  4  gm ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  129  mg dl; blood gas blood lactate  1.0  mmol l$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; insulin  0  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; insulin  14  unit ; metoclopramide  10  mg ; heparin  5000  unit ; furosemide  40  mg ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; insulin  30  unit ; diphenhydramine  25  mg ; golytely  4  l ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; magnesium sulfate  4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; oxycodone (immediate release)   5-10  mg ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  266  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  82  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; metoclopramide  10  mg ; heparin  5000  unit ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; diphenhydramine  25  mg ; golytely  4  l ; sw  50  ml ; magnesium sulfate  2  gm ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  281  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  64  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; metoclopramide  10  mg ; heparin  5000  unit ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; diphenhydramine  25  mg ; golytely  4  l ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; sw  100  ml ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
black african american f 59 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; verapamil sr  240  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; metoclopramide  10  mg ; heparin  5000  unit ; nifedipine cr  90  mg ; omeprazole  20  mg ; ondansetron  8  mg ; diphenhydramine  25  mg ; golytely  4  l ; oxycodone (immediate release)   5-10  mg ; morphine sulfate  2  mg ; 0.9% sodium chloride  100  ml ; ferric gluconate  125  mg ; sw  100  ml ; chlorthalidone  25  mg ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; 
leiomyoma of uterus, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled pure hypercholesterolemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled proteinuria nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere gastroparesis abdominal pain, unspecified site unspecified essential hypertension nausea alone edema
white f 86 $temp  98.0  heartrate  100.0  resprate  16.0  o2sat  96.0  sbp  146.0  dbp  91.0  rhythm    pain  0 10  $nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; cyanocobalamin  1000  mcg ; levothyroxine sodium  25  mcg ; ranitidine  150  mg ; simvastatin  20  mg ; losartan potassium  50  mg ; acetaminophen  650  mg ; hydrochlorothiazide  6.25  mg ; 
other amyloidosis unspecified essential hypertension unspecified intracranial hemorrhage urinary tract infection, site not specified other and unspecified hyperlipidemia unspecified cerebrovascular disease
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; cyanocobalamin  1000  mcg ; levothyroxine sodium  25  mcg ; ranitidine  150  mg ; simvastatin  20  mg ; losartan potassium  50  mg ; acetaminophen  650  mg ; hydrochlorothiazide  6.25  mg ; docusate sodium  200  mg ; vitamin d  800  unit ; calcium carbonate  1000  mg ; morphine sulfate  1-2  mg ; tramadol (ultram)  25  mg ; ciprofloxacin hcl  500  mg ; 
other amyloidosis unspecified essential hypertension unspecified intracranial hemorrhage urinary tract infection, site not specified other and unspecified hyperlipidemia unspecified cerebrovascular disease
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; cyanocobalamin  1000  mcg ; levothyroxine sodium  25  mcg ; ranitidine  150  mg ; simvastatin  20  mg ; losartan potassium  50  mg ; hydrochlorothiazide  6.25  mg ; docusate sodium  200  mg ; tramadol (ultram)  25  mg ; ciprofloxacin hcl  500  mg ; 
other amyloidosis unspecified essential hypertension unspecified intracranial hemorrhage urinary tract infection, site not specified other and unspecified hyperlipidemia unspecified cerebrovascular disease
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; cyanocobalamin  1000  mcg ; levothyroxine sodium  25  mcg ; ranitidine  150  mg ; simvastatin  20  mg ; losartan potassium  50  mg ; hydrochlorothiazide  6.25  mg ; docusate sodium  200  mg ; tramadol (ultram)  25  mg ; ciprofloxacin hcl  500  mg ; 
other amyloidosis unspecified essential hypertension unspecified intracranial hemorrhage urinary tract infection, site not specified other and unspecified hyperlipidemia unspecified cerebrovascular disease
white f 86 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; cyanocobalamin  1000  mcg ; levothyroxine sodium  25  mcg ; ranitidine  150  mg ; simvastatin  20  mg ; losartan potassium  50  mg ; hydrochlorothiazide  6.25  mg ; docusate sodium  200  mg ; tramadol (ultram)  25  mg ; ciprofloxacin hcl  500  mg ; 
other amyloidosis unspecified essential hypertension unspecified intracranial hemorrhage urinary tract infection, site not specified other and unspecified hyperlipidemia unspecified cerebrovascular disease
black african american f 47 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; simethicone  40-80  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; acetaminophen iv  1000  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter agranulocytosis secondary to cancer chemotherapy other specified disorders of bone, unspecified site candidal stomatitis nausea with vomiting, unspecified constipation, unspecified unspecified abdominal pain malignant neoplasm of unspecified site of left female breast estrogen receptor positive status [er+] vitamin d deficiency, unspecified migraine, unspecified, not intractable, without status migrainosus spinal stenosis, cervical region
black african american f 47 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5  mg ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; simethicone  40-80  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; acetaminophen iv  1000  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; lorazepam  1  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter agranulocytosis secondary to cancer chemotherapy other specified disorders of bone, unspecified site candidal stomatitis nausea with vomiting, unspecified constipation, unspecified unspecified abdominal pain malignant neoplasm of unspecified site of left female breast estrogen receptor positive status [er+] vitamin d deficiency, unspecified migraine, unspecified, not intractable, without status migrainosus spinal stenosis, cervical region
black african american f 47 $nan$nan$heparin  5000  unit ; influenza vaccine quadrivalent  0.5  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; acetaminophen  1000  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125  mg ; sodium chloride 0.9%  flush  3  ml ; maalox diphenhydramine lidocaine  15-30  ml ; nystatin oral suspension  5  ml ; simethicone  40-80  mg ; lactated ringers  1000  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-10  mg ; prochlorperazine  10  mg ; docusate sodium  100  mg ; lorazepam  1  mg ; bisacodyl  10  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter agranulocytosis secondary to cancer chemotherapy other specified disorders of bone, unspecified site candidal stomatitis nausea with vomiting, unspecified constipation, unspecified unspecified abdominal pain malignant neoplasm of unspecified site of left female breast estrogen receptor positive status [er+] vitamin d deficiency, unspecified migraine, unspecified, not intractable, without status migrainosus spinal stenosis, cervical region
white f 59 $nan$hematology blood hematocrit  36.2  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  277  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  6.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood glucose  131  mg dl$nan
 
white f 59 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  6.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry urine chloride, urine  83  meq l; chemistry urine creatinine, urine  39  mg dl; chemistry urine potassium, urine  33  meq l; chemistry urine sodium, urine  85  meq l; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  101  mg dl$ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; bisacodyl  10  mg ; amlodipine  10  mg ; atenolol  100  mg ; levothyroxine sodium  125  mcg ; aspirin  81  mg ; multivitamins  1  cap ; simvastatin  20  mg ; sodium polystyrene sulfonate  30  gm ; 
 
white f 59 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  90  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; bisacodyl  10  mg ; amlodipine  10  mg ; atenolol  100  mg ; levothyroxine sodium  125  mcg ; aspirin  81  mg ; multivitamins  1  cap ; simvastatin  20  mg ; sodium polystyrene sulfonate  30  gm ; 
 
white m 60 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; polyethylene glycol  17  g ; morphine sr (ms contin)  15  mg ; morphine sulfate ir  15-30  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; diazepam  2.5  mg ; senna  8.6  mg ; 
personal history of tobacco use other and unspecified angina pectoris chronic total occlusion of coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery intermediate coronary syndrome personal history of tobacco use 
white m 60 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; polyethylene glycol  17  g ; morphine sr (ms contin)  15  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; diazepam  2.5  mg ; senna  8.6  mg ; diazepam  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
personal history of tobacco use other and unspecified angina pectoris chronic total occlusion of coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery intermediate coronary syndrome personal history of tobacco use 
white m 60 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; morphine sr (ms contin)  15  mg ; docusate sodium  100  mg ; enoxaparin sodium  40  mg ; senna  8.6  mg ; diazepam  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
personal history of tobacco use other and unspecified angina pectoris chronic total occlusion of coronary artery other and unspecified hyperlipidemia coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery intermediate coronary syndrome personal history of tobacco use 
white f 50 $nan$nan$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; senna  1  tab ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; sucralfate  1  gm ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; iso-osmotic dextrose  200  ml ; docusate sodium  100  mg ; bisacodyl  10  mg ; fluoxetine  40  mg ; omeprazole  40  mg ; vitamin d  400  unit ; gabapentin  1200  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; senna  1  tab ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; sucralfate  1  gm ; docusate sodium  100  mg ; bisacodyl  10  mg ; fluoxetine  40  mg ; omeprazole  40  mg ; vitamin d  400  unit ; gabapentin  1200  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; senna  1  tab ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; sucralfate  1  gm ; docusate sodium  100  mg ; bisacodyl  10  mg ; fluoxetine  40  mg ; omeprazole  40  mg ; vitamin d  400  unit ; gabapentin  1200  mg ; oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  2  mg ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; sucralfate  1  gm ; docusate sodium  100  mg ; bisacodyl  10  mg ; fluoxetine  40  mg ; omeprazole  40  mg ; vitamin d  400  unit ; gabapentin  1200  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  2  mg ; milk of magnesia  30  ml ; 
 
white f 50 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; acetaminophen  325-650  mg ; diazepam  2-5  mg ; sucralfate  1  gm ; docusate sodium  100  mg ; bisacodyl  10  mg ; fluoxetine  40  mg ; omeprazole  40  mg ; vitamin d  400  unit ; gabapentin  1200  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; milk of magnesia  30  ml ; 
 
white f 73 $temp    heartrate  70.0  resprate  18.0  o2sat  100.0  sbp  142.0  dbp  69.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  69.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  62.0  rhythm  sinus rhythm  pain  0  ; temp    heartrate  70.0  resprate  18.0  o2sat  98.0  sbp  120.0  dbp  56.0  rhythm  sinus rhythm  pain  0  $nan$aspirin  325  mg ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; prasugrel  10  mg ; diltiazem extended-release  120  mg ; 
subendocardial infarction, initial episode of care systemic lupus erythematosus other iatrogenic hypotension atrial fibrillation other and unspecified hyperlipidemia urinary tract infection, site not specified coronary atherosclerosis of native coronary artery cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other and unspecified escherichia coli [e. coli] hematoma complicating a procedure do not resuscitate status 
white f 73 $temp  97.9  heartrate  69.0  resprate  17.0  o2sat  100.0  sbp  124.0  dbp  62.0  rhythm    pain    $hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  113  mg dl$aspirin  325  mg ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; prasugrel  10  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; clonazepam  0.5  mg ; docusate sodium  100  mg ; atorvastatin  10  mg ; ciprofloxacin hcl  500  mg ; hydroxychloroquine sulfate  200  mg ; restasis  1  gtt ; amlodipine  5  mg ; 
subendocardial infarction, initial episode of care systemic lupus erythematosus other iatrogenic hypotension atrial fibrillation other and unspecified hyperlipidemia urinary tract infection, site not specified coronary atherosclerosis of native coronary artery cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other and unspecified escherichia coli [e. coli] hematoma complicating a procedure do not resuscitate status 
white f 73 $nan$nan$aspirin  325  mg ; metoprolol succinate xl  25  mg ; multivitamins  1  tab ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; prasugrel  10  mg ; diltiazem extended-release  120  mg ; sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; heparin  5000  unit ; oxycodone (immediate release)   5  mg ; pantoprazole  40  mg ; clonazepam  0.5  mg ; docusate sodium  100  mg ; atorvastatin  10  mg ; ciprofloxacin hcl  500  mg ; hydroxychloroquine sulfate  200  mg ; restasis  1  gtt ; amlodipine  5  mg ; potassium chloride  20  meq ; 
subendocardial infarction, initial episode of care systemic lupus erythematosus other iatrogenic hypotension atrial fibrillation other and unspecified hyperlipidemia urinary tract infection, site not specified coronary atherosclerosis of native coronary artery cardiac catheterization as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure other and unspecified escherichia coli [e. coli] hematoma complicating a procedure do not resuscitate status 
white f 82 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; heparin  900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; levothyroxine sodium  50  mcg ; acetaminophen  325-650  mg ; citalopram  10  mg ; fluticasone propionate nasal  2  spry ; omeprazole  40  mg ; vitamin d  2000  unit ; atenolol  25  mg ; hydrochlorothiazide  12.5  mg ; aspirin  81  mg ; atorvastatin  80  mg ; 
 
other m 64 $nan$nan$bisacodyl  10  mg ; metoprolol succinate xl  25  mg ; probenecid  500  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; morphine sulfate  100  mg ; diazepam  2-5  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; oxycodone (immediate release)   5-15  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  1  appl ; 
 
other m 64 $nan$nan$bisacodyl  10  mg ; metoprolol succinate xl  25  mg ; probenecid  500  mg ; simvastatin  10  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; milk of magnesia  30  ml ; ondansetron  4  mg ; diazepam  2-5  mg ; acetaminophen  325-650  mg ; oxycodone (immediate release)   5-15  mg ; lorazepam  0.5  mg ; docusate sodium  100  mg ; senna  1  tab ; lidocaine jelly 2% (urojet)  1  appl ; 
 
other f 39 $temp    heartrate  77.0  resprate  16.0  o2sat  100.0  sbp  98.0  dbp  71.0  rhythm    pain  0  ; temp    heartrate  75.0  resprate  16.0  o2sat  99.0  sbp  100.0  dbp  56.0  rhythm    pain  0  $nan$isosorbide mononitrate (extended release)  60  mg ; 
 
other f 39 $temp  98.0  heartrate  76.0  resprate  16.0  o2sat  99.0  sbp  102.0  dbp  66.0  rhythm    pain  0  ; temp    heartrate  78.0  resprate  16.0  o2sat  100.0  sbp  99.0  dbp  73.0  rhythm    pain  0  $hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  19  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry urine chloride, urine  15  meq l; chemistry urine creatinine, urine  93  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  13  meq l; hematology urine wbc  2  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  91  mg dl; chemistry urine protein creatinine ratio  0.2  mg mg; chemistry urine calcium, urine  1.7  mg dl$isosorbide mononitrate (extended release)  60  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; neutra-phos  2  pkt ; 
 
other f 39 $nan$chemistry urine chloride, urine  79  meq l; chemistry urine creatinine, urine  58  mg dl; chemistry urine potassium, urine  53  meq l; chemistry urine sodium, urine  79  meq l; chemistry urine urea nitrogen, urine  487  mg dl; chemistry urine calcium, urine  9.0  mg dl$isosorbide mononitrate (extended release)  60  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; potassium chloride  60  meq ; bag  50  ml ; magnesium sulfate  2  gm ; neutra-phos  2  pkt ; 
 
black african american m 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; aspirin  325  mg ; memantine  10  mg ; simvastatin  10  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction other and unspecified hyperlipidemia malignant neoplasm of prostate unspecified essential hypertension dementia, unspecified, without behavioral disturbance 
black african american m 76 $nan$nan$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; clopidogrel  75  mg ; atorvastatin  80  mg ; atorvastatin  20  mg ; 
cerebral artery occlusion, unspecified with cerebral infarction other and unspecified hyperlipidemia malignant neoplasm of prostate unspecified essential hypertension dementia, unspecified, without behavioral disturbance 
black african american m 76 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  99  mg dl$sodium chloride 0.9%  flush  3  ml ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; hydralazine  10  mg ; insulin  0  unit ; heparin  5000  unit ; docusate sodium  100  mg ; memantine  10  mg ; clopidogrel  75  mg ; atorvastatin  20  mg ; atorvastatin  40  mg ; potassium chloride  40  meq ; 
cerebral artery occlusion, unspecified with cerebral infarction other and unspecified hyperlipidemia malignant neoplasm of prostate unspecified essential hypertension dementia, unspecified, without behavioral disturbance 
black african american f 82 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  91  mg dl; chemistry blood % hemoglobin a1c  5.8  %$senna  8.6  mg ; bisacodyl  10  mg ; acetaminophen  650  mg ; hydralazine  10  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; atorvastatin  40  mg ; heparin  5000  unit ; 
malignant neoplasm of thyroid gland 
black african american f 82 $nan$hematology blood hematocrit  42.3  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  102  mg dl$acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; atorvastatin  40  mg ; heparin  5000  unit ; aspirin  81  mg ; 
malignant neoplasm of thyroid gland 
black african american f 82 $nan$nan$acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; atorvastatin  40  mg ; heparin  5000  unit ; aspirin  81  mg ; 
malignant neoplasm of thyroid gland 
white f 32 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  212  k ul$naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 32 $nan$nan$naloxone  40-80  mcg ; ketorolac  15-30  mg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 32 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 32 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 32 $nan$nan$naloxone  40-80  mcg ; ondansetron  4  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; oxycodone (immediate release)   5-10  mg ; 
 
white f 47 $nan$nan$ezetimibe  10  mg ; pravastatin  20  mg ; prednisone  5  mg ; valsartan  80  mg ; aspirin  81  mg ; clopidogrel  75  mg ; 
urinary tract infection, site not specified hyperpotassemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy ulcer of heel and midfoot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia old myocardial infarction neurogenic bladder nos kidney replaced by transplant chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled kidney replaced by transplant neurogenic bladder nos chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications long-term (current) use of insulin ulcer of heel and midfoot diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled leukocytopenia, unspecified end stage renal disease old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cellulitis and abscess of foot, except toes end stage renal disease polyneuropathy in diabetes kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
white f 47 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  209  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$ezetimibe  10  mg ; pravastatin  20  mg ; prednisone  5  mg ; valsartan  80  mg ; aspirin  81  mg ; clopidogrel  75  mg ; ciprofloxacin hcl  500  mg ; hydrocodone-acetaminophen  1-2  tab ; metoclopramide  5  mg ; pregabalin  100  mg ; insulin  0  unit ; 0.9% sodium chloride  500  ml ; acetylcysteine 20%  1200  mg ; mycophenolate mofetil  1000  mg ; pregabalin  50  mg ; pregabalin  150  mg ; ferrous sulfate  325  mg ; famotidine  20  mg ; docusate sodium  100  mg ; insulin  28  unit ; hydromorphone (dilaudid)  2-4  mg ; insulin  20  unit ; insulin  6  unit ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; tacrolimus  3  mg ; tacrolimus  0.5  mg ; mycophenolate mofetil  500  mg ; clopidogrel  150  mg ; 
urinary tract infection, site not specified hyperpotassemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy ulcer of heel and midfoot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia old myocardial infarction neurogenic bladder nos kidney replaced by transplant chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled kidney replaced by transplant neurogenic bladder nos chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications long-term (current) use of insulin ulcer of heel and midfoot diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled leukocytopenia, unspecified end stage renal disease old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cellulitis and abscess of foot, except toes end stage renal disease polyneuropathy in diabetes kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
white f 47 $nan$hematology blood hematocrit  29.0  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  216  mg dl$aspirin  81  mg ; insulin  0  unit ; acetylcysteine 20%  1200  mg ; pregabalin  50  mg ; pregabalin  150  mg ; ferrous sulfate  325  mg ; famotidine  20  mg ; docusate sodium  100  mg ; insulin  28  unit ; hydromorphone (dilaudid)  2-4  mg ; insulin  20  unit ; insulin  6  unit ; tacrolimus  0.5  mg ; clopidogrel  150  mg ; 
urinary tract infection, site not specified hyperpotassemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy ulcer of heel and midfoot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia old myocardial infarction neurogenic bladder nos kidney replaced by transplant chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled kidney replaced by transplant neurogenic bladder nos chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications long-term (current) use of insulin ulcer of heel and midfoot diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled leukocytopenia, unspecified end stage renal disease old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cellulitis and abscess of foot, except toes end stage renal disease polyneuropathy in diabetes kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
white f 47 $nan$nan$aspirin  81  mg ; insulin  0  unit ; acetylcysteine 20%  1200  mg ; pregabalin  50  mg ; pregabalin  150  mg ; ferrous sulfate  325  mg ; famotidine  20  mg ; docusate sodium  100  mg ; insulin  28  unit ; hydromorphone (dilaudid)  2-4  mg ; tacrolimus  0.5  mg ; clopidogrel  150  mg ; 
urinary tract infection, site not specified hyperpotassemia car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled polyneuropathy in diabetes background diabetic retinopathy ulcer of heel and midfoot diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia old myocardial infarction neurogenic bladder nos kidney replaced by transplant chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin unspecified essential hypertension diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled atherosclerosis of native arteries of the extremities with gangrene nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled kidney replaced by transplant neurogenic bladder nos chronic hepatitis c without mention of hepatic coma atherosclerosis of native arteries of the extremities with ulceration long-term (current) use of other medications long-term (current) use of insulin ulcer of heel and midfoot diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled leukocytopenia, unspecified end stage renal disease old myocardial infarction hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident cellulitis and abscess of foot, except toes end stage renal disease polyneuropathy in diabetes kidney replaced by transplant hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease chronic hepatitis c without mention of hepatic coma long-term (current) use of insulin neurogenic bladder nos car driver injured in collision with two- or three-wheeled motor vehicle in nontraffic accident diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled chronic hepatitis c without mention of hepatic coma
white m 63 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  5.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  175  mg dl; hematology blood bands  0  %$nan
 
white m 63 $temp  97.6  heartrate  73.0  resprate  16.0  o2sat  99.0  sbp  149.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  22.9  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  230  k ul; hematology blood platelet count  226  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  5.4  mg dl; chemistry blood creatinine  5.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  62  mg dl; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine chloride, urine  46  meq l; chemistry urine creatinine, urine  24  mg dl; chemistry urine potassium, urine  9  meq l; chemistry urine sodium, urine  49  meq l; chemistry urine urea nitrogen, urine  168  mg dl; hematology urine wbc  0  # hpf; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  198  mg dl; chemistry urine protein creatinine ratio  1.7  ratio; hematology urine glucose  300  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; carvedilol  25  mg ; amlodipine  10  mg ; aspirin  81  mg ; omeprazole  20  mg ; rosuvastatin calcium  20  mg ; vitamin d  1000  unit ; lorazepam  1-2  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; 
 
white m 63 $nan$hematology blood hematocrit  22.1  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  230  k ul; hematology blood platelet count  266  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  4.5  mg dl; chemistry blood creatinine  3.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  50  mg dl; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  177  mg dl$sodium chloride 0.9%  flush  3  ml ; carvedilol  25  mg ; amlodipine  10  mg ; rosuvastatin calcium  20  mg ; vitamin d  1000  unit ; lorazepam  1-2  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; prednisone  40  mg ; cyanocobalamin  1000  mcg ; 
 
white m 63 $nan$hematology blood hematocrit  28.9  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  4.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  44  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  170  mg dl; hematology urine glucose  150  mg dl$sodium chloride 0.9%  flush  3  ml ; carvedilol  25  mg ; amlodipine  10  mg ; rosuvastatin calcium  20  mg ; vitamin d  1000  unit ; lorazepam  1-2  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prednisone  40  mg ; cyanocobalamin  1000  mcg ; ranitidine  150  mg ; bag  50  ml ; magnesium sulfate  4  gm ; insulin  10  unit ; 
 
white m 63 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  9.8  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; carvedilol  25  mg ; amlodipine  10  mg ; rosuvastatin calcium  20  mg ; vitamin d  1000  unit ; lorazepam  1-2  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; prednisone  40  mg ; ranitidine  150  mg ; bag  50  ml ; magnesium sulfate  4  gm ; insulin  10  unit ; 
 
white m 62 $nan$nan$atenolol  25  mg ; omeprazole  20  mg ; 
anemia, unspecified other respiratory abnormalities malignant neoplasm of lower third of esophagus percutaneous transluminal coronary angioplasty status old myocardial infarction antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use accidents occurring in residential institution long-term (current) use of other medications need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery esophageal reflux old myocardial infarction esophageal reflux osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified malignant neoplasm of lower third of esophagus cervical spondylosis without myelopathy chest pain, unspecified hyposmolality and/or hyponatremia coronary atherosclerosis of native coronary artery hypovolemia old myocardial infarction personal history of tobacco use malignant neoplasm of esophagus, unspecified site unspecified essential hypertension dysphagia, unspecified malignant neoplasm of esophagus, unspecified site esophageal reflux 
white m 62 $nan$hematology blood hematocrit  31.4  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.8  g dl; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  60  k ul; hematology blood platelet count  61  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  94  mg dl$atenolol  25  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride  40  meq ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
anemia, unspecified other respiratory abnormalities malignant neoplasm of lower third of esophagus percutaneous transluminal coronary angioplasty status old myocardial infarction antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use accidents occurring in residential institution long-term (current) use of other medications need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery esophageal reflux old myocardial infarction esophageal reflux osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified malignant neoplasm of lower third of esophagus cervical spondylosis without myelopathy chest pain, unspecified hyposmolality and/or hyponatremia coronary atherosclerosis of native coronary artery hypovolemia old myocardial infarction personal history of tobacco use malignant neoplasm of esophagus, unspecified site unspecified essential hypertension dysphagia, unspecified malignant neoplasm of esophagus, unspecified site esophageal reflux 
white m 62 $nan$nan$atenolol  25  mg ; omeprazole  20  mg ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; 
anemia, unspecified other respiratory abnormalities malignant neoplasm of lower third of esophagus percutaneous transluminal coronary angioplasty status old myocardial infarction antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use accidents occurring in residential institution long-term (current) use of other medications need for prophylactic vaccination and inoculation against influenza coronary atherosclerosis of native coronary artery esophageal reflux old myocardial infarction esophageal reflux osteoarthrosis involving, or with mention of more than one site, but not specified as generalized, site unspecified malignant neoplasm of lower third of esophagus cervical spondylosis without myelopathy chest pain, unspecified hyposmolality and/or hyponatremia coronary atherosclerosis of native coronary artery hypovolemia old myocardial infarction personal history of tobacco use malignant neoplasm of esophagus, unspecified site unspecified essential hypertension dysphagia, unspecified malignant neoplasm of esophagus, unspecified site esophageal reflux 
white f 23 $temp  98.7  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  113.0  dbp  78.0  rhythm    pain  4  ; temp  98.0  heartrate  88.0  resprate  18.0  o2sat  99.0  sbp  124.0  dbp  75.0  rhythm    pain    $hematology blood hematocrit  39.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  76  mg dl$nan
 
white f 42 $temp  98.1  heartrate  64.0  resprate  16.0  o2sat  100.0  sbp  133.0  dbp  71.0  rhythm    pain  3  $hematology blood hematocrit  36.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  84  mg dl; chemistry blood lactate dehydrogenase (ld)  144  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; lactated ringers  1000  ml ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; nicotine patch  14  mg ; 
 
white f 42 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  75  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; nicotine patch  14  mg ; d5 1 2ns  1000  ml ; 
 
white f 42 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; nicotine patch  14  mg ; d5 1 2ns  1000  ml ; 
 
white f 42 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  3  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; nicotine patch  14  mg ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; acetaminophen  500-1000  mg ; 
 
white f 42 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ondansetron  4  mg ; oxycodone (immediate release)  5-10  mg ; acetaminophen  500-1000  mg ; 
 
white f 61 $temp  99.5  heartrate  74.0  resprate  16.0  o2sat    sbp  128.0  dbp  82.0  rhythm    pain  4  $hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  209  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  158  mg dl; chemistry blood lactate dehydrogenase (ld)  270  iu l; chemistry blood albumin  4.1  g dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood glucose  103  mg dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  40  meq ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$hematology blood hematocrit  38.6  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  92  mg dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  40  meq ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  89  mg dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  60  meq ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  94  mg dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; potassium chloride  60  meq ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  94  mg dl$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 61 $nan$nan$chlorthalidone  25  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; ondansetron  4-8  mg ; dexamethasone  4  mg ; fluoxetine  40  mg ; levetiracetam  250  mg ; levetiracetam  2000  mg ; lorazepam  1  mg ; omeprazole  20  mg ; zonisamide  100  mg ; metoprolol tartrate  12.5  mg ; 
hemiplegia, unspecified affecting left nondominant side major depressive disorder, single episode, unspecified personal history of nicotine dependence facial weakness other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus malignant neoplasm of frontal lobe essential (primary) hypertension paresthesia of skin cysticercosis of central nervous system disorder of brain, unspecified localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus major depressive disorder, single episode, unspecified major depressive disorder, single episode, unspecified personal history of nicotine dependence unspecified convulsions cysticercosis of central nervous system essential (primary) hypertension cerebral edema
white f 28 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  244  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; fluoxetine  20  mg ; ranitidine  150  mg ; prednisone  10  mg ; 
pain in joint, ankle and foot psoriatic arthropathy candidiasis of vulva and vagina backache, unspecified edema other diseases of spleen other chronic nonalcoholic liver disease 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; fluoxetine  20  mg ; ranitidine  150  mg ; prednisone  10  mg ; 
pain in joint, ankle and foot psoriatic arthropathy candidiasis of vulva and vagina backache, unspecified edema other diseases of spleen other chronic nonalcoholic liver disease 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; fluoxetine  20  mg ; ranitidine  150  mg ; prednisone  10  mg ; 
pain in joint, ankle and foot psoriatic arthropathy candidiasis of vulva and vagina backache, unspecified edema other diseases of spleen other chronic nonalcoholic liver disease 
white f 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; oxycodone (immediate release)   5-10  mg ; fluoxetine  20  mg ; ranitidine  150  mg ; prednisone  10  mg ; 
pain in joint, ankle and foot psoriatic arthropathy candidiasis of vulva and vagina backache, unspecified edema other diseases of spleen other chronic nonalcoholic liver disease 
white m 91 $nan$nan$finasteride  5  mg ; hydrochlorothiazide  12.5  mg ; simvastatin  5  mg ; acetaminophen  650  mg ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; pilocarpine 4%  1  drop ; oxycodone-acetaminophen  1-2  tab ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; timolol maleate 0.5%  1  drop ; gabapentin  300  mg ; tamsulosin  0.4  mg ; lumigan  1  gtt ; 
 
white m 91 $nan$nan$finasteride  5  mg ; hydrochlorothiazide  12.5  mg ; simvastatin  5  mg ; acetaminophen  650  mg ; simethicone  40-80  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5  mg ; clonazepam  0.5  mg ; pilocarpine 4%  1  drop ; oxycodone-acetaminophen  1-2  tab ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; timolol maleate 0.5%  1  drop ; gabapentin  300  mg ; tamsulosin  0.4  mg ; lumigan  1  gtt ; 
 
white m 73 $nan$nan$zonisamide  75  mg ; simvastatin  20  mg ; metoprolol tartrate  12.5  mg ; heparin  5000  unit ; 
 
white m 73 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  88  mg dl$zonisamide  75  mg ; simvastatin  20  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  1500-2900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; clopidogrel  75  mg ; zonisamide  25  mg ; aspirin  81  mg ; omeprazole  20  mg ; lidocaine jelly 2% (urojet)  1  appl ; carbidopa-levodopa (10-100)  1  tab ; 
 
white m 73 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  97  mg dl$zonisamide  75  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  1500-2900  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; zonisamide  25  mg ; aspirin  81  mg ; omeprazole  20  mg ; lidocaine jelly 2% (urojet)  1  appl ; carbidopa-levodopa (10-100)  1  tab ; potassium chloride  40  meq ; dabigatran etexilate  150  mg ; 
 
white m 73 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  89  mg dl$zonisamide  75  mg ; simvastatin  20  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; zonisamide  25  mg ; aspirin  81  mg ; omeprazole  20  mg ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  40  meq ; dabigatran etexilate  150  mg ; polyethylene glycol  17  g ; senna  1  tab ; influenza virus vaccine  0.5  ml ; 
 
white m 77 $temp  97.7  heartrate  68.0  resprate  18.0  o2sat  100.0  sbp  149.0  dbp  79.0  rhythm    pain    $hematology blood hematocrit  29.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  272  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  85  mg dl; chemistry blood lactate dehydrogenase (ld)  174  iu l$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; aspirin  81  mg ; docusate sodium  100  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; senna  8.6  mg ; polyethylene glycol  17  g ; lidocaine 1%  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  200  mg ; senna  17.2  mg ; 
hypothyroidism, unspecified diffuse large b-cell lymphoma, lymph nodes of head, face, and neck essential (primary) hypertension 
white m 77 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  252  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  107  mg dl$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; aspirin  81  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; polyethylene glycol  17  g ; lidocaine 1%  1  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  200  mg ; senna  17.2  mg ; 
hypothyroidism, unspecified diffuse large b-cell lymphoma, lymph nodes of head, face, and neck essential (primary) hypertension 
white m 77 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  294  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  102  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; aspirin  81  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  200  mg ; senna  17.2  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; dexamethasone  12  mg ; 0.9% sodium chloride  500  ml ; rituximab  800  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1620  mg ; syringe (chemo)  54.5  ml ; doxorubicin  109  mg ; syringe (chemo)  2  ml ; vincristine (oncovin)  2  mg ; prednisone  100  mg ; sodium chloride 0.9%  1000  ml ; 
hypothyroidism, unspecified diffuse large b-cell lymphoma, lymph nodes of head, face, and neck essential (primary) hypertension 
white m 77 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  263  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  234  mg dl; chemistry blood glucose  94  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; hematology blood bands  1  %$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; aspirin  81  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; polyethylene glycol  17  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  200  mg ; senna  17.2  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; dexamethasone  12  mg ; 0.9% sodium chloride  500  ml ; rituximab  800  mg ; 0.9% sodium chloride  250  ml ; cyclophosphamide  1620  mg ; syringe (chemo)  54.5  ml ; doxorubicin  109  mg ; syringe (chemo)  2  ml ; vincristine (oncovin)  2  mg ; prednisone  100  mg ; sodium chloride 0.9%  1000  ml ; cephalexin  500  mg ; neutra-phos  2  pkt ; 
hypothyroidism, unspecified diffuse large b-cell lymphoma, lymph nodes of head, face, and neck essential (primary) hypertension 
white m 77 $nan$nan$heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; heparin  5000  unit ; aspirin  81  mg ; hydrochlorothiazide  12.5  mg ; levothyroxine sodium  112  mcg ; losartan potassium  50  mg ; polyethylene glycol  17  g ; docusate sodium  200  mg ; senna  17.2  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; ondansetron  16  mg ; prednisone  100  mg ; sodium chloride 0.9%  1000  ml ; cephalexin  500  mg ; neutra-phos  2  pkt ; 
hypothyroidism, unspecified diffuse large b-cell lymphoma, lymph nodes of head, face, and neck essential (primary) hypertension 
white f 91 $temp  98.1  heartrate  68.0  resprate  18.0  o2sat  95.0  sbp  117.0  dbp  70.0  rhythm    pain  0  ; temp  98.0  heartrate  70.0  resprate  18.0  o2sat  96.0  sbp  105.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  32.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  42  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  81  mg dl; blood gas blood lactate  1.4  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; senna  17.2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; trazodone  37.5  mg ; isosorbide dinitrate  5  mg ; vitamin d  1000  unit ; omeprazole  20  mg ; multivitamins w minerals  1  tab ; metoprolol succinate xl  150  mg ; ferrous sulfate  325  mg ; citalopram  30  mg ; buspirone  10  mg ; metoprolol tartrate  37.5  mg ; furosemide  40  mg ; warfarin  1  mg ; 
 
white f 91 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  25  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  107  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; senna  17.2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; isosorbide dinitrate  5  mg ; vitamin d  1000  unit ; omeprazole  20  mg ; multivitamins w minerals  1  tab ; ferrous sulfate  325  mg ; metoprolol tartrate  37.5  mg ; furosemide  40  mg ; warfarin  1  mg ; bumetanide  1.5  mg ; 
 
white f 91 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  186  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; senna  17.2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; isosorbide dinitrate  5  mg ; vitamin d  1000  unit ; omeprazole  20  mg ; multivitamins w minerals  1  tab ; ferrous sulfate  325  mg ; metoprolol tartrate  37.5  mg ; cefpodoxime proxetil  200  mg ; 
 
white m 53 $nan$nan$cefazolin  1  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cyclobenzaprine  10  mg ; hydromorphone (dilaudid)  0.12  mg ; hydromorphone (dilaudid)  0.25  mg ; lr  1000  ml ; lorazepam  0.5  mg ; oxycodone-acetaminophen elixir  5-10  ml ; 

white m 53 $nan$nan$cefazolin  1  g ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cyclobenzaprine  10  mg ; lr  1000  ml ; oxycodone-acetaminophen elixir  5-10  ml ; dexamethasone  6  mg ; trazodone  25  mg ; oxycodone-acetaminophen  1-2  tab ; 

white m 53 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; acetaminophen  325-650  mg ; cyclobenzaprine  10  mg ; dexamethasone  6  mg ; trazodone  25  mg ; oxycodone-acetaminophen  1-2  tab ; 

white f 23 $nan$nan$acetaminophen  650  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; naltrexone  25  mg ; apixaban  10  mg ; duloxetine  30  mg ; sodium chloride 0.9%  flush  10-20  ml ; ondansetron  4  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; naltrexone  25  mg ; apixaban  10  mg ; ondansetron  4  mg ; duloxetine  60  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; duloxetine  60  mg ; naltrexone  50  mg ; apixaban  5  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; duloxetine  60  mg ; naltrexone  50  mg ; apixaban  5  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  664  k ul$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; duloxetine  60  mg ; naltrexone  50  mg ; apixaban  5  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; duloxetine  60  mg ; naltrexone  50  mg ; apixaban  5  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  532  k ul; chemistry blood creatinine  0.7  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood bilirubin, total  0.2  mg dl$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; heparin flush (10 units ml)  2  ml ; duloxetine  90  mg ; *nf* ertapenem sodium  1  g ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; heparin flush (10 units ml)  2  ml ; duloxetine  90  mg ; *nf* ertapenem sodium  1  g ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; duloxetine  90  mg ; fluconazole  150  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; duloxetine  90  mg ; fluconazole  150  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; duloxetine  90  mg ; levofloxacin  500  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; duloxetine  90  mg ; levofloxacin  500  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 23 $nan$nan$sodium chloride 0.9%  flush  20  ml ; cepastat (phenol) lozenge  2  loz ; sodium chloride nasal  1-2  spry ; ondansetron  4  mg ; naltrexone  50  mg ; apixaban  5  mg ; duloxetine  90  mg ; levofloxacin  500  mg ; 
streptococcal septicemia diarrhea cardiac arrest severe sepsis home accidents other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure depressive disorder, not elsewhere classified alcohol abuse, unspecified suicide and self-inflicted poisoning by tranquilizers and other psychotropic agents acute and subacute necrosis of liver acidosis unspecified pleural effusion septic shock pneumonitis due to inhalation of food or vomitus poisoning by other antidepressants anemia, unspecified accidents occurring in residential institution pneumonia due to other streptococcus rhabdomyolysis acute respiratory failure methicillin susceptible staphylococcus aureus septicemia other nonspecific findings on examination of blood physical restraints status interstitial emphysema suicidal ideation ventilator associated pneumonia other pulmonary embolism and infarction educational circumstances alcohol abuse, unspecified physical restraints status anxiety state, unspecified major depressive affective disorder, recurrent episode, severe, without mention of psychotic behavior suicidal ideation unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident alcohol abuse, unspecified pedal cycle driver injured in collision with fixed or stationary object in nontraffic accident suicidal ideation depressive disorder, not elsewhere classified family history of psychiatric condition headache alcohol abuse, unspecified unspecified occupant of heavy transport vehicle injured in collision with two- or three-wheeled motor vehicle in nontraffic accident depressive disorder, not elsewhere classified suicidal ideation educational circumstances esophageal reflux physical restraints status 
white f 73 $temp    heartrate  89.0  resprate  28.0  o2sat  100.0  sbp  140.0  dbp  77.0  rhythm    pain  0  ; temp    heartrate  83.0  resprate  33.0  o2sat  97.0  sbp  110.0  dbp  59.0  rhythm    pain  0  ; temp  98.1  heartrate  81.0  resprate  22.0  o2sat  94.0  sbp  117.0  dbp  52.0  rhythm    pain  sleeping  $chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  165  mg dl$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  500  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; gabapentin  600  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  120  mg ; potassium chloride  40  meq ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; enoxaparin sodium  90  mg ; ipratropium bromide neb  1  neb ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$hematology blood hematocrit  31.7  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  95  mg dl$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; furosemide  20  mg ; enoxaparin sodium  90  mg ; ipratropium bromide neb  1  neb ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  85  mg dl$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  90  mg ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; diphenhydramine  25  mg ; furosemide  40  mg ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  92  k ul$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  90  mg ; levofloxacin  750  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; furosemide  40  mg ; acetaminophen  650  mg ; guaifenesin-codeine phosphate  5-10  ml ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  102  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  97  mg dl; hematology blood bands  1  %$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  90  mg ; levofloxacin  750  mg ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; furosemide  40  mg ; acetaminophen  650  mg ; guaifenesin-codeine phosphate  5-10  ml ; lorazepam  0.5-1  mg ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$nan$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  90  mg ; levofloxacin  750  mg ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; furosemide  40  mg ; acetaminophen  650  mg ; guaifenesin-codeine phosphate  5-10  ml ; lorazepam  0.5-1  mg ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
white f 73 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  84  mg dl$levothyroxine sodium  112  mcg ; sodium chloride 0.9%  flush  10  ml ; polyethylene glycol  17  g ; pravastatin  40  mg ; omeprazole  20  mg ; oxycodone (immediate release)   5-10  mg ; acyclovir  400  mg ; ascorbic acid  500  mg ; docusate sodium  100  mg ; metoprolol succinate xl  25  mg ; heparin flush (100 units ml)  5  ml ; enoxaparin sodium  90  mg ; levofloxacin  750  mg ; benzonatate  100  mg ; heparin flush (10 units ml)  5  ml ; levothyroxine sodium  56  mcg ; oseltamivir  75  mg ; furosemide  40  mg ; acetaminophen  650  mg ; guaifenesin-codeine phosphate  5-10  ml ; lorazepam  0.5-1  mg ; potassium chloride  60  meq ; 
toxic diffuse goiter without mention of thyrotoxic crisis or storm antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use personal history of malignant neoplasm of large intestine drug induced neutropenia other and unspecified hyperlipidemia postprocedural fever other alteration of consciousness antineoplastic chemotherapy induced pancytopenia personal history of irradiation, presenting hazards to health person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle multiple myeloma, without mention of having achieved remission pathologic fracture of humerus personal history of antineoplastic chemotherapy fever presenting with conditions classified elsewhere mononeuritis of unspecified site peripheral stem cells replaced by transplant dermatitis due to drugs and medicines taken internally examination of participant in clinical trial multiple myeloma, in relapse person on outside of bus injured in collision with pedestrian or animal in traffic accident rash and other nonspecific skin eruption toxic diffuse goiter without mention of thyrotoxic crisis or storm other drugs and medicinal substances causing adverse effects in therapeutic use blister of foot and toe(s), without mention of infection nausea alone 
black african american f 58 $nan$nan$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  80  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  8  mg ; oxycodone sr (oxycontin)  10  mg ; potassium chl 40 meq   1000 ml ns  1000  ml ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  2  cap ; creon 12  4  cap ; potassium chloride  20  meq ; d5 1 2ns  1000  ml ; potassium chloride  60  meq ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; artificial tears  1-2  drop ; potassium chloride (powder)  60  meq ; sw  100  ml ; magnesium sulfate  4  gm ; folic acid  1  mg ; heparin  5000  unit ; multivitamins  1  tab ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  165  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  88  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; potassium chloride (powder)  60  meq ; folic acid  1  mg ; heparin  5000  unit ; multivitamins  1  tab ; zolpidem tartrate  5-10  mg ; thiamine  100  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  174  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  77  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; folic acid  1  mg ; heparin  5000  unit ; multivitamins  1  tab ; zolpidem tartrate  5-10  mg ; thiamine  100  mg ; tuberculin protein  0.1  ml ; multivitamin iv  10  ml ; loperamide  2  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry urine chloride, urine  128  meq l; chemistry urine creatinine, urine  45  mg dl; chemistry urine potassium, urine  17  meq l; chemistry urine sodium, urine  88  meq l; chemistry urine urea nitrogen, urine  163  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  77  mg dl; chemistry urine 24 hr creatinine  664  mg 24hr$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; tuberculin protein  0.1  ml ; loperamide  2  mg ; neutra-phos  2  pkt ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  26.6  %; hematology blood hematocrit  24.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  207  k ul; hematology blood platelet count  172  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  78  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; loperamide  2  mg ; neutra-phos  2  pkt ; potassium chloride (powder)  20  meq ; magnesium sulfate  2  gm ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  28.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  75  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; tramadol (ultram)  100  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; loperamide  2  mg ; potassium chloride (powder)  20  meq ; magnesium sulfate  2  gm ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  175  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  72  mg dl; chemistry blood albumin  3.5  g dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; loperamide  2  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  79  mg dl$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; loperamide  2  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
black african american f 58 $nan$nan$omeprazole  20  mg ; prednisone  10  mg ; prednisone  5  mg ; sodium chloride 0.9%  flush  3  ml ; ondansetron  8  mg ; hydromorphone (dilaudid)  2  mg ; creon 12  4  cap ; artificial tears  1-2  drop ; heparin  5000  unit ; zolpidem tartrate  5-10  mg ; loperamide  2  mg ; 
other thalassemia other and unspecified noninfectious gastroenteritis and colitis nutritional marasmus rheumatoid arthritis chronic pancreatitis postprocedural fever hyperpotassemia disorders of magnesium metabolism sicca syndrome other chest pain regional enteritis of unspecified site diarrhea other postprocedural status nutritional marasmus chronic pancreatitis hypopotassemia sicca syndrome other thalassemia dehydration precordial pain other functional disorders of intestine unspecified essential hypertension arthropathy, unspecified, site unspecified abdominal pain, epigastric esophageal reflux acute kidney failure, unspecified hyperpotassemia sicca syndrome other thalassemia ulcerative colitis, unspecified hypopotassemia lymphocytopenia other postprocedural status hypocalcemia rheumatoid arthritis nutritional marasmus internal hemorrhoids without mention of complication anemia, unspecified irritable bowel syndrome other ovarian dysfunction unspecified symptom associated with female genital organs other chronic pain other noninflammatory disorders of ovary, fallopian tube, and broad ligament nausea alone pelvic peritoneal adhesions, female (postoperative) (postinfection) hypopotassemia nausea alone iron deficiency anemia, unspecified
white f 47 $nan$hematology blood hematocrit  41.6  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  11  # hpf; chemistry blood glucose  214  mg dl; blood gas blood lactate  2.6  mmol l$tiotropium bromide  1  cap ; duloxetine  60  mg ; levothyroxine sodium  50  mcg ; lisinopril  10  mg ; nicotine patch  21  mg ; aspirin  81  mg ; oxycodone-acetaminophen  1-2  tab ; oxycodone (immediate release)   5  mg ; quetiapine fumarate  200  mg ; pantoprazole  40  mg ; trazodone  200  mg ; guaifenesin-codeine phosphate  10  ml ; albuterol inhaler  2  puff ; tizanidine  2  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  1000  ml ; dicyclomine  10  mg ; fluticasone-salmeterol diskus (500 50)   1  inh ; mesalamine  2000  mg ; ranitidine  150  mg ; cholestyramine  4  gm ; heparin  5000  unit ; 
postmenopausal bleeding unspecified essential hypertension rhabdomyolysis other emphysema tobacco use disorder person on outside of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident aftercare for healing traumatic fracture of other bone alcoholic liver damage, unspecified unspecified acquired hypothyroidism aftercare for healing traumatic fracture of lower arm unspecified hereditary and idiopathic peripheral neuropathy other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases history of fall inadequate material resources person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident esophageal reflux other and unspecified alcohol dependence, continuous dysthymic disorder other and unspecified noninfectious gastroenteritis and colitis other and unspecified alcohol dependence, continuous ostium secundum type atrial septal defect closed dislocation of elbow, other dysthymic disorder unspecified essential hypertension irritable bowel syndrome radial collateral ligament sprain esophageal reflux closed fracture of head of radius polycythemia vera chronic airway obstruction, not elsewhere classified noncollision motor vehicle traffic accident while boarding or alighting injuring passenger in motor vehicle other than motorcycle obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases fracture of lateral malleolus, closed closed fracture of neck of radius tobacco use disorder other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other emphysema esophageal reflux alcohol abuse, unspecified hypopotassemia regional enteritis of small intestine with large intestine alcoholic polyneuropathy dysthymic disorder diarrhea
white f 47 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry urine chloride, urine  28  meq l; chemistry urine creatinine, urine  39  mg dl; chemistry urine potassium, urine  8  meq l; chemistry urine sodium, urine  25  meq l; chemistry urine urea nitrogen, urine  174  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  136  mg dl; blood gas blood lactate  1.1  mmol l$duloxetine  60  mg ; levothyroxine sodium  50  mcg ; nicotine patch  21  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  1000  ml ; ranitidine  150  mg ; cholestyramine  4  gm ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sr (ms contin)  15  mg ; baclofen  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; 
postmenopausal bleeding unspecified essential hypertension rhabdomyolysis other emphysema tobacco use disorder person on outside of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident aftercare for healing traumatic fracture of other bone alcoholic liver damage, unspecified unspecified acquired hypothyroidism aftercare for healing traumatic fracture of lower arm unspecified hereditary and idiopathic peripheral neuropathy other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases history of fall inadequate material resources person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident esophageal reflux other and unspecified alcohol dependence, continuous dysthymic disorder other and unspecified noninfectious gastroenteritis and colitis other and unspecified alcohol dependence, continuous ostium secundum type atrial septal defect closed dislocation of elbow, other dysthymic disorder unspecified essential hypertension irritable bowel syndrome radial collateral ligament sprain esophageal reflux closed fracture of head of radius polycythemia vera chronic airway obstruction, not elsewhere classified noncollision motor vehicle traffic accident while boarding or alighting injuring passenger in motor vehicle other than motorcycle obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases fracture of lateral malleolus, closed closed fracture of neck of radius tobacco use disorder other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other emphysema esophageal reflux alcohol abuse, unspecified hypopotassemia regional enteritis of small intestine with large intestine alcoholic polyneuropathy dysthymic disorder diarrhea
white f 47 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  121  mg dl$duloxetine  60  mg ; levothyroxine sodium  50  mcg ; nicotine patch  21  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ranitidine  150  mg ; cholestyramine  4  gm ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sr (ms contin)  15  mg ; baclofen  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
postmenopausal bleeding unspecified essential hypertension rhabdomyolysis other emphysema tobacco use disorder person on outside of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident aftercare for healing traumatic fracture of other bone alcoholic liver damage, unspecified unspecified acquired hypothyroidism aftercare for healing traumatic fracture of lower arm unspecified hereditary and idiopathic peripheral neuropathy other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases history of fall inadequate material resources person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident esophageal reflux other and unspecified alcohol dependence, continuous dysthymic disorder other and unspecified noninfectious gastroenteritis and colitis other and unspecified alcohol dependence, continuous ostium secundum type atrial septal defect closed dislocation of elbow, other dysthymic disorder unspecified essential hypertension irritable bowel syndrome radial collateral ligament sprain esophageal reflux closed fracture of head of radius polycythemia vera chronic airway obstruction, not elsewhere classified noncollision motor vehicle traffic accident while boarding or alighting injuring passenger in motor vehicle other than motorcycle obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases fracture of lateral malleolus, closed closed fracture of neck of radius tobacco use disorder other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other emphysema esophageal reflux alcohol abuse, unspecified hypopotassemia regional enteritis of small intestine with large intestine alcoholic polyneuropathy dysthymic disorder diarrhea
white f 47 $nan$nan$duloxetine  60  mg ; levothyroxine sodium  50  mcg ; nicotine patch  21  mg ; aspirin  81  mg ; sodium chloride 0.9%  flush  3  ml ; albuterol 0.083% neb soln  1  neb ; ranitidine  150  mg ; cholestyramine  4  gm ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; morphine sr (ms contin)  15  mg ; baclofen  10  mg ; lidocaine 5% patch  1  ptch ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; potassium chloride  40  meq ; magnesium oxide  400  mg ; 
postmenopausal bleeding unspecified essential hypertension rhabdomyolysis other emphysema tobacco use disorder person on outside of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident aftercare for healing traumatic fracture of other bone alcoholic liver damage, unspecified unspecified acquired hypothyroidism aftercare for healing traumatic fracture of lower arm unspecified hereditary and idiopathic peripheral neuropathy other dependence on machines, supplemental oxygen obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases history of fall inadequate material resources person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident esophageal reflux other and unspecified alcohol dependence, continuous dysthymic disorder other and unspecified noninfectious gastroenteritis and colitis other and unspecified alcohol dependence, continuous ostium secundum type atrial septal defect closed dislocation of elbow, other dysthymic disorder unspecified essential hypertension irritable bowel syndrome radial collateral ligament sprain esophageal reflux closed fracture of head of radius polycythemia vera chronic airway obstruction, not elsewhere classified noncollision motor vehicle traffic accident while boarding or alighting injuring passenger in motor vehicle other than motorcycle obstructive sleep apnea (adult)(pediatric) other chronic pulmonary heart diseases fracture of lateral malleolus, closed closed fracture of neck of radius tobacco use disorder other dependence on machines, supplemental oxygen person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other emphysema esophageal reflux alcohol abuse, unspecified hypopotassemia regional enteritis of small intestine with large intestine alcoholic polyneuropathy dysthymic disorder diarrhea
asian m 24 $nan$hematology blood hematocrit  39.6  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  214  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  97  mg dl$levetiracetam  1000  mg ; sodium chloride 0.9%  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; oxycodone (immediate release)   5-10  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; 
coma other speech disturbance tobacco use disorder hemangioma of intracranial structures intracerebral hemorrhage epilepsy, unspecified, without mention of intractable epilepsy cerebral edema compression of brain
asian m 24 $nan$nan$levetiracetam  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; oxycodone (immediate release)   5-10  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; docusate sodium  100  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; heparin  5000  unit ; senna  17.2  mg ; 
coma other speech disturbance tobacco use disorder hemangioma of intracranial structures intracerebral hemorrhage epilepsy, unspecified, without mention of intractable epilepsy cerebral edema compression of brain
asian m 24 $nan$nan$levetiracetam  1000  mg ; influenza vaccine quadrivalent  0.5  ml ; oxycodone (immediate release)   5-10  mg ; hydralazine  10-20  mg ; ondansetron  4  mg ; bisacodyl  10  mg ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; heparin  5000  unit ; senna  17.2  mg ; 
coma other speech disturbance tobacco use disorder hemangioma of intracranial structures intracerebral hemorrhage epilepsy, unspecified, without mention of intractable epilepsy cerebral edema compression of brain
black african american f 75 $nan$hematology blood hematocrit  37.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  291  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  166  mg dl$insulin  30  unit ; furosemide  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  304  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  141  mg dl; chemistry blood % hemoglobin a1c  7.8  %$insulin  30  unit ; furosemide  40  mg ; levofloxacin  250  mg ; levofloxacin  500  mg ; levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; alprazolam  0.25  mg ; acetaminophen  500-1000  mg ; heparin  5000  unit ; insulin  25  unit ; prednisone  40  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  38.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  84  mg dl$levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; alprazolam  0.25  mg ; acetaminophen  500-1000  mg ; heparin  5000  unit ; prednisone  40  mg ; 
 
black african american f 75 $nan$hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  386  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  51  mg dl$levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; alprazolam  0.25  mg ; acetaminophen  500-1000  mg ; heparin  5000  unit ; prednisone  40  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; magnesium oxide  400  mg ; 
 
black african american f 75 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood glucose  98  mg dl$levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; alprazolam  0.25  mg ; acetaminophen  500-1000  mg ; heparin  5000  unit ; prednisone  40  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; magnesium oxide  400  mg ; oxycodone (immediate release)   2.5-5  mg ; pneumococcal vac polyvalent  0.5  ml ; insulin  20  unit ; 
 
black african american f 75 $nan$nan$levofloxacin  750  mg ; aspirin  81  mg ; lisinopril  20  mg ; atenolol  50  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium bromide neb  1  neb ; alprazolam  0.25  mg ; acetaminophen  500-1000  mg ; heparin  5000  unit ; prednisone  40  mg ; guaifenesin  5-10  ml ; benzonatate  100  mg ; oxycodone (immediate release)   2.5-5  mg ; pneumococcal vac polyvalent  0.5  ml ; insulin  20  unit ; 
 
asian m 47 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  288  k ul; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  146  mg dl$nan
person on outside of bus injured in collision with pedestrian or animal in traffic accident examination of participant in clinical trial
white m 77 $nan$hematology blood hematocrit  36.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  133  mg dl$diltiazem  90  mg ; docusate sodium  100  mg ; heparin  5000  unit ; warfarin  2.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; milk of magnesia  30  ml ; fluticasone propionate nasal  2  spry ; lidocaine jelly 2% (urojet)  1  appl ; aspirin  81  mg ; atenolol  50  mg ; bromocriptine mesylate  1.25  mg ; diltiazem extended-release  180  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
coronary atherosclerosis of native coronary artery unspecified glaucoma obesity, unspecified personal history of malignant neoplasm of bladder chronic ischemic heart disease, unspecified percutaneous transluminal coronary angioplasty status fever, unspecified malignant neoplasm of long bones of lower limb personal history of tobacco use other iatrogenic hypotension acute posthemorrhagic anemia atrial fibrillation body mass index 35.0-35.9, adult acute kidney failure, unspecified hypoxemia long-term (current) use of anticoagulants hypovolemia other acute and subacute forms of ischemic heart disease, other long-term (current) use of aspirin unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other specified hypertrophic and atrophic conditions of skin other and unspecified anterior pituitary hyperfunction enlargement of lymph nodes personal history of colonic polyps obesity, unspecified pain in limb coronary atherosclerosis of native coronary artery abnormal coagulation profile unspecified disorder of kidney and ureter other postprocedural status closed fracture of one rib pure hypercholesterolemia unspecified glaucoma atrial fibrillation allergic rhinitis, cause unspecified other and unspecified hyperlipidemia pain in joint, lower leg hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) person boarding or alighting a car injured in collision with railway train or railway vehicle solitary pulmonary nodule nontoxic uninodular goiter personal history of malignant neoplasm of bladder other abnormal glucose spinal stenosis, unspecified region malignant neoplasm of long bones of lower limb retinal arterial branch occlusion other and unspecified disc disorder, cervical region
white m 77 $nan$nan$docusate sodium  100  mg ; heparin  5000  unit ; warfarin  2.5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; milk of magnesia  30  ml ; fluticasone propionate nasal  2  spry ; lidocaine jelly 2% (urojet)  1  appl ; aspirin  81  mg ; atenolol  50  mg ; bromocriptine mesylate  1.25  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bag  1  bag ; magnesium sulfate  2  gm ; bromocriptine mesylate  2.5  mg ; atorvastatin  40  mg ; 
coronary atherosclerosis of native coronary artery unspecified glaucoma obesity, unspecified personal history of malignant neoplasm of bladder chronic ischemic heart disease, unspecified percutaneous transluminal coronary angioplasty status fever, unspecified malignant neoplasm of long bones of lower limb personal history of tobacco use other iatrogenic hypotension acute posthemorrhagic anemia atrial fibrillation body mass index 35.0-35.9, adult acute kidney failure, unspecified hypoxemia long-term (current) use of anticoagulants hypovolemia other acute and subacute forms of ischemic heart disease, other long-term (current) use of aspirin unspecified essential hypertension anticoagulants causing adverse effects in therapeutic use other specified hypertrophic and atrophic conditions of skin other and unspecified anterior pituitary hyperfunction enlargement of lymph nodes personal history of colonic polyps obesity, unspecified pain in limb coronary atherosclerosis of native coronary artery abnormal coagulation profile unspecified disorder of kidney and ureter other postprocedural status closed fracture of one rib pure hypercholesterolemia unspecified glaucoma atrial fibrillation allergic rhinitis, cause unspecified other and unspecified hyperlipidemia pain in joint, lower leg hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) person boarding or alighting a car injured in collision with railway train or railway vehicle solitary pulmonary nodule nontoxic uninodular goiter personal history of malignant neoplasm of bladder other abnormal glucose spinal stenosis, unspecified region malignant neoplasm of long bones of lower limb retinal arterial branch occlusion other and unspecified disc disorder, cervical region
white m 62 $nan$nan$citalopram  10  mg ; metoprolol succinate xl  50  mg ; 
pressure ulcer, stage i lumbosacral spondylosis without myelopathy long-term (current) use of insulin pressure ulcer, lower back personal history of malignant neoplasm of kidney hiccough secondary malignant neoplasm of lung unspecified erythematous condition esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gout, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified secondary malignant neoplasm of bone and bone marrow acquired absence of kidney other and unspecified hyperlipidemia bilious emesis anemia, unspecified lumbosacral spondylosis without myelopathy degeneration of intervertebral disc, site unspecified gout, unspecified other specified cardiac dysrhythmias hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum other and unspecified hyperlipidemia esophageal reflux postprocedural fever secondary malignant neoplasm of other specified sites hypocalcemia personal history of tobacco use other fluid overload secondary malignant neoplasm of bone and bone marrow 
white m 62 $nan$hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  406  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine chloride, urine  44  meq l; chemistry urine creatinine, urine  42  mg dl; chemistry urine potassium, urine  21  meq l; chemistry urine sodium, urine  43  meq l; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  96  mg dl; chemistry urine protein creatinine ratio  1.2  mg mg$citalopram  10  mg ; metoprolol succinate xl  50  mg ; sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; mirtazapine  7.5  mg ; ondansetron  4-8  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; oxycodone sr (oxycontin)  10  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  325-650  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; chlorpromazine  25  mg ; docusate sodium  100  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; senna  2  tab ; insulin  0  unit ; allopurinol  100  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
pressure ulcer, stage i lumbosacral spondylosis without myelopathy long-term (current) use of insulin pressure ulcer, lower back personal history of malignant neoplasm of kidney hiccough secondary malignant neoplasm of lung unspecified erythematous condition esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gout, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified secondary malignant neoplasm of bone and bone marrow acquired absence of kidney other and unspecified hyperlipidemia bilious emesis anemia, unspecified lumbosacral spondylosis without myelopathy degeneration of intervertebral disc, site unspecified gout, unspecified other specified cardiac dysrhythmias hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum other and unspecified hyperlipidemia esophageal reflux postprocedural fever secondary malignant neoplasm of other specified sites hypocalcemia personal history of tobacco use other fluid overload secondary malignant neoplasm of bone and bone marrow 
white m 62 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  366  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  169  mg dl$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; mirtazapine  7.5  mg ; ondansetron  4-8  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; oxycodone sr (oxycontin)  10  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  325-650  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; chlorpromazine  25  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; dexamethasone  4  mg ; 
pressure ulcer, stage i lumbosacral spondylosis without myelopathy long-term (current) use of insulin pressure ulcer, lower back personal history of malignant neoplasm of kidney hiccough secondary malignant neoplasm of lung unspecified erythematous condition esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gout, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified secondary malignant neoplasm of bone and bone marrow acquired absence of kidney other and unspecified hyperlipidemia bilious emesis anemia, unspecified lumbosacral spondylosis without myelopathy degeneration of intervertebral disc, site unspecified gout, unspecified other specified cardiac dysrhythmias hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum other and unspecified hyperlipidemia esophageal reflux postprocedural fever secondary malignant neoplasm of other specified sites hypocalcemia personal history of tobacco use other fluid overload secondary malignant neoplasm of bone and bone marrow 
white m 62 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  404  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood glucose  241  mg dl$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; mirtazapine  7.5  mg ; ondansetron  4-8  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; oxycodone sr (oxycontin)  10  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  325-650  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; chlorpromazine  25  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; dexamethasone  4  mg ; trazodone  50  mg ; ondansetron  4  mg ; metoprolol succinate xl  100  mg ; 
pressure ulcer, stage i lumbosacral spondylosis without myelopathy long-term (current) use of insulin pressure ulcer, lower back personal history of malignant neoplasm of kidney hiccough secondary malignant neoplasm of lung unspecified erythematous condition esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gout, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified secondary malignant neoplasm of bone and bone marrow acquired absence of kidney other and unspecified hyperlipidemia bilious emesis anemia, unspecified lumbosacral spondylosis without myelopathy degeneration of intervertebral disc, site unspecified gout, unspecified other specified cardiac dysrhythmias hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum other and unspecified hyperlipidemia esophageal reflux postprocedural fever secondary malignant neoplasm of other specified sites hypocalcemia personal history of tobacco use other fluid overload secondary malignant neoplasm of bone and bone marrow 
white m 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; enoxaparin sodium  40  mg ; mirtazapine  7.5  mg ; ondansetron  4-8  mg ; lorazepam  0.25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; tamsulosin  0.4  mg ; oxycodone sr (oxycontin)  10  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  325-650  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; chlorpromazine  25  mg ; pantoprazole  40  mg ; polyethylene glycol  17  g ; insulin  0  unit ; dexamethasone  4  mg ; trazodone  50  mg ; ondansetron  4  mg ; metoprolol succinate xl  100  mg ; 
pressure ulcer, stage i lumbosacral spondylosis without myelopathy long-term (current) use of insulin pressure ulcer, lower back personal history of malignant neoplasm of kidney hiccough secondary malignant neoplasm of lung unspecified erythematous condition esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled gout, unspecified chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified secondary malignant neoplasm of bone and bone marrow acquired absence of kidney other and unspecified hyperlipidemia bilious emesis anemia, unspecified lumbosacral spondylosis without myelopathy degeneration of intervertebral disc, site unspecified gout, unspecified other specified cardiac dysrhythmias hyperpotassemia hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified malignant neoplasm of kidney, except pelvis secondary malignant neoplasm of lung diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic kidney disease, unspecified secondary malignant neoplasm of retroperitoneum and peritoneum other and unspecified hyperlipidemia esophageal reflux postprocedural fever secondary malignant neoplasm of other specified sites hypocalcemia personal history of tobacco use other fluid overload secondary malignant neoplasm of bone and bone marrow 
other f 55 $nan$hematology blood hematocrit  29.5  %; hematology blood hematocrit  35.4  %; hematology blood hematocrit  37.1  %; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  147  k ul; hematology blood platelet count  146  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.2  ; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.34  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood chloride, whole blood  111  meq l; blood gas blood glucose  155  mg dl; blood gas blood glucose  181  mg dl; blood gas blood glucose  199  mg dl; blood gas blood glucose  159  mg dl; blood gas blood glucose  143  mg dl; blood gas blood hematocrit, calculated  38  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  12.8  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  10.0  g dl; blood gas blood hemoglobin  10.3  g dl; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  140  meq l$sodium chloride 0.9%  flush  10  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; acetaminophen  650  mg ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; fentanyl citrate  12.5-50  mcg ; oxycodone (immediate release)  5-10  mg ; ondansetron  4  mg ; neostigmine  2  mg ; glycopyrrolate  0.4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; albumin 5% (25g   500ml)  25  g ; ketorolac  15  mg ; 
 
other f 55 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; glucagon  1  mg ; glucose gel  15  g ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; ondansetron  4  mg ; neostigmine  2  mg ; glycopyrrolate  0.4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; albumin 5% (25g   500ml)  25  g ; ketorolac  15  mg ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; furosemide  10  mg ; warfarin  1  mg ; warfarin  2  mg ; warfarin  1  dose ; insulin  30  unit ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; 
 
other f 55 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood glucose  129  mg dl$ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; metoprolol tartrate  12.5  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  10  mg ; warfarin  1  mg ; warfarin  2  mg ; warfarin  1  dose ; insulin  30  unit ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; warfarin  5  mg ; 
 
other f 55 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  103  mg dl$ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; ketorolac  15  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  10  mg ; warfarin  1  dose ; insulin  30  unit ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metformin (glucophage)  500  mg ; warfarin  5  mg ; warfarin  2.5  mg ; 
 
other f 55 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.9  ; hematology blood inr(pt)  2.2  ; chemistry blood glucose  84  mg dl$ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  10  mg ; warfarin  1  dose ; insulin  30  unit ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; warfarin  2.5  mg ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; metformin (glucophage)  1000  mg ; insulin  10  unit ; potassium chloride  40  meq ; lidocaine 5% patch  1  ptch ; 
 
other f 55 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood glucose  68  mg dl$ondansetron  4  mg ; docusate sodium  100  mg ; ranitidine  150  mg ; acetaminophen iv  1000  mg ; aspirin ec  81  mg ; milk of magnesia  30  ml ; furosemide  10  mg ; warfarin  1  dose ; sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  1  ml ; bisacodyl  10  mg ; metoprolol tartrate  25  mg ; metformin (glucophage)  1000  mg ; insulin  10  unit ; potassium chloride  40  meq ; lidocaine 5% patch  1  ptch ; glipizide  5  mg ; 
 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; acetaminophen  650  mg ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; meperidine  25-50  mg ; morphine sulfate  50  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; oxycodone-acetaminophen  1-2  tab ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; acetaminophen  650  mg ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diazepam  5  mg ; lidocaine 5% patch  3  ptch ; gabapentin  300  mg ; oxycodone (immediate release)   5-10  mg ; oxycodone (immediate release)   10  mg ; oxycodone sr (oxycontin)  20  mg ; meperidine  25  mg ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; diazepam  5  mg ; lidocaine 5% patch  3  ptch ; gabapentin  300  mg ; oxycodone (immediate release)   10  mg ; oxycodone sr (oxycontin)  20  mg ; meperidine  25  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; promethazine  12.5  mg ; promethazine  25  mg ; granisetron hcl  1  mg ; oxycodone sr (oxycontin)  10  mg ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; diazepam  5  mg ; gabapentin  300  mg ; oxycodone (immediate release)   10  mg ; oxycodone sr (oxycontin)  20  mg ; promethazine  12.5  mg ; promethazine  25  mg ; oxycodone sr (oxycontin)  10  mg ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; diazepam  5  mg ; oxycodone (immediate release)   10  mg ; promethazine  12.5  mg ; promethazine  25  mg ; oxycodone sr (oxycontin)  10  mg ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white f 50 $nan$nan$multivitamins  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  1  g ; senna  1  tab ; metoclopramide  10  mg ; bisacodyl  10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; ascorbic acid  500  mg ; heparin  5000  unit ; diazepam  5  mg ; oxycodone (immediate release)   10  mg ; promethazine  12.5  mg ; promethazine  25  mg ; oxycodone sr (oxycontin)  10  mg ; 
body mass index between 19-24, adult incisional hernia without mention of obstruction or gangrene cyst and pseudocyst of pancreas peritoneal adhesions (postoperative) (postinfection) passenger of special construction vehicle injured in traffic accident unspecified procedure as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure digestive system complications, not elsewhere classified gastrostomy status abdominal pain, unspecified site status of other artificial opening of gastrointestinal tract other specified diseases of pancreas personal history of venous thrombosis and embolism person boarding or alighting a car injured in collision with heavy transport vehicle or bus other postprocedural status car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident 
white m 64 $nan$hematology blood hematocrit  42.3  %; hematology blood platelet count  216  k ul; hematology blood platelet count  232  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  109  mg dl$sodium chloride 0.9%  1000  ml ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  80  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ramelteon  8  mg ; sw  600  ml ; potassium chloride  60  meq ; aspirin  81  mg ; clopidogrel  75  mg ; atenolol  50  mg ; amlodipine  10  mg ; 
 
white m 64 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; atorvastatin  80  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; senna  8.6  mg ; ramelteon  8  mg ; aspirin  81  mg ; clopidogrel  75  mg ; atenolol  50  mg ; amlodipine  10  mg ; 
 
white m 80 $nan$hematology blood hematocrit  32.8  %; hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  218  k ul; hematology blood platelet count  185  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  147  mg dl; chemistry blood glucose  217  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; enoxaparin sodium  30  mg ; amlodipine  5  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prednisone  2.5  mg ; insulin  0  unit ; acetaminophen  1000  mg ; morphine sulfate ir  15  mg ; senna  8.6  mg ; docusate sodium  100  mg ; lactated ringers  1000  ml ; multivitamins  1  cap ; vitamin d  800  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   2.5-5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.4  mg ; 
malignant neoplasm of prostate percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery myelopathy in other diseases classified elsewhere personal history of malignant neoplasm of large intestine pneumonia, organism unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease shortness of breath unspecified essential hypertension other and unspecified hyperlipidemia do not resuscitate status secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae
white m 80 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  211  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  5  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prednisone  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  cap ; vitamin d  800  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; oxycodone (immediate release)   2.5-5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.4  mg ; calcium carbonate  1250  mg ; enoxaparin sodium  40  mg ; 
malignant neoplasm of prostate percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery myelopathy in other diseases classified elsewhere personal history of malignant neoplasm of large intestine pneumonia, organism unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease shortness of breath unspecified essential hypertension other and unspecified hyperlipidemia do not resuscitate status secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae
white m 80 $nan$hematology blood hematocrit  27.6  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  5  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prednisone  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  cap ; vitamin d  800  unit ; oxycodone (immediate release)   2.5-5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.4  mg ; calcium carbonate  1250  mg ; enoxaparin sodium  40  mg ; 
malignant neoplasm of prostate percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery myelopathy in other diseases classified elsewhere personal history of malignant neoplasm of large intestine pneumonia, organism unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease shortness of breath unspecified essential hypertension other and unspecified hyperlipidemia do not resuscitate status secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae
white m 80 $nan$hematology blood hematocrit  25.0  %$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; amlodipine  5  mg ; atorvastatin  80  mg ; aspirin  81  mg ; prednisone  2.5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; multivitamins  1  cap ; vitamin d  800  unit ; oxycodone (immediate release)   2.5-5  mg ; acetaminophen  650  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.2-0.4  mg ; calcium carbonate  1250  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; cefpodoxime proxetil  400  mg ; 
malignant neoplasm of prostate percutaneous transluminal coronary angioplasty status coronary atherosclerosis of native coronary artery myelopathy in other diseases classified elsewhere personal history of malignant neoplasm of large intestine pneumonia, organism unspecified acquired absence of intestine (large) (small) personal history of peptic ulcer disease shortness of breath unspecified essential hypertension other and unspecified hyperlipidemia do not resuscitate status secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae
white m 70 $temp  98.3  heartrate  81.0  resprate  13.0  o2sat  100.0  sbp  131.0  dbp  61.0  rhythm    pain  0  $hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  91  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3-10  ml ; phosphorus  250  mg ; ranitidine  150  mg ; senna  8.6  mg ; simvastatin  10  mg ; acetaminophen  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; levetiracetam  500  mg ; losartan potassium  50  mg ; carbidopa-levodopa (25-100)  2  tab ; vial  1  vial ; ceftriaxone  1  gm ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  101  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; senna  8.6  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; vial  1  vial ; ceftriaxone  1  gm ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; heparin  5000  unit ; lidocaine jelly 2% (glydo)  1  appl ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  108  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; senna  8.6  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; docusate sodium  100  mg ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  110  ml ; bevacizumab (avastin)  808.76  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  109  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; 0.9% sodium chloride  110  ml ; bevacizumab (avastin)  808.76  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  1000  ml ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  102  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; heparin  5000  unit ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  101  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  106  mg dl$phosphorus  250  mg ; ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; ciprofloxacin hcl  500  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  223  iu l$ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  102  mg dl$ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; polyethylene glycol  17  g ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white m 70 $nan$nan$ranitidine  150  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; levetiracetam  500  mg ; carbidopa-levodopa (25-100)  2  tab ; heparin flush (100 units ml)  5  ml ; multivitamins  1  tab ; methylphenidate (ritalin)  10  mg ; venlafaxine xr  150  mg ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; ondansetron  4-8  mg ; methylphenidate (ritalin)  5  mg ; 
essential (primary) hypertension fall on stairs or ladders in water transport injuring unspecified person hyperlipidemia, unspecified malignant neoplasm of temporal lobe fever, unspecified personal history of nicotine dependence major depressive disorder, single episode, unspecified other pancytopenia other disorders of phosphorus metabolism type 2 diabetes mellitus without complications weakness history of falling parkinson's disease unspecified mood [affective] disorder malignant neoplasm of frontal lobe type 2 diabetes mellitus with hyperglycemia hyperlipidemia, unspecified major depressive disorder, single episode, unspecified bradycardia, unspecified other complications following infusion, transfusion and therapeutic injection, initial encounter obstructive sleep apnea (adult) (pediatric) personal history of nicotine dependence other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure unspecified place or not applicable essential (primary) hypertension adverse effect of glucocorticoids and synthetic analogues, initial encounter other encephalopathy obstructive sleep apnea (adult)(pediatric) cerebral edema diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled family history of other specified malignant neoplasm other and unspecified hyperlipidemia anemia, unspecified person on outside of bus injured in collision with pedestrian or animal in traffic accident lack of coordination personal history of tobacco use malignant neoplasm of temporal lobe pure hypercholesterolemia depressive disorder, not elsewhere classified long-term (current) use of aspirin other and unspecified special symptoms or syndromes, not elsewhere classified unspecified essential hypertension examination of participant in clinical trial thrombocytopenia, unspecified
white f 49 $temp  98.4  heartrate  72.0  resprate  18.0  o2sat  98.0  sbp  119.0  dbp  74.0  rhythm    pain    $hematology blood hematocrit  35.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  260  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  91  mg dl; chemistry blood % hemoglobin a1c  5.1  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; oxcarbazepine  300  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; 
celiac disease long-term (current) use of aspirin cerebral aneurysm, nonruptured asthma, unspecified type, unspecified unspecified essential hypertension 
white f 49 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  82  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; oxcarbazepine  300  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; 
celiac disease long-term (current) use of aspirin cerebral aneurysm, nonruptured asthma, unspecified type, unspecified unspecified essential hypertension 
white f 49 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; aspirin  325  mg ; oxcarbazepine  300  mg ; hydralazine  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; 
celiac disease long-term (current) use of aspirin cerebral aneurysm, nonruptured asthma, unspecified type, unspecified unspecified essential hypertension 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; ramelteon  8  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  325  mg ; hydrochlorothiazide  12.5  mg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; pravastatin  40  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; losartan potassium  25  mg ; 
hypo-osmolality and hyponatremia hyperlipidemia, unspecified presence of xenogenic heart valve atrioventricular block, second degree unspecified asthma, uncomplicated unspecified osteoarthritis, unspecified site essential (primary) hypertension 
white m 63 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; ramelteon  8  mg ; aluminum-magnesium hydrox.-simethicone  30  ml ; aspirin  325  mg ; hydrochlorothiazide  12.5  mg ; lorazepam  0.5  mg ; losartan potassium  50  mg ; pravastatin  40  mg ; oxycodone--acetaminophen (5mg-325mg)  1  tab ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
hypo-osmolality and hyponatremia hyperlipidemia, unspecified presence of xenogenic heart valve atrioventricular block, second degree unspecified asthma, uncomplicated unspecified osteoarthritis, unspecified site essential (primary) hypertension 
white m 52 $temp  98.7  heartrate  73.0  resprate  22.0  o2sat  98.0  sbp  157.0  dbp  75.0  rhythm    pain  0  ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain  uta  $nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; ketorolac  15  mg ; docusate sodium  100  mg ; senna  8.6  mg ; artificial tears  2  drop ; ibuprofen  600  mg ; 
 
white m 52 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; oxycodone (immediate release)  5  mg ; acetaminophen  1000  mg ; docusate sodium  100  mg ; senna  8.6  mg ; artificial tears  2  drop ; ibuprofen  600  mg ; 
 
white m 47 $nan$nan$simvastatin  80  mg ; citalopram  60  mg ; clopidogrel  75  mg ; isosorbide mononitrate (extended release)  60  mg ; aspirin  325  mg ; 
diastolic heart failure, unspecified constrictive pericarditis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postoperative infection obstructive sleep apnea (adult)(pediatric) aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft congestive heart failure, unspecified esophageal reflux unspecified essential hypertension methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified unspecified essential hypertension coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery congestive heart failure, unspecified chronic diastolic heart failure intermediate coronary syndrome other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) morbid obesity aortocoronary bypass status aortocoronary bypass status other diseases of lung, not elsewhere classified appendicitis, unqualified esophageal reflux unspecified essential hypertension coronary atherosclerosis of native coronary artery acute combined systolic and diastolic heart failure other primary cardiomyopathies other and unspecified angina pectoris congestive heart failure, unspecified unspecified essential hypertension aortocoronary bypass status methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection coronary atherosclerosis of unspecified type of vessel, native or graft carrier or suspected carrier of methicillin resistant staphylococcus aureus family history of ischemic heart disease intermediate coronary syndrome coronary atherosclerosis of native coronary artery unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with fixed or stationary object esophageal reflux percutaneous transluminal coronary angioplasty status urinary tract infection, site not specified morbid obesity
white m 47 $nan$nan$simvastatin  80  mg ; citalopram  60  mg ; clopidogrel  75  mg ; isosorbide mononitrate (extended release)  60  mg ; aspirin  325  mg ; atropine sulfate  0.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; ranexa  500  mg ; pantoprazole  40  mg ; bumetanide  3  mg ; bupropion (sustained release)  200  mg ; cyclobenzaprine  10  mg ; lorazepam  1  mg ; oxycodone sr (oxycontin)  40  mg ; oxycodone (immediate release)   5  mg ; clindamycin  300  mg ; docusate sodium  100  mg ; senna  1  tab ; miconazole powder 2%  1  appl ; metolazone  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; nitroglycerin sl  0.3  mg ; insulin  40  unit ; 
diastolic heart failure, unspecified constrictive pericarditis diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other postoperative infection obstructive sleep apnea (adult)(pediatric) aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft congestive heart failure, unspecified esophageal reflux unspecified essential hypertension methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site iron deficiency anemia secondary to blood loss (chronic) chronic airway obstruction, not elsewhere classified unspecified essential hypertension coronary atherosclerosis of native coronary artery coronary atherosclerosis of native coronary artery congestive heart failure, unspecified chronic diastolic heart failure intermediate coronary syndrome other and unspecified hyperlipidemia obstructive sleep apnea (adult)(pediatric) morbid obesity aortocoronary bypass status aortocoronary bypass status other diseases of lung, not elsewhere classified appendicitis, unqualified esophageal reflux unspecified essential hypertension coronary atherosclerosis of native coronary artery acute combined systolic and diastolic heart failure other primary cardiomyopathies other and unspecified angina pectoris congestive heart failure, unspecified unspecified essential hypertension aortocoronary bypass status methicillin resistant staphylococcus aureus in conditions classified elsewhere and of unspecified site other postoperative infection coronary atherosclerosis of unspecified type of vessel, native or graft carrier or suspected carrier of methicillin resistant staphylococcus aureus family history of ischemic heart disease intermediate coronary syndrome coronary atherosclerosis of native coronary artery unspecified essential hypertension person boarding or alighting a pedal cycle injured in collision with fixed or stationary object esophageal reflux percutaneous transluminal coronary angioplasty status urinary tract infection, site not specified morbid obesity
white f 31 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  143  mg dl$influenza vaccine quadrivalent  0.5  ml ; oseltamivir  75  mg ; ranitidine  75  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; albuterol inhaler  2  puff ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident post term pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition threatened premature labor, antepartum condition or complication outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident anxiety state, unspecified asthma, unspecified type, unspecified mental disorders of mother, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; oseltamivir  75  mg ; ranitidine  75  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; albuterol inhaler  2  puff ; magnesium oxide  400  mg ; albuterol 0.083% neb soln  1  neb ; ferrous sulfate  325  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident post term pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition threatened premature labor, antepartum condition or complication outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident anxiety state, unspecified asthma, unspecified type, unspecified mental disorders of mother, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; oseltamivir  75  mg ; docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; dermoplast spray  1  spry ; albuterol inhaler  2  puff ; magnesium oxide  400  mg ; albuterol 0.083% neb soln  1  neb ; ferrous sulfate  325  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident post term pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition threatened premature labor, antepartum condition or complication outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident anxiety state, unspecified asthma, unspecified type, unspecified mental disorders of mother, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
white f 31 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; dermoplast spray  1  spry ; albuterol inhaler  2  puff ; albuterol 0.083% neb soln  1  neb ; ferrous sulfate  325  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident post term pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn second-degree perineal laceration, delivered, with or without mention of antepartum condition threatened premature labor, antepartum condition or complication outcome of delivery, single liveborn other current conditions classifiable elsewhere of mother, delivered, with or without mention of antepartum condition motorcycle driver injured in collision with fixed or stationary object in nontraffic accident anxiety state, unspecified asthma, unspecified type, unspecified mental disorders of mother, delivered, with or without mention of antepartum condition post term pregnancy, delivered, with or without mention of antepartum condition second-degree perineal laceration, delivered, with or without mention of antepartum condition 
unable to obtain m 60 $nan$nan$lisinopril  5  mg ; aspirin  81  mg ; fluoxetine  30  mg ; potassium chloride  20  meq ; allopurinol  100  mg ; 
tracheostomy status pressure ulcer, stage ii chronic airway obstruction, not elsewhere classified car driver injured in collision with heavy transport vehicle or bus in nontraffic accident pressure ulcer, buttock other specified cardiac dysrhythmias other diseases of trachea and bronchus morbid obesity chronic respiratory failure other tracheostomy complications gout, unspecified 
unable to obtain m 60 $nan$hematology blood hematocrit  29.4  %; hematology blood hematocrit  29.0  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  153  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  40  meq l; chemistry blood bicarbonate  38  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3-5  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl; chemistry blood glucose  95  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$lisinopril  5  mg ; aspirin  81  mg ; fluoxetine  30  mg ; potassium chloride  20  meq ; allopurinol  100  mg ; heparin  5000  unit ; albuterol-ipratropium  1-2  puff ; famotidine  20  mg ; guaifenesin  5-10  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; sarna lotion  1  appl ; lr  1000  ml ; insulin  0  unit ; calcipotriene 0.005% cream  1  appl ; acetylcysteine 20%  1-10  ml ; gabapentin  600  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetazolamide  250  mg ; midazolam  2-4  mg ; fentanyl citrate  25-100  mcg ; furosemide  40  mg ; digoxin  0.125  mg ; lidocaine jelly 2% (urojet)  1  appl ; 
tracheostomy status pressure ulcer, stage ii chronic airway obstruction, not elsewhere classified car driver injured in collision with heavy transport vehicle or bus in nontraffic accident pressure ulcer, buttock other specified cardiac dysrhythmias other diseases of trachea and bronchus morbid obesity chronic respiratory failure other tracheostomy complications gout, unspecified 
unable to obtain m 60 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine creatinine, urine  30  mg dl; chemistry urine sodium, urine  46  meq l; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  95  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lisinopril  5  mg ; aspirin  81  mg ; fluoxetine  30  mg ; allopurinol  100  mg ; heparin  5000  unit ; albuterol-ipratropium  1-2  puff ; famotidine  20  mg ; guaifenesin  5-10  ml ; sarna lotion  1  appl ; insulin  0  unit ; calcipotriene 0.005% cream  1  appl ; gabapentin  600  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  15  mmol ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; acetazolamide  250  mg ; midazolam  2-4  mg ; fentanyl citrate  25-100  mcg ; digoxin  0.125  mg ; lidocaine jelly 2% (urojet)  1  appl ; potassium chloride  40  meq ; acetaminophen  500-1000  mg ; 
tracheostomy status pressure ulcer, stage ii chronic airway obstruction, not elsewhere classified car driver injured in collision with heavy transport vehicle or bus in nontraffic accident pressure ulcer, buttock other specified cardiac dysrhythmias other diseases of trachea and bronchus morbid obesity chronic respiratory failure other tracheostomy complications gout, unspecified 
unable to obtain m 60 $nan$hematology blood hematocrit  48.1  %; hematology blood hemoglobin  16.6  g dl; hematology blood platelet count  77  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  95  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  81  mg ; fluoxetine  30  mg ; allopurinol  100  mg ; heparin  5000  unit ; albuterol-ipratropium  1-2  puff ; famotidine  20  mg ; guaifenesin  5-10  ml ; sarna lotion  1  appl ; insulin  0  unit ; calcipotriene 0.005% cream  1  appl ; gabapentin  600  mg ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; digoxin  0.125  mg ; acetaminophen  500-1000  mg ; 
tracheostomy status pressure ulcer, stage ii chronic airway obstruction, not elsewhere classified car driver injured in collision with heavy transport vehicle or bus in nontraffic accident pressure ulcer, buttock other specified cardiac dysrhythmias other diseases of trachea and bronchus morbid obesity chronic respiratory failure other tracheostomy complications gout, unspecified 
unable to obtain m 60 $nan$nan$aspirin  81  mg ; fluoxetine  30  mg ; allopurinol  100  mg ; heparin  5000  unit ; albuterol-ipratropium  1-2  puff ; famotidine  20  mg ; guaifenesin  5-10  ml ; sarna lotion  1  appl ; insulin  0  unit ; calcipotriene 0.005% cream  1  appl ; gabapentin  600  mg ; lorazepam  0.5  mg ; morphine sulfate  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; digoxin  0.125  mg ; acetaminophen  500-1000  mg ; 
tracheostomy status pressure ulcer, stage ii chronic airway obstruction, not elsewhere classified car driver injured in collision with heavy transport vehicle or bus in nontraffic accident pressure ulcer, buttock other specified cardiac dysrhythmias other diseases of trachea and bronchus morbid obesity chronic respiratory failure other tracheostomy complications gout, unspecified 
white f 76 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.3  ; chemistry urine creatinine, urine  22  mg dl; chemistry urine sodium, urine  39  meq l; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  74  mg dl; chemistry blood lactate dehydrogenase (ld)  148  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; enoxaparin (prophylaxis)  30  mg ; vial  1  vial ; ceftriaxone  1  gm ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iohexol 240 (omnipaque 240)  40  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; metronidazole  500  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  374  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  133  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ceftriaxone  1  gm ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; multivitamins  1  tab ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; iohexol 240 (omnipaque 240)  40  ml ; heparin  5000  unit ; lactated ringers  1000  ml ; metronidazole  500  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  369  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  132  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; vial  1  vial ; ceftriaxone  1  gm ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; metronidazole  500  mg ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; insulin  10  unit ; multivitamins w minerals  1  tab ; bag  1  bag ; magnesium sulfate  4  gm ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  121  mg dl; chemistry blood glucose  138  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; insulin  10  unit ; multivitamins w minerals  1  tab ; bag  1  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  323  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  170  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; insulin  12  unit ; neutra-phos  2  pkt ; insulin  1  unit ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  218  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; neutra-phos  2  pkt ; insulin  1  unit ; insulin  15  unit ; magnesium sulfate  2  gm ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  333  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  158  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood albumin  2.3  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; multivitamins w minerals  1  tab ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; insulin  1  unit ; insulin  15  unit ; magnesium sulfate  2  gm ; insulin  2  unit ; phenazopyridine  100  mg ; amoxicillin  500  mg ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
white f 76 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; senna  8.6  mg ; acetaminophen  500-1000  mg ; docusate sodium  100  mg ; atorvastatin  80  mg ; levothyroxine sodium  200  mcg ; mirtazapine  15  mg ; omeprazole  20  mg ; ondansetron  4  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; heparin  5000  unit ; oxycodone (immediate release)  5-10  mg ; simethicone  80  mg ; polyethylene glycol  17  g ; ascorbic acid  250  mg ; multivitamins w minerals  1  tab ; magnesium sulfate  2  gm ; insulin  2  unit ; phenazopyridine  100  mg ; amoxicillin  500  mg ; insulin  17  unit ; 
type 2 diabetes mellitus with diabetic chronic kidney disease tubulo-interstitial nephritis, not specified as acute or chronic sepsis, unspecified organism urinary catheterization as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure hyperlipidemia, unspecified type 2 diabetes mellitus with other specified complication infection and inflammatory reaction due to indwelling urethral catheter, initial encounter cutaneous abscess of trunk, unspecified unspecified hydronephrosis acute kidney failure, unspecified personal history of antineoplastic chemotherapy other abnormalities of breathing long term (current) use of insulin other chronic osteomyelitis, other site severe sepsis without septic shock chronic kidney disease, stage 3 (moderate) hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease hypothyroidism, unspecified personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus pressure ulcer of sacral region, stage 4 secondary malignant neoplasm of bone acquired absence of kidney gastro-esophageal reflux disease without esophagitis personal history of other malignant neoplasm of rectum, rectosigmoid junction, and anus family history of malignant neoplasm of digestive organs myelopathy in diseases classified elsewhere history of falling personal history of other malignant neoplasm of kidney family history of malignant neoplasm of trachea, bronchus and lung acquired absence of right breast and nipple personal history of irradiation secondary malignant neoplasm of bone long term (current) use of insulin personal history of malignant neoplasm of breast unspecified urinary incontinence unspecified hydronephrosis chronic kidney disease, unspecified acquired absence of kidney type 2 diabetes mellitus with diabetic chronic kidney disease hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease personal history of antineoplastic chemotherapy acquired absence of other specified parts of digestive tract hypothyroidism, unspecified colostomy status hyperlipidemia, unspecified retention of urine, unspecified personal history of malignant neoplasm of breast unspecified acquired hypothyroidism
black african american f 72 $nan$nan$amlodipine  10  mg ; atorvastatin  80  mg ; cinacalcet  30  mg ; metoprolol succinate xl  12.5  mg ; clopidogrel  75  mg ; aspirin ec  325  mg ; ascorbic acid  500  mg ; ferrous sulfate  325  mg ; valsartan  80  mg ; nephrocaps  1  cap ; 
polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot chronic systolic heart failure intestinal infection due to clostridium difficile anemia in chronic kidney disease end stage renal disease diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident congestive heart failure, unspecified chronic hepatitis c without mention of hepatic coma gastrostomy status atherosclerosis of native arteries of the extremities with ulceration senile dementia with delirium diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere cellulitis and abscess of toe, unspecified other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma end stage renal disease other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia in chronic kidney disease peripheral vascular disease, unspecified depressive disorder, not elsewhere classified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere background diabetic retinopathy gastroparesis diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled secondary hyperparathyroidism (of renal origin) sickle-cell trait celiac artery compression syndrome chronic systolic heart failure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified polyneuropathy in diabetes hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of gastrostomy insulins and antidiabetic agents causing adverse effects in therapeutic use accidents occurring in residential institution chronic systolic heart failure sickle-cell trait diabetes with renal manifestations, type ii or unspecified type, uncontrolled car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident anemia in chronic kidney disease hypocalcemia
black african american f 72 $nan$hematology blood hematocrit  27.8  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  269  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  5.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  125  mg dl$amlodipine  10  mg ; atorvastatin  80  mg ; cinacalcet  30  mg ; metoprolol succinate xl  12.5  mg ; clopidogrel  75  mg ; aspirin ec  325  mg ; ascorbic acid  500  mg ; ferrous sulfate  325  mg ; valsartan  80  mg ; nephrocaps  1  cap ; heparin flush (10 units ml)  1  ml ; famotidine  20  mg ; sevelamer hydrochloride  2400  mg ; gabapentin  100  mg ; insulin  0  unit ; metoprolol tartrate  5  mg ; hydralazine  10  mg ; mirtazapine  30  mg ; vitamin d  50,000  unit ; metoprolol succinate xl  25  mg ; pantoprazole  40  mg ; citalopram hydrobromide  20  mg ; atorvastatin  20  mg ; cinacalcet  60  mg ; metoclopramide  10  mg ; sevelamer hydrochloride  1600  mg ; 
polyneuropathy in diabetes diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled ulcer of other part of foot chronic systolic heart failure intestinal infection due to clostridium difficile anemia in chronic kidney disease end stage renal disease diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident congestive heart failure, unspecified chronic hepatitis c without mention of hepatic coma gastrostomy status atherosclerosis of native arteries of the extremities with ulceration senile dementia with delirium diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled background diabetic retinopathy staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere cellulitis and abscess of toe, unspecified other and unspecified hyperlipidemia unspecified viral hepatitis c without hepatic coma end stage renal disease other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure anemia in chronic kidney disease peripheral vascular disease, unspecified depressive disorder, not elsewhere classified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere background diabetic retinopathy gastroparesis diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled secondary hyperparathyroidism (of renal origin) sickle-cell trait celiac artery compression syndrome chronic systolic heart failure diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled congestive heart failure, unspecified polyneuropathy in diabetes hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of gastrostomy insulins and antidiabetic agents causing adverse effects in therapeutic use accidents occurring in residential institution chronic systolic heart failure sickle-cell trait diabetes with renal manifestations, type ii or unspecified type, uncontrolled car passenger injured in collision with heavy transport vehicle or bus in nontraffic accident anemia in chronic kidney disease hypocalcemia
white f 43 $nan$nan$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; ondansetron  4  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; morphine sulfate  1-4  mg ; senna  8.6  mg ; oxycodone (immediate release)   10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; fluticasone propionate 110mcg  1  puff ; lisinopril  10  mg ; ranitidine  150  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   10-15  mg ; 
personal history of tobacco use unspecified essential hypertension anxiety state, unspecified degeneration of lumbar or lumbosacral intervertebral disc acquired absence of both cervix and uterus thoracic or lumbosacral neuritis or radiculitis, unspecified depressive disorder, not elsewhere classified other specified disorders of uterus, not elsewhere classified anxiety state, unspecified premenopausal menorrhagia unspecified essential hypertension peritoneal adhesions (postoperative) (postinfection) need for prophylactic vaccination and inoculation against influenza nonspecific (abnormal) findings on radiological and other examination of genitourinary organs
white f 43 $nan$nan$docusate sodium  100  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml ns  1000  ml ; ondansetron  4  mg ; senna  8.6  mg ; ranitidine  150  mg ; morphine sr (ms contin)  15  mg ; oxycodone (immediate release)   10-15  mg ; 
personal history of tobacco use unspecified essential hypertension anxiety state, unspecified degeneration of lumbar or lumbosacral intervertebral disc acquired absence of both cervix and uterus thoracic or lumbosacral neuritis or radiculitis, unspecified depressive disorder, not elsewhere classified other specified disorders of uterus, not elsewhere classified anxiety state, unspecified premenopausal menorrhagia unspecified essential hypertension peritoneal adhesions (postoperative) (postinfection) need for prophylactic vaccination and inoculation against influenza nonspecific (abnormal) findings on radiological and other examination of genitourinary organs
white m 88 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  27.6  %; hematology blood hematocrit  29.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  379  k ul; hematology blood platelet count  385  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  94  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; vial  1  vial ; pantoprazole  40  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; d5 1 2ns  500  ml ; miconazole powder 2%  1  appl ; moviprep  1  l ; magnesium citrate  300  ml ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  26.5  %; hematology blood hematocrit  25.4  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  9.0  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  377  k ul; hematology blood platelet count  366  k ul; hematology blood platelet count  358  k ul; hematology blood platelet count  367  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; vial  1  vial ; pantoprazole  40  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; magnesium citrate  300  ml ; heparin  5000  unit ; d5 1 2ns  1000  ml ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  26.7  %; hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  349  k ul; hematology blood platelet count  382  k ul; hematology blood platelet count  330  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; vial  1  vial ; pantoprazole  40  mg ; calcium carbonate  500  mg ; sulfameth trimethoprim ds  1  tab ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; d5 1 2ns  1000  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; sucralfate  1  gm ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  27.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; sucralfate  1  gm ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  319  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; furosemide  10  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  25.5  %; hematology blood hematocrit  25.5  %; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; furosemide  10  mg ; atorvastatin  20  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  22.7  %; hematology blood hematocrit  29.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  2.2  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; aspirin  81  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; atorvastatin  20  mg ; furosemide  20  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  28.3  %; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  23  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; atorvastatin  20  mg ; furosemide  20  mg ; lr  1000  ml ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  26.5  %; hematology blood hematocrit  30.4  %; chemistry blood anion gap  11  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  5.8  meq l; chemistry blood potassium  6.5  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  108  mg dl; chemistry blood glucose  202  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  650  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; atorvastatin  20  mg ; lr  1000  ml ; ciprofloxacin hcl  250  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; insulin  5  unit ; d5ns  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  29.7  %; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.8  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.2  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  248  mg dl; chemistry blood glucose  189  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; cyanocobalamin  1000  mcg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; sucralfate  1  gm ; atorvastatin  20  mg ; morphine sulfate  1-2  mg ; acetaminophen  325-650  mg ; insulin  5  unit ; d5ns  1000  ml ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; insulin  10  unit ; ciprofloxacin hcl  500  mg ; albumin 5% (25g   500ml)  25  g ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  126  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; calcium carbonate  500  mg ; vitamin d  800  unit ; multivitamins  1  tab ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; miconazole powder 2%  1  appl ; heparin  5000  unit ; morphine sulfate  1-2  mg ; 0.9% sodium chloride  500  ml ; insulin  10  unit ; ciprofloxacin hcl  500  mg ; albumin 5% (25g   500ml)  25  g ; 0.9% sodium chloride  1000  ml ; tamsulosin  0.4  mg ; metoprolol tartrate  5  mg ; lidocaine jelly 2% (urojet)  1  appl ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; digoxin  0.125  mg ; ferrous sulfate  325  mg ; losartan potassium  50  mg ; heparin  5000  unit ; morphine sulfate  1-2  mg ; metoprolol tartrate  5  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; bag  50  ml ; magnesium sulfate  2  gm ; metoclopramide  10  mg ; bisacodyl  10  mg ; chloraseptic throat spray  1-2  spry ; 0.45% sodium chloride  1000  ml ; digoxin  0.1  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  71  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; losartan potassium  50  mg ; heparin  5000  unit ; morphine sulfate  1-2  mg ; metoprolol tartrate  5  mg ; metoclopramide  10  mg ; bisacodyl  10  mg ; chloraseptic throat spray  1-2  spry ; 0.45% sodium chloride  1000  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; glyburide  2.5  mg ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; metoprolol tartrate  2.5  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; losartan potassium  50  mg ; heparin  5000  unit ; metoclopramide  10  mg ; chloraseptic throat spray  1-2  spry ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  325  mg ; metoprolol tartrate  12.5  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; losartan potassium  50  mg ; heparin  5000  unit ; metoclopramide  10  mg ; chloraseptic throat spray  1-2  spry ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  325  mg ; metoprolol tartrate  12.5  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 88 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; losartan potassium  50  mg ; heparin  5000  unit ; metoclopramide  10  mg ; chloraseptic throat spray  1-2  spry ; oxycodone (immediate release)   2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; aspirin  325  mg ; metoprolol tartrate  12.5  mg ; 
personal history of malignant neoplasm of prostate acute posthemorrhagic anemia diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled macroglobulinemia atrial fibrillation atrioventricular block, complete atherosclerosis of native arteries of the extremities with ulceration personal history of other malignant neoplasm of skin personal history of malignant melanoma of skin chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction cardiac pacemaker in situ examination of participant in clinical trial ulcer of other part of foot chronic total occlusion of artery of the extremities person on outside of bus injured in collision with pedestrian or animal in traffic accident 
white m 71 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  114  mg dl$sodium chloride 0.9%  flush  3-10  ml ; thiamine  100  mg ; carvedilol  12.5  mg ; gabapentin  300  mg ; miconazole powder 2%  1  appl ; budesonide  9  mg ; sertraline  100  mg ; apixaban  5  mg ; atovaquone suspension  1500  mg ; multivitamins  1  tab ; omeprazole  20  mg ; oxycodone (immediate release)  5  mg ; prednisone  10  mg ; tamsulosin  0.8  mg ; acyclovir  400  mg ; furosemide  20  mg ; acetaminophen  325-650  mg ; 
other retention of urine sepsis, unspecified organism cardiomyopathy, unspecified chronic diastolic (congestive) heart failure rash and other nonspecific skin eruption cellulitis of left lower limb unspecified osteoarthritis, unspecified site hyperlipidemia, unspecified hypertensive heart disease with heart failure adverse effect of glucocorticoids and synthetic analogues, sequela other specified bacterial agents as the cause of diseases classified elsewhere gastro-esophageal reflux disease without esophagitis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure enterocolitis due to clostridium difficile, not specified as recurrent long term (current) use of antithrombotics/antiplatelets unspecified atrial fibrillation anxiety disorder, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter dry eye syndrome of bilateral lacrimal glands exposure to other specified factors, subsequent encounter attention-deficit hyperactivity disorder, unspecified type antineoplastic chemotherapy induced pancytopenia other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris major depressive disorder, single episode, unspecified other adrenocortical insufficiency unspecified b-cell lymphoma, unspecified site other specified noninfective gastroenteritis and colitis obstructive sleep apnea (adult) (pediatric) gout, unspecified unspecified place in hospital as the place of occurrence of the external cause exposure to other specified factors, initial encounter infection following a procedure, initial encounter unspecified open wound of lower back and pelvis without penetration into retroperitoneum, initial encounter splenomegaly, not elsewhere classified unspecified place or not applicable benign prostatic hyperplasia with lower urinary tract symptoms strain of right achilles tendon, subsequent encounter pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere benign prostatic hyperplasia without lower urinary tract symptoms drug-induced adrenocortical insufficiency major depressive disorder, single episode, unspecified toxic encephalopathy strain of right achilles tendon, subsequent encounter pneumonia, unspecified organism respiratory failure, unspecified with hypoxia anxiety disorder, unspecified acute posthemorrhagic anemia
white m 71 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  85  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3-10  ml ; thiamine  100  mg ; carvedilol  12.5  mg ; gabapentin  300  mg ; miconazole powder 2%  1  appl ; budesonide  9  mg ; sertraline  100  mg ; apixaban  5  mg ; atovaquone suspension  1500  mg ; multivitamins  1  tab ; omeprazole  20  mg ; oxycodone (immediate release)  5  mg ; prednisone  10  mg ; tamsulosin  0.8  mg ; acyclovir  400  mg ; furosemide  20  mg ; acetaminophen  325-650  mg ; vial  1  vial ; meropenem  500  mg ; furosemide  40  mg ; 
other retention of urine sepsis, unspecified organism cardiomyopathy, unspecified chronic diastolic (congestive) heart failure rash and other nonspecific skin eruption cellulitis of left lower limb unspecified osteoarthritis, unspecified site hyperlipidemia, unspecified hypertensive heart disease with heart failure adverse effect of glucocorticoids and synthetic analogues, sequela other specified bacterial agents as the cause of diseases classified elsewhere gastro-esophageal reflux disease without esophagitis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure enterocolitis due to clostridium difficile, not specified as recurrent long term (current) use of antithrombotics/antiplatelets unspecified atrial fibrillation anxiety disorder, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter dry eye syndrome of bilateral lacrimal glands exposure to other specified factors, subsequent encounter attention-deficit hyperactivity disorder, unspecified type antineoplastic chemotherapy induced pancytopenia other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris major depressive disorder, single episode, unspecified other adrenocortical insufficiency unspecified b-cell lymphoma, unspecified site other specified noninfective gastroenteritis and colitis obstructive sleep apnea (adult) (pediatric) gout, unspecified unspecified place in hospital as the place of occurrence of the external cause exposure to other specified factors, initial encounter infection following a procedure, initial encounter unspecified open wound of lower back and pelvis without penetration into retroperitoneum, initial encounter splenomegaly, not elsewhere classified unspecified place or not applicable benign prostatic hyperplasia with lower urinary tract symptoms strain of right achilles tendon, subsequent encounter pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere benign prostatic hyperplasia without lower urinary tract symptoms drug-induced adrenocortical insufficiency major depressive disorder, single episode, unspecified toxic encephalopathy strain of right achilles tendon, subsequent encounter pneumonia, unspecified organism respiratory failure, unspecified with hypoxia anxiety disorder, unspecified acute posthemorrhagic anemia
white m 71 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  78  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  149  mg dl$sodium chloride 0.9%  flush  3-10  ml ; thiamine  100  mg ; carvedilol  12.5  mg ; gabapentin  300  mg ; miconazole powder 2%  1  appl ; budesonide  9  mg ; sertraline  100  mg ; apixaban  5  mg ; atovaquone suspension  1500  mg ; multivitamins  1  tab ; omeprazole  20  mg ; oxycodone (immediate release)  5  mg ; prednisone  10  mg ; tamsulosin  0.8  mg ; acyclovir  400  mg ; acetaminophen  325-650  mg ; vial  1  vial ; meropenem  500  mg ; lisinopril  10  mg ; 
other retention of urine sepsis, unspecified organism cardiomyopathy, unspecified chronic diastolic (congestive) heart failure rash and other nonspecific skin eruption cellulitis of left lower limb unspecified osteoarthritis, unspecified site hyperlipidemia, unspecified hypertensive heart disease with heart failure adverse effect of glucocorticoids and synthetic analogues, sequela other specified bacterial agents as the cause of diseases classified elsewhere gastro-esophageal reflux disease without esophagitis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure enterocolitis due to clostridium difficile, not specified as recurrent long term (current) use of antithrombotics/antiplatelets unspecified atrial fibrillation anxiety disorder, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter dry eye syndrome of bilateral lacrimal glands exposure to other specified factors, subsequent encounter attention-deficit hyperactivity disorder, unspecified type antineoplastic chemotherapy induced pancytopenia other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris major depressive disorder, single episode, unspecified other adrenocortical insufficiency unspecified b-cell lymphoma, unspecified site other specified noninfective gastroenteritis and colitis obstructive sleep apnea (adult) (pediatric) gout, unspecified unspecified place in hospital as the place of occurrence of the external cause exposure to other specified factors, initial encounter infection following a procedure, initial encounter unspecified open wound of lower back and pelvis without penetration into retroperitoneum, initial encounter splenomegaly, not elsewhere classified unspecified place or not applicable benign prostatic hyperplasia with lower urinary tract symptoms strain of right achilles tendon, subsequent encounter pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere benign prostatic hyperplasia without lower urinary tract symptoms drug-induced adrenocortical insufficiency major depressive disorder, single episode, unspecified toxic encephalopathy strain of right achilles tendon, subsequent encounter pneumonia, unspecified organism respiratory failure, unspecified with hypoxia anxiety disorder, unspecified acute posthemorrhagic anemia
white m 71 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  96  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  133  mg dl$sodium chloride 0.9%  flush  3-10  ml ; thiamine  100  mg ; carvedilol  12.5  mg ; gabapentin  300  mg ; miconazole powder 2%  1  appl ; budesonide  9  mg ; sertraline  100  mg ; apixaban  5  mg ; atovaquone suspension  1500  mg ; multivitamins  1  tab ; omeprazole  20  mg ; oxycodone (immediate release)  5  mg ; prednisone  10  mg ; tamsulosin  0.8  mg ; acyclovir  400  mg ; acetaminophen  325-650  mg ; vial  1  vial ; meropenem  500  mg ; lisinopril  10  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; meropenem  1000  mg ; 
other retention of urine sepsis, unspecified organism cardiomyopathy, unspecified chronic diastolic (congestive) heart failure rash and other nonspecific skin eruption cellulitis of left lower limb unspecified osteoarthritis, unspecified site hyperlipidemia, unspecified hypertensive heart disease with heart failure adverse effect of glucocorticoids and synthetic analogues, sequela other specified bacterial agents as the cause of diseases classified elsewhere gastro-esophageal reflux disease without esophagitis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure enterocolitis due to clostridium difficile, not specified as recurrent long term (current) use of antithrombotics/antiplatelets unspecified atrial fibrillation anxiety disorder, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter dry eye syndrome of bilateral lacrimal glands exposure to other specified factors, subsequent encounter attention-deficit hyperactivity disorder, unspecified type antineoplastic chemotherapy induced pancytopenia other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris major depressive disorder, single episode, unspecified other adrenocortical insufficiency unspecified b-cell lymphoma, unspecified site other specified noninfective gastroenteritis and colitis obstructive sleep apnea (adult) (pediatric) gout, unspecified unspecified place in hospital as the place of occurrence of the external cause exposure to other specified factors, initial encounter infection following a procedure, initial encounter unspecified open wound of lower back and pelvis without penetration into retroperitoneum, initial encounter splenomegaly, not elsewhere classified unspecified place or not applicable benign prostatic hyperplasia with lower urinary tract symptoms strain of right achilles tendon, subsequent encounter pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere benign prostatic hyperplasia without lower urinary tract symptoms drug-induced adrenocortical insufficiency major depressive disorder, single episode, unspecified toxic encephalopathy strain of right achilles tendon, subsequent encounter pneumonia, unspecified organism respiratory failure, unspecified with hypoxia anxiety disorder, unspecified acute posthemorrhagic anemia
white m 71 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; thiamine  100  mg ; carvedilol  12.5  mg ; gabapentin  300  mg ; miconazole powder 2%  1  appl ; budesonide  9  mg ; sertraline  100  mg ; apixaban  5  mg ; atovaquone suspension  1500  mg ; multivitamins  1  tab ; omeprazole  20  mg ; oxycodone (immediate release)  5  mg ; prednisone  10  mg ; tamsulosin  0.8  mg ; acyclovir  400  mg ; acetaminophen  325-650  mg ; lisinopril  10  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10  ml ; meropenem  1000  mg ; loperamide  2  mg ; 
other retention of urine sepsis, unspecified organism cardiomyopathy, unspecified chronic diastolic (congestive) heart failure rash and other nonspecific skin eruption cellulitis of left lower limb unspecified osteoarthritis, unspecified site hyperlipidemia, unspecified hypertensive heart disease with heart failure adverse effect of glucocorticoids and synthetic analogues, sequela other specified bacterial agents as the cause of diseases classified elsewhere gastro-esophageal reflux disease without esophagitis other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure enterocolitis due to clostridium difficile, not specified as recurrent long term (current) use of antithrombotics/antiplatelets unspecified atrial fibrillation anxiety disorder, unspecified adverse effect of antineoplastic and immunosuppressive drugs, initial encounter dry eye syndrome of bilateral lacrimal glands exposure to other specified factors, subsequent encounter attention-deficit hyperactivity disorder, unspecified type antineoplastic chemotherapy induced pancytopenia other pancytopenia atherosclerotic heart disease of native coronary artery without angina pectoris major depressive disorder, single episode, unspecified other adrenocortical insufficiency unspecified b-cell lymphoma, unspecified site other specified noninfective gastroenteritis and colitis obstructive sleep apnea (adult) (pediatric) gout, unspecified unspecified place in hospital as the place of occurrence of the external cause exposure to other specified factors, initial encounter infection following a procedure, initial encounter unspecified open wound of lower back and pelvis without penetration into retroperitoneum, initial encounter splenomegaly, not elsewhere classified unspecified place or not applicable benign prostatic hyperplasia with lower urinary tract symptoms strain of right achilles tendon, subsequent encounter pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere benign prostatic hyperplasia without lower urinary tract symptoms drug-induced adrenocortical insufficiency major depressive disorder, single episode, unspecified toxic encephalopathy strain of right achilles tendon, subsequent encounter pneumonia, unspecified organism respiratory failure, unspecified with hypoxia anxiety disorder, unspecified acute posthemorrhagic anemia
white m 70 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  132  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood glucose  129  mg dl$d5lr  1000  ml ; atenolol  100  mg ; amlodipine  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  50  mg ; docusate sodium  100  mg ; terazosin  5  mg ; atenolol  25  mg ; 
 
white m 70 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood glucose  97  mg dl$d5lr  1000  ml ; atenolol  100  mg ; amlodipine  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; morphine sulfate  50  mg ; docusate sodium  100  mg ; terazosin  5  mg ; atenolol  25  mg ; warfarin  2  mg ; 
 
white m 70 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  95  mg dl$d5lr  1000  ml ; atenolol  100  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; terazosin  5  mg ; atenolol  25  mg ; warfarin  2  mg ; 
 
white m 70 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood glucose  93  mg dl$d5lr  1000  ml ; atenolol  100  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; terazosin  5  mg ; atenolol  25  mg ; warfarin  3  mg ; 
 
white m 70 $nan$nan$d5lr  1000  ml ; atenolol  100  mg ; amlodipine  5  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; ondansetron  4  mg ; hydrocodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; terazosin  5  mg ; atenolol  25  mg ; 
 
white m 75 $nan$nan$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; diltiazem extended-release  120  mg ; 
 
white m 75 $nan$hematology blood hematocrit  42.3  %; hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.1  g dl; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  209  k ul; hematology blood platelet count  228  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  2.2  ; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  86  mg dl$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; diltiazem extended-release  120  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  80  mg ; lorazepam  0.5-1  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; digoxin  0.25  mg ; oxazepam  10  mg ; trazodone  25  mg ; 
 
white m 75 $nan$hematology blood hematocrit  41.7  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  204  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  39  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  3.9  g dl$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  80  mg ; lorazepam  0.5-1  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; digoxin  0.25  mg ; trazodone  25  mg ; warfarin  2.5  mg ; 
 
white m 75 $nan$chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  41  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood glucose  93  mg dl$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  80  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; digoxin  0.25  mg ; trazodone  25  mg ; heparin  5000  unit ; 
 
white m 75 $nan$hematology blood hematocrit  40.2  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  41  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  70  mg dl$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  80  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; digoxin  0.25  mg ; trazodone  25  mg ; heparin  5000  unit ; 
 
white m 75 $nan$nan$furosemide  40  mg ; citalopram hydrobromide  20  mg ; finasteride  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; simvastatin  80  mg ; acetaminophen  325-650  mg ; docusate sodium  100  mg ; senna  1  tab ; digoxin  0.25  mg ; trazodone  25  mg ; heparin  5000  unit ; 
 
white f 55 $temp  98.3  heartrate  75.0  resprate  16.0  o2sat  99.0  sbp  131.0  dbp  74.0  rhythm    pain  3  $hematology blood hematocrit  42.2  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  241  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; hematology urine wbc  78  # hpf; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, indirect  0.7  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  222  mg dl; chemistry blood bilirubin, direct  0.2  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; paroxetine  20  mg ; 
 
white f 55 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; insulin  0  unit ; morphine sulfate  2-4  mg ; docusate sodium  100  mg ; senna  1  tab ; paroxetine  20  mg ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; 
 
white f 55 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  255  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  213  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; paroxetine  20  mg ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; ondansetron  4  mg ; topiramate (topamax)  50  mg ; metoclopramide  5  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; 
 
white f 55 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; vial  1  vial ; pantoprazole  40  mg ; docusate sodium  100  mg ; senna  1  tab ; paroxetine  20  mg ; ciprofloxacin hcl  250  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-4  mg ; topiramate (topamax)  50  mg ; omeprazole  20  mg ; lorazepam  0.5  mg ; metformin (glucophage)  500  mg ; 
 
black african american f 34 $temp  96.5  heartrate  96.0  resprate  18.0  o2sat  100.0  sbp  123.0  dbp  74.0  rhythm    pain  6  ; temp    heartrate  84.0  resprate  16.0  o2sat  97.0  sbp  121.0  dbp  77.0  rhythm    pain  8  ; temp    heartrate  75.0  resprate  18.0  o2sat  96.0  sbp  111.0  dbp  61.0  rhythm    pain  4  $nan$sodium chloride 0.9%  flush  3-10  ml ; 
unspecified asthma, uncomplicated dysphagia, unspecified acute pharyngitis, unspecified tracheostomy status other diseases of bronchus, not elsewhere classified stenosis of larynx unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis other chest pain bronchopulmonary dysplasia originating in the perinatal period other chronic pain anxiety disorder, unspecified other somatoform disorders other specified diseases of upper respiratory tract major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified stenosis of larynx encounter for attention to tracheostomy other chronic pain phlebitis and thrombophlebitis of other sites anxiety disorder, unspecified bronchopulmonary dysplasia originating in the perinatal period unspecified asthma, uncomplicated bronchopulmonary dysplasia originating in the perinatal period tracheostomy status anxiety disorder, unspecified unspecified asthma, uncomplicated stenosis of larynx gastro-esophageal reflux disease without esophagitis other chronic pain unspecified chronic bronchitis hypoxemia major depressive disorder, single episode, unspecified congenital bronchomalacia anxiety disorder, unspecified other chronic pain other congenital malformations of larynx family history of malignant neoplasm of other organs or systems myalgia hemoptysis acute upper respiratory infection, unspecified cough acute bronchitis, unspecified family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis other diseases of bronchus, not elsewhere classified other specified diseases of upper respiratory tract
black african american f 34 $temp  98.5  heartrate  71.0  resprate  16.0  o2sat  97.0  sbp  116.0  dbp  50.0  rhythm    pain    ; temp  98.1  heartrate  76.0  resprate  18.0  o2sat  97.0  sbp  116.0  dbp  73.0  rhythm    pain  0  $nan$d5 1 2ns  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; influenza vaccine quadrivalent  0.5  ml ; acetylcysteine 20%  3-5  ml ; albuterol inhaler  1-2  puff ; fluticasone propionate nasal  1  spry ; guaifenesin  15  ml ; ipratropium-albuterol neb  1  neb ; ranitidine  150  mg ; senna  8.6  mg ; sodium chloride 3% inhalation soln  15  ml ; acetaminophen (liquid)  650  mg ; hydroxyzine  50  mg ; ketorolac  15  mg ; gabapentin  400  mg ; sodium chloride 0.9%  1000  ml ; soln  100  ml ; acetaminophen iv  1000  mg ; heparin  5000  unit ; fluoxetine  60  mg ; loratadine  10  mg ; omeprazole  40  mg ; cepacol (sore throat lozenge)  2  loz ; 
unspecified asthma, uncomplicated dysphagia, unspecified acute pharyngitis, unspecified tracheostomy status other diseases of bronchus, not elsewhere classified stenosis of larynx unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis other chest pain bronchopulmonary dysplasia originating in the perinatal period other chronic pain anxiety disorder, unspecified other somatoform disorders other specified diseases of upper respiratory tract major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified stenosis of larynx encounter for attention to tracheostomy other chronic pain phlebitis and thrombophlebitis of other sites anxiety disorder, unspecified bronchopulmonary dysplasia originating in the perinatal period unspecified asthma, uncomplicated bronchopulmonary dysplasia originating in the perinatal period tracheostomy status anxiety disorder, unspecified unspecified asthma, uncomplicated stenosis of larynx gastro-esophageal reflux disease without esophagitis other chronic pain unspecified chronic bronchitis hypoxemia major depressive disorder, single episode, unspecified congenital bronchomalacia anxiety disorder, unspecified other chronic pain other congenital malformations of larynx family history of malignant neoplasm of other organs or systems myalgia hemoptysis acute upper respiratory infection, unspecified cough acute bronchitis, unspecified family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis other diseases of bronchus, not elsewhere classified other specified diseases of upper respiratory tract
black african american f 34 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetylcysteine 20%  3-5  ml ; albuterol inhaler  1-2  puff ; fluticasone propionate nasal  1  spry ; guaifenesin  15  ml ; ipratropium-albuterol neb  1  neb ; sodium chloride 3% inhalation soln  15  ml ; acetaminophen (liquid)  650  mg ; hydroxyzine  50  mg ; gabapentin  400  mg ; heparin  5000  unit ; loratadine  10  mg ; cepacol (sore throat lozenge)  2  loz ; gabapentin  800  mg ; lansoprazole oral disintegrating tab  30  mg ; ibuprofen suspension  600  mg ; 
unspecified asthma, uncomplicated dysphagia, unspecified acute pharyngitis, unspecified tracheostomy status other diseases of bronchus, not elsewhere classified stenosis of larynx unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis other chest pain bronchopulmonary dysplasia originating in the perinatal period other chronic pain anxiety disorder, unspecified other somatoform disorders other specified diseases of upper respiratory tract major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified stenosis of larynx encounter for attention to tracheostomy other chronic pain phlebitis and thrombophlebitis of other sites anxiety disorder, unspecified bronchopulmonary dysplasia originating in the perinatal period unspecified asthma, uncomplicated bronchopulmonary dysplasia originating in the perinatal period tracheostomy status anxiety disorder, unspecified unspecified asthma, uncomplicated stenosis of larynx gastro-esophageal reflux disease without esophagitis other chronic pain unspecified chronic bronchitis hypoxemia major depressive disorder, single episode, unspecified congenital bronchomalacia anxiety disorder, unspecified other chronic pain other congenital malformations of larynx family history of malignant neoplasm of other organs or systems myalgia hemoptysis acute upper respiratory infection, unspecified cough acute bronchitis, unspecified family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis other diseases of bronchus, not elsewhere classified other specified diseases of upper respiratory tract
black african american f 34 $nan$hematology blood hematocrit  34.1  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  248  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  161  mg dl; chemistry blood % hemoglobin a1c  7.9  %$sodium chloride 0.9%  flush  3-10  ml ; acetylcysteine 20%  3-5  ml ; albuterol inhaler  1-2  puff ; fluticasone propionate nasal  1  spry ; guaifenesin  15  ml ; ipratropium-albuterol neb  1  neb ; sodium chloride 3% inhalation soln  15  ml ; hydroxyzine  50  mg ; gabapentin  400  mg ; heparin  5000  unit ; loratadine  10  mg ; cepacol (sore throat lozenge)  2  loz ; gabapentin  800  mg ; lansoprazole oral disintegrating tab  30  mg ; ibuprofen suspension  600  mg ; acetaminophen  650  mg ; neutra-phos  1  pkt ; 
unspecified asthma, uncomplicated dysphagia, unspecified acute pharyngitis, unspecified tracheostomy status other diseases of bronchus, not elsewhere classified stenosis of larynx unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis other chest pain bronchopulmonary dysplasia originating in the perinatal period other chronic pain anxiety disorder, unspecified other somatoform disorders other specified diseases of upper respiratory tract major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified stenosis of larynx encounter for attention to tracheostomy other chronic pain phlebitis and thrombophlebitis of other sites anxiety disorder, unspecified bronchopulmonary dysplasia originating in the perinatal period unspecified asthma, uncomplicated bronchopulmonary dysplasia originating in the perinatal period tracheostomy status anxiety disorder, unspecified unspecified asthma, uncomplicated stenosis of larynx gastro-esophageal reflux disease without esophagitis other chronic pain unspecified chronic bronchitis hypoxemia major depressive disorder, single episode, unspecified congenital bronchomalacia anxiety disorder, unspecified other chronic pain other congenital malformations of larynx family history of malignant neoplasm of other organs or systems myalgia hemoptysis acute upper respiratory infection, unspecified cough acute bronchitis, unspecified family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis other diseases of bronchus, not elsewhere classified other specified diseases of upper respiratory tract
black african american f 34 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetylcysteine 20%  3-5  ml ; albuterol inhaler  1-2  puff ; fluticasone propionate nasal  1  spry ; guaifenesin  15  ml ; ipratropium-albuterol neb  1  neb ; sodium chloride 3% inhalation soln  15  ml ; heparin  5000  unit ; loratadine  10  mg ; cepacol (sore throat lozenge)  2  loz ; lansoprazole oral disintegrating tab  30  mg ; ibuprofen suspension  600  mg ; acetaminophen  650  mg ; neutra-phos  1  pkt ; 
unspecified asthma, uncomplicated dysphagia, unspecified acute pharyngitis, unspecified tracheostomy status other diseases of bronchus, not elsewhere classified stenosis of larynx unspecified chronic bronchitis gastro-esophageal reflux disease without esophagitis other chest pain bronchopulmonary dysplasia originating in the perinatal period other chronic pain anxiety disorder, unspecified other somatoform disorders other specified diseases of upper respiratory tract major depressive disorder, single episode, unspecified gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified stenosis of larynx encounter for attention to tracheostomy other chronic pain phlebitis and thrombophlebitis of other sites anxiety disorder, unspecified bronchopulmonary dysplasia originating in the perinatal period unspecified asthma, uncomplicated bronchopulmonary dysplasia originating in the perinatal period tracheostomy status anxiety disorder, unspecified unspecified asthma, uncomplicated stenosis of larynx gastro-esophageal reflux disease without esophagitis other chronic pain unspecified chronic bronchitis hypoxemia major depressive disorder, single episode, unspecified congenital bronchomalacia anxiety disorder, unspecified other chronic pain other congenital malformations of larynx family history of malignant neoplasm of other organs or systems myalgia hemoptysis acute upper respiratory infection, unspecified cough acute bronchitis, unspecified family history of malignant neoplasm of breast gastro-esophageal reflux disease without esophagitis other diseases of bronchus, not elsewhere classified other specified diseases of upper respiratory tract
white m 62 $nan$nan$simvastatin  20  mg ; 
unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission malignant neoplasm of prostate other and unspecified hyperlipidemia
white m 62 $nan$nan$ondansetron  4  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; diphenhydramine  25  mg ; milk of magnesia  30  ml ; vial  1  vial ; pantoprazole  40  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; zolpidem tartrate  5  mg ; cepacol (menthol)  1  loz ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium  100  mg ; gabapentin  300  mg ; gemfibrozil  600  mg ; metformin (glucophage)  500  mg ; hydrocodone-acetaminophen  1-2  tab ; amitriptyline  25  mg ; 
unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission malignant neoplasm of prostate other and unspecified hyperlipidemia
white m 62 $nan$nan$ondansetron  4  mg ; simvastatin  20  mg ; acetaminophen  650  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; bisacodyl  10  mg ; diphenhydramine  25  mg ; milk of magnesia  30  ml ; vial  1  vial ; pantoprazole  40  mg ; senna  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; zolpidem tartrate  5  mg ; cepacol (menthol)  1  loz ; insulin  0  unit ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; docusate sodium  100  mg ; gabapentin  300  mg ; gemfibrozil  600  mg ; metformin (glucophage)  500  mg ; hydrocodone-acetaminophen  1-2  tab ; amitriptyline  25  mg ; 
unspecified essential hypertension chronic lymphoid leukemia, without mention of having achieved remission malignant neoplasm of prostate other and unspecified hyperlipidemia
white m 79 $nan$nan$simvastatin  10  mg ; 
 
white m 79 $nan$hematology blood hematocrit  23.3  %; hematology blood hematocrit  34.0  %; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  154  k ul; hematology blood platelet count  164  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  165  mg dl; blood gas blood free calcium  1.07  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood glucose  112  mg dl; blood gas blood glucose  153  mg dl; blood gas blood potassium, whole blood  3.4  meq l$simvastatin  10  mg ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  100  ml ; cefazolin  2  g ; metoprolol tartrate  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; sw  50-100  ml ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; potassium chloride  20-40  meq ; potassium chloride  40-60  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  500  ml ; potassium phosphate  15  mmol ; potassium phosphate  15-30  mmol ; hydralazine  10  mg ; morphine sulfate  2-10  mg ; d5w  250  ml ; nitroglycerin  1  mcg ; metoprolol tartrate  50  mg ; valsartan  40  mg ; isosorbide mononitrate (extended release)  90  mg ; aspirin  81  mg ; omeprazole  40  mg ; rosuvastatin calcium  40  mg ; warfarin  3  mg ; 
 
white m 79 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  92  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; valsartan  40  mg ; isosorbide mononitrate (extended release)  90  mg ; aspirin  81  mg ; omeprazole  40  mg ; rosuvastatin calcium  40  mg ; warfarin  3  mg ; metoprolol tartrate  100  mg ; tamsulosin  0.4  mg ; furosemide  40  mg ; warfarin  2  mg ; bisacodyl  10  mg ; senna  1  tab ; 
 
white m 79 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  86  mg dl$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; valsartan  40  mg ; aspirin  81  mg ; omeprazole  40  mg ; rosuvastatin calcium  40  mg ; metoprolol tartrate  100  mg ; tamsulosin  0.4  mg ; furosemide  40  mg ; warfarin  2  mg ; bisacodyl  10  mg ; senna  1  tab ; nitroglycerin sl  0.3  mg ; docusate sodium  100  mg ; isosorbide mononitrate (extended release)  30  mg ; isosorbide mononitrate (extended release)  60  mg ; potassium chloride  40  meq ; 
 
other m 88 $temp    heartrate  98.0  resprate  20.0  o2sat  93.0  sbp  124.0  dbp  57.0  rhythm    pain    ; temp    heartrate  95.0  resprate  18.0  o2sat  96.0  sbp  119.0  dbp  49.0  rhythm    pain    ; temp    heartrate  95.0  resprate  18.0  o2sat  98.0  sbp  117.0  dbp  75.0  rhythm    pain    ; temp  98.3  heartrate  90.0  resprate  18.0  o2sat  97.0  sbp  113.0  dbp  75.0  rhythm    pain    ; temp  97.8  heartrate  95.0  resprate  14.0  o2sat  96.0  sbp  105.0  dbp  67.0  rhythm  atrial fibrillation  pain    ; temp  98.3  heartrate  80.0  resprate  18.0  o2sat  99.0  sbp  114.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  42.1  %; hematology blood hemoglobin  15.0  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  2.9  ; hematology urine wbc  3  # hpf; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  132  mg dl; chemistry blood albumin  4.4  g dl; blood gas blood lactate  2.8  mmol l; blood gas blood potassium, whole blood  3.5  meq l$nan
unspecified essential hypertension atrial fibrillation depressive disorder, not elsewhere classified other and unspecified hyperlipidemia long-term (current) use of anticoagulants other specified cardiac dysrhythmias abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified transient cerebral ischemia
other m 88 $temp  98.6  heartrate  65.0  resprate  16.0  o2sat    sbp  109.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  38.3  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  153  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  96  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; finasteride  5  mg ; amlodipine  5  mg ; digoxin  0.125  mg ; citalopram  10  mg ; heparin  5000  unit ; vial  1  vial ; pantoprazole  40  mg ; sodium chloride nasal  1-2  spry ; omeprazole  20  mg ; pravastatin  20  mg ; 
unspecified essential hypertension atrial fibrillation depressive disorder, not elsewhere classified other and unspecified hyperlipidemia long-term (current) use of anticoagulants other specified cardiac dysrhythmias abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified transient cerebral ischemia
other m 88 $nan$hematology blood hematocrit  37.3  %; hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.9  g dl; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  147  k ul; hematology blood platelet count  120  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; finasteride  5  mg ; amlodipine  5  mg ; digoxin  0.125  mg ; citalopram  10  mg ; heparin  5000  unit ; sodium chloride nasal  1-2  spry ; omeprazole  20  mg ; pravastatin  20  mg ; alfuzosin  10  mg ; warfarin  3  mg ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
unspecified essential hypertension atrial fibrillation depressive disorder, not elsewhere classified other and unspecified hyperlipidemia long-term (current) use of anticoagulants other specified cardiac dysrhythmias abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified transient cerebral ischemia
other m 88 $nan$hematology blood inr(pt)  1.9  $sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; finasteride  5  mg ; amlodipine  5  mg ; digoxin  0.125  mg ; citalopram  10  mg ; sodium chloride nasal  1-2  spry ; omeprazole  20  mg ; pravastatin  20  mg ; alfuzosin  10  mg ; potassium chloride  20  meq ; bag  50  ml ; magnesium sulfate  2  gm ; warfarin  2  mg ; milk of magnesia  30  ml ; warfarin  2.5  mg ; 
unspecified essential hypertension atrial fibrillation depressive disorder, not elsewhere classified other and unspecified hyperlipidemia long-term (current) use of anticoagulants other specified cardiac dysrhythmias abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified transient cerebral ischemia
other m 88 $nan$nan$sodium chloride 0.9%  flush  3  ml ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; ondansetron  4  mg ; acetaminophen  650  mg ; finasteride  5  mg ; amlodipine  5  mg ; digoxin  0.125  mg ; citalopram  10  mg ; sodium chloride nasal  1-2  spry ; omeprazole  20  mg ; pravastatin  20  mg ; alfuzosin  10  mg ; warfarin  2  mg ; milk of magnesia  30  ml ; warfarin  2.5  mg ; warfarin  4.5  mg ; ciprofloxacin hcl  500  mg ; 
unspecified essential hypertension atrial fibrillation depressive disorder, not elsewhere classified other and unspecified hyperlipidemia long-term (current) use of anticoagulants other specified cardiac dysrhythmias abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified transient cerebral ischemia
white f 26 $nan$hematology blood hematocrit  32.0  %; hematology blood hematocrit  33.8  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.2  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  347  k ul; hematology blood platelet count  352  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  174  mg dl; chemistry blood glucose  120  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.5  mmol l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  160  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.8  g dl; blood gas blood potassium, whole blood  3.8  meq l; blood gas blood sodium, whole blood  135  meq l$metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; diphenhydramine  25  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; lr  1000  ml ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; metoprolol tartrate  2.5  mg ; hydromorphone (dilaudid)  0.5  mg ; metoprolol tartrate  7.5  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$nan$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; diphenhydramine  25  mg ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; hydromorphone (dilaudid)  0.5  mg ; metoprolol tartrate  7.5  mg ; acetaminophen  1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; acetaminophen  650  mg ; prochlorperazine  10  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$nan$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; insulin  0  unit ; metoprolol tartrate  7.5  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; prochlorperazine  10  mg ; pneumococcal vac polyvalent  0.5  ml ; meningococcal conj vaccine (menactra)  0.5  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  2  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$hematology blood hematocrit  29.3  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  450  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  108  mg dl$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; lorazepam  0.5  mg ; insulin  0  unit ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; prochlorperazine  10  mg ; hydromorphone (dilaudid)  4  mg ; ibuprofen  600  mg ; fludrocortisone acetate  0.1  mg ; betaxolol  20  mg ; hydromorphone (dilaudid)  6  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  84  mg dl$heparin flush (10 units ml)  1  ml ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; fludrocortisone acetate  0.1  mg ; betaxolol  20  mg ; hydromorphone (dilaudid)  6  mg ; potassium chloride  60  meq ; neutra-phos  2  pkt ; alprazolam  0.5  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; pantoprazole  40  mg ; cyanocobalamin  50  mcg ; escitalopram oxalate  20  mg ; folic acid  1  mg ; yasmin 28  3  mg ; amitriptyline  50  mg ; amitriptyline  25  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  577  k ul$heparin flush (10 units ml)  1  ml ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; fludrocortisone acetate  0.1  mg ; betaxolol  20  mg ; hydromorphone (dilaudid)  6  mg ; alprazolam  0.5  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; pantoprazole  40  mg ; folic acid  1  mg ; yasmin 28  3  mg ; amitriptyline  50  mg ; neutra-phos  1  pkt ; sw  50  ml ; magnesium sulfate  2  gm ; omeprazole  20  mg ; nystatin  500,000  unit ; hydromorphone (dilaudid)  2-6  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white f 26 $nan$nan$heparin flush (10 units ml)  1  ml ; heparin  5000  unit ; ondansetron  4  mg ; albuterol 0.083% neb soln  1  neb ; insulin  0  unit ; fludrocortisone acetate  0.1  mg ; betaxolol  20  mg ; alprazolam  0.5  mg ; fluticasone propionate 110mcg  2  puff ; docusate sodium  100  mg ; folic acid  1  mg ; yasmin 28  3  mg ; amitriptyline  50  mg ; neutra-phos  1  pkt ; sw  50  ml ; magnesium sulfate  2  gm ; omeprazole  20  mg ; nystatin  500,000  unit ; hydromorphone (dilaudid)  2-6  mg ; bisacodyl  10  mg ; 
acute pancreatitis unspecified intestinal malabsorption sicca syndrome chronic pancreatitis von willebrand's disease iron deficiency anemia, unspecified sicca syndrome depressive disorder, not elsewhere classified iron deficiency anemia, unspecified acute pancreatitis von willebrand's disease unspecified intestinal malabsorption urinary tract infection, site not specified von willebrand's disease acute pancreatitis unspecified intestinal malabsorption sicca syndrome pneumonia, organism unspecified von willebrand's disease sicca syndrome acute pancreatitis orthostatic hypotension unspecified intestinal malabsorption tachycardia, unspecified iron deficiency anemia, unspecified depressive disorder, not elsewhere classified
white m 62 $nan$nan$dextrose 5%  150  ml ; levofloxacin  750  mg ; 
 
white m 62 $nan$hematology blood hematocrit  43.6  %; hematology blood hemoglobin  14.3  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  21-50  # hpf; hematology urine wbc  9  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  141  mg dl; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood glucose  145  mg dl; blood gas blood potassium, whole blood  3.2  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$iso-osmotic dextrose  200  ml ; dextrose 5%  150  ml ; levofloxacin  750  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; hydralazine  10  mg ; lorazepam  1  mg ; propofol  1000  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; 5% dextrose  250  ml ; azithromycin   500  mg ; sulfameth trimethoprim  160  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; 
 
white m 62 $nan$hematology blood hematocrit  42.6  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  287  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  116  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  sm  mg dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; lorazepam  1  mg ; propofol  1000  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; vancomycin  1000  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; 
 
white m 62 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  292  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  149  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  119  mg dl; chemistry blood albumin  2.9  g dl$iso-osmotic dextrose  200  ml ; sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; lorazepam  1  mg ; propofol  1000  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; 1 2 ns  1000  ml ; vancomycin  1250  mg ; d5 1 2ns  1000  ml ; 
 
white m 62 $nan$hematology blood hematocrit  38.7  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  150  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; lorazepam  1  mg ; propofol  1000  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; fentanyl citrate  25-100  mcg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; vancomycin  1250  mg ; d5 1 2ns  1000  ml ; aspirin  325  mg ; 
 
white m 62 $nan$hematology blood hematocrit  35.9  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  318  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  129  mg dl$sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; lorazepam  1  mg ; insulin  0  unit ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; sw  50  ml ; magnesium sulfate  2  gm ; sw  200  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; aspirin  325  mg ; 
 
white m 62 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  279  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  146  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; hydralazine  10  mg ; lorazepam  1  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; acetaminophen  325-650  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; aspirin  325  mg ; scopolamine patch  1  ptch ; morphine sulfate (concentrated oral soln)  2-5  mg ; 
 
white m 62 $nan$nan$scopolamine patch  1  ptch ; morphine sulfate (concentrated oral soln)  2-5  mg ; 
 
white m 62 $nan$nan$scopolamine patch  1  ptch ; morphine sulfate (concentrated oral soln)  2-5  mg ; 
 
white m 62 $nan$nan$scopolamine patch  1  ptch ; morphine sulfate (concentrated oral soln)  2-5  mg ; 
 
white f 38 $nan$nan$insulin  10  unit ; omeprazole  20  mg ; azathioprine  75  mg ; fluoxetine  20  mg ; furosemide  40  mg ; folic acid  1  mg ; prednisone  15  mg ; spironolactone  100  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  114  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l; blood gas blood lactate  1.4  mmol l$insulin  10  unit ; omeprazole  20  mg ; azathioprine  75  mg ; fluoxetine  20  mg ; furosemide  40  mg ; folic acid  1  mg ; prednisone  15  mg ; spironolactone  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; clotrimazole  1  troc ; oxycodone (immediate release)   10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; trazodone  50  mg ; potassium chloride  40  meq ; prednisone  7.5  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  104  mg dl; chemistry blood albumin  3.2  g dl; blood gas blood free calcium  1.13  mmol l; blood gas blood lactate  0.9  mmol l$insulin  10  unit ; omeprazole  20  mg ; azathioprine  75  mg ; fluoxetine  20  mg ; furosemide  40  mg ; folic acid  1  mg ; spironolactone  100  mg ; lactulose  30  ml ; rifaximin  550  mg ; calcium carbonate  500  mg ; heparin  5000  unit ; sodium chloride 0.9%  flush  3  ml ; clotrimazole  1  troc ; oxycodone (immediate release)   10  mg ; sulfameth trimethoprim ss  1  tab ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; trazodone  50  mg ; potassium chloride  40  meq ; prednisone  7.5  mg ; oxycodone (immediate release)   5  mg ; alendronate sodium  70  mg ; vitamin d  50,000  unit ; prednisone  5  mg ; prednisone  10  mg ; oxycodone (immediate release)   2.5-5  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  169  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.3  g dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood lactate  3.4  mmol l; blood gas blood lactate  3.1  mmol l$prednisone  10  mg ; oxycodone (immediate release)   2.5-5  mg ; 0.9% sodium chloride  500  ml ; bag  50  ml ; magnesium sulfate  2  gm ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  31.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  204  mg dl; chemistry blood glucose  156  mg dl; chemistry blood lactate dehydrogenase (ld)  143  iu l; chemistry blood albumin  3.1  g dl; blood gas blood lactate  1.4  mmol l$prednisone  10  mg ; oxycodone (immediate release)   2.5-5  mg ; 0.9% sodium chloride  500  ml ; bag  50  ml ; magnesium sulfate  2  gm ; oxycodone (immediate release)   5-10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  117  mg dl; chemistry blood albumin  3.1  g dl; hematology blood bands  1  %$oxycodone (immediate release)   5-10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.3  g dl$oxycodone (immediate release)   5-10  mg ; potassium chloride  20  meq ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  37.8  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  100  mg dl; chemistry blood albumin  3.8  g dl$oxycodone (immediate release)   5-10  mg ; potassium chloride  20  meq ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  3.6  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  98  mg dl; chemistry blood albumin  3.6  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; insulin  5  unit ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.1  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.5  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; lorazepam  0.5  mg ; insulin  5  unit ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  137  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  94  mg dl; chemistry blood albumin  3.4  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.3  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  154  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  97  mg dl; chemistry blood albumin  3.4  g dl$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  1.6  mmol l$oxycodone (immediate release)   5-10  mg ; ondansetron  4  mg ; prochlorperazine  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  167  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  77  mg dl; chemistry blood albumin  3.5  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate  2-4  mg ; morphine sulfate  2  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; morphine sulfate  2  mg ; fluoxetine  40  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  92  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  82  mg dl; chemistry blood albumin  3.4  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.4  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  108  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; morphine sulfate ir  15  mg ; morphine sulfate  1  mg ; lidocaine 5% patch  1  ptch ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.5  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  101  mg dl; chemistry blood albumin  3.6  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; morphine sulfate ir  15  mg ; morphine sulfate  1  mg ; lidocaine 5% patch  1  ptch ; morphine sulfate  1-2  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  126  mg dl; chemistry blood albumin  3.6  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; morphine sulfate  1-2  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  140  mg dl; chemistry blood albumin  3.6  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; morphine sulfate  1-2  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  79  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  78  mg dl; chemistry blood albumin  3.5  g dl; blood gas blood lactate  0.7  mmol l$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; insulin  12  unit ; oxycodone sr (oxycontin)  20  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  121  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; insulin  12  unit ; oxycodone sr (oxycontin)  20  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  91  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; insulin  12  unit ; oxycodone sr (oxycontin)  20  mg ; insulin  14  unit ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  112  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; insulin  14  unit ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  113  mg dl; chemistry blood lactate dehydrogenase (ld)  153  iu l; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  110  mg dl; chemistry blood albumin  3.5  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  109  mg dl; chemistry blood albumin  3.4  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; bacitracin ointment  1  appl ; miconazole powder 2%  1  appl ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  106  mg dl; chemistry blood albumin  3.3  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; sulfameth trimethoprim ds  1  tab ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  145  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.5  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  3.6  g dl$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white f 38 $nan$nan$ondansetron  4  mg ; prochlorperazine  10  mg ; fluoxetine  40  mg ; bisacodyl  10  mg ; senna  1  tab ; lidocaine 5% patch  1  ptch ; oxycodone sr (oxycontin)  20  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  30  ml ; azathioprine  50  mg ; acetaminophen  650  mg ; 
generalized hyperhidrosis secondary diabetes mellitus without mention of complication, not stated as uncontrolled, or unspecified abdominal pain, left lower quadrant other diseases of lung, not elsewhere classified obesity, unspecified long-term (current) use of anticoagulants autoimmune hepatitis abnormal weight gain adrenal cortical steroids causing adverse effects in therapeutic use cirrhosis of liver without mention of alcohol splenomegaly portal hypertension migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other ascites hyposmolality and/or hyponatremia other chronic pain varices of other sites helicobacter pylori [h. pylori] abdominal pain, unspecified site cirrhosis of liver without mention of alcohol person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified other dependence on machines, supplemental oxygen depressive disorder, not elsewhere classified autoimmune hepatitis diarrhea nonspecific abnormal findings in stool contents unspecified hemorrhoids with other complication obstructive chronic bronchitis with (acute) exacerbation migraine, unspecified, without mention of intractable migraine without mention of status migrainosus autoimmune hepatitis portal hypertension cirrhosis of liver without mention of alcohol splenomegaly cirrhosis of liver without mention of alcohol leukocytopenia, unspecified long-term (current) use of steroids abdominal pain, other specified site splenomegaly autoimmune hepatitis anomalies of pulmonary artery other chronic pain ostium secundum type atrial septal defect nausea with vomiting varices of other sites other specified disorders of liver other chronic pulmonary heart diseases
white m 43 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  300  k ul; hematology blood inr(pt)  2.6  $sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; warfarin  5  mg ; gabapentin  1200  mg ; oxycodone (immediate release)   5-15  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  325  mg ; clopidogrel  75  mg ; simvastatin  10  mg ; oxycodone sr (oxycontin)  20  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; 
atherosclerosis of native arteries of the extremities with gangrene phlebitis and thrombophlebitis of unspecified site non-healing surgical wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft cellulitis and abscess of foot, except toes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene accidents occurring in residential institution penicillins causing adverse effects in therapeutic use other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other postoperative infection dermatitis due to drugs and medicines taken internally cellulitis and abscess of leg, except foot long-term (current) use of anticoagulants neuralgia, neuritis, and radiculitis, unspecified arterial embolism and thrombosis of lower extremity 
white m 43 $nan$hematology blood inr(pt)  2.6  $sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; gabapentin  1200  mg ; oxycodone (immediate release)   5-15  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; aspirin  325  mg ; clopidogrel  75  mg ; simvastatin  10  mg ; oxycodone sr (oxycontin)  20  mg ; docusate sodium  100  mg ; senna  1  tab ; acetaminophen  650  mg ; warfarin  7.5  mg ; nortriptyline  25  mg ; sulfameth trimethoprim ds  1  tab ; 
atherosclerosis of native arteries of the extremities with gangrene phlebitis and thrombophlebitis of unspecified site non-healing surgical wound other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation arterial embolism and thrombosis of lower extremity other complications due to other vascular device, implant, and graft cellulitis and abscess of foot, except toes other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of native arteries of the extremities with gangrene accidents occurring in residential institution penicillins causing adverse effects in therapeutic use other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation personal history of venous thrombosis and embolism other postoperative infection dermatitis due to drugs and medicines taken internally cellulitis and abscess of leg, except foot long-term (current) use of anticoagulants neuralgia, neuritis, and radiculitis, unspecified arterial embolism and thrombosis of lower extremity 
hispanic latino m 47 $nan$hematology blood hematocrit  32.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  117  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  13.2  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  124  mg dl$1 2 ns  1000  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; acetaminophen  325-650  mg ; zolpidem tartrate  5-10  mg ; verapamil sr  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; heparin  5000  unit ; sevelamer carbonate  800  mg ; metoclopramide  10  mg ; minoxidil  10  mg ; carvedilol  25  mg ; insulin  11  unit ; omeprazole  20  mg ; sucralfate  1  gm ; citalopram  40  mg ; morphine sulfate ir  7.5-15  mg ; doxepin hcl  25  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease suicidal ideation abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified anemia in chronic kidney disease abdominal pain, other specified site gastroparesis polyneuropathy in diabetes chronic diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified myalgia and myositis, unspecified end stage renal disease chronic diastolic heart failure gastroparesis hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type i [juvenile type], uncontrolled thrombocytopenia, unspecified depressive disorder, not elsewhere classified chronic diastolic heart failure chest pain, unspecified gastroparesis unspecified persistent mental disorders due to conditions classified elsewhere diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled congestive heart failure, unspecified myalgia and myositis, unspecified
hispanic latino m 47 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  128  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  131  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; zolpidem tartrate  5-10  mg ; verapamil sr  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; sevelamer carbonate  800  mg ; metoclopramide  10  mg ; minoxidil  10  mg ; carvedilol  25  mg ; insulin  11  unit ; omeprazole  20  mg ; sucralfate  1  gm ; citalopram  40  mg ; morphine sulfate ir  7.5-15  mg ; doxepin hcl  25  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease suicidal ideation abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified anemia in chronic kidney disease abdominal pain, other specified site gastroparesis polyneuropathy in diabetes chronic diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified myalgia and myositis, unspecified end stage renal disease chronic diastolic heart failure gastroparesis hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type i [juvenile type], uncontrolled thrombocytopenia, unspecified depressive disorder, not elsewhere classified chronic diastolic heart failure chest pain, unspecified gastroparesis unspecified persistent mental disorders due to conditions classified elsewhere diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled congestive heart failure, unspecified myalgia and myositis, unspecified
hispanic latino m 47 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; zolpidem tartrate  5-10  mg ; verapamil sr  120  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; heparin  5000  unit ; sevelamer carbonate  800  mg ; metoclopramide  10  mg ; minoxidil  10  mg ; carvedilol  25  mg ; insulin  11  unit ; omeprazole  20  mg ; sucralfate  1  gm ; citalopram  40  mg ; morphine sulfate ir  7.5-15  mg ; doxepin hcl  25  mg ; 
hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease chest pain, unspecified chronic diastolic heart failure congestive heart failure, unspecified unspecified episodic mood disorder nausea with vomiting diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease suicidal ideation abdominal pain, unspecified site renal dialysis status gastroparesis other chronic pain migraine, unspecified, without mention of intractable migraine without mention of status migrainosus other specified hypotension chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta suicidal ideation depressive disorder, not elsewhere classified end stage renal disease diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled myalgia and myositis, unspecified anemia in chronic kidney disease abdominal pain, other specified site gastroparesis polyneuropathy in diabetes chronic diastolic heart failure congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease depressive disorder, not elsewhere classified myalgia and myositis, unspecified end stage renal disease chronic diastolic heart failure gastroparesis hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease congestive heart failure, unspecified migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with neurological manifestations, type i [juvenile type], uncontrolled thrombocytopenia, unspecified depressive disorder, not elsewhere classified chronic diastolic heart failure chest pain, unspecified gastroparesis unspecified persistent mental disorders due to conditions classified elsewhere diabetes mellitus without mention of complication, type i [juvenile type], uncontrolled congestive heart failure, unspecified myalgia and myositis, unspecified
white m 91 $nan$nan$docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; torsemide  10  mg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; warfarin  5  mg ; folic acid  1  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  31.6  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  115  k ul; hematology blood platelet count  90  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.9  ; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  254  iu l; chemistry blood albumin  4.2  g dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl; chemistry blood % hemoglobin a1c  6.1  %$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; torsemide  10  mg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; warfarin  5  mg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pyridostigmine bromide  60  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; donepezil  5  mg ; pravastatin  20  mg ; levothyroxine sodium  25  mcg ; torsemide  20  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  32.0  %; hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  104  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; torsemide  10  mg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pyridostigmine bromide  60  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; donepezil  5  mg ; pravastatin  20  mg ; levothyroxine sodium  25  mcg ; torsemide  20  mg ; donepezil  10  mg ; pravastatin  40  mg ; potassium chloride  20  meq ; warfarin  4  mg ; sw  50  ml ; magnesium sulfate  2  gm ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; pyridostigmine bromide  60  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; torsemide  20  mg ; donepezil  10  mg ; pravastatin  40  mg ; warfarin  4  mg ; sw  50  ml ; magnesium sulfate  2  gm ; warfarin  6  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; torsemide  20  mg ; donepezil  10  mg ; pravastatin  40  mg ; warfarin  4  mg ; warfarin  6  mg ; torsemide  30  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  144  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  95  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; torsemide  20  mg ; donepezil  10  mg ; pravastatin  40  mg ; warfarin  4  mg ; warfarin  6  mg ; torsemide  30  mg ; senna  1  tab ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; donepezil  10  mg ; pravastatin  40  mg ; warfarin  4  mg ; warfarin  6  mg ; senna  1  tab ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$hematology blood hematocrit  30.1  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  100  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; pravastatin  40  mg ; warfarin  4  mg ; warfarin  6  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white m 91 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; allopurinol  100  mg ; calcitriol  0.25  mcg ; finasteride  5  mg ; omeprazole  40  mg ; levothyroxine sodium  37.5  mcg ; folic acid  1  mg ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; docusate sodium  200  mg ; tamsulosin  0.4  mg ; levothyroxine sodium  25  mcg ; pravastatin  40  mg ; warfarin  4  mg ; warfarin  6  mg ; 
chronic systolic heart failure unspecified acquired hypothyroidism myasthenia gravis without (acute) exacerbation other and unspecified hyperlipidemia other persistent mental disorders due to conditions classified elsewhere coronary atherosclerosis of native coronary artery gout, unspecified congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified blood in stool chronic kidney disease, stage iii (moderate) aortic valve disorders atrial fibrillation polymyalgia rheumatica chronic kidney disease, unspecified other specified cardiac dysrhythmias knee joint replacement long-term (current) use of anticoagulants percutaneous transluminal coronary angioplasty status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified unspecified acquired hypothyroidism atrial fibrillation acute on chronic diastolic heart failure gout, unspecified unspecified local infection of skin and subcutaneous tissue myasthenia gravis without (acute) exacerbation anemia, unspecified paroxysmal ventricular tachycardia hypotension, unspecified coronary atherosclerosis of native coronary artery aortic valve disorders congestive heart failure, unspecified other persistent mental disorders due to conditions classified elsewhere other chronic pulmonary heart diseases hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) microscopic hematuria other persistent mental disorders due to conditions classified elsewhere venous (peripheral) insufficiency, unspecified urge incontinence acute on chronic diastolic heart failure unspecified accident anemia, unspecified myasthenia gravis without (acute) exacerbation chronic kidney disease, unspecified unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery atrial fibrillation gout, unspecified
white f 67 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  251  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  129  mg dl$gabapentin  800  mg ; acetaminophen  1000  mg ; ascorbic acid  500  mg ; bupropion (sustained release)  150  mg ; carbamazepine  100  mg ; duloxetine  120  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; morphine sulfate  100  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh enthesopathy of hip region anxiety state, unspecified knee joint replacement spondylosis of unspecified site, without mention of myelopathy allergic rhinitis, cause unspecified other chronic pain irritable bowel syndrome asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified sinusitis (chronic) effusion of joint, pelvic region and thigh anxiety state, unspecified other specified transient mental disorders due to conditions classified elsewhere, other unspecified essential hypertension extrinsic asthma, unspecified altered mental status depressive disorder, not elsewhere classified osteoarthrosis, localized, not specified whether primary or secondary, lower leg irritable bowel syndrome knee joint replacement body mass index 31.0-31.9, adult depressive disorder, not elsewhere classified asthma, unspecified type, unspecified obesity, unspecified personal history of other infectious and parasitic diseases osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified depressive disorder, not elsewhere classified 
white f 67 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  221  k ul$ascorbic acid  500  mg ; bupropion (sustained release)  150  mg ; carbamazepine  100  mg ; duloxetine  120  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; morphine sulfate  100  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate ir  15-30  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh enthesopathy of hip region anxiety state, unspecified knee joint replacement spondylosis of unspecified site, without mention of myelopathy allergic rhinitis, cause unspecified other chronic pain irritable bowel syndrome asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified sinusitis (chronic) effusion of joint, pelvic region and thigh anxiety state, unspecified other specified transient mental disorders due to conditions classified elsewhere, other unspecified essential hypertension extrinsic asthma, unspecified altered mental status depressive disorder, not elsewhere classified osteoarthrosis, localized, not specified whether primary or secondary, lower leg irritable bowel syndrome knee joint replacement body mass index 31.0-31.9, adult depressive disorder, not elsewhere classified asthma, unspecified type, unspecified obesity, unspecified personal history of other infectious and parasitic diseases osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified depressive disorder, not elsewhere classified 
white f 67 $nan$nan$ascorbic acid  500  mg ; bupropion (sustained release)  150  mg ; carbamazepine  100  mg ; duloxetine  120  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate ir  15-30  mg ; enoxaparin sodium  40  mg ; sodium chloride 0.9%  1000  ml ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh enthesopathy of hip region anxiety state, unspecified knee joint replacement spondylosis of unspecified site, without mention of myelopathy allergic rhinitis, cause unspecified other chronic pain irritable bowel syndrome asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified sinusitis (chronic) effusion of joint, pelvic region and thigh anxiety state, unspecified other specified transient mental disorders due to conditions classified elsewhere, other unspecified essential hypertension extrinsic asthma, unspecified altered mental status depressive disorder, not elsewhere classified osteoarthrosis, localized, not specified whether primary or secondary, lower leg irritable bowel syndrome knee joint replacement body mass index 31.0-31.9, adult depressive disorder, not elsewhere classified asthma, unspecified type, unspecified obesity, unspecified personal history of other infectious and parasitic diseases osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified depressive disorder, not elsewhere classified 
white f 67 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  278  k ul$ascorbic acid  500  mg ; bupropion (sustained release)  150  mg ; carbamazepine  100  mg ; duloxetine  120  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate ir  15-30  mg ; enoxaparin sodium  40  mg ; clonazepam  0.5  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh enthesopathy of hip region anxiety state, unspecified knee joint replacement spondylosis of unspecified site, without mention of myelopathy allergic rhinitis, cause unspecified other chronic pain irritable bowel syndrome asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified sinusitis (chronic) effusion of joint, pelvic region and thigh anxiety state, unspecified other specified transient mental disorders due to conditions classified elsewhere, other unspecified essential hypertension extrinsic asthma, unspecified altered mental status depressive disorder, not elsewhere classified osteoarthrosis, localized, not specified whether primary or secondary, lower leg irritable bowel syndrome knee joint replacement body mass index 31.0-31.9, adult depressive disorder, not elsewhere classified asthma, unspecified type, unspecified obesity, unspecified personal history of other infectious and parasitic diseases osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified depressive disorder, not elsewhere classified 
white f 67 $nan$nan$ascorbic acid  500  mg ; bupropion (sustained release)  150  mg ; carbamazepine  100  mg ; duloxetine  120  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; vitamin d  400  unit ; sodium chloride 0.9%  flush  3  ml ; pantoprazole  40  mg ; aluminum-magnesium hydrox.-simethicone  15-30  ml ; bisacodyl  10  mg ; milk of magnesia  30  ml ; albuterol 0.083% neb soln  1  neb ; clonazepam  1  mg ; docusate sodium  100  mg ; senna  8.6  mg ; calcium carbonate  500  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; morphine sulfate ir  15-30  mg ; enoxaparin sodium  40  mg ; clonazepam  0.5  mg ; 
osteoarthrosis, localized, not specified whether primary or secondary, pelvic region and thigh enthesopathy of hip region anxiety state, unspecified knee joint replacement spondylosis of unspecified site, without mention of myelopathy allergic rhinitis, cause unspecified other chronic pain irritable bowel syndrome asthma, unspecified type, unspecified depressive disorder, not elsewhere classified unspecified sinusitis (chronic) effusion of joint, pelvic region and thigh anxiety state, unspecified other specified transient mental disorders due to conditions classified elsewhere, other unspecified essential hypertension extrinsic asthma, unspecified altered mental status depressive disorder, not elsewhere classified osteoarthrosis, localized, not specified whether primary or secondary, lower leg irritable bowel syndrome knee joint replacement body mass index 31.0-31.9, adult depressive disorder, not elsewhere classified asthma, unspecified type, unspecified obesity, unspecified personal history of other infectious and parasitic diseases osteoarthrosis, localized, not specified whether primary or secondary, lower leg asthma, unspecified type, unspecified depressive disorder, not elsewhere classified 
white f 60 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; senna  1  tab ; ibuprofen  400  mg ; vitamin d  5000  unit ; 
 
white f 60 $nan$chemistry blood creatinine  0.8  mg dl; chemistry blood urea nitrogen  20  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; senna  1  tab ; ibuprofen  400  mg ; vitamin d  5000  unit ; vitamin d-3  4000  unit ; 
 
white f 60 $nan$hematology blood hematocrit  45.8  %; hematology blood hemoglobin  15.4  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  129  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; senna  1  tab ; ibuprofen  400  mg ; vitamin d-3  4000  unit ; 
 
white f 60 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; senna  1  tab ; ibuprofen  400  mg ; vitamin d-3  4000  unit ; 
 
white f 22 $temp  99.0  heartrate  102.0  resprate  16.0  o2sat  100.0  sbp  101.0  dbp  38.0  rhythm    pain  0  ; temp    heartrate  80.0  resprate  15.0  o2sat  100.0  sbp  118.0  dbp  60.0  rhythm    pain  0  ; temp    heartrate  86.0  resprate  16.0  o2sat  100.0  sbp  118.0  dbp  52.0  rhythm    pain  0  ; temp    heartrate  87.0  resprate  16.0  o2sat  100.0  sbp  140.0  dbp  59.0  rhythm    pain  0  ; temp  98.7  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $hematology blood hematocrit  38.1  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  283  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  180  mg dl$nan
 
white f 54 $nan$hematology blood hematocrit  36.9  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  249  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5-1  mg ; acetaminophen  325-650  mg ; d5 1 2ns  1000  ml ; hydromorphone (dilaudid)  20  mg ; senna  8.6  mg ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white f 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; d5 1 2ns  1000  ml ; senna  8.6  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
asian m 69 $temp  97.6  heartrate  71.0  resprate  14.0  o2sat  98.0  sbp  99.0  dbp  67.0  rhythm    pain  0  ; temp  97.8  heartrate  78.0  resprate  14.0  o2sat  99.0  sbp  100.0  dbp  68.0  rhythm    pain  0  ; temp  98.1  heartrate  7.0  resprate    o2sat  98.0  sbp  11.0  dbp  65.0  rhythm    pain    $hematology blood hematocrit  23.1  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  70  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  13.1  mg dl; chemistry blood glucose  64  mg dl; blood gas blood lactate  2.4  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; docusate sodium  100  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; albumin 25% (12.5g   50ml)  50  g ; trazodone  25  mg ; ursodiol  300  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified cataract other pulmonary embolism and infarction body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident thoracic aneurysm without mention of rupture cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary loss of weight 
asian m 69 $nan$blood gas blood lactate  2.6  mmol l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; docusate sodium  100  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; albumin 25% (12.5g   50ml)  50  g ; trazodone  25  mg ; ursodiol  300  mg ; folic acid  1  mg ; cholestyramine  4  gm ; enoxaparin sodium  70  mg ; 5% dextrose  50  ml ; phytonadione  10  mg ; phytonadione  5  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified cataract other pulmonary embolism and infarction body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident thoracic aneurysm without mention of rupture cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary loss of weight 
asian m 69 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  79  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  14.7  mg dl; chemistry blood glucose  67  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; docusate sodium  100  mg ; trazodone  25  mg ; ursodiol  300  mg ; cholestyramine  4  gm ; enoxaparin sodium  70  mg ; levothyroxine sodium  25  mcg ; furosemide  30  mg ; spironolactone  50  mg ; 
chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta unspecified cataract other pulmonary embolism and infarction body mass index between 19-24, adult passenger of special construction vehicle injured in traffic accident family history of malignant neoplasm of gastrointestinal tract pedal cycle driver injured in collision with other nonmotor vehicle in nontraffic accident thoracic aneurysm without mention of rupture cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary loss of weight 
hispanic latino m 64 $temp  98.1  heartrate  92.0  resprate  19.0  o2sat  100.0  sbp  135.0  dbp  68.0  rhythm    pain  3  $hematology blood hematocrit  26.3  %; hematology blood hematocrit  22.0  %; hematology blood hematocrit  27.5  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  178  k ul; hematology blood platelet count  141  k ul; hematology blood platelet count  152  k ul; hematology blood platelet count  142  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  6.0  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  137  mg dl; chemistry urine urea nitrogen, urine  245  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  120  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  230  mg dl; blood gas blood lactate  4.0  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood sodium, whole blood  123  meq l; blood gas blood sodium, whole blood  124  meq l$famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; oxycodone (immediate release)  5  mg ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; lactated ringers  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; lidocaine jelly 2% (glydo)  1  appl ; thiamine  200  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; iso-osmotic sodium chloride  1  bag ; fentanyl citrate  25-50  mcg ; lidocaine 1%  10  ml ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; oxycodone (immediate release)  5-10  mg ; oxycodone (immediate release)  10-20  mg ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  25.4  %; hematology blood hematocrit  24.9  %; hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  152  k ul; hematology blood platelet count  149  k ul; hematology blood platelet count  145  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.3  meq l; chemistry blood potassium  4.9  meq l; chemistry blood potassium  6.1  meq l; chemistry blood potassium  6.9  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  125  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  31  mg dl; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  217  mg dl; chemistry blood glucose  184  mg dl; chemistry blood glucose  172  mg dl; chemistry blood glucose  155  mg dl; chemistry blood glucose  141  mg dl; blood gas blood free calcium  1.24  mmol l; blood gas blood lactate  1.6  mmol l$famotidine  20  mg ; sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lidocaine jelly 2% (glydo)  1  appl ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; iso-osmotic sodium chloride  1  bag ; fentanyl citrate  25-50  mcg ; lidocaine 1%  10  ml ; ns syringe (intrapleural)  40  ml ; alteplase  10  mg ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-20  mg ; furosemide  20  mg ; acetaminophen  1000  mg ; sodium polystyrene sulfonate  30  gm ; furosemide  80  mg ; polyethylene glycol  17  g ; sodium chloride  2  gm ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen  500  mg ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  20.4  %; hematology blood hematocrit  25.3  %; hematology blood hemoglobin  6.6  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  133  k ul; hematology blood platelet count  150  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  31  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  127  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-20  mg ; polyethylene glycol  17  g ; sodium chloride  2  gm ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen  500  mg ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  149  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; oxycodone (immediate release)  5-20  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  20.7  %; hematology blood hematocrit  21.9  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  189  k ul; hematology blood platelet count  167  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  180  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  1000  ml ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  137  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; sodium chloride 0.9%  1000  ml ; tamsulosin  0.4  mg ; senna  17.2  mg ; clonidine patch 0.2 mg 24 hr  1  ptch ; milk of magnesia  30  ml ; 
 
hispanic latino m 64 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; atenolol  50  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; tamsulosin  0.4  mg ; senna  17.2  mg ; clonidine patch 0.2 mg 24 hr  1  ptch ; milk of magnesia  30  ml ; atenolol  25  mg ; hydralazine  10  mg ; phosphorus  500  mg ; 
 
hispanic latino m 64 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; lidocaine 5% patch  1  ptch ; diazepam - ciwa protocol  10  mg ; aspirin  81  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; thiamine  100  mg ; folic acid  1  mg ; multivitamins w minerals chewable  1  tab ; simvastatin  40  mg ; gabapentin  300  mg ; docusate sodium  100  mg ; polyethylene glycol  17  g ; sodium chloride 0.9%  flush  10-20  ml ; tamsulosin  0.4  mg ; senna  17.2  mg ; clonidine patch 0.2 mg 24 hr  1  ptch ; hydralazine  10  mg ; phosphorus  500  mg ; metformin (glucophage)  1000  mg ; 
 
white f 93 $nan$nan$aspirin  81  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; 
dehydration acute kidney failure, unspecified
white f 93 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  230  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl; blood gas blood potassium, whole blood  5.5  meq l$aspirin  81  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; acetaminophen  1000  mg ; diazepam  10  mg ; famotidine  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; sodium polystyrene sulfonate  30  gm ; tramadol (ultram)  25  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; lidocaine 5% patch  1  ptch ; 
dehydration acute kidney failure, unspecified
white f 93 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  243  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  97  mg dl$aspirin  81  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; acetaminophen  1000  mg ; diazepam  10  mg ; famotidine  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; sodium polystyrene sulfonate  30  gm ; tramadol (ultram)  25  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; morphine sulfate  1-2  mg ; 
dehydration acute kidney failure, unspecified
white f 93 $nan$nan$aspirin  81  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; acetaminophen  1000  mg ; diazepam  10  mg ; famotidine  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; morphine sulfate  1-2  mg ; 
dehydration acute kidney failure, unspecified
white f 93 $nan$nan$aspirin  81  mg ; sertraline  50  mg ; metoprolol tartrate  50  mg ; acetaminophen  1000  mg ; diazepam  10  mg ; famotidine  20  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; tramadol (ultram)  25  mg ; senna  1  tab ; heparin  5000  unit ; docusate sodium  100  mg ; calcitriol  0.25  mcg ; morphine sulfate  1-2  mg ; 
dehydration acute kidney failure, unspecified
white f 82 $temp  98.4  heartrate  97.0  resprate  26.0  o2sat  97.0  sbp  158.0  dbp  72.0  rhythm    pain  0  ; temp    heartrate  117.0  resprate  24.0  o2sat  98.0  sbp  170.0  dbp  100.0  rhythm    pain  0  ; temp    heartrate  147.0  resprate  25.0  o2sat  97.0  sbp  160.0  dbp  91.0  rhythm    pain  0  ; temp    heartrate  116.0  resprate  28.0  o2sat  97.0  sbp  152.0  dbp  76.0  rhythm    pain  0  ; temp    heartrate  108.0  resprate  26.0  o2sat  97.0  sbp  139.0  dbp  70.0  rhythm    pain  0  ; temp  98.9  heartrate  99.0  resprate  22.0  o2sat  94.0  sbp  133.0  dbp  65.0  rhythm    pain  0  ; temp  99.6  heartrate  109.0  resprate  19.0  o2sat  95.0  sbp  125.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  136  mg dl; chemistry blood lactate dehydrogenase (ld)  268  iu l; chemistry blood albumin  3.2  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; heparin  5000  unit ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; amlodipine  2.5  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; metoprolol tartrate  25  mg ; vitamin d  1000  unit ; 5% dextrose  250  ml ; thiamine  500  mg ; diazepam  10  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; quetiapine fumarate  25  mg ; heparin  1500-3000  unit ; heparin sodium  25,000  unit ; multivitamins  1  tab ; folic acid  1  mg ; metoprolol tartrate  5  mg ; 
 
white f 82 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  97  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; amlodipine  2.5  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; 5% dextrose  250  ml ; thiamine  500  mg ; diazepam  10  mg ; 0.9% sodium chloride  100  ml ; levetiracetam  1000  mg ; quetiapine fumarate  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; metoprolol tartrate  5  mg ; dabigatran etexilate  150  mg ; azithromycin  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; 
 
white f 82 $nan$hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  176  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  96  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; amlodipine  2.5  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; 5% dextrose  250  ml ; thiamine  500  mg ; diazepam  10  mg ; quetiapine fumarate  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; azithromycin  500  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; azithromycin  250  mg ; hydralazine  20  mg ; amlodipine  5  mg ; metoprolol succinate xl  100  mg ; levofloxacin  750  mg ; amlodipine  10  mg ; 
 
white f 82 $nan$hematology blood hematocrit  35.5  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  2.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  106  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; 5% dextrose  250  ml ; thiamine  500  mg ; quetiapine fumarate  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; sodium chloride 0.9%  1000  ml ; docusate sodium  100  mg ; hydralazine  20  mg ; metoprolol succinate xl  100  mg ; levofloxacin  750  mg ; amlodipine  10  mg ; hydrochlorothiazide  25  mg ; valsartan  40  mg ; amlodipine  7.5  mg ; potassium chloride  40  meq ; hydralazine  25  mg ; 
 
white f 82 $nan$hematology blood hematocrit  34.8  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  99  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; quetiapine fumarate  25  mg ; multivitamins  1  tab ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; docusate sodium  100  mg ; metoprolol succinate xl  100  mg ; levofloxacin  750  mg ; hydrochlorothiazide  25  mg ; potassium chloride  40  meq ; hydralazine  25  mg ; 
 
white f 82 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  94  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; docusate sodium  100  mg ; metoprolol succinate xl  100  mg ; levofloxacin  750  mg ; calcium carbonate  500  mg ; 
 
white f 82 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; bisacodyl  10  mg ; senna  8.6  mg ; donepezil  10  mg ; escitalopram oxalate  15  mg ; vitamin d  1000  unit ; multivitamins  1  tab ; folic acid  1  mg ; sodium chloride 0.9%  flush  3  ml ; ipratropium-albuterol neb  1  neb ; acetaminophen  650  mg ; docusate sodium  100  mg ; metoprolol succinate xl  100  mg ; calcium carbonate  500  mg ; 
 
white m 63 $temp  98.6  heartrate  79.0  resprate  21.0  o2sat  100.0  sbp  124.0  dbp  64.0  rhythm    pain  0  $nan$atorvastatin  20  mg ; clopidogrel  75  mg ; 
 
white m 63 $temp    heartrate  77.0  resprate  15.0  o2sat  100.0  sbp  149.0  dbp  73.0  rhythm    pain    $hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  66  mg dl; hematology blood inr(pt)  0.9  ; chemistry urine creatinine, urine  50  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  64  mg dl; chemistry urine protein creatinine ratio  0.9  mg mg$atorvastatin  20  mg ; clopidogrel  75  mg ; heparin  5000  unit ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  15  unit ; insulin  0  unit ; 0.9% sodium chloride  1000  ml ; insulin pump (self administering medication)     ; 
 
white m 63 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  201  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  3.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  62  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  93  mg dl$atorvastatin  20  mg ; clopidogrel  75  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; 
 
white m 63 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  185  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  57  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  43  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  48  mg dl; chemistry urine albumin, urine  1.0  mg dl; chemistry urine albumin creatinine, urine  23.3  mg g$atorvastatin  20  mg ; clopidogrel  75  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; calcium acetate  667  mg ; 
 
white m 63 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.0  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  199  mg dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; calcium acetate  667  mg ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; 
 
white m 63 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  221  mg dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin pump (self administering medication)     ; calcium acetate  667  mg ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; bag  50  ml ; magnesium sulfate  2  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  1  g ; 
 
white m 63 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  49  mg dl; chemistry blood lactate dehydrogenase (ld)  136  iu l; chemistry blood albumin  3.5  g dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; calcium acetate  667  mg ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; 
 
white m 63 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; calcium acetate  667  mg ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; senna  1  tab ; docusate sodium  100  mg ; calcium acetate  1334  mg ; 
 
white m 63 $nan$hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  3.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  64  mg dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; senna  1  tab ; docusate sodium  100  mg ; calcium acetate  1334  mg ; heparin flush (10 units ml)  2  ml ; 
 
white m 63 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  3.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  53  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  66  mg dl$atorvastatin  20  mg ; topiramate (topamax)  100  mg ; metoprolol tartrate  12.5  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; sodium bicarbonate  650  mg ; iso-osmotic dextrose  100  ml ; nafcillin  2  g ; senna  1  tab ; docusate sodium  100  mg ; calcium acetate  1334  mg ; heparin flush (10 units ml)  2  ml ; 
 
other f 56 $nan$nan$lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  2-4  mg ; ibuprofen  400  mg ; morphine sulfate  2-4  mg ; ondansetron  4  mg ; oxycodone-acetaminophen  1-2  tab ; bisacodyl  10  mg ; diphenhydramine  25  mg ; hydromorphone (dilaudid)  0.5-1.0  mg ; docusate sodium  100  mg ; famotidine  20  mg ; methocarbamol  500  mg ; hydromorphone (dilaudid)  1  mg ; ibuprofen  800  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; diazepam  10  mg ; diazepam  5  mg ; 
 
other f 56 $nan$nan$lisinopril  10  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ondansetron  4  mg ; bisacodyl  10  mg ; diphenhydramine  25  mg ; docusate sodium  100  mg ; famotidine  20  mg ; hydromorphone (dilaudid)  1  mg ; ibuprofen  800  mg ; acetaminophen  650  mg ; hydromorphone (dilaudid)  2-6  mg ; diazepam  10  mg ; diazepam  5  mg ; 
 
hispanic latino m 60 $nan$hematology blood hematocrit  40.4  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  259  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  122  mg dl; blood gas blood lactate  4.7  mmol l$nan
malignant essential hypertension alcohol withdrawal acute alcoholic hepatitis unspecified protein-calorie malnutrition mood disorder in conditions classified elsewhere unspecified essential hypertension depressive disorder, not elsewhere classified alcohol withdrawal delirium
hispanic latino m 60 $nan$hematology blood hematocrit  33.5  %; hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  7.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  135  mg dl; chemistry blood lactate dehydrogenase (ld)  168  iu l; chemistry blood albumin  3.4  g dl; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  3.3  mmol l; blood gas blood lactate  4.3  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$sodium chloride 0.9%  flush  3  ml ; d5ns  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 5% dextrose  250  ml ; azithromycin   500  mg ; ondansetron  4  mg ; lorazepam  1-2  mg ; azithromycin  250  mg ; diazepam  5  mg ; d5 1 2ns  1000  ml ; thiamine  100  mg ; syringe  1  syr ; folic acid  1  mg ; multivitamins  10  ml ; omeprazole  20  mg ; sw  100  ml ; magnesium sulfate  4  gm ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; heparin  5000  unit ; calcium carbonate  500  mg ; furosemide  20  mg ; cefpodoxime proxetil  200  mg ; prochlorperazine  10  mg ; 
malignant essential hypertension alcohol withdrawal acute alcoholic hepatitis unspecified protein-calorie malnutrition mood disorder in conditions classified elsewhere unspecified essential hypertension depressive disorder, not elsewhere classified alcohol withdrawal delirium
hispanic latino m 60 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood urea nitrogen  5  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  123  mg dl$azithromycin  250  mg ; diazepam  5  mg ; omeprazole  20  mg ; heparin  5000  unit ; cefpodoxime proxetil  200  mg ; prochlorperazine  10  mg ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; acetaminophen     ; acetaminophen  650  mg ; 
malignant essential hypertension alcohol withdrawal acute alcoholic hepatitis unspecified protein-calorie malnutrition mood disorder in conditions classified elsewhere unspecified essential hypertension depressive disorder, not elsewhere classified alcohol withdrawal delirium
hispanic latino m 60 $nan$nan$azithromycin  250  mg ; diazepam  5  mg ; omeprazole  20  mg ; heparin  5000  unit ; cefpodoxime proxetil  200  mg ; prochlorperazine  10  mg ; potassium chloride  40  meq ; sw  50  ml ; magnesium sulfate  2  gm ; neutra-phos  1  pkt ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; acetaminophen  650  mg ; 
malignant essential hypertension alcohol withdrawal acute alcoholic hepatitis unspecified protein-calorie malnutrition mood disorder in conditions classified elsewhere unspecified essential hypertension depressive disorder, not elsewhere classified alcohol withdrawal delirium
white f 71 $nan$hematology blood hematocrit  39.2  %; hematology blood hematocrit  39.4  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  309  k ul; hematology blood platelet count  301  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  157  mg dl; chemistry blood glucose  110  mg dl$dofetilide  500  mcg ; influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dabigatran etexilate  150  mg ; diltiazem extended-release  120  mg ; furosemide  40  mg ; lisinopril  20  mg ; omeprazole  20  mg ; pregabalin  225  mg ; simvastatin  10  mg ; lorazepam  0.5  mg ; bag  150  ml ; magnesium sulfate  6  gm ; potassium chloride  60  meq ; 
surgical or other procedure not carried out because of contraindication atrial fibrillation encounter for therapeutic drug monitoring passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white f 71 $nan$hematology blood hematocrit  39.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  108  mg dl$dofetilide  500  mcg ; sodium chloride 0.9%  flush  3  ml ; dabigatran etexilate  150  mg ; furosemide  40  mg ; lisinopril  20  mg ; omeprazole  20  mg ; pregabalin  225  mg ; simvastatin  10  mg ; lorazepam  0.5  mg ; bag  150  ml ; magnesium sulfate  6  gm ; potassium chloride  60  meq ; sodium chloride nasal  1-2  spry ; bag  50  ml ; magnesium sulfate  2  gm ; 
surgical or other procedure not carried out because of contraindication atrial fibrillation encounter for therapeutic drug monitoring passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white f 71 $nan$chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  130  mg dl$dofetilide  500  mcg ; sodium chloride 0.9%  flush  3  ml ; dabigatran etexilate  150  mg ; furosemide  40  mg ; lisinopril  20  mg ; omeprazole  20  mg ; pregabalin  225  mg ; simvastatin  10  mg ; lorazepam  0.5  mg ; bag  50  ml ; magnesium sulfate  2  gm ; senna  1  tab ; docusate sodium  100  mg ; 
surgical or other procedure not carried out because of contraindication atrial fibrillation encounter for therapeutic drug monitoring passenger in heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident
white m 48 $temp  98.1  heartrate  85.0  resprate  16.0  o2sat    sbp  96.0  dbp  54.0  rhythm  sinus rhythm  pain  0  $hematology blood hematocrit  29.0  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  129  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  83  mg dl; blood gas blood lactate  0.7  mmol l$ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; heparin  5000  unit ; docusate sodium  100  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; omeprazole  20  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; docusate sodium  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; bisacodyl  10  mg ; 
pure hypercholesterolemia unspecified intellectual disabilities esophageal reflux unspecified essential hypertension other constipation iron deficiency anemia, unspecified epilepsy, unspecified, without mention of intractable epilepsy diverticulosis of colon with hemorrhage polyuria hypotension, unspecified acute kidney failure, unspecified unspecified essential hypertension urinary frequency iron deficiency anemia, unspecified leukocytosis, unspecified fever, unspecified pure hypercholesterolemia severe intellectual disabilities dehydration constipation, unspecified need for prophylactic vaccination and inoculation against influenza epilepsy, unspecified, without mention of intractable epilepsy esophageal reflux 
white m 48 $nan$hematology blood hematocrit  29.1  %; hematology blood hematocrit  32.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  148  k ul; hematology blood platelet count  163  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  80  mg dl$ns  100  ml ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; omeprazole  20  mg ; docusate sodium  200  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  2  gm ; bisacodyl  10  mg ; senna  8.6  mg ; ciprofloxacin hcl  500  mg ; 
pure hypercholesterolemia unspecified intellectual disabilities esophageal reflux unspecified essential hypertension other constipation iron deficiency anemia, unspecified epilepsy, unspecified, without mention of intractable epilepsy diverticulosis of colon with hemorrhage polyuria hypotension, unspecified acute kidney failure, unspecified unspecified essential hypertension urinary frequency iron deficiency anemia, unspecified leukocytosis, unspecified fever, unspecified pure hypercholesterolemia severe intellectual disabilities dehydration constipation, unspecified need for prophylactic vaccination and inoculation against influenza epilepsy, unspecified, without mention of intractable epilepsy esophageal reflux 
black african american m 66 $temp  99.0  heartrate  87.0  resprate  22.0  o2sat  100.0  sbp  137.0  dbp  69.0  rhythm    pain  0  $hematology blood hematocrit  24.2  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  9.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  115  mg dl$insulin  25  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  60  mg ; docusate sodium  100  mg ; hydralazine  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ipratropium bromide neb  1  neb ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  50  mg ; metoprolol tartrate  75  mg ; omeprazole  20  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  3200  mg ; trazodone  50  mg ; paricalcitol  5.5  mcg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; epoetin alfa  1500  unit ; insulin  0  unit ; 
long-term (current) use of insulin sickle-cell trait percutaneous transluminal coronary angioplasty status hyperpotassemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits coronary atherosclerosis of native coronary artery other fluid overload end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psychophysical visual disturbances background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled renal osteodystrophy anemia in chronic kidney disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other complications due to other cardiac device, implant, and graft coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia end stage renal disease intermediate coronary syndrome diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease other and unspecified hyperlipidemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery awaiting organ transplant status anemia, unspecified 
black african american m 66 $nan$hematology blood hematocrit  23.7  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  5.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  66  mg dl$insulin  25  unit ; heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ondansetron  4  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  60  mg ; docusate sodium  100  mg ; hydralazine  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ipratropium bromide neb  1  neb ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  50  mg ; metoprolol tartrate  75  mg ; omeprazole  20  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  3200  mg ; trazodone  50  mg ; paricalcitol  5.5  mcg ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; epoetin alfa  1500  unit ; insulin  0  unit ; insulin  10  unit ; ibuprofen  400  mg ; 
long-term (current) use of insulin sickle-cell trait percutaneous transluminal coronary angioplasty status hyperpotassemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits coronary atherosclerosis of native coronary artery other fluid overload end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psychophysical visual disturbances background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled renal osteodystrophy anemia in chronic kidney disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other complications due to other cardiac device, implant, and graft coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia end stage renal disease intermediate coronary syndrome diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease other and unspecified hyperlipidemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery awaiting organ transplant status anemia, unspecified 
black african american m 66 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  270  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  7.7  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  221  mg dl$heparin flush (10 units ml)  1  ml ; sodium chloride 0.9%  flush  10  ml ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; ondansetron  4  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; aspirin  81  mg ; atorvastatin  80  mg ; bisacodyl  10  mg ; cinacalcet  60  mg ; docusate sodium  100  mg ; hydralazine  50  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; ipratropium bromide neb  1  neb ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  50  mg ; metoprolol tartrate  75  mg ; omeprazole  20  mg ; polyethylene glycol  17  g ; senna  17.2  mg ; sevelamer carbonate  3200  mg ; trazodone  50  mg ; lidocaine 1%  1  ml ; insulin  10  unit ; ibuprofen  400  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftazidime  1  g ; 0.9% sodium chloride  250  ml ; epoetin alfa  2000  unit ; 
long-term (current) use of insulin sickle-cell trait percutaneous transluminal coronary angioplasty status hyperpotassemia personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits coronary atherosclerosis of native coronary artery other fluid overload end stage renal disease diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled psychophysical visual disturbances background diabetic retinopathy diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled renal osteodystrophy anemia in chronic kidney disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease other complications due to other cardiac device, implant, and graft coronary atherosclerosis of native coronary artery other and unspecified hyperlipidemia end stage renal disease intermediate coronary syndrome diabetes with ophthalmic manifestations, type ii or unspecified type, not stated as uncontrolled surgical operation with implant of artificial internal device causing abnormal patient reaction, or later complication,without mention of misadventure at time of operation background diabetic retinopathy hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease end stage renal disease other and unspecified hyperlipidemia diabetes with renal manifestations, type ii or unspecified type, not stated as uncontrolled coronary atherosclerosis of native coronary artery awaiting organ transplant status anemia, unspecified 
white f 74 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.3  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride nasal  1-2  spry ; vancomycin oral liquid  125  mg ; rosuvastatin calcium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; dofetilide  250  mcg ; bag  1  bag ; magnesium sulfate  2  gm ; torsemide  20  mg ; magnesium oxide  800  mg ; 
nonrheumatic mitral (valve) insufficiency surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction hypertensive heart disease with heart failure unspecified atrial fibrillation hypotension, unspecified long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants kitchen of unspecified non-institutional (private) residence as the place of occurrence of the external cause enterocolitis due to clostridium difficile, not specified as recurrent presence of coronary angioplasty implant and graft type 2 diabetes mellitus without complications chronic systolic (congestive) heart failure hyperlipidemia, unspecified personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified other mechanical complication of other cardiac electronic device, initial encounter other specified disorders of bone density and structure, unspecified site paroxysmal atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft encounter for adjustment and management of other part of cardiac pacemaker chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified hyperlipidemia, unspecified hypothyroidism, unspecified nonrheumatic mitral (valve) insufficiency long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable acute kidney failure, unspecified hypertensive heart disease with heart failure ischemic cardiomyopathy encounter for immunization hypotension, unspecified stenosis of coronary artery stent, initial encounter enterocolitis due to clostridium difficile, recurrent type 2 diabetes mellitus without complications atherosclerotic heart disease of native coronary artery with unstable angina pectoris old myocardial infarction hypertensive heart disease with heart failure long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure
white f 74 $nan$chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood urea nitrogen  17  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride nasal  1-2  spry ; vancomycin oral liquid  125  mg ; rosuvastatin calcium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; dofetilide  250  mcg ; bag  1  bag ; magnesium sulfate  2  gm ; torsemide  20  mg ; magnesium oxide  800  mg ; fluticasone propionate nasal  2  spry ; clopidogrel  75  mg ; calcium carbonate  500  mg ; levothyroxine sodium  88  mcg ; vitamin d  1000  unit ; losartan potassium  12.5  mg ; glipizide xl  2.5  mg ; umeclidinium-vilanterol  1  dose ; warfarin  5  mg ; albuterol inhaler  1  puff ; ramelteon  8  mg ; 
nonrheumatic mitral (valve) insufficiency surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction hypertensive heart disease with heart failure unspecified atrial fibrillation hypotension, unspecified long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants kitchen of unspecified non-institutional (private) residence as the place of occurrence of the external cause enterocolitis due to clostridium difficile, not specified as recurrent presence of coronary angioplasty implant and graft type 2 diabetes mellitus without complications chronic systolic (congestive) heart failure hyperlipidemia, unspecified personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified other mechanical complication of other cardiac electronic device, initial encounter other specified disorders of bone density and structure, unspecified site paroxysmal atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft encounter for adjustment and management of other part of cardiac pacemaker chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified hyperlipidemia, unspecified hypothyroidism, unspecified nonrheumatic mitral (valve) insufficiency long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable acute kidney failure, unspecified hypertensive heart disease with heart failure ischemic cardiomyopathy encounter for immunization hypotension, unspecified stenosis of coronary artery stent, initial encounter enterocolitis due to clostridium difficile, recurrent type 2 diabetes mellitus without complications atherosclerotic heart disease of native coronary artery with unstable angina pectoris old myocardial infarction hypertensive heart disease with heart failure long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure
white f 74 $nan$hematology blood hematocrit  33.1  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  2.7  ; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  110  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride nasal  1-2  spry ; vancomycin oral liquid  125  mg ; rosuvastatin calcium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; dofetilide  250  mcg ; fluticasone propionate nasal  2  spry ; clopidogrel  75  mg ; calcium carbonate  500  mg ; levothyroxine sodium  88  mcg ; vitamin d  1000  unit ; losartan potassium  12.5  mg ; glipizide xl  2.5  mg ; umeclidinium-vilanterol  1  dose ; warfarin  5  mg ; albuterol inhaler  1  puff ; ramelteon  8  mg ; 
nonrheumatic mitral (valve) insufficiency surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction hypertensive heart disease with heart failure unspecified atrial fibrillation hypotension, unspecified long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants kitchen of unspecified non-institutional (private) residence as the place of occurrence of the external cause enterocolitis due to clostridium difficile, not specified as recurrent presence of coronary angioplasty implant and graft type 2 diabetes mellitus without complications chronic systolic (congestive) heart failure hyperlipidemia, unspecified personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified other mechanical complication of other cardiac electronic device, initial encounter other specified disorders of bone density and structure, unspecified site paroxysmal atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft encounter for adjustment and management of other part of cardiac pacemaker chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified hyperlipidemia, unspecified hypothyroidism, unspecified nonrheumatic mitral (valve) insufficiency long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable acute kidney failure, unspecified hypertensive heart disease with heart failure ischemic cardiomyopathy encounter for immunization hypotension, unspecified stenosis of coronary artery stent, initial encounter enterocolitis due to clostridium difficile, recurrent type 2 diabetes mellitus without complications atherosclerotic heart disease of native coronary artery with unstable angina pectoris old myocardial infarction hypertensive heart disease with heart failure long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure
white f 74 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; sodium chloride nasal  1-2  spry ; vancomycin oral liquid  125  mg ; rosuvastatin calcium  40  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; dofetilide  250  mcg ; fluticasone propionate nasal  2  spry ; clopidogrel  75  mg ; calcium carbonate  500  mg ; levothyroxine sodium  88  mcg ; vitamin d  1000  unit ; losartan potassium  12.5  mg ; glipizide xl  2.5  mg ; umeclidinium-vilanterol  1  dose ; warfarin  5  mg ; albuterol inhaler  1  puff ; ramelteon  8  mg ; 
nonrheumatic mitral (valve) insufficiency surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure old myocardial infarction hypertensive heart disease with heart failure unspecified atrial fibrillation hypotension, unspecified long term (current) use of antithrombotics/antiplatelets long term (current) use of anticoagulants kitchen of unspecified non-institutional (private) residence as the place of occurrence of the external cause enterocolitis due to clostridium difficile, not specified as recurrent presence of coronary angioplasty implant and graft type 2 diabetes mellitus without complications chronic systolic (congestive) heart failure hyperlipidemia, unspecified personal history of nicotine dependence chronic obstructive pulmonary disease, unspecified ischemic cardiomyopathy atherosclerotic heart disease of native coronary artery without angina pectoris hypothyroidism, unspecified other mechanical complication of other cardiac electronic device, initial encounter other specified disorders of bone density and structure, unspecified site paroxysmal atrial fibrillation surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure personal history of nicotine dependence acute on chronic systolic (congestive) heart failure presence of coronary angioplasty implant and graft encounter for adjustment and management of other part of cardiac pacemaker chronic kidney disease, stage 3 (moderate) chronic obstructive pulmonary disease, unspecified hyperlipidemia, unspecified hypothyroidism, unspecified nonrheumatic mitral (valve) insufficiency long term (current) use of antithrombotics/antiplatelets unspecified place or not applicable acute kidney failure, unspecified hypertensive heart disease with heart failure ischemic cardiomyopathy encounter for immunization hypotension, unspecified stenosis of coronary artery stent, initial encounter enterocolitis due to clostridium difficile, recurrent type 2 diabetes mellitus without complications atherosclerotic heart disease of native coronary artery with unstable angina pectoris old myocardial infarction hypertensive heart disease with heart failure long term (current) use of anticoagulants atherosclerotic heart disease of native coronary artery without angina pectoris acute on chronic systolic (congestive) heart failure
white f 61 $nan$hematology blood hematocrit  33.8  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  283  k ul; hematology blood platelet count  279  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  174  mg dl; blood gas blood free calcium  1.26  mmol l; blood gas blood free calcium  1.25  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood lactate  2.3  mmol l; blood gas blood lactate  3.1  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood chloride, whole blood  103  meq l; blood gas blood glucose  204  mg dl; blood gas blood glucose  180  mg dl; blood gas blood glucose  200  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  11.9  g dl; blood gas blood hemoglobin  12.0  g dl; blood gas blood hemoglobin  11.8  g dl; blood gas blood potassium, whole blood  3.5  meq l; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.6  meq l; blood gas blood sodium, whole blood  139  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  139  meq l$syringe  1  ml ; heparin sodium  5000  unit ; heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; lr  1000  ml ; insulin  0  unit ; magnesium sulfate  2  gm ; metoprolol tartrate  5  mg ; metoclopramide  10  mg ; 
 
white f 61 $nan$nan$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  12.5  mg ; lr  1000  ml ; magnesium sulfate  2  gm ; metoprolol tartrate  5  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  15  mg ; 
 
white f 61 $nan$nan$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  15  mg ; 
 
white f 61 $nan$hematology blood hematocrit  33.4  %; hematology blood hemoglobin  11.2  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  162  mg dl$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; ketorolac  15  mg ; hydrochlorothiazide  12.5  mg ; hydralazine  10  mg ; 
 
white f 61 $nan$chemistry blood potassium  3.5  meq l$heparin flush (10 units ml)  1  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; ondansetron  4  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydrochlorothiazide  12.5  mg ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; sw  50  ml ; potassium chloride  20  meq ; hydrochlorothiazide  50  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; 
 
white f 61 $nan$chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl$heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; sw  50  ml ; potassium chloride  20  meq ; hydrochlorothiazide  50  mg ; 5% dextrose  500  ml ; potassium chloride  40  meq ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 61 $nan$nan$heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydrochlorothiazide  50  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white f 61 $nan$nan$heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; metoclopramide  10  mg ; hydrochlorothiazide  50  mg ; pantoprazole  40  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 50 $temp  98.0  heartrate  74.0  resprate  24.0  o2sat  94.0  sbp  165.0  dbp  94.0  rhythm    pain  0 10  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  224  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  166  mg dl; chemistry blood % hemoglobin a1c  5.4  %$sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; labetalol  100  mg ; enoxaparin sodium  130  mg ; insulin  0  unit ; lisinopril  30  mg ; escitalopram oxalate  30  mg ; acetaminophen  650  mg ; senna  8.6  mg ; atorvastatin  20  mg ; docusate sodium  100  mg ; rivaroxaban  15  mg ; labetalol  50  mg ; oxcarbazepine  2400  mg ; 
 
white m 50 $nan$hematology blood hematocrit  35.0  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; trazodone  100  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; labetalol  100  mg ; insulin  0  unit ; lisinopril  30  mg ; escitalopram oxalate  30  mg ; acetaminophen  650  mg ; senna  8.6  mg ; atorvastatin  20  mg ; docusate sodium  100  mg ; rivaroxaban  15  mg ; labetalol  50  mg ; oxcarbazepine  2400  mg ; 
 
white f 75 $nan$hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  302  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  68  mg dl; chemistry blood lactate dehydrogenase (ld)  122  iu l; chemistry blood albumin  4.4  g dl$milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; quetiapine fumarate  50  mg ; risperidone  0.5  mg ; diazepam  10  mg ; ipratropium-albuterol inhalation spray  1  inh ; fluticasone propionate 110mcg  2  puff ; apixaban  5  mg ; amlodipine  10  mg ; fluoxetine  30  mg ; quetiapine fumarate  25  mg ; benzonatate  100  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; atorvastatin  10  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; diazepam  10  mg ; fluticasone propionate 110mcg  2  puff ; apixaban  5  mg ; amlodipine  10  mg ; benzonatate  100  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; atorvastatin  10  mg ; risperidone  1  mg ; modafinil  100  mg ; fluoxetine  10  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$milk of magnesia  30  ml ; aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; diazepam  10  mg ; fluticasone propionate 110mcg  2  puff ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; modafinil  100  mg ; fluoxetine  10  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; modafinil  100  mg ; fluoxetine  10  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  74  mg dl$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; modafinil  100  mg ; fluoxetine  10  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood glucose  58  mg dl$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; sodium polystyrene sulfonate  15  gm ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; sodium polystyrene sulfonate  15  gm ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white f 75 $nan$nan$aluminum-magnesium hydrox.-simethicone  30  ml ; nicotine patch  21  mg day ; apixaban  5  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; folic acid  0.5  mg ; thiamine  100  mg ; multivitamins w minerals  1  tab ; risperidone  1  mg ; fluticasone propionate 110mcg  4  puff ; oxcarbazepine  150  mg ; polyethylene glycol  17  g ; quetiapine fumarate  12.5  mg ; ramelteon  8  mg ; 
major depressive disorder, recurrent, unspecified hyperlipidemia, unspecified heart failure, unspecified alcohol abuse, uncomplicated anxiety disorder, unspecified suicidal ideations personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits essential (primary) hypertension chronic obstructive pulmonary disease, unspecified age-related osteoporosis without current pathological fracture age-related osteoporosis without current pathological fracture alcohol abuse, uncomplicated unspecified lump in unspecified breast hyperlipidemia, unspecified hypertensive heart disease with heart failure chronic diastolic (congestive) heart failure major depressive disorder, recurrent, unspecified nicotine dependence, cigarettes, uncomplicated anxiety disorder, unspecified personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits unspecified lump in unspecified breast enlarged lymph nodes, unspecified personal history of nicotine dependence slurred speech other foreign object in other parts of respiratory tract causing asphyxiation, initial encounter alcohol abuse, uncomplicated poisoning by benzodiazepines, intentional self-harm, initial encounter personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits emphysema, unspecified age-related osteoporosis without current pathological fracture hyperlipidemia, unspecified toxic encephalopathy essential (primary) hypertension poisoning by amphetamines, intentional self-harm, initial encounter vascular disorder of intestine, unspecified unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause anxiety disorder, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified pneumonia, unspecified organism body mass index (bmi) 19.9 or less, adult gastro-esophageal reflux disease without esophagitis personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits nicotine dependence, cigarettes, uncomplicated vascular disorder of intestine, unspecified hypo-osmolality and hyponatremia major depressive disorder, single episode, unspecified hyperlipidemia, unspecified
white m 65 $temp  100.2  heartrate  138.0  resprate  26.0  o2sat  100.0  sbp  128.0  dbp  78.0  rhythm  sinus tachycardia  pain  0  ; temp  98.9  heartrate  137.0  resprate  24.0  o2sat  100.0  sbp  85.0  dbp  39.0  rhythm  sinus tachycardia  pain  0  ; temp  98.9  heartrate  137.0  resprate  24.0  o2sat  99.0  sbp  93.0  dbp  45.0  rhythm  sinus tachycardia  pain  0  ; temp  99.7  heartrate  129.0  resprate  24.0  o2sat  97.0  sbp  99.0  dbp  54.0  rhythm  sinus rhythm  pain  6  $hematology blood hematocrit  20.3  %; hematology blood hematocrit  21.9  %; hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  381  k ul; hematology blood platelet count  371  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  96  mg dl; blood gas blood lactate  2.7  mmol l; blood gas blood lactate  2.3  mmol l$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  325  mg ; morphine sulfate  2-4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; morphine sulfate  5  mg ; morphine sulfate  2-6  mg ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  25.2  %; hematology blood hematocrit  25.1  %; hematology blood hematocrit  25.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.3  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  389  k ul; hematology blood platelet count  395  k ul; hematology blood platelet count  372  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.0  mg dl; chemistry blood glucose  84  mg dl; chemistry blood albumin  1.9  g dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; acetaminophen  325  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; morphine sulfate  5  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  339  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  84  mg dl$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; aspirin  81  mg ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  26.4  %; hematology blood hematocrit  23.9  %; hematology blood hemoglobin  8.7  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  365  k ul; hematology blood platelet count  356  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  88  mg dl$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; heparin  5000  unit ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  349  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  109  # hpf; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  77  mg dl$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  341  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  103  mg dl$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; fluconazole  200  mg ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood glucose  89  mg dl$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; fluconazole  200  mg ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
white m 65 $nan$nan$acetaminophen  325  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; bisacodyl  10  mg ; docusate sodium  100  mg ; multivitamins  1  tab ; oxycodone (immediate release)   5-10  mg ; pantoprazole  40  mg ; senna  8.6  mg ; vitamin d  800  unit ; tamsulosin  0.4  mg ; morphine sulfate  2-6  mg ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 
lumbago pathologic fracture of other specified part of femur urinary obstruction, not elsewhere classified tachycardia, unspecified esophageal reflux acute edema of lung, unspecified secondary malignant neoplasm of bone and bone marrow pressure ulcer, stage ii edema malignant neoplasm of prostate retention of urine, unspecified fever presenting with conditions classified elsewhere anemia of other chronic disease neoplasm related pain (acute) (chronic) pressure ulcer, lower back antineoplastic chemotherapy induced anemia leukocytosis, unspecified other agents affecting blood constituents causing adverse effects in therapeutic use volume depletion, unspecified anemia in neoplastic disease secondary malignant neoplasm of bone and bone marrow malignant neoplasm of prostate unspecified sinusitis (chronic) pathologic fracture of vertebrae pneumonia, organism unspecified secondary malignant neoplasm of bone and bone marrow pathologic fracture of vertebrae malignant neoplasm of prostate anemia of other chronic disease antineoplastic chemotherapy induced anemia urinary tract infection, site not specified antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use staphylococcus infection in conditions classified elsewhere and of unspecified site, other staphylococcus long-term (current) use of aspirin hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) do not resuscitate status pathologic fracture of vertebrae iron deficiency anemia, unspecified malignant neoplasm of prostate hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) anxiety state, unspecified secondary malignant neoplasm of bone and bone marrow constipation, unspecified 
hispanic latino f 28 $nan$nan$prenatal vitamins  1  tab ; progesterone micronized  100  mg ; 

hispanic latino f 28 $nan$nan$prenatal vitamins  1  tab ; progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; ranitidine  150  mg ; amoxicillin  500  mg ; 

hispanic latino f 28 $nan$nan$prenatal vitamins  1  tab ; progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; ranitidine  150  mg ; 

hispanic latino f 28 $nan$nan$prenatal vitamins  1  tab ; progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; syringe  1  syr ; betamethasone sodium phos acet  12  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; fluconazole  150  mg ; miconazole powder 2%  1  appl ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; fluconazole  150  mg ; miconazole powder 2%  1  appl ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; miconazole powder 2%  1  appl ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; miconazole powder 2%  1  appl ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; nitrofurantoin monohyd (macrobid)  100  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; nitrofurantoin monohyd (macrobid)  100  mg ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; nitrofurantoin monohyd (macrobid)  100  mg ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; influenza virus vaccine  0.5  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; nitrofurantoin monohyd (macrobid)  100  mg ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; terbutaline sulfate  0.25  mg ; terbutaline sulfate  2.5  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; terbutaline sulfate  2.5  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; ranitidine  150  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; ondansetron  4  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; ondansetron  4  mg ; diphenhydramine  25  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; ondansetron  4  mg ; 

hispanic latino f 28 $nan$nan$progesterone micronized  100  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; oxazepam  15-30  mg ; calcium carbonate  500  mg ; milk of magnesia  15-30  ml ; bisacodyl  10  mg ; gummy dinos  2  gum ; polyethylene glycol  17  g ; omeprazole  20  mg ; ondansetron  4  mg ; 

unknown m 19 $nan$nan$5% dextrose  250  ml ; norepinephrine  16  mg ; 5% dextrose  100  ml ; vasopressin  40  unit ; epinephrine  8  mg ; sodium bicarbonate  50  meq ; dextrose 50%  25  gm ; 0.9% sodium chloride  1000  ml ; calcium chloride  3  gm ; phenylephrine  60  mg ; 
 
unknown f 30 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
unknown f 30 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
unknown f 30 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
unknown f 30 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white m 78 $temp    heartrate  84.0  resprate  27.0  o2sat  96.0  sbp  177.0  dbp  81.0  rhythm    pain  0  ; temp  98.9  heartrate  81.0  resprate  25.0  o2sat  95.0  sbp  154.0  dbp  88.0  rhythm    pain  0  $nan$aspirin  81  mg ; atenolol  100  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; 
atrial fibrillation anticoagulants causing adverse effects in therapeutic use hemorrhage, unspecified other and unspecified hyperlipidemia acute systolic heart failure unspecified essential hypertension congestive heart failure, unspecified 
white m 78 $temp  98.8  heartrate  84.0  resprate  24.0  o2sat  95.0  sbp  163.0  dbp  79.0  rhythm    pain  0  ; temp    heartrate  100.0  resprate  20.0  o2sat  93.0  sbp  145.0  dbp  62.0  rhythm    pain  0  $hematology blood hematocrit  41.3  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  117  mg dl$aspirin  81  mg ; atenolol  100  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; furosemide  80  mg ; acetaminophen  325-650  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; levalbuterol neb  0.63  mg ; potassium chloride  60  meq ; metoprolol tartrate  25  mg ; senna  1  tab ; warfarin  5  mg ; 
atrial fibrillation anticoagulants causing adverse effects in therapeutic use hemorrhage, unspecified other and unspecified hyperlipidemia acute systolic heart failure unspecified essential hypertension congestive heart failure, unspecified 
white m 78 $nan$hematology blood hematocrit  42.4  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  114  mg dl$aspirin  81  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  80  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; levalbuterol neb  0.63  mg ; potassium chloride  60  meq ; metoprolol tartrate  25  mg ; senna  1  tab ; warfarin  5  mg ; docusate sodium  100  mg ; metoprolol tartrate  50  mg ; milk of magnesia  30  ml ; furosemide  40  mg ; 
atrial fibrillation anticoagulants causing adverse effects in therapeutic use hemorrhage, unspecified other and unspecified hyperlipidemia acute systolic heart failure unspecified essential hypertension congestive heart failure, unspecified 
white m 78 $nan$nan$aspirin  81  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ipratropium bromide neb  1  neb ; levalbuterol neb  0.63  mg ; senna  1  tab ; warfarin  5  mg ; docusate sodium  100  mg ; milk of magnesia  30  ml ; furosemide  40  mg ; 
atrial fibrillation anticoagulants causing adverse effects in therapeutic use hemorrhage, unspecified other and unspecified hyperlipidemia acute systolic heart failure unspecified essential hypertension congestive heart failure, unspecified 
white f 69 $temp  98.4  heartrate  89.0  resprate  18.0  o2sat  100.0  sbp  120.0  dbp  57.0  rhythm    pain  0  $hematology blood hematocrit  26.9  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  250  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  15.8  mg dl; chemistry blood glucose  74  mg dl; chemistry blood lactate dehydrogenase (ld)  215  iu l; chemistry blood albumin  3.1  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; montelukast  10  mg ; simvastatin  10  mg ; trazodone  25  mg ; alprazolam  0.25  mg ; albuterol inhaler  2  puff ; bupropion  75  mg ; exemestane  25  mg ; fluticasone propionate 110mcg  4  puff ; levothyroxine sodium  50  mcg ; venlafaxine  125  mg ; levalbuterol hcl  0.63  mg ; sodium chloride 0.9%  1000  ml ; 
 
white f 69 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  13.8  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  305  iu l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; montelukast  10  mg ; alprazolam  0.25  mg ; bupropion  75  mg ; exemestane  25  mg ; fluticasone propionate 110mcg  4  puff ; levothyroxine sodium  50  mcg ; venlafaxine  125  mg ; levalbuterol hcl  0.63  mg ; sodium chloride 0.9%  1000  ml ; heparin  5000  unit ; d5 1 2ns  1000  ml ; 
 
white f 69 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  256  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  13.4  mg dl; chemistry blood glucose  144  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; montelukast  10  mg ; bupropion  75  mg ; exemestane  25  mg ; fluticasone propionate 110mcg  4  puff ; levothyroxine sodium  50  mcg ; venlafaxine  125  mg ; levalbuterol hcl  0.63  mg ; heparin  5000  unit ; d5 1 2ns  1000  ml ; ciprofloxacin hcl  500  mg ; lactated ringers  1000  ml ; levofloxacin  500  mg ; 
 
white f 69 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  357  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood bilirubin, total  17.7  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; montelukast  10  mg ; bupropion  75  mg ; exemestane  25  mg ; fluticasone propionate 110mcg  4  puff ; levothyroxine sodium  50  mcg ; venlafaxine  125  mg ; levalbuterol hcl  0.63  mg ; lactated ringers  1000  ml ; levofloxacin  500  mg ; lorazepam  0.5  mg ; alprazolam  0.5  mg ; 
 
white f 69 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  12.7  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; montelukast  10  mg ; bupropion  75  mg ; exemestane  25  mg ; fluticasone propionate 110mcg  4  puff ; levothyroxine sodium  50  mcg ; venlafaxine  125  mg ; levalbuterol hcl  0.63  mg ; levofloxacin  500  mg ; alprazolam  0.5  mg ; 
 
white m 80 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  148  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  97  mg dl$acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; atorvastatin  40  mg ; docusate sodium  100  mg ; enoxaparin sodium  80  mg ; guaifenesin-dextromethorphan  5  ml ; isosorbide mononitrate (extended release)  30  mg ; lisinopril  10  mg ; metoprolol succinate xl  50  mg ; multivitamins w minerals  1  tab ; oxycodone (immediate release)   5-10  mg ; polyethylene glycol  17  g ; senna  8.6  mg ; prednisone  10  mg ; prednisone  50  mg ; 
chronic airway obstruction, not elsewhere classified antineoplastic chemotherapy induced anemia other acute pain personal history of other malignant neoplasm of skin long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft lumbosacral spondylosis without myelopathy cough acute on chronic systolic heart failure secondary malignant neoplasm of mediastinum car passenger injured in collision with van in traffic accident aortocoronary bypass status secondary malignant neoplasm of adrenal gland pathologic fracture of vertebrae personal history of tobacco use hip joint replacement malignant neoplasm of upper lobe, bronchus or lung hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity secondary and unspecified malignant neoplasm of intrathoracic lymph nodes atherosclerosis of native arteries of the extremities, unspecified other specified forms of chronic ischemic heart disease secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle other and unspecified hyperlipidemia hypoxemia personal history of irradiation, presenting hazards to health personal history of antineoplastic chemotherapy other chronic pain chronic kidney disease, stage iii (moderate) ulcer of heel and midfoot personal history of tobacco use aortocoronary bypass status intermediate coronary syndrome congestive heart failure, unspecified other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia chronic systolic heart failure peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) abdominal aneurysm without mention of rupture osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified peripheral vascular disease, unspecified postprocedural fever
white m 80 $nan$chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  110  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; atorvastatin  40  mg ; docusate sodium  100  mg ; enoxaparin sodium  80  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; prednisone  10  mg ; prednisone  50  mg ; sulfameth trimethoprim ss  1  tab ; furosemide  40  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; 
chronic airway obstruction, not elsewhere classified antineoplastic chemotherapy induced anemia other acute pain personal history of other malignant neoplasm of skin long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft lumbosacral spondylosis without myelopathy cough acute on chronic systolic heart failure secondary malignant neoplasm of mediastinum car passenger injured in collision with van in traffic accident aortocoronary bypass status secondary malignant neoplasm of adrenal gland pathologic fracture of vertebrae personal history of tobacco use hip joint replacement malignant neoplasm of upper lobe, bronchus or lung hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity secondary and unspecified malignant neoplasm of intrathoracic lymph nodes atherosclerosis of native arteries of the extremities, unspecified other specified forms of chronic ischemic heart disease secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle other and unspecified hyperlipidemia hypoxemia personal history of irradiation, presenting hazards to health personal history of antineoplastic chemotherapy other chronic pain chronic kidney disease, stage iii (moderate) ulcer of heel and midfoot personal history of tobacco use aortocoronary bypass status intermediate coronary syndrome congestive heart failure, unspecified other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia chronic systolic heart failure peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) abdominal aneurysm without mention of rupture osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified peripheral vascular disease, unspecified postprocedural fever
white m 80 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500  mg ; ascorbic acid  500  mg ; aspirin  81  mg ; atorvastatin  40  mg ; docusate sodium  100  mg ; enoxaparin sodium  80  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; prednisone  10  mg ; prednisone  50  mg ; sulfameth trimethoprim ss  1  tab ; furosemide  40  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; enoxaparin sodium  120  mg ; morphine sr (ms contin)  15  mg ; cyclobenzaprine  5  mg ; acetaminophen  650  mg ; 
chronic airway obstruction, not elsewhere classified antineoplastic chemotherapy induced anemia other acute pain personal history of other malignant neoplasm of skin long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft lumbosacral spondylosis without myelopathy cough acute on chronic systolic heart failure secondary malignant neoplasm of mediastinum car passenger injured in collision with van in traffic accident aortocoronary bypass status secondary malignant neoplasm of adrenal gland pathologic fracture of vertebrae personal history of tobacco use hip joint replacement malignant neoplasm of upper lobe, bronchus or lung hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity secondary and unspecified malignant neoplasm of intrathoracic lymph nodes atherosclerosis of native arteries of the extremities, unspecified other specified forms of chronic ischemic heart disease secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle other and unspecified hyperlipidemia hypoxemia personal history of irradiation, presenting hazards to health personal history of antineoplastic chemotherapy other chronic pain chronic kidney disease, stage iii (moderate) ulcer of heel and midfoot personal history of tobacco use aortocoronary bypass status intermediate coronary syndrome congestive heart failure, unspecified other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia chronic systolic heart failure peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) abdominal aneurysm without mention of rupture osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified peripheral vascular disease, unspecified postprocedural fever
white m 80 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ascorbic acid  500  mg ; aspirin  81  mg ; atorvastatin  40  mg ; docusate sodium  100  mg ; multivitamins w minerals  1  tab ; polyethylene glycol  17  g ; senna  8.6  mg ; prednisone  10  mg ; prednisone  50  mg ; sulfameth trimethoprim ss  1  tab ; furosemide  40  mg ; tiotropium bromide  1  cap ; albuterol 0.083% neb soln  1  neb ; enoxaparin sodium  120  mg ; morphine sr (ms contin)  15  mg ; cyclobenzaprine  5  mg ; acetaminophen  650  mg ; 
chronic airway obstruction, not elsewhere classified antineoplastic chemotherapy induced anemia other acute pain personal history of other malignant neoplasm of skin long-term (current) use of aspirin coronary atherosclerosis of unspecified type of vessel, native or graft lumbosacral spondylosis without myelopathy cough acute on chronic systolic heart failure secondary malignant neoplasm of mediastinum car passenger injured in collision with van in traffic accident aortocoronary bypass status secondary malignant neoplasm of adrenal gland pathologic fracture of vertebrae personal history of tobacco use hip joint replacement malignant neoplasm of upper lobe, bronchus or lung hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute venous embolism and thrombosis of deep vessels of distal lower extremity secondary and unspecified malignant neoplasm of intrathoracic lymph nodes atherosclerosis of native arteries of the extremities, unspecified other specified forms of chronic ischemic heart disease secondary malignant neoplasm of other specified sites person boarding or alighting a pedal cycle injured in collision with railway train or railway vehicle other and unspecified hyperlipidemia hypoxemia personal history of irradiation, presenting hazards to health personal history of antineoplastic chemotherapy other chronic pain chronic kidney disease, stage iii (moderate) ulcer of heel and midfoot personal history of tobacco use aortocoronary bypass status intermediate coronary syndrome congestive heart failure, unspecified other specified forms of chronic ischemic heart disease other and unspecified hyperlipidemia chronic systolic heart failure peripheral vascular disease, unspecified coronary atherosclerosis of native coronary artery chronic kidney disease, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) abdominal aneurysm without mention of rupture osteoarthrosis, unspecified whether generalized or localized, pelvic region and thigh hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified peripheral vascular disease, unspecified postprocedural fever
white m 63 $nan$nan$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; methadone  135  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$hematology blood hematocrit  26.2  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  140  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  81  mg dl$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; methadone  135  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen  600  mg ; furosemide  20  mg ; clonazepam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  12.5  mg ; tamsulosin  0.4  mg ; quetiapine fumarate  100  mg ; warfarin  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; levofloxacin  250  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$nan$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen  600  mg ; clonazepam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; levofloxacin  250  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; warfarin  2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood glucose  128  mg dl$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen  600  mg ; clonazepam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; warfarin  2.5  mg ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  163  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  6.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  5.0  ; chemistry blood glucose  102  mg dl$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen  600  mg ; clonazepam  2  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; warfarin  7.5  mg ; furosemide  40  mg ; phytonadione  2  mg ; metronidazole (flagyl)  500  mg ; clonazepam  1.5  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  138  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood glucose  117  mg dl$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; ibuprofen  600  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; furosemide  40  mg ; phytonadione  2  mg ; metronidazole (flagyl)  500  mg ; clonazepam  1.5  mg ; ferrous sulfate  325  mg ; clonazepam  0.5  mg ; clonazepam  1  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood glucose  110  mg dl$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; metronidazole (flagyl)  500  mg ; ferrous sulfate  325  mg ; clonazepam  0.5  mg ; clonazepam  1  mg ; sodium polystyrene sulfonate  30  gm ; warfarin  5  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 63 $nan$nan$aspirin ec  325  mg ; thiamine  100  mg ; duloxetine  60  mg ; simvastatin  40  mg ; levofloxacin  750  mg ; gabapentin  600  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; fluticasone-salmeterol diskus (250 50)   1  inh ; quetiapine fumarate  100  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; ondansetron  4  mg ; promethazine  12.5  mg ; methadone  10  mg ; methadone  5  mg ; methadone  120  mg ; docusate sodium  100  mg ; senna  1  tab ; lactulose  30  ml ; metronidazole (flagyl)  500  mg ; ferrous sulfate  325  mg ; clonazepam  0.5  mg ; clonazepam  1  mg ; warfarin  5  mg ; 
lack of housing dysthymic disorder acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified delirium due to conditions classified elsewhere congestive heart failure, unspecified percutaneous transluminal coronary angioplasty status pancytopenia hypovolemia chronic systolic heart failure chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident accidental poisoning by methadone poisoning by methadone chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta hypotension, unspecified posttraumatic stress disorder old myocardial infarction coronary atherosclerosis of native coronary artery chronic hepatitis c without mention of hepatic coma driver of heavy transport vehicle injured in collision with pedestrian or animal in nontraffic accident lack of housing other ill-defined heart diseases opioid type dependence, continuous pneumonia, organism unspecified chronic airway obstruction, not elsewhere classified anxiety state, unspecified percutaneous transluminal coronary angioplasty status personal history of surgery to heart and great vessels, presenting hazards to health pedal cycle passenger injured in collision with railway train or railway vehicle in nontraffic accident chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta other venous embolism and thrombosis of inferior vena cava coronary atherosclerosis of native coronary artery personal history of noncompliance with medical treatment, presenting hazards to health chronic kidney disease, stage iii (moderate) old myocardial infarction unspecified gastritis and gastroduodenitis, without mention of hemorrhage hemoptysis congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute on chronic systolic heart failure esophageal reflux other specified forms of chronic ischemic heart disease congestive heart failure, unspecified lack of housing chronic systolic heart failure acute kidney failure, unspecified chronic airway obstruction, not elsewhere classified
white m 72 $nan$hematology blood hematocrit  36.1  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  52  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  149  mg dl; chemistry blood albumin  3.8  g dl$nan
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$hematology blood hematocrit  34.3  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  199  k ul; hematology blood platelet count  198  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  151  mg dl; chemistry blood glucose  115  mg dl; hematology blood bands  17  %$bag  100  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; ondansetron  4  mg ; vial  1  vial ; pantoprazole  40  mg ; metoprolol tartrate  5  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride  1000  ml ; ceftriaxone  1  gm ; diltiazem  10  mg ; 5% dextrose  100  ml ; diltiazem  125  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; heparin  5000  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  119  mg dl$bag  100  ml ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; sw  200-400  ml ; potassium chloride  20-40  meq ; sw  400  ml ; potassium chloride  40  meq ; potassium chloride  60  meq ; magnesium sulfate  4  gm ; bag  50-100  ml ; magnesium sulfate  2-4  gm ; bag  50  ml ; magnesium sulfate  2  gm ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  1-2  bag ; calcium gluconate  2-4  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  250  ml ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; diltiazem  60  mg ; labetalol  200  mg ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  42  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  126  mg dl$iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chloraseptic throat spray  1  spry ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; aspirin  81  mg ; atorvastatin  80  mg ; hydrochlorothiazide  12.5  mg ; ciprofloxacin hcl  500  mg ; furosemide  20  mg ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  94  mg dl$iso-osmotic sodium chloride  50  ml ; famotidine  20  mg ; chloraseptic throat spray  1  spry ; aspirin  81  mg ; atorvastatin  80  mg ; hydrochlorothiazide  12.5  mg ; ciprofloxacin hcl  500  mg ; furosemide  20  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; senna  1  tab ; calcium carbonate  500  mg ; 5% dextrose  500  ml ; potassium phosphate  30  mmol ; neutra-phos  1  pkt ; docusate sodium  100  mg ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.6  g dl; hematology blood platelet count  338  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  112  mg dl$chloraseptic throat spray  1  spry ; aspirin  81  mg ; atorvastatin  80  mg ; hydrochlorothiazide  12.5  mg ; ciprofloxacin hcl  500  mg ; hydromorphone (dilaudid)  2-4  mg ; acetaminophen  650  mg ; senna  1  tab ; calcium carbonate  500  mg ; neutra-phos  1  pkt ; docusate sodium  100  mg ; hydrocodone-acetaminophen  1-2  tab ; d5 1 2ns  1000  ml ; methylnaltrexone  8  mg ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  308  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  145  mg dl; chemistry blood glucose  119  mg dl$chloraseptic throat spray  1  spry ; aspirin  81  mg ; atorvastatin  80  mg ; hydrochlorothiazide  12.5  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; hydrocodone-acetaminophen  1-2  tab ; d5 1 2ns  1000  ml ; methylnaltrexone  8  mg ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
white m 72 $nan$nan$chloraseptic throat spray  1  spry ; aspirin  81  mg ; atorvastatin  80  mg ; hydrochlorothiazide  12.5  mg ; ciprofloxacin hcl  500  mg ; acetaminophen  650  mg ; senna  1  tab ; docusate sodium  100  mg ; hydrocodone-acetaminophen  1-2  tab ; 
gout, unspecified other postprocedural status hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) atherosclerosis of renal artery hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified congestive heart failure, unspecified other and unspecified hyperlipidemia chronic diastolic heart failure atrial fibrillation full incontinence of feces pressure ulcer, unstageable chronic kidney disease, unspecified pressure ulcer, lower back other urinary incontinence cardiac pacemaker in situ urinary tract infection, site not specified unspecified renovascular hypertension atherosclerosis of renal artery cardiac pacemaker in situ other and unspecified hyperlipidemia acute on chronic diastolic heart failure hyposmolality and/or hyponatremia chronic kidney disease, unspecified iron deficiency anemia secondary to blood loss (chronic) late effects of injury, undetermined whether accidentally or purposely inflicted atrial fibrillation hyperpotassemia full incontinence of feces congestive heart failure, unspecified late effect of spinal cord injury hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified unspecified pleural effusion anemia in chronic kidney disease escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site urinary incontinence, unspecified unspecified renovascular hypertension atherosclerosis of renal artery acute diastolic heart failure acute kidney failure, unspecified diastolic heart failure, unspecified atrial fibrillation long-term (current) use of anticoagulants cardiac pacemaker in situ congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) hyposmolality and/or hyponatremia
black african american m 55 $temp  98.4  heartrate  87.0  resprate  16.0  o2sat  100.0  sbp  103.0  dbp  49.0  rhythm    pain  0  $hematology blood hematocrit  27.5  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.7  ; chemistry urine creatinine, urine  123  mg dl; chemistry urine sodium, urine  20  meq l; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.9  mg dl; chemistry blood glucose  97  mg dl; chemistry blood lactate dehydrogenase (ld)  219  iu l; chemistry urine protein creatinine ratio  2.0  mg mg; blood gas blood lactate  1.5  mmol l$albumin 25% (12.5g   50ml)  75  g ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; folic acid  1  mg ; lactulose  30  ml ; ledipasvir sofosbuvir  1  tab ; magnesium oxide  400  mg ; omeprazole  20  mg ; thiamine  100  mg ; potassium chloride  40  meq ; albumin 25% (12.5g   50ml)  50  g ; 
unspecified severe protein-calorie malnutrition central demyelination of corpus callosum cyst of pancreas alcohol abuse with intoxication, unspecified urinary tract infection, site not specified unspecified viral hepatitis c without hepatic coma pedestrian injured in unspecified transport accident, initial encounter portal vein thrombosis nicotine dependence, cigarettes, uncomplicated portal hypertension alcoholic hepatitis without ascites alcoholic cirrhosis of liver without ascites major depressive disorder, single episode, unspecified unspecified place or not applicable sprain of unspecified ligament of right ankle, initial encounter essential (primary) hypertension acquired absence of right finger(s) acidosis body mass index (bmi) 19.9 or less, adult cannabis abuse, uncomplicated alcoholic hepatitis without ascites degeneration of nervous system due to alcohol unspecified viral hepatitis c without hepatic coma nutritional anemia, unspecified retention of urine, unspecified physical restraint status thrombocytopenia, unspecified alkalosis calculus of gallbladder without cholecystitis without obstruction central demyelination of corpus callosum hyperosmolality and hypernatremia major depressive disorder, single episode, unspecified toxic encephalopathy hypovolemia gastro-esophageal reflux disease without esophagitis suicidal ideations epistaxis acquired coagulation factor deficiency chronic sinusitis, unspecified acute posthemorrhagic anemia other shock essential (primary) hypertension nicotine dependence, cigarettes, uncomplicated acute kidney failure, unspecified alcoholic cirrhosis of liver without ascites respiratory failure, unspecified with hypoxia pneumonitis due to inhalation of food and vomit alcohol dependence with withdrawal delirium
white f 31 $temp  98.0  heartrate  121.0  resprate  18.0  o2sat  97.0  sbp  133.0  dbp  74.0  rhythm    pain    ; temp  98.0  heartrate  121.0  resprate  18.0  o2sat  97.0  sbp  133.0  dbp  74.0  rhythm    pain    $chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  157  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; clonidine  0.1  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; metoclopramide  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; trazodone  50  mg ; lactated ringers  1000  ml ; oxycodone (immediate release)  5  mg ; oxycodone (immediate release)  10  mg ; neutra-phos  1  pkt ; potassium chloride  40  meq ; diphenhydramine  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; diazepam - ciwa protocol  10  mg ; prednisone  20  mg ; albumin 5% (12.5g   250ml)  50  g ; lorazepam  2  mg ; hydromorphone (dilaudid)  2-4  mg ; 
other diseases of stomach and duodenum tobacco use other chronic pancreatitis cyclic neutropenia anxiety disorder, unspecified other disorders of phosphorus metabolism other secondary thrombocytopenia alcoholic cirrhosis of liver without ascites secondary esophageal varices without bleeding abnormal coagulation profile alcohol abuse, in remission acute pancreatitis without necrosis or infection, unspecified hypovolemia fall on stairs or ladders in water transport injuring unspecified person tachycardia, unspecified portal hypertension acidosis alcohol dependence with withdrawal, unspecified other pancytopenia anxiety disorder, unspecified alcoholic cirrhosis of liver without ascites acidosis tobacco use tachycardia, unspecified other hypotension hypovolemia dehydration alcoholic hepatitis without ascites major depressive disorder, single episode, unspecified acquired coagulation factor deficiency hypo-osmolality and hyponatremia other disorders of phosphorus metabolism ileus, unspecified fall on stairs or ladders in water transport injuring unspecified person ulcer of esophagus with bleeding acute kidney failure, unspecified other diseases of stomach and duodenum alcoholic cirrhosis of liver with ascites hypokalemia portal hypertension secondary esophageal varices without bleeding acute posthemorrhagic anemia alcoholic hepatitis with ascites other secondary thrombocytopenia anxiety disorder, unspecified alcohol dependence, uncomplicated candidal esophagitis nicotine dependence, cigarettes, uncomplicated
white f 31 $nan$hematology blood hematocrit  32.2  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  2  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  116  mg dl; chemistry blood lactate dehydrogenase (ld)  184  iu l; chemistry blood albumin  4.4  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; clonidine  0.1  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; metoclopramide  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; trazodone  50  mg ; lactated ringers  1000  ml ; neutra-phos  1  pkt ; potassium chloride  40  meq ; diphenhydramine  25  mg ; bag  1  bag ; magnesium sulfate  4  gm ; prednisone  20  mg ; albumin 5% (12.5g   250ml)  50  g ; lorazepam  2  mg ; hydromorphone (dilaudid)  2-4  mg ; hydromorphone (dilaudid)  2  mg ; 
other diseases of stomach and duodenum tobacco use other chronic pancreatitis cyclic neutropenia anxiety disorder, unspecified other disorders of phosphorus metabolism other secondary thrombocytopenia alcoholic cirrhosis of liver without ascites secondary esophageal varices without bleeding abnormal coagulation profile alcohol abuse, in remission acute pancreatitis without necrosis or infection, unspecified hypovolemia fall on stairs or ladders in water transport injuring unspecified person tachycardia, unspecified portal hypertension acidosis alcohol dependence with withdrawal, unspecified other pancytopenia anxiety disorder, unspecified alcoholic cirrhosis of liver without ascites acidosis tobacco use tachycardia, unspecified other hypotension hypovolemia dehydration alcoholic hepatitis without ascites major depressive disorder, single episode, unspecified acquired coagulation factor deficiency hypo-osmolality and hyponatremia other disorders of phosphorus metabolism ileus, unspecified fall on stairs or ladders in water transport injuring unspecified person ulcer of esophagus with bleeding acute kidney failure, unspecified other diseases of stomach and duodenum alcoholic cirrhosis of liver with ascites hypokalemia portal hypertension secondary esophageal varices without bleeding acute posthemorrhagic anemia alcoholic hepatitis with ascites other secondary thrombocytopenia anxiety disorder, unspecified alcohol dependence, uncomplicated candidal esophagitis nicotine dependence, cigarettes, uncomplicated
white f 31 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; clonidine  0.1  mg ; cyanocobalamin  100  mcg ; folic acid  1  mg ; metoclopramide  10  mg ; multivitamins  1  tab ; ondansetron  4  mg ; pantoprazole  40  mg ; rifaximin  550  mg ; thiamine  100  mg ; trazodone  50  mg ; albumin 5% (12.5g   250ml)  50  g ; lorazepam  2  mg ; hydromorphone (dilaudid)  2  mg ; 
other diseases of stomach and duodenum tobacco use other chronic pancreatitis cyclic neutropenia anxiety disorder, unspecified other disorders of phosphorus metabolism other secondary thrombocytopenia alcoholic cirrhosis of liver without ascites secondary esophageal varices without bleeding abnormal coagulation profile alcohol abuse, in remission acute pancreatitis without necrosis or infection, unspecified hypovolemia fall on stairs or ladders in water transport injuring unspecified person tachycardia, unspecified portal hypertension acidosis alcohol dependence with withdrawal, unspecified other pancytopenia anxiety disorder, unspecified alcoholic cirrhosis of liver without ascites acidosis tobacco use tachycardia, unspecified other hypotension hypovolemia dehydration alcoholic hepatitis without ascites major depressive disorder, single episode, unspecified acquired coagulation factor deficiency hypo-osmolality and hyponatremia other disorders of phosphorus metabolism ileus, unspecified fall on stairs or ladders in water transport injuring unspecified person ulcer of esophagus with bleeding acute kidney failure, unspecified other diseases of stomach and duodenum alcoholic cirrhosis of liver with ascites hypokalemia portal hypertension secondary esophageal varices without bleeding acute posthemorrhagic anemia alcoholic hepatitis with ascites other secondary thrombocytopenia anxiety disorder, unspecified alcohol dependence, uncomplicated candidal esophagitis nicotine dependence, cigarettes, uncomplicated
white m 90 $temp    heartrate  77.0  resprate  18.0  o2sat  96.0  sbp  115.0  dbp  59.0  rhythm    pain  0  $hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  120  mg dl$bag  1  bag ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; guaifenesin-dextromethorphan  5  ml ; aspirin  81  mg ; brimonidine tartrate 0.15% ophth.  0.2  % ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; dorzolamide 2% timolol 0.5% ophth.  22.3-6.8  mg ml ; finasteride  5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.8  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; azithromycin  250  mg ; codeine sulfate  15-30  mg ; sodium chloride 0.9%  1000  ml ; magnesium sulfate  2  gm ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; potassium chl 20 meq   1000 ml d5ns  1000  ml ; ipratropium bromide neb  1  neb ; metoprolol tartrate  5  mg ; furosemide  80  mg ; lidocaine jelly 2% (glydo)  1  appl ; morphine sulfate  2-4  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; labetalol  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; 
essential (primary) hypertension benign prostatic hyperplasia with lower urinary tract symptoms other sequelae of nontraumatic intracerebral hemorrhage hypovolemia unspecified sensorineural hearing loss do not resuscitate unspecified osteoarthritis, unspecified site other specified degenerative diseases of nervous system acute kidney failure, unspecified long term (current) use of aspirin paresthesia of skin weakness dehydration urge incontinence hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic polyneuropathy obstructive sleep apnea (adult) (pediatric) personal history of other malignant neoplasm of skin iron deficiency anemia, unspecified paroxysmal atrial fibrillation constipation, unspecified legal blindness, as defined in usa unspecified glaucoma profound impairment, one eye, impairment level not further specified unspecified essential hypertension other amyloidosis paroxysmal ventricular tachycardia atrial fibrillation difficulty in walking diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) esophageal reflux sensorineural hearing loss, unspecified aortic valve disorders intracerebral hemorrhage iron deficiency anemia, unspecified other musculoskeletal symptoms referable to limbs unspecified cerebrovascular disease unspecified hereditary and idiopathic peripheral neuropathy disturbance of skin sensation other and unspecified hyperlipidemia unspecified glaucoma personal history of other malignant neoplasm of skin paroxysmal ventricular tachycardia sensorineural hearing loss, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 90 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  113  mg dl$bag  1  bag ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; guaifenesin-dextromethorphan  5  ml ; aspirin  81  mg ; brimonidine tartrate 0.15% ophth.  0.2  % ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; dorzolamide 2% timolol 0.5% ophth.  22.3-6.8  mg ml ; finasteride  5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.8  mg ; azithromycin  250  mg ; magnesium sulfate  2  gm ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; ipratropium bromide neb  1  neb ; metoprolol tartrate  5  mg ; furosemide  80  mg ; lidocaine jelly 2% (glydo)  1  appl ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; labetalol  5  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen iv  1000  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; 
essential (primary) hypertension benign prostatic hyperplasia with lower urinary tract symptoms other sequelae of nontraumatic intracerebral hemorrhage hypovolemia unspecified sensorineural hearing loss do not resuscitate unspecified osteoarthritis, unspecified site other specified degenerative diseases of nervous system acute kidney failure, unspecified long term (current) use of aspirin paresthesia of skin weakness dehydration urge incontinence hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic polyneuropathy obstructive sleep apnea (adult) (pediatric) personal history of other malignant neoplasm of skin iron deficiency anemia, unspecified paroxysmal atrial fibrillation constipation, unspecified legal blindness, as defined in usa unspecified glaucoma profound impairment, one eye, impairment level not further specified unspecified essential hypertension other amyloidosis paroxysmal ventricular tachycardia atrial fibrillation difficulty in walking diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) esophageal reflux sensorineural hearing loss, unspecified aortic valve disorders intracerebral hemorrhage iron deficiency anemia, unspecified other musculoskeletal symptoms referable to limbs unspecified cerebrovascular disease unspecified hereditary and idiopathic peripheral neuropathy disturbance of skin sensation other and unspecified hyperlipidemia unspecified glaucoma personal history of other malignant neoplasm of skin paroxysmal ventricular tachycardia sensorineural hearing loss, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 90 $nan$nan$heparin  5000  unit ; guaifenesin-dextromethorphan  5  ml ; aspirin  81  mg ; brimonidine tartrate 0.15% ophth.  0.2  % ; calcium carbonate  1000  mg ; docusate sodium  100  mg ; dorzolamide 2% timolol 0.5% ophth.  22.3-6.8  mg ml ; finasteride  5  mg ; latanoprost 0.005% ophth. soln.  1  drop ; multivitamins  1  tab ; omeprazole  20  mg ; simvastatin  20  mg ; tamsulosin  0.8  mg ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride  100  ml ; hydromorphone  20  mg ; acetaminophen iv  1000  mg ; 5% dextrose  250  ml ; azithromycin   250  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; glycopyrrolate  0.1  mg ; lorazepam  0.5-2  mg ; 
essential (primary) hypertension benign prostatic hyperplasia with lower urinary tract symptoms other sequelae of nontraumatic intracerebral hemorrhage hypovolemia unspecified sensorineural hearing loss do not resuscitate unspecified osteoarthritis, unspecified site other specified degenerative diseases of nervous system acute kidney failure, unspecified long term (current) use of aspirin paresthesia of skin weakness dehydration urge incontinence hyperlipidemia, unspecified type 2 diabetes mellitus with diabetic polyneuropathy obstructive sleep apnea (adult) (pediatric) personal history of other malignant neoplasm of skin iron deficiency anemia, unspecified paroxysmal atrial fibrillation constipation, unspecified legal blindness, as defined in usa unspecified glaucoma profound impairment, one eye, impairment level not further specified unspecified essential hypertension other amyloidosis paroxysmal ventricular tachycardia atrial fibrillation difficulty in walking diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) urinary frequency hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) esophageal reflux sensorineural hearing loss, unspecified aortic valve disorders intracerebral hemorrhage iron deficiency anemia, unspecified other musculoskeletal symptoms referable to limbs unspecified cerebrovascular disease unspecified hereditary and idiopathic peripheral neuropathy disturbance of skin sensation other and unspecified hyperlipidemia unspecified glaucoma personal history of other malignant neoplasm of skin paroxysmal ventricular tachycardia sensorineural hearing loss, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled
white m 84 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; metoprolol succinate xl  100  mg ; metolazone  5  mg ; furosemide  80  mg ; warfarin  5  mg ; 
 
white m 84 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  166  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood glucose  152  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; metoprolol succinate xl  100  mg ; metolazone  5  mg ; furosemide  80  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2  mg ; hydralazine  5  mg ; nitroglycerin sl  0.3  mg ; pantoprazole  40  mg ; 
 
white m 84 $nan$hematology blood hematocrit  37.2  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  119  mg dl$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; metoprolol succinate xl  100  mg ; metolazone  5  mg ; furosemide  80  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2  mg ; hydralazine  5  mg ; nitroglycerin sl  0.3  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  250  ml ; 
 
white m 84 $nan$nan$aspirin  325  mg ; atorvastatin  80  mg ; lisinopril  20  mg ; metoprolol succinate xl  100  mg ; warfarin  5  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; nitroglycerin sl  0.3  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  250  ml ; 
 
white m 55 $temp  99.0  heartrate  70.0  resprate  16.0  o2sat  99.0  sbp  110.0  dbp  82.0  rhythm    pain  8  ; temp  97.9  heartrate  56.0  resprate  14.0  o2sat  99.0  sbp  105.0  dbp  65.0  rhythm    pain  3  $hematology blood hematocrit  37.3  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  229  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood glucose  108  mg dl$nan
 
white m 55 $nan$hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  212  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  104  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; methadone  20  mg ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; potassium chloride  20  meq ; ibuprofen  400  mg ; trazodone  50  mg ; 
 
white m 55 $nan$hematology blood hematocrit  35.3  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  196  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; methadone  20  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; potassium chloride  20  meq ; ibuprofen  400  mg ; trazodone  50  mg ; risperidone  0.5  mg ; 
 
white m 55 $nan$hematology blood hematocrit  37.0  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  225  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  90  mg dl; chemistry blood albumin  3.3  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; risperidone  0.5  mg ; potassium chloride  40  meq ; tramadol  25  mg ; 
 
white m 55 $nan$hematology blood hematocrit  37.5  %; hematology blood hemoglobin  13.5  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  100  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; risperidone  0.5  mg ; potassium chloride  40  meq ; tramadol  25  mg ; 0.9% sodium chloride  250  ml ; thiamine  250  mg ; 
 
white m 55 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  13.9  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; risperidone  0.5  mg ; tramadol  25  mg ; multivitamins w minerals  1  tab ; folic acid  1  mg ; thiamine  500  mg ; acetaminophen  500-1000  mg ; 
 
white m 55 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; loperamide  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; risperidone  0.5  mg ; tramadol  25  mg ; multivitamins w minerals  1  tab ; folic acid  1  mg ; thiamine  500  mg ; acetaminophen  500-1000  mg ; 
 
white m 55 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; loperamide  2  mg ; ondansetron  4  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; diphenhydramine  12.5  mg ; risperidone  0.5  mg ; tramadol  25  mg ; multivitamins w minerals  1  tab ; folic acid  1  mg ; thiamine  500  mg ; risperidone  4  mg ; 
 
white m 52 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  525  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  124  mg dl; chemistry blood % hemoglobin a1c  6.1  %$hydromorphone (dilaudid)  0.5  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; 0.45% sodium chloride  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; iso-osmotic dextrose  200  ml ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; 
 
white m 52 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  495  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  107  mg dl$hydromorphone (dilaudid)  0.5  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; iso-osmotic dextrose  200  ml ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; d5 1 2ns  1000  ml ; 
 
white m 52 $nan$hematology blood hematocrit  26.0  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  502  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  102  mg dl$influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; iso-osmotic dextrose  200  ml ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; d5 1 2ns  1000  ml ; 5% dextrose  250  ml ; vancomycin  750  mg ; 
 
white m 52 $nan$nan$influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; 5% dextrose  250  ml ; vancomycin  750  mg ; 
 
white m 52 $nan$hematology blood hematocrit  25.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  460  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  188  mg dl$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; 5% dextrose  250  ml ; vancomycin  750  mg ; senna  1  tab ; bisacodyl  10  mg ; 
 
white m 52 $nan$hematology blood hematocrit  26.6  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  484  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  192  mg dl$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; hydromorphone (dilaudid)  2-4  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; 
 
white m 52 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  528  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  149  mg dl$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; 
 
white m 52 $nan$nan$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5-1  mg ; polyethylene glycol  17  g ; 
 
white m 52 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  190  mg dl$vancomycin  1000  mg ; influenza virus vaccine  0.5  ml ; insulin  0  unit ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  5000  unit ; amlodipine  10  mg ; amitriptyline  25  mg ; gabapentin  800  mg ; furosemide  80  mg ; clonidine  0.1  mg ; pantoprazole  40  mg ; aspirin  81  mg ; docusate sodium  100  mg ; ferrous sulfate  325  mg ; pravastatin  20  mg ; metoprolol succinate xl  25  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; insulin  32  unit ; senna  1  tab ; bisacodyl  10  mg ; acetaminophen  325-650  mg ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  0.5-1  mg ; polyethylene glycol  17  g ; sulfameth trimethoprim ds  1  tab ; 
 
white f 87 $nan$nan$fluticasone propionate nasal  1  spry ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$hematology blood hematocrit  32.1  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  21  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  78  mg dl; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  1.0  ; chemistry urine creatinine, urine  81  mg dl; chemistry urine potassium, urine  37  meq l; chemistry urine sodium, urine  46  meq l; hematology urine wbc  14  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  4.0  g dl$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  1000  ml ; furosemide  20  mg ; hydralazine  10  mg ; calcium carbonate  500  mg ; furosemide  40  mg ; amlodipine  10  mg ; vitamin d  2000  unit ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  28.7  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  206  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  67  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  105  mg dl$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; hydralazine  10  mg ; calcium carbonate  500  mg ; vitamin d  2000  unit ; albuterol 0.083% neb soln  1  neb ; d5w  250  ml ; nitroglycerin  100  mg ; atenolol  50  mg ; clindamycin  150  mg ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$hematology blood hematocrit  24.9  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  87  mg dl$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; calcium carbonate  500  mg ; vitamin d  2000  unit ; albuterol 0.083% neb soln  1  neb ; atenolol  50  mg ; clindamycin  150  mg ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  173  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  63  mg dl; chemistry blood glucose  85  mg dl$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; calcium carbonate  500  mg ; vitamin d  2000  unit ; albuterol 0.083% neb soln  1  neb ; atenolol  50  mg ; prednisone  5  mg ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$hematology blood hematocrit  27.1  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  222  k ul; chemistry blood anion gap  26  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  65  mg dl$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; calcium carbonate  500  mg ; vitamin d  2000  unit ; albuterol 0.083% neb soln  1  neb ; atenolol  50  mg ; prednisone  5  mg ; furosemide  60  mg ; atenolol  75  mg ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white f 87 $nan$nan$fluticasone propionate nasal  1  spry ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; heparin  5000  unit ; simethicone  40-80  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; calcium carbonate  500  mg ; vitamin d  2000  unit ; albuterol 0.083% neb soln  1  neb ; furosemide  60  mg ; atenolol  75  mg ; 
arthropathy, unspecified, site unspecified anemia, unspecified nephritis and nephropathy, not specified as acute or chronic, with unspecified pathological lesion in kidney unspecified glaucoma unspecified essential hypertension acute kidney failure with other specified pathological lesion in kidney osteoarthrosis, localized, not specified whether primary or secondary, lower leg lyme disease unspecified essential hypertension osteoporosis, unspecified other and unspecified hyperlipidemia 
white m 78 $nan$nan$aspirin  81  mg ; levofloxacin  750  mg ; 
 
white m 78 $nan$hematology blood hematocrit  37.7  %; hematology blood hematocrit  33.3  %; hematology blood hematocrit  37.1  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  163  k ul; hematology blood platelet count  146  k ul; hematology blood platelet count  187  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  255  iu l; blood gas blood lactate  1.5  mmol l$senna  1  tab ; aspirin  81  mg ; levofloxacin  750  mg ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; ipratropium bromide neb  1  neb ; methylprednisolone sodium succ  125  mg ; dextrose 5%  150  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  g ; 0.9% sodium chloride  500  ml ; docusate sodium (liquid)  100  mg ; heparin  5000  unit ; timolol maleate 0.5%  1  drop ; prednisone  60  mg ; aspirin  325  mg ; cyanocobalamin  250  mcg ; atorvastatin  10  mg ; albuterol 0.083% neb soln  1  neb ; 
 
white m 78 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  180  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  154  mg dl$senna  1  tab ; levofloxacin  750  mg ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; ipratropium bromide neb  1  neb ; 0.9% sodium chloride  500  ml ; docusate sodium (liquid)  100  mg ; timolol maleate 0.5%  1  drop ; prednisone  60  mg ; aspirin  325  mg ; cyanocobalamin  250  mcg ; atorvastatin  10  mg ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  40  meq ; diltiazem extended-release  120  mg ; 
 
white m 78 $nan$hematology blood hematocrit  36.8  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  203  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  36  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  97  mg dl$senna  1  tab ; levofloxacin  750  mg ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; ipratropium bromide neb  1  neb ; docusate sodium (liquid)  100  mg ; prednisone  60  mg ; aspirin  325  mg ; cyanocobalamin  250  mcg ; atorvastatin  10  mg ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; potassium chloride  40  meq ; diltiazem extended-release  120  mg ; latanoprost 0.005% ophth. soln.  1  drop ; 0.9% sodium chloride  1000  ml ; diltiazem extended-release  180  mg ; tiotropium bromide  1  cap ; diltiazem  30  mg ; albuterol inhaler  1-2  puff ; 
 
white m 78 $nan$nan$senna  1  tab ; levofloxacin  750  mg ; bisacodyl  10  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; pantoprazole  40  mg ; ipratropium bromide neb  1  neb ; docusate sodium (liquid)  100  mg ; prednisone  60  mg ; aspirin  325  mg ; cyanocobalamin  250  mcg ; atorvastatin  10  mg ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; latanoprost 0.005% ophth. soln.  1  drop ; 0.9% sodium chloride  1000  ml ; diltiazem extended-release  180  mg ; tiotropium bromide  1  cap ; diltiazem  30  mg ; albuterol inhaler  1-2  puff ; guaifenesin-dextromethorphan  5  ml ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
white m 20 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; acetaminophen  650  mg ; oxycodone (immediate release)   10  mg ; hydromorphone (dilaudid)  0.25  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5  mg ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
white m 20 $nan$nan$sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   10  mg ; ondansetron  4  mg ; docusate sodium  100  mg ; heparin  5000  unit ; acetaminophen  1000  mg ; hydromorphone (dilaudid)  2-4  mg ; 
 
other f 36 $temp    heartrate  110.0  resprate  18.0  o2sat  100.0  sbp  189.0  dbp  110.0  rhythm    pain  0  ; temp    heartrate  128.0  resprate  16.0  o2sat  100.0  sbp  160.0  dbp  104.0  rhythm  sinus tachycardia  pain  0  ; temp    heartrate  112.0  resprate  14.0  o2sat  100.0  sbp  150.0  dbp  99.0  rhythm    pain  0  ; temp  98.4  heartrate  122.0  resprate  18.0  o2sat    sbp  153.0  dbp  94.0  rhythm  normal sinus rhythm  pain  0 10  ; temp    heartrate  140.0  resprate  18.0  o2sat  100.0  sbp  161.0  dbp  89.0  rhythm  normal sinus rhythm  pain    ; temp    heartrate  111.0  resprate  18.0  o2sat  99.0  sbp  153.0  dbp  99.0  rhythm  normal sinus rhythm  pain  0 10  $hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  108  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  1-2  puff ; diazepam  10  mg ; clonidine  0.1  mg ; diazepam  5  mg ; heparin  5000  unit ; hydrochlorothiazide  25  mg ; paroxetine  40  mg ; fluticasone propionate nasal  1  spry ; 
 
other f 36 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; albuterol inhaler  1-2  puff ; diazepam  10  mg ; clonidine  0.1  mg ; diazepam  5  mg ; heparin  5000  unit ; hydrochlorothiazide  25  mg ; paroxetine  40  mg ; fluticasone propionate nasal  1  spry ; 
 
other m 54 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  159  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.3  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  127  mg dl$sodium chloride 0.9%  flush  3  ml ; levetiracetam  1000  mg ; ondansetron  4  mg ; omeprazole  40  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; lorazepam  1  mg ; dexamethasone  4  mg ; lorazepam  2  mg ; 0.9% sodium chloride  100  ml ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  11.1  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  153  mg dl; chemistry blood albumin  4.0  g dl$sodium chloride 0.9%  flush  3  ml ; ondansetron  4  mg ; omeprazole  40  mg ; acetaminophen  650  mg ; ondansetron  4-8  mg ; lorazepam  2  mg ; 0.9% sodium chloride  100  ml ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; chlorpromazine  25  mg ; acetaminophen iv  1000  mg ; chlorpromazine  25-50  mg ; levetiracetam oral solution  2000  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; acetaminophen iv  1000  mg ; chlorpromazine  25-50  mg ; levetiracetam oral solution  2000  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  128  iu l$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$hematology blood hematocrit  34.3  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  183  k ul$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
other m 54 $nan$nan$sodium chloride 0.9%  flush  3  ml ; lorazepam  2  mg ; levetiracetam oral solution  1500  mg ; enoxaparin sodium  40  mg ; acetaminophen (liquid)  650  mg ; oxycodone (immediate release)  5-10  mg ; senna  8.6  mg ; bisacodyl  10  mg ; polyethylene glycol  17  g ; dexamethasone  8  mg ; sulfameth trimethoprim ss  1  tab ; protonix (granules for dr suspension)  40  mg ; 
candidal stomatitis adverse effect of glucocorticoids and synthetic analogues, initial encounter elevated white blood cell count, unspecified orthostatic hypotension malignant neoplasm of upper lobe, left bronchus or lung cerebral edema unspecified convulsions gastro-esophageal reflux disease without esophagitis personal history of nicotine dependence unspecified place in hospital as the place of occurrence of the external cause secondary malignant neoplasm of brain compression of brain other problems related to lifestyle secondary malignant neoplasm of brain allergic rhinitis, unspecified nontraumatic intracerebral hemorrhage, multiple localized malignant neoplasm of upper lobe, left bronchus or lung cerebral edema major depressive disorder, single episode, unspecified personal history of nicotine dependence elevated white blood cell count, unspecified orthostatic hypotension
white f 91 $temp  98.7  heartrate  84.0  resprate  14.0  o2sat  95.0  sbp  116.0  dbp  76.0  rhythm    pain  0  $hematology blood hematocrit  32.8  %; hematology blood hematocrit  34.2  %; hematology blood hematocrit  26.6  %; hematology blood hematocrit  31.3  %; hematology blood hematocrit  30.9  %; hematology blood hemoglobin  11.0  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  193  k ul; hematology blood platelet count  194  k ul; hematology blood platelet count  168  k ul; hematology blood platelet count  169  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  144  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  500-1000  mg ; furosemide  20  mg ; amlodipine  2.5  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  12.5  mg ; acetaminophen iv  1000  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  27.5  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  9.1  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  142  k ul; hematology blood platelet count  158  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  117  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; furosemide  20  mg ; amlodipine  2.5  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  12.5  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; quetiapine fumarate  25  mg ; docusate sodium  100  mg ; senna  8.6  mg ; olanzapine (disintegrating tablet)  2.5  mg ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  26.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; furosemide  20  mg ; amlodipine  2.5  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  12.5  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  188  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  108  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; furosemide  20  mg ; amlodipine  2.5  mg ; isosorbide mononitrate (extended release)  60  mg ; metoprolol succinate xl  12.5  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; potassium chloride  20  meq ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; heparin  250-500  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  211  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  102  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  500-1000  mg ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  250-500  unit ; aspirin  81  mg ; acetaminophen  1000  mg ; tramadol  25  mg ; warfarin  5  mg ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  106  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; heparin  250-500  unit ; aspirin  81  mg ; acetaminophen  1000  mg ; tramadol  25  mg ; neutra-phos  1  pkt ; heparin  5000  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  285  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  99  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; tramadol  25  mg ; neutra-phos  1  pkt ; heparin  5000  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  311  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  94  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; tramadol  25  mg ; heparin  5000  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
white f 91 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; nitroglycerin sl  0.3  mg ; atorvastatin  10  mg ; docusate sodium  100  mg ; senna  8.6  mg ; aspirin  81  mg ; acetaminophen  1000  mg ; tramadol  25  mg ; heparin  5000  unit ; 
chest pain, unspecified personal history of pulmonary embolism other and unspecified hyperlipidemia unspecified essential hypertension
other f 68 $temp  99.6  heartrate  90.0  resprate  16.0  o2sat  100.0  sbp  114.0  dbp  74.0  rhythm    pain  0  $hematology blood hematocrit  35.7  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  161  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pravastatin  80  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  43  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; 
 
other f 68 $nan$hematology blood hematocrit  33.9  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  131  mg dl; chemistry blood glucose  163  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; pravastatin  80  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  43  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sodium chloride 0.9%  1000  ml ; doxycycline hyclate  100  mg ; 
 
other f 68 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  102  mg dl$sodium chloride 0.9%  flush  3  ml ; pravastatin  80  mg ; metoprolol tartrate  12.5  mg ; acetaminophen  500-1000  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  43  unit ; sodium chloride 0.9%  1000  ml ; doxycycline hyclate  100  mg ; 
 
white m 92 $nan$nan$modafinil  200  mg ; levothyroxine sodium  75  mcg ; simvastatin  20  mg ; aspirin  81  mg ; paroxetine  30  mg ; vitamin d  800  unit ; 
hyperpotassemia syncope and collapse hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified contusion of knee chronic kidney disease, unspecified atrial fibrillation anemia in chronic kidney disease anemia, unspecified unspecified acquired hypothyroidism dehydration fall from other slipping, tripping, or stumbling other and unspecified hyperlipidemia sprains and strains of other specified sites of knee and leg
white m 92 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  6.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  10.7  mg dl; chemistry blood calcium, total  11.2  mg dl; chemistry blood glucose  95  mg dl; chemistry blood albumin  3.8  g dl$modafinil  200  mg ; levothyroxine sodium  75  mcg ; simvastatin  20  mg ; aspirin  81  mg ; paroxetine  30  mg ; vitamin d  800  unit ; metoprolol tartrate  12.5  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; colchicine  0.6  mg ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; bag  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  500  ml ; sodium polystyrene sulfonate  30  gm ; 
hyperpotassemia syncope and collapse hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified contusion of knee chronic kidney disease, unspecified atrial fibrillation anemia in chronic kidney disease anemia, unspecified unspecified acquired hypothyroidism dehydration fall from other slipping, tripping, or stumbling other and unspecified hyperlipidemia sprains and strains of other specified sites of knee and leg
white m 92 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  136  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  10.2  mg dl; chemistry blood glucose  99  mg dl$modafinil  200  mg ; levothyroxine sodium  75  mcg ; simvastatin  20  mg ; aspirin  81  mg ; paroxetine  30  mg ; vitamin d  800  unit ; metoprolol tartrate  12.5  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; colchicine  0.6  mg ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; sodium polystyrene sulfonate  30  gm ; polyethylene glycol  17  g ; 
hyperpotassemia syncope and collapse hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified contusion of knee chronic kidney disease, unspecified atrial fibrillation anemia in chronic kidney disease anemia, unspecified unspecified acquired hypothyroidism dehydration fall from other slipping, tripping, or stumbling other and unspecified hyperlipidemia sprains and strains of other specified sites of knee and leg
white m 92 $nan$nan$modafinil  200  mg ; levothyroxine sodium  75  mcg ; simvastatin  20  mg ; aspirin  81  mg ; paroxetine  30  mg ; vitamin d  800  unit ; metoprolol tartrate  12.5  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; heparin  5000  unit ; colchicine  0.6  mg ; sodium chloride 0.9%  flush  3  ml ; amlodipine  10  mg ; polyethylene glycol  17  g ; 
hyperpotassemia syncope and collapse hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified acute kidney failure, unspecified contusion of knee chronic kidney disease, unspecified atrial fibrillation anemia in chronic kidney disease anemia, unspecified unspecified acquired hypothyroidism dehydration fall from other slipping, tripping, or stumbling other and unspecified hyperlipidemia sprains and strains of other specified sites of knee and leg
black african american f 69 $nan$nan$acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; levothyroxine sodium  75  mcg ; vitamin d  4000  unit ; triamterene  50  mg ; 
personal history of tobacco use esophageal reflux obstructive sleep apnea (adult)(pediatric) hyperparathyroidism, unspecified hypoxemia asymptomatic varicose veins person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other dependence on machines, supplemental oxygen unspecified essential hypertension unspecified acquired hypothyroidism need for prophylactic vaccination and inoculation against influenza personal history of pulmonary embolism myalgia and myositis, unspecified edema osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension myalgia and myositis, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified acquired hypothyroidism 
black african american f 69 $nan$nan$acetaminophen  650  mg ; sodium chloride 0.9%  flush  3  ml ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; morphine sulfate  2  mg ; ondansetron  4  mg ; oxycodone (immediate release)   5  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; levothyroxine sodium  75  mcg ; vitamin d  4000  unit ; triamterene  50  mg ; pantoprazole  40  mg ; heparin  5000  unit ; 
personal history of tobacco use esophageal reflux obstructive sleep apnea (adult)(pediatric) hyperparathyroidism, unspecified hypoxemia asymptomatic varicose veins person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident other dependence on machines, supplemental oxygen unspecified essential hypertension unspecified acquired hypothyroidism need for prophylactic vaccination and inoculation against influenza personal history of pulmonary embolism myalgia and myositis, unspecified edema osteoarthrosis, localized, not specified whether primary or secondary, lower leg unspecified essential hypertension myalgia and myositis, unspecified calculus of gallbladder with acute cholecystitis, without mention of obstruction unspecified acquired hypothyroidism 
unknown f 35 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  12.7  g dl; hematology blood platelet count  215  k ul$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident second-degree perineal laceration, delivered, with or without mention of antepartum condition other specified complications of pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn prolonged second stage of labor, delivered, with or without mention of antepartum condition legally induced abortion, without mention of complication, complete legally induced abortion, without mention of complication, complete 
unknown f 35 $nan$nan$docusate sodium  100  mg ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; simethicone  80  mg ; calcium carbonate  500  mg ; 
motorcycle driver injured in collision with fixed or stationary object in nontraffic accident second-degree perineal laceration, delivered, with or without mention of antepartum condition other specified complications of pregnancy, delivered, with or without mention of antepartum condition outcome of delivery, single liveborn prolonged second stage of labor, delivered, with or without mention of antepartum condition legally induced abortion, without mention of complication, complete legally induced abortion, without mention of complication, complete 
other m 77 $nan$nan$atorvastatin  40  mg ; 
 
other m 77 $nan$hematology blood hematocrit  39.2  %; hematology blood hematocrit  26.6  %; hematology blood hematocrit  33.8  %; hematology blood hemoglobin  13.5  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  179  k ul; hematology blood platelet count  113  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  87  mg dl; chemistry blood lactate dehydrogenase (ld)  206  iu l; chemistry blood albumin  4.5  g dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.71  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  2.5  mmol l; blood gas blood chloride, whole blood  106  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  101  mg dl; blood gas blood glucose  120  mg dl; blood gas blood glucose  160  mg dl; blood gas blood glucose  187  mg dl; blood gas blood glucose  152  mg dl; blood gas blood glucose  117  mg dl; blood gas blood hematocrit, calculated  36  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  28  %; blood gas blood hematocrit, calculated  25  %; blood gas blood hematocrit, calculated  27  %; blood gas blood hemoglobin  12.1  g dl; blood gas blood hemoglobin  9.4  g dl; blood gas blood hemoglobin  9.2  g dl; blood gas blood hemoglobin  8.3  g dl; blood gas blood hemoglobin  9.1  g dl; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  5.4  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  5.3  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  140  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  137  meq l; chemistry blood % hemoglobin a1c  5.9  %$atorvastatin  40  mg ; influenza virus vaccine  0.5  ml ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; clonazepam  0.5  mg ; mupirocin nasal ointment 2%  1  appl ; aspirin ec  81  mg ; aspirin  81  mg ; lactated ringers  1000  ml ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; propofol  1000  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; 
 
other m 77 $nan$hematology blood hematocrit  31.5  %; hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  118  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  111  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.12  mmol l; blood gas blood free calcium  1.19  mmol l; blood gas blood lactate  2.6  mmol l; blood gas blood lactate  2.8  mmol l; blood gas blood lactate  1.4  mmol l; blood gas blood chloride, whole blood  99  meq l; blood gas blood glucose  142  mg dl; blood gas blood glucose  158  mg dl; blood gas blood glucose  123  mg dl; blood gas blood glucose  112  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.2  g dl; blood gas blood potassium, whole blood  4.5  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood sodium, whole blood  135  meq l$aspirin ec  81  mg ; aspirin  81  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; propofol  1000  mg ; syringe  1  syr ; nitroglycerin  20  mg ; phenylephrine  60  mg ; phenylephrine  12  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; meperidine  12.5  mg ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; ranitidine  150  mg ; docusate sodium (liquid)  100  mg ; metoprolol tartrate  5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  20  mg ; metoprolol tartrate  12.5  mg ; insulin  10  unit ; warfarin  1  dose ; celebrex  200  mg ; 
 
other m 77 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  37  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  104  mg dl$aspirin ec  81  mg ; syringe  1  syr ; nitroglycerin  20  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  50  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; cefazolin  2  g ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  150  mg ; albuterol 0.083% neb soln  1  neb ; insulin  10  unit ; warfarin  1  dose ; celebrex  200  mg ; warfarin  2.5  mg ; oxycodone-acetaminophen  1-2  tab ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  40  meq ; 
 
other m 77 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  109  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  113  mg dl$insulin  10  unit ; warfarin  1  dose ; celebrex  200  mg ; glucagon  1  mg ; insulin  0  unit ; potassium chloride  40  meq ; warfarin  5  mg ; 
 
other m 77 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  103  mg dl$insulin  10  unit ; warfarin  1  dose ; celebrex  200  mg ; glucagon  1  mg ; insulin  0  unit ; warfarin  5  mg ; 
 
other m 77 $nan$nan$insulin  10  unit ; warfarin  1  dose ; celebrex  200  mg ; glucagon  1  mg ; insulin  0  unit ; 
 
white m 81 $temp  97.9  heartrate  62.0  resprate  16.0  o2sat  100.0  sbp  107.0  dbp  73.0  rhythm    pain    ; temp  98.0  heartrate  71.0  resprate  18.0  o2sat  100.0  sbp  176.0  dbp  71.0  rhythm    pain  2 10  ; temp  98.1  heartrate  82.0  resprate  16.0  o2sat  100.0  sbp  158.0  dbp  57.0  rhythm    pain  0 10  ; temp  98.3  heartrate  87.0  resprate  22.0  o2sat  100.0  sbp  162.0  dbp  56.0  rhythm    pain  0 10  ; temp  98.2  heartrate  84.0  resprate  22.0  o2sat  100.0  sbp  146.0  dbp  58.0  rhythm    pain  0 10  ; temp    heartrate  80.0  resprate  36.0  o2sat  97.0  sbp  141.0  dbp  65.0  rhythm    pain  0  ; temp    heartrate  87.0  resprate  32.0  o2sat  100.0  sbp  149.0  dbp  57.0  rhythm    pain    ; temp    heartrate  90.0  resprate  32.0  o2sat  92.0  sbp  149.0  dbp  57.0  rhythm    pain    ; temp  101.8  heartrate  90.0  resprate  33.0  o2sat  97.0  sbp  147.0  dbp  55.0  rhythm    pain    $nan$levothyroxine sodium  100  mcg ; heparin  5000  unit ; 
chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified malnutrition of mild degree portal hypertension unspecified acquired hypothyroidism other specified metabolic disorders splenomegaly anemia, unspecified acute diastolic heart failure pneumonitis due to inhalation of food or vomitus acute kidney failure, unspecified other specified disorders of metabolism other chronic pulmonary heart diseases unspecified fall unspecified cataract closed fracture of sacrum and coccyx without mention of spinal cord injury closed fracture of pubis congestive heart failure, unspecified cyclic neutropenia hypocalcemia myelofibrosis with myeloid metaplasia macular degeneration (senile), unspecified diverticulum of esophagus, acquired pressure ulcer, stage ii pneumonitis due to inhalation of food or vomitus pressure ulcer, lower back hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diverticulum of esophagus, acquired nutritional marasmus anemia in neoplastic disease thrombocytopenia, unspecified acute kidney failure, unspecified unspecified pleural effusion acute respiratory failure myelofibrosis with myeloid metaplasia other ascites other chronic pulmonary heart diseases myelofibrosis with myeloid metaplasia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pneumonitis due to inhalation of food or vomitus congestive heart failure, unspecified other specified disorders of liver chronic diastolic heart failure urinary tract infection, site not specified diverticulum of esophagus, acquired bacteremia hyperosmolality and/or hypernatremia 
white m 81 $temp  102.0  heartrate  90.0  resprate  33.0  o2sat  95.0  sbp  153.0  dbp  60.0  rhythm    pain    $hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  329  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  106  mg dl; chemistry blood lactate dehydrogenase (ld)  382  iu l; blood gas blood lactate  0.7  mmol l$levothyroxine sodium  100  mcg ; heparin  5000  unit ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; 5% dextrose  250  ml ; azithromycin   500  mg ; azithromycin   250  mg ; 
chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified malnutrition of mild degree portal hypertension unspecified acquired hypothyroidism other specified metabolic disorders splenomegaly anemia, unspecified acute diastolic heart failure pneumonitis due to inhalation of food or vomitus acute kidney failure, unspecified other specified disorders of metabolism other chronic pulmonary heart diseases unspecified fall unspecified cataract closed fracture of sacrum and coccyx without mention of spinal cord injury closed fracture of pubis congestive heart failure, unspecified cyclic neutropenia hypocalcemia myelofibrosis with myeloid metaplasia macular degeneration (senile), unspecified diverticulum of esophagus, acquired pressure ulcer, stage ii pneumonitis due to inhalation of food or vomitus pressure ulcer, lower back hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diverticulum of esophagus, acquired nutritional marasmus anemia in neoplastic disease thrombocytopenia, unspecified acute kidney failure, unspecified unspecified pleural effusion acute respiratory failure myelofibrosis with myeloid metaplasia other ascites other chronic pulmonary heart diseases myelofibrosis with myeloid metaplasia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pneumonitis due to inhalation of food or vomitus congestive heart failure, unspecified other specified disorders of liver chronic diastolic heart failure urinary tract infection, site not specified diverticulum of esophagus, acquired bacteremia hyperosmolality and/or hypernatremia 
white m 81 $nan$hematology blood hematocrit  21.7  %; hematology blood hematocrit  20.7  %; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  6.3  g dl; hematology blood platelet count  331  k ul; hematology blood platelet count  296  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  104  mg dl$levothyroxine sodium  100  mcg ; heparin  5000  unit ; lidocaine jelly 2% (urojet)  1  appl ; bisacodyl  10  mg ; senna  1  tab ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  1.5  g ; 5% dextrose  250  ml ; azithromycin   500  mg ; azithromycin   250  mg ; sodium chloride 0.9%  flush  3  ml ; azithromycin  250  mg ; acetaminophen  650  mg ; clindamycin  450  mg ; cephalexin  500  mg ; furosemide  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; amoxicillin-clavulanic acid  500  mg ; 
chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified malnutrition of mild degree portal hypertension unspecified acquired hypothyroidism other specified metabolic disorders splenomegaly anemia, unspecified acute diastolic heart failure pneumonitis due to inhalation of food or vomitus acute kidney failure, unspecified other specified disorders of metabolism other chronic pulmonary heart diseases unspecified fall unspecified cataract closed fracture of sacrum and coccyx without mention of spinal cord injury closed fracture of pubis congestive heart failure, unspecified cyclic neutropenia hypocalcemia myelofibrosis with myeloid metaplasia macular degeneration (senile), unspecified diverticulum of esophagus, acquired pressure ulcer, stage ii pneumonitis due to inhalation of food or vomitus pressure ulcer, lower back hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diverticulum of esophagus, acquired nutritional marasmus anemia in neoplastic disease thrombocytopenia, unspecified acute kidney failure, unspecified unspecified pleural effusion acute respiratory failure myelofibrosis with myeloid metaplasia other ascites other chronic pulmonary heart diseases myelofibrosis with myeloid metaplasia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pneumonitis due to inhalation of food or vomitus congestive heart failure, unspecified other specified disorders of liver chronic diastolic heart failure urinary tract infection, site not specified diverticulum of esophagus, acquired bacteremia hyperosmolality and/or hypernatremia 
white m 81 $nan$hematology blood hematocrit  24.9  %; hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  44  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  91  mg dl$levothyroxine sodium  100  mcg ; heparin  5000  unit ; bisacodyl  10  mg ; senna  1  tab ; azithromycin   250  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; furosemide  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; amoxicillin-clavulanic acid  500  mg ; sodium chloride nasal  1-2  spry ; nystatin oral suspension  5  ml ; acetaminophen  1000  mg ; 
chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified malnutrition of mild degree portal hypertension unspecified acquired hypothyroidism other specified metabolic disorders splenomegaly anemia, unspecified acute diastolic heart failure pneumonitis due to inhalation of food or vomitus acute kidney failure, unspecified other specified disorders of metabolism other chronic pulmonary heart diseases unspecified fall unspecified cataract closed fracture of sacrum and coccyx without mention of spinal cord injury closed fracture of pubis congestive heart failure, unspecified cyclic neutropenia hypocalcemia myelofibrosis with myeloid metaplasia macular degeneration (senile), unspecified diverticulum of esophagus, acquired pressure ulcer, stage ii pneumonitis due to inhalation of food or vomitus pressure ulcer, lower back hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diverticulum of esophagus, acquired nutritional marasmus anemia in neoplastic disease thrombocytopenia, unspecified acute kidney failure, unspecified unspecified pleural effusion acute respiratory failure myelofibrosis with myeloid metaplasia other ascites other chronic pulmonary heart diseases myelofibrosis with myeloid metaplasia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pneumonitis due to inhalation of food or vomitus congestive heart failure, unspecified other specified disorders of liver chronic diastolic heart failure urinary tract infection, site not specified diverticulum of esophagus, acquired bacteremia hyperosmolality and/or hypernatremia 
white m 81 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  48  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  82  mg dl$levothyroxine sodium  100  mcg ; heparin  5000  unit ; bisacodyl  10  mg ; senna  1  tab ; sodium chloride 0.9%  flush  3  ml ; furosemide  20  mg ; folic acid  1  mg ; cyanocobalamin  1000  mcg ; amoxicillin-clavulanic acid  500  mg ; sodium chloride nasal  1-2  spry ; nystatin oral suspension  5  ml ; acetaminophen  1000  mg ; calcium carbonate  500  mg ; 
chronic kidney disease, stage iii (moderate) depressive disorder, not elsewhere classified malnutrition of mild degree portal hypertension unspecified acquired hypothyroidism other specified metabolic disorders splenomegaly anemia, unspecified acute diastolic heart failure pneumonitis due to inhalation of food or vomitus acute kidney failure, unspecified other specified disorders of metabolism other chronic pulmonary heart diseases unspecified fall unspecified cataract closed fracture of sacrum and coccyx without mention of spinal cord injury closed fracture of pubis congestive heart failure, unspecified cyclic neutropenia hypocalcemia myelofibrosis with myeloid metaplasia macular degeneration (senile), unspecified diverticulum of esophagus, acquired pressure ulcer, stage ii pneumonitis due to inhalation of food or vomitus pressure ulcer, lower back hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) diverticulum of esophagus, acquired nutritional marasmus anemia in neoplastic disease thrombocytopenia, unspecified acute kidney failure, unspecified unspecified pleural effusion acute respiratory failure myelofibrosis with myeloid metaplasia other ascites other chronic pulmonary heart diseases myelofibrosis with myeloid metaplasia hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) pneumonitis due to inhalation of food or vomitus congestive heart failure, unspecified other specified disorders of liver chronic diastolic heart failure urinary tract infection, site not specified diverticulum of esophagus, acquired bacteremia hyperosmolality and/or hypernatremia 
white m 35 $nan$nan$insulin  14  unit ; 
depressive disorder, not elsewhere classified suicidal ideation anemia, unspecified hyperpotassemia other specified disorders of skin accidental poisoning by other opiates and related narcotics opioid type dependence, continuous other, mixed, or unspecified drug abuse, unspecified poisoning by opium (alkaloids), unspecified amphetamine or related acting sympathomimetic abuse, unspecified hyposmolality and/or hyponatremia cocaine abuse, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 35 $temp  98.6  heartrate  61.0  resprate  16.0  o2sat  97.0  sbp  101.0  dbp  55.0  rhythm    pain  0  ; temp  97.8  heartrate  76.0  resprate  16.0  o2sat  100.0  sbp  119.0  dbp  76.0  rhythm    pain    $chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood glucose  411  mg dl$insulin  14  unit ; insulin  33  unit ; insulin  15  unit ; insulin  5  unit ; insulin  0  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; diazepam  10  mg ; diazepam  15  mg ; acetaminophen  650  mg ; clonidine  0.1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; methocarbamol  750  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; loperamide  2  mg ; lorazepam  1  mg ; ondansetron  4  mg ; ibuprofen  400  mg ; gabapentin  600  mg ; docusate sodium  100  mg ; heparin  5000  unit ; phenylephrine  0.5% nasal spray  2  spry ; 
depressive disorder, not elsewhere classified suicidal ideation anemia, unspecified hyperpotassemia other specified disorders of skin accidental poisoning by other opiates and related narcotics opioid type dependence, continuous other, mixed, or unspecified drug abuse, unspecified poisoning by opium (alkaloids), unspecified amphetamine or related acting sympathomimetic abuse, unspecified hyposmolality and/or hyponatremia cocaine abuse, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 35 $nan$nan$0.9% sodium chloride  1000  ml ; senna  1  tab ; methocarbamol  750  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; loperamide  2  mg ; lorazepam  1  mg ; ondansetron  4  mg ; ibuprofen  400  mg ; gabapentin  600  mg ; docusate sodium  100  mg ; heparin  5000  unit ; phenylephrine  0.5% nasal spray  2  spry ; insulin  30  unit ; 
depressive disorder, not elsewhere classified suicidal ideation anemia, unspecified hyperpotassemia other specified disorders of skin accidental poisoning by other opiates and related narcotics opioid type dependence, continuous other, mixed, or unspecified drug abuse, unspecified poisoning by opium (alkaloids), unspecified amphetamine or related acting sympathomimetic abuse, unspecified hyposmolality and/or hyponatremia cocaine abuse, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 35 $nan$nan$senna  1  tab ; methocarbamol  750  mg ; dicyclomine  20  mg ; hydroxyzine  50  mg ; loperamide  2  mg ; lorazepam  1  mg ; ondansetron  4  mg ; ibuprofen  400  mg ; gabapentin  600  mg ; docusate sodium  100  mg ; heparin  5000  unit ; phenylephrine  0.5% nasal spray  2  spry ; insulin  30  unit ; 
depressive disorder, not elsewhere classified suicidal ideation anemia, unspecified hyperpotassemia other specified disorders of skin accidental poisoning by other opiates and related narcotics opioid type dependence, continuous other, mixed, or unspecified drug abuse, unspecified poisoning by opium (alkaloids), unspecified amphetamine or related acting sympathomimetic abuse, unspecified hyposmolality and/or hyponatremia cocaine abuse, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$nan$amlodipine  10  mg ; lisinopril  40  mg ; glyburide  5  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$hematology blood hematocrit  33.7  %; hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  569  k ul; hematology blood platelet count  522  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood urea nitrogen  4  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  158  mg dl; chemistry blood glucose  144  mg dl; blood gas blood hematocrit, calculated  29  %; blood gas blood hemoglobin  9.5  g dl$amlodipine  10  mg ; lisinopril  40  mg ; glyburide  5  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; heparin  5000  unit ; metformin (glucophage)  1000  mg ; bupropion (sustained release)  150  mg ; oxycodone-acetaminophen  1-2  tab ; sw  50  ml ; magnesium sulfate  2  gm ; aspirin  325  mg ; simvastatin  20  mg ; morphine sulfate  50  mg ; lr  1000  ml ; metoprolol tartrate  5  mg ; insulin  0  unit ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  483  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  4  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  100  mg dl$amlodipine  10  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; aspirin  325  mg ; simvastatin  20  mg ; morphine sulfate  50  mg ; lr  1000  ml ; metoprolol tartrate  5  mg ; insulin  0  unit ; docusate sodium  100  mg ; hydromorphone (dilaudid)  12.5  mg ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2-4  mg ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$hematology blood hematocrit  34.6  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  607  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood glucose  117  mg dl$amlodipine  10  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; aspirin  325  mg ; simvastatin  20  mg ; lr  1000  ml ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; bisacodyl  10  mg ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; cepacol (menthol)  1  loz ; phenaseptic throat spray  1  spry ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  556  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.4  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood glucose  219  mg dl$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; amlodipine  10  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; d5w  200  ml ; ciprofloxacin iv  400  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; aspirin  325  mg ; simvastatin  20  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; cepacol (menthol)  1  loz ; phenaseptic throat spray  1  spry ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$nan$amlodipine  10  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; aspirin  325  mg ; simvastatin  20  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; cepacol (menthol)  1  loz ; phenaseptic throat spray  1  spry ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
black african american m 59 $nan$nan$amlodipine  10  mg ; lisinopril  40  mg ; sodium chloride 0.9%  flush  3  ml ; lorazepam  0.5-2  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; bupropion (sustained release)  150  mg ; aspirin  325  mg ; simvastatin  20  mg ; insulin  0  unit ; docusate sodium  100  mg ; senna  1  tab ; hydromorphone (dilaudid)  2-4  mg ; metoprolol tartrate  12.5  mg ; cepacol (menthol)  1  loz ; phenaseptic throat spray  1  spry ; 
diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes atherosclerosis of native arteries of the extremities with gangrene unspecified essential hypertension unspecified glaucoma atherosclerosis of native arteries of the extremities with gangrene hematoma complicating a procedure pressure ulcer, other site tobacco use disorder diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension arterial embolism and thrombosis of lower extremity surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation unspecified essential hypertension ulcer of other part of foot atherosclerosis of native arteries of the extremities with gangrene diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white m 75 $temp    heartrate  72.0  resprate  17.0  o2sat  96.0  sbp  130.0  dbp  54.0  rhythm    pain  5  ; temp    heartrate  63.0  resprate  16.0  o2sat  95.0  sbp  146.0  dbp  83.0  rhythm    pain  5  ; temp    heartrate  65.0  resprate  16.0  o2sat  99.0  sbp  145.0  dbp  85.0  rhythm    pain  3  ; temp    heartrate  58.0  resprate  18.0  o2sat  99.0  sbp  125.0  dbp  59.0  rhythm    pain  3  ; temp    heartrate  87.0  resprate  18.0  o2sat  97.0  sbp  119.0  dbp  61.0  rhythm    pain  asleep  ; temp    heartrate  56.0  resprate  18.0  o2sat  99.0  sbp  122.0  dbp  59.0  rhythm    pain  asleep  ; temp    heartrate  59.0  resprate  18.0  o2sat  98.0  sbp  124.0  dbp  62.0  rhythm    pain  asleep  ; temp    heartrate  94.0  resprate  18.0  o2sat  98.0  sbp  121.0  dbp  58.0  rhythm    pain  asleep  ; temp    heartrate  78.0  resprate  18.0  o2sat  99.0  sbp  130.0  dbp  58.0  rhythm    pain    ; temp    heartrate  58.0  resprate  19.0  o2sat  99.0  sbp  128.0  dbp  60.0  rhythm    pain  asleep  ; temp  98.9  heartrate  59.0  resprate  20.0  o2sat  99.0  sbp  110.0  dbp  56.0  rhythm    pain  3  ; temp    heartrate  65.0  resprate  23.0  o2sat  99.0  sbp  143.0  dbp  70.0  rhythm    pain    ; temp    heartrate  67.0  resprate  21.0  o2sat  99.0  sbp  135.0  dbp  75.0  rhythm    pain  asleep  ; temp    heartrate  81.0  resprate  19.0  o2sat  99.0  sbp  145.0  dbp  69.0  rhythm    pain  asleep  ; temp    heartrate  71.0  resprate  24.0  o2sat  98.0  sbp  128.0  dbp  66.0  rhythm    pain  asleep  ; temp    heartrate  59.0  resprate  25.0  o2sat  97.0  sbp  144.0  dbp  60.0  rhythm    pain  asleep  ; temp    heartrate  62.0  resprate  23.0  o2sat  98.0  sbp  147.0  dbp  64.0  rhythm    pain  asleep  $hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  80  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  3.0  ; hematology blood inr(pt)  1.2  ; chemistry blood glucose  145  mg dl; hematology blood bands  0  %$nan
chronic lymphoid leukemia, without mention of having achieved remission atrial fibrillation unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hypogammaglobulinemia, unspecified chronic systolic heart failure hyposmolality and/or hyponatremia urinary tract infection, site not specified acute kidney failure, unspecified long-term (current) use of anticoagulants congestive heart failure, unspecified chronic lymphoid leukemia, without mention of having achieved remission knee joint replacement hypogammaglobulinemia, unspecified acute on chronic systolic heart failure long-term (current) use of anticoagulants pneumonia, organism unspecified unspecified pleural effusion hypopotassemia congestive heart failure, unspecified acute kidney failure, unspecified unspecified essential hypertension atrial fibrillation other abnormal blood chemistry atrial fibrillation mitral valve disorders acute kidney failure, unspecified pneumonia, organism unspecified chronic lymphoid leukemia, in relapse hypopotassemia unspecified essential hypertension chronic systolic heart failure long-term (current) use of anticoagulants congestive heart failure, unspecified disorders of phosphorus metabolism hypogammaglobulinemia, unspecified other primary cardiomyopathies other and unspecified special symptoms or syndromes, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract family history of malignant neoplasm of trachea, bronchus, and lung acute kidney failure, unspecified hypotension, unspecified dermatophytosis of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) acute on chronic systolic heart failure hypogammaglobulinemia, unspecified
white m 75 $temp  99.4  heartrate  65.0  resprate  22.0  o2sat  100.0  sbp  138.0  dbp  62.0  rhythm  atrial fibrillation  pain  0  $hematology blood hematocrit  31.1  %; hematology blood hematocrit  31.2  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  67  k ul; hematology blood platelet count  69  k ul; hematology blood platelet count  92  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  19  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.2  ; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.8  mg dl; chemistry blood glucose  138  mg dl; chemistry blood albumin  4.2  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; prochlorperazine  5-10  mg ; multivitamins  1  tab ; lorazepam  1-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; alprazolam  0.25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; citalopram  10  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; furosemide  60  mg ; furosemide  40  mg ; glipizide xl  2.5  mg ; lisinopril  5  mg ; metoprolol succinate xl  200  mg ; simvastatin  20  mg ; terazosin  2  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission atrial fibrillation unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hypogammaglobulinemia, unspecified chronic systolic heart failure hyposmolality and/or hyponatremia urinary tract infection, site not specified acute kidney failure, unspecified long-term (current) use of anticoagulants congestive heart failure, unspecified chronic lymphoid leukemia, without mention of having achieved remission knee joint replacement hypogammaglobulinemia, unspecified acute on chronic systolic heart failure long-term (current) use of anticoagulants pneumonia, organism unspecified unspecified pleural effusion hypopotassemia congestive heart failure, unspecified acute kidney failure, unspecified unspecified essential hypertension atrial fibrillation other abnormal blood chemistry atrial fibrillation mitral valve disorders acute kidney failure, unspecified pneumonia, organism unspecified chronic lymphoid leukemia, in relapse hypopotassemia unspecified essential hypertension chronic systolic heart failure long-term (current) use of anticoagulants congestive heart failure, unspecified disorders of phosphorus metabolism hypogammaglobulinemia, unspecified other primary cardiomyopathies other and unspecified special symptoms or syndromes, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract family history of malignant neoplasm of trachea, bronchus, and lung acute kidney failure, unspecified hypotension, unspecified dermatophytosis of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) acute on chronic systolic heart failure hypogammaglobulinemia, unspecified
white m 75 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  73  k ul; hematology blood platelet count  83  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  21  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  123  mg dl$sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  100  ml ; levetiracetam  1500  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; prochlorperazine  5-10  mg ; multivitamins  1  tab ; lorazepam  1-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; alprazolam  0.25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; citalopram  10  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; furosemide  60  mg ; furosemide  40  mg ; glipizide xl  2.5  mg ; lisinopril  5  mg ; metoprolol succinate xl  200  mg ; simvastatin  20  mg ; terazosin  2  mg ; oxycodone (immediate release)   5  mg ; levetiracetam  2000  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission atrial fibrillation unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hypogammaglobulinemia, unspecified chronic systolic heart failure hyposmolality and/or hyponatremia urinary tract infection, site not specified acute kidney failure, unspecified long-term (current) use of anticoagulants congestive heart failure, unspecified chronic lymphoid leukemia, without mention of having achieved remission knee joint replacement hypogammaglobulinemia, unspecified acute on chronic systolic heart failure long-term (current) use of anticoagulants pneumonia, organism unspecified unspecified pleural effusion hypopotassemia congestive heart failure, unspecified acute kidney failure, unspecified unspecified essential hypertension atrial fibrillation other abnormal blood chemistry atrial fibrillation mitral valve disorders acute kidney failure, unspecified pneumonia, organism unspecified chronic lymphoid leukemia, in relapse hypopotassemia unspecified essential hypertension chronic systolic heart failure long-term (current) use of anticoagulants congestive heart failure, unspecified disorders of phosphorus metabolism hypogammaglobulinemia, unspecified other primary cardiomyopathies other and unspecified special symptoms or syndromes, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract family history of malignant neoplasm of trachea, bronchus, and lung acute kidney failure, unspecified hypotension, unspecified dermatophytosis of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) acute on chronic systolic heart failure hypogammaglobulinemia, unspecified
white m 75 $nan$hematology blood hematocrit  32.4  %; hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  78  k ul; hematology blood platelet count  78  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  121  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; prochlorperazine  5-10  mg ; multivitamins  1  tab ; lorazepam  1-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; alprazolam  0.25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; citalopram  10  mg ; digoxin  0.125  mg ; diltiazem extended-release  240  mg ; furosemide  60  mg ; furosemide  40  mg ; glipizide xl  2.5  mg ; lisinopril  5  mg ; simvastatin  20  mg ; terazosin  2  mg ; oxycodone (immediate release)   5  mg ; levetiracetam  2000  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission atrial fibrillation unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hypogammaglobulinemia, unspecified chronic systolic heart failure hyposmolality and/or hyponatremia urinary tract infection, site not specified acute kidney failure, unspecified long-term (current) use of anticoagulants congestive heart failure, unspecified chronic lymphoid leukemia, without mention of having achieved remission knee joint replacement hypogammaglobulinemia, unspecified acute on chronic systolic heart failure long-term (current) use of anticoagulants pneumonia, organism unspecified unspecified pleural effusion hypopotassemia congestive heart failure, unspecified acute kidney failure, unspecified unspecified essential hypertension atrial fibrillation other abnormal blood chemistry atrial fibrillation mitral valve disorders acute kidney failure, unspecified pneumonia, organism unspecified chronic lymphoid leukemia, in relapse hypopotassemia unspecified essential hypertension chronic systolic heart failure long-term (current) use of anticoagulants congestive heart failure, unspecified disorders of phosphorus metabolism hypogammaglobulinemia, unspecified other primary cardiomyopathies other and unspecified special symptoms or syndromes, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract family history of malignant neoplasm of trachea, bronchus, and lung acute kidney failure, unspecified hypotension, unspecified dermatophytosis of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) acute on chronic systolic heart failure hypogammaglobulinemia, unspecified
white m 75 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; latanoprost 0.005% ophth. soln.  1  drop ; prochlorperazine  5-10  mg ; multivitamins  1  tab ; lorazepam  1-2  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  1000  mg ; alprazolam  0.25  mg ; brimonidine tartrate 0.15% ophth.  1  drop ; citalopram  10  mg ; furosemide  60  mg ; furosemide  40  mg ; glipizide xl  2.5  mg ; lisinopril  5  mg ; simvastatin  20  mg ; terazosin  2  mg ; levetiracetam  2000  mg ; 
chronic lymphoid leukemia, without mention of having achieved remission atrial fibrillation unspecified essential hypertension other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms hypogammaglobulinemia, unspecified chronic systolic heart failure hyposmolality and/or hyponatremia urinary tract infection, site not specified acute kidney failure, unspecified long-term (current) use of anticoagulants congestive heart failure, unspecified chronic lymphoid leukemia, without mention of having achieved remission knee joint replacement hypogammaglobulinemia, unspecified acute on chronic systolic heart failure long-term (current) use of anticoagulants pneumonia, organism unspecified unspecified pleural effusion hypopotassemia congestive heart failure, unspecified acute kidney failure, unspecified unspecified essential hypertension atrial fibrillation other abnormal blood chemistry atrial fibrillation mitral valve disorders acute kidney failure, unspecified pneumonia, organism unspecified chronic lymphoid leukemia, in relapse hypopotassemia unspecified essential hypertension chronic systolic heart failure long-term (current) use of anticoagulants congestive heart failure, unspecified disorders of phosphorus metabolism hypogammaglobulinemia, unspecified other primary cardiomyopathies other and unspecified special symptoms or syndromes, not elsewhere classified family history of malignant neoplasm of gastrointestinal tract family history of malignant neoplasm of trachea, bronchus, and lung acute kidney failure, unspecified hypotension, unspecified dermatophytosis of unspecified site hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified abnormal coagulation profile hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) acute on chronic systolic heart failure hypogammaglobulinemia, unspecified
white f 69 $temp  98.0  heartrate  66.0  resprate  19.0  o2sat  96.0  sbp  141.0  dbp  47.0  rhythm    pain  0  $hematology blood hematocrit  27.5  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  377  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  4.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  173  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  80  mg ; bupropion  75  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; escitalopram oxalate  10  mg ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  25  mg ; metoprolol tartrate  12.5  mg ; nephrocaps  1  cap ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; alprazolam  0.25  mg ; calcitriol  0.5  mcg ; epoetin alfa  10,000  unit ; heparin (hemodialysis)  5000  unit ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; 
stenosis of coronary artery stent, initial encounter unspecified place in single-family (private) house as the place of occurrence of the external cause major depressive disorder, single episode, unspecified anxiety disorder, unspecified non-st elevation (nstemi) myocardial infarction chronic obstructive pulmonary disease, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease end stage renal disease coronary atherosclerosis due to calcified coronary lesion dependence on renal dialysis anemia in chronic kidney disease unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere nicotine dependence, cigarettes, uncomplicated encounter for examination for normal comparison and control in clinical research program unspecified asthma, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris acute posthemorrhagic anemia surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease urinary tract infection, site not specified 
white f 69 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  3.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  119  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  80  mg ; bupropion  75  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; escitalopram oxalate  10  mg ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  25  mg ; nephrocaps  1  cap ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; alprazolam  0.25  mg ; calcitriol  0.5  mcg ; epoetin alfa  10,000  unit ; heparin (hemodialysis)  5000  unit ; lidocaine 1%  1  ml ; sodium chloride 0.9%  1000  ml ; metoprolol succinate xl  25  mg ; hydralazine  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; hydralazine  10  mg ; 
stenosis of coronary artery stent, initial encounter unspecified place in single-family (private) house as the place of occurrence of the external cause major depressive disorder, single episode, unspecified anxiety disorder, unspecified non-st elevation (nstemi) myocardial infarction chronic obstructive pulmonary disease, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease end stage renal disease coronary atherosclerosis due to calcified coronary lesion dependence on renal dialysis anemia in chronic kidney disease unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere nicotine dependence, cigarettes, uncomplicated encounter for examination for normal comparison and control in clinical research program unspecified asthma, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris acute posthemorrhagic anemia surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease urinary tract infection, site not specified 
white f 69 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  92  meq l; chemistry blood creatinine  5.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  113  mg dl$sodium chloride 0.9%  flush  3-10  ml ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  80  mg ; bupropion  75  mg ; clopidogrel  75  mg ; docusate sodium  100  mg ; escitalopram oxalate  10  mg ; isosorbide mononitrate (extended release)  30  mg ; losartan potassium  25  mg ; nephrocaps  1  cap ; fluticasone-salmeterol diskus (500 50)   1  inh ; albuterol 0.083% neb soln  1  neb ; tramadol  50  mg ; alprazolam  0.25  mg ; calcitriol  0.5  mcg ; metoprolol succinate xl  25  mg ; hydralazine  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; carvedilol  3.125  mg ; 
stenosis of coronary artery stent, initial encounter unspecified place in single-family (private) house as the place of occurrence of the external cause major depressive disorder, single episode, unspecified anxiety disorder, unspecified non-st elevation (nstemi) myocardial infarction chronic obstructive pulmonary disease, unspecified awaiting organ transplant status hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease end stage renal disease coronary atherosclerosis due to calcified coronary lesion dependence on renal dialysis anemia in chronic kidney disease unspecified escherichia coli [e. coli] as the cause of diseases classified elsewhere nicotine dependence, cigarettes, uncomplicated encounter for examination for normal comparison and control in clinical research program unspecified asthma, uncomplicated atherosclerotic heart disease of native coronary artery without angina pectoris acute posthemorrhagic anemia surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure type 2 diabetes mellitus with diabetic chronic kidney disease urinary tract infection, site not specified 
white m 70 $nan$hematology urine wbc  0  # hpf$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; hydralazine  25  mg ; lorazepam  0.25  mg ; omeprazole  20  mg ; mupirocin ointment 2%  1  appl ; metoprolol tartrate  25  mg ; glipizide  5  mg ; montelukast  10  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; citalopram  20  mg ; benicar  20  mg ; 
 
white m 70 $nan$hematology blood platelet count  87  k ul$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; lorazepam  0.25  mg ; omeprazole  20  mg ; mupirocin ointment 2%  1  appl ; metoprolol tartrate  25  mg ; glipizide  5  mg ; montelukast  10  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; citalopram  20  mg ; benicar  20  mg ; hydralazine  50  mg ; insulin  0  unit ; diphenhydramine  12.5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  42.5  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  97  k ul; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; lorazepam  0.25  mg ; omeprazole  20  mg ; mupirocin ointment 2%  1  appl ; metoprolol tartrate  25  mg ; montelukast  10  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; citalopram  20  mg ; benicar  20  mg ; hydralazine  50  mg ; insulin  0  unit ; diphenhydramine  12.5  mg ; 
 
white m 70 $nan$blood gas blood free calcium  1.21  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  133  mg dl; blood gas blood glucose  141  mg dl; blood gas blood glucose  174  mg dl; blood gas blood hematocrit, calculated  40  %; blood gas blood hematocrit, calculated  29  %; blood gas blood hematocrit, calculated  31  %; blood gas blood hemoglobin  13.3  g dl; blood gas blood hemoglobin  9.7  g dl; blood gas blood hemoglobin  10.3  g dl; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood sodium, whole blood  139  meq l$influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  325-650  mg ; lorazepam  0.25  mg ; omeprazole  20  mg ; mupirocin ointment 2%  1  appl ; metoprolol tartrate  25  mg ; montelukast  10  mg ; aspirin ec  325  mg ; atorvastatin  20  mg ; citalopram  20  mg ; benicar  20  mg ; hydralazine  50  mg ; insulin  0  unit ; sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  500  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; 
 
white m 70 $nan$hematology blood hematocrit  34.9  %; hematology blood hematocrit  31.2  %; hematology blood hematocrit  29.1  %; hematology blood hematocrit  26.6  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  124  k ul; hematology blood platelet count  101  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  110  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  109  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  127  mg dl; chemistry blood glucose  109  mg dl; blood gas blood free calcium  1.13  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.15  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.17  mmol l; blood gas blood lactate  1.6  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood lactate  1.3  mmol l; blood gas blood chloride, whole blood  112  meq l; blood gas blood glucose  146  mg dl; blood gas blood glucose  170  mg dl; blood gas blood glucose  144  mg dl; blood gas blood glucose  136  mg dl; blood gas blood glucose  124  mg dl; blood gas blood glucose  190  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  11.1  g dl; blood gas blood potassium, whole blood  4.4  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.1  meq l; blood gas blood potassium, whole blood  4.0  meq l; blood gas blood sodium, whole blood  138  meq l; blood gas blood sodium, whole blood  136  meq l$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; propofol  500  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; syringe  1  syr ; phenylephrine  12  mg ; glycopyrrolate  0.6  mg ; neostigmine  3  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albumin 25% (12.5g   50ml)  25  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; albumin 5% (12.5g   250ml)  12.5  g ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  35  unit ; insulin  10  unit ; 
 
white m 70 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  74  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  41  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  10  ml ; aspirin ec  81  mg ; aspirin  81  mg ; milk of magnesia  30  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; syringe  20  ml ; nitroglycerin  8  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; morphine sulfate  0.5-5  mg ; metoclopramide  10  mg ; oxycodone-acetaminophen (5mg-325mg)  1-2  tab ; acetaminophen  650  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; albumin 25% (12.5g   50ml)  25  g ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; docusate sodium  100  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; albumin 5% (12.5g   250ml)  12.5  g ; metoprolol tartrate  12.5  mg ; furosemide  20  mg ; insulin  35  unit ; insulin  10  unit ; furosemide  40  mg ; insulin  14  unit ; bisacodyl  10  mg ; 
 
white m 70 $nan$hematology blood hematocrit  27.2  %; hematology blood hematocrit  27.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  82  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  46  mg dl; chemistry blood urea nitrogen  51  mg dl; hematology urine wbc  8  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  86  mg dl$bisacodyl  10  mg ; acetaminophen iv  1000  mg ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  6.25  mg ; ondansetron  4  mg ; amiodarone  400  mg ; 
 
white m 70 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  126  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  60  mg dl$bisacodyl  10  mg ; acetaminophen iv  1000  mg ; heparin flush (10 units ml)  1  ml ; metoprolol tartrate  6.25  mg ; ondansetron  4  mg ; amiodarone  400  mg ; warfarin  3  mg ; insulin  20  unit ; warfarin  5  mg ; 
 
white m 70 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  59  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood glucose  122  mg dl$bisacodyl  10  mg ; heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; amiodarone  400  mg ; warfarin  3  mg ; insulin  20  unit ; warfarin  5  mg ; 
 
white m 70 $nan$nan$bisacodyl  10  mg ; heparin flush (10 units ml)  1  ml ; ondansetron  4  mg ; amiodarone  400  mg ; amiodarone  200  mg ; warfarin  1  mg ; 
 
white m 45 $temp  96.2  heartrate  62.0  resprate  16.0  o2sat  100.0  sbp  143.0  dbp  92.0  rhythm    pain  uta  ; temp  97.0  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    $blood gas blood lactate  0.8  mmol l$influenza vaccine quadrivalent  0.5  ml ; bisacodyl  10  mg ; heparin  5000  unit ; senna  8.6  mg ; soln  50  ml ; fentanyl citrate  2.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; raltegravir  400  mg ; emtricitabine-tenofovir (truvada)  1  tab ; iso-osmotic sodium chloride  1  bag ; famotidine  20  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; 
 
unable to obtain f 84 $nan$nan$chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  31.3  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  324  k ul; hematology blood platelet count  289  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  150  mg dl; chemistry blood glucose  168  mg dl; blood gas blood free calcium  1.12  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood chloride, whole blood  94  meq l; blood gas blood glucose  153  mg dl; blood gas blood glucose  147  mg dl; blood gas blood hematocrit, calculated  34  %; blood gas blood hemoglobin  11.2  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood sodium, whole blood  130  meq l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; pneumococcal vac polyvalent  0.5  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; 5% dextrose  250  ml ; norepinephrine  8  mg ; vial  1  vial ; pantoprazole sodium  80  mg ; lr  1000  ml ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; 0.9% sodium chloride  250  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; hydrocortisone na succ.  25  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  6  g ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  24.3  %; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  240  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood urea nitrogen  27  mg dl; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  122  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood lactate  1.8  mmol l; blood gas blood potassium, whole blood  3.0  meq l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; lr  1000  ml ; iso-osmotic sodium chloride  100  ml ; fluconazole  200  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; hydrocortisone na succ.  25  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  6  g ; acetaminophen  325-650  mg ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; potassium chl 20 meq   1000 ml d5lr  1000  ml ; methylprednisolone sodium succ  10  mg ; hydrocortisone na succ.  20  mg ; furosemide  20  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  27.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  320  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  111  mg dl; chemistry blood albumin  2.3  g dl; blood gas blood free calcium  1.13  mmol l$chlorhexidine gluconate 0.12% oral rinse  15  ml ; heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; fentanyl citrate  25-100  mcg ; propofol  1000  mg ; propofol  200  mg ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  6  g ; acetaminophen  325-650  mg ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; methylprednisolone sodium succ  10  mg ; furosemide  20  mg ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  317  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  99  mg dl; chemistry blood glucose  125  mg dl; blood gas blood potassium, whole blood  2.9  meq l$heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  6  g ; acetaminophen  325-650  mg ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; amino acids 4.25% w  dextrose 5%  1000  ml ; multivitamin iv  10  ml ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; sw  50  ml ; potassium chloride  20  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  150  ml ; docusate sodium (liquid)  100  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  27.9  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  314  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  36  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  165  mg dl; chemistry blood glucose  232  mg dl$heparin  5000  unit ; pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; sw  100  ml ; magnesium sulfate  4  gm ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; 0.9% sodium chloride  1  bag ; calcium gluconate  6  g ; acetaminophen  325-650  mg ; sodium phosphate  15  mmol ; sodium phosphate  30  mmol ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; sw  150  ml ; docusate sodium (liquid)  100  mg ; senna  1  tab ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  26.7  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  352  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  34  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  152  mg dl$pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  44  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  132  mg dl$pneumococcal vac polyvalent  0.5  ml ; 5% dextrose  100  ml ; ciprofloxacin iv  200  mg ; ns  100  ml ; metronidazole (flagyl)  500  mg ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  445  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  51  mg dl; chemistry blood calcium, total  9.9  mg dl; chemistry blood glucose  156  mg dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  46  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.7  mg dl; chemistry blood glucose  128  mg dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  30.1  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood lactate dehydrogenase (ld)  294  iu l; chemistry blood albumin  3.1  g dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  154  mg dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  27.1  %; hematology blood hematocrit  28.4  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  335  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  2.1  mmol l; blood gas blood lactate  1.7  mmol l; blood gas blood lactate  2.2  mmol l; blood gas blood lactate  2.0  mmol l; blood gas blood glucose  215  mg dl; blood gas blood glucose  218  mg dl; blood gas blood hematocrit, calculated  30  %; blood gas blood hematocrit, calculated  30  %; blood gas blood hemoglobin  9.9  g dl; blood gas blood hemoglobin  9.9  g dl; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  136  meq l; blood gas blood sodium, whole blood  134  meq l$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; albumin 5% (12.5g   250ml)  12.5  g ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  27.1  %; hematology blood hematocrit  30.3  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  332  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  129  mg dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; albumin 5% (12.5g   250ml)  12.5  g ; morphine sulfate  2-6  mg ; morphine sulfate  50  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  25.7  %; hematology blood hematocrit  24.0  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  131  mg dl$pneumococcal vac polyvalent  0.5  ml ; insulin  0  unit ; pantoprazole sodium  40  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; morphine sulfate  50  mg ; furosemide  10  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  290  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  122  mg dl$pneumococcal vac polyvalent  0.5  ml ; pantoprazole sodium  40  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; morphine sulfate  50  mg ; furosemide  10  mg ; 
 
unable to obtain f 84 $nan$hematology blood hematocrit  27.6  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  281  k ul; hematology blood platelet count  297  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  136  mg dl$pneumococcal vac polyvalent  0.5  ml ; pantoprazole sodium  40  mg ; ipratropium bromide neb  1-2  neb ; albuterol 0.083% neb soln  1-2  neb ; heparin flush (10 units ml)  2  ml ; bisacodyl  10  mg ; tiotropium bromide  1  cap ; fluticasone-salmeterol diskus (250 50)   1  inh ; metoprolol tartrate  5  mg ; heparin flush (10 units ml)  1  ml ; morphine sulfate  50  mg ; oxycodone-acetaminophen elixir  5  ml ; metoprolol tartrate  12.5  mg ; 
 
asian m 77 $temp  98.9  heartrate  109.0  resprate  21.0  o2sat  100.0  sbp  109.0  dbp  53.0  rhythm    pain    ; temp  98.8  heartrate  107.0  resprate  25.0  o2sat  100.0  sbp  106.0  dbp  60.0  rhythm    pain  0  ; temp  98.3  heartrate  118.0  resprate  23.0  o2sat  100.0  sbp  111.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  20.4  %; hematology blood hematocrit  22.0  %; hematology blood hematocrit  19.0  %; hematology blood hemoglobin  6.1  g dl; hematology blood hemoglobin  6.5  g dl; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  330  k ul; hematology blood platelet count  369  k ul; hematology blood platelet count  335  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  90  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  18  mg dl; hematology blood inr(pt)  1.2  ; chemistry urine sodium, urine  36  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  94  mg dl; blood gas blood lactate  1.9  mmol l$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  26.1  %; hematology blood hematocrit  24.7  %; hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  337  k ul; hematology blood platelet count  343  k ul; hematology blood platelet count  420  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  95  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; lidocaine jelly 2% (glydo)  1  appl ; sodium chloride 0.9%  1000  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  25.1  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  331  k ul; hematology blood platelet count  301  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  95  mg dl; chemistry blood glucose  130  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; docusate sodium  100  mg ; lactated ringers  1000  ml ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; guaifenesin-dextromethorphan  5  ml ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  322  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  92  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; guaifenesin-dextromethorphan  5  ml ; bag  1  bag ; magnesium sulfate  4  gm ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  328  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  78  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; guaifenesin-dextromethorphan  5  ml ; bag  1  bag ; magnesium sulfate  4  gm ; benzonatate  100  mg ; metoprolol tartrate  5  mg ; metoprolol tartrate  12.5  mg ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  347  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  76  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  350  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  86  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  50  ml ; ampicillin sodium  500  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; ipratropium-albuterol neb  1  neb ; ampicillin  500  mg ; furosemide  10  mg ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  120  mg dl; chemistry blood albumin  2.5  g dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; metoprolol tartrate  25  mg ; heparin  5000  unit ; ampicillin  500  mg ; furosemide  10  mg ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  101  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; heparin  5000  unit ; ampicillin  500  mg ; metoprolol succinate xl  25  mg ; potassium chloride  40  meq ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$hematology blood hematocrit  29.6  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  411  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; heparin  5000  unit ; ampicillin  500  mg ; potassium chloride  40  meq ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
asian m 77 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; ramelteon  8  mg ; acetaminophen  650  mg ; docusate sodium  100  mg ; guaifenesin-dextromethorphan  5  ml ; benzonatate  100  mg ; heparin  5000  unit ; potassium chloride  40  meq ; 
personal history of malignant neoplasm of kidney personal history of pulmonary embolism secondary malignant neoplasm of adrenal gland oliguria and anuria personal history of venous thrombosis and embolism personal history of tobacco use personal history of malignant neoplasm of bronchus and lung radiological procedure and radiotherapy as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure accidents occurring in residential institution other iatrogenic hypotension chronic kidney disease, unspecified hemorrhage complicating a procedure personal history of tobacco use personal history of malignant neoplasm of kidney malignant neoplasm of upper lobe, bronchus or lung malignant neoplasm of lower lobe, bronchus or lung personal history of malignant neoplasm of kidney personal history of venous thrombosis and embolism other pulmonary embolism and infarction tobacco use disorder chronic kidney disease, unspecified calculus of kidney personal history of malignant neoplasm of kidney 
other m 42 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  381  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.8  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  219  mg dl; chemistry blood albumin  4.2  g dl$lorazepam  2  mg ; 0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; d5w  50  ml ; aldesleukin  51.8  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone-acetaminophen  1  tab ; 
 
other m 42 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  303  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  149  iu l; chemistry blood albumin  3.1  g dl$0.9% sodium chloride  1000  ml ; 0.9% sodium chloride  250  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; d5w  50  ml ; aldesleukin  51.8  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone-acetaminophen  1  tab ; oxycodone (immediate release)   5-10  mg ; 
 
other m 42 $nan$hematology blood hematocrit  28.8  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.7  mg dl; chemistry blood glucose  156  mg dl; chemistry blood albumin  3.0  g dl$0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; d5w  50  ml ; aldesleukin  51.8  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  5  ml ; gelclair  15  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; 
 
other m 42 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood bilirubin, total  2.4  mg dl; chemistry blood glucose  172  mg dl; chemistry blood albumin  2.9  g dl$0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; d5w  50  ml ; aldesleukin  51.8  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  5  ml ; gelclair  15  ml ; 0.9% sodium chloride  500  ml ; potassium phosphate  30  mmol ; nystatin  500,000  unit ; nystatin oral suspension  5  ml ; 
 
other m 42 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  179  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood bilirubin, total  2.0  mg dl; chemistry blood glucose  140  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  2.7  g dl$0.9% sodium chloride  1000  ml ; d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; d5w  50  ml ; aldesleukin  51.8  mu ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  5  ml ; gelclair  15  ml ; nystatin oral suspension  5  ml ; furosemide  20  mg ; ipratropium bromide neb  1  neb ; 
 
other m 42 $nan$nan$d5 1 2ns  1000  ml ; sodium bicarbonate  50  meq ; acetaminophen  975  mg ; lorazepam  1-2  mg ; meperidine  25-50  mg ; diphenhydramine  25-50  mg ; prochlorperazine  10  mg ; diphenoxylate-atropine  1-2  tab ; d5w  250  ml ; dopamine  400  mg ; 5% dextrose  250  ml ; phenylephrine  60  mg ; potassium chloride  40  meq ; potassium chloride  60  meq ; potassium chloride  80  meq ; sw  100  ml ; sw  150  ml ; calcium replacement (oncology)  2  gm ; calcium gluconate  3  gm ; potassium phosphate  15  mmol ; naproxen  375  mg ; magnesium sulfate replacement (oncology)  4  gm ; magnesium sulfate replacement (oncology)  2-4  gm ; magnesium sulfate replacement (oncology)  2  gm ; hydrocerin  1  appl ; sarna lotion  1  appl ; zolpidem tartrate  5-10  mg ; heparin flush (10 units ml)  1  ml ; ranitidine  150  mg ; cephalexin  500  mg ; oxycodone (immediate release)   5-10  mg ; cepacol (menthol)  1  loz ; maalox diphenhydramine lidocaine  5  ml ; gelclair  15  ml ; nystatin oral suspension  5  ml ; furosemide  20  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; 
 
black african american f 51 $temp  97.7  heartrate  82.0  resprate  18.0  o2sat  100.0  sbp  136.0  dbp  84.0  rhythm    pain  0  $hematology blood hematocrit  36.5  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  351  k ul; chemistry blood anion gap  24  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  271  mg dl; chemistry blood albumin  4.6  g dl$nan
asthma, unspecified type, with (acute) exacerbation insulins and antidiabetic agents causing adverse effects in therapeutic use pure hypercholesterolemia esophageal reflux other abnormal clinical findings unspecified essential hypertension diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled nontoxic uninodular goiter other specified cardiac dysrhythmias nonspecific abnormal results of function study of thyroid unspecified essential hypertension chest pain, unspecified diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled 
white f 81 $temp    heartrate    resprate    o2sat  98.0  sbp  90.0  dbp  37.0  rhythm    pain    ; temp    heartrate  67.0  resprate  16.0  o2sat  97.0  sbp  113.0  dbp  56.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  16.0  o2sat  99.0  sbp  103.0  dbp  49.0  rhythm  sinus rhythm  pain  0  ; temp  102.9  heartrate  96.0  resprate  16.0  o2sat  99.0  sbp  122.0  dbp  72.0  rhythm  sr  pain  0  $hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  184  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  137  mg dl$pneumococcal vac polyvalent  0.5  ml ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  1000  ml ; ciprofloxacin hcl  250  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; hydrochlorothiazide  25  mg ; isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; levothyroxine sodium  50  mcg ; 
 
white f 81 $nan$nan$sodium chloride 0.9%  flush  3  ml ; ciprofloxacin hcl  250  mg ; ondansetron  4  mg ; trazodone  25  mg ; acetaminophen  500-1000  mg ; senna  1  tab ; metoprolol tartrate  25  mg ; docusate sodium  100  mg ; heparin  5000  unit ; hydrochlorothiazide  25  mg ; isosorbide mononitrate (extended release)  30  mg ; omeprazole  20  mg ; levothyroxine sodium  50  mcg ; 
 
white f 91 $temp  97.5  heartrate  71.0  resprate  20.0  o2sat  94.0  sbp  204.0  dbp  66.0  rhythm    pain  0  ; temp    heartrate  69.0  resprate  18.0  o2sat  96.0  sbp  173.0  dbp  61.0  rhythm    pain  0  ; temp  97.0  heartrate  75.0  resprate  16.0  o2sat  94.0  sbp  173.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  67.0  resprate  14.0  o2sat  96.0  sbp  152.0  dbp  58.0  rhythm    pain  0  $hematology blood hematocrit  33.6  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$influenza virus vaccine  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; benzonatate  100  mg ; senna  8.6  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; oseltamivir  75  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; captopril  6.25  mg ; polyethylene glycol  17  g ; lidocaine viscous 2%  15  ml ; hydralazine  10  mg ; furosemide  10  mg ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) 
white f 91 $nan$hematology blood hematocrit  34.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  79  mg dl$sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; albuterol 0.083% neb soln  1  neb ; ipratropium bromide neb  1  neb ; captopril  6.25  mg ; polyethylene glycol  17  g ; lidocaine viscous 2%  15  ml ; hydralazine  10  mg ; furosemide  10  mg ; potassium chloride  40  meq ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) 
white f 91 $nan$hematology blood hematocrit  34.9  %; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  245  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood glucose  108  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; polyethylene glycol  17  g ; lidocaine viscous 2%  15  ml ; potassium chloride  40  meq ; lisinopril  10  mg ; guaifenesin-dextromethorphan  5  ml ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) 
white f 91 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood glucose  112  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; acetaminophen  650  mg ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; polyethylene glycol  17  g ; lidocaine viscous 2%  15  ml ; lisinopril  10  mg ; guaifenesin-dextromethorphan  5  ml ; 
inguinal hernia, without mention of obstruction or gangrene, unilateral or unspecified (not specified as recurrent) 
white f 70 $temp  98.9  heartrate  79.0  resprate  16.0  o2sat  96.0  sbp  121.0  dbp  72.0  rhythm    pain  0  $hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  419  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  78  mg dl; chemistry blood glucose  169  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metronidazole  500  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; methadone  30  mg ; lactated ringers  1000  ml ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; magnesium sulfate  2  gm ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white f 70 $nan$hematology blood hematocrit  22.4  %; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  27  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  91  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metronidazole  500  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; methadone  30  mg ; lactated ringers  1000  ml ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; magnesium sulfate  2  gm ; insulin  12  unit ; methadone  20  mg ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white f 70 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  425  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  56  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metronidazole  500  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; insulin  12  unit ; methadone  20  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; sodium chloride 0.9%  1000  ml ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white f 70 $nan$hematology blood hematocrit  21.8  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  358  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  35  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  51  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metronidazole  500  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; heparin  1400-2700  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; insulin  12  unit ; methadone  20  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; sodium chloride 0.9%  1000  ml ; d5 1 2ns  1000  ml ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white f 70 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  368  k ul; chemistry blood anion gap  22  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  83  mg dl$ns  100  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; metronidazole  500  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 5% dextrose  200  ml ; ciprofloxacin iv  400  mg ; insulin  12  unit ; methadone  20  mg ; d5 1 2ns  1000  ml ; sulfameth trimethoprim ds  1  tab ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white f 70 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; clopidogrel  75  mg ; aspirin  81  mg ; omeprazole  20  mg ; gabapentin  800  mg ; lisinopril  10  mg ; atenolol  25  mg ; simvastatin  10  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; insulin  12  unit ; methadone  20  mg ; sulfameth trimethoprim ds  1  tab ; 
adverse effect of other systemic antibiotics, initial encounter hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease infection following a procedure, initial encounter acquired absence of right great toe acquired absence of other right toe(s) type 2 diabetes mellitus with diabetic polyneuropathy type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene pain in leg, unspecified personal history of nicotine dependence non-pressure chronic ulcer of other part of left foot with unspecified severity surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified unspecified place or not applicable dehydration hyperlipidemia, unspecified low back pain long term (current) use of insulin type 2 diabetes mellitus with diabetic chronic kidney disease chronic kidney disease, unspecified long term (current) use of antithrombotics/antiplatelets other chronic pain non-pressure chronic ulcer of left heel and midfoot with unspecified severity gastro-esophageal reflux disease without esophagitis type 2 diabetes mellitus with foot ulcer personal history of nicotine dependence cellulitis of left lower limb gastro-esophageal reflux disease without esophagitis non-pressure chronic ulcer of other part of left foot limited to breakdown of skin hyperlipidemia, unspecified other chronic pain long term (current) use of insulin bradycardia, unspecified type 2 diabetes mellitus with foot ulcer adverse effect of other antihypertensive drugs, initial encounter essential (primary) hypertension patient room in hospital as the place of occurrence of the external cause surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified low back pain non-pressure chronic ulcer of left heel and midfoot limited to breakdown of skin non-pressure chronic ulcer of right heel and midfoot limited to breakdown of skin hyperkalemia type 2 diabetes mellitus with diabetic polyneuropathy infection following a procedure, initial encounter hypotension due to drugs abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum atherosclerosis of native arteries of extremities with intermittent claudication, bilateral legs other postprocedural complications and disorders of the circulatory system, not elsewhere classified
white m 73 $temp  97.7  heartrate  81.0  resprate  18.0  o2sat  98.0  sbp  115.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  44.2  %; hematology blood hemoglobin  14.6  g dl; hematology blood platelet count  215  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; tramadol  50  mg ; carbidopa-levodopa (25-100)  1  tab ; tamsulosin  0.4  mg ; metoprolol tartrate  25  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; carbidopa-levodopa (25-100)  0.5  tab ; oxycodone (immediate release)  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  105  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; carbidopa-levodopa (25-100)  0.5  tab ; oxycodone (immediate release)  5  mg ; lactated ringers  1000  ml ; 
 
white m 73 $nan$hematology blood hematocrit  46.1  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  232  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; tamsulosin  0.4  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; 
 
white m 73 $nan$hematology blood hematocrit  43.8  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  246  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  97  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; lactated ringers  1000  ml ; finasteride  5  mg ; sodium chloride  1  gm ; 
 
white m 73 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; finasteride  5  mg ; sodium chloride  1  gm ; 
 
white m 73 $nan$hematology blood hematocrit  45.9  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  254  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  98  mg dl$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; finasteride  5  mg ; sodium chloride  1  gm ; 
 
white m 73 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; bupropion xl (once daily)  300  mg ; polyethylene glycol  17  g ; oxycodone (immediate release)  5  mg ; finasteride  5  mg ; sodium chloride  1  gm ; 
 
unknown m 71 $nan$nan$thiamine  100  mg ; folic acid  1  mg ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  35.8  %; hematology blood hematocrit  32.0  %; hematology blood hemoglobin  12.5  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  118  k ul; hematology blood platelet count  105  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood potassium  2.9  meq l; chemistry blood potassium  3.0  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  15  mg dl; hematology blood inr(pt)  1.4  ; chemistry urine potassium, urine  72  meq l; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  1.2  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  76  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.11  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  101  meq l; blood gas blood glucose  74  mg dl; blood gas blood potassium, whole blood  2.9  meq l; blood gas blood sodium, whole blood  138  meq l$thiamine  100  mg ; folic acid  1  mg ; influenza vaccine quadrivalent  0.5  ml ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; heparin  5000  unit ; famotidine  20  mg ; propofol  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sw  800  ml ; potassium chloride  80  meq ; labetalol  10  mg ; hydralazine  10  mg ; fentanyl citrate  25-100  mcg ; lactated ringers  1000  ml ; erythromycin 0.5% ophth oint  0.5  in ; prednisolone acetate 1% ophth. susp.  1  drop ; moxifloxacin  0.5  % ; propofol  200  mg ; iso-osmotic sodium chloride  1  bag ; moxifloxacin  1  drop ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; diltiazem  90  mg ; midazolam  0.5-1  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  30.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  87  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  80  mg dl; chemistry blood glucose  89  mg dl; blood gas blood free calcium  1.06  mmol l; blood gas blood free calcium  1.05  mmol l; blood gas blood lactate  0.6  mmol l; blood gas blood glucose  78  mg dl; blood gas blood potassium, whole blood  4.5  meq l$propofol  200  mg ; iso-osmotic sodium chloride  1  bag ; moxifloxacin  1  drop ; diltiazem  90  mg ; midazolam  0.5-1  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 0.9% sodium chloride  1000  ml ; potassium chloride (powder)  80  meq ; acetaminophen  1000  mg ; ibuprofen  400  mg ; diltiazem  60  mg ; diltiazem  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  31.8  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  153  mg dl$iso-osmotic sodium chloride  1  bag ; moxifloxacin  1  drop ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lorazepam  0.5-1  mg ; lorazepam  1  mg ; oxycodone (immediate release)  5  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; senna  8.6  mg ; docusate sodium  100  mg ; furosemide  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 3% inhalation soln  15  ml ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  35.8  %; hematology blood hematocrit  36.4  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  166  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  12  mg dl; hematology urine wbc  4  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  134  mg dl$iso-osmotic sodium chloride  1  bag ; moxifloxacin  1  drop ; 0.9% sodium chloride  250  ml ; phenylephrine  60  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lorazepam  0.5-1  mg ; lorazepam  1  mg ; oxycodone (immediate release)  5  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; senna  8.6  mg ; furosemide  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 3% inhalation soln  15  ml ; sodium chloride 0.9%  flush  10  ml ; haloperidol  0.5  mg ; haloperidol  0.25  mg ; haloperidol  1  mg ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  162  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  144  mg dl$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; lorazepam  1  mg ; oxycodone (immediate release)  5  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; potassium chloride (powder)  60  meq ; trazodone  200  mg ; lidocaine 5% patch  1  ptch ; potassium chloride  20  meq ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  31.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  134  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  88  mg dl$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; trazodone  200  mg ; lidocaine 5% patch  1  ptch ; potassium chloride  20  meq ; ondansetron  4  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  135  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  101  mg dl$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; hydrochlorothiazide  25  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; ondansetron  4  mg ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride  500  ml ; potassium chloride (powder)  40  meq ; lidocaine jelly 2% (urojet)  1  appl ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$hematology blood hematocrit  37.6  %; hematology blood hemoglobin  12.2  g dl; hematology blood platelet count  171  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  165  mg dl$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; 0.9% sodium chloride  500  ml ; potassium chloride (powder)  40  meq ; lidocaine jelly 2% (urojet)  1  appl ; senna  17.2  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$chemistry urine sodium, urine  91  meq l$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; senna  17.2  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$nan$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  200  mg ; apixaban  5  mg ; furosemide  20  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; senna  17.2  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
unknown m 71 $nan$nan$moxifloxacin  1  drop ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  10-20  ml ; ipratropium-albuterol neb  1  neb ; salmeterol xinafoate diskus (50 mcg)  1  inh ; fluticasone propionate 110mcg  2  puff ; apixaban  5  mg ; furosemide  20  mg ; lisinopril  10  mg ; omeprazole  40  mg ; sertraline  150  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine 5% patch  1  ptch ; tamsulosin  0.4  mg ; trazodone  100  mg ; trazodone  50  mg ; senna  17.2  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
acute tracheitis without obstruction adverse effect of beta-adrenoreceptor antagonists, initial encounter chronic atrial fibrillation shock, unspecified personal history of malignant neoplasm of larynx chronic obstructive pulmonary disease, unspecified bradycardia, unspecified acute and subacute hepatic failure without coma essential (primary) hypertension acute kidney failure, unspecified blindness, both eyes gastro-esophageal reflux disease without esophagitis major depressive disorder, single episode, unspecified long term (current) use of anticoagulants hyperkalemia corneal transplant status hypoxemia infection of tracheostomy stoma thrombocytopenia, unspecified insomnia, unspecified other sites of candidiasis unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause acidosis anxiety disorder, unspecified toxic encephalopathy 
white f 91 $temp  98.6  heartrate  64.0  resprate  18.0  o2sat  94.0  sbp  182.0  dbp  54.0  rhythm    pain  0  ; temp  98.7  heartrate  112.0  resprate  16.0  o2sat  95.0  sbp  139.0  dbp  75.0  rhythm    pain  uta  ; temp  98.1  heartrate  88.0  resprate  16.0  o2sat  94.0  sbp  100.0  dbp  49.0  rhythm    pain  0  ; temp  97.8  heartrate  73.0  resprate  15.0  o2sat  97.0  sbp  112.0  dbp  57.0  rhythm    pain  0  ; temp  97.5  heartrate  123.0  resprate  18.0  o2sat  94.0  sbp  153.0  dbp  79.0  rhythm    pain  0  $hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  183  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood glucose  108  mg dl$nan
 
white f 91 $nan$hematology blood hematocrit  30.9  %; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  112  mg dl$enoxaparin sodium  40  mg ; pantoprazole  40  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5  mg ; ramelteon  8  mg ; 
 
white f 91 $nan$hematology blood hematocrit  28.1  %$enoxaparin sodium  40  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5  mg ; ramelteon  8  mg ; sodium chloride 0.9%  1000  ml ; 
 
white f 91 $nan$hematology blood hematocrit  23.3  %$enoxaparin sodium  40  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5  mg ; ramelteon  8  mg ; sodium chloride 0.9%  1000  ml ; 
 
white f 91 $nan$hematology blood hematocrit  26.3  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  180  k ul$enoxaparin sodium  40  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5  mg ; ramelteon  8  mg ; 
 
white f 91 $nan$nan$enoxaparin sodium  40  mg ; pantoprazole  40  mg ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  1000  mg ; senna  8.6  mg ; docusate sodium  100  mg ; ondansetron  4  mg ; lactated ringers  1000  ml ; sodium chloride 0.9%  flush  3-10  ml ; morphine sulfate  1-2  mg ; oxycodone (immediate release)  2.5  mg ; ramelteon  8  mg ; 
 
other m 80 $nan$hematology blood hematocrit  29.6  %; hematology blood hematocrit  26.9  %; hematology blood hematocrit  27.2  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  72  k ul; hematology blood platelet count  77  k ul; hematology blood platelet count  87  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  92  meq l; chemistry blood chloride  94  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  2.7  meq l; chemistry blood sodium  132  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  131  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  37  mg dl; hematology blood inr(pt)  1.6  ; hematology blood inr(pt)  1.6  ; chemistry urine creatinine, urine  154  mg dl; chemistry urine urea nitrogen, urine  597  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  146  mg dl; chemistry blood glucose  121  mg dl; chemistry blood lactate dehydrogenase (ld)  203  iu l; chemistry blood lactate dehydrogenase (ld)  210  iu l; chemistry blood albumin  3.1  g dl; chemistry blood albumin  2.6  g dl; chemistry blood albumin  2.8  g dl; blood gas blood lactate  2.2  mmol l; chemistry blood % hemoglobin a1c  6.0  %$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; dextrose 50%  25  gm ; potassium chloride  40  meq ; 0.9% sodium chloride  250  ml ; potassium chloride  20  meq ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; heparin  5000  unit ; bag  1  bag ; magnesium sulfate  2  gm ; potassium chloride  10  meq ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; magnesium oxide  400  mg ; neutra-phos  1  pkt ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lactated ringers  1000  ml ; syringe  1  syr ; filgrastim-sndz  480  mcg ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  83  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  141  mg dl; chemistry blood lactate dehydrogenase (ld)  209  iu l; chemistry blood albumin  2.7  g dl; hematology blood bands  2  %$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; neutra-phos  1  pkt ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; lactated ringers  1000  ml ; syringe  1  syr ; filgrastim-sndz  480  mcg ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; ampicillin sodium  2  g ; rivaroxaban  15  mg ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  103  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  160  mg dl; hematology blood bands  6  %$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; lidocaine 5% patch  1  ptch ; rivaroxaban  15  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  33.3  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  6.7  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood urea nitrogen  18  mg dl; hematology urine wbc  3  # hpf; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  244  mg dl; chemistry blood glucose  322  mg dl; chemistry blood albumin  2.5  g dl$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; acetaminophen  650  mg ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; rivaroxaban  15  mg ; gastroview (diatrizoate meglumine & sodium)  30  ml ; oxycodone (immediate release)  2.5  mg ; insulin  10  unit ; insulin  2  unit ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  90  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  236  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; rivaroxaban  15  mg ; oxycodone (immediate release)  2.5  mg ; insulin  10  unit ; insulin  8  unit ; torsemide  40  mg ; insulin  30  unit ; insulin  24  unit ; insulin  20  unit ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.2  g dl; hematology blood platelet count  94  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  213  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; rivaroxaban  15  mg ; torsemide  40  mg ; insulin  24  unit ; insulin  20  unit ; insulin  40  unit ; insulin  32  unit ; insulin  16  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; magnesium sulfate  4  gm ; rivaroxaban  20  mg ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  28.7  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  76  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  135  mg dl$sodium chloride 0.9%  flush  3-10  ml ; lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; torsemide  40  mg ; insulin  32  unit ; insulin  16  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; magnesium sulfate  4  gm ; rivaroxaban  20  mg ; insulin  18  unit ; sodium chloride 0.9%  flush  10-20  ml ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$hematology blood hematocrit  29.0  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  72  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  116  mg dl$lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; torsemide  40  mg ; rivaroxaban  20  mg ; insulin  18  unit ; sodium chloride 0.9%  flush  10-20  ml ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
other m 80 $nan$nan$lactulose  30  ml ; influenza vaccine quadrivalent  0.5  ml ; senna  17.2  mg ; omeprazole  40  mg ; rifaximin  550  mg ; diazepam  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; rosuvastatin calcium  40  mg ; ramelteon  8  mg ; aspirin  81  mg ; torsemide  40  mg ; rivaroxaban  20  mg ; sodium chloride 0.9%  flush  10-20  ml ; 
unspecified atrial fibrillation acute kidney failure, unspecified chronic lymphocytic leukemia of b-cell type not having achieved remission unspecified atrioventricular block acute on chronic diastolic (congestive) heart failure type 1 diabetes mellitus with hypoglycemia without coma long term (current) use of anticoagulants ventricular tachycardia melena atherosclerotic heart disease of native coronary artery without angina pectoris anemia, unspecified presence of prosthetic heart valve long term (current) use of insulin hypertensive heart disease with heart failure encounter for examination for normal comparison and control in clinical research program chronic lymphocytic leukemia of b-cell type not having achieved remission anemia, unspecified unspecified atrial fibrillation acute on chronic diastolic (congestive) heart failure nonrheumatic aortic (valve) stenosis family history of ischemic heart disease and other diseases of the circulatory system long term (current) use of insulin presence of coronary angioplasty implant and graft atherosclerotic heart disease of native coronary artery without angina pectoris hyperlipidemia, unspecified hypertensive heart disease with heart failure type 2 diabetes mellitus without complications bell's palsy acute kidney failure, unspecified hypo-osmolality and hyponatremia long term (current) use of insulin personal history of nicotine dependence long term (current) use of antithrombotics/antiplatelets hyperlipidemia, unspecified iron deficiency anemia, unspecified other specified abnormal findings of blood chemistry paroxysmal atrial fibrillation presence of coronary angioplasty implant and graft chronic kidney disease, stage 3 (moderate) type 2 diabetes mellitus without complications chronic lymphocytic leukemia of b-cell type not having achieved remission acute on chronic diastolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease atherosclerotic heart disease of native coronary artery without angina pectoris atrioventricular block, second degree abnormal coagulation profile bradycardia, unspecified acute on chronic diastolic (congestive) heart failure
white f 83 $nan$hematology blood hematocrit  41.7  %; hematology blood hematocrit  44.1  %; hematology blood hematocrit  47.2  %; hematology blood hemoglobin  14.8  g dl; hematology blood platelet count  187  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  103  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; metoprolol tartrate  75  mg ; senna  1  tab ; 0.9% sodium chloride  1000  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; pantoprazole  40  mg ; 
 
white f 83 $nan$hematology blood hematocrit  43.8  %; hematology blood hematocrit  43.6  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  2.1  ; hematology urine wbc  0-2  # hpf; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  125  mg dl; hematology urine glucose  tr  mg dl; hematology urine bilirubin  neg  mg dl$pantoprazole  40  mg ; potassium chloride  40  meq ; ondansetron  4  mg ; 
 
white m 55 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  38.3  %; hematology blood hemoglobin  12.6  g dl; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  82  k ul; hematology blood platelet count  82  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.0  meq l; chemistry blood potassium  3.2  meq l; chemistry blood sodium  148  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood urea nitrogen  9  mg dl; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  7.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  90  mg dl; chemistry blood glucose  87  mg dl$clopidogrel  75  mg ; aspirin  325  mg ; paroxetine  12.5  mg ; amlodipine  10  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5  mg ; acetaminophen-caff-butalbital  1-2  tab ; heparin  1500-3000  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; famotidine  20  mg ; lorazepam  1-2  mg ; senna  1  tab ; potassium chloride  60  meq ; potassium chloride  40  meq ; 
thrombocytopenia, unspecified cerebral aneurysm, nonruptured chronic hepatitis c without mention of hepatic coma muscle weakness (generalized) tobacco use disorder alcohol abuse, unspecified alcohol withdrawal personal history of other infectious and parasitic diseases fever, unspecified subarachnoid hemorrhage other specified transient cerebral ischemias thrombocytopenia, unspecified
white m 55 $nan$hematology blood hematocrit  37.3  %$clopidogrel  75  mg ; aspirin  325  mg ; paroxetine  12.5  mg ; amlodipine  10  mg ; heparin flush (10 units ml)  2  ml ; 0.9% sodium chloride  1000  ml ; oxycodone (immediate release)   5  mg ; acetaminophen-caff-butalbital  1-2  tab ; docusate sodium  100  mg ; famotidine  20  mg ; lorazepam  1-2  mg ; senna  1  tab ; potassium chloride  60  meq ; potassium chloride  40  meq ; heparin  5000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; magnesium citrate  150  ml ; 
thrombocytopenia, unspecified cerebral aneurysm, nonruptured chronic hepatitis c without mention of hepatic coma muscle weakness (generalized) tobacco use disorder alcohol abuse, unspecified alcohol withdrawal personal history of other infectious and parasitic diseases fever, unspecified subarachnoid hemorrhage other specified transient cerebral ischemias thrombocytopenia, unspecified
white m 55 $nan$nan$clopidogrel  75  mg ; aspirin  325  mg ; paroxetine  12.5  mg ; amlodipine  10  mg ; heparin flush (10 units ml)  2  ml ; oxycodone (immediate release)   5  mg ; acetaminophen-caff-butalbital  1-2  tab ; docusate sodium  100  mg ; lorazepam  1-2  mg ; senna  1  tab ; heparin  5000  unit ; simethicone  40-80  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; magnesium citrate  150  ml ; 
thrombocytopenia, unspecified cerebral aneurysm, nonruptured chronic hepatitis c without mention of hepatic coma muscle weakness (generalized) tobacco use disorder alcohol abuse, unspecified alcohol withdrawal personal history of other infectious and parasitic diseases fever, unspecified subarachnoid hemorrhage other specified transient cerebral ischemias thrombocytopenia, unspecified
white f 36 $nan$hematology blood hematocrit  39.3  %; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  289  k ul$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 36 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
white f 36 $nan$nan$docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; codeine sulfate  30-60  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; 
 
other f 46 $temp    heartrate  90.0  resprate  23.0  o2sat  97.0  sbp  171.0  dbp  66.0  rhythm    pain  unable  ; temp  100.0  heartrate  90.0  resprate  20.0  o2sat  100.0  sbp  179.0  dbp  149.0  rhythm    pain  unable  $hematology blood hematocrit  31.3  %; hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  130  k ul; hematology blood platelet count  128  k ul; chemistry blood anion gap  32  meq l; chemistry blood anion gap  18  meq l; chemistry blood anion gap  23  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  80  meq l; chemistry blood chloride  91  meq l; chemistry blood chloride  88  meq l; chemistry blood chloride  93  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  12.4  mg dl; chemistry blood creatinine  8.1  mg dl; chemistry blood creatinine  8.6  mg dl; chemistry blood creatinine  9.2  mg dl; chemistry blood creatinine  9.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.6  meq l; chemistry blood potassium  5.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  6.2  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  127  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  122  meq l; chemistry blood urea nitrogen  127  mg dl; chemistry blood urea nitrogen  65  mg dl; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  72  mg dl; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  2.4  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  553  mg dl; chemistry blood glucose  738  mg dl; chemistry blood glucose  443  mg dl; chemistry blood glucose  284  mg dl; chemistry blood glucose  143  mg dl; chemistry blood glucose  359  mg dl; chemistry blood glucose  178  mg dl; chemistry blood glucose  125  mg dl; chemistry blood albumin  2.9  g dl; blood gas blood free calcium  1.07  mmol l$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; insulin  8  unit ; lidocaine 1%  1  ml ; 0.9% sodium chloride  250  ml ; haloperidol  2-5  mg ; aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  200  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 5% dextrose  150  ml ; vancomycin  500  mg ; pantoprazole  40  mg ; 0.9% sodium chloride  50  ml ; cefepime  500  mg ; sevelamer carbonate  2400  mg ; vial  1  vial ; acetaminophen  650  mg ; acetaminophen iv  1000  mg ; 5% dextrose  1000  ml ; metoprolol tartrate  75  mg ; valsartan  160  mg ; d5 1 2ns  1000  ml ; d5ns  1000  ml ; dextrose 50%  12.5  gm ; 
diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified diabetes with other coma, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of native coronary artery renal dialysis status nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes other toe(s) amputation status unspecified acquired hypothyroidism end stage renal disease diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia hypoxemia arthropathy associated with neurological disorders esophageal reflux polyneuropathy in diabetes diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia unspecified acquired hypothyroidism procedure not carried out for other reasons hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident awaiting organ transplant status long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease other and unspecified hyperlipidemia hyperpotassemia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other toe(s) amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders personal history of tobacco use occlusion and stenosis of carotid artery without mention of cerebral infarction background diabetic retinopathy end stage renal disease unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of other vascular device, implant, and graft hyperparathyroidism, unspecified long-term (current) use of insulin
other f 46 $nan$chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  5.4  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  32  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  114  mg dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; insulin  8  unit ; lidocaine 1%  1  ml ; aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  200  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sevelamer carbonate  2400  mg ; vial  1  vial ; acetaminophen iv  1000  mg ; metoprolol tartrate  75  mg ; valsartan  160  mg ; d5ns  1000  ml ; dextrose 50%  12.5  gm ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; metoprolol tartrate  37.5  mg ; glucagon  1  mg ; insulin  16  unit ; insulin  0  unit ; metoprolol tartrate  50  mg ; trazodone  25  mg ; 
diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified diabetes with other coma, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of native coronary artery renal dialysis status nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes other toe(s) amputation status unspecified acquired hypothyroidism end stage renal disease diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia hypoxemia arthropathy associated with neurological disorders esophageal reflux polyneuropathy in diabetes diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia unspecified acquired hypothyroidism procedure not carried out for other reasons hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident awaiting organ transplant status long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease other and unspecified hyperlipidemia hyperpotassemia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other toe(s) amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders personal history of tobacco use occlusion and stenosis of carotid artery without mention of cerebral infarction background diabetic retinopathy end stage renal disease unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of other vascular device, implant, and graft hyperparathyroidism, unspecified long-term (current) use of insulin
other f 46 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  6.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  40  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  252  mg dl; hematology blood bands  2  %$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  200  mcg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; sevelamer carbonate  2400  mg ; vial  1  vial ; dextrose 50%  12.5  gm ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; trazodone  25  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; hydralazine  10  mg ; doxazosin  8  mg ; sodium chloride 0.9%  flush  3  ml ; 
diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified diabetes with other coma, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of native coronary artery renal dialysis status nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes other toe(s) amputation status unspecified acquired hypothyroidism end stage renal disease diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia hypoxemia arthropathy associated with neurological disorders esophageal reflux polyneuropathy in diabetes diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia unspecified acquired hypothyroidism procedure not carried out for other reasons hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident awaiting organ transplant status long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease other and unspecified hyperlipidemia hyperpotassemia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other toe(s) amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders personal history of tobacco use occlusion and stenosis of carotid artery without mention of cerebral infarction background diabetic retinopathy end stage renal disease unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of other vascular device, implant, and graft hyperparathyroidism, unspecified long-term (current) use of insulin
other f 46 $nan$hematology blood hematocrit  33.4  %; hematology blood hematocrit  32.5  %; hematology blood hemoglobin  10.2  g dl; hematology blood hemoglobin  9.9  g dl; hematology blood platelet count  110  k ul; hematology blood platelet count  117  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  8.6  mg dl; chemistry blood creatinine  8.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  60  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  140  mg dl; chemistry blood glucose  220  mg dl$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  200  mcg ; sevelamer carbonate  2400  mg ; dextrose 50%  12.5  gm ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; hydralazine  10  mg ; doxazosin  8  mg ; sodium chloride 0.9%  flush  3  ml ; 
diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified diabetes with other coma, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of native coronary artery renal dialysis status nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes other toe(s) amputation status unspecified acquired hypothyroidism end stage renal disease diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia hypoxemia arthropathy associated with neurological disorders esophageal reflux polyneuropathy in diabetes diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia unspecified acquired hypothyroidism procedure not carried out for other reasons hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident awaiting organ transplant status long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease other and unspecified hyperlipidemia hyperpotassemia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other toe(s) amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders personal history of tobacco use occlusion and stenosis of carotid artery without mention of cerebral infarction background diabetic retinopathy end stage renal disease unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of other vascular device, implant, and graft hyperparathyroidism, unspecified long-term (current) use of insulin
other f 46 $nan$hematology blood hematocrit  36.3  %; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  142  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  93  meq l; chemistry blood creatinine  5.7  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  449  mg dl; hematology blood bands  0  %$influenza virus vaccine  0.5  ml ; heparin  5000  unit ; aspirin  81  mg ; atorvastatin  10  mg ; levothyroxine sodium  200  mcg ; sevelamer carbonate  2400  mg ; oxycodone-acetaminophen (5mg-325mg)  1  tab ; glucagon  1  mg ; insulin  0  unit ; metoprolol tartrate  50  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin sodium  2  g ; doxazosin  8  mg ; sodium chloride 0.9%  flush  3  ml ; 
diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified diabetes with other coma, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy long-term (current) use of insulin hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease coronary atherosclerosis of native coronary artery renal dialysis status nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere polyneuropathy in diabetes other toe(s) amputation status unspecified acquired hypothyroidism end stage renal disease diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia hypoxemia arthropathy associated with neurological disorders esophageal reflux polyneuropathy in diabetes diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other and unspecified hyperlipidemia unspecified acquired hypothyroidism procedure not carried out for other reasons hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease renal dialysis status unspecified occupant of heavy transport vehicle injured in collision with heavy transport vehicle or bus in nontraffic accident awaiting organ transplant status long-term (current) use of insulin diabetes with renal manifestations, type i [juvenile type], not stated as uncontrolled background diabetic retinopathy diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled end stage renal disease other and unspecified hyperlipidemia hyperpotassemia diabetes with neurological manifestations, type i [juvenile type], not stated as uncontrolled other toe(s) amputation status diabetes with ophthalmic manifestations, type i [juvenile type], not stated as uncontrolled arthropathy associated with neurological disorders personal history of tobacco use occlusion and stenosis of carotid artery without mention of cerebral infarction background diabetic retinopathy end stage renal disease unspecified acquired hypothyroidism hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease mechanical complication of other vascular device, implant, and graft hyperparathyroidism, unspecified long-term (current) use of insulin
white m 72 $temp  97.6  heartrate  95.0  resprate  16.0  o2sat  96.0  sbp  141.0  dbp  71.0  rhythm    pain  7  $hematology blood hematocrit  30.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  527  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  79  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; morphine sulfate  1-2  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; heparin  5000  unit ; hydromorphone (dilaudid)  0.5-1  mg ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  20  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; 
cyst of kidney, acquired other specified diseases of liver acute cholecystitis with chronic cholecystitis essential (primary) hypertension obstruction of bile duct personal history of nicotine dependence gout, unspecified pleural effusion, not elsewhere classified personal history of other malignant neoplasm of skin sepsis, unspecified organism unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent 
white m 72 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  10.8  g dl; hematology blood platelet count  621  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  68  mg dl$iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; heparin  5000  unit ; soln  100  ml ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  20  mg ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; d5 1 2ns  1000  ml ; acetaminophen  325-650  mg ; ibuprofen  400  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)   5  mg ; 
cyst of kidney, acquired other specified diseases of liver acute cholecystitis with chronic cholecystitis essential (primary) hypertension obstruction of bile duct personal history of nicotine dependence gout, unspecified pleural effusion, not elsewhere classified personal history of other malignant neoplasm of skin sepsis, unspecified organism unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent 
white m 72 $nan$hematology blood hematocrit  29.7  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  571  k ul$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; 0.9% sodium chloride (mini bag plus)  2  bag ; cefepime  2  g ; ns  100  ml ; metronidazole  500  mg ; acetaminophen  325-650  mg ; ibuprofen  400  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; diphenhydramine  25  mg ; lisinopril  5  mg ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; 
cyst of kidney, acquired other specified diseases of liver acute cholecystitis with chronic cholecystitis essential (primary) hypertension obstruction of bile duct personal history of nicotine dependence gout, unspecified pleural effusion, not elsewhere classified personal history of other malignant neoplasm of skin sepsis, unspecified organism unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent 
white m 72 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  325-650  mg ; ibuprofen  400  mg ; polyethylene glycol  17  g ; hydromorphone (dilaudid)  0.25-0.5  mg ; oxycodone (immediate release)   5  mg ; docusate sodium  100  mg ; diphenhydramine  25  mg ; lisinopril  5  mg ; ciprofloxacin hcl  500  mg ; sarna lotion  1  appl ; 
cyst of kidney, acquired other specified diseases of liver acute cholecystitis with chronic cholecystitis essential (primary) hypertension obstruction of bile duct personal history of nicotine dependence gout, unspecified pleural effusion, not elsewhere classified personal history of other malignant neoplasm of skin sepsis, unspecified organism unilateral inguinal hernia, without obstruction or gangrene, not specified as recurrent 
white m 64 $nan$hematology blood hematocrit  29.5  %; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  480  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  128  mg dl; chemistry blood lactate dehydrogenase (ld)  234  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; triamterene-hctz (37.5 25)  1  cap ; docusate sodium  100  mg ; senna  8.6  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  10  mg ; metoprolol succinate xl  25  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  28.4  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  464  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  100  mg dl; chemistry blood lactate dehydrogenase (ld)  207  iu l; chemistry blood albumin  3.6  g dl; hematology blood bands  2  %$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; 5% dextrose  50  ml ; clindamycin  600  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  10  mg ; metoprolol succinate xl  25  mg ; diphenhydramine  25  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  516  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  96  mg dl; chemistry blood lactate dehydrogenase (ld)  201  iu l; chemistry blood albumin  3.7  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  10  mg ; metoprolol succinate xl  25  mg ; diphenhydramine  25  mg ; metoprolol succinate xl  37.5  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  23.0  %; hematology blood hematocrit  30.1  %; hematology blood hemoglobin  6.8  g dl; hematology blood hemoglobin  9.0  g dl; hematology blood platelet count  378  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  99  mg dl; chemistry blood lactate dehydrogenase (ld)  194  iu l; chemistry blood lactate dehydrogenase (ld)  179  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  10  mg ; lisinopril  2.5  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  491  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.1  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  172  iu l; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  500  ml ; rituximab  700  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; cytarabine  3700  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  573  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.3  mg dl; chemistry blood glucose  120  mg dl; chemistry blood lactate dehydrogenase (ld)  177  iu l; chemistry blood albumin  3.3  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; mupirocin ointment 2%  1  appl ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  500  ml ; rituximab  700  mg ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; cytarabine  3700  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; furosemide  20  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  543  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  146  mg dl; chemistry blood lactate dehydrogenase (ld)  159  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; cytarabine  3700  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; furosemide  20  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  528  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  160  iu l; chemistry blood albumin  3.5  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; cytarabine  3700  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; enoxaparin sodium  40  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  24.5  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  531  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  17  mg dl; hematology urine wbc  0  # hpf; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  103  mg dl; chemistry blood lactate dehydrogenase (ld)  147  iu l; chemistry blood albumin  3.4  g dl$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; enoxaparin sodium  40  mg ; tamsulosin  0.4  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$hematology blood hematocrit  23.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  475  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  17  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  157  iu l; chemistry blood albumin  3.3  g dl; hematology blood bands  1  %$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; ondansetron  16  mg ; dexamethasone  12  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; enoxaparin sodium  40  mg ; tamsulosin  0.4  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 64 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin flush (100 units ml)  5  ml ; duloxetine  90  mg ; pantoprazole  40  mg ; sulfameth trimethoprim ss  1  tab ; docusate sodium  100  mg ; senna  8.6  mg ; acyclovir  400  mg ; gabapentin  900  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; heparin flush (10 units ml)  5  ml ; sodium chloride 0.9%  flush  10  ml ; cetirizine  10  mg ; lisinopril  2.5  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; sodium chloride 0.9%  1000  ml ; ondansetron  8  mg ; lorazepam  0.5-1  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; dexamethasone  12  mg ; etoposide  110  mg ; ifosfamide  2775  mg ; 0.9% sodium chloride  50  ml ; mesna  700  mg ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; enoxaparin sodium  40  mg ; tamsulosin  0.4  mg ; 
adverse effect of antineoplastic and immunosuppressive drugs, initial encounter adverse effect of glucocorticoids and synthetic analogues, initial encounter angioneurotic edema, initial encounter pneumonia, unspecified organism other visual disturbances contusion of other part of head, initial encounter diarrhea, unspecified essential (hemorrhagic) thrombocythemia diffuse large b-cell lymphoma, extranodal and solid organ sites unspecified abdominal pain personal history of nicotine dependence neutropenia, unspecified headache urticaria, unspecified venous insufficiency (chronic) (peripheral) hyperlipidemia, unspecified essential (primary) hypertension adverse effect of other systemic antibiotics, initial encounter acute posthemorrhagic anemia atopic dermatitis, unspecified hesitancy of micturition acne vulgaris personal history of antineoplastic chemotherapy urinary tract infection, site not specified other postherpetic nervous system involvement other chronic pain pseudomonas (aeruginosa) (mallei) (pseudomallei) as the cause of diseases classified elsewhere family history of malignant neoplasm of digestive organs fever presenting with conditions classified elsewhere gastro-esophageal reflux disease without esophagitis benign prostatic hyperplasia without lower urinary tract symptoms unspecified intestinal obstruction chronic systolic (congestive) heart failure nausea with vomiting, unspecified patient room in hospital as the place of occurrence of the external cause other fall on same level, initial encounter bacteremia 
white m 28 $nan$hematology blood hematocrit  36.1  %; hematology blood hematocrit  35.9  %; hematology blood hematocrit  35.5  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  186  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; 
 
white m 28 $nan$hematology blood hematocrit  36.0  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  186  k ul$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
 
white m 28 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; hydromorphone (dilaudid)  0.25  mg ; docusate sodium  100  mg ; acetaminophen  650  mg ; 
 
white m 72 $temp  98.0  heartrate  97.0  resprate  18.0  o2sat  96.0  sbp  93.0  dbp  54.0  rhythm    pain  0  $hematology blood hematocrit  31.5  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  843  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  102  mg dl; chemistry blood glucose  98  mg dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin  10  ml ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; sertraline  50  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; ropinirole  0.5  mg ; furosemide  40  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; amiodarone  200  mg ; aspirin  81  mg ; gabapentin  400  mg ; lidocaine 5% patch  1  ptch ; mycophenolate mofetil  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; meropenem  500  mg ; 
iron deficiency anemia, unspecified malignant pleural effusion malignant neoplasm of bronchus and lung, unspecified congestive heart failure, unspecified mechanical complication due to other implant and internal device, not elsewhere classified combined systolic and diastolic heart failure, unspecified personal history of malignant neoplasm of large intestine myasthenia gravis without (acute) exacerbation personal history of tobacco use pneumonia, organism unspecified other chronic pulmonary heart diseases aortocoronary bypass status unspecified essential hypertension old myocardial infarction atrial fibrillation chronic pulmonary embolism other acquired absence of organ malignant neoplasm of kidney, except pelvis esophageal reflux hypoxemia peripheral vascular disease, unspecified other pulmonary embolism and infarction long-term (current) use of anticoagulants hypotension, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft below knee amputation status leukemoid reaction other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia pure hypercholesterolemia enlargement of lymph nodes restless legs syndrome (rls) obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified aortocoronary bypass status chronic systolic heart failure unspecified pleural effusion atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene scleral ectasia retention of urine, unspecified unspecified essential hypertension pressure ulcer, stage ii diverticulosis of colon (without mention of hemorrhage) urinary tract infection, site not specified
white m 72 $nan$hematology blood hematocrit  32.4  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  862  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood urea nitrogen  14  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  104  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin  10  ml ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; sertraline  50  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; ropinirole  0.5  mg ; furosemide  40  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; amiodarone  200  mg ; aspirin  81  mg ; gabapentin  400  mg ; lidocaine 5% patch  1  ptch ; mycophenolate mofetil  1000  mg ; meropenem  500  mg ; pantoprazole  40  mg ; 
iron deficiency anemia, unspecified malignant pleural effusion malignant neoplasm of bronchus and lung, unspecified congestive heart failure, unspecified mechanical complication due to other implant and internal device, not elsewhere classified combined systolic and diastolic heart failure, unspecified personal history of malignant neoplasm of large intestine myasthenia gravis without (acute) exacerbation personal history of tobacco use pneumonia, organism unspecified other chronic pulmonary heart diseases aortocoronary bypass status unspecified essential hypertension old myocardial infarction atrial fibrillation chronic pulmonary embolism other acquired absence of organ malignant neoplasm of kidney, except pelvis esophageal reflux hypoxemia peripheral vascular disease, unspecified other pulmonary embolism and infarction long-term (current) use of anticoagulants hypotension, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft below knee amputation status leukemoid reaction other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia pure hypercholesterolemia enlargement of lymph nodes restless legs syndrome (rls) obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified aortocoronary bypass status chronic systolic heart failure unspecified pleural effusion atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene scleral ectasia retention of urine, unspecified unspecified essential hypertension pressure ulcer, stage ii diverticulosis of colon (without mention of hemorrhage) urinary tract infection, site not specified
white m 72 $nan$hematology blood hematocrit  32.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  921  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  92  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin  10  ml ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; sertraline  50  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; ropinirole  0.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; amiodarone  200  mg ; aspirin  81  mg ; gabapentin  400  mg ; lidocaine 5% patch  1  ptch ; mycophenolate mofetil  1000  mg ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
iron deficiency anemia, unspecified malignant pleural effusion malignant neoplasm of bronchus and lung, unspecified congestive heart failure, unspecified mechanical complication due to other implant and internal device, not elsewhere classified combined systolic and diastolic heart failure, unspecified personal history of malignant neoplasm of large intestine myasthenia gravis without (acute) exacerbation personal history of tobacco use pneumonia, organism unspecified other chronic pulmonary heart diseases aortocoronary bypass status unspecified essential hypertension old myocardial infarction atrial fibrillation chronic pulmonary embolism other acquired absence of organ malignant neoplasm of kidney, except pelvis esophageal reflux hypoxemia peripheral vascular disease, unspecified other pulmonary embolism and infarction long-term (current) use of anticoagulants hypotension, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft below knee amputation status leukemoid reaction other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia pure hypercholesterolemia enlargement of lymph nodes restless legs syndrome (rls) obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified aortocoronary bypass status chronic systolic heart failure unspecified pleural effusion atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene scleral ectasia retention of urine, unspecified unspecified essential hypertension pressure ulcer, stage ii diverticulosis of colon (without mention of hemorrhage) urinary tract infection, site not specified
white m 72 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  892  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  118  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin  10  ml ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; sertraline  50  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; ropinirole  0.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; amiodarone  200  mg ; aspirin  81  mg ; gabapentin  400  mg ; lidocaine 5% patch  1  ptch ; mycophenolate mofetil  1000  mg ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; 
iron deficiency anemia, unspecified malignant pleural effusion malignant neoplasm of bronchus and lung, unspecified congestive heart failure, unspecified mechanical complication due to other implant and internal device, not elsewhere classified combined systolic and diastolic heart failure, unspecified personal history of malignant neoplasm of large intestine myasthenia gravis without (acute) exacerbation personal history of tobacco use pneumonia, organism unspecified other chronic pulmonary heart diseases aortocoronary bypass status unspecified essential hypertension old myocardial infarction atrial fibrillation chronic pulmonary embolism other acquired absence of organ malignant neoplasm of kidney, except pelvis esophageal reflux hypoxemia peripheral vascular disease, unspecified other pulmonary embolism and infarction long-term (current) use of anticoagulants hypotension, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft below knee amputation status leukemoid reaction other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia pure hypercholesterolemia enlargement of lymph nodes restless legs syndrome (rls) obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified aortocoronary bypass status chronic systolic heart failure unspecified pleural effusion atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene scleral ectasia retention of urine, unspecified unspecified essential hypertension pressure ulcer, stage ii diverticulosis of colon (without mention of hemorrhage) urinary tract infection, site not specified
white m 72 $nan$hematology blood hematocrit  31.9  %; hematology blood hemoglobin  9.5  g dl; hematology blood platelet count  847  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  88  mg dl$sodium chloride 0.9%  flush  3  ml ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; guaifenesin  10  ml ; ipratropium bromide neb  1  neb ; lorazepam  0.5  mg ; oxycodone (immediate release)   5-10  mg ; senna  8.6  mg ; sertraline  50  mg ; simvastatin  20  mg ; tamsulosin  0.4  mg ; enoxaparin sodium  80  mg ; ropinirole  0.5  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; bag  1  bag ; magnesium sulfate  2  gm ; bag  2  bag ; magnesium sulfate  4  gm ; potassium chloride replacement (critical care and oncology)   40  meq ; potassium chloride replacement (critical care and oncology)   60  meq ; potassium chloride replacement (critical care and oncology)   80  meq ; amiodarone  200  mg ; aspirin  81  mg ; gabapentin  400  mg ; lidocaine 5% patch  1  ptch ; mycophenolate mofetil  1000  mg ; pantoprazole  40  mg ; lidocaine 1%  5  ml ; sodium chloride 0.9%  flush  20  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
iron deficiency anemia, unspecified malignant pleural effusion malignant neoplasm of bronchus and lung, unspecified congestive heart failure, unspecified mechanical complication due to other implant and internal device, not elsewhere classified combined systolic and diastolic heart failure, unspecified personal history of malignant neoplasm of large intestine myasthenia gravis without (acute) exacerbation personal history of tobacco use pneumonia, organism unspecified other chronic pulmonary heart diseases aortocoronary bypass status unspecified essential hypertension old myocardial infarction atrial fibrillation chronic pulmonary embolism other acquired absence of organ malignant neoplasm of kidney, except pelvis esophageal reflux hypoxemia peripheral vascular disease, unspecified other pulmonary embolism and infarction long-term (current) use of anticoagulants hypotension, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft below knee amputation status leukemoid reaction other specified procedures as the cause of abnormal reaction of patient, or of later complication, without mention of misadventure at time of procedure diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled other and unspecified hyperlipidemia pure hypercholesterolemia enlargement of lymph nodes restless legs syndrome (rls) obstructive chronic bronchitis with (acute) exacerbation congestive heart failure, unspecified aortocoronary bypass status chronic systolic heart failure unspecified pleural effusion atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled long-term (current) use of anticoagulants atherosclerosis of native arteries of the extremities with gangrene scleral ectasia retention of urine, unspecified unspecified essential hypertension pressure ulcer, stage ii diverticulosis of colon (without mention of hemorrhage) urinary tract infection, site not specified
white m 76 $temp    heartrate  102.0  resprate  14.0  o2sat  98.0  sbp  113.0  dbp  66.0  rhythm    pain    $hematology blood hematocrit  23.2  %; hematology blood hematocrit  23.3  %; hematology blood hematocrit  28.1  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  9.1  g dl; hematology blood platelet count  156  k ul; hematology blood platelet count  161  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  94  mg dl; chemistry blood urea nitrogen  91  mg dl; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  101  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  108  mg dl; blood gas blood free calcium  1.17  mmol l; blood gas blood free calcium  1.22  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  1.2  mmol l; blood gas blood chloride, whole blood  102  meq l; blood gas blood chloride, whole blood  102  meq l; blood gas blood glucose  106  mg dl; blood gas blood glucose  117  mg dl; blood gas blood hematocrit, calculated  21  %; blood gas blood hematocrit, calculated  26  %; blood gas blood hemoglobin  6.9  g dl; blood gas blood hemoglobin  8.5  g dl; blood gas blood potassium, whole blood  3.3  meq l; blood gas blood potassium, whole blood  3.7  meq l; blood gas blood sodium, whole blood  130  meq l; blood gas blood sodium, whole blood  132  meq l; blood gas blood calculated bicarbonate, whole blood  24  meq l; blood gas blood carboxyhemoglobin  1  %; blood gas blood methemoglobin  1  %$heparin  5000  unit ; d5 1 2ns  1000  ml ; metoprolol tartrate  50  mg ; acetaminophen  650  mg ; atorvastatin  40  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; aspirin  81  mg ; clevidipine  25  mg ; metronidazole  500  mg ; sodium chloride 0.9%  flush  3-10  ml ; lidocaine jelly 2% (glydo)  1  appl ; iso-osmotic dextrose  100  ml ; piperacillin-tazobactam  4.5  g ; lactated ringers  1000  ml ; propofol  1000  mg ; phenylephrine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; vial  1  vial ; ceftriaxone  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  30.8  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  10.0  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  164  k ul; hematology blood platelet count  139  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood urea nitrogen  84  mg dl; chemistry urine creatinine, urine  101  mg dl; chemistry urine potassium, urine  32  meq l; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  114  mg dl; chemistry blood glucose  124  mg dl; blood gas blood lactate  1.7  mmol l$heparin  5000  unit ; metoprolol tartrate  50  mg ; atorvastatin  40  mg ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; aspirin  81  mg ; sodium chloride 0.9%  flush  3-10  ml ; propofol  1000  mg ; phenylephrine  50  mg ; iso-osmotic dextrose  50  ml ; piperacillin-tazobactam  2.25  g ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; acetaminophen iv  1000  mg ; hydromorphone (dilaudid)  0.125  mg ; albumin 5% (12.5g   250ml)  12.5  g ; hydromorphone (dilaudid)  0.25  mg ; hydromorphone (dilaudid)  0.25-0.5  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.8  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  105  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  103  mg dl$heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3-10  ml ; phenylephrine  50  mg ; hydromorphone (dilaudid)  0.25-0.75  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  27.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  87  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  109  mg dl$heparin  5000  unit ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; 0.9% sodium chloride  250  ml ; calcium gluconate  4  g ; magnesium sulfate  4  gm ; sw  200  ml ; potassium chloride  20  meq ; sw  400  ml ; potassium chloride  40  meq ; sw  600  ml ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3-10  ml ; phenylephrine  50  mg ; omeprazole  40  mg ; ns  100  ml ; cefepime  1  g ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.1  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  157  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  3.0  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  89  mg dl; hematology blood inr(pt)  3.5  ; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  118  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; omeprazole  40  mg ; ns  100  ml ; cefepime  1  g ; metoprolol tartrate  5  mg ; phytonadione  5  mg ; 5% dextrose  50  ml ; pantoprazole  40  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.3  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  91  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  114  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; metoprolol tartrate  5  mg ; pantoprazole  40  mg ; ondansetron  4  mg ; metoprolol succinate xl  50  mg ; atorvastatin  10  mg ; acetaminophen  500-1000  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  21.9  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  197  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  2.9  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  97  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  106  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; acetaminophen  500-1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.2  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  194  k ul; hematology blood platelet count  194  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.8  mg dl; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  95  mg dl; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  100  mg dl; chemistry blood glucose  99  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; acetaminophen  500-1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; haloperidol  1  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  21.4  %; hematology blood hemoglobin  6.7  g dl; hematology blood platelet count  172  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  88  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  96  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; acetaminophen  500-1000  mg ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; 0.9% sodium chloride  500  ml ; haloperidol  1  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.8  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  147  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  2.5  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  76  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  106  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phytonadione  2.5  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  147  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood glucose  94  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; potassium chl 40 meq   1000 ml d5 1 2 ns  1000  ml ; phytonadione  2.5  mg ; heparin flush (10 units ml)  3  ml ; lidocaine 1%  1  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.4  %; hematology blood hemoglobin  8.0  g dl; hematology blood platelet count  131  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  62  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  83  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; heparin flush (10 units ml)  3  ml ; lidocaine 1%  1  ml ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  60  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  82  mg dl$ceftriaxone  2  gm ; heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; heparin flush (10 units ml)  3  ml ; acetaminophen  325-650  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; iohexol 240  50  ml ; sodium chloride 0.9%  flush  10-20  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hematocrit  25.0  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  129  k ul; hematology blood platelet count  118  k ul; chemistry blood anion gap  8  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  56  mg dl; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  88  mg dl; chemistry blood glucose  89  mg dl; chemistry blood albumin  1.9  g dl; blood gas blood free calcium  1.39  mmol l; chemistry blood bilirubin, direct  0.3  mg dl$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; heparin flush (10 units ml)  3  ml ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; iohexol 240  50  ml ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  5  mg ; baclofen  2.5  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.6  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  141  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  4.8  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  54  mg dl; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.8  ; hematology blood inr(pt)  1.8  ; hematology urine wbc  4  # hpf; chemistry blood calcium, total  9.4  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  72  mg dl; chemistry blood glucose  100  mg dl; blood gas blood lactate  1.4  mmol l$heparin  5000  unit ; sodium chloride 0.9%  flush  3-10  ml ; ns  100  ml ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; heparin flush (10 units ml)  3  ml ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; sodium chloride 0.9%  flush  10-20  ml ; warfarin  5  mg ; influenza vaccine quadrivalent  0.5  ml ; dextrose 50%  12.5  gm ; warfarin  1  dose ; diphenhydramine  12.5  mg ; clonazepam  0.25  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.7  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  151  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  118  mg dl; chemistry blood albumin  2.0  g dl; blood gas blood free calcium  1.43  mmol l; blood gas blood lactate  1.0  mmol l; blood gas blood glucose  110  mg dl$heparin  5000  unit ; pantoprazole  40  mg ; ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; warfarin  2.5  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  123  k ul; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  118  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  3.1  ; hematology blood inr(pt)  3.1  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  134  mg dl; chemistry blood albumin  1.7  g dl$heparin  5000  unit ; ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; warfarin  2.5  mg ; 5% dextrose  1  vial ; miconazole powder 2%  1  appl ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.6  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  130  k ul; chemistry blood anion gap  5  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  116  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  46  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  123  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; miconazole powder 2%  1  appl ; neutra-phos  2  pkt ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  25.0  %; hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  122  k ul; hematology blood platelet count  123  k ul; chemistry blood anion gap  6  meq l; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  116  meq l; chemistry blood chloride  115  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.2  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  49  mg dl; chemistry blood urea nitrogen  49  mg dl; hematology blood inr(pt)  2.1  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  108  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; warfarin  1  dose ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.0  %; hematology blood hemoglobin  6.9  g dl; hematology blood platelet count  114  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  51  mg dl; hematology blood inr(pt)  2.2  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  119  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.8  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  122  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  54  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  113  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; neutra-phos  1  pkt ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.5  %; hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  130  k ul; hematology blood platelet count  132  k ul; chemistry blood anion gap  7  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  5.7  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  58  mg dl; chemistry blood urea nitrogen  58  mg dl; hematology blood inr(pt)  2.6  ; hematology blood inr(pt)  2.8  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  113  mg dl; chemistry blood glucose  105  mg dl; chemistry blood albumin  1.7  g dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; neutra-phos  1  pkt ; ramelteon  8  mg ; iso-osmotic sodium chloride  1  bag ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium chloride 0.9%  1000  ml ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.4  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  141  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  130  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  60  mg dl; chemistry blood urea nitrogen  63  mg dl; hematology blood inr(pt)  2.7  ; chemistry urine creatinine, urine  92  mg dl; chemistry urine urea nitrogen, urine  573  mg dl; hematology urine wbc  0  # hpf; hematology urine wbc  102  # hpf; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  103  mg dl; chemistry blood glucose  118  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; iso-osmotic sodium chloride  1  bag ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium chloride 0.9%  1000  ml ; sodium polystyrene sulfonate  15  gm ; furosemide  20  mg ; tamsulosin  0.4  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  21.5  %; hematology blood hemoglobin  6.6  g dl; hematology blood platelet count  106  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  64  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  129  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; sodium polystyrene sulfonate  15  gm ; furosemide  20  mg ; tamsulosin  0.4  mg ; furosemide  80  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  24.6  %; hematology blood hemoglobin  7.8  g dl; hematology blood platelet count  127  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  64  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.6  mg dl; chemistry blood glucose  130  mg dl; chemistry blood glucose  108  mg dl$bag  1  bag ; ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; furosemide  100  mg ; magnesium sulfate  2  gm ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  125  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  129  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  65  mg dl; hematology blood inr(pt)  2.9  ; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  7.3  mg dl; chemistry blood glucose  117  mg dl; chemistry blood glucose  124  mg dl; chemistry blood albumin  1.5  g dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; metoprolol tartrate  25  mg ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; furosemide  250  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.8  %; hematology blood hemoglobin  7.5  g dl; hematology blood platelet count  124  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  18  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  128  meq l; chemistry blood urea nitrogen  70  mg dl; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  2.5  ; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  115  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; furosemide  250  mg ; ferrous gluconate  324  mg ; furosemide  120  mg ; furosemide  160  mg ; chlorothiazide sodium  500  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.6  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  128  meq l; chemistry blood sodium  130  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  69  mg dl; hematology blood inr(pt)  2.6  ; chemistry urine creatinine, urine  15  mg dl; chemistry urine potassium, urine  26  meq l; chemistry urine sodium, urine  93  meq l; chemistry urine urea nitrogen, urine  139  mg dl; hematology urine wbc  6  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  123  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; ferrous gluconate  324  mg ; furosemide  120  mg ; furosemide  160  mg ; chlorothiazide sodium  500  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  22.8  %; hematology blood hemoglobin  7.3  g dl; hematology blood platelet count  115  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  127  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  3.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  83  mg dl; chemistry blood glucose  110  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; furosemide  200  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  22.5  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  116  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  129  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  73  mg dl; chemistry blood urea nitrogen  72  mg dl; hematology blood inr(pt)  2.7  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  92  mg dl; chemistry blood glucose  75  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; furosemide  200  mg ; warfarin  2  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  22.9  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  120  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  71  mg dl; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  3.0  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  97  mg dl; chemistry blood glucose  96  mg dl; chemistry blood glucose  116  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; warfarin  2  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.2  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  129  k ul; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  131  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  69  mg dl; chemistry blood urea nitrogen  70  mg dl; hematology blood inr(pt)  3.6  ; hematology blood inr(pt)  3.4  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  110  mg dl; chemistry blood glucose  104  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.9  %; hematology blood hemoglobin  7.6  g dl; hematology blood platelet count  111  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  68  mg dl; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  3.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  89  mg dl; chemistry blood glucose  104  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; torsemide  80  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.3  %; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  113  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  6  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  66  mg dl; chemistry blood urea nitrogen  73  mg dl; hematology blood inr(pt)  2.3  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  111  mg dl; chemistry blood glucose  77  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; torsemide  80  mg ; torsemide  40  mg ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 76 $nan$hematology blood hematocrit  23.5  %; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  112  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  88  mg dl$ondansetron  4  mg ; atorvastatin  10  mg ; sodium chloride 0.9%  flush  10-20  ml ; influenza vaccine quadrivalent  0.5  ml ; clonazepam  0.25  mg ; lidocaine 5% patch  1  ptch ; sodium chloride 0.9%  flush  10  ml ; nystatin oral suspension  5  ml ; senna  8.6  mg ; polyethylene glycol  17  g ; docusate sodium  100  mg ; ramelteon  8  mg ; tamsulosin  0.4  mg ; chloraseptic throat spray  1  spry ; multivitamins w minerals  1  tab ; 
nephropathy induced by other drugs, medicaments and biological substances adverse effect of diagnostic agents, initial encounter acute on chronic diastolic (congestive) heart failure unspecified atrial flutter chronic kidney disease, stage 3 (moderate) unspecified atrial fibrillation other specified complication of vascular prosthetic devices, implants and grafts, initial encounter long term (current) use of anticoagulants hyperlipidemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified place in unspecified non-institutional (private) residence as the place of occurrence of the external cause other shock acute posthemorrhagic anemia abdominal aortic aneurysm, ruptured surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure acute kidney failure, unspecified patient room in hospital as the place of occurrence of the external cause anuria and oliguria gout, unspecified abdominal aortic aneurysm, without rupture chronic diastolic (congestive) heart failure leakage of other cardiac and vascular devices and implants, initial encounter abnormal coagulation profile unspecified place or not applicable anemia, unspecified hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease unspecified atrial fibrillation chronic kidney disease, unspecified hyperlipidemia, unspecified personal history of other malignant neoplasm of skin presence of xenogenic heart valve long term (current) use of anticoagulants surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure presence of coronary angioplasty implant and graft personal history of nicotine dependence other complications due to other vascular device, implant, and graft acute kidney failure, unspecified leukocytosis, unspecified paralytic ileus congestive heart failure, unspecified acute on chronic diastolic heart failure unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident personal history of tobacco use accidents occurring in other specified places esophageal reflux long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other specified cardiac dysrhythmias
white m 80 $temp  100.3  heartrate  68.0  resprate  17.0  o2sat  94.0  sbp  126.0  dbp  73.0  rhythm    pain  uta  ; temp  101.1  heartrate  56.0  resprate  16.0  o2sat  94.0  sbp  138.0  dbp  66.0  rhythm    pain  uta  ; temp  100.8  heartrate  56.0  resprate  20.0  o2sat  96.0  sbp  123.0  dbp  60.0  rhythm    pain  uta  ; temp    heartrate  51.0  resprate  20.0  o2sat  94.0  sbp  111.0  dbp  62.0  rhythm    pain  sleeping  ; temp  98.6  heartrate  55.0  resprate  20.0  o2sat  98.0  sbp  125.0  dbp  66.0  rhythm    pain  unable  ; temp    heartrate  53.0  resprate  18.0  o2sat  98.0  sbp  126.0  dbp  84.0  rhythm    pain  0  ; temp    heartrate  50.0  resprate  18.0  o2sat  98.0  sbp  114.0  dbp  58.0  rhythm    pain    ; temp    heartrate  60.0  resprate  18.0  o2sat  100.0  sbp  121.0  dbp  75.0  rhythm    pain    $nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; citalopram  20  mg ; donepezil  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; memantine  10  mg ; 
 
white m 80 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; senna  17.2  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ceftriaxone  1  gm ; citalopram  20  mg ; donepezil  10  mg ; acetaminophen  650  mg ; heparin  5000  unit ; memantine  10  mg ; levofloxacin  750  mg ; azithromycin  250  mg ; acetaminophen  500  mg ; psyllium powder  1  pkt ; 
 
white m 80 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  17.2  mg ; citalopram  20  mg ; donepezil  10  mg ; heparin  5000  unit ; memantine  10  mg ; levofloxacin  750  mg ; acetaminophen  500  mg ; psyllium powder  1  pkt ; 
 
white m 80 $nan$nan$pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; senna  17.2  mg ; citalopram  20  mg ; donepezil  10  mg ; heparin  5000  unit ; memantine  10  mg ; acetaminophen  500  mg ; psyllium powder  1  pkt ; 
 
other m 67 $temp  98.4  heartrate  90.0  resprate  22.0  o2sat  93.0  sbp  191.0  dbp  110.0  rhythm    pain  0  ; temp    heartrate  77.0  resprate  26.0  o2sat  99.0  sbp  179.0  dbp  117.0  rhythm    pain    ; temp    heartrate  100.0  resprate  28.0  o2sat  96.0  sbp  170.0  dbp  159.0  rhythm    pain    ; temp    heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp    heartrate  83.0  resprate  19.0  o2sat  93.0  sbp  183.0  dbp  115.0  rhythm    pain    ; temp    heartrate    resprate    o2sat  92.0  sbp    dbp    rhythm    pain    $nan$magnesium oxide  400  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $temp    heartrate  71.0  resprate  22.0  o2sat  93.0  sbp  163.0  dbp  101.0  rhythm    pain    ; temp    heartrate  74.0  resprate  18.0  o2sat  94.0  sbp  160.0  dbp  97.0  rhythm    pain    $hematology blood hematocrit  34.7  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  160  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.3  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  19  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  152  mg dl; chemistry blood glucose  138  mg dl$magnesium oxide  400  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; carvedilol  25  mg ; cyanocobalamin  100  mcg ; lisinopril  20  mg ; furosemide  20  mg ; furosemide  100  mg ; furosemide  80  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  36.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  25  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  170  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  110  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; furosemide  20  mg ; furosemide  100  mg ; furosemide  80  mg ; magnesium sulfate  2  gm ; lisinopril  7.5  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; albuterol 0.083% neb soln  1  neb ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  38.3  %; hematology blood hemoglobin  11.8  g dl; hematology blood platelet count  182  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  35  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  34  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  234  mg dl; chemistry blood glucose  144  mg dl; chemistry blood glucose  159  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; lisinopril  7.5  mg ; 5% dextrose  50  ml ; furosemide  250  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride  20  meq ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  39.2  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  8.9  mg dl; chemistry blood calcium, total  8.8  mg dl; chemistry blood glucose  193  mg dl; chemistry blood glucose  90  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; lisinopril  7.5  mg ; albuterol 0.083% neb soln  1  neb ; potassium chloride  20  meq ; furosemide  160  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  39.0  %; hematology blood hemoglobin  11.9  g dl; hematology blood platelet count  191  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  169  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; lisinopril  7.5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  160  mg ; furosemide  200  mg ; metolazone  2.5  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  34  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  172  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; lisinopril  7.5  mg ; albuterol 0.083% neb soln  1  neb ; furosemide  200  mg ; metolazone  2.5  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  41.2  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  221  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  91  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  45  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  186  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; insulin  6  unit ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$chemistry blood anion gap  17  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  38  mg dl; chemistry blood urea nitrogen  36  mg dl; chemistry blood calcium, total  9.7  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  191  mg dl; chemistry blood glucose  239  mg dl; chemistry blood % hemoglobin a1c  6.8  %$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; insulin  10  unit ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$hematology blood hematocrit  39.9  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  94  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.8  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  36  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  260  mg dl; chemistry blood glucose  240  mg dl; chemistry blood glucose  212  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; insulin  10  unit ; bag  1  bag ; sarna lotion  1  appl ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$chemistry blood anion gap  10  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  32  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.7  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  37  mg dl; chemistry blood urea nitrogen  35  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  176  mg dl; chemistry blood glucose  185  mg dl; blood gas blood potassium, whole blood  4.3  meq l$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; bag  1  bag ; sarna lotion  1  appl ; insulin  12  unit ; torsemide  40  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  33  meq l; chemistry blood chloride  95  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  33  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  167  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; sarna lotion  1  appl ; insulin  12  unit ; torsemide  40  mg ; lisinopril  2.5  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
other m 67 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  2  puff ; fluticasone propionate nasal  2  spry ; polyethylene glycol  17  g ; atorvastatin  20  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; rivaroxaban  20  mg ; spironolactone  25  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; acetaminophen  650  mg ; vitamin d  1000  unit ; folic acid  1  mg ; multivitamins  1  tab ; cyanocobalamin  100  mcg ; albuterol 0.083% neb soln  1  neb ; sarna lotion  1  appl ; insulin  12  unit ; torsemide  40  mg ; lisinopril  2.5  mg ; 
chronic kidney disease, unspecified type 2 diabetes mellitus with diabetic chronic kidney disease obesity, unspecified long term (current) use of anticoagulants unspecified atrial fibrillation hyperlipidemia, unspecified syncope and collapse unspecified atrial flutter personal history of sudden cardiac arrest obstructive sleep apnea (adult) (pediatric) personal history of other venous thrombosis and embolism hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease body mass index (bmi) 40.0-44.9, adult acute kidney failure with tubular necrosis unspecified asthma, uncomplicated unspecified fall, initial encounter encounter for examination for normal comparison and control in clinical research program benign paroxysmal vertigo, unspecified ear respiratory failure, unspecified with hypercapnia multiple fractures of ribs, bilateral, initial encounter for closed fracture coma scale, best motor response, none, at hospital admission chronic kidney disease, stage 2 (mild) acute embolism and thrombosis of deep veins of left upper extremity nutritional anemia, unspecified type 2 diabetes mellitus with hyperglycemia type 2 diabetes mellitus with diabetic chronic kidney disease long term (current) use of oral hypoglycemic drugs cardiac arrest, cause unspecified delirium due to known physiological condition long term (current) use of anticoagulants ventricular tachycardia encephalopathy, unspecified other forms of acute ischemic heart disease unspecified atrial flutter thrombocytopenia, unspecified deficiency of other specified b group vitamins unspecified atrial fibrillation traumatic subarachnoid hemorrhage without loss of consciousness, initial encounter personal history of nicotine dependence dilated cardiomyopathy obstructive sleep apnea (adult) (pediatric) cyst of kidney, acquired hyperosmolality and hypernatremia acute systolic (congestive) heart failure hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease obesity, unspecified other place in hospital as the place of occurrence of the external cause pneumonitis due to inhalation of food and vomit
white m 54 $nan$hematology blood hematocrit  36.0  %; hematology blood hematocrit  25.6  %; hematology blood hematocrit  25.9  %; hematology blood hematocrit  28.9  %; hematology blood hemoglobin  12.0  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  178  k ul; hematology blood platelet count  113  k ul; hematology blood platelet count  155  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  16  meq l; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  107  meq l; chemistry blood creatinine  9.9  mg dl; chemistry blood creatinine  9.1  mg dl; chemistry blood creatinine  9.2  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  7.7  meq l; chemistry blood sodium  143  meq l; chemistry blood sodium  145  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  59  mg dl; chemistry blood urea nitrogen  57  mg dl; chemistry blood urea nitrogen  67  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  87  mg dl; chemistry blood glucose  151  mg dl; chemistry blood albumin  5.0  g dl; blood gas blood free calcium  0.90  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  107  meq l; blood gas blood glucose  103  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.5  g dl; blood gas blood potassium, whole blood  6.4  meq l; blood gas blood sodium, whole blood  138  meq l; hematology blood wbc count  6.0  k ul$0.9% sodium chloride  50  ml ; methylprednisolone sodium succ  500  mg ; mycophenolate mofetil  1000  mg ; heparin  5000  unit ; prochlorperazine  5-10  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; ondansetron  4  mg ; sulfameth trimethoprim ss  1  tab ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; valganciclovir  450  mg ; lamivudine  50  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; 5 syringes (ns)  250  ml ; anti-thymocyte globulin (rabbit)  75  mg ; dextrose 5%  100  ml ; levofloxacin  500  mg ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; 1 2 ns  1000  ml ; pantoprazole  40  mg ; morphine sulfate  1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; nystatin oral suspension  5  ml ; fosamprenavir  700  mg ; tacrolimus  1  mg ; docusate sodium  100  mg ; ritonavir  100  mg ; gemfibrozil  600  mg ; furosemide  40  mg ; dextrose 50%  25  gm ; insulin  10  unit ; sodium bicarbonate  150  meq ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium bicarbonate  50  meq ; 
 
white m 54 $nan$hematology blood hematocrit  27.4  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  161  k ul; chemistry blood anion gap  23  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  10.0  mg dl; chemistry blood creatinine  6.5  mg dl; chemistry blood creatinine  7.1  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.6  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  41  mg dl; chemistry blood urea nitrogen  55  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  168  mg dl; chemistry blood glucose  192  mg dl; chemistry blood glucose  142  mg dl$sulfameth trimethoprim ss  1  tab ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; valganciclovir  450  mg ; lamivudine  50  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; pantoprazole  40  mg ; morphine sulfate  1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; nystatin oral suspension  5  ml ; fosamprenavir  700  mg ; tacrolimus  1  mg ; docusate sodium  100  mg ; ritonavir  100  mg ; dextrose 50%  25  gm ; insulin  10  unit ; 0.9% sodium chloride  2  bag ; calcium gluconate  4  g ; sodium bicarbonate  50  meq ; methylprednisolone sodium succ  100  mg ; insulin  0  unit ; 
 
white m 54 $nan$hematology blood hematocrit  22.6  %; hematology blood hematocrit  24.3  %; hematology blood hemoglobin  7.8  g dl; hematology blood hemoglobin  8.2  g dl; hematology blood platelet count  128  k ul; hematology blood platelet count  139  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  8.2  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  84  mg dl; chemistry blood calcium, total  6.7  mg dl; chemistry blood glucose  133  mg dl$sulfameth trimethoprim ss  1  tab ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; valganciclovir  450  mg ; lamivudine  50  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; pantoprazole  40  mg ; morphine sulfate  1  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; nystatin oral suspension  5  ml ; fosamprenavir  700  mg ; docusate sodium  100  mg ; ritonavir  100  mg ; insulin  0  unit ; tenofovir disoproxil (viread)  300  mg ; oxycodone-acetaminophen  1-2  tab ; tacrolimus  0  mg ; methylprednisolone sodium succ  50  mg ; 
 
white m 54 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  133  k ul; chemistry blood anion gap  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  8.4  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  101  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood glucose  163  mg dl; chemistry blood lactate dehydrogenase (ld)  250  iu l$sulfameth trimethoprim ss  1  tab ; 0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; valganciclovir  450  mg ; lamivudine  50  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; heparin flush (10 units ml)  1  ml ; d5 1 2ns  1000  ml ; pantoprazole  40  mg ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; nystatin oral suspension  5  ml ; fosamprenavir  700  mg ; docusate sodium  100  mg ; ritonavir  100  mg ; insulin  0  unit ; tenofovir disoproxil (viread)  300  mg ; oxycodone-acetaminophen  1-2  tab ; tacrolimus  0  mg ; furosemide  60  mg ; furosemide  80  mg ; tacrolimus (self med)  1  mg ; transplant self medication program  1  bag ; bisacodyl  10  mg ; tacrolimus  0.5  mg ; 
 
white m 54 $nan$nan$0.9% sodium chloride  250  ml ; anti-thymocyte globulin (rabbit)  0  md to order daily dose ; lamivudine  50  mg ; levothyroxine sodium  112  mcg ; levothyroxine sodium  25  mcg ; heparin flush (10 units ml)  1  ml ; acetaminophen  650  mg ; diphenhydramine  25-50  mg ; fosamprenavir  700  mg ; docusate sodium  100  mg ; ritonavir  100  mg ; tenofovir disoproxil (viread)  300  mg ; oxycodone-acetaminophen  1-2  tab ; furosemide  80  mg ; tacrolimus (self med)  1  mg ; transplant self medication program  1  bag ; bisacodyl  10  mg ; tacrolimus  0.5  mg ; calcium carbonate  1000  mg ; prednisolone acetate 1% ophth. susp.  1  drop ; prednisone  25  mg ; 
 
hispanic latino f 52 $nan$nan$aspirin  81  mg ; simvastatin  40  mg ; metoprolol succinate xl  25  mg ; losartan potassium  50  mg ; paroxetine  60  mg ; 
asthma, unspecified type, unspecified tobacco use disorder heart valve replaced by other means atherosclerosis of native arteries of the extremities with intermittent claudication abnormal coagulation profile person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension rheumatic heart disease, unspecified examination of participant in clinical trial major depressive affective disorder, single episode, unspecified major depressive affective disorder, single episode, unspecified abnormal coagulation profile other and unspecified hyperlipidemia unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled heart valve replaced by other means coronary atherosclerosis of native coronary artery asthma, unspecified type, unspecified long-term (current) use of anticoagulants personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension other chest pain 
hispanic latino f 52 $nan$hematology blood hematocrit  33.0  %; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  134  meq l; hematology blood inr(pt)  1.1  $aspirin  81  mg ; simvastatin  40  mg ; metoprolol succinate xl  25  mg ; losartan potassium  50  mg ; paroxetine  60  mg ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; insulin  0  unit ; warfarin  5  mg ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; docusate sodium  100  mg ; clopidogrel  75  mg ; enoxaparin sodium  100  mg ; 
asthma, unspecified type, unspecified tobacco use disorder heart valve replaced by other means atherosclerosis of native arteries of the extremities with intermittent claudication abnormal coagulation profile person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension rheumatic heart disease, unspecified examination of participant in clinical trial major depressive affective disorder, single episode, unspecified major depressive affective disorder, single episode, unspecified abnormal coagulation profile other and unspecified hyperlipidemia unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled heart valve replaced by other means coronary atherosclerosis of native coronary artery asthma, unspecified type, unspecified long-term (current) use of anticoagulants personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension other chest pain 
hispanic latino f 52 $nan$nan$aspirin  81  mg ; simvastatin  40  mg ; metoprolol succinate xl  25  mg ; losartan potassium  50  mg ; paroxetine  60  mg ; pneumococcal vac polyvalent  0.5  ml ; 0.9% sodium chloride  1000  ml ; senna  1  tab ; albuterol 0.083% neb soln  1  neb ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; lorazepam  1  mg ; insulin  0  unit ; warfarin  5  mg ; docusate sodium  100  mg ; clopidogrel  75  mg ; enoxaparin sodium  100  mg ; 
asthma, unspecified type, unspecified tobacco use disorder heart valve replaced by other means atherosclerosis of native arteries of the extremities with intermittent claudication abnormal coagulation profile person on outside of bus injured in collision with pedestrian or animal in traffic accident anxiety state, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident other and unspecified hyperlipidemia unspecified essential hypertension rheumatic heart disease, unspecified examination of participant in clinical trial major depressive affective disorder, single episode, unspecified major depressive affective disorder, single episode, unspecified abnormal coagulation profile other and unspecified hyperlipidemia unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled heart valve replaced by other means coronary atherosclerosis of native coronary artery asthma, unspecified type, unspecified long-term (current) use of anticoagulants personal history of noncompliance with medical treatment, presenting hazards to health unspecified essential hypertension other chest pain 
white f 53 $nan$hematology urine wbc  44  # hpf$nan
hypovolemia suicide and self-inflicted injury by other specified means unspecified acquired hypothyroidism swelling of limb hypotension, unspecified pain in limb retention of urine, unspecified contusion of forearm home accidents contusion of forearm accidents occurring in unspecified place unspecified acquired hypothyroidism suicide and self-inflicted injury by other specified means major depressive affective disorder, single episode, unspecified urinary tract infection, site not specified swelling of limb pain in limb dysthymic disorder suicide and self-inflicted injury by other specified means accidents occurring in unspecified place pain in limb suicide and self-inflicted injury by other specified means contusion of forearm unspecified acquired hypothyroidism home accidents major depressive affective disorder, single episode, unspecified pain in limb unspecified fall swelling of limb other specified metabolic disorders unspecified acquired hypothyroidism unspecified acquired hypothyroidism major depressive affective disorder, single episode, unspecified suicidal ideation elbow, forearm, and wrist injury major depressive affective disorder, single episode, unspecified hypertonicity of bladder suicide and self-inflicted injury by cutting and piercing instrument unspecified acquired hypothyroidism major depressive affective disorder, recurrent episode, unspecified unspecified acquired hypothyroidism major depressive affective disorder, recurrent episode, unspecified unspecified acquired hypothyroidism 
white m 57 $temp    heartrate  84.0  resprate  16.0  o2sat  100.0  sbp  112.0  dbp  55.0  rhythm    pain  9  $hematology blood hematocrit  44.2  %; hematology blood hemoglobin  14.7  g dl; hematology blood platelet count  192  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  98  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood glucose  90  mg dl$sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; multivitamins  1  tab ; zolpidem tartrate  5  mg ; ciprofloxacin hcl  500  mg ; diltiazem extended-release  240  mg ; levetiracetam  500  mg ; levothyroxine sodium  175  mcg ; lisinopril  20  mg ; prednisone  10  mg ; prednisone  15  mg ; loratadine  10  mg ; magnesium citrate  300  ml ; 
unspecified asthma, uncomplicated obstruction of bile duct localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus dorsalgia, unspecified personal history of malignant melanoma of skin hypopituitarism other postprocedural complications and disorders of digestive system secondary malignant neoplasm of unspecified lung obstructive sleep apnea (adult) (pediatric) unspecified place or not applicable essential (primary) hypertension other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure constipation, unspecified hypothyroidism, unspecified insomnia, unspecified do not resuscitate acute pancreatitis without necrosis or infection, unspecified 
white m 57 $nan$hematology blood hematocrit  40.3  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  226  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  78  mg dl$sodium chloride 0.9%  flush  3  ml ; hydromorphone (dilaudid)  0.5  mg ; heparin  5000  unit ; albuterol inhaler  2  puff ; multivitamins  1  tab ; zolpidem tartrate  5  mg ; ciprofloxacin hcl  500  mg ; diltiazem extended-release  240  mg ; levetiracetam  500  mg ; levothyroxine sodium  175  mcg ; lisinopril  20  mg ; prednisone  15  mg ; loratadine  10  mg ; magnesium citrate  300  ml ; lorazepam  0.25  mg ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; morphine sulfate  2  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; 
unspecified asthma, uncomplicated obstruction of bile duct localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus dorsalgia, unspecified personal history of malignant melanoma of skin hypopituitarism other postprocedural complications and disorders of digestive system secondary malignant neoplasm of unspecified lung obstructive sleep apnea (adult) (pediatric) unspecified place or not applicable essential (primary) hypertension other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure constipation, unspecified hypothyroidism, unspecified insomnia, unspecified do not resuscitate acute pancreatitis without necrosis or infection, unspecified 
white m 57 $nan$hematology blood hematocrit  41.9  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  244  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  23  mg dl; chemistry blood bilirubin, total  1.0  mg dl; chemistry blood glucose  68  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; multivitamins  1  tab ; zolpidem tartrate  5  mg ; ciprofloxacin hcl  500  mg ; diltiazem extended-release  240  mg ; levetiracetam  500  mg ; levothyroxine sodium  175  mcg ; lisinopril  20  mg ; prednisone  15  mg ; loratadine  10  mg ; lorazepam  0.25  mg ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; morphine sulfate  2  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; 
unspecified asthma, uncomplicated obstruction of bile duct localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus dorsalgia, unspecified personal history of malignant melanoma of skin hypopituitarism other postprocedural complications and disorders of digestive system secondary malignant neoplasm of unspecified lung obstructive sleep apnea (adult) (pediatric) unspecified place or not applicable essential (primary) hypertension other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure constipation, unspecified hypothyroidism, unspecified insomnia, unspecified do not resuscitate acute pancreatitis without necrosis or infection, unspecified 
white m 57 $nan$hematology blood hematocrit  41.0  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  262  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  24  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  62  mg dl; chemistry blood lactate dehydrogenase (ld)  264  iu l; chemistry blood albumin  2.8  g dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; multivitamins  1  tab ; zolpidem tartrate  5  mg ; diltiazem extended-release  240  mg ; levetiracetam  500  mg ; levothyroxine sodium  175  mcg ; lisinopril  20  mg ; prednisone  15  mg ; loratadine  10  mg ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; morphine sulfate  2  mg ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
unspecified asthma, uncomplicated obstruction of bile duct localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus dorsalgia, unspecified personal history of malignant melanoma of skin hypopituitarism other postprocedural complications and disorders of digestive system secondary malignant neoplasm of unspecified lung obstructive sleep apnea (adult) (pediatric) unspecified place or not applicable essential (primary) hypertension other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure constipation, unspecified hypothyroidism, unspecified insomnia, unspecified do not resuscitate acute pancreatitis without necrosis or infection, unspecified 
white m 57 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; albuterol inhaler  2  puff ; multivitamins  1  tab ; zolpidem tartrate  5  mg ; diltiazem extended-release  240  mg ; levetiracetam  500  mg ; levothyroxine sodium  175  mcg ; lisinopril  20  mg ; prednisone  15  mg ; loratadine  10  mg ; bisacodyl  10  mg ; fluticasone propionate nasal  1  spry ; morphine sulfate  2  mg ; sodium chloride 0.9%  1000  ml ; simethicone  40-80  mg ; acetaminophen  500-1000  mg ; calcium carbonate  500  mg ; polyethylene glycol  17  g ; 
unspecified asthma, uncomplicated obstruction of bile duct localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus dorsalgia, unspecified personal history of malignant melanoma of skin hypopituitarism other postprocedural complications and disorders of digestive system secondary malignant neoplasm of unspecified lung obstructive sleep apnea (adult) (pediatric) unspecified place or not applicable essential (primary) hypertension other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure constipation, unspecified hypothyroidism, unspecified insomnia, unspecified do not resuscitate acute pancreatitis without necrosis or infection, unspecified 
white m 57 $temp  97.6  heartrate  78.0  resprate  18.0  o2sat  98.0  sbp  137.0  dbp  69.0  rhythm    pain  4  $hematology blood hematocrit  37.6  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.6  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  56  mg dl; chemistry blood calcium, total  9.0  mg dl; chemistry blood glucose  85  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; sodium chloride 0.9%  1000  ml ; anastrozole  1  mg ; lamotrigine  200  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; 
obesity, unspecified severe sepsis constipation, unspecified acute kidney failure, unspecified straining on urination sulfonamides causing adverse effects in therapeutic use other specified forms of chronic ischemic heart disease generalized convulsive epilepsy, without mention of intractable epilepsy unspecified essential hypertension methicillin susceptible staphylococcus aureus septicemia venous (peripheral) insufficiency, unspecified cellulitis and abscess of leg, except foot hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) septic shock
white m 57 $nan$hematology blood hematocrit  38.1  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  149  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  5.3  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  39  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  108  mg dl; hematology urine glucose  1000  mg dl$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; acetaminophen  1000  mg ; oxycodone (immediate release)   5  mg ; anastrozole  1  mg ; lamotrigine  200  mg ; aspirin  81  mg ; polyethylene glycol  17  g ; lactated ringers  1000  ml ; 
obesity, unspecified severe sepsis constipation, unspecified acute kidney failure, unspecified straining on urination sulfonamides causing adverse effects in therapeutic use other specified forms of chronic ischemic heart disease generalized convulsive epilepsy, without mention of intractable epilepsy unspecified essential hypertension methicillin susceptible staphylococcus aureus septicemia venous (peripheral) insufficiency, unspecified cellulitis and abscess of leg, except foot hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts) septic shock
white f 74 $temp  98.3  heartrate  100.0  resprate  17.0  o2sat  95.0  sbp  148.0  dbp  87.0  rhythm    pain  10  ; temp  97.7  heartrate  97.0  resprate  16.0  o2sat  95.0  sbp  143.0  dbp  77.0  rhythm    pain  10  $hematology blood hematocrit  35.8  %; hematology blood hemoglobin  12.0  g dl; hematology blood platelet count  391  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood glucose  176  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  27.7  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  9.3  g dl; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  351  k ul; hematology blood platelet count  311  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  9  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood glucose  103  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; hydralazine  10  mg ; lactated ringers  1000  ml ; albuterol inhaler  1-2  puff ; metoprolol tartrate  5  mg ; morphine sulfate  2-4  mg ; heparin  1100-2200  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; fluticasone-salmeterol diskus (100 50)  1  inh ; atorvastatin  80  mg ; potassium chloride  60  meq ; prednisone  5  mg ; warfarin  2  mg ; bag  2  bag ; magnesium sulfate  4  gm ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  23.7  %; hematology blood hematocrit  27.3  %; hematology blood hemoglobin  7.9  g dl; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  365  k ul; hematology blood platelet count  408  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  94  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; morphine sulfate  2-4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; atorvastatin  80  mg ; prednisone  5  mg ; warfarin  2  mg ; oxycodone (immediate release)   5-10  mg ; bumetanide  1  mg ; enoxaparin sodium  60  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  25.2  %; hematology blood hemoglobin  8.6  g dl; hematology blood platelet count  395  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  107  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; morphine sulfate  2-4  mg ; fluticasone-salmeterol diskus (100 50)  1  inh ; atorvastatin  80  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; bumetanide  1  mg ; enoxaparin sodium  60  mg ; nifedipine cr  60  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  435  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  5  mg dl; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  84  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; fluticasone-salmeterol diskus (100 50)  1  inh ; atorvastatin  80  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; bumetanide  1  mg ; enoxaparin sodium  60  mg ; nifedipine cr  60  mg ; readi-cat 2 (barium sulfate 2% suspension)  900  ml ; warfarin  5  mg ; warfarin  3  mg ; acetaminophen  325-650  mg ; losartan potassium  25  mg ; losartan potassium  50  mg ; potassium chloride  40  meq ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  8.3  g dl; hematology blood platelet count  438  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  308  iu l; chemistry blood albumin  2.9  g dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; fluticasone-salmeterol diskus (100 50)  1  inh ; atorvastatin  80  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; bumetanide  1  mg ; enoxaparin sodium  60  mg ; nifedipine cr  60  mg ; acetaminophen  325-650  mg ; losartan potassium  25  mg ; losartan potassium  50  mg ; potassium chloride  40  meq ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; aspirin  81  mg ; losartan potassium  75  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  30.0  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  578  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  6  mg dl; hematology blood inr(pt)  1.6  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  90  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; oxycodone (immediate release)   5-10  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; pneumococcal 23-valent polysaccharide vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   10  mg ; lidocaine 5% patch  1  ptch ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  509  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  86  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   5  mg ; oxycodone (immediate release)   10  mg ; lidocaine 5% patch  1  ptch ; heparin  4500  unit ; warfarin  1  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  29.8  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  483  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  2.5  ; hematology urine wbc  11  # hpf; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  87  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; oxycodone (immediate release)   10  mg ; lidocaine 5% patch  1  ptch ; heparin  4500  unit ; warfarin  1  mg ; calcium carbonate  500  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  499  k ul; hematology blood inr(pt)  2.3  $montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; warfarin  1.5  mg ; ondansetron  4  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  473  k ul; hematology blood inr(pt)  2.5  $montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; levofloxacin  750  mg ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; warfarin  1.5  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  30.7  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  441  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  89  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; sodium chloride 0.9%  1000  ml ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  31.0  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  282  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.7  ; chemistry blood glucose  85  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; sodium chloride 0.9%  1000  ml ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood platelet count  288  k ul$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  35.3  %; hematology blood hematocrit  30.5  %; hematology blood hemoglobin  11.6  g dl; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  292  k ul; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.5  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  92  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen  650  mg ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$hematology blood hematocrit  31.4  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  79  mg dl$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen  1000  mg ; metoprolol succinate xl  12.5  mg ; 0.9% sodium chloride  500  ml ; bag  1  bag ; magnesium sulfate  2  gm ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
white f 74 $nan$nan$montelukast  10  mg ; omeprazole  20  mg ; tiotropium bromide  1  cap ; albuterol inhaler  1-2  puff ; atorvastatin  80  mg ; prednisone  5  mg ; bumetanide  1  mg ; sodium chloride 0.9%  flush  3  ml ; losartan potassium  75  mg ; docusate sodium  100  mg ; senna  8.6  mg ; lidocaine 5% patch  1  ptch ; calcium carbonate  500  mg ; ondansetron  4  mg ; polyethylene glycol  17  g ; prochlorperazine  10  mg ; acetaminophen  1000  mg ; 
neurologic neglect syndrome encephalopathy, unspecified unspecified essential hypertension other diuretics causing adverse effects in therapeutic use long-term (current) use of steroids other and unspecified hyperlipidemia alkalosis systemic inflammatory response syndrome, unspecified retention of urine, unspecified rhabdomyolysis history of fall hyperosmolality and/or hypernatremia personal history of tobacco use hypopotassemia physical restraints status long-term (current) use of aspirin atheroembolism of lower extremity obstructive chronic bronchitis with (acute) exacerbation disturbance of skin sensation accidents occurring in residential institution other acute and subacute forms of ischemic heart disease, other atheroembolism of upper extremity acidosis cerebral embolism with cerebral infarction obesity, unspecified 
black african american f 50 $nan$nan$hydrochlorothiazide  25  mg ; methadone  120  mg ; aspirin  325  mg ; 
 
black african american f 50 $nan$hematology blood hematocrit  34.0  %; hematology blood hemoglobin  11.3  g dl; hematology blood platelet count  207  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  92  mg dl$hydrochlorothiazide  25  mg ; methadone  120  mg ; aspirin  325  mg ; 1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; nitroglycerin  100  mg ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; metoprolol  25  mg ; heparin  5000  unit ; captopril  6.25  mg ; morphine sulfate  1  mg ; captopril  12.5  mg ; lisinopril  20  mg ; atenolol  25  mg ; lisinopril  40  mg ; amlodipine  5  mg ; 
 
black african american f 50 $nan$hematology blood hematocrit  38.5  %; hematology blood hemoglobin  12.5  g dl; hematology blood platelet count  143  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  11  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  101  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$hydrochlorothiazide  25  mg ; methadone  120  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; d5w  250  ml ; nitroglycerin  100  mg ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; heparin  5000  unit ; morphine sulfate  1  mg ; atenolol  25  mg ; lisinopril  40  mg ; amlodipine  5  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; amlodipine  10  mg ; 
 
black african american f 50 $nan$hematology blood hematocrit  38.0  %; hematology blood hemoglobin  12.9  g dl; hematology blood platelet count  169  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood glucose  93  mg dl$hydrochlorothiazide  25  mg ; methadone  120  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; atenolol  25  mg ; lisinopril  40  mg ; potassium chloride  40  meq ; magnesium sulfate  2  gm ; amlodipine  10  mg ; 
 
black african american f 50 $nan$nan$hydrochlorothiazide  25  mg ; methadone  120  mg ; aspirin  325  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; ibuprofen  400  mg ; acetaminophen  325-650  mg ; atenolol  25  mg ; lisinopril  40  mg ; 
 
white f 59 $temp  99.8  heartrate    resprate    o2sat    sbp    dbp    rhythm    pain    ; temp  98.9  heartrate  106.0  resprate  16.0  o2sat    sbp  109.0  dbp  65.0  rhythm    pain  0  ; temp  99.1  heartrate  103.0  resprate  16.0  o2sat    sbp  101.0  dbp  70.0  rhythm    pain  0  $nan$ondansetron odt  4  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; omeprazole  20  mg ; gabapentin  200  mg ; prednisone  50  mg ; azathioprine  200  mg ; sulfameth trimethoprim ss  1  tab ; 
hypotension, unspecified hip joint replacement anemia, unspecified car passenger injured in collision with van in traffic accident wegener's granulomatosis hyposmolality and/or hyponatremia
white f 59 $temp  98.7  heartrate  102.0  resprate  16.0  o2sat    sbp  99.0  dbp  59.0  rhythm    pain  0  $hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  139  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  107  mg dl; blood gas blood lactate  2.2  mmol l$ondansetron odt  4  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; omeprazole  20  mg ; gabapentin  200  mg ; prednisone  50  mg ; azathioprine  200  mg ; sulfameth trimethoprim ss  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; 0.9% sodium chloride  1000  ml ; insulin  0  unit ; gabapentin  300  mg ; clonazepam  2  mg ; clonazepam  1  mg ; 5% dextrose  100  ml ; tigecycline  100  mg ; acetaminophen  1000  mg ; ciprofloxacin hcl  500  mg ; metronidazole (flagyl)  500  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
hypotension, unspecified hip joint replacement anemia, unspecified car passenger injured in collision with van in traffic accident wegener's granulomatosis hyposmolality and/or hyponatremia
white f 59 $nan$hematology blood hematocrit  27.0  %; hematology blood hemoglobin  9.3  g dl; hematology blood platelet count  156  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  112  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  13  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  105  mg dl$ondansetron odt  4  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; omeprazole  20  mg ; gabapentin  200  mg ; prednisone  50  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; gabapentin  300  mg ; clonazepam  1  mg ; acetaminophen  1000  mg ; 0.9% sodium chloride  1  bag ; calcium gluconate  2  g ; potassium chloride  40  meq ; bag  50  ml ; magnesium sulfate  2  gm ; 
hypotension, unspecified hip joint replacement anemia, unspecified car passenger injured in collision with van in traffic accident wegener's granulomatosis hyposmolality and/or hyponatremia
white f 59 $nan$nan$ondansetron odt  4  mg ; multivitamins  1  tab ; calcium carbonate  500  mg ; vitamin d  400  unit ; fish oil (omega 3)  1000  mg ; omeprazole  20  mg ; gabapentin  200  mg ; prednisone  50  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; gabapentin  300  mg ; clonazepam  1  mg ; 
hypotension, unspecified hip joint replacement anemia, unspecified car passenger injured in collision with van in traffic accident wegener's granulomatosis hyposmolality and/or hyponatremia
black african american f 62 $nan$hematology blood hematocrit  38.4  %; hematology blood hemoglobin  12.8  g dl; hematology blood platelet count  261  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood glucose  116  mg dl; blood gas blood lactate  0.7  mmol l$nan
 
black african american f 62 $nan$hematology blood hematocrit  38.2  %; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  234  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  15  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  207  mg dl$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; diclofenac sodium dr  50  mg ; glyburide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  40  mg ; lisinopril  10  mg ; nifedipine cr  90  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.25  mg ; insulin  0  unit ; acetaminophen  1000  mg ; 
 
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; diclofenac sodium dr  50  mg ; glyburide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  40  mg ; lisinopril  10  mg ; nifedipine cr  90  mg ; aspirin  81  mg ; hydromorphone (dilaudid)  0.25  mg ; insulin  0  unit ; acetaminophen  1000  mg ; nicotine patch  14  mg ; 
 
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; diclofenac sodium dr  50  mg ; glyburide  5  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; atorvastatin  40  mg ; lisinopril  10  mg ; nifedipine cr  90  mg ; aspirin  81  mg ; insulin  0  unit ; acetaminophen  1000  mg ; nicotine patch  14  mg ; nicotine patch  21  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
 
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; diclofenac sodium dr  50  mg ; glyburide  5  mg ; atorvastatin  40  mg ; lisinopril  10  mg ; nifedipine cr  90  mg ; aspirin  81  mg ; insulin  0  unit ; acetaminophen  1000  mg ; nicotine patch  21  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
 
black african american f 62 $nan$nan$sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; oxycodone (immediate release)   5-10  mg ; diclofenac sodium dr  50  mg ; glyburide  5  mg ; atorvastatin  40  mg ; lisinopril  10  mg ; nifedipine cr  90  mg ; aspirin  81  mg ; insulin  0  unit ; acetaminophen  1000  mg ; nicotine patch  21  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; ampicillin-sulbactam  3  g ; 
 
white m 90 $nan$nan$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  80  mg ; levothyroxine sodium  50  mcg ; 
hemorrhage of gastrointestinal tract, unspecified subendocardial infarction, initial episode of care atrial fibrillation pressure ulcer, stage ii chronic diastolic heart failure coronary atherosclerosis of native coronary artery benign neoplasm of duodenum, jejunum, and ileum heart valve replaced by other means acute kidney failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diaphragmatic hernia without mention of obstruction or gangrene hyperosmolality and/or hypernatremia pressure ulcer, buttock chronic kidney disease, stage ii (mild) long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate pressure ulcer, lower back senile dementia with delirium urethral stricture, unspecified acute posthemorrhagic anemia
white m 90 $nan$hematology blood hematocrit  26.2  %; hematology blood hematocrit  23.4  %; hematology blood hematocrit  22.2  %; hematology blood hematocrit  23.4  %; hematology blood hemoglobin  8.4  g dl; hematology blood hemoglobin  7.5  g dl; hematology blood hemoglobin  7.0  g dl; hematology blood platelet count  128  k ul; hematology blood platelet count  118  k ul; hematology blood platelet count  112  k ul; chemistry blood anion gap  15  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.3  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  3.3  ; hematology blood inr(pt)  2.9  ; hematology blood inr(pt)  3.2  ; chemistry urine creatinine, urine  83  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood calcium, total  6.8  mg dl; chemistry blood glucose  138  mg dl; chemistry blood glucose  110  mg dl; chemistry urine protein creatinine ratio  0.5  ratio; blood gas blood lactate  1.0  mmol l$ceftriaxone  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  80  mg ; levothyroxine sodium  50  mcg ; metoprolol tartrate  12.5  mg ; oseltamivir  75  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; iso-osmotic dextrose  50  ml ; acetaminophen  325-650  mg ; 0.9% sodium chloride  500  ml ; 0.9% sodium chloride (mini bag plus)  100  ml ; piperacillin-tazobactam  4.5  gm ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; 
hemorrhage of gastrointestinal tract, unspecified subendocardial infarction, initial episode of care atrial fibrillation pressure ulcer, stage ii chronic diastolic heart failure coronary atherosclerosis of native coronary artery benign neoplasm of duodenum, jejunum, and ileum heart valve replaced by other means acute kidney failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diaphragmatic hernia without mention of obstruction or gangrene hyperosmolality and/or hypernatremia pressure ulcer, buttock chronic kidney disease, stage ii (mild) long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate pressure ulcer, lower back senile dementia with delirium urethral stricture, unspecified acute posthemorrhagic anemia
white m 90 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  24.8  %; hematology blood hematocrit  25.8  %; hematology blood hemoglobin  7.9  g dl; hematology blood platelet count  101  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood potassium  3.0  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  28  mg dl; hematology blood inr(pt)  3.6  ; chemistry blood calcium, total  6.9  mg dl; chemistry blood glucose  80  mg dl; chemistry blood lactate dehydrogenase (ld)  307  iu l$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  80  mg ; levothyroxine sodium  50  mcg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; pantoprazole sodium  40  mg ; acetaminophen  325-650  mg ; 0.9% sodium chloride  500  ml ; piperacillin-tazobactam  2.25  g ; 0.9% sodium chloride  1000  ml ; 5% dextrose  250  ml ; norepinephrine  8  mg ; potassium chloride  40  meq ; omeprazole  20  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; senna  1  tab ; docusate sodium  100  mg ; furosemide  40  mg ; 
hemorrhage of gastrointestinal tract, unspecified subendocardial infarction, initial episode of care atrial fibrillation pressure ulcer, stage ii chronic diastolic heart failure coronary atherosclerosis of native coronary artery benign neoplasm of duodenum, jejunum, and ileum heart valve replaced by other means acute kidney failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diaphragmatic hernia without mention of obstruction or gangrene hyperosmolality and/or hypernatremia pressure ulcer, buttock chronic kidney disease, stage ii (mild) long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate pressure ulcer, lower back senile dementia with delirium urethral stricture, unspecified acute posthemorrhagic anemia
white m 90 $nan$hematology blood hematocrit  26.6  %$iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; simvastatin  80  mg ; levothyroxine sodium  50  mcg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; piperacillin-tazobactam  2.25  g ; 5% dextrose  250  ml ; norepinephrine  8  mg ; potassium chloride  40  meq ; omeprazole  20  mg ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; senna  1  tab ; docusate sodium  100  mg ; furosemide  40  mg ; 
hemorrhage of gastrointestinal tract, unspecified subendocardial infarction, initial episode of care atrial fibrillation pressure ulcer, stage ii chronic diastolic heart failure coronary atherosclerosis of native coronary artery benign neoplasm of duodenum, jejunum, and ileum heart valve replaced by other means acute kidney failure, unspecified unspecified car occupant injured in collision with car, pick-up truck or van in nontraffic accident diaphragmatic hernia without mention of obstruction or gangrene hyperosmolality and/or hypernatremia pressure ulcer, buttock chronic kidney disease, stage ii (mild) long-term (current) use of anticoagulants hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified other and unspecified hyperlipidemia personal history of malignant neoplasm of prostate pressure ulcer, lower back senile dementia with delirium urethral stricture, unspecified acute posthemorrhagic anemia
black african american f 71 $temp  97.1  heartrate  68.0  resprate  18.0  o2sat  97.0  sbp  121.0  dbp  67.0  rhythm    pain  0  $hematology blood hematocrit  29.6  %; hematology blood hematocrit  29.9  %; hematology blood hematocrit  28.3  %; hematology blood hemoglobin  9.4  g dl; hematology blood hemoglobin  9.5  g dl; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  296  k ul; hematology blood platelet count  334  k ul; hematology blood platelet count  274  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  124  mg dl$sodium chloride 0.9%  flush  3-10  ml ; docusate sodium  100  mg ; senna  8.6  mg ; bisacodyl  10  mg ; albuterol inhaler  1  puff ; levothyroxine sodium  200  mcg ; multivitamins  1  tab ; famotidine  20  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; 
unspecified essential hypertension unspecified acquired hypothyroidism hematoma complicating a procedure precipitous drop in hematocrit other iatrogenic hypotension other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified carcinoma in situ of breast
black african american f 71 $nan$hematology blood hematocrit  27.0  %; hematology blood hematocrit  25.8  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.5  g dl; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  267  k ul; hematology blood platelet count  262  k ul; hematology blood platelet count  270  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  111  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  1  puff ; levothyroxine sodium  200  mcg ; multivitamins  1  tab ; famotidine  20  mg ; acetaminophen  1000  mg ; ramelteon  8  mg ; moviprep  1  l ; 
unspecified essential hypertension unspecified acquired hypothyroidism hematoma complicating a procedure precipitous drop in hematocrit other iatrogenic hypotension other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified carcinoma in situ of breast
black african american f 71 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.7  g dl; hematology blood platelet count  293  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  106  mg dl$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  1  puff ; levothyroxine sodium  200  mcg ; multivitamins  1  tab ; famotidine  20  mg ; ramelteon  8  mg ; moviprep  1  l ; 
unspecified essential hypertension unspecified acquired hypothyroidism hematoma complicating a procedure precipitous drop in hematocrit other iatrogenic hypotension other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified carcinoma in situ of breast
black african american f 71 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; albuterol inhaler  1  puff ; levothyroxine sodium  200  mcg ; multivitamins  1  tab ; famotidine  20  mg ; ramelteon  8  mg ; 
unspecified essential hypertension unspecified acquired hypothyroidism hematoma complicating a procedure precipitous drop in hematocrit other iatrogenic hypotension other restorative surgery causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation asthma, unspecified type, unspecified carcinoma in situ of breast
black african american f 60 $nan$nan$ciprofloxacin hcl  500  mg ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; atazanavir  600  mg ; 
chronic hepatitis c without mention of hepatic coma poisoning by other specified central nervous system stimulants unspecified essential hypertension unspecified acquired hypothyroidism accidental poisoning by central nervous system stimulants cocaine abuse, unspecified anemia of other chronic disease other chest pain human immunodeficiency virus [hiv] disease 
black african american f 60 $nan$hematology blood hematocrit  36.7  %; hematology blood hemoglobin  12.6  g dl; hematology blood platelet count  403  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  147  mg dl; hematology blood wbc count  3.5  k ul$ciprofloxacin hcl  500  mg ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; atazanavir  600  mg ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lorazepam  0.5  mg ; nitroglycerin sl  0.3  mg ; ciprofloxacin hcl  250  mg ; heparin  5000  unit ; atazanavir  300  mg ; 
chronic hepatitis c without mention of hepatic coma poisoning by other specified central nervous system stimulants unspecified essential hypertension unspecified acquired hypothyroidism accidental poisoning by central nervous system stimulants cocaine abuse, unspecified anemia of other chronic disease other chest pain human immunodeficiency virus [hiv] disease 
black african american f 60 $nan$nan$ciprofloxacin hcl  500  mg ; aspirin  325  mg ; sulfameth trimethoprim ss  1  tab ; influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325  mg ; emtricitabine-tenofovir (truvada)  1  tab ; lorazepam  0.5  mg ; nitroglycerin sl  0.3  mg ; heparin  5000  unit ; 
chronic hepatitis c without mention of hepatic coma poisoning by other specified central nervous system stimulants unspecified essential hypertension unspecified acquired hypothyroidism accidental poisoning by central nervous system stimulants cocaine abuse, unspecified anemia of other chronic disease other chest pain human immunodeficiency virus [hiv] disease 
white f 41 $temp  97.6  heartrate  64.0  resprate  18.0  o2sat  98.0  sbp  110.0  dbp  72.0  rhythm    pain  10  $nan$acetaminophen  650  mg ; multivitamins  1  tab ; ondansetron  4  mg ; oxycodone (immediate release)   10-20  mg ; alprazolam  1  mg ; gabapentin  600  mg ; omeprazole  40  mg ; simvastatin  40  mg ; tizanidine  4  mg ; nicotine patch  14  mg ; sodium chloride 0.9%  flush  3  ml ; sodium chloride 0.9%  1000  ml ; 
long-term (current) use of anticoagulants body mass index 28.0-28.9, adult obesity, unspecified personal history of pulmonary embolism spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia personal history of venous thrombosis and embolism tobacco use disorder other symptoms involving digestive system pain in joint, pelvic region and thigh history of fall spinal stenosis, lumbar region, without neurogenic claudication other acquired absence of organ head injury, unspecified tobacco use disorder anxiety state, unspecified personal history of venous thrombosis and embolism unspecified fall pure hypercholesterolemia other specified metabolic disorders pain in joint, shoulder region other chronic pain personal history of pulmonary embolism accidents occurring in residential institution
white f 41 $nan$nan$acetaminophen  650  mg ; multivitamins  1  tab ; ondansetron  4  mg ; oxycodone (immediate release)   10-20  mg ; alprazolam  1  mg ; omeprazole  40  mg ; simvastatin  40  mg ; nicotine patch  14  mg ; sodium chloride 0.9%  flush  3  ml ; 
long-term (current) use of anticoagulants body mass index 28.0-28.9, adult obesity, unspecified personal history of pulmonary embolism spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia personal history of venous thrombosis and embolism tobacco use disorder other symptoms involving digestive system pain in joint, pelvic region and thigh history of fall spinal stenosis, lumbar region, without neurogenic claudication other acquired absence of organ head injury, unspecified tobacco use disorder anxiety state, unspecified personal history of venous thrombosis and embolism unspecified fall pure hypercholesterolemia other specified metabolic disorders pain in joint, shoulder region other chronic pain personal history of pulmonary embolism accidents occurring in residential institution
white f 41 $nan$nan$acetaminophen  650  mg ; multivitamins  1  tab ; ondansetron  4  mg ; oxycodone (immediate release)   10-20  mg ; alprazolam  1  mg ; omeprazole  40  mg ; simvastatin  40  mg ; nicotine patch  14  mg ; sodium chloride 0.9%  flush  3  ml ; 
long-term (current) use of anticoagulants body mass index 28.0-28.9, adult obesity, unspecified personal history of pulmonary embolism spinal stenosis, lumbar region, without neurogenic claudication other and unspecified hyperlipidemia personal history of venous thrombosis and embolism tobacco use disorder other symptoms involving digestive system pain in joint, pelvic region and thigh history of fall spinal stenosis, lumbar region, without neurogenic claudication other acquired absence of organ head injury, unspecified tobacco use disorder anxiety state, unspecified personal history of venous thrombosis and embolism unspecified fall pure hypercholesterolemia other specified metabolic disorders pain in joint, shoulder region other chronic pain personal history of pulmonary embolism accidents occurring in residential institution
asian m 63 $nan$nan$aspirin  81  mg ; clopidogrel  75  mg ; losartan potassium  12.5  mg ; rosuvastatin calcium  20  mg ; metoprolol succinate xl  50  mg ; 
hypotension, unspecified other and unspecified hyperlipidemia unspecified essential hypertension diastolic heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter long-term (current) use of anticoagulants atrial fibrillation aortocoronary bypass status congestive heart failure, unspecified personal history of other infectious and parasitic diseases aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other and unspecified hyperlipidemia other and unspecified angina pectoris aortocoronary bypass status acute on chronic diastolic heart failure other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft intermediate coronary syndrome congestive heart failure, unspecified unspecified essential hypertension mitral valve insufficiency and aortic valve insufficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of other infectious and parasitic diseases coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dermatophytosis of groin and perianal area unspecified essential hypertension aortocoronary bypass status other and unspecified hyperlipidemia aortocoronary bypass status other and unspecified anti-infectives causing adverse effects in therapeutic use old myocardial infarction cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally atrial fibrillation other and unspecified hyperlipidemia viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of coronary artery coronary atherosclerosis of native coronary artery
asian m 63 $nan$hematology blood hematocrit  47.6  %; hematology blood hemoglobin  15.2  g dl; hematology blood platelet count  181  k ul; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  96  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  4.0  ; chemistry blood glucose  176  mg dl$aspirin  81  mg ; clopidogrel  75  mg ; losartan potassium  12.5  mg ; rosuvastatin calcium  20  mg ; metoprolol succinate xl  50  mg ; influenza virus vaccine  0.5  ml ; acetaminophen  500-1000  mg ; potassium chloride  20  meq ; potassium chloride  40  meq ; potassium chloride  60  meq ; sodium chloride 0.9%  flush  3  ml ; glipizide  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; warfarin  3  mg ; lidocaine 1% epinephrine 1:100000  1  ml ; 
hypotension, unspecified other and unspecified hyperlipidemia unspecified essential hypertension diastolic heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter long-term (current) use of anticoagulants atrial fibrillation aortocoronary bypass status congestive heart failure, unspecified personal history of other infectious and parasitic diseases aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other and unspecified hyperlipidemia other and unspecified angina pectoris aortocoronary bypass status acute on chronic diastolic heart failure other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft intermediate coronary syndrome congestive heart failure, unspecified unspecified essential hypertension mitral valve insufficiency and aortic valve insufficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of other infectious and parasitic diseases coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dermatophytosis of groin and perianal area unspecified essential hypertension aortocoronary bypass status other and unspecified hyperlipidemia aortocoronary bypass status other and unspecified anti-infectives causing adverse effects in therapeutic use old myocardial infarction cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally atrial fibrillation other and unspecified hyperlipidemia viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of coronary artery coronary atherosclerosis of native coronary artery
asian m 63 $nan$hematology blood hematocrit  43.6  %; hematology blood hemoglobin  13.8  g dl; hematology blood platelet count  170  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  25  mg dl; hematology blood inr(pt)  3.5  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood glucose  122  mg dl$aspirin  81  mg ; clopidogrel  75  mg ; losartan potassium  12.5  mg ; rosuvastatin calcium  20  mg ; metoprolol succinate xl  50  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; glipizide  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nitroglycerin sl  0.3  mg ; insulin  0  unit ; 
hypotension, unspecified other and unspecified hyperlipidemia unspecified essential hypertension diastolic heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter long-term (current) use of anticoagulants atrial fibrillation aortocoronary bypass status congestive heart failure, unspecified personal history of other infectious and parasitic diseases aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other and unspecified hyperlipidemia other and unspecified angina pectoris aortocoronary bypass status acute on chronic diastolic heart failure other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft intermediate coronary syndrome congestive heart failure, unspecified unspecified essential hypertension mitral valve insufficiency and aortic valve insufficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of other infectious and parasitic diseases coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dermatophytosis of groin and perianal area unspecified essential hypertension aortocoronary bypass status other and unspecified hyperlipidemia aortocoronary bypass status other and unspecified anti-infectives causing adverse effects in therapeutic use old myocardial infarction cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally atrial fibrillation other and unspecified hyperlipidemia viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of coronary artery coronary atherosclerosis of native coronary artery
asian m 63 $nan$nan$aspirin  81  mg ; clopidogrel  75  mg ; rosuvastatin calcium  20  mg ; acetaminophen  500-1000  mg ; sodium chloride 0.9%  flush  3  ml ; glipizide  5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; nitroglycerin sl  0.3  mg ; insulin  0  unit ; 
hypotension, unspecified other and unspecified hyperlipidemia unspecified essential hypertension diastolic heart failure, unspecified coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled atrial flutter long-term (current) use of anticoagulants atrial fibrillation aortocoronary bypass status congestive heart failure, unspecified personal history of other infectious and parasitic diseases aortocoronary bypass status coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension other and unspecified hyperlipidemia other and unspecified angina pectoris aortocoronary bypass status acute on chronic diastolic heart failure other and unspecified hyperlipidemia coronary atherosclerosis of unspecified type of vessel, native or graft intermediate coronary syndrome congestive heart failure, unspecified unspecified essential hypertension mitral valve insufficiency and aortic valve insufficiency diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled personal history of other infectious and parasitic diseases coronary atherosclerosis of unspecified type of vessel, native or graft diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled dermatophytosis of groin and perianal area unspecified essential hypertension aortocoronary bypass status other and unspecified hyperlipidemia aortocoronary bypass status other and unspecified anti-infectives causing adverse effects in therapeutic use old myocardial infarction cellulitis and abscess of leg, except foot dermatitis due to drugs and medicines taken internally atrial fibrillation other and unspecified hyperlipidemia viral hepatitis b without mention of hepatic coma, acute or unspecified, without mention of hepatitis delta diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled unspecified essential hypertension atrial fibrillation diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic total occlusion of coronary artery coronary atherosclerosis of native coronary artery
hispanic latino m 73 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lr  1000  ml ; morphine sulfate  2-4  mg ; oxycodone-acetaminophen  1-2  tab ; docusate sodium  100  mg ; hydroxyzine  25  mg ; tamsulosin  0.4  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$hematology blood hematocrit  35.2  %; hematology blood hemoglobin  12.3  g dl; hematology blood platelet count  213  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  143  mg dl$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; neutra-phos  1  pkt ; pantoprazole  40  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; neutra-phos  1  pkt ; pantoprazole  40  mg ; mirtazapine  7.5  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; mirtazapine  7.5  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; mirtazapine  7.5  mg ; cyclobenzaprine  5  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
hispanic latino m 73 $nan$nan$sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; hydroxyzine  25  mg ; acetaminophen  650  mg ; oxycodone (immediate release)   2.5-5  mg ; senna  1  tab ; milk of magnesia  30  ml ; tramadol (ultram)  25  mg ; bisacodyl  10  mg ; hydrochlorothiazide  25  mg ; metoprolol succinate xl  25  mg ; simvastatin  20  mg ; aspirin  81  mg ; multivitamins  1  tab ; pantoprazole  40  mg ; mirtazapine  7.5  mg ; cyclobenzaprine  5  mg ; 
unspecified essential hypertension unspecified gastritis and gastroduodenitis, without mention of hemorrhage esophageal reflux acute kidney failure, unspecified
white f 75 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; ezetimibe  10  mg ; sertraline  50  mg ; atorvastatin  80  mg ; amlodipine  10  mg ; losartan potassium  50  mg ; triamterene-hydrochlorothiazide  1  cap ; multivitamins  1  tab ; ferrous sulfate  325  mg ; 
old myocardial infarction unspecified essential hypertension percutaneous transluminal coronary angioplasty status anemia, unspecified hemorrhage complicating a procedure aortocoronary bypass status pulmonary insufficiency following trauma and surgery other respiratory complications pneumonia, organism unspecified other acquired absence of organ other acute postoperative pain personal history, urinary (tract) infection depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication atrial fibrillation atherosclerosis of aorta acquired absence of both cervix and uterus surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of other specified arteries acquired absence of both cervix and uterus percutaneous transluminal coronary angioplasty status atrial fibrillation atherosclerosis of native arteries of the extremities with intermittent claudication occlusion and stenosis of carotid artery without mention of cerebral infarction old myocardial infarction personal history of tobacco use depressive disorder, not elsewhere classified abdominal aneurysm without mention of rupture aortocoronary bypass status anemia, unspecified other acquired absence of organ occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension atrial fibrillation acquired absence of both cervix and uterus old myocardial infarction other acquired absence of organ coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux aortocoronary bypass status atherosclerosis of native arteries of the extremities with intermittent claudication depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of unspecified type of vessel, native or graft
white f 75 $nan$hematology blood hematocrit  34.4  %; hematology blood hematocrit  33.0  %; hematology blood hemoglobin  11.4  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  494  k ul; hematology blood platelet count  507  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  100  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  43  mg dl; chemistry blood urea nitrogen  30  mg dl; hematology blood inr(pt)  0.9  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  153  mg dl; chemistry blood glucose  163  mg dl; chemistry blood albumin  3.6  g dl$aspirin  325  mg ; clopidogrel  75  mg ; ezetimibe  10  mg ; sertraline  50  mg ; atorvastatin  80  mg ; amlodipine  10  mg ; losartan potassium  50  mg ; triamterene-hydrochlorothiazide  1  cap ; multivitamins  1  tab ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  1000  mg ; metoprolol tartrate  37.5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; potassium chloride  40  meq ; 
old myocardial infarction unspecified essential hypertension percutaneous transluminal coronary angioplasty status anemia, unspecified hemorrhage complicating a procedure aortocoronary bypass status pulmonary insufficiency following trauma and surgery other respiratory complications pneumonia, organism unspecified other acquired absence of organ other acute postoperative pain personal history, urinary (tract) infection depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication atrial fibrillation atherosclerosis of aorta acquired absence of both cervix and uterus surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of other specified arteries acquired absence of both cervix and uterus percutaneous transluminal coronary angioplasty status atrial fibrillation atherosclerosis of native arteries of the extremities with intermittent claudication occlusion and stenosis of carotid artery without mention of cerebral infarction old myocardial infarction personal history of tobacco use depressive disorder, not elsewhere classified abdominal aneurysm without mention of rupture aortocoronary bypass status anemia, unspecified other acquired absence of organ occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension atrial fibrillation acquired absence of both cervix and uterus old myocardial infarction other acquired absence of organ coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux aortocoronary bypass status atherosclerosis of native arteries of the extremities with intermittent claudication depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of unspecified type of vessel, native or graft
white f 75 $nan$chemistry blood creatinine  1.5  mg dl; chemistry blood urea nitrogen  23  mg dl$aspirin  325  mg ; clopidogrel  75  mg ; ezetimibe  10  mg ; sertraline  50  mg ; atorvastatin  80  mg ; amlodipine  10  mg ; losartan potassium  50  mg ; triamterene-hydrochlorothiazide  1  cap ; multivitamins  1  tab ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; acetaminophen  1000  mg ; metoprolol tartrate  37.5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; potassium chloride  40  meq ; 
old myocardial infarction unspecified essential hypertension percutaneous transluminal coronary angioplasty status anemia, unspecified hemorrhage complicating a procedure aortocoronary bypass status pulmonary insufficiency following trauma and surgery other respiratory complications pneumonia, organism unspecified other acquired absence of organ other acute postoperative pain personal history, urinary (tract) infection depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication atrial fibrillation atherosclerosis of aorta acquired absence of both cervix and uterus surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of other specified arteries acquired absence of both cervix and uterus percutaneous transluminal coronary angioplasty status atrial fibrillation atherosclerosis of native arteries of the extremities with intermittent claudication occlusion and stenosis of carotid artery without mention of cerebral infarction old myocardial infarction personal history of tobacco use depressive disorder, not elsewhere classified abdominal aneurysm without mention of rupture aortocoronary bypass status anemia, unspecified other acquired absence of organ occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension atrial fibrillation acquired absence of both cervix and uterus old myocardial infarction other acquired absence of organ coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux aortocoronary bypass status atherosclerosis of native arteries of the extremities with intermittent claudication depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of unspecified type of vessel, native or graft
white f 75 $nan$nan$aspirin  325  mg ; clopidogrel  75  mg ; ezetimibe  10  mg ; sertraline  50  mg ; atorvastatin  80  mg ; amlodipine  10  mg ; losartan potassium  50  mg ; triamterene-hydrochlorothiazide  1  cap ; multivitamins  1  tab ; ferrous sulfate  325  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  1000  mg ; metoprolol tartrate  37.5  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; lorazepam  0.5  mg ; 
old myocardial infarction unspecified essential hypertension percutaneous transluminal coronary angioplasty status anemia, unspecified hemorrhage complicating a procedure aortocoronary bypass status pulmonary insufficiency following trauma and surgery other respiratory complications pneumonia, organism unspecified other acquired absence of organ other acute postoperative pain personal history, urinary (tract) infection depressive disorder, not elsewhere classified atherosclerosis of native arteries of the extremities with intermittent claudication atrial fibrillation atherosclerosis of aorta acquired absence of both cervix and uterus surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation atherosclerosis of other specified arteries acquired absence of both cervix and uterus percutaneous transluminal coronary angioplasty status atrial fibrillation atherosclerosis of native arteries of the extremities with intermittent claudication occlusion and stenosis of carotid artery without mention of cerebral infarction old myocardial infarction personal history of tobacco use depressive disorder, not elsewhere classified abdominal aneurysm without mention of rupture aortocoronary bypass status anemia, unspecified other acquired absence of organ occlusion and stenosis of carotid artery without mention of cerebral infarction unspecified essential hypertension atrial fibrillation acquired absence of both cervix and uterus old myocardial infarction other acquired absence of organ coronary atherosclerosis of unspecified type of vessel, native or graft esophageal reflux aortocoronary bypass status atherosclerosis of native arteries of the extremities with intermittent claudication depressive disorder, not elsewhere classified percutaneous transluminal coronary angioplasty status chronic kidney disease, unspecified depressive disorder, not elsewhere classified other and unspecified hyperlipidemia atherosclerosis of native arteries of the extremities with intermittent claudication coronary atherosclerosis of unspecified type of vessel, native or graft
white m 60 $temp  97.8  heartrate  56.0  resprate  14.0  o2sat  99.0  sbp  108.0  dbp  68.0  rhythm    pain  0  $hematology blood hematocrit  44.3  %; hematology blood hemoglobin  14.2  g dl; hematology blood platelet count  67  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  1.8  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  3.2  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; heparin  5000  unit ; spironolactone  100  mg ; venlafaxine xr  37.5  mg ; nadolol  20  mg ; furosemide  40  mg ; 
encephalopathy, unspecified other ascites long-term (current) use of other medications cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary disorders of phosphorus metabolism other malaise and fatigue unspecified viral hepatitis c without hepatic coma
white m 60 $nan$hematology blood hematocrit  45.7  %; hematology blood hemoglobin  14.9  g dl; hematology blood platelet count  64  k ul; chemistry blood anion gap  7  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  12  mg dl; hematology blood inr(pt)  1.9  ; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  4.2  mg dl; chemistry blood glucose  122  mg dl; chemistry blood albumin  2.5  g dl$sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; heparin  5000  unit ; spironolactone  100  mg ; venlafaxine xr  37.5  mg ; nadolol  20  mg ; rifaximin  550  mg ; 
encephalopathy, unspecified other ascites long-term (current) use of other medications cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary disorders of phosphorus metabolism other malaise and fatigue unspecified viral hepatitis c without hepatic coma
white m 60 $nan$hematology blood hematocrit  45.2  %; hematology blood hemoglobin  15.1  g dl; hematology blood platelet count  54  k ul; chemistry blood anion gap  9  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.5  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  10  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  3.9  mg dl; chemistry blood glucose  139  mg dl$sodium chloride 0.9%  flush  3  ml ; lactulose  30  ml ; heparin  5000  unit ; spironolactone  100  mg ; venlafaxine xr  37.5  mg ; nadolol  20  mg ; rifaximin  550  mg ; 
encephalopathy, unspecified other ascites long-term (current) use of other medications cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary disorders of phosphorus metabolism other malaise and fatigue unspecified viral hepatitis c without hepatic coma
white m 60 $nan$nan$sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; spironolactone  100  mg ; venlafaxine xr  37.5  mg ; nadolol  20  mg ; rifaximin  550  mg ; 
encephalopathy, unspecified other ascites long-term (current) use of other medications cirrhosis of liver without mention of alcohol malignant neoplasm of liver, primary disorders of phosphorus metabolism other malaise and fatigue unspecified viral hepatitis c without hepatic coma
white m 67 $nan$nan$omeprazole  20  mg ; simvastatin  40  mg ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  35.0  %; hematology blood hematocrit  31.9  %; hematology blood hemoglobin  11.7  g dl; hematology blood hemoglobin  10.7  g dl; hematology blood platelet count  372  k ul; hematology blood platelet count  343  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood potassium  3.1  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  13  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.5  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  254  mg dl; chemistry blood glucose  226  mg dl; blood gas blood glucose  269  mg dl; blood gas blood hematocrit, calculated  32  %; blood gas blood hemoglobin  10.5  g dl; chemistry blood % hemoglobin a1c  10.4  %$glucagon  1  mg ; omeprazole  20  mg ; simvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; insulin  0  unit ; labetalol  10  mg ; propofol  1000  mg ; propofol  200  mg ; fentanyl citrate  25-50  mcg ; metoprolol tartrate  12.5  mg ; 0.9% sodium chloride  100  ml ; midazolam  100  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; insulin human regular  100  unit ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  33.5  %; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  370  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  110  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  16  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood glucose  124  mg dl; blood gas blood glucose  87  mg dl; blood gas blood glucose  117  mg dl; blood gas blood potassium, whole blood  3.0  meq l$glucagon  1  mg ; omeprazole  20  mg ; simvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; labetalol  10  mg ; fentanyl citrate  25-50  mcg ; metoprolol tartrate  12.5  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; insulin human regular  100  unit ; folic acid  1  mg ; thiamine  100  mg ; multivitamins  1  tab ; insulin  10  unit ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; neutra-phos  2  pkt ; diazepam  5  mg ; heparin  5000  unit ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  32.6  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  325  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  109  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  201  mg dl; blood gas blood free calcium  1.10  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood potassium, whole blood  3.6  meq l$glucagon  1  mg ; simvastatin  40  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; metoprolol tartrate  12.5  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; insulin human regular  100  unit ; folic acid  1  mg ; thiamine  100  mg ; insulin  10  unit ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; neutra-phos  2  pkt ; diazepam  5  mg ; heparin  5000  unit ; d10w  1000  ml ; metoprolol tartrate  5  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; insulin  15  unit ; soln.  500  ml ; mannitol 20 %  100  g ; sodium chloride 3% (hypertonic)  500  ml ; lorazepam  4  mg ; soln.  250  ml ; mannitol 20 %  50  g ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  32.7  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  297  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  111  meq l; chemistry blood chloride  112  meq l; chemistry blood chloride  114  meq l; chemistry blood chloride  117  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  28  mg dl; chemistry blood urea nitrogen  32  mg dl; chemistry blood urea nitrogen  29  mg dl; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  201  mg dl; chemistry blood glucose  162  mg dl; chemistry blood glucose  187  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  181  mg dl$glucagon  1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; metoprolol tartrate  12.5  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; folic acid  1  mg ; thiamine  100  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; diazepam  5  mg ; heparin  5000  unit ; metoprolol tartrate  5  mg ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; insulin  15  unit ; soln.  500  ml ; mannitol 20 %  100  g ; sodium chloride 3% (hypertonic)  500  ml ; lorazepam  4  mg ; soln.  250  ml ; mannitol 20 %  50  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; multivitamins  5  ml ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  32.9  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  307  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  12  meq l; chemistry blood anion gap  9  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  123  meq l; chemistry blood chloride  126  meq l; chemistry blood chloride  125  meq l; chemistry blood chloride  124  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  3.9  meq l; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  154  meq l; chemistry blood sodium  154  meq l; chemistry blood sodium  154  meq l; chemistry blood sodium  153  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; hematology urine wbc  10  # hpf; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  210  mg dl; chemistry blood glucose  156  mg dl; chemistry blood glucose  129  mg dl; chemistry blood glucose  189  mg dl$glucagon  1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; metoprolol tartrate  12.5  mg ; potassium chloride (powder)  40  meq ; potassium chloride (powder)  60  meq ; potassium chloride (powder)  80  meq ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; folic acid  1  mg ; thiamine  100  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; diazepam  5  mg ; heparin  5000  unit ; 0.83% sodium chloride  200  ml ; nicardipine iv  40  mg ; insulin  15  unit ; soln.  250  ml ; mannitol 20 %  50  g ; ns  100  ml ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; multivitamins  5  ml ; diltiazem  10  mg ; diltiazem  20  mg ; amiodarone  150  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; 5% dextrose (excel bag)  500  ml ; amiodarone  600  mg ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; tobramycin sulfate  600  mg ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  31.2  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  124  meq l; chemistry blood creatinine  1.3  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.3  meq l; chemistry blood potassium  4.4  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  35  mg dl; chemistry urine chloride, urine  62  meq l; chemistry urine creatinine, urine  67  mg dl; chemistry urine potassium, urine  29  meq l; chemistry urine sodium, urine  19  meq l; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  189  mg dl; chemistry blood glucose  200  mg dl$glucagon  1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; folic acid  1  mg ; thiamine  100  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; insulin  15  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; multivitamins  5  ml ; amiodarone  150  mg ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; tobramycin sulfate  600  mg ; midazolam  4  mg ; amiodarone  400  mg ; chlordiazepoxide hcl  50  mg ; d5ns  1000  ml ; 0.9% sodium chloride  1000  ml ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.1  g dl; hematology blood platelet count  346  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  126  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  153  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.4  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  234  mg dl$glucagon  1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; folic acid  1  mg ; thiamine  100  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; insulin  15  unit ; ns  100  ml ; metronidazole (flagyl)  500  mg ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; multivitamins  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; amiodarone  400  mg ; chlordiazepoxide hcl  50  mg ; d5ns  1000  ml ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  415  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  127  meq l; chemistry blood chloride  124  meq l; chemistry blood chloride  126  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood potassium  3.5  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  153  meq l; chemistry blood sodium  152  meq l; chemistry blood sodium  154  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.4  ; hematology urine wbc  15  # hpf; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  172  mg dl$glucagon  1  mg ; pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; dextrose 50%  12.5  gm ; fentanyl citrate  25-50  mcg ; bag  100  ml ; magnesium sulfate  4  gm ; bag  50  ml ; magnesium sulfate  2-4  gm ; magnesium sulfate  2  gm ; folic acid  1  mg ; thiamine  100  mg ; aspirin  81  mg ; vial  1  vial ; pantoprazole  40  mg ; heparin  5000  unit ; chlorhexidine gluconate 0.12% oral rinse  15  ml ; sodium chloride 0.9%  flush  10  ml ; multivitamins  5  ml ; sterile water  50  ml ; potassium chloride  20  meq ; sterile water  100  ml ; potassium chloride  40  meq ; sterile water  150  ml ; potassium chloride  60  meq ; amiodarone  400  mg ; metoprolol tartrate  10  mg ; chlordiazepoxide hcl  25  mg ; chlordiazepoxide hcl  5  mg ; chlordiazepoxide hcl  10  mg ; 0.9% sodium chloride  250  ml ; potassium phosphate  30  mmol ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white m 67 $nan$nan$pneumococcal vac polyvalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; fentanyl citrate  25-50  mcg ; sodium chloride 0.9%  flush  10  ml ; chlordiazepoxide hcl  10  mg ; 5% dextrose  100  ml ; morphine sulfate  100  mg ; scopolamine patch  1  ptch ; lorazepam  2-4  mg ; 
obesity, unspecified atrial fibrillation long-term (current) use of insulin unspecified essential hypertension abscess of anal and rectal regions esophageal reflux tobacco use disorder retention of urine, unspecified congestive heart failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, uncontrolled polyneuropathy in diabetes 
white f 44 $temp  98.9  heartrate  66.0  resprate  15.0  o2sat  100.0  sbp  90.0  dbp  56.0  rhythm    pain  asleep  ; temp    heartrate  82.0  resprate  18.0  o2sat  100.0  sbp  118.0  dbp  67.0  rhythm    pain  sleeping  ; temp  99.3  heartrate  108.0  resprate  18.0  o2sat  99.0  sbp  116.0  dbp  74.0  rhythm    pain  9  ; temp  99.4  heartrate  68.0  resprate  16.0  o2sat  98.0  sbp  118.0  dbp  70.0  rhythm    pain  7  ; temp  98.7  heartrate  88.0  resprate  16.0  o2sat  99.0  sbp  123.0  dbp  69.0  rhythm    pain  6  $hematology blood hematocrit  31.2  %; hematology blood hematocrit  30.5  %; hematology blood hematocrit  31.5  %; hematology blood hematocrit  29.5  %; hematology blood hemoglobin  10.7  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  177  k ul; hematology blood platelet count  170  k ul; hematology blood platelet count  179  k ul; hematology blood platelet count  177  k ul$sodium chloride 0.9%  flush  3-10  ml ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; acetaminophen  500-1000  mg ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; ibuprofen  600  mg ; acetaminophen  1000  mg ; 
 
white f 44 $nan$hematology blood hematocrit  31.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  183  k ul$sodium chloride 0.9%  flush  3-10  ml ; influenza vaccine quadrivalent  0.5  ml ; lactated ringers  1000  ml ; oxycodone (immediate release)  5-10  mg ; docusate sodium  100  mg ; morphine sulfate  2-4  mg ; ibuprofen  600  mg ; acetaminophen  1000  mg ; 
 
white f 29 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; 5% dextrose  50  ml ; clindamycin  900  mg ; oxytocin  20  unit ; sodium citrate  30  ml ; oxytocin  10  unit ; ondansetron  4-8  mg ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 29 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white f 29 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; lactated ringers  1000  ml ; docusate sodium  100  mg ; oxycodone-acetaminophen  1-2  tab ; ibuprofen  600  mg ; acetaminophen  500-1000  mg ; bisacodyl  10  mg ; milk of magnesia  30  ml ; dibucaine  1  appl ; simethicone  80  mg ; calcium carbonate  500  mg ; tetanus-diphtox-acellular pertuss (adacel)  0.5  ml ; 
 
white m 94 $nan$hematology blood hematocrit  35.6  %; hematology blood hemoglobin  11.6  g dl; hematology blood platelet count  275  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  3.7  ; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  107  mg dl$1 2 ns  1000  ml ; influenza virus vaccine  0.5  ml ; 0.9% sodium chloride  1000  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; iso-osmotic dextrose  50  ml ; ceftriaxone  1  gm ; iso-osmotic dextrose  200  ml ; vancomycin  1000  mg ; azithromycin  250  mg ; docusate sodium  100  mg ; calcium carbonate  500  mg ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; oxybutynin  5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  80  mg ; omeprazole  20  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; senna  2  tab ; terazosin  1  mg ; 
dysphagia, unspecified late effects of cerebrovascular disease, aphasia hypotension, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia long-term (current) use of anticoagulants pyogenic arthritis, shoulder region constipation, unspecified chronic airway obstruction, not elsewhere classified hypovolemia other late effects of cerebrovascular disease, dysphagia cardiac pacemaker in situ right bundle branch block atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site esophageal reflux long-term (current) use of anticoagulants cellulitis and abscess of upper arm and forearm other impaction of intestine cardiac pacemaker in situ personal history of tobacco use atrial fibrillation dementia in conditions classified elsewhere without behavioral disturbance hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits benign essential hypertension other constipation alzheimer's disease other and unspecified hyperlipidemia urinary tract infection, site not specified chronic obstructive asthma, unspecified dementia in conditions classified elsewhere without behavioral disturbance alzheimer's disease anticoagulants causing adverse effects in therapeutic use hypertonicity of bladder urinary tract infection, site not specified unspecified essential hypertension other and unspecified noninfectious gastroenteritis and colitis other and unspecified hyperlipidemia abnormal coagulation profile cardiac pacemaker in situ other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms atrial fibrillation other postprocedural status pneumonia, organism unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts)
white m 94 $nan$hematology blood hematocrit  30.0  %; hematology blood hematocrit  30.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  244  k ul; hematology blood platelet count  237  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  135  meq l; chemistry blood urea nitrogen  20  mg dl; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  3.6  ; hematology urine wbc  6-10  # hpf; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  104  mg dl; chemistry blood glucose  143  mg dl; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  mg dl$influenza virus vaccine  0.5  ml ; ipratropium bromide neb  1  neb ; albuterol 0.083% neb soln  1  neb ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; oxybutynin  5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  80  mg ; omeprazole  20  mg ; dextrose 5%  150  ml ; levofloxacin  750  mg ; senna  2  tab ; terazosin  1  mg ; 5% dextrose  250  ml ; vancomycin  1250  mg ; 
dysphagia, unspecified late effects of cerebrovascular disease, aphasia hypotension, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia long-term (current) use of anticoagulants pyogenic arthritis, shoulder region constipation, unspecified chronic airway obstruction, not elsewhere classified hypovolemia other late effects of cerebrovascular disease, dysphagia cardiac pacemaker in situ right bundle branch block atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site esophageal reflux long-term (current) use of anticoagulants cellulitis and abscess of upper arm and forearm other impaction of intestine cardiac pacemaker in situ personal history of tobacco use atrial fibrillation dementia in conditions classified elsewhere without behavioral disturbance hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits benign essential hypertension other constipation alzheimer's disease other and unspecified hyperlipidemia urinary tract infection, site not specified chronic obstructive asthma, unspecified dementia in conditions classified elsewhere without behavioral disturbance alzheimer's disease anticoagulants causing adverse effects in therapeutic use hypertonicity of bladder urinary tract infection, site not specified unspecified essential hypertension other and unspecified noninfectious gastroenteritis and colitis other and unspecified hyperlipidemia abnormal coagulation profile cardiac pacemaker in situ other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms atrial fibrillation other postprocedural status pneumonia, organism unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts)
white m 94 $nan$hematology blood hematocrit  31.1  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  267  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.9  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  3.1  ; hematology urine wbc  40  # hpf; chemistry blood glucose  91  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; oxybutynin  5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  80  mg ; omeprazole  20  mg ; senna  2  tab ; terazosin  1  mg ; 
dysphagia, unspecified late effects of cerebrovascular disease, aphasia hypotension, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia long-term (current) use of anticoagulants pyogenic arthritis, shoulder region constipation, unspecified chronic airway obstruction, not elsewhere classified hypovolemia other late effects of cerebrovascular disease, dysphagia cardiac pacemaker in situ right bundle branch block atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site esophageal reflux long-term (current) use of anticoagulants cellulitis and abscess of upper arm and forearm other impaction of intestine cardiac pacemaker in situ personal history of tobacco use atrial fibrillation dementia in conditions classified elsewhere without behavioral disturbance hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits benign essential hypertension other constipation alzheimer's disease other and unspecified hyperlipidemia urinary tract infection, site not specified chronic obstructive asthma, unspecified dementia in conditions classified elsewhere without behavioral disturbance alzheimer's disease anticoagulants causing adverse effects in therapeutic use hypertonicity of bladder urinary tract infection, site not specified unspecified essential hypertension other and unspecified noninfectious gastroenteritis and colitis other and unspecified hyperlipidemia abnormal coagulation profile cardiac pacemaker in situ other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms atrial fibrillation other postprocedural status pneumonia, organism unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts)
white m 94 $nan$hematology blood hematocrit  30.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  265  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  20  mg dl; hematology blood inr(pt)  2.0  ; chemistry blood glucose  99  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; docusate sodium  100  mg ; calcium carbonate  500  mg ; benzonatate  100  mg ; metoprolol tartrate  12.5  mg ; oxybutynin  5  mg ; fluticasone-salmeterol diskus (250 50)   1  inh ; vitamin d  800  unit ; multivitamins  1  tab ; simvastatin  80  mg ; omeprazole  20  mg ; senna  2  tab ; terazosin  1  mg ; fluconazole  200  mg ; warfarin  3  mg ; 
dysphagia, unspecified late effects of cerebrovascular disease, aphasia hypotension, unspecified unspecified gastritis and gastroduodenitis, without mention of hemorrhage anemia, unspecified late effects of cerebrovascular disease, hemiplegia affecting unspecified side other and unspecified hyperlipidemia long-term (current) use of anticoagulants pyogenic arthritis, shoulder region constipation, unspecified chronic airway obstruction, not elsewhere classified hypovolemia other late effects of cerebrovascular disease, dysphagia cardiac pacemaker in situ right bundle branch block atrial fibrillation escherichia coli [e. coli] infection in conditions classified elsewhere and of unspecified site esophageal reflux long-term (current) use of anticoagulants cellulitis and abscess of upper arm and forearm other impaction of intestine cardiac pacemaker in situ personal history of tobacco use atrial fibrillation dementia in conditions classified elsewhere without behavioral disturbance hypertrophy (benign) of prostate without urinary obstruction and other lower urinary tract symptom (luts) personal history of transient ischemic attack (tia), and cerebral infarction without residual deficits benign essential hypertension other constipation alzheimer's disease other and unspecified hyperlipidemia urinary tract infection, site not specified chronic obstructive asthma, unspecified dementia in conditions classified elsewhere without behavioral disturbance alzheimer's disease anticoagulants causing adverse effects in therapeutic use hypertonicity of bladder urinary tract infection, site not specified unspecified essential hypertension other and unspecified noninfectious gastroenteritis and colitis other and unspecified hyperlipidemia abnormal coagulation profile cardiac pacemaker in situ other specified bacterial infections in conditions classified elsewhere and of unspecified site, other gram-negative organisms atrial fibrillation other postprocedural status pneumonia, organism unspecified hypertrophy (benign) of prostate with urinary obstruction and other lower urinary tract symptoms (luts)
white m 43 $nan$hematology blood hematocrit  45.8  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  336  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  12  mg dl; chemistry blood glucose  123  mg dl$nan
 
black african american f 63 $nan$hematology blood hematocrit  27.6  %; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  407  k ul; chemistry blood anion gap  8  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood sodium  144  meq l; chemistry blood urea nitrogen  7  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood glucose  88  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; morphine sulfate  2-4  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; ibuprofen  600  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  28.6  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  404  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  6  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood glucose  91  mg dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; 0.9% sodium chloride  500  ml ; potassium chloride  40  meq ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; ibuprofen  600  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; polyethylene glycol  17  g ; sw  100  ml ; magnesium sulfate  2  gm ; 
 
black african american f 63 $nan$chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood glucose  93  mg dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; ibuprofen  600  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; polyethylene glycol  17  g ; sw  100  ml ; magnesium sulfate  2  gm ; senna  1  tab ; docusate sodium  100  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  30.2  %; hematology blood hemoglobin  9.2  g dl; hematology blood platelet count  388  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.8  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  8  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.8  mg dl; chemistry blood bilirubin, total  0.4  mg dl; chemistry blood glucose  93  mg dl; chemistry blood lactate dehydrogenase (ld)  181  iu l; chemistry blood albumin  3.2  g dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; ibuprofen  600  mg ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; polyethylene glycol  17  g ; senna  1  tab ; docusate sodium  100  mg ; sw  50  ml ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; 
 
black african american f 63 $nan$hematology blood hematocrit  28.5  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  355  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  8  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood glucose  101  mg dl$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; docusate sodium  100  mg ; sw  50  ml ; potassium chloride  60  meq ; nitroglycerin sl  0.3  mg ; 
 
black african american f 63 $nan$chemistry blood chloride  99  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  136  meq l$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; docusate sodium  100  mg ; sw  50  ml ; potassium chloride  60  meq ; 
 
black african american f 63 $nan$nan$sodium chloride 0.9%  flush  3  ml ; prochlorperazine  10  mg ; ondansetron  8  mg ; acetaminophen  650  mg ; heparin  5000  unit ; omeprazole  20  mg ; guaifenesin  5-10  ml ; morphine sr (ms contin)  30  mg ; morphine sulfate ir  15  mg ; heparin flush (10 units ml)  5  ml ; heparin flush (100 units ml)  5  ml ; senna  1  tab ; docusate sodium  100  mg ; sw  50  ml ; potassium chloride  60  meq ; 
 
white m 60 $nan$nan$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; 
 
white m 60 $nan$hematology blood hematocrit  39.4  %; hematology blood hematocrit  40.0  %; hematology blood hemoglobin  13.2  g dl; hematology blood hemoglobin  13.4  g dl; hematology blood platelet count  189  k ul; hematology blood platelet count  205  k ul; chemistry blood anion gap  10  meq l; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  96  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood potassium  4.2  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.1  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  105  mg dl; chemistry blood glucose  108  mg dl; chemistry blood lactate dehydrogenase (ld)  146  iu l; chemistry blood lactate dehydrogenase (ld)  129  iu l; chemistry blood albumin  3.8  g dl; chemistry blood albumin  3.7  g dl; chemistry blood % hemoglobin a1c  5.4  %$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; 
 
white m 60 $nan$hematology blood hematocrit  40.7  %; hematology blood hemoglobin  13.3  g dl; hematology blood platelet count  208  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood glucose  111  mg dl$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; metoprolol tartrate  12.5  mg ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; 
 
white m 60 $nan$hematology blood hematocrit  41.8  %; hematology blood hemoglobin  13.6  g dl; hematology blood platelet count  219  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  30  mg dl; chemistry blood glucose  105  mg dl$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; polyethylene glycol  17  g ; 
 
white m 60 $nan$hematology blood hematocrit  40.6  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  200  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  29  mg dl; chemistry blood glucose  108  mg dl$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; polyethylene glycol  17  g ; 
 
white m 60 $nan$hematology blood hematocrit  43.1  %; hematology blood hemoglobin  14.0  g dl; hematology blood platelet count  237  k ul; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  28  mg dl; chemistry blood calcium, total  9.4  mg dl; chemistry blood glucose  113  mg dl$mupirocin ointment 2%  1  appl ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
 
white m 60 $nan$hematology blood hematocrit  41.1  %; hematology blood hemoglobin  13.2  g dl; hematology blood platelet count  216  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  29  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  116  mg dl$atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; 
 
white m 60 $nan$hematology blood hematocrit  40.6  %; hematology blood hematocrit  33.8  %; hematology blood hematocrit  38.2  %; hematology blood hemoglobin  13.0  g dl; hematology blood hemoglobin  11.1  g dl; hematology blood hemoglobin  12.4  g dl; hematology blood platelet count  220  k ul; hematology blood platelet count  127  k ul; hematology blood platelet count  160  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; chemistry blood urea nitrogen  23  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.4  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  9.3  mg dl; chemistry blood glucose  104  mg dl; blood gas blood free calcium  1.19  mmol l; blood gas blood free calcium  1.21  mmol l; blood gas blood free calcium  1.20  mmol l; blood gas blood lactate  0.7  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood chloride, whole blood  105  meq l; blood gas blood chloride, whole blood  109  meq l; blood gas blood glucose  106  mg dl; blood gas blood glucose  117  mg dl; blood gas blood glucose  146  mg dl; blood gas blood glucose  154  mg dl; blood gas blood glucose  137  mg dl; blood gas blood hematocrit, calculated  42  %; blood gas blood hematocrit, calculated  32  %; blood gas blood hematocrit, calculated  34  %; blood gas blood hematocrit, calculated  35  %; blood gas blood hemoglobin  13.9  g dl; blood gas blood hemoglobin  10.6  g dl; blood gas blood hemoglobin  11.2  g dl; blood gas blood hemoglobin  11.7  g dl; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  5.1  meq l; blood gas blood potassium, whole blood  4.3  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood sodium, whole blood  137  meq l; blood gas blood sodium, whole blood  134  meq l; blood gas blood sodium, whole blood  133  meq l$glucagon  1  mg ; atorvastatin  80  mg ; influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3-10  ml ; heparin  1400  unit ; 5% dextrose  250  ml ; heparin sodium  25,000  unit ; aspirin  81  mg ; senna  8.6  mg ; metoprolol tartrate  25  mg ; nitroglycerin sl  0.3  mg ; polyethylene glycol  17  g ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine jelly 2% (glydo)  1  appl ; lactated ringers  1000  ml ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; cefazolin  3  g ; mouth care oral rinse  7-15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; 
 
white m 60 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.5  g dl; hematology blood platelet count  158  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.0  meq l; chemistry blood potassium  4.4  meq l; chemistry blood potassium  6.1  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  22  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  119  mg dl; blood gas blood free calcium  1.18  mmol l; blood gas blood free calcium  1.16  mmol l; blood gas blood free calcium  1.08  mmol l; blood gas blood lactate  1.1  mmol l; blood gas blood lactate  0.5  mmol l; blood gas blood glucose  156  mg dl; blood gas blood glucose  112  mg dl; blood gas blood glucose  119  mg dl; blood gas blood potassium, whole blood  5.6  meq l; blood gas blood potassium, whole blood  4.6  meq l; blood gas blood potassium, whole blood  4.7  meq l; blood gas blood potassium, whole blood  4.3  meq l$glucagon  1  mg ; sodium chloride 0.9%  flush  10  ml ; lidocaine jelly 2% (glydo)  1  appl ; dextrose 5%  1000  ml ; propofol  1000  mg ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; insulin human regular  100  unit ; dextrose 50%  12.5  gm ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; acetaminophen iv  1000  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; 0.9 % sodium chloride  25  ml ; phenylephrine  6  mg ; cefazolin  3  g ; mouth care oral rinse  7-15  ml ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; neostigmine (cvicu reversal protocol)  3  mg ; glycopyrrolate (cvicu reversal protocol)  0.5  mg ; dexmedetomidine  0.4  mg ; insulin (regular) for hyperkalemia  10  unit ; albumin 5% (12.5g   250ml)  25  g ; insulin glargine  (cvicu protocol)  0-50  unit ; insulin  0-10  unit ; aspirin ec  81  mg ; isosorbide mononitrate (extended release)  30  mg ; furosemide  20  mg ; insulin  0  unit ; albumin 5% (12.5g   250ml)  12.5  g ; oxycodone (immediate release)  5-10  mg ; scopolamine patch  1  ptch ; metoclopramide  10  mg ; meclizine  12.5  mg ; acetaminophen  1000  mg ; tramadol  50  mg ; heparin  5000  unit ; 
 
white m 60 $nan$hematology blood hematocrit  33.0  %; hematology blood hematocrit  33.2  %; hematology blood hemoglobin  10.6  g dl; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  159  k ul; hematology blood platelet count  156  k ul; chemistry blood anion gap  12  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.7  mg dl; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  142  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  24  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  112  mg dl; chemistry blood glucose  117  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; sterile water  50  ml ; potassium chloride  20  meq ; 0.9% sodium chloride  100  ml ; calcium gluconate  2  g ; bag  1  ml ; magnesium sulfate  2  gm ; dextrose 50%  12.5  gm ; glucose gel  15  g ; fentanyl citrate  12.5-50  mcg ; ondansetron  4  mg ; d5w  250  ml ; nitroglycerin  100  mg ; syringe (iso-osmotic dextrose)  20  ml ; nitroglycerin  8  mg ; 0.9% sodium chloride  250  ml ; phenylephrine  50  mg ; cefazolin  3  g ; ranitidine  150  mg ; docusate sodium  100  mg ; 0.9% sodium chloride  500  ml ; vancomycin  1500  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; scopolamine patch  1  ptch ; metoclopramide  10  mg ; meclizine  12.5  mg ; acetaminophen  1000  mg ; tramadol  50  mg ; heparin  5000  unit ; clopidogrel  75  mg ; senna  17.2  mg ; 
 
white m 60 $nan$hematology blood hematocrit  33.7  %; hematology blood hemoglobin  10.5  g dl; hematology blood platelet count  164  k ul; chemistry blood anion gap  14  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  106  mg dl$glucagon  1  mg ; sodium chloride 0.9%  flush  10  ml ; dextrose 5%  1000  ml ; dextrose 50%  12.5  gm ; glucose gel  15  g ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; furosemide  20  mg ; insulin  0  unit ; acetaminophen  1000  mg ; clopidogrel  75  mg ; senna  17.2  mg ; furosemide  40  mg ; 
 
white m 60 $nan$hematology blood hematocrit  32.3  %; hematology blood hemoglobin  10.4  g dl; hematology blood platelet count  199  k ul; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  4.2  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  26  mg dl; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood glucose  100  mg dl$dextrose 50%  12.5  gm ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; acetaminophen  1000  mg ; clopidogrel  75  mg ; senna  17.2  mg ; furosemide  40  mg ; lidocaine 5% patch  1  ptch ; ipratropium-albuterol neb  1  neb ; lactulose  30  ml ; 
 
white m 60 $nan$hematology blood hematocrit  32.0  %; hematology blood hemoglobin  10.3  g dl; hematology blood platelet count  217  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  1.6  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  27  mg dl; chemistry blood glucose  108  mg dl$dextrose 50%  12.5  gm ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; acetaminophen  1000  mg ; clopidogrel  75  mg ; senna  17.2  mg ; furosemide  40  mg ; lidocaine 5% patch  1  ptch ; ipratropium-albuterol neb  1  neb ; lactulose  30  ml ; 
 
white m 60 $nan$nan$dextrose 50%  12.5  gm ; ondansetron  4  mg ; ranitidine  150  mg ; docusate sodium  100  mg ; aspirin ec  81  mg ; acetaminophen  1000  mg ; clopidogrel  75  mg ; senna  17.2  mg ; furosemide  40  mg ; lidocaine 5% patch  1  ptch ; ipratropium-albuterol neb  1  neb ; lactulose  30  ml ; cepacol (sore throat lozenge)  2  loz ; 
 
black african american f 43 $temp  98.7  heartrate  92.0  resprate  16.0  o2sat  99.0  sbp  111.0  dbp  64.0  rhythm    pain  0  $hematology blood hematocrit  37.4  %; hematology blood hemoglobin  12.1  g dl; hematology blood platelet count  146  k ul; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  14  mg dl; chemistry blood calcium, total  9.5  mg dl; chemistry blood glucose  119  mg dl$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; escitalopram oxalate  15  mg ; montelukast  10  mg ; fluticasone-salmeterol diskus (500 50)   2  inh ; risperidone  1  mg ; prednisone  40  mg ; nicotine patch  7  mg ; 
shortness of breath tobacco use disorder cough asthma, unspecified type, with (acute) exacerbation posttraumatic stress disorder tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health bipolar disorder, unspecified asthma, unspecified type, with status asthmaticus family history of asthma pedal cycle passenger injured in collision with fixed or stationary object in traffic accident suicidal ideation depressive disorder, not elsewhere classified depressive disorder, not elsewhere classified unspecified acute reaction to stress 
black african american f 43 $nan$nan$influenza vaccine quadrivalent  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; heparin  5000  unit ; docusate sodium  100  mg ; senna  8.6  mg ; acetaminophen  650  mg ; albuterol 0.083% neb soln  1  neb ; escitalopram oxalate  15  mg ; montelukast  10  mg ; fluticasone-salmeterol diskus (500 50)   2  inh ; risperidone  1  mg ; prednisone  40  mg ; nicotine patch  7  mg ; 
shortness of breath tobacco use disorder cough asthma, unspecified type, with (acute) exacerbation posttraumatic stress disorder tobacco use disorder personal history of noncompliance with medical treatment, presenting hazards to health bipolar disorder, unspecified asthma, unspecified type, with status asthmaticus family history of asthma pedal cycle passenger injured in collision with fixed or stationary object in traffic accident suicidal ideation depressive disorder, not elsewhere classified depressive disorder, not elsewhere classified unspecified acute reaction to stress 
white f 35 $nan$nan$omeprazole  40  mg ; amlodipine  10  mg ; simvastatin  20  mg ; torsemide  20  mg ; sertraline  50  mg ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 35 $nan$hematology blood hematocrit  33.0  %; hematology blood hematocrit  34.5  %; hematology blood hemoglobin  10.3  g dl; hematology blood hemoglobin  10.9  g dl; hematology blood platelet count  467  k ul; hematology blood platelet count  470  k ul; chemistry blood anion gap  11  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  113  meq l; chemistry blood chloride  113  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  3.8  meq l; chemistry blood sodium  146  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  21  mg dl; chemistry blood urea nitrogen  21  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.3  mg dl; chemistry blood glucose  137  mg dl; chemistry blood glucose  57  mg dl$omeprazole  40  mg ; amlodipine  10  mg ; simvastatin  20  mg ; torsemide  20  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; d5 1 2ns  1000  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; insulin  0  unit ; lorazepam  0.25-0.5  mg ; senna  1  tab ; metoprolol tartrate  37.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; insulin  10  unit ; acetaminophen  325-650  mg ; 0.45% sodium chloride  1000  ml ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 35 $nan$hematology blood hematocrit  30.3  %; hematology blood hemoglobin  9.6  g dl; hematology blood platelet count  368  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  22  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood glucose  47  mg dl$omeprazole  40  mg ; amlodipine  10  mg ; torsemide  20  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; lorazepam  0.25-0.5  mg ; senna  1  tab ; metoprolol tartrate  37.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; lorazepam  0.25  mg ; oxycodone (immediate release)   5  mg ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 35 $nan$hematology blood hematocrit  30.6  %; hematology blood hemoglobin  9.8  g dl; hematology blood platelet count  337  k ul; chemistry blood anion gap  11  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  299  mg dl$omeprazole  40  mg ; amlodipine  10  mg ; torsemide  20  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; senna  1  tab ; metoprolol tartrate  37.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; acetaminophen  325-650  mg ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; 0.9% sodium chloride  150  ml ; erythromycin  250  mg ; lorazepam  0.25  mg ; oxycodone (immediate release)   5  mg ; acetaminophen iv  1000  mg ; buspirone  5  mg ; insulin  5  unit ; acetaminophen  500-1000  mg ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 35 $nan$hematology blood hematocrit  27.7  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  331  k ul; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  4.3  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  18  mg dl; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  173  mg dl$omeprazole  40  mg ; amlodipine  10  mg ; torsemide  20  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; senna  1  tab ; metoprolol tartrate  37.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; buspirone  5  mg ; acetaminophen  500-1000  mg ; insulin  3  unit ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 35 $nan$nan$omeprazole  40  mg ; amlodipine  10  mg ; torsemide  20  mg ; sertraline  50  mg ; sodium chloride 0.9%  flush  3  ml ; dextrose 50%  12.5  gm ; glucagon  1  mg ; albuterol inhaler  2  puff ; senna  1  tab ; metoprolol tartrate  37.5  mg ; heparin  5000  unit ; docusate sodium  100  mg ; gabapentin  800  mg ; zolpidem tartrate  10  mg ; sodium chloride 0.9%  flush  10  ml ; calcium carbonate  500  mg ; buspirone  5  mg ; acetaminophen  500-1000  mg ; 
osteoporosis, unspecified urinary tract infection, site not specified long-term (current) use of insulin esophageal reflux polyneuropathy in diabetes depressive disorder, not elsewhere classified acute kidney failure, unspecified unspecified essential hypertension gastroparesis proliferative diabetic retinopathy gastroesophageal laceration-hemorrhage syndrome anemia, unspecified acquired hemophilia diabetes with renal manifestations, type i [juvenile type], uncontrolled other and unspecified hyperlipidemia migraine, unspecified, without mention of intractable migraine without mention of status migrainosus diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diabetes with ketoacidosis, type i [juvenile type], uncontrolled diabetes with neurological manifestations, type i [juvenile type], uncontrolled chronic diastolic heart failure barrett's esophagus nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere congestive heart failure, unspecified unspecified septicemia essential thrombocythemia congestive heart failure, unspecified osteoporosis, unspecified hyposmolality and/or hyponatremia hypoxemia congenital factor viii disorder acute kidney failure, unspecified nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere long-term (current) use of insulin diabetes with ophthalmic manifestations, type i [juvenile type], uncontrolled diarrhea diabetes with renal manifestations, type i [juvenile type], uncontrolled background diabetic retinopathy acute on chronic diastolic heart failure diabetes with neurological manifestations, type i [juvenile type], uncontrolled pneumonia, organism unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified pneumonitis due to inhalation of food or vomitus gastroparesis chronic kidney disease, unspecified urinary tract infection, site not specified anemia in chronic kidney disease depressive disorder, not elsewhere classified other and unspecified hyperlipidemia
white f 23 $temp    heartrate  88.0  resprate  16.0  o2sat  97.0  sbp  120.0  dbp  81.0  rhythm    pain  10  ; temp    heartrate  80.0  resprate  14.0  o2sat  98.0  sbp  118.0  dbp  74.0  rhythm    pain  8  ; temp  99.9  heartrate  125.0  resprate  16.0  o2sat  95.0  sbp  123.0  dbp  72.0  rhythm    pain    $hematology blood hematocrit  41.4  %; hematology blood hemoglobin  14.1  g dl; hematology blood platelet count  168  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  21  meq l; chemistry blood chloride  102  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  3.6  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  11  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood glucose  126  mg dl$nan
 
white f 23 $nan$hematology blood hematocrit  38.3  %; hematology blood hematocrit  32.1  %; hematology blood hemoglobin  12.8  g dl; hematology blood hemoglobin  11.0  g dl; hematology blood platelet count  127  k ul; hematology blood platelet count  100  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  105  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood creatinine  0.6  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  4.1  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  137  meq l; chemistry blood urea nitrogen  11  mg dl; chemistry blood urea nitrogen  9  mg dl; hematology blood inr(pt)  1.1  ; chemistry blood calcium, total  8.2  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  124  mg dl; chemistry blood glucose  155  mg dl$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; morphine sulfate  2-4  mg ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; 0.9% sodium chloride  1000  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  20  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; 
 
white f 23 $nan$hematology blood hematocrit  29.4  %; hematology blood hemoglobin  10.0  g dl; hematology blood platelet count  102  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  20  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; iso-osmotic dextrose  50  ml ; cefazolin  2  g ; enoxaparin sodium  40  mg ; 
 
white f 23 $nan$hematology blood hematocrit  28.2  %; hematology blood hemoglobin  9.7  g dl; hematology blood platelet count  110  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; hydromorphone (dilaudid)  20  mg ; lorazepam  0.5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 23 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 23 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 23 $nan$hematology blood hematocrit  28.1  %; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  281  k ul$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 23 $nan$nan$influenza virus vaccine  0.5  ml ; sodium chloride 0.9%  flush  3  ml ; oxycodone (immediate release)   5-10  mg ; acetaminophen  650  mg ; milk of magnesia  30  ml ; docusate sodium  100  mg ; senna  1  tab ; potassium chl 20 meq   1000 ml d5 1 2 ns  1000  ml ; lorazepam  0.5  mg ; ondansetron  4  mg ; enoxaparin sodium  40  mg ; hydromorphone (dilaudid)  0.5-1  mg ; 
 
white f 51 $nan$chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  7  mg dl; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  115  mg dl$sodium chloride 0.9%  flush  3  ml ; lorazepam  1-2  mg ; haloperidol  5  mg ; lorazepam  1  mg ; ziprasidone  40  mg ; milk of magnesia  30  ml ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$ziprasidone  40  mg ; milk of magnesia  30  ml ; bisacodyl  10  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  60  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  60  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  80  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; lorazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; lorazepam  2  mg ; visine  1  gtt ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  500  mg ; cepacol (menthol)  1  loz ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; cepacol (menthol)  1  loz ; divalproex sodium  250  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; cepacol (menthol)  1  loz ; divalproex sodium  250  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  250  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  250  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  250  mg ; divalproex sodium  1000  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; clonazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$hematology blood hematocrit  39.5  %; hematology blood hemoglobin  13.0  g dl; hematology blood platelet count  373  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood chloride  103  meq l; chemistry blood creatinine  0.8  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  142  meq l; chemistry blood urea nitrogen  16  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood bilirubin, total  0.2  mg dl; chemistry blood glucose  137  mg dl; chemistry blood lactate dehydrogenase (ld)  217  iu l; chemistry blood albumin  4.0  g dl$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; clonazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; clonazepam  0.5  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
white f 51 $nan$nan$milk of magnesia  30  ml ; bisacodyl  10  mg ; ziprasidone  10  mg ; visine  1  gtt ; divalproex sodium  1000  mg ; ziprasidone  20  mg ; 
unspecified disturbance of conduct unspecified nonpsychotic mental disorder bipolar i disorder, most recent episode (or current) manic, unspecified 
black african american f 54 $temp  97.6  heartrate  59.0  resprate  16.0  o2sat  100.0  sbp  179.0  dbp  104.0  rhythm    pain  0  ; temp    heartrate  61.0  resprate  17.0  o2sat  100.0  sbp  127.0  dbp  84.0  rhythm    pain  0  ; temp    heartrate  82.0  resprate  18.0  o2sat  99.0  sbp  136.0  dbp  92.0  rhythm    pain  0  ; temp    heartrate  70.0  resprate  16.0  o2sat  99.0  sbp  151.0  dbp  99.0  rhythm    pain  0  $hematology blood hematocrit  48.4  %; hematology blood hemoglobin  16.0  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  0.7  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood sodium  140  meq l; chemistry blood urea nitrogen  10  mg dl; chemistry blood glucose  115  mg dl; blood gas blood lactate  2.1  mmol l$nan
 
black african american f 54 $temp  98.2  heartrate  76.0  resprate  17.0  o2sat  100.0  sbp  144.0  dbp  88.0  rhythm    pain  0  ; temp    heartrate  81.0  resprate  18.0  o2sat  100.0  sbp  153.0  dbp  93.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  19.0  o2sat  100.0  sbp  118.0  dbp  82.0  rhythm  normal sinus rhythm  pain  4  ; temp  98.3  heartrate  84.0  resprate  16.0  o2sat  97.0  sbp  137.0  dbp  90.0  rhythm    pain    ; temp    heartrate  67.0  resprate  14.0  o2sat  9.0  sbp  135.0  dbp  81.0  rhythm    pain  0  ; temp    heartrate  62.0  resprate  14.0  o2sat  97.0  sbp  143.0  dbp  94.0  rhythm    pain  0  ; temp    heartrate  64.0  resprate  13.0  o2sat  99.0  sbp  164.0  dbp  94.0  rhythm    pain  0  ; temp  98.1  heartrate  65.0  resprate  21.0  o2sat  100.0  sbp  145.0  dbp  81.0  rhythm    pain  0  $hematology urine glucose  70  mg dl$nan
 
black african american f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; hydroxyzine  25  mg ; lorazepam  1  mg ; aspirin  81  mg ; 
 
black african american f 54 $nan$nan$sodium chloride 0.9%  flush  3-10  ml ; sodium chloride 0.9%  1000  ml ; senna  8.6  mg ; acetaminophen  650  mg ; heparin  5000  unit ; hydralazine  10  mg ; hydroxyzine  25  mg ; lorazepam  1  mg ; aspirin  81  mg ; 
 
white f 47 $nan$nan$bisacodyl  10  mg ; 
nontoxic multinodular goiter 
white f 47 $nan$nan$senna  1  tab ; bisacodyl  10  mg ; sodium chloride 0.9%  flush  3  ml ; acetaminophen  325-650  mg ; hydralazine  10  mg ; ondansetron  4  mg ; hydromorphone (dilaudid)  0.125-0.25  mg ; docusate sodium  100  mg ; hydromorphone (dilaudid)  0.5  mg ; 
nontoxic multinodular goiter 
white f 65 $nan$nan$insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; metolazone  2.5  mg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; diltiazem extended-release  120  mg ; fluticasone propionate nasal  2  spry ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$hematology blood hematocrit  35.1  %; hematology blood hemoglobin  11.7  g dl; hematology blood platelet count  253  k ul; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  89  meq l; chemistry blood creatinine  6.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood sodium  136  meq l; chemistry blood urea nitrogen  47  mg dl; hematology blood inr(pt)  2.6  ; chemistry blood calcium, total  7.8  mg dl; chemistry blood glucose  130  mg dl$insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; metolazone  2.5  mg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; diltiazem extended-release  120  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; albuterol inhaler  2  puff ; ipratropium bromide neb  1  neb ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  37.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; phytonadione  5  mg ; hydromorphone (dilaudid)  0.25  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; 0.9% sodium chloride  1000  ml ; hydromorphone (dilaudid)  0.25-0.5  mg ; warfarin  5  mg ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$hematology blood hematocrit  33.1  %; hematology blood hematocrit  33.3  %; hematology blood hemoglobin  11.3  g dl; hematology blood hemoglobin  11.4  g dl; hematology blood platelet count  231  k ul; hematology blood platelet count  255  k ul; chemistry blood anion gap  24  meq l; chemistry blood anion gap  30  meq l; chemistry blood bicarbonate  28  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  6.3  mg dl; chemistry blood creatinine  8.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  137  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  55  mg dl; chemistry blood urea nitrogen  68  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  115  mg dl; chemistry blood glucose  185  mg dl; blood gas blood hematocrit, calculated  33  %; blood gas blood hemoglobin  11.1  g dl$insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; metolazone  2.5  mg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; diltiazem extended-release  120  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; albuterol inhaler  2  puff ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; metoprolol tartrate  37.5  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; phytonadione  5  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  0.25-0.5  mg ; warfarin  5  mg ; d5 1 2ns  1000  ml ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; sodium polystyrene sulfonate  30  gm ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$hematology blood hematocrit  28.6  %; hematology blood hematocrit  28.5  %; hematology blood hemoglobin  9.7  g dl; hematology blood hemoglobin  9.4  g dl; hematology blood platelet count  224  k ul; hematology blood platelet count  233  k ul; chemistry blood anion gap  27  meq l; chemistry blood anion gap  30  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  22  meq l; chemistry blood chloride  90  meq l; chemistry blood chloride  87  meq l; chemistry blood creatinine  7.8  mg dl; chemistry blood creatinine  8.0  mg dl; chemistry blood potassium  5.2  meq l; chemistry blood potassium  4.5  meq l; chemistry blood sodium  135  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  74  mg dl; chemistry blood urea nitrogen  78  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood glucose  167  mg dl; chemistry blood glucose  152  mg dl$5% dextrose  250  ml ; insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; hydromorphone (dilaudid)  0.25-0.5  mg ; warfarin  5  mg ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; 0.9% sodium chloride  500  ml ; sodium polystyrene sulfonate  30  gm ; vial  1  vial ; heparin sodium  500-1000  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; folic acid  1  mg ; diltiazem  30  mg ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$hematology blood hematocrit  26.8  %; hematology blood hemoglobin  8.9  g dl; hematology blood platelet count  227  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  27  meq l; chemistry blood bicarbonate  24  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  85  meq l; chemistry blood chloride  79  meq l; chemistry blood creatinine  8.8  mg dl; chemistry blood creatinine  9.8  mg dl; chemistry blood potassium  5.0  meq l; chemistry blood potassium  5.5  meq l; chemistry blood sodium  126  meq l; chemistry blood sodium  123  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood urea nitrogen  99  mg dl; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.9  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  145  mg dl$5% dextrose  250  ml ; insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; heparin sodium  500-1000  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; hydromorphone (dilaudid)  0.5  mg ; hydromorphone (dilaudid)  0.25-1  mg ; folic acid  1  mg ; diltiazem  30  mg ; warfarin  6  mg ; calcium acetate  1334  mg ; aluminum hydroxide suspension  30  ml ; sarna lotion  1  appl ; hydromorphone (dilaudid)  2-6  mg ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  75  mg ; aluminum hydroxide suspension  5  ml ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$hematology blood hematocrit  26.9  %; hematology blood hemoglobin  8.8  g dl; hematology blood platelet count  276  k ul; chemistry blood anion gap  19  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood chloride  85  meq l; chemistry blood creatinine  6.1  mg dl; chemistry blood potassium  4.5  meq l; chemistry blood sodium  126  meq l; chemistry blood urea nitrogen  55  mg dl; hematology blood inr(pt)  1.3  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  8.0  mg dl; chemistry blood glucose  175  mg dl$5% dextrose  250  ml ; insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; heparin sodium  500-1000  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; folic acid  1  mg ; diltiazem  30  mg ; warfarin  6  mg ; calcium acetate  1334  mg ; sarna lotion  1  appl ; hydromorphone (dilaudid)  2-4  mg ; ranitidine  75  mg ; aluminum hydroxide suspension  5  ml ; hydromorphone (dilaudid)  2  mg ; fentanyl patch  12  mcg hr ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
white f 65 $nan$nan$5% dextrose  250  ml ; insulin  17  unit ; allopurinol  200  mg ; vitamin b complex w c  1  tab ; levothyroxine sodium  175  mcg ; omeprazole  20  mg ; paroxetine  40  mg ; polyethylene glycol  17  g ; aspirin  81  mg ; simvastatin  80  mg ; fluticasone propionate nasal  2  spry ; sevelamer hydrochloride  2400  mg ; insulin  12  unit ; heparin flush (1000 units ml)  4000-11000  unit ; gabapentin  200  mg ; fluticasone propionate 110mcg  2  puff ; dextrose 50%  12.5  gm ; glucagon  1  mg ; insulin  0  unit ; albuterol 0.083% neb soln  1  neb ; acetaminophen  1000  mg ; sodium chloride 0.9%  flush  3  ml ; vial  1  vial ; heparin sodium  500-1000  unit ; heparin sodium  25,000  unit ; metoprolol tartrate  25  mg ; folic acid  1  mg ; diltiazem  30  mg ; warfarin  6  mg ; calcium acetate  1334  mg ; sarna lotion  1  appl ; ranitidine  75  mg ; aluminum hydroxide suspension  5  ml ; fentanyl patch  12  mcg hr ; 
obstructive sleep apnea (adult)(pediatric) chronic obstructive asthma, unspecified congestive heart failure, unspecified atrial fibrillation person injured while boarding or alighting from special construction vehicle anemia in chronic kidney disease other chronic pulmonary heart diseases acute on chronic diastolic heart failure gout, unspecified body mass index 40 and over, adult hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia unspecified acquired hypothyroidism morbid obesity end stage renal disease percutaneous transluminal coronary angioplasty status diabetes mellitus without mention of complication, type ii or unspecified type, uncontrolled coronary atherosclerosis of native coronary artery old myocardial infarction chronic diastolic heart failure acute upper respiratory infections of unspecified site diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled obstructive sleep apnea (adult)(pediatric) obesity, unspecified atrial fibrillation old myocardial infarction long-term (current) use of insulin congestive heart failure, unspecified chronic obstructive asthma with (acute) exacerbation other chronic pulmonary heart diseases unspecified acquired hypothyroidism coronary atherosclerosis of native coronary artery percutaneous transluminal coronary angioplasty status end stage renal disease hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease other and unspecified hyperlipidemia other and unspecified angina pectoris hyposmolality and/or hyponatremia other dependence on machines, supplemental oxygen other chronic pain person on outside of car injured in collision with other nonmotor vehicle in nontraffic accident gout, unspecified hypertensive chronic kidney disease, benign, with chronic kidney disease stage v or end stage renal disease peripheral vascular disease, unspecified obstructive sleep apnea (adult)(pediatric) diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled other disorders of bone and cartilage end stage renal disease
asian f 64 $temp  98.3  heartrate  94.0  resprate  16.0  o2sat  100.0  sbp  107.0  dbp  70.0  rhythm    pain  0  ; temp    heartrate  95.0  resprate  22.0  o2sat  94.0  sbp  110.0  dbp  70.0  rhythm    pain  0  ; temp  98.6  heartrate  98.0  resprate  18.0  o2sat  100.0  sbp  102.0  dbp  69.0  rhythm    pain    $hematology blood hematocrit  28.3  %; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  17  k ul; chemistry blood anion gap  21  meq l; chemistry blood bicarbonate  17  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  5.9  meq l; chemistry blood sodium  138  meq l; chemistry blood urea nitrogen  96  mg dl; hematology urine wbc  1  # hpf; chemistry blood calcium, total  12.7  mg dl; chemistry blood bilirubin, total  0.6  mg dl; chemistry blood glucose  147  mg dl; chemistry blood albumin  1.9  g dl; hematology blood bands  1  %; blood gas blood lactate  9.6  mmol l; blood gas blood lactate  8.6  mmol l; hematology urine glucose  neg  mg dl; hematology urine bilirubin  neg  n a$nan
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $temp  98.5  heartrate  89.0  resprate  16.0  o2sat  99.0  sbp  124.0  dbp  78.0  rhythm    pain  0  ; temp    heartrate  97.0  resprate  20.0  o2sat  100.0  sbp  128.0  dbp  71.0  rhythm    pain  0  ; temp  97.9  heartrate  97.0  resprate  19.0  o2sat  97.0  sbp  110.0  dbp  66.0  rhythm    pain  asleep  $hematology blood hematocrit  28.8  %; hematology blood hematocrit  29.4  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  8.5  g dl; hematology blood platelet count  15  k ul; hematology blood platelet count  23  k ul; chemistry blood anion gap  22  meq l; chemistry blood anion gap  24  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  15  meq l; chemistry blood bicarbonate  11  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  103  meq l; chemistry blood chloride  111  meq l; chemistry blood creatinine  1.9  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.8  meq l; chemistry blood potassium  6.4  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  140  meq l; chemistry blood sodium  132  meq l; chemistry blood urea nitrogen  93  mg dl; chemistry blood urea nitrogen  92  mg dl; chemistry blood urea nitrogen  94  mg dl; hematology blood inr(pt)  1.1  ; chemistry urine creatinine, urine  22  mg dl; chemistry urine potassium, urine  34  meq l; chemistry urine sodium, urine  84  meq l; chemistry blood calcium, total  12.1  mg dl; chemistry blood calcium, total  11.4  mg dl; chemistry blood calcium, total  11.0  mg dl; chemistry blood glucose  176  mg dl; chemistry blood glucose  106  mg dl; chemistry blood glucose  68  mg dl; chemistry blood lactate dehydrogenase (ld)  664  iu l; hematology blood bands  0  %; blood gas blood lactate  8.7  mmol l; blood gas blood lactate  9.3  mmol l; blood gas blood potassium, whole blood  4.7  meq l; chemistry urine calcium, urine  7.5  mg dl$insulin  20  unit ; insulin  2  unit ; sodium chloride 0.9%  flush  3-10  ml ; cyclosporine (neoral) modified  50  mg ; valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; furosemide  40  mg ; sodium chloride 0.9%  1000  ml ; 0.9% sodium chloride  50  ml ; rasburicase  3  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  30  gm ; sodium bicarbonate  100  meq ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  27.3  %; hematology blood hematocrit  30.1  %; hematology blood hematocrit  26.4  %; hematology blood hematocrit  23.1  %; hematology blood hematocrit  25.7  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  8.6  g dl; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  6.7  g dl; hematology blood hemoglobin  7.4  g dl; hematology blood platelet count  17  k ul; hematology blood platelet count  19  k ul; hematology blood platelet count  17  k ul; hematology blood platelet count  11  k ul; hematology blood platelet count  12  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  15  meq l; chemistry blood anion gap  14  meq l; chemistry blood anion gap  13  meq l; chemistry blood anion gap  20  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  16  meq l; chemistry blood bicarbonate  14  meq l; chemistry blood bicarbonate  12  meq l; chemistry blood bicarbonate  7  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  104  meq l; chemistry blood chloride  106  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.4  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.1  mg dl; chemistry blood potassium  4.9  meq l; chemistry blood potassium  5.7  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  134  meq l; chemistry blood sodium  133  meq l; chemistry blood sodium  133  meq l; chemistry blood urea nitrogen  90  mg dl; chemistry blood urea nitrogen  89  mg dl; chemistry blood urea nitrogen  97  mg dl; chemistry blood urea nitrogen  96  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.3  ; chemistry blood calcium, total  10.9  mg dl; chemistry blood calcium, total  10.6  mg dl; chemistry blood calcium, total  10.5  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  0.8  mg dl; chemistry blood glucose  327  mg dl; chemistry blood glucose  417  mg dl; chemistry blood glucose  343  mg dl; chemistry blood glucose  315  mg dl; chemistry blood glucose  294  mg dl; chemistry blood lactate dehydrogenase (ld)  702  iu l; chemistry blood lactate dehydrogenase (ld)  870  iu l; chemistry blood lactate dehydrogenase (ld)  814  iu l; chemistry blood lactate dehydrogenase (ld)  831  iu l; chemistry blood lactate dehydrogenase (ld)  999  iu l; chemistry blood albumin  1.5  g dl; hematology blood bands  1  %; blood gas blood free calcium  1.30  mmol l; blood gas blood free calcium  1.28  mmol l; blood gas blood lactate  13.2  mmol l; blood gas blood lactate  14.3  mmol l; blood gas blood lactate  12.6  mmol l; chemistry blood bilirubin, direct  0.6  mg dl; blood gas blood potassium, whole blood  5.1  meq l$insulin  20  unit ; insulin  2  unit ; sodium chloride 0.9%  flush  3-10  ml ; cyclosporine (neoral) modified  50  mg ; valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; insulin  0  unit ; 0.9% sodium chloride  50  ml ; rasburicase  3  mg ; 0.9% sodium chloride  250  ml ; thiamine  500  mg ; acetaminophen  650  mg ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; insulin (regular) for hyperkalemia  10  unit ; dextrose 50%  25  gm ; sodium polystyrene sulfonate  30  gm ; sodium bicarbonate  100  meq ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; lactated ringers  1000  ml ; insulin  12  unit ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; lidocaine 1% (for picc midline insertions)  5  ml ; 5% dextrose  1000  ml ; sodium bicarbonate  150  meq ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; oxycodone (immediate release)  5  mg ; thiamine  200  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  28.2  %; hematology blood hematocrit  26.9  %; hematology blood hematocrit  26.1  %; hematology blood hemoglobin  8.1  g dl; hematology blood hemoglobin  7.7  g dl; hematology blood hemoglobin  4.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  13  k ul; hematology blood platelet count  9  k ul; hematology blood platelet count  6  k ul; hematology blood platelet count  15  k ul; chemistry blood anion gap  17  meq l; chemistry blood anion gap  17  meq l; chemistry blood anion gap  21  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  19  meq l; chemistry blood bicarbonate  20  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  95  meq l; chemistry blood chloride  98  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.3  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.5  meq l; chemistry blood potassium  5.6  meq l; chemistry blood potassium  4.9  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  138  meq l; chemistry blood sodium  136  meq l; chemistry blood sodium  134  meq l; chemistry blood urea nitrogen  96  mg dl; chemistry blood urea nitrogen  94  mg dl; chemistry blood urea nitrogen  98  mg dl; chemistry blood urea nitrogen  94  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.5  ; chemistry blood calcium, total  10.2  mg dl; chemistry blood calcium, total  10.0  mg dl; chemistry blood calcium, total  9.2  mg dl; chemistry blood calcium, total  9.6  mg dl; chemistry blood bilirubin, total  0.9  mg dl; chemistry blood bilirubin, total  1.5  mg dl; chemistry blood glucose  161  mg dl; chemistry blood glucose  200  mg dl; chemistry blood glucose  118  mg dl; chemistry blood glucose  129  mg dl; chemistry blood lactate dehydrogenase (ld)  1143  iu l; chemistry blood lactate dehydrogenase (ld)  1265  iu l; chemistry blood lactate dehydrogenase (ld)  1150  iu l; chemistry blood lactate dehydrogenase (ld)  1650  iu l; chemistry blood albumin  1.8  g dl; chemistry blood albumin  2.7  g dl; hematology blood bands  0  %; hematology blood bands  0  %; blood gas blood free calcium  1.34  mmol l; blood gas blood free calcium  1.36  mmol l; blood gas blood lactate  6.9  mmol l; blood gas blood lactate  9.1  mmol l; blood gas blood lactate  11.0  mmol l; blood gas blood hematocrit, calculated  19  %; blood gas blood hemoglobin  6.3  g dl$sodium chloride 0.9%  flush  3-10  ml ; cyclosporine (neoral) modified  50  mg ; valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; heparin flush (10 units ml)  2  ml ; sodium chloride 0.9%  flush  20  ml ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; acetaminophen  1000  mg ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; oxycodone (immediate release)  5  mg ; thiamine  200  mg ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; insulin  40  unit ; insulin  10  unit ; lidocaine jelly 2% (glydo)  1  appl ; lactulose  30  ml ; albumin 25% (12.5g   50ml)  25  g ; morphine sulfate  2-4  mg ; labetalol  5  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  25.3  %; hematology blood hematocrit  26.7  %; hematology blood hemoglobin  7.6  g dl; hematology blood hemoglobin  8.1  g dl; hematology blood platelet count  19  k ul; hematology blood platelet count  12  k ul; hematology blood platelet count  8  k ul; chemistry blood anion gap  16  meq l; chemistry blood anion gap  19  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood chloride  97  meq l; chemistry blood creatinine  2.1  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.2  mg dl; chemistry blood potassium  5.1  meq l; chemistry blood potassium  5.4  meq l; chemistry blood potassium  5.4  meq l; chemistry blood sodium  141  meq l; chemistry blood sodium  139  meq l; chemistry blood sodium  139  meq l; chemistry blood urea nitrogen  104  mg dl; chemistry blood urea nitrogen  102  mg dl; chemistry blood urea nitrogen  98  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  8.8  mg dl; chemistry blood calcium, total  8.6  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood bilirubin, total  1.4  mg dl; chemistry blood glucose  125  mg dl; chemistry blood glucose  245  mg dl; chemistry blood glucose  223  mg dl; chemistry blood lactate dehydrogenase (ld)  1730  iu l; chemistry blood albumin  2.2  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; sodium chloride 0.9%  flush  20  ml ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; thiamine  200  mg ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; insulin  40  unit ; insulin  10  unit ; lidocaine jelly 2% (glydo)  1  appl ; lactulose  30  ml ; albumin 25% (12.5g   50ml)  25  g ; morphine sulfate  2-4  mg ; labetalol  5  mg ; insulin  5  unit ; d5 1 2ns  1000  ml ; insulin  4  unit ; insulin  36  unit ; insulin  7  unit ; nystatin oral suspension  5  ml ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  26.8  %; hematology blood hematocrit  23.6  %; hematology blood hemoglobin  8.0  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  37  k ul; hematology blood platelet count  22  k ul; hematology blood platelet count  14  k ul; chemistry blood anion gap  18  meq l; chemistry blood anion gap  18  meq l; chemistry blood bicarbonate  27  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  99  meq l; chemistry blood chloride  99  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.4  meq l; chemistry blood potassium  4.8  meq l; chemistry blood sodium  144  meq l; chemistry blood sodium  143  meq l; chemistry blood urea nitrogen  101  mg dl; chemistry blood urea nitrogen  95  mg dl; hematology blood inr(pt)  1.2  ; hematology blood inr(pt)  1.2  ; chemistry blood calcium, total  8.5  mg dl; chemistry blood calcium, total  8.5  mg dl; chemistry blood bilirubin, total  1.3  mg dl; chemistry blood bilirubin, total  1.1  mg dl; chemistry blood glucose  213  mg dl; chemistry blood glucose  240  mg dl; chemistry blood lactate dehydrogenase (ld)  1677  iu l; chemistry blood lactate dehydrogenase (ld)  1594  iu l; chemistry blood albumin  2.1  g dl; hematology blood bands  0  %$sodium chloride 0.9%  flush  3-10  ml ; valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; sodium chloride 0.9%  flush  20  ml ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; 0.9% sodium chloride  100  ml ; insulin human regular  100  unit ; thiamine  200  mg ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; insulin  40  unit ; insulin  10  unit ; labetalol  5  mg ; insulin  4  unit ; nystatin oral suspension  5  ml ; furosemide  60  mg ; insulin  8  unit ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  25.7  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  7  k ul; hematology blood platelet count  37  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  100  meq l; chemistry blood creatinine  2.0  mg dl; chemistry blood potassium  4.7  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  103  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  9.1  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  176  mg dl; chemistry blood lactate dehydrogenase (ld)  1596  iu l; hematology blood bands  0  %$valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  26.5  %; hematology blood hemoglobin  8.4  g dl; hematology blood platelet count  7  k ul; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  101  meq l; chemistry blood creatinine  1.8  mg dl; chemistry blood potassium  3.9  meq l; chemistry blood sodium  141  meq l; chemistry blood urea nitrogen  103  mg dl; hematology blood inr(pt)  1.0  ; chemistry blood calcium, total  8.9  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  341  mg dl; chemistry blood lactate dehydrogenase (ld)  1560  iu l; chemistry blood albumin  1.9  g dl; blood gas blood lactate  5.6  mmol l$valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; insulin  42  unit ; levofloxacin  500  mg ; sevelamer carbonate  1600  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  20.9  %; hematology blood hemoglobin  6.5  g dl; hematology blood platelet count  32  k ul; hematology blood platelet count  7  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  12  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood chloride  101  meq l; chemistry blood chloride  104  meq l; chemistry blood creatinine  1.4  mg dl; chemistry blood creatinine  1.5  mg dl; chemistry blood potassium  4.0  meq l; chemistry blood potassium  4.0  meq l; chemistry blood sodium  147  meq l; chemistry blood sodium  146  meq l; chemistry blood urea nitrogen  99  mg dl; chemistry blood urea nitrogen  99  mg dl; chemistry blood calcium, total  8.7  mg dl; chemistry blood calcium, total  8.4  mg dl; chemistry blood bilirubin, total  0.7  mg dl; chemistry blood glucose  212  mg dl; chemistry blood glucose  208  mg dl; chemistry blood lactate dehydrogenase (ld)  1187  iu l$valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; dexamethasone  20  mg ; ondansetron  8  mg ; dextrose 5%  1000  ml ; 0.9% sodium chloride  500  ml ; etoposide  190  mg ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; insulin  42  unit ; levofloxacin  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; insulin  14  unit ; sevelamer carbonate  800  mg ; insulin  30  unit ; dexamethasone  10  mg ; furosemide  20  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  24.1  %; hematology blood hemoglobin  7.7  g dl; hematology blood platelet count  42  k ul; hematology blood platelet count  9  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  10  meq l; chemistry blood bicarbonate  31  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.2  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.7  meq l; chemistry blood potassium  3.7  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  148  meq l; chemistry blood urea nitrogen  91  mg dl; chemistry blood urea nitrogen  88  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood calcium, total  8.1  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  136  mg dl; chemistry blood glucose  101  mg dl; chemistry blood lactate dehydrogenase (ld)  1257  iu l; chemistry blood lactate dehydrogenase (ld)  1204  iu l; chemistry blood albumin  2.0  g dl$valganciclovir  450  mg ; dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; levofloxacin  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; insulin  14  unit ; sevelamer carbonate  800  mg ; insulin  30  unit ; furosemide  20  mg ; dexamethasone  8  mg ; posaconazole delayed release tablet  300  mg ; etoposide  90  mg ; insulin  6  unit ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  22.1  %; hematology blood hemoglobin  7.1  g dl; hematology blood platelet count  30  k ul; hematology blood platelet count  6  k ul; chemistry blood anion gap  13  meq l; chemistry blood anion gap  13  meq l; chemistry blood bicarbonate  30  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.5  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  151  meq l; chemistry blood urea nitrogen  84  mg dl; chemistry blood urea nitrogen  80  mg dl; chemistry blood calcium, total  7.7  mg dl; chemistry blood calcium, total  7.5  mg dl; chemistry blood bilirubin, indirect  0.3  mg dl; chemistry blood bilirubin, total  2.2  mg dl; chemistry blood glucose  142  mg dl; chemistry blood glucose  91  mg dl; chemistry blood lactate dehydrogenase (ld)  1095  iu l; chemistry blood lactate dehydrogenase (ld)  981  iu l; chemistry blood albumin  1.9  g dl; chemistry blood bilirubin, direct  1.9  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; levofloxacin  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; sevelamer carbonate  800  mg ; etoposide  90  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; insulin  25  unit ; loperamide  2  mg ; furosemide  80  mg ; posaconazole suspension  200  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  16.4  %; hematology blood hematocrit  16.9  %; hematology blood hemoglobin  5.0  g dl; hematology blood hemoglobin  5.3  g dl; hematology blood platelet count  33  k ul; hematology blood platelet count  6  k ul; hematology blood platelet count  5  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  17  meq l; chemistry blood bicarbonate  29  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood chloride  107  meq l; chemistry blood chloride  105  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.3  meq l; chemistry blood potassium  3.4  meq l; chemistry blood sodium  150  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  75  mg dl; hematology blood inr(pt)  1.3  ; hematology urine wbc  1  # hpf; chemistry blood calcium, total  7.4  mg dl; chemistry blood calcium, total  7.1  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  2.3  mg dl; chemistry blood glucose  175  mg dl; chemistry blood glucose  95  mg dl; chemistry blood lactate dehydrogenase (ld)  651  iu l; chemistry blood albumin  2.7  g dl; chemistry blood bilirubin, direct  1.4  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; ranitidine  150  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; nystatin oral suspension  5  ml ; levofloxacin  500  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; sevelamer carbonate  800  mg ; etoposide  90  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; loperamide  2  mg ; posaconazole suspension  200  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; 0.9% sodium chloride (mini bag plus)  100  ml ; cefepime  2  g ; albumin 25% (12.5g   50ml)  50  g ; micafungin  50  mg ; potassium chloride  40  meq ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  20.7  %; hematology blood hematocrit  22.1  %; hematology blood hemoglobin  6.9  g dl; hematology blood hemoglobin  7.2  g dl; hematology blood platelet count  18  k ul; hematology blood platelet count  6  k ul; chemistry blood anion gap  14  meq l; chemistry blood anion gap  15  meq l; chemistry blood bicarbonate  25  meq l; chemistry blood bicarbonate  26  meq l; chemistry blood chloride  108  meq l; chemistry blood chloride  108  meq l; chemistry blood creatinine  1.0  mg dl; chemistry blood creatinine  1.0  mg dl; chemistry blood potassium  3.4  meq l; chemistry blood potassium  3.6  meq l; chemistry blood sodium  149  meq l; chemistry blood sodium  147  meq l; chemistry blood urea nitrogen  76  mg dl; chemistry blood urea nitrogen  77  mg dl; chemistry blood calcium, total  7.0  mg dl; chemistry blood calcium, total  7.4  mg dl; chemistry blood bilirubin, indirect  0.9  mg dl; chemistry blood bilirubin, total  3.3  mg dl; chemistry blood glucose  180  mg dl; chemistry blood glucose  281  mg dl; chemistry blood lactate dehydrogenase (ld)  731  iu l; chemistry blood lactate dehydrogenase (ld)  814  iu l; chemistry blood albumin  2.6  g dl; chemistry blood bilirubin, direct  2.4  mg dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; sevelamer carbonate  800  mg ; etoposide  90  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; loperamide  2  mg ; iso-osmotic dextrose  150  ml ; vancomycin  750  mg ; albumin 25% (12.5g   50ml)  50  g ; micafungin  50  mg ; potassium chloride  40  meq ; sterile water  50  ml ; potassium chloride  20  meq ; cyclosporine (neoral) modified  75  mg ; daptomycin  400  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]
asian f 64 $nan$hematology blood hematocrit  20.6  %; hematology blood hemoglobin  6.8  g dl; hematology blood platelet count  22  k ul; chemistry blood anion gap  16  meq l; chemistry blood bicarbonate  23  meq l; chemistry blood chloride  106  meq l; chemistry blood creatinine  1.1  mg dl; chemistry blood potassium  3.2  meq l; chemistry blood sodium  145  meq l; chemistry blood urea nitrogen  86  mg dl; chemistry blood calcium, total  7.2  mg dl; chemistry blood bilirubin, total  3.4  mg dl; chemistry blood glucose  226  mg dl; chemistry blood lactate dehydrogenase (ld)  786  iu l; chemistry blood albumin  2.4  g dl$dextrose 50%  12.5  gm ; glucagon  1  mg ; glucose gel  15  g ; senna  8.6  mg ; docusate sodium  100  mg ; sodium bicarbonate  650  mg ; sulfameth trimethoprim ss  1  tab ; sodium chloride 0.9%  flush  10  ml ; sodium chloride 0.9%  flush  10-20  ml ; oxycodone (immediate release)  10  mg ; allopurinol  300  mg ; labetalol  5  mg ; syringe (0.9% sodium chloride)  2  ml ; alteplase (catheter clearance)  1  mg ; sevelamer carbonate  800  mg ; etoposide  90  mg ; lidocaine viscous 2%  15  ml ; morphine 0.2% oral rinse  15  ml ; caphosol  30  ml ; acyclovir  400  mg ; loperamide  2  mg ; micafungin  50  mg ; sterile water  50  ml ; potassium chloride  20  meq ; daptomycin  400  mg ; dexamethasone  4  mg ; lidocaine jelly 2%  1  appl ; hydrocortisone oint 1%  1  appl ; pantoprazole (granules for dr suspension)  40  mg ; daptomycin  500  mg ; 
chronic pulmonary edema essential (primary) hypertension unspecified place or not applicable bacteriuria fever presenting with conditions classified elsewhere unspecified place in hospital as the place of occurrence of the external cause adverse effect of glucocorticoids and synthetic analogues, initial encounter drug or chemical induced diabetes mellitus with hypoglycemia without coma kidney transplant status hemophagocytic lymphohistiocytosis other pancytopenia long term (current) use of insulin surgical operation with transplant of whole organ as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure drug-induced adrenocortical insufficiency adverse effect of glucocorticoids and synthetic analogues, initial encounter localized edema pneumonia, unspecified organism diarrhea, unspecified kidney transplant status long term (current) use of insulin thrombocytopenia, unspecified drug-induced adrenocortical insufficiency drug or chemical induced diabetes mellitus with hyperglycemia cytomegaloviral disease, unspecified unspecified place or not applicable essential (primary) hypertension abnormal levels of other serum enzymes addisonian crisis shock, unspecified nutritional anemia, unspecified encounter for examination for normal comparison and control in clinical research program underdosing of glucocorticoids and synthetic analogues, initial encounter unspecified place or not applicable other adrenocortical insufficiency nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh] other shock other specified diabetes mellitus without complications chronic kidney disease, unspecified toxic encephalopathy hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease localized edema pure hyperglyceridemia acute kidney failure, unspecified gout, unspecified other specified nutritional anemias kidney transplant status long term (current) use of insulin nonspecific elevation of levels of transaminase and lactic acid dehydrogenase [ldh]